<SEC-DOCUMENT>0000927653-22-000077.txt : 20220804
<SEC-HEADER>0000927653-22-000077.hdr.sgml : 20220804
<ACCEPTANCE-DATETIME>20220803173558
ACCESSION NUMBER:		0000927653-22-000077
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		84
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220804
DATE AS OF CHANGE:		20220803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		221133834

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mck-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:18507b8d-c172-4d9a-9fef-a030c1e6a2f5,g:26ea8e13-0c76-4471-91f9-3ae4cfe6c737,d:da37730e58094407b89f4630fc6c6b2d--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:mck="http://mckesson123.com/20220630" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV8zLTItMS0xLTE0MDUyMw_f2e5f57b-5e12-4814-89e8-de50691a964a">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV80LTQtMS0xLTE0MDUyMw_b033910c-ab02-4eb2-895a-9fdd8b07111a">03/31</ix:nonNumeric><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV8xMS0yLTEtMS0xNDA1MjM_2b4bbe69-c4b7-4b0e-89bf-c6f765cf2b4b">2023</ix:nonNumeric><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV8xMi0yLTEtMS0xNDA1MjM_71b70785-5bab-4651-b25b-57efe6c77e45">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV8xMy0yLTEtMS0xNDA1MjM_04916df7-36ed-4e00-9e9f-e05c524b0cb9">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74fd4c8aee6d4010ab7706397f856ed2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6f9902a7b234823ae104e7c4f2c65de_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5786b575ab14c9086b23a1d0e5b5366_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3438dd3f84f74a70a816f4abae28fdd4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3006488f024c45fcaf5dbd509e6c0e56_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4f241c72875e4d98bd23bb25744707d7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34daad1897684d7cb9165b77d17ca934_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc276c29bee440b1be1ec46674de1a06_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i151489c821d34264ba84b7c360fadace_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ead1497b6d497b80e44b48146936b5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65ab8217fe89483e8a1f4f965ba5729e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f0afdd8a78b4984a7c33d73ebec78e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fd9d9552a334e37b133dfa12dc23516_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae2638ed49674216b6fc56801fe2326f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i183a8c52537c45628ea1a4b23722e45c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba579ff5d35d41aea8face8b5fd431db_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1df9375c53a54770836b443aebe65d3b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa15a292151249278a75938323d1968f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i965a6647bfcc4c34af4e145de7a94e66_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb0e60dee72643d9b8f7da1912eb9d0c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc273f7fc5b247c0846600e051da1759_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5026063ddbbd426490dc361b9a57ba33_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f79f8849ffd4f6d92a5100af46ef410_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302a7aa1b388436ba21034ef5118cefb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic25a09d084d74900927f8d3b2d327f34_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib222089abc8b4a0984b44963c8a6da6c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0356030a71f4cedad29132c59391b27_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31619d5dfb2942f181793348c62fa60a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd8f1ea1e497400f8334891264c28e85_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibacc7e1f23d649749320d4f48e0caff5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bf29a8b64e74d7c8e6324067684ba02_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d4cc7ccee34f9a8a8f2544e232a63f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12ff8ccdcd1d43578af7654618f2847f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7f38fed308149759889e7a524621b45_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06e4115630544b9a8ecb71896a8d29ae_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6a849346f984ba7a24863f281ff99ca_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1257a17abb1d49209b1ecf7010d647c4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i915d93beb3944977a2b115e5a05ff593_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97688416d8624c10a48f226d71563b9e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e0da06428444108f6f30cfdedaf625_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mck:segment</xbrli:measure></xbrli:unit><xbrli:context id="i2151c060ee864dcf9cc0a315dedcb4bc_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb94994718b406dbc1a53f8dab8d938_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i184217f9158a415e9fe088348387b9e9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5d065ca8604d0bbd24e8e67b95eb01_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5150b5ddba2945abbc839f1edd5fea5f_I20210705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i8c16ef6d38344729a8077cc7cfbddb3e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d358bf2d514516969073c17eb16cab_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i966d0672f94e47d48297a66c14bc69ae_I20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i393f7b257bbf4a2fb7a4b7d3c3e8cc5b_I20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd413ff00624a0d8270f7ea278d9a55_D20220406-20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i372251adcd1648eab091c52b5f01446e_D20220406-20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc8fba8571641aeaca7afef9370cf88_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8810900c5c324fd89fbada461816423d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aac3ab068164da3a45be34214805860_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bd299c03b254bf08ef56a66adc41c05_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i160ffe77823e4333a979c33b283947f8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18e67fe7460b4e2ea12fbbd5167e3238_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41993913d47d47799af347f96dffc5fa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ca90c76b5f8423db112b3afece54ca7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6171834fcd894e66b9bdf8b9a377ecff_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf9d9c26183c4805bf511847202547f9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c025968801c4a25945836d01ed6ac95_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08861b972b284eedaa85076ea9b4829f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4d963bead34459498d2d03f537cf122_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88d93fed8d3a43138335a08e977df9ef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d022b083bbc45939920f85e12d37954_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i216779d361ff48b8b7d99ea6028d66c7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92e13fab3344b80882529369055d140_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if81042ef89a44749b328252179e501f0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e446b32652445c78cd737bf63c505d0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="icb71f08be1794969b42bcb9fbb8584e9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i555ad7eb9be24508ab277351083f8b95_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71f3011cbd3947f88570706f2746d1cd_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i97348d9c0c3c492caee0d7de4e918481_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62f4dfc0153d46679ff78f542f7e14de_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17aa11bc6b1c4164b6719d0eae227c3b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83027e4dbfea4e06a441bc5aa8dc605f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffeb32001f68497d8267ddc9ae2c0968_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64e32cd74f0c4010a3e8e787177c3aaa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d9a039d97f4e1f810d8c8939c48515_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c9753fdbc8c42afa67a387dbdc341f2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac0f191ee9524cc4a123dca1beca64b2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d41c1016b54583a7525969593331c4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1603e72ed6c4daa8b8ca5a07fbd1091_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f27ef316774f2ebcc0ec59b1f39297_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib406df4db52b4b27b436c0fc953e4a8e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79bce56293174c7db4e539b562cc2526_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e71847d225b4930bef9de929f3f2a3c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9167671dc7c472eb51af611bf7cc7e4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c30ffbc257945ba83eb82993a8be420_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b46e42465d84c47a2183912a0e10716_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2973547bb0b04222a89b6729430ffa65_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b7ea531f5944e9a9d6f976d44806d0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e7f49efd664e9eb7c79c6728a445c6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i403f9ff68d8c4127940b5ac3bf567cb2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8356415b26f44a79a7bef9dd35e8c8c6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37712c0066f64e0bb1e51fcf34f13275_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebea36d3b82e4242a79f2cb24837bf11_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56b572e5f85647c2bb4157a3e9274374_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7584d2566eb4f808e5b3c32bf252562_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e32fde2d0c74321a6ffc1d2e7fcfab3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b0754d6d499499ea1f08e091a6e4313_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0dcd0a8f12f4512a836f6114659037f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bee33b48ae745368d813bb179998562_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1884f32c95e4196b9733d13eed48df6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f5a01c7f75b4124be2e8212faabad25_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id45be366e31e4b0eb3bb557a83a956d4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aeceba0472c4993b4306ff3c946485a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93d8e3ed6e654406a8a87749f03f9693_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1e9f681efc9418e8d647ad3a6c73873_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff711db73c6f4c5e9f9a44b9edfa2c8f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i964e360bb5304a7a91cbb307fe41a400_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc091ee1ba943d9bd16e2df30bb21cb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if32ca5071eb44a8fafb2dc2af15d5f2a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4cd5447a107486e8828badac335b9ea_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b43926998845dbb130d523377325ab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3167bf1182f948fdba7729ff76cf27b3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfe85e7a9b641a78490906855cf69b3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a0b0abcd2744a1582bac3909196080c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6328397e5e846f2926603d07bf5629f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565074a91efd4e2baba451998e9fe4e9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafef158a41cf4048baa5a93cb0b6620d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b7fb8d52da24328b8964b016e0c3351_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab1fe3e771e4795b92c3519d4aa2a57_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9575f4f1c94440dbcd550e774d94cf2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1c01fc67d7d4672a61f5062adaa04d9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c6e596876c14eceb35218c7197c764c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24aabefa576e4aa09449e0603fd27472_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0e935c6a9174c0198aeceebe6d8008b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb8a57a80a64603b803e2b679fdc63b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3d0ea03571840b0b0defd993f65540b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaac3251871f54afb9e05a2dd9845dd86_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8e2051458de4ca3b3ff972dc1e5df47_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i466138b603084d54be88ad1a34567c8b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i752a8a7f16074f689ee9d1b4892d270f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2166a8ac1e96401c8f1600c898c367ac_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb8a1defb0594686a254e66fc7830f7d_I20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7e42ec92f674a79afbd81e8fb750262_D20190925-20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-25</xbrli:startDate><xbrli:endDate>2019-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib12270524a7b4cc6b7b87975f0b31013_I20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce62c7971874b97a640c6606962ea01_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icefd77afd24c4487924437959cfe8fbc_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece544191d5240e3b1283537222c41a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044fe80187ac47b3b779f3f5fa0c3a15_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3341b4ea67b4eb1bfc0be50fbf79480_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:CommittedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8185c82e2434a0c84ff562df7ae24ab_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:UncommittedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03515862174f44c7b695b85111ea920d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec54ae004102491b9606ef01cb1fdf20_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ae8a14adb19498bb9dded3088ccc4a5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98edbf2764e9413891b48258d46b8d5a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd567c67685b42aba4f0f9ef5b214c07_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d909bc2a8994f798b89f3084cf96826_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8767bea4ed9b4241b64e9c77192c274d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51ae381b635041b2a03df829498f103d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i695dd9f4cbbd46edaa4b764478844aa6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1628a1ef0d3b482691b8aa3e61736647_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24e204f409be4b29a94900362c7cef4e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3254c69cbee481f97c6743efa9150c3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6f9d6fa7ca7441e8a4987577b13651e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2af5ce20fb04be99d4d91c3837262bd_I20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ebb607246c4e2991322746c42fa818_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic770e7e260c6494e91714f00ee4061af_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9200147039b4d23906d2205705299fd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="ic0f94a4fe40647dcad8d868e1ecf16d5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2122223b4e24f6a94b2791de320374a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaedc0e4a45e442fa6d6beac1dcb1ca9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i727c52e939144af4b31c1f88bc2836cc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4a2f796909a429daa27355e79f80ddd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i864b745cf60843c5aaf96b4cc4f1a217_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5d560c2041344ab9c85f9e013cc904f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66b4897d62c94e129073ebc6630ec481_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ef45188f1b4c4fae080a330a7456bf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedcceae98f1745c18c291607c35f1154_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7abd9fb0b51412e99b4001e9c3d02c3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib695670fac054a96998413f0f81621bf_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0d302cd168e4ac5b3e8c93a2b801655_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf70302177a746cfb31a8c813fc9e576_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2567e9d256a74d91967a6dcec0897b06_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614af20eb8bf45108edd1be8b5e30eb7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic93afc9722af414ebd768788768bc773_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1d25f973adc48d18bbace1d7f69620e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06c2da02d95474691982974e55aa7cc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae6d3027e7b40d19a5f999387bb5a94_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7702e8b3e0242449e9281863062b488_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c492e20719648568963f8577647d24f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4228622f82ae4dcd8f033204a9968b56_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f56ba1a598a4a829b10b8749df60caf_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f0747ce2512401a84d2048c76eb4934_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf4b0c9f108245a0ab670e3765ab193c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2ebfdac84e4abbb90a1e8f5ae7e490_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6628b987433540f19ebb8c735161874b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0efcc5cada804b01af7a7152f7f15ce1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9dcecf8036248a0a44938b3a51b3d54_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic42ce3a7a52742d682e55d121a735789_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe98279f3daf4cac829f141c68680c29_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="distributor"><xbrli:measure>mck:distributor</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:context id="idd41c4e1c30c44259a7ba92d433dfc8a_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia25c48fcadfa411c87b9b338ed7c17cf_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91fd5b95930f48feafff5e007780cca1_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfAlabamaAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>mck:installment</xbrli:measure></xbrli:unit><xbrli:context id="i7cce7634359c49e6bb6d0498ed0e65cb_D20220503-20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-03</xbrli:startDate><xbrli:endDate>2022-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib624e26e3984429eb8c566e69a33ac6a_I20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6347fef3d684c6884e7d1d8b83e0f28_D20220503-20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-03</xbrli:startDate><xbrli:endDate>2022-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5af3b3c7d04f4b9061d24c01dfc96a_D20220627-20220627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-27</xbrli:startDate><xbrli:endDate>2022-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c5c1f1d6da349fcbcbcc5d4ee10b2db_I20220627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c9164e71857427a9e3f6fb313e6f958_D20220705-20220705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-05</xbrli:startDate><xbrli:endDate>2022-07-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic78671dfdbde4f1da51669767a156413_I20220705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88b0d90d6afe4e72801e173856f8f730_D20220705-20220705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-05</xbrli:startDate><xbrli:endDate>2022-07-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dd43cb0b7cc4ad7a6b61b07881c8a2a_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49d09f3e82e04ef68ecb9c2396cd73c1_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie80fd48f4e8d4c678b4ce9cef44086f1_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f19aed3491848fe9a6318bd365640c4_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib15c8902459948b8800a989e5b1ee1ab_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b65fe316bc46c7a65913e0e73468b4_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55b70e47e8e34b20ab513c75c1bd8f1a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibacb5dc687fb421890cdd8812f84593a_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785cd0fca728419db26ae24ee9b6d389_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc26f3e4e9d14faaaf590fbb3e98fd58_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib182ad32ae1a4140ba81d1576ebb67fd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndStateOfAlabamaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1aa40a3d3642ff855da782b897135b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndStateOfAlabamaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ca6a0d3d4048d7928d1ed7a412b532_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="i583c48262f76490389c5bfa859e9c30c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf2512ace2434b2992e2e25b1b514696_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefa43f959af643fa81156301548309e0_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d1725cc0bf34e1b9b6258af7a6286da_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia156720ce72f43da8c988dd169e9286f_I20190813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="faxnumber"><xbrli:measure>mck:faxNumber</xbrli:measure></xbrli:unit><xbrli:unit id="fax"><xbrli:measure>mck:fax</xbrli:measure></xbrli:unit><xbrli:context id="i95823add3af04d3eb3962971d102762c_D20220427-20220427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-27</xbrli:startDate><xbrli:endDate>2022-04-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa5a8bf25a1c492f8877a4d52f7a8892_D20191209-20191209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-09</xbrli:startDate><xbrli:endDate>2019-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="city"><xbrli:measure>mck:city</xbrli:measure></xbrli:unit><xbrli:context id="id32341657ec2405d904a9a2b92c4f261_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9db5a1c9a3b4448b90e7d790fddd929_I20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:OpioidStewardshipActStateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:OpioidStewardshipActStateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5b8f534c4f94a2286245c2844a0b617_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:OpioidStewardshipActStateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="iae2bcb78271948b4a1ebf3f41dcd15bf_D20220630-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifef2c199d98e42be9e9661e3aba687b3_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c0920ece63d40bcb5b7571d38f78484_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2221b7fadd8a4d1f9694fd8e401e6039_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04054837ec0342f9b8450625e682723a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6d27ffef9104861bb0e13a1caea6f92_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i142d11dab4f1472296e0e34a0a568a1c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae923b8233e9431eb94789aba9fc18b0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i778742d22ea2469ba0d763c4abaf0a0e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c3f3f9cc2a4fe5809c48e5837aa33b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia153c233c3224f40b8bee60f5ca03330_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3b36ae57df4556b852d256a5051b7c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i834def9396054b11a7467a8892ddc33e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i826edda2198046dba4823c7a7d93044e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0586dbdd097949bc84d2b6538b7c21a1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibea2a408cb5143869cd6f99a7f554856_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8f74d47337f44069d4abbae67a7e76f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i812bd8eaa6f848db94fa9829cb892c51_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37c280e5ed9e46c793e2b72e48c5aa9b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48723ecc89164f63a596685462e8682d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a1ba08501874acda7d8038964225375_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb860711704471396b6ab18f5a00a89_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f48074346a94363895ed8e84a8026ab_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4499ac651c794efc9fddcb3b54af3036_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7db9df2543f7470aae07e22c69f7fa2a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>mck:product</xbrli:measure></xbrli:unit><xbrli:context id="i2c6e06d925d44f989655a7673bdde907_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>mck:country</xbrli:measure></xbrli:unit><xbrli:unit id="business_operation"><xbrli:measure>mck:business_operation</xbrli:measure></xbrli:unit><xbrli:context id="i5de3e5bddea84662aeab82793750ac17_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1577c607c8ab49f392ecdd91decbed0f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4001c0764b641b489a0e6a821b1bc2a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb05392f0a4c4daea446534a262c49ce_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac647f2ab1ea4e1aab5af149078db642_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aebb076b6b54144a3cd96e1ece30f3b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i507200d519254ee5b810cc4ba9c9eb26_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2177f40437f42b6809296d7905c7869_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cd60915c3dd465caaf23b140f67daf3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4588d9a710614530af4777a0d6ec981e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6158e4d86384dd3835014e2ff918ab3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cb66cdf2011438e8e70e27b549a9862_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9d7a308dd141549bede7bfa3e5cbf0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ida37730e58094407b89f4630fc6c6b2d_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;           &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQx_deec14c3-1b69-4420-aac5-c8d49174f832">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzAwNTY0MmRkMWM3NGM1Zjk0YTdjYTAwN2UyZDk3MWUvdGFibGVyYW5nZTo3MDA1NjQyZGQxYzc0YzVmOTRhN2NhMDA3ZTJkOTcxZV8wLTAtMS0xLTE0MDUyMw_aeb453af-fcd1-4435-bfe3-4c136cfe6e75">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8zMjk4NTM0ODg1NjUx_17a322ae-4842-42fe-b946-f397b749bd7f">June 30, 2022</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6MTVkODI0NWNkMDAzNDBhMzg4ZDczOGMyZjhiOTYyMzYvdGFibGVyYW5nZToxNWQ4MjQ1Y2QwMDM0MGEzODhkNzM4YzJmOGI5NjIzNl8wLTAtMS0xLTE0MDUyMw_639c6eef-0014-488d-ab23-bab8af914036">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTM2_197cd679-55b7-401c-b8f0-6696eb6ce8c3">1-13252</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><img src="mck-20220630_g1.jpg" alt="mck-20220630_g1.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:196px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQy_5e3e4d7c-e625-4bf4-a0cf-c845c0e81fb1">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NDQwYmIzMDNjZDg3NDQ5MWI5OTM2YjIwMDQ3OWU0MGQvdGFibGVyYW5nZTo0NDBiYjMwM2NkODc0NDkxYjk5MzZiMjAwNDc5ZTQwZF8wLTAtMS0xLTE0MDUyMw_69ea231e-6bf8-4c55-bcf6-e1a52e176465">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NDQwYmIzMDNjZDg3NDQ5MWI5OTM2YjIwMDQ3OWU0MGQvdGFibGVyYW5nZTo0NDBiYjMwM2NkODc0NDkxYjk5MzZiMjAwNDc5ZTQwZF8wLTItMS0xLTE0MDUyMw_c624b6b5-845e-490c-9f96-ddefbe77d6f3">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQz_47e238b0-cb8d-49ea-a778-8f57bac24443">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTM3_334d0e46-32b9-4f58-b28c-8396351bf8fd">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTM4_a5f11564-68bb-4f23-9f43-2b6b7d72f352">TX</ix:nonNumeric> <ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQ0_59b6660e-6395-4730-93f4-b6055c0a59cf">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQ1_82b2cafb-61b7-4bb9-afdf-37a66de0a60d">972</ix:nonNumeric>) <ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQ2_85ba6238-0291-4163-9fae-4e1ad49d276d">446-4800</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i74fd4c8aee6d4010ab7706397f856ed2_D20220401-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8xLTAtMS0xLTE0MDUyMw_569819e1-fc16-452f-9eee-12cdd85c7ed6">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i74fd4c8aee6d4010ab7706397f856ed2_D20220401-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8xLTEtMS0xLTE0MDUyMw_09c258d8-7b83-4be0-8c2a-4dbf4007bbde">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i74fd4c8aee6d4010ab7706397f856ed2_D20220401-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8xLTItMS0xLTE0MDUyMw_44ad49fe-3de9-4a6d-89c5-36b367cdc95b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id6f9902a7b234823ae104e7c4f2c65de_D20220401-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8yLTAtMS0xLTE0MDUyMw_4dffdad2-63a5-490b-ad04-20a77a16d068">1.500% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id6f9902a7b234823ae104e7c4f2c65de_D20220401-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8yLTEtMS0xLTE0MDUyMw_0d864f7a-4e96-4738-bdfe-0fb27030d509">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id6f9902a7b234823ae104e7c4f2c65de_D20220401-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8yLTItMS0xLTE0MDUyMw_c8b99359-f282-4bcb-869f-e3ff39c6a047">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib5786b575ab14c9086b23a1d0e5b5366_D20220401-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8zLTAtMS0xLTE0MDUyMw_3a5aaaac-67c7-48ac-82e8-898219bfcf4c">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib5786b575ab14c9086b23a1d0e5b5366_D20220401-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8zLTEtMS0xLTE0MDUyMw_2eb5d1f9-5831-4ce5-85cf-8cd41598a7a6">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib5786b575ab14c9086b23a1d0e5b5366_D20220401-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8zLTItMS0xLTE0MDUyMw_53166bbe-9ab4-4b10-a40e-b72ef2798e3d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3438dd3f84f74a70a816f4abae28fdd4_D20220401-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF80LTAtMS0xLTE0MDUyMw_1ae6ef01-57f0-47e8-8e42-8243ac29ce44">3.125% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3438dd3f84f74a70a816f4abae28fdd4_D20220401-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF80LTEtMS0xLTE0MDUyMw_09d98b70-54ad-4383-9ce3-846b4f08f7bc">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3438dd3f84f74a70a816f4abae28fdd4_D20220401-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF80LTItMS0xLTE0MDUyMw_2f2eaa88-44cf-4aeb-a949-0111ad55b30c">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQ3_6dcb8bc9-e178-48bf-bbcc-7f8a9c785e6b">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQw_eb17c891-eb18-4aac-9d15-56f28b1fd800">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:29.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6MjUwMzUzZWU2MmJkNDFlN2FhNTBmM2E2NDI4ZTE0M2MvdGFibGVyYW5nZToyNTAzNTNlZTYyYmQ0MWU3YWE1MGYzYTY0MjhlMTQzY18wLTAtMS0xLTE0MDUyMw_e19ea9e1-e850-4a28-bf5b-37a6de72897a">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6MjUwMzUzZWU2MmJkNDFlN2FhNTBmM2E2NDI4ZTE0M2MvdGFibGVyYW5nZToyNTAzNTNlZTYyYmQ0MWU3YWE1MGYzYTY0MjhlMTQzY18xLTYtMS0xLTE0MDUyMw_e4bf7514-94e2-4fb2-a434-3b4bf76af48d">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6MjUwMzUzZWU2MmJkNDFlN2FhNTBmM2E2NDI4ZTE0M2MvdGFibGVyYW5nZToyNTAzNTNlZTYyYmQ0MWU3YWE1MGYzYTY0MjhlMTQzY18yLTYtMS0xLTE0MDUyMw_8cf38ec0-bb85-482e-bac5-283b014f4d38">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTM5_a56a8775-3ee6-4651-91a7-b78a9ca4f89e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date. <ix:nonFraction unitRef="shares" contextRef="i3006488f024c45fcaf5dbd509e6c0e56_I20220729" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMDcw_6990d18f-73dd-4346-8497-eb9fe4f031bc">143,730,455</ix:nonFraction> shares of the issuer&#8217;s common stock were outstanding as of July&#160;29, 2022.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_10">PART I&#8212;FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_10">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_13">Condensed Consolidated Statements of Operations for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_13">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_13"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_13">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_16">Condensed Consolidated Statements of Comprehensive Income </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_16">for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_16">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_16"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_19">Condensed Consolidated Balance Sheets as of </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_19"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_22">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_22">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_22"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_28">three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_28"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_28"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_28">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_31">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_31">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_34">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_34">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_37">Note 2 - Held for Sale</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_37">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_40">Note 3 - Restructuring, Impairment, and Related Charges</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_40">, </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_40">Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_40">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_43">Note 4 - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_43">13</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_46">Note 5 - Redeemable Noncontrolling Interests and Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_46">13</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_49">Note 6 - Earnings </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_49">(Loss)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_49"> per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_49">14</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_52">Note 7 - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_52">15</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_55">Note 8 - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_55">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_58">Note 9 - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_58">18</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_6597069767980">Note 10 - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_6597069767980">18</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_64">Note 11 - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_64">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_67">Note 12 - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_67">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_70">Note 13 - Stockholders&#8217; Equity (Deficit)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_70">27</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_73">Note 14 - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_73">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_79">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_118">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_118">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_121">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_121">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_124">PART II&#8212;OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_127">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_127">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_130">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_130">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_133">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_133">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_136">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_136">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_139">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_139">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_142">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_142">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_145">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_145">52</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_148">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_148">53</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Financial Statements.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div id="ida37730e58094407b89f4630fc6c6b2d_13"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMi01LTEtMS0xNDA1MjM_213c2ed9-3b00-427d-bd77-bb60bb51d2ec">67,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMi03LTEtMS0xNDA1MjM_1795ae78-8c60-49a9-8162-a4f1955a15dd">62,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMy01LTEtMS0xNDA1MjM_3b252648-dbe1-4f7c-8b4e-b22bedf39af4">64,131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMy03LTEtMS0xNDA1MjM_2e2582b3-f667-4862-bead-354e5097ff48">59,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNC01LTEtMS0xNDA1MjM_81fcd0f8-6053-4113-8120-2a96e86e45f8">3,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNC03LTEtMS0xNDA1MjM_10f5766d-b90b-4a3e-979c-25056c3c8d76">3,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNS01LTEtMS0xNDA1MjM_c106f105-f413-4c05-8510-f64e95c51f86">1,959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNS03LTEtMS0xNDA1MjM_a1de24aa-828c-49c4-8866-3284d403666b">2,232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNi01LTEtMS0xNDA1MjM_4ac71133-0928-4f1f-aa6d-2ca0e87b3732">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNi03LTEtMS0xNDA1MjM_38d34740-1f48-442c-96ee-c6ebde4fdada">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfOC01LTEtMS0xNDA1MjM_c56da72f-f301-4793-a66a-77863a31078f">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfOC03LTEtMS0xNDA1MjM_312dbb9a-2a20-4958-9cdd-6c6577f496a4">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfOS01LTEtMS0xNDA1MjM_e12bc96a-955f-43e5-a97e-e097772f4bb2">1,987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfOS03LTEtMS0xNDA1MjM_3f31c55d-0a37-454b-855c-e62f18d89979">2,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTAtNS0xLTEtMTQwNTIz_8eb15c95-65f6-444e-b977-da4cbe0eb839">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTAtNy0xLTEtMTQwNTIz_2eaf40da-4081-430a-a70a-21b9c32143e1">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTEtNS0xLTEtMTQwNTIz_c5ca3430-506a-44d6-aa09-0d57c402ef27">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTEtNy0xLTEtMTQwNTIz_c33db36b-1570-4595-b371-95996fb6e0e5">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTQtNS0xLTEtMTQwNTIz_0d3cebc3-e180-477d-9132-3d1052820771">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTQtNy0xLTEtMTQwNTIz_8233dce3-1b5e-4788-98b3-d2831c9e7132">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTUtNS0xLTEtMTQwNTIz_bda3ce93-aafa-4b79-bf8e-cb44531910df">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTUtNy0xLTEtMTQwNTIz_0027ecce-6a95-4ebf-9f52-45b94f53d938">562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTYtNS0xLTEtMTQwNTIz_281843c7-fa17-4408-bf70-4c788979b286">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTYtNy0xLTEtMTQwNTIz_677a6a68-6a8c-4773-96dd-43100e2858a0">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTctNS0xLTEtMTQwNTIz_f95fc791-0b42-4987-8187-5e43959fddd7">807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTctNy0xLTEtMTQwNTIz_39fd911e-4915-4743-965b-a0f67095efb0">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTgtNS0xLTEtMTQwNTIz_5aeb7b74-a6b3-4096-817e-25a18c2d4c4f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTgtNy0xLTEtMTQwNTIz_e93678aa-0d4c-455e-b242-6c9727802bed">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTktNS0xLTEtMTQwNTIz_f1fcbf25-e9a9-47c8-86e3-4ea95d36fd43">809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTktNy0xLTEtMTQwNTIz_f1f2ec39-4da5-4730-acf2-8f78c33d5104">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjAtNS0xLTEtMTQwNTIz_9631025b-9053-41c5-bffb-da75e20ef3a3">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjAtNy0xLTEtMTQwNTIz_4bb7d894-4bf1-4ebb-84cf-67ab8bfc4326">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjEtNS0xLTEtMTQwNTIz_74cb5243-0ba2-40bd-994c-3319892664f1">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjEtNy0xLTEtMTQwNTIz_62e26a7c-2865-47c3-847b-9bf4a2e454c4">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjUtNS0xLTEtMTQwNTIz_1da48506-699e-4b31-bb6a-05bb39562d1b">5.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjUtNy0xLTEtMTQwNTIz_25de7533-0be1-472c-a952-87fd18456291">3.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjYtNS0xLTEtMTQwNTIz_1d806951-f367-486f-a687-90f6f0cbb3db">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjYtNy0xLTEtMTQwNTIz_7d0777b9-52e7-4704-8e16-81c92827b817">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjctNS0xLTEtMTQwNTIz_369fb0a8-869b-4b25-a824-6183131388b7">5.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjctNy0xLTEtMTQwNTIz_cbbb01d0-39be-4ecf-a80e-9acda2ceb51b">3.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjktNS0xLTEtMTQwNTIz_22f17d06-c9a1-4e82-b439-421748631e83">5.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjktNy0xLTEtMTQwNTIz_633be044-61bc-4ff4-b0fa-605bd433d58d">3.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzAtNS0xLTEtMTQwNTIz_4fa3ed2f-2fe7-4674-b255-b84bce879acb">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzAtNy0xLTEtMTQwNTIz_5045aefc-52bc-4cc0-984a-24283a36b234">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzEtNS0xLTEtMTQwNTIz_5bbc5452-2d21-44ad-8bcf-df6321c61561">5.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzEtNy0xLTEtMTQwNTIz_ca0db8e0-a6bf-4567-811b-a3ef4776a9d7">3.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzQtNS0xLTEtMTQwNTIz_e7252a97-1ac5-4274-8256-133f25f466bc">145.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzQtNy0xLTEtMTQwNTIz_2f79ec5b-4399-4aa5-a847-3c660b496e0e">158.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzUtNS0xLTEtMTQwNTIz_eeb6a170-05f0-45ca-b0cf-2312958dbc06">144.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzUtNy0xLTEtMTQwNTIz_e78c3a01-9784-47ee-a40e-d7244d1c69e9">156.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMi01LTEtMS0xNDA1MjM_6e9399fb-6110-4dab-a790-f96d1dc7b912">809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMi03LTEtMS0xNDA1MjM_b611828e-324e-4ea8-8c42-d1c74c308952">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNS01LTEtMS0xNDA1MjM_8a05d4cb-7ac6-441b-b44f-23f4eb9af852">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNS03LTEtMS0xNDA1MjM_49b28b76-f9af-4917-8314-95db496cdac6">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains on cash flow hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNi01LTEtMS0xNDA1MjM_b6840a72-013e-4c00-a294-57e06649cbca">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNi03LTEtMS0xNDA1MjM_b5c0279e-57e8-457b-8c1d-0e15bbf213ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNy01LTEtMS0xNDA1MjM_f9022c2e-e8d4-4398-9936-d1ecebf12a3e">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNy03LTEtMS0xNDA1MjM_074c9c18-3658-4225-81a2-7961172b284e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfOC01LTEtMS0xNDA1MjM_c2819c7a-60c0-41ed-a1ef-a99396b3c09d">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfOC03LTEtMS0xNDA1MjM_43fa290e-23e8-48c8-bfd1-191f390a09c4">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTAtNS0xLTEtMTQwNTIz_e5fae243-0e40-4cb9-92ad-6dae58085938">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTAtNy0xLTEtMTQwNTIz_e519534f-370e-4a16-a569-9c922205cd89">559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTEtNS0xLTEtMTQwNTIz_c5674d90-e7a5-48be-8b5a-a997c72ddaaf">91</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTEtNy0xLTEtMTQwNTIz_706ebb80-6005-4e5b-94d6-c000b951cbed">50</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTItNS0xLTEtMTQwNTIz_72950f41-90f9-46fc-8b1c-a52cf612ba92">1,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTItNy0xLTEtMTQwNTIz_15861498-1ec0-434e-9412-700b5c1b89fb">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMy0xLTEtMS0xNDA1MjM_b54b676c-54ec-42bf-8fbd-c7fc8f921086">2,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMy0zLTEtMS0xNDA1MjM_9cdbbb77-89dd-4b13-9dcb-71b3919d2fc4">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNC0xLTEtMS0xNDA1MjM_c9f3c55c-fad6-4d8f-be2c-bad063a186de">19,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNC0zLTEtMS0xNDA1MjM_13383178-5ef5-4bdc-afcb-5143ef1969a2">18,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNS0xLTEtMS0xNDA1MjM_3e2d4da8-a83a-44fe-a7e2-89f714f975d2">19,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNS0zLTEtMS0xNDA1MjM_fe246cc1-b86f-4826-86c7-a4de1b3ab554">18,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNi0xLTEtMS0xNDA1MjM_a88f18d7-c03b-43dc-b5bc-b6da78b2a567">3,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNi0zLTEtMS0xNDA1MjM_59a1e127-a781-4585-866c-01bd284bd329">4,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNy0xLTEtMS0xNDA1MjM_1b569a28-dc8a-480f-ada3-c36a626b0bcb">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNy0zLTEtMS0xNDA1MjM_617d279b-4c0c-4524-b4b2-17508da65c7c">898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfOC0xLTEtMS0xNDA1MjM_8aeeccbc-58f6-497b-ba85-e6bb1da96e77">45,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfOC0zLTEtMS0xNDA1MjM_6648f122-6eff-4085-8147-e3ed015dc31c">46,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfOS0xLTEtMS0xNDA1MjM_7e2d13c2-c39b-4dd6-887c-cc97eb30dc77">2,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfOS0zLTEtMS0xNDA1MjM_37f2b384-bc51-428f-a899-4d73ed997b44">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTAtMS0xLTEtMTQwNTIz_5ada50d0-0a41-49aa-9d8d-25a4b84005b3">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTAtMy0xLTEtMTQwNTIz_b8ddcf81-6a7a-43a1-bee2-fb530b9787f7">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTEtMS0xLTEtMTQwNTIz_9ed19517-e073-4875-a672-a509a35092f0">9,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTEtMy0xLTEtMTQwNTIz_28835702-79e8-4dae-9809-078334150e00">9,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTItMS0xLTEtMTQwNTIz_0692e9e1-4003-4a7d-8e06-8853af388bd1">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTItMy0xLTEtMTQwNTIz_0107f239-040e-4fc7-b794-ee971fbe447d">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTQtMS0xLTEtMTQwNTIz_9a22262d-0138-4731-8dc4-60a0bd8143a3">1,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTQtMy0xLTEtMTQwNTIz_85978cc5-f80d-475f-8be5-66568ab8dc75">1,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTUtMS0xLTEtMTQwNTIz_567ad466-838b-4a45-9e6a-2210719de08f">62,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTUtMy0xLTEtMTQwNTIz_d874a62a-8e8f-43f9-a263-c8fbaf9ce754">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND DEFICIT</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTktMS0xLTEtMTQwNTIz_1ec8cb1e-407d-40dd-a6cc-74453ccaad2d">39,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTktMy0xLTEtMTQwNTIz_69948100-e4a5-4371-84e2-f67f2f7d28da">38,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjEtMS0xLTEtMTQwNTIz_a66dcce2-bcc5-45e6-b0fa-3b0cc03b9f4c">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjEtMy0xLTEtMTQwNTIz_4ec8e9e0-275e-43cc-8307-3618d3b8305b">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjItMS0xLTEtMTQwNTIz_23e9358d-1c40-420d-8360-d34eacedfe73">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjItMy0xLTEtMTQwNTIz_5beeafa9-8945-4b06-8669-b91f21ec70ad">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjMtMS0xLTEtMTQwNTIz_bc99830f-6acb-4b0d-92d5-4bccd3dadb75">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjMtMy0xLTEtMTQwNTIz_7803dbf4-2851-4723-b3bf-8362729e8c6c">4,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjQtMS0xLTEtMTQwNTIz_5b8831f0-9da4-4bf2-966c-161fbaed017b">4,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjQtMy0xLTEtMTQwNTIz_6552751e-eb40-4f4b-bd1a-559e0b81ed06">4,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjUtMS0xLTEtMTQwNTIz_c4f6a45c-c6a4-4a1d-9139-78e1e802d3a5">47,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjUtMy0xLTEtMTQwNTIz_d2ae62dc-c25e-4093-bee4-9d7375511a1c">48,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjYtMS0xLTEtMTQwNTIz_73205358-ce3a-433a-8e61-2e83f1ee730f">4,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjYtMy0xLTEtMTQwNTIz_264a60a8-9502-4dc4-a8da-3924416e9d39">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjctMS0xLTEtMTQwNTIz_df54459f-8d0a-4ae2-814d-ed6586732ea5">1,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjctMy0xLTEtMTQwNTIz_aaf21053-1589-4488-b817-661cece08972">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjgtMS0xLTEtMTQwNTIz_50bcdaa1-17e4-4baa-9381-6641f201ae87">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjgtMy0xLTEtMTQwNTIz_b52161de-ed6e-4723-b864-b46111eece08">1,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjktMS0xLTEtMTQwNTIz_b2b2f38a-ad64-4581-b256-a12c329de294">7,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjktMy0xLTEtMTQwNTIz_bfa5acda-7ea7-47a0-bf2e-f0f546a44b9a">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzAtMS0xLTEtMTQwNTIz_9ab10e1a-4871-4619-ad37-86962a2c356f">1,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzAtMy0xLTEtMTQwNTIz_16ad14eb-a8fc-485d-80aa-81395ba09aa3">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfMjE_283e2be5-a095-49fe-befe-f39664ff5fb6"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfMjE_fe528565-0b67-4f6d-8c89-b3cf68d2dbba">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfMzU_7796a514-c91f-4754-92ba-999be08c42fb"><ix:nonFraction unitRef="shares" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfMzU_db45f0df-3271-4dec-849e-4c08387264aa">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfNTc_46eff81d-d708-462d-ad44-4f6846fa2ae9"><ix:nonFraction unitRef="shares" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfNTc_70b5663e-2d04-453d-8156-f23f8a7b9e09"><ix:nonFraction unitRef="shares" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfNTc_d3bffe25-5a31-4d02-a7dc-ee04aef85a85"><ix:nonFraction unitRef="shares" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfNTc_e3114b95-e836-4972-b005-a1208edfbafb">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMS0xLTEtMTQwNTIz_7d02d9a6-d197-4b9a-b502-dfa75d1b6192">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMy0xLTEtMTQwNTIz_cffcba4a-33df-439f-85d6-840a1f4c3173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfMTg_934bf147-6a3f-4914-9fe5-a2522ad8a0e1"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfMTg_e3d5ac4b-44b0-447d-b178-6fd4c0e043c3">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfMzI_24ccafe8-2b08-4863-89ad-841ef6f81d62"><ix:nonFraction unitRef="shares" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfMzI_5114a3c0-4456-4311-badd-794e3ad469f1">800</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfNTc_7ac43b6b-f68c-424c-8195-fd4cbcc5560f">277</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfNjQ_943b6758-6784-4dd9-be9e-34412f24d76e">275</ix:nonFraction> shares issued at June 30, 2022 and March 31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMS0xLTEtMTQwNTIz_cbaae212-2e17-45fb-bbd6-e52139ca4170">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMy0xLTEtMTQwNTIz_3931ef09-7c7c-40b6-b15c-0ba7c96a03ef">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzUtMS0xLTEtMTQwNTIz_886cd743-bb59-44b3-85d7-1e9d8064230d">7,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzUtMy0xLTEtMTQwNTIz_79cbda3b-bf96-46b6-b488-0e40aa5757fa">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzYtMS0xLTEtMTQwNTIz_7e134c48-9223-4932-b261-3825bac709c4">9,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzYtMy0xLTEtMTQwNTIz_798169b7-7f47-4648-93b2-2b4513a24620">9,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzctMS0xLTEtMTQwNTIz_a6c0c820-2692-4074-92b0-560f8573f8b3">948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzctMy0xLTEtMTQwNTIz_7dd0d0ec-94c8-4505-885a-a214d4e240f2">1,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzktMC0xLTEtMTQwNTIzL3RleHRyZWdpb246M2Q1MTdkNmFiMDYwNDI3NmI2MTZmYWI3MjA5YTFhMTlfMzA_1b506d7c-69c9-47f3-a6f8-410b6f79d6e3">133</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzktMC0xLTEtMTQwNTIzL3RleHRyZWdpb246M2Q1MTdkNmFiMDYwNDI3NmI2MTZmYWI3MjA5YTFhMTlfMzc_276ae702-b66f-4a76-bcda-c74e1297d006">130</ix:nonFraction> shares at June 30, 2022 and March 31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzktMS0xLTEtMTQwNTIz_73549f85-85c6-4b9f-a13b-0ef75c930044">18,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzktMy0xLTEtMTQwNTIz_a4a966ee-8fac-4e94-b0e4-18b8b69aaa10">17,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDAtMS0xLTEtMTQwNTIz_cbb6b199-05be-4544-b405-4456b35dab9f">2,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDAtMy0xLTEtMTQwNTIz_47c49cc5-c4b6-4624-9730-1c168ff338dd">2,272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDEtMS0xLTEtMTQwNTIz_5d7a28aa-c106-4380-957c-5b7d5cb7109a">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDEtMy0xLTEtMTQwNTIz_37b2a48a-d73c-4728-950a-212458572da3">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDItMS0xLTEtMTQwNTIz_0a383910-9fda-41e8-a9e0-50b3303c983e">1,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDItMy0xLTEtMTQwNTIz_c0970d07-5b64-4483-9b97-0607167c31a6">1,792</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDMtMS0xLTEtMTQwNTIz_097f36bd-1cc4-4687-93aa-5e448312d9b1">62,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDMtMy0xLTEtMTQwNTIz_956ccb2c-cb60-451d-b7e7-188947ad8c48">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Deficit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:19pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34daad1897684d7cb9165b77d17ca934_I20220331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xLTEtMS0xNDA1MjM_54b9b326-b8f1-46bd-8065-5a9d1f6426ad">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34daad1897684d7cb9165b77d17ca934_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0zLTEtMS0xNDA1MjM_15254d67-c27f-4522-9734-7005f0830458">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc276c29bee440b1be1ec46674de1a06_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy01LTEtMS0xNDA1MjM_a6820f96-f354-44c9-b51f-a67137404d31">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151489c821d34264ba84b7c360fadace_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy05LTEtMS0xNDA1MjM_6e9cb05a-2689-4e72-ac78-2a1a305035f1">9,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ead1497b6d497b80e44b48146936b5_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xMS0xLTEtMTQwNTIz_6a137951-2f3f-4d70-8ef9-259c35706f8e">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i65ab8217fe89483e8a1f4f965ba5729e_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xMy0xLTEtMTQwNTIz_76ccd318-c7d0-4b9f-9b16-841f960abba3">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65ab8217fe89483e8a1f4f965ba5729e_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xNS0xLTEtMTQwNTIz_f00f8066-86c3-4c28-8d17-88107579cbf3">17,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0afdd8a78b4984a7c33d73ebec78e1_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xNy0xLTEtMTQwNTIz_7224e876-4d1c-44c6-bdc6-34f36c4dcfc7">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xOS0xLTEtMTQwNTIz_98f6dfea-8823-416d-bac9-24b190634f16">1,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8fd9d9552a334e37b133dfa12dc23516_D20220401-20220630" decimals="-6" name="mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC0xLTEtMS0xNDA1MjM_f87f7266-87f6-4048-989d-f7948c3ac924">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd9d9552a334e37b133dfa12dc23516_D20220401-20220630" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC0zLTEtMS0xNDA1MjM_d3ffcba5-e3a6-4f14-b6be-c4c4f42c62e3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC01LTEtMS0xNDA1MjM_a0a39bbb-0031-4f4a-b3e7-da5706f79884">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae2638ed49674216b6fc56801fe2326f_D20220401-20220630" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC0xNS0xLTEtMTQwNTIz_5767788b-eb8f-4932-a4f7-cba3469aa3ab">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC0xOS0xLTEtMTQwNTIz_3e718a05-4dc9-4d6e-86bb-2b1f896bfe34">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNS01LTEtMS0xNDA1MjM_ca34bdb8-3221-47b1-80a2-b99c1fda92b2">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNS0xOS0xLTEtMTQwNTIz_958ee3b7-71b2-4b84-abde-872c39295b59">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNi0xNy0xLTEtMTQwNTIz_ffc45c09-3a5c-4252-ab16-afdb7eda2b6d">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNi0xOS0xLTEtMTQwNTIz_7a393951-ce6b-4556-8f19-fa355f5da4b6">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i183a8c52537c45628ea1a4b23722e45c_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNy0xMS0xLTEtMTQwNTIz_fb57c4be-f4a2-4f92-9392-8ae8f4bd33b4">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNy0xNy0xLTEtMTQwNTIz_2c6adfe3-af1b-455e-8cf3-b688e436a127">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNy0xOS0xLTEtMTQwNTIz_841d6b72-b200-4264-8dd4-4ef396fea582">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba579ff5d35d41aea8face8b5fd431db_D20220401-20220630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOC05LTEtMS0xNDA1MjM_b9170422-095d-405a-aa08-95d43605561c">768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOC0xNy0xLTEtMTQwNTIz_8b70718c-9aeb-4e06-bff3-410256b15184">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOC0xOS0xLTEtMTQwNTIz_b3946e93-606d-4d49-b1fe-a3b9074398f2">809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOS01LTEtMS0xNDA1MjM_7cac02fe-b9cc-4d98-bba1-11882fc76915">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iae2638ed49674216b6fc56801fe2326f_D20220401-20220630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOS0xMy0xLTEtMTQwNTIz_dee3ec4a-90bb-490e-b465-56d4d4bc9454">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae2638ed49674216b6fc56801fe2326f_D20220401-20220630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOS0xNS0xLTEtMTQwNTIz_697fc3a9-a99b-440c-b0e8-72c9f2618414">944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOS0xOS0xLTEtMTQwNTIz_ce624f94-fe5d-445a-b34e-dafdcd228813">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTItMTctMS0xLTE0MDUyMw_a901e8f2-379c-4167-b48f-9adba304d351">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTItMTktMS0xLTE0MDUyMw_acb4635c-4024-449b-b171-355ac0640ebc">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246Nzc1YTI2NTRkNmU2NGRkMjhlNDZmMmQwODk3YmQwYjlfMjE5OTAyMzI1NTYwMQ_99b0774a-4a87-4938-98e8-d33679f67bf5">0.47</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba579ff5d35d41aea8face8b5fd431db_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTMtOS0xLTEtMTQwNTIz_a65dfa7c-a475-43a9-ac5d-6b0d90921707">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTMtMTktMS0xLTE0MDUyMw_7b101a7b-7b3b-442f-8bda-480013389875">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630" decimals="-6" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTQtNS0xLTEtMTQwNTIz_638da495-66a9-4430-8e3a-e46a7a5883a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba579ff5d35d41aea8face8b5fd431db_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTQtOS0xLTEtMTQwNTIz_b2f956b2-fd9d-433b-b50f-c5b1eb6a5a94">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTQtMTctMS0xLTE0MDUyMw_8c477b3b-02fa-4326-9101-0229c7387503">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTQtMTktMS0xLTE0MDUyMw_e0f299ee-ba5b-4a10-b02e-ad7b6dbcdbde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1df9375c53a54770836b443aebe65d3b_I20220630" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMS0xLTEtMTQwNTIz_96224887-58b4-4fde-92a4-bd6dc223d730">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df9375c53a54770836b443aebe65d3b_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMy0xLTEtMTQwNTIz_d814d444-bef0-4541-8fa6-07400e809aaf">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa15a292151249278a75938323d1968f_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtNS0xLTEtMTQwNTIz_1e496a94-314b-41ed-ab11-bda82c91d241">7,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i965a6647bfcc4c34af4e145de7a94e66_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtOS0xLTEtMTQwNTIz_aeb2c9bc-e3ba-40c5-83e6-d369a5ebc0ab">9,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb0e60dee72643d9b8f7da1912eb9d0c_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTEtMS0xLTE0MDUyMw_eae04a42-0585-4495-bd94-774e7dcc1106">948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifc273f7fc5b247c0846600e051da1759_I20220630" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTMtMS0xLTE0MDUyMw_6f056045-c964-436a-a8c3-d3336e3ebcbb">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc273f7fc5b247c0846600e051da1759_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTUtMS0xLTE0MDUyMw_9d3bbe1b-eaf9-4c5d-b705-e2cacca0bf8d">18,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5026063ddbbd426490dc361b9a57ba33_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTctMS0xLTE0MDUyMw_95c49a46-b8d9-4128-aad4-a3e3102fb5a2">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTktMS0xLTE0MDUyMw_94907bdf-090f-4204-ace6-244e6a7e5317">1,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8f79f8849ffd4f6d92a5100af46ef410_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xLTEtMS0xNDA1MjM_c809f0ee-4c5a-4685-a518-b2a16df768cc">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f79f8849ffd4f6d92a5100af46ef410_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0zLTEtMS0xNDA1MjM_612439e3-1ee9-41b8-852a-9b77596dab94">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302a7aa1b388436ba21034ef5118cefb_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy01LTEtMS0xNDA1MjM_3d996a02-b142-4207-b6fe-0e8896833def">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic25a09d084d74900927f8d3b2d327f34_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy05LTEtMS0xNDA1MjM_1d17511d-59b0-4aec-aa84-fa311bf24198">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib222089abc8b4a0984b44963c8a6da6c_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xMS0xLTEtMTQwNTIz_6ecc688f-e7af-4180-a51a-2f510364bf7e">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if0356030a71f4cedad29132c59391b27_I20210331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xMy0xLTEtMTQwNTIz_c39ca7ff-d719-487c-8223-d9e9f797102f">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0356030a71f4cedad29132c59391b27_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xNS0xLTEtMTQwNTIz_1613c806-9ae5-414e-a0d7-a610d8a4e715">13,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31619d5dfb2942f181793348c62fa60a_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xNy0xLTEtMTQwNTIz_cde8d456-9c82-4052-a92a-66f2899bcdfd">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8f1ea1e497400f8334891264c28e85_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xOS0xLTEtMTQwNTIz_045be4c9-9461-43b8-bc6a-e4689b023650">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibacc7e1f23d649749320d4f48e0caff5_D20210401-20210630" decimals="-6" name="mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNC0xLTEtMS0xNDA1MjM_8fddf6be-188d-4fa4-9762-5100f1d1db97">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNC01LTEtMS0xNDA1MjM_f60c9940-c3ff-4880-950c-967b1c2e9b38">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bf29a8b64e74d7c8e6324067684ba02_D20210401-20210630" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNC0xNS0xLTEtMTQwNTIz_65ae4bd0-e431-4d31-9003-9a7b9fd7005e">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNC0xOS0xLTEtMTQwNTIz_7699d7fc-c487-41b8-8c34-182dc02c1751">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNS01LTEtMS0xNDA1MjM_e2c9d757-39c1-4571-bee3-997e8c1a4c20">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNS0xOS0xLTEtMTQwNTIz_2188b0f2-72f2-4a81-b3ff-88d969561e3e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNi0xNy0xLTEtMTQwNTIz_613a36c9-c60f-4777-950b-f6fa8659fe74">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNi0xOS0xLTEtMTQwNTIz_3d40b802-72e0-4a32-8e0d-152480434f11">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d4cc7ccee34f9a8a8f2544e232a63f_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNy0xMS0xLTEtMTQwNTIz_ed1ed3fc-2646-4694-898b-734b88fdfe7d">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNy0xOS0xLTEtMTQwNTIz_9ed6e012-b958-41d7-8cee-38ea95486acb">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ff8ccdcd1d43578af7654618f2847f_D20210401-20210630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOC05LTEtMS0xNDA1MjM_d452fbe4-7b7e-4d3c-8f20-d70487c57451">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOC0xNy0xLTEtMTQwNTIz_4d8a0179-4a08-4af0-a517-71df3f0f497b">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOC0xOS0xLTEtMTQwNTIz_acaa9f6c-5ba2-49a4-b0cd-d27d14fafdee">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOS01LTEtMS0xNDA1MjM_5503c05f-d144-40ad-afec-1d938020738e">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2bf29a8b64e74d7c8e6324067684ba02_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOS0xMy0xLTEtMTQwNTIz_a92b78e5-2945-4e45-b0c1-c6c0c937d2c4">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bf29a8b64e74d7c8e6324067684ba02_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOS0xNS0xLTEtMTQwNTIz_fc68bbbb-2cf3-4806-8820-f63468d92b21">850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOS0xOS0xLTEtMTQwNTIz_014b48b1-2ff3-4bd7-b907-5a764d3bfce3">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTAtNS0xLTEtMTQwNTIz_34167755-113e-4158-b5d7-702debeb61bb">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9d4cc7ccee34f9a8a8f2544e232a63f_D20210401-20210630" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTAtMTEtMS0xLTE0MDUyMw_58ff1c31-c26e-4240-b727-b17c9f9242b8">170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTAtMTktMS0xLTE0MDUyMw_e6fee47a-0fb7-4721-b002-c462de1f5f6f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe AG redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtMTctMS0xLTE0MjcxMQ_43a27e9b-7e85-4cca-a3c8-bb5c667c0b69">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtMTktMS0xLTE0MjcxMQ_2881fcd2-be9d-44c6-86f6-219d846cfe90">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246MzU0YzQzMDM1ZjdjNGM0YmIyNzlmNzZkZWRjZmQ4YTJfMjE5OTAyMzI1NTYwNQ_e028c053-9320-4285-ae33-9f9f1b69cc9e">0.42</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12ff8ccdcd1d43578af7654618f2847f_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtOS0xLTEtMTQwNTIz_e047a03a-c92c-48b0-9673-f2bdd3a347a8">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtMTktMS0xLTE0MDUyMw_94dddc55-88a4-425f-8aff-18234b218070">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12ff8ccdcd1d43578af7654618f2847f_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTItOS0xLTEtMTQwNTIz_48dbc399-4f75-4245-ac0d-0987f9470601">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTItMTctMS0xLTE0MDUyMw_24dffae6-6d7b-4416-a13d-0e14f248379a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTItMTktMS0xLTE0MDUyMw_f3cff37b-a2b4-4462-a16f-d1a0fb1e7e8a">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7f38fed308149759889e7a524621b45_I20210630" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMS0xLTEtMTQwNTIz_d58f8318-93ea-4e4e-aed3-2e14944eb9a2">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f38fed308149759889e7a524621b45_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMy0xLTEtMTQwNTIz_d48f3d20-3c15-4c8c-9230-850a52dd5cb0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e4115630544b9a8ecb71896a8d29ae_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtNS0xLTEtMTQwNTIz_5679bc96-e640-43f5-b0a7-a254d448c4bd">7,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a849346f984ba7a24863f281ff99ca_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtOS0xLTEtMTQwNTIz_6f33df38-766a-40de-aa60-dc086936f933">8,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1257a17abb1d49209b1ecf7010d647c4_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTEtMS0xLTE0MDUyMw_f1b74b8c-4df4-4691-9336-c30cdcfce489">1,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i915d93beb3944977a2b115e5a05ff593_I20210630" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTMtMS0xLTE0MDUyMw_4d17e2ae-ff19-42e3-946a-9106b6399a6e">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i915d93beb3944977a2b115e5a05ff593_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTUtMS0xLTE0MDUyMw_ab23776f-7851-4fbb-9383-c9ac46f6b75d">14,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97688416d8624c10a48f226d71563b9e_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTctMS0xLTE0MDUyMw_561391d7-14ac-49b0-9c6a-b76271e7139b">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52e0da06428444108f6f30cfdedaf625_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTktMS0xLTE0MDUyMw_6dcca419-ff14-465a-8fa8-2bb4123ce363">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMy0xLTEtMS0xNDA1MjM_8b13cc02-c121-443f-a5c1-4269fcd5a81e">809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMy0zLTEtMS0xNDA1MjM_e14d1c32-062c-4c4b-84af-223424f5be4d">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNS0xLTEtMS0xNDA1MjM_03ce0e84-3eeb-40b8-9a1d-53466901ab7c">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNS0zLTEtMS0xNDA1MjM_5e8731bf-50e6-461a-a762-7d88f23718b2">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNi0xLTEtMS0xNDA1MjM_374db198-fe6c-462b-9450-02d45500b969">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNi0zLTEtMS0xNDA1MjM_d25c51bf-8c13-4827-820f-c34440fe08bd">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNy0xLTEtMS0xNDA1MjM_a2fd73f0-f1d0-401c-9e2f-f028bf41aefc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNy0zLTEtMS0xNDA1MjM_c744a723-401e-4a7f-b512-377c63afe11c">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfOS0xLTEtMS0xNDA1MjM_591afe81-75b4-4aa3-adf0-3fcf79ee4518">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfOS0zLTEtMS0xNDA1MjM_d88cdaf6-13fb-44a2-a7f1-2e05c198e1c0">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTAtMS0xLTEtMTQwNTIz_b3198013-35fb-426a-b9c3-eb7b4840c097">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTAtMy0xLTEtMTQwNTIz_e778847e-b353-4845-be99-cab262e51b8f">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTEtMS0xLTEtMTQwNTIz_9c775a1f-3469-46e6-aaee-32725f2e5a9c">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTEtMy0xLTEtMTQwNTIz_ef258711-d771-4f2f-ace4-35afb4aa8775">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sales of businesses and investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTItMS0xLTEtMTQwNTIz_f03fd7e8-8429-4801-962f-ca3f4dee7dcb">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTItMy0xLTEtMTQwNTIz_53d78a5b-0801-4a55-81e1-ce424bb77df9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European businesses held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTMtMS0xLTEtMTQwNTIz_f95253bb-e08e-447b-8eec-b8293e5878a1">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTMtMy0xLTEtMTQwNTIz_50e4d9d7-a563-430e-8d5a-378efdfd7c33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTQtMS0xLTEtMTQwNTIz_9d5859a7-f113-4b99-abb2-8920e22b1548">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTQtMy0xLTEtMTQwNTIz_3a194b22-c63a-4ba2-b639-081fb5bd230e">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTYtMS0xLTEtMTQwNTIz_4aee28b1-5f70-4a4c-9327-1b44b08093de">1,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTYtMy0xLTEtMTQwNTIz_1510b006-7657-48ca-a8f9-6ed593e9be4b">1,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTctMS0xLTEtMTQwNTIz_b22c5503-4035-4b1d-a138-acd4034ef605">955</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTctMy0xLTEtMTQwNTIz_23d72ea8-f348-4725-a2ef-2b1de2d77731">901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTgtMS0xLTEtMTQwNTIz_51b8108b-5baa-42c1-be56-c888bb050ed8">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTgtMy0xLTEtMTQwNTIz_a76c47a3-df29-46cb-a1a0-0dbb58407e1b">609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTktMS0xLTEtMTQwNTIz_641514b9-d70c-472a-8f61-7ad862b54696">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTktMy0xLTEtMTQwNTIz_81dfb5ef-d8af-4a8a-970d-dbff25ab7b70">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjAtMS0xLTEtMTQwNTIz_48c17984-393e-4e96-846e-11680511982e">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjAtMy0xLTEtMTQwNTIz_acbbde0d-dabc-408e-8ffe-9efcd03d64c0">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjEtMS0xLTEtMTQwNTIz_7957005f-6e56-4e87-acc3-2e713ce499ed">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjEtMy0xLTEtMTQwNTIz_40649795-85e1-4ace-ad02-cae1f38d047a">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjItMS0xLTEtMTQwNTIz_5d0f8399-2c41-46bb-b4db-c858ae30e22f">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjItMy0xLTEtMTQwNTIz_0d0a30ae-033e-4f44-bf90-b2a4e792db02">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjMtMS0xLTEtMTQwNTIz_8c0765f5-394b-431b-88d5-be1bcfeda4b7">941</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjMtMy0xLTEtMTQwNTIz_c3d7a1e4-16d4-4048-ad62-5611424e8645">1,622</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjYtMS0xLTEtMTQwNTIz_2a42bb59-24ff-44b8-bcae-509f7b574025">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjYtMy0xLTEtMTQwNTIz_bcbde926-c012-47bd-ac7a-3ca8f5a6653e">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjctMS0xLTEtMTQwNTIz_d5f4e2e4-9661-4c38-8d4d-0c8f02acc119">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjctMy0xLTEtMTQwNTIz_e7366951-ba4a-4045-8957-463996fbbb54">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjgtMS0xLTEtMTQwNTIz_2b5e18cf-8b4f-4c2f-bb43-80ccb3dc9e7b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjgtMy0xLTEtMTQwNTIz_de4ecdf3-b053-4c17-bffd-9fe79a081202">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjktMS0xLTEtMTQwNTIz_fcafea40-ba4b-4ca5-a1e1-248880821306">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjktMy0xLTEtMTQwNTIz_e8719aff-bc30-45f7-bfac-77af2e13e87f">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMzAtMS0xLTEtMTQwNTIz_21df8427-2354-413e-971b-573ba69557c6">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMzAtMy0xLTEtMTQwNTIz_98de40bd-769e-4a05-b64c-00e06b8b9e62">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMzEtMS0xLTEtMTQwNTIz_74e207b8-e428-49a8-b662-ec17d376bdba">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMzEtMy0xLTEtMTQwNTIz_da0d5e94-fc60-4cb3-8a15-a2b673faebb1">99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDAtMS0xLTEtMTQwNTIz_99964275-543f-4e13-b08f-8a6a8ace6e3f">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDAtMy0xLTEtMTQwNTIz_cfdef47e-e3d7-4795-8b19-05fa863c1144">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDMtMS0xLTEtMTQwNTIz_93ae0b1d-174b-41fb-9549-b96254cf0f68">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDMtMy0xLTEtMTQwNTIz_98e3d54b-826c-4a13-b89c-324a530e6baa">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDQtMS0xLTEtMTQwNTIz_fe922240-cfb0-4f26-bb86-ad6acbf77587">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDQtMy0xLTEtMTQwNTIz_82db5f3a-84f6-4be4-9946-f89957c954ed">1,008</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDUtMS0xLTEtMTQwNTIz_0f08e6e7-0702-4f07-98b4-2ad4bf986b80">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDUtMy0xLTEtMTQwNTIz_db8c799b-33cb-418b-a13c-6570e5ef9d84">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDYtMS0xLTEtMTQwNTIz_6ae56968-b61e-4ef1-9f24-bd7cc2887d60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDYtMy0xLTEtMTQwNTIz_38ffdfb8-9239-4ff7-b488-727e72f6b05e">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDctMS0xLTEtMTQwNTIz_0e4f8115-9ee8-4f19-8c5b-9eab436796a2">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDctMy0xLTEtMTQwNTIz_dcf5141a-97d5-44f6-aec8-eedb498bdadd">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDgtMS0xLTEtMTQwNTIz_d29524c7-1588-4247-8357-354bc529ee67">1,181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDgtMy0xLTEtMTQwNTIz_40d0f0a5-5377-4bca-92a0-948762a9a175">2,151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDktMS0xLTEtMTQwNTIz_2fd25dd5-dcd4-478a-8cba-bffb9f044f49">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDktMy0xLTEtMTQwNTIz_ff8d65fa-0c36-4734-9963-9b1911f0c40c">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTAtMS0xLTEtMTQwNTIz_4dfed151-51d8-4875-8ff0-1769e884433b">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTAtMy0xLTEtMTQwNTIz_2f9a355a-b1fb-4c18-a47f-9c3155760d11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTEtMS0xLTEtMTQwNTIz_57c14943-6f5f-463c-8c85-05760d4173d0">1,595</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTEtMy0xLTEtMTQwNTIz_fb7e11dd-3d6d-4ed4-be34-2637af0b4bb9">3,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTItMS0xLTEtMTQwNTIz_0756d3a9-758d-42c6-97fe-64deefb76383">3,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8f1ea1e497400f8334891264c28e85_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTItMy0xLTEtMTQwNTIz_447f6c9a-35dd-47b6-b512-20ab77c4724e">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTMtMS0xLTEtMTQwNTIz_c02a3342-a5be-4fc0-8043-c3ab62b3ed16">2,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e0da06428444108f6f30cfdedaf625_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTMtMy0xLTEtMTQwNTIz_fbb5316f-4c3a-4caf-bb9d-fa5231a001e0">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Restricted cash at end of period included in Prepaid expenses and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTQtMS0xLTEtMTQwNTIz_e980515f-af8f-43b2-b320-62597190b7bb">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52e0da06428444108f6f30cfdedaf625_I20210630" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTQtMy0xLTEtMTQwNTIz_47c2c06d-06f0-4f4b-9253-086621b3eda6">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTYtMS0xLTEtMTQwNTIz_1a3430e4-028c-463e-8f8e-324242f447d8">2,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e0da06428444108f6f30cfdedaf625_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTYtMy0xLTEtMTQwNTIz_a93ed6d4-9ebe-4479-8fd5-d7df2304f1f4">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ida37730e58094407b89f4630fc6c6b2d_34"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDY5OA_604ab9a0-b56e-45a7-b48b-5261fb6466cb" continuedAt="icc012cbb60134faea82db42cca314a9e" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="icc012cbb60134faea82db42cca314a9e" continuedAt="i451b69e069214570b77fbfffbafca31c"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNTcx_94fdc16a-0bb9-4750-a14f-616eb0918b98">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; for additional information.</span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDcwMA_e983649b-8df5-4fc9-be65-358a827936ab" continuedAt="i9f5a7bc921e3416db7e34bc9625b27bb" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. </span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9f5a7bc921e3416db7e34bc9625b27bb">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMzg0ODI5MDcxMTIxNA_75eb4ae6-b658-46c3-9222-fcaff2d992b4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMzg0ODI5MDcxMTIxNQ_830db0c9-cf7a-4651-b1b4-6f59ef5c9f41" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain prior period amounts have been reclassified to conform to the current year presentation.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDY3Ng_b850864a-6efd-4d99-8a51-088d74cfa7e5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;), and therefore the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ComparabilityOfPriorYearFinancialData" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDcwNg_516a818f-80fa-493d-8a37-f94823cf5b8b" escape="true">The results of operations for the three months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#8220;2022 Annual Report&#8221;).</ix:nonNumeric> </span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDcwOA_16499c54-9f75-4382-a931-c8578f15796b" continuedAt="i9d2d2c238e9c4f65957cab14a4c2490b" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during the first quarter of fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i451b69e069214570b77fbfffbafca31c"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i9d2d2c238e9c4f65957cab14a4c2490b" continuedAt="i34e809d20d1f418dac611fdc340facc1">Recently Issued Accounting Pronouncements Not Yet Adopted</ix:continuation></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:continuation id="i34e809d20d1f418dac611fdc340facc1" continuedAt="i1dbc23c5c9864bf7bf54debc8104eacb"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1dbc23c5c9864bf7bf54debc8104eacb">, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of this guidance but does not expect it to have a material impact on its consolidated financial statements or related disclosures</ix:continuation>.</span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMTM3NDM4OTUzNjQ0Njg_30d3b7c1-3874-4690-81b8-f59b98f1da06" escape="true"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMTM3NDM4OTUzNjQ0Njk_d9e22b32-dfb9-484a-917b-c8fef10bdb4c" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company exited one of its investments in equity securities for proceeds of $<ix:nonFraction unitRef="usd" contextRef="i2151c060ee864dcf9cc0a315dedcb4bc_D20220701-20220731" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMjE5OTAyMzI3Mjc3Mw_382d2bfa-50c8-4c2d-b3eb-de265e097019">179</ix:nonFraction>&#160;million. The Company expects to recognize a gain within &#8220;Other income, net&#8221; in its Condensed Consolidated Statement of Operations for the second quarter of fiscal 2023 related to the disposition. The cost basis of the investment was $<ix:nonFraction unitRef="usd" contextRef="iacb94994718b406dbc1a53f8dab8d938_I20220731" decimals="-6" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMjE5OTAyMzI3Mjc4Nw_8482b785-8a55-4510-a63d-d13930455cbc">38</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_37"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNzE0OA_9e93e09a-aee0-4018-b3a4-690cbb6f7109" continuedAt="i8dd6a080d3f44524b4b3a6bba24d81f9" escape="true">Held for Sale</ix:nonNumeric></span></div><ix:continuation id="i8dd6a080d3f44524b4b3a6bba24d81f9" continuedAt="i0f669d933aa84268bbd1a4bb0037bbe5"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe resulting in classification of certain assets and liabilities as held for sale. Assets and liabilities of $<ix:nonFraction unitRef="usd" contextRef="i184217f9158a415e9fe088348387b9e9_I20220630" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1NTUwOA_36dca706-15b1-4bf4-93d1-7c281768cf8b">3.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i184217f9158a415e9fe088348387b9e9_I20220630" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1NTUxOA_e94fedeb-f23e-459f-a026-cdc39c9f1170">2.3</ix:nonFraction> billion, respectively, at June 30, 2022, and $<ix:nonFraction unitRef="usd" contextRef="icd5d065ca8604d0bbd24e8e67b95eb01_I20220331" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1NTU3OQ_db143ce2-585b-42f2-b0d3-bf76dd46fe95">4.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="icd5d065ca8604d0bbd24e8e67b95eb01_I20220331" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1NTU4Nw_4f627ac8-c701-4d23-b945-6e9a35d3b5e8">4.7</ix:nonFraction> billion, respectively, at March 31, 2022, met the criteria for classification as held for sale, primarily consisting of disposal groups related to the Company&#8217;s European divestiture activities discussed below. The decrease in assets and liabilities held for sale during the first quarter of fiscal 2023 was primarily due to the divestiture of the Company&#8217;s U.K. disposal group in April 2022, as discussed in more detail below.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="mck:HeldForSalePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNzE1Mg_9fa05918-a097-406a-9a76-627c8a2b98cc" escape="true">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.</ix:nonNumeric> When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;<ix:nonFraction unitRef="eur" contextRef="i5150b5ddba2945abbc839f1edd5fea5f_I20210705" decimals="-8" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMjY4OA_a1c5cfc0-4e7b-4de8-af8d-80f86fb3ff13">1.2</ix:nonFraction> billion (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i5150b5ddba2945abbc839f1edd5fea5f_I20210705" decimals="-8" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMjcxMA_43de0cb7-63af-44be-8f67-5bc18b9bc1f0">1.3</ix:nonFraction> billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. The transaction is anticipated to close within the second half of fiscal 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. As of June 30, 2022 and March 31, 2022, the E.U. disposal group within the Company&#8217;s International segment, was classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i8c16ef6d38344729a8077cc7cfbddb3e_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ0OTcwOQ_47608615-5667-49ab-a98f-e54cc415a063">12</ix:nonFraction>&#160;million to remeasure the E.U. disposal group to fair value less costs to sell. This amount was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i0f669d933aa84268bbd1a4bb0037bbe5" continuedAt="i875960d006244f5ca6f2941248c220a6"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNzE1MA_664bb01c-7f7b-41df-8377-7ffa079e5e34" continuedAt="i5e57dd5bf4124e9d93e8b8afd5a5e1b1" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMy0xLTEtMS0xNDgzNjg_858f651f-998e-4933-aaae-bab2ee18364d">1,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMy0xLTEtMS0xNDA1MjM_d56ead55-b4fc-432f-aa25-4864da2aaca5">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNC0xLTEtMS0xNDgzNjg_bdd923d8-08f3-4669-b951-21a3eeeacaf7">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNC0xLTEtMS0xNDA1MjM_ebec8c7b-2847-4fac-a0a7-29b08a1bacfc">809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNS0xLTEtMS0xNDgzNjg_e550fcab-f7b2-4195-8298-70320c60d76e">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNS0xLTEtMS0xNDA1MjM_4b562db9-9677-4525-a0e4-399a7b15d51f">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNi0xLTEtMS0xNDgzNjg_25419df7-f463-496b-8c0b-5029f071fc79">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNi0xLTEtMS0xNDA1MjM_9c9285c6-746c-4a11-b6d3-cae433941dcf">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNy0xLTEtMS0xNDgzNjg_8563e113-cb1f-4451-8c3e-c4c196ec3527">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNy0xLTEtMS0xNDA1MjM_898b43a7-5818-4d94-86c3-78567a63a86c">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfOC0xLTEtMS0xNDgzNjg_1bd4d292-47cb-4a96-a383-319ca5ffd5b0">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfOC0xLTEtMS0xNDA1MjM_ac746ea9-4132-4dec-9083-17a747c53253">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfOS0xLTEtMS0xNDgzNjg_0e18e0f4-3232-4204-9dcd-18651b22920b">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfOS0xLTEtMS0xNDA1MjM_32a38a2a-4242-44be-a7d4-b66c6b676c08">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTAtMS0xLTEtMTQ4MzY4_7e1ddeeb-fb11-4da1-8785-fd9bea1473ee">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTAtMS0xLTEtMTQwNTIz_af5a5c3e-d26f-4b7d-867f-0d10c6018026">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTEtMS0xLTEtMTQ4MzY4_90fae5ee-ec2a-481e-a851-7e58b1ec6058">2,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTEtMS0xLTEtMTQwNTIz_6f0b3286-4bac-4675-9184-61d7667db5a3">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTUtMS0xLTEtMTQ4Mzg3_9f18c076-5628-4a8a-a8c0-f1638c26596d">1,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTUtMS0xLTEtMTQwNTIz_b1272146-14a1-4943-9629-6abf1f4f7780">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTYtMS0xLTEtMTQ4Mzg3_0e8de5b3-e556-4e63-84c6-09eb9d1539e4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTYtMS0xLTEtMTQwNTIz_dcff6364-1e9f-43cd-90c4-f922412d5180">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTctMS0xLTEtMTQ4Mzg3_123f9dc7-60a2-4347-bfc3-885e21b284db">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTctMS0xLTEtMTQwNTIz_593e63b1-dfbe-4a4c-9531-45e44faade29">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTgtMS0xLTEtMTQ4Mzg3_ad8f9427-8b88-4bb4-a30c-2e963527973c">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTgtMS0xLTEtMTQwNTIz_ab8c4bfd-8d80-4cb3-9986-0be3f7895b42">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTktMS0xLTEtMTQ4Mzg3_bda18a9f-97fe-4c99-b65e-33e1a260f811">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTktMS0xLTEtMTQwNTIz_2be4d7aa-e105-491c-b9fa-ec18568e1149">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjAtMS0xLTEtMTQ4Mzg3_af08de43-5ab5-49fc-812b-cb531ea4a2d4">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjAtMS0xLTEtMTQwNTIz_20a6fd86-1788-4237-b7a7-3645bc3c057d">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjEtMS0xLTEtMTQ4Mzg3_e3d29a9d-62b8-4f9b-a7c3-e01ad31d72a5">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjEtMS0xLTEtMTQwNTIz_82f31399-c1a7-4637-b5f1-dee218723692">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjItMS0xLTEtMTQ4Mzg3_0c4e80cc-defa-4666-8a54-72ff96d9acd3">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjItMS0xLTEtMTQwNTIz_4f6457b0-e5c4-4ea5-916b-3758b23b0d5c">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjMtMS0xLTEtMTQ4Mzg3_f045371c-019d-460f-915c-07b2a8bcd14f">2,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjMtMS0xLTEtMTQwNTIz_0d9b6482-9ba8-49b0-b436-14d6985b0f0a">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, which are primarily comprised of a $<ix:nonFraction unitRef="usd" contextRef="i24d358bf2d514516969073c17eb16cab_D20200401-20210331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNDcwNg_eec5a67d-78e8-4ad4-8fc2-872ccfdf90fe">113</ix:nonFraction> million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;<ix:nonFraction unitRef="gbp" contextRef="i966d0672f94e47d48297a66c14bc69ae_I20220406" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNTAyMQ_d82900c8-3c79-420f-b2d3-479be5efe57c">110</ix:nonFraction>&#160;million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i966d0672f94e47d48297a66c14bc69ae_I20220406" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNTA0Mw_366f504c-7527-4ee7-b52f-c9ab30906499">144</ix:nonFraction>&#160;million), including certain adjustments. As part of the transaction, the Company divested net assets of $<ix:nonFraction unitRef="usd" contextRef="i393f7b257bbf4a2fb7a4b7d3c3e8cc5b_I20220406" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1MjE1Mw_efe20072-42ac-4650-83d9-d0041162faf9">615</ix:nonFraction>&#160;million and released $<ix:nonFraction unitRef="usd" contextRef="i3cd413ff00624a0d8270f7ea278d9a55_D20220406-20220406" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1ODUxNA_cfa279f1-ad93-45eb-adc8-e2161ca26246">731</ix:nonFraction>&#160;million of accumulated other comprehensive loss, within the International segment, and the buyer assumed and repaid a note payable to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="i372251adcd1648eab091c52b5f01446e_D20220406-20220406" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1MjE2OQ_fd353c07-70c2-4e08-9517-f23bc51a2926">118</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i875960d006244f5ca6f2941248c220a6"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the transaction on April 6, 2022, there were no assets or liabilities of the U.K. disposal group classified as held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet. <ix:continuation id="i5e57dd5bf4124e9d93e8b8afd5a5e1b1" continuedAt="i93e3c79148be4bf496a8bfbe1e2fb636">The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:</ix:continuation></span></div><div style="margin-bottom:12pt"><ix:continuation id="i93e3c79148be4bf496a8bfbe1e2fb636"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMy0xLTEtMS0xNDA1MjM_6d464d66-82e4-4615-90b5-c8ee1fd8d197">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfNC0xLTEtMS0xNDA1MjM_88f4ba5e-f276-4e53-949a-726dcb18dbe7">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfNS0xLTEtMS0xNDA1MjM_33116be0-f26d-4517-b7d0-ad46d2b5634d">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfNi0xLTEtMS0xNDA1MjM_1715ed1e-85b4-47c7-8ef0-83e1ec7b6bbb">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfNy0xLTEtMS0xNDA1MjM_85f1b985-a7d9-410d-b4ca-381e26a4b22a">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfOC0xLTEtMS0xNDA1MjM_84cedb84-5892-4d30-a37a-e7b06a0d3f83">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfOS0xLTEtMS0xNDA1MjM_a8b9952a-6a10-4462-bcce-3857e97bda09">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTAtMS0xLTEtMTQwNTIz_4e9153d2-ba76-4956-9cb7-c8abc413768c">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTEtMS0xLTEtMTQwNTIz_4ebbd378-91a7-4015-b684-2c3e882eeac9">1,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTItMS0xLTEtMTQwNTIz_266804a7-722e-480b-a9e5-84d92611a227">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTYtMS0xLTEtMTQwNTIz_292dad69-aa9f-4142-ae0f-5015c537bef8">1,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTgtMS0xLTEtMTQwNTIz_33c99ea3-5449-4b28-9597-f6b4898550e9">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTktMS0xLTEtMTQwNTIz_78cc86ea-4837-4330-88c7-d6db198efe30">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMjEtMS0xLTEtMTQwNTIz_9bb07f3b-7930-48cd-a043-ac57b1a1b1af">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMjItMS0xLTEtMTQwNTIz_d202a9e8-c563-47ef-977c-357a2808e00d">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMjMtMS0xLTEtMTQwNTIz_aad1a5ee-c33f-4dc8-91e9-98607dc10f71">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMjQtMS0xLTEtMTQwNTIz_eaa389c9-be49-4664-8f5d-6c3b83f69ee2">2,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_40"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNTY0Mw_b8280c52-5601-48fb-b4de-52f21abbc99e" continuedAt="i6a4db93235ed427eb621161899de1d75" escape="true">Restructuring, Impairment, and Related Charges, Net</ix:nonNumeric></span></div><ix:continuation id="i6a4db93235ed427eb621161899de1d75" continuedAt="i336b2f88515e4c4993689883ea21a93e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges, net of $<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfODM_a2f000a7-7f9e-4746-a441-f5154a191099">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfMTI2_27e8ef37-ef46-49c6-b5e4-4d9785aa7c06">158</ix:nonFraction> million for the three months ended June 30, 2022 and 2021, respectively. These charges were included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Condensed Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#8217;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i8810900c5c324fd89fbada461816423d_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNjU5NzA2OTc3Mzk0Mw_dc8f1787-39a8-43f9-a3b2-d4c94f9866c8">95</ix:nonFraction> million for the three months ended June 30, 2021 primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 and remaining costs the Company expects to record under this initiative are not material.</span></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNTY0NQ_2e1341be-9cf9-42f0-abab-88cad522277c" continuedAt="i2acedebfec1a40cfbb039deebda934ef" escape="true"></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i336b2f88515e4c4993689883ea21a93e" continuedAt="i81de2cd00d5c400eb7e981ccb4e2a83e"><ix:continuation id="i2acedebfec1a40cfbb039deebda934ef"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the three months ended June 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi0xLTEtMS0xNDA1MjM_db62a0a4-255f-4500-bcc0-03575688af25">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi0zLTEtMS0xNDA1MjM_7bb8e5dd-1ec9-4222-962b-76c1b0867eeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi01LTEtMS0xNDA1MjM_0096a234-3e48-45f0-b757-576693a4ab05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi03LTEtMS0xNDA1MjM_efa4528c-560d-4673-98c6-5a92dcd97b63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi05LTEtMS0xNDA1MjM_95a5ec05-5ea9-499f-bd19-64f714c3240e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi0xMS0xLTEtMTQwNTIz_9e414d92-fe10-4b73-8c36-7a4d5849942a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy0xLTEtMS0xNDA1MjM_962d02ea-ada3-4c12-a16c-c4349b5e7b59">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy0zLTEtMS0xNDA1MjM_6ebd489c-976a-4b5c-b0e9-c3c1ee60e110">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy01LTEtMS0xNDA1MjM_fab2b9c3-bedb-4d50-8ebd-5a695d911c00">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy03LTEtMS0xNDA1MjM_265ea13e-58ed-439b-8447-6784efe93382">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy05LTEtMS0xNDA1MjM_5b4814d4-eca4-4821-86c9-7c1cc3cd9cc1">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy0xMS0xLTEtMTQwNTIz_9167a9b7-f58a-42cc-86ca-b1100d041923">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC0xLTEtMS0xNDA1MjM_6524ba35-c5f5-4c9f-83ac-5256c6a4f2d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC0zLTEtMS0xNDA1MjM_bf5e1660-441e-4e27-8bbd-0201a878baf1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC01LTEtMS0xNDA1MjM_207b28bb-ae07-4f6b-ad6e-0679a3d1d1a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC03LTEtMS0xNDA1MjM_73b22a84-c406-4bfc-a637-2f9df20a56c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630" decimals="-6" sign="-" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC05LTEtMS0xNDA1MjM_cebeb0f0-0fe1-46e0-b24f-1864ac033147">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC0xMS0xLTEtMTQwNTIz_d4ba5136-3dab-4bef-83bd-fc82238cb7bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS0xLTEtMS0xNDA1MjM_7ea29a07-0a81-4b20-8db6-596d265d9650">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS0zLTEtMS0xNDA1MjM_38f425d6-16a4-40a4-a157-40d632a9db8b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS01LTEtMS0xNDA1MjM_5240a7e9-68e7-4459-ab10-713587e71ec2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS03LTEtMS0xNDA1MjM_5b4708a5-354e-47e5-b2c2-a41a47b1163f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS05LTEtMS0xNDA1MjM_486734ac-98e8-4300-908e-1dde5ce0ca4f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS0xMS0xLTEtMTQwNTIz_f8fd530f-e58f-4ee8-a528-e7d5d3338119">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi0xLTEtMS0xNDA1MjM_7d5d4ef1-c23b-44fa-a8f3-44dd0a13df71">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi0zLTEtMS0xNDA1MjM_c93902eb-31fb-4091-a7f2-1ef8d39a848b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi01LTEtMS0xNDA1MjM_e84bc8d4-cfa5-46b5-9aa4-f3ccc920f96a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi03LTEtMS0xNDA1MjM_e5341080-5f7b-4673-872d-b8dd3aa0f206">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi05LTEtMS0xNDA1MjM_1503828a-50ba-4850-afd4-56b6e4d52adb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi0xMS0xLTEtMTQwNTIz_5bc4d324-64d1-4b74-b6d1-401e0aea9301">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy0xLTEtMS0xNDA1MjM_fce97ff3-4e5d-472e-9c93-f4a01d30ec40">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy0zLTEtMS0xNDA1MjM_eb47368b-a747-4053-a3bb-6062a6edf038">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy01LTEtMS0xNDA1MjM_c91fdd7c-0158-429d-9a67-ad0004e8e536">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy03LTEtMS0xNDA1MjM_7cfc0654-6e35-47a4-b36a-e0f5397dc2b1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy05LTEtMS0xNDA1MjM_9f8d8aad-d03d-4ee0-985a-f63595e0ffc9">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy0xMS0xLTEtMTQwNTIz_34e5c2cc-90f7-4fb6-a451-3c457763f7a1">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC0xLTEtMS0xNDA1MjM_54554fe5-d1c2-4ca6-97ef-88e961780c99">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC0zLTEtMS0xNDA1MjM_31f3eb68-1e10-4e72-b841-4aa16ed0a7ec">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC01LTEtMS0xNDA1MjM_fa7cb7a4-f514-47a4-be39-0cb13eb42c02">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC03LTEtMS0xNDA1MjM_db1f10aa-032d-4c6b-8c6a-892e510934e8">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC05LTEtMS0xNDA1MjM_5b6d1d6a-f199-4ae3-ab13-16f8f14157b3">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC0xMS0xLTEtMTQwNTIz_1dd2ad20-af11-4d59-8530-ac28958564b0">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS0xLTEtMS0xNDA1MjM_26290a51-d171-43d9-b408-e9a965f573b3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS0zLTEtMS0xNDA1MjM_668f2ca0-7f84-483f-ba57-55fb294aa16d">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS01LTEtMS0xNDA1MjM_99d493ce-2abd-4aed-a441-a7f53ad93705">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS03LTEtMS0xNDA1MjM_08ea0e11-6a26-4eb9-9228-a504b1efe51a">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS05LTEtMS0xNDA1MjM_bbdc54e6-ca76-4d0e-8df0-feae4c52c490">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS0xMS0xLTEtMTQwNTIz_8f371c8b-d9d2-48cd-b061-2b83e77363e1">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above and U.K. operating model and cost optimization efforts, as well as costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div></ix:continuation><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNTYzNQ_cf1e50e8-be2e-4ab0-ad72-d1e3df569376" continuedAt="if592c2623ed447e787e64fe14bc21a6b" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the liabilities associated with the Company&#8217;s restructuring initiatives for the three months ended June 30, 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd299c03b254bf08ef56a66adc41c05_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS0xLTEtMS0xNDA1MjM_bd41398e-233b-4fa9-9745-3060b2764df0">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i160ffe77823e4333a979c33b283947f8_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS0zLTEtMS0xNDA1MjM_9f86f2d1-6ba6-47db-8407-21ef8d6ba27b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18e67fe7460b4e2ea12fbbd5167e3238_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS01LTEtMS0xNDA1MjM_5b02612a-9ad4-4d51-9081-0a851294b87b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41993913d47d47799af347f96dffc5fa_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS03LTEtMS0xNDA1MjM_d3a7dc48-47f8-443a-9b06-113a1259f966">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ca90c76b5f8423db112b3afece54ca7_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS05LTEtMS0xNDA1MjM_b3129de3-55ed-4b13-be73-7289fb641c5a">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS0xMS0xLTEtMTQwNTIz_f3e8249c-d6f8-49a1-9948-03c3e3fbe213">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi0xLTEtMS0xNDA1MjM_b3943928-bffe-483b-8370-45aa0eb6882c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi0zLTEtMS0xNDA1MjM_b687cfa9-eb06-440e-a9d9-eea5ebfcee07">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi01LTEtMS0xNDA1MjM_9b199791-69e2-4b08-aad1-1f472a2a68ee">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi03LTEtMS0xNDA1MjM_49c0fe5f-21d1-452c-a908-796df4a568b7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi05LTEtMS0xNDA1MjM_fdcbfa4b-a256-42c2-a028-690b62d16d9c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi0xMS0xLTEtMTQwNTIz_6a9982ce-87e4-43f2-a642-1db4e64d0db5">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy0xLTEtMS0xNDA1MjM_f6ebdaac-6f52-4d30-8b5e-52da5ec65a53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy0zLTEtMS0xNDA1MjM_005248d1-4f72-48a0-bd72-476cd747c8d2">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy01LTEtMS0xNDA1MjM_11cd5ffa-6e7d-45fa-a7c3-f14cbf7404fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy03LTEtMS0xNDA1MjM_37006f3f-8c6b-481b-a9d2-5654d9985e40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy05LTEtMS0xNDA1MjM_57a76983-7b7b-432d-8cfa-2b2474b946e3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy0xMS0xLTEtMTQwNTIz_47341491-d493-4779-b1b5-6271e33f1c85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC0xLTEtMS0xNDA1MjM_da2060b7-9992-4a61-aae5-5b8a324dde96">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC0zLTEtMS0xNDA1MjM_e255be03-7115-432e-9908-6e633c5397d3">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC01LTEtMS0xNDA1MjM_8c1544ac-cdef-40ee-a391-6a92cda4cbe5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC03LTEtMS0xNDA1MjM_b21b493d-91c4-4d1c-b4db-86288901cade">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC05LTEtMS0xNDA1MjM_6ce506f8-af0e-4e5a-84da-e703f01cd7bb">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC0xMS0xLTEtMTQwNTIz_3b970fd1-1420-47ce-8f3e-0878e6cc5dff">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS0xLTEtMS0xNDA1MjM_facd753c-1cb9-408c-b487-c127c5c42e04">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS0zLTEtMS0xNDA1MjM_19e70442-c016-4ef1-886d-d08f0090d76d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS01LTEtMS0xNDA1MjM_4948581d-3856-438e-96fc-ff2449dee728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS03LTEtMS0xNDA1MjM_ea337a3e-8aaf-49c2-84ef-25681e65e3e1">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS05LTEtMS0xNDA1MjM_05207564-1460-4ab3-98ed-37cd18862f65">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS0xMS0xLTEtMTQwNTIz_6e216f2a-8611-42d9-87a7-9c0aec974732">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6171834fcd894e66b9bdf8b9a377ecff_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi0xLTEtMS0xNDA1MjM_9b3454a0-6e53-4eb7-bd64-832841b85d8f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9d9c26183c4805bf511847202547f9_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi0zLTEtMS0xNDA1MjM_abf8d8fc-1f85-4da3-b19f-e879b9ce0c72">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c025968801c4a25945836d01ed6ac95_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi01LTEtMS0xNDA1MjM_94173133-f191-48f9-b588-4fb644235e7d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08861b972b284eedaa85076ea9b4829f_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi03LTEtMS0xNDA1MjM_49793198-4c06-4511-8818-87d416056291">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4d963bead34459498d2d03f537cf122_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi05LTEtMS0xNDA1MjM_aa792b20-c4fb-4578-8e5e-1ccdc7fdf4ad">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi0xMS0xLTEtMTQwNTIz_fbb794cc-b678-4d71-9d6e-3e35bb695f16">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2022, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDQ4Mw_eb67454e-6091-4f70-b3ff-348c500997e9">130</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i88d93fed8d3a43138335a08e977df9ef_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDQ5Ng_3ea9c089-d000-435f-9621-216132212232">58</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities,&#8221; $<ix:nonFraction unitRef="usd" contextRef="i6d022b083bbc45939920f85e12d37954_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNjU5NzA2OTc3NzEzMg_02ad3755-9193-4de1-9a05-b7167c84e3d9">36</ix:nonFraction> million was recorded in &#8220;Liabilities held for sale,&#8221; and $<ix:nonFraction unitRef="usd" contextRef="i216779d361ff48b8b7d99ea6028d66c7_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDUyNA_d548c96c-f4ea-4647-8cc9-e1013b9176d7">36</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily includes cumulative translation adjustments and transfers to certain other liabilities.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="i81de2cd00d5c400eb7e981ccb4e2a83e"><ix:continuation id="if592c2623ed447e787e64fe14bc21a6b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of June 30, 2022, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDYzNA_d953eec1-193c-4e41-9363-cad000f4e013">116</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ib92e13fab3344b80882529369055d140_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDY0Nw_1532ac37-d2fd-4417-a9b8-485f86eb5f7d">62</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities,&#8221; $<ix:nonFraction unitRef="usd" contextRef="if81042ef89a44749b328252179e501f0_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDY3Mg_407cf9c6-de97-4775-9656-ae630eef27a6">26</ix:nonFraction> million was recorded in &#8220;Liabilities held for sale,&#8221; and $<ix:nonFraction unitRef="usd" contextRef="i6e446b32652445c78cd737bf63c505d0_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDcwMQ_cd332634-e45b-45b3-9b0d-5b2a0abb2958">28</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></ix:continuation></ix:continuation></div><div id="ida37730e58094407b89f4630fc6c6b2d_43"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfNDAwOA_2527b60f-eaef-4258-ba57-73a3fa328508" continuedAt="i6f031b8970514b6789036a2e2055bff3" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i6f031b8970514b6789036a2e2055bff3"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022 and 2021, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfOTc_5c975a2f-08c1-450b-a6d3-1cf4ed198731">199</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMTI5_495f9138-450a-486c-aa78-48b540f91bf4">26</ix:nonFraction> million, respectively. The Company&#8217;s reported income tax expense rate was <ix:nonFraction unitRef="number" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMzI5_6d3fbb24-e972-4877-a026-4ffa141ad857">19.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMzY2_fd519098-5460-4085-a545-b92050b5ce25">4.6</ix:nonFraction>% for the three months ended June 30, 2022 and 2021, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to discrete benefits recognized in the quarter. During the three months ended June 30, 2022, the Company recognized a net discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfNjU5NzA2OTc3NDU5OA_9a2c27d7-4b64-4a20-853c-dfae158a3748">45</ix:nonFraction> million primarily related to the tax impact of share-based compensation. During the three months ended June 30, 2021, the Company recognized a net discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfNjU5NzA2OTc3NTQ3NQ_ed2e6f5e-6b6d-498c-bcda-89a7ed1bb6ac">97</ix:nonFraction>&#160;million primarily related to statute of limitation expirations in various taxing jurisdictions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-8" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMjg3Mw_bb343733-7c9f-4178-94b5-b90527ced1a2">1.5</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-8" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMjkxNQ_19bfacbd-2c64-4836-84ac-f2182a1fce8b">1.3</ix:nonFraction> billion would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that our unrecognized tax benefits may decrease by as much as $<ix:nonFraction unitRef="usd" contextRef="icb71f08be1794969b42bcb9fbb8584e9_I20220630" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMTY0OTI2NzQ1MDk0OQ_a0f4e714-c20d-4ba2-9ed6-2d0a9b5223c2">150</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i555ad7eb9be24508ab277351083f8b95_I20220630" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfNjU5NzA2OTc3NDQ4Ng_3a8616b0-82e9-4cc4-b55f-0e85477a216b">190</ix:nonFraction>&#160;million due to settlements of tax examinations and statute of limitation expirations based on the information currently available. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year or statute of limitations expire, and if the ultimate resolution of unrecognized tax benefits differs from this estimated range, the Company will record any additional income tax expense or benefit as necessary in the appropriate period. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.</span></div></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_46"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfNDYwNQ_cac161fb-d30f-4908-b928-58083b53aac4" continuedAt="i10220f299a2d4d5d98adbb16349cdf25" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></span></div><ix:continuation id="i10220f299a2d4d5d98adbb16349cdf25" continuedAt="i5633e67acafd42b987e98e7f11c7bda9"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s previously recognized redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i71f3011cbd3947f88570706f2746d1cd_I20141231" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMzg4_93b1ea95-94a0-4f2e-b814-188be186ac17">0.83</ix:nonFraction> per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="i97348d9c0c3c492caee0d7de4e918481_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfNTI3_be0e7a42-bd04-4ee5-b1cf-7adf1393cd4b">8</ix:nonFraction> million during the three months ended June 30, 2021. This amount was recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statement of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i62f4dfc0153d46679ff78f542f7e14de_I20141231" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfOTgx_9510bf7e-b717-420c-b1b9-6a24ab34bb3b">22.99</ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="i62f4dfc0153d46679ff78f542f7e14de_I20141231" decimals="2" name="mck:PutRightValueInterestRateSpread" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTA0NA_adf24d71-b8c7-4c12-8fa9-c4124a93e25a">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). During the three months ended June 30, 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i97348d9c0c3c492caee0d7de4e918481_D20210401-20210630" decimals="-8" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMjM2Mg_de0da708-ca6e-4c35-8dab-4e7f59fb43b3">1.0</ix:nonFraction>&#160;billion to purchase <ix:nonFraction unitRef="shares" contextRef="i97348d9c0c3c492caee0d7de4e918481_D20210401-20210630" decimals="-5" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMjM5OQ_46e00ad8-c89c-4f15-9b28-4f4f65b0d112">34.5</ix:nonFraction>&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMjU5MA_9fc8812a-e288-4cab-b6ce-edbe56da1265">983</ix:nonFraction> million for the three months ended June 30, 2021, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $<ix:nonFraction unitRef="usd" contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTY0OTI2NzQ0NzY1OQ_34167755-113e-4158-b5d7-702debeb61bb">178</ix:nonFraction> million as an increase to McKesson stockholders&#8217; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTY0OTI2NzQ0NzY2Ng_361a5373-6ec0-4ac1-9bc5-64ccb40f434e">287</ix:nonFraction> million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Condensed Consolidated Balance Sheet.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i5633e67acafd42b987e98e7f11c7bda9"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. The Company&#8217;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221; The Company allocated $<ix:nonFraction unitRef="usd" contextRef="i17aa11bc6b1c4164b6719d0eae227c3b_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTY0OTI2NzQ0NzU0NQ_92d05628-6f8a-4ab7-bd00-270bd746a1e4">41</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i83027e4dbfea4e06a441bc5aa8dc605f_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTY0OTI2NzQ0NzUxOA_acf6cd67-9e0d-4bf1-959b-44f84f31fe73">39</ix:nonFraction> million of net income to noncontrolling interests during the during the three months ended June 30, 2022 and 2021, respectively, which was recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations.</span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfNDYwOA_b029e867-70d0-40ea-a1be-9a69796d8770" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in noncontrolling interests for the three months ended June 30, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0afdd8a78b4984a7c33d73ebec78e1_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfMS0xLTEtMS0xNDA1MjM_619046c3-08f7-485e-bf87-f0ab3bd2bb00">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfMi0xLTEtMS0xNDA1MjM_baee3cf4-b822-43bf-bcb9-053b87d821f7">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfMy0xLTEtMS0xNDA1MjM_89a875a6-c20b-4755-b431-15ada152b42b">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfNC0xLTEtMS0xNDA1MjM_12dd8c7b-52c5-4be8-9adb-53b733499621">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfNS0xLTEtMS0xNDA1MjM_d449f582-7f3e-4bfa-8f76-aec67f779681">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfOC0xLTEtMS0xNDA1MjM_5e7c01c1-8328-407f-ad41-311eff514725">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5026063ddbbd426490dc361b9a57ba33_I20220630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfOS0xLTEtMS0xNDA1MjM_d5c156bc-47b5-437a-baeb-6f58b2dae711">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31619d5dfb2942f181793348c62fa60a_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMS0yLTEtMS0xNDA1MjM_7fca2c12-0729-4162-9186-0df0818409f7">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffeb32001f68497d8267ddc9ae2c0968_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMS00LTEtMS0xNDA1MjM_bf5a1e70-8e0f-4e88-b755-29d7e56bfe5a">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMi0yLTEtMS0xNDA1MjM_be78f9af-68d0-4e05-836b-b2498d07c7e6">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMi00LTEtMS0xNDA1MjM_4074dd1d-f8a7-461d-b758-1a57ef2c912b">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMy0yLTEtMS0xNDA1MjM_6d397555-4949-4a68-86f2-2fd4350959a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMy00LTEtMS0xNDA1MjM_d29235ff-e65e-4ee3-8b01-da894cfbaf41">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNC0yLTEtMS0xNDA1MjM_386f0f0b-16bb-4e97-8adc-432c32a43050">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNC00LTEtMS0xNDA1MjM_1b7d8a5f-d793-4969-8e34-e335f6dc8343">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNS0yLTEtMS0xNDA1MjM_bb1779b1-8035-415e-b739-81c7e58e8a9d">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNS00LTEtMS0xNDA1MjM_0d38c7b8-e103-4729-9379-9848f3e0eae2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNi0yLTEtMS0xNDA1MjM_b8f65b13-05f2-4779-94d8-651e33b20713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNi00LTEtMS0xNDA1MjM_9fc8812a-e288-4cab-b6ce-edbe56da1265">983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNy0yLTEtMS0xNTQ3Mjc_361a5373-6ec0-4ac1-9bc5-64ccb40f434e">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNy00LTEtMS0xNTQ3MzY_6c389b3c-ce19-4f2e-ad2c-0ee1e9d83fdc">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNy0yLTEtMS0xNDA1MjM_70a47b80-a870-41bb-bb0b-ba943ed04894">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNy00LTEtMS0xNDA1MjM_389c7673-59bb-45c6-8221-280312d11a40">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97688416d8624c10a48f226d71563b9e_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfOC0yLTEtMS0xNDA1MjM_440c1839-1e05-4caf-91d6-457c70dadb88">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e32cd74f0c4010a3e8e787177c3aaa_I20210630" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfOC00LTEtMS0xNDA1MjM_96467a25-f964-47d8-a498-2de6627b38a7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_49"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RleHRyZWdpb246NjVmOTk4YzU0ZjJlNDA4ZWJmYmFjYzNjZmU0N2ZlNGNfMTI3Mg_5d657c45-bd2d-4315-9484-16530de84450" continuedAt="i68fa94edd56b4ccfb86bce3443aef9bf" escape="true">Earnings (Loss) Per Common Share</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i68fa94edd56b4ccfb86bce3443aef9bf" continuedAt="id8afcd7a81fb4b1fbae88056d027a1a3">Basic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Fewer than <ix:nonFraction unitRef="shares" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RleHRyZWdpb246NjVmOTk4YzU0ZjJlNDA4ZWJmYmFjYzNjZmU0N2ZlNGNfMTY0OTI2NzQ0MzAzMw_155444f4-875e-423f-ac99-ca8e0de64777">1</ix:nonFraction> million potentially dilutive securities for each of the three months ended June 30, 2022 and 2021, respectively, were excluded from the computation of diluted earnings per common share as they were anti-dilutive.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id8afcd7a81fb4b1fbae88056d027a1a3"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RleHRyZWdpb246NjVmOTk4YzU0ZjJlNDA4ZWJmYmFjYzNjZmU0N2ZlNGNfMTI3NQ_1a10ed82-ca34-4eb5-8ba4-70f74a39bdb9" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMi0xLTEtMS0xNDA1MjM_312ff5ce-b34f-46da-a003-5c3bd299c2a4">807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMi0zLTEtMS0xNDA1MjM_187972ae-8337-4eb6-8a2a-acd09acaf320">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMy0xLTEtMS0xNDA1MjM_3578a51e-a642-49d7-b323-26b1ba517fa3">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMy0zLTEtMS0xNDA1MjM_257686ba-b8dc-48c5-9e43-30f626173ced">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNC0xLTEtMS0xNDA1MjM_19869bdd-4bdc-4ac0-8f85-a3baf42fb75c">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNC0zLTEtMS0xNDA1MjM_7e404d90-8d60-4892-ba1b-fb45c16a5a4a">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNS0xLTEtMS0xNDA1MjM_591f0444-9854-4675-9a64-f565fcb4b3e7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNS0zLTEtMS0xNDA1MjM_81cf4019-2ef8-40c6-b4ba-6d7bbf6a6cce">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNi0xLTEtMS0xNDA1MjM_e89d46e2-ef0b-42d2-beac-630fc303bf34">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNi0zLTEtMS0xNDA1MjM_b2b76f2f-c4b1-46e7-9f2a-c531de8a318a">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfOS0xLTEtMS0xNDA1MjM_549a0e94-7eae-4337-b47b-f560b6a12207">144.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfOS0zLTEtMS0xNDA1MjM_8cb35a3b-e378-4eda-b7c1-7dc666e925db">156.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82d9a039d97f4e1f810d8c8939c48515_D20220401-20220630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTEtMS0xLTEtMTQwNTIz_87868986-81e9-4a2f-af72-3f3e8c391dd4">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c9753fdbc8c42afa67a387dbdc341f2_D20210401-20210630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTEtMy0xLTEtMTQwNTIz_917747bc-a970-40cf-953d-ee54a9d3d125">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac0f191ee9524cc4a123dca1beca64b2_D20220401-20220630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTItMS0xLTEtMTQwNTIz_cec84d04-9ce5-4dd7-960d-aaf95e98fef0">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0d41c1016b54583a7525969593331c4_D20210401-20210630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTItMy0xLTEtMTQwNTIz_e8e3449c-eb64-40f0-a566-488f4642b6f1">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTMtMS0xLTEtMTQwNTIz_5d0044b9-b988-4f14-a92a-1777d6b6f4da">145.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTMtMy0xLTEtMTQwNTIz_f5fd5943-e0dc-43d2-a069-09aba5384f54">158.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTctMS0xLTEtMTQwNTIz_928190b2-49a3-4c3c-90ca-3081a8b5d1ba">5.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTctMy0xLTEtMTQwNTIz_8c3cde3c-e414-442d-a50e-01d947c2dca7">3.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTgtMS0xLTEtMTQwNTIz_f0e977a6-fdc7-4c2b-8d67-525eeac1860f">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTgtMy0xLTEtMTQwNTIz_d11b337c-0ceb-4f0f-bcb4-cbb65d5166a4">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTktMS0xLTEtMTQwNTIz_5fb7939a-92db-4494-8b4e-541b248c2895">5.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTktMy0xLTEtMTQwNTIz_682a72e9-cbcf-4c2f-bfea-d2ba2c1a175a">3.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjEtMS0xLTEtMTQwNTIz_36240e28-0668-4136-b2e0-f2584239a09d">5.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjEtMy0xLTEtMTQwNTIz_ad38c9fb-35cb-454b-9036-b17f3a94f402">3.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjItMS0xLTEtMTQwNTIz_eb53841e-0677-4e2e-8c93-02095d5af7fc">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjItMy0xLTEtMTQwNTIz_ada368c7-932f-448f-86f7-e503d1ce8b09">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjMtMS0xLTEtMTQwNTIz_5f96ca38-4434-409e-8151-f439914df0c4">5.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjMtMy0xLTEtMTQwNTIz_c0dd2cb0-f3fc-4369-b814-4a240f4afa9b">3.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div></ix:nonNumeric></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_52"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTk0OA_2a74f095-c9fe-40eb-b4f4-c998a1f3c6a6" continuedAt="id87d0d7f02fd4602becf78d6f0ed576e" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:continuation id="id87d0d7f02fd4602becf78d6f0ed576e" continuedAt="ide4d5b87153842cfa2e0046f096e1cda"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. The Company voluntarily changed its annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with a change in timing of the Company&#8217;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#8217;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. The annual impairment testing performed as of April 1, 2022 did not indicate an impairment of goodwill.</span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ide4d5b87153842cfa2e0046f096e1cda" continuedAt="ifff85063e4f8476ba7c91d9560b517b0"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTkzNQ_030166de-8720-4539-81cf-b63fb6d2d7c8" escape="true"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1603e72ed6c4daa8b8ca5a07fbd1091_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS0xLTEtMS0xNDA1MjM_5efb923d-6cc2-42e0-8b3d-88f1ffe7db8c">3,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f27ef316774f2ebcc0ec59b1f39297_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS0zLTEtMS0xNDA1MjM_3df21db0-d6fe-402c-aac8-bddec7f7e537">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib406df4db52b4b27b436c0fc953e4a8e_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS01LTEtMS0xNDA1MjM_97c083e4-2c9c-4582-b8e9-d18d363ba2df">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79bce56293174c7db4e539b562cc2526_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS03LTEtMS0xNDA1MjM_a2472b30-5edd-4521-a808-1301122f1f75">1,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS05LTEtMS0xNDA1MjM_40ce87c0-aacf-44d7-8178-7a7896e5b49e">9,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e71847d225b4930bef9de929f3f2a3c_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi0xLTEtMS0xNDA1MjM_a56b33ca-c233-4b63-8784-418e04fe471f">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9167671dc7c472eb51af611bf7cc7e4_D20220401-20220630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi0zLTEtMS0xNDA1MjM_4c96850a-18a4-4108-a471-425357806cc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c30ffbc257945ba83eb82993a8be420_D20220401-20220630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi01LTEtMS0xNDA1MjM_1c0a0b06-0840-4729-9ca0-7341ea5aca8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b46e42465d84c47a2183912a0e10716_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi03LTEtMS0xNDA1MjM_59141d38-f7ca-4b1d-a831-a5a5346c2e67">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi05LTEtMS0xNDA1MjM_f0bb0690-11c0-4694-8b20-b38fd87c610b">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e71847d225b4930bef9de929f3f2a3c_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy0xLTEtMS0xNjI5Njk_b2134f10-b4aa-4712-934e-38bfcb2a8fa3">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9167671dc7c472eb51af611bf7cc7e4_D20220401-20220630" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy0zLTEtMS0xNjI5Njk_a0115323-ac25-44e9-9e75-fcfb1164c3e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c30ffbc257945ba83eb82993a8be420_D20220401-20220630" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy01LTEtMS0xNjI5Njk_126a805c-cf0e-451c-a018-8800ce2cbd77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b46e42465d84c47a2183912a0e10716_D20220401-20220630" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy03LTEtMS0xNjI5Njk_69108c8f-feb4-48bf-8599-b0b7502e088a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy05LTEtMS0xNjI5Njk_fc166c71-3f5e-4e68-8f13-fe426d7fda84">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2973547bb0b04222a89b6729430ffa65_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy0xLTEtMS0xNDA1MjM_c14cd4c2-c48d-44bb-8f70-29a1644aca5d">3,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b7ea531f5944e9a9d6f976d44806d0_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy0zLTEtMS0xNDA1MjM_ccd89322-ffc7-4fa8-8a47-1e0aca0b00ea">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e7f49efd664e9eb7c79c6728a445c6_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy01LTEtMS0xNDA1MjM_80b93670-8186-484e-a8c5-86094064d432">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i403f9ff68d8c4127940b5ac3bf567cb2_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy03LTEtMS0xNDA1MjM_e781be29-51cd-497e-b847-c5ca9a595875">1,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy05LTEtMS0xNDA1MjM_15721dab-e078-4943-8b3c-3310382c0b3d">9,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTk1Mw_b41c987e-f1ca-4e0f-8f81-085b57c2d870" escape="true"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8356415b26f44a79a7bef9dd35e8c8c6_D20220401-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi0xLTEtMS0xNDA1MjM_25fe78fd-6cad-4a8e-ab91-0298f893172c">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37712c0066f64e0bb1e51fcf34f13275_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi0zLTEtMS0xNDA1MjM_edad1a97-8754-425c-9f19-0eff2c03e64a">2,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37712c0066f64e0bb1e51fcf34f13275_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi01LTEtMS0xNDA1MjM_6301e4ac-e55a-4ac9-b551-0aa4f350071a">1,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37712c0066f64e0bb1e51fcf34f13275_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi03LTEtMS0xNDA1MjM_acc67291-096e-4669-a9fb-7b59789c926e">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebea36d3b82e4242a79f2cb24837bf11_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi05LTEtMS0xNDA1MjM_4bf8aef5-36c8-469e-98f5-a66de36ba713">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebea36d3b82e4242a79f2cb24837bf11_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi0xMS0xLTEtMTQwNTIz_68a0e80e-def0-469f-9ee1-cbf1c52ddb31">1,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebea36d3b82e4242a79f2cb24837bf11_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi0xMy0xLTEtMTQwNTIz_f90cd998-7e0a-44e5-93f6-99a619868567">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i56b572e5f85647c2bb4157a3e9274374_D20220401-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy0xLTEtMS0xNDA1MjM_ccb98979-ad8a-42a3-9d8e-1a8a5c865507">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7584d2566eb4f808e5b3c32bf252562_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy0zLTEtMS0xNDA1MjM_1194d1c2-be7c-4dab-8ac6-ab3a53577473">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7584d2566eb4f808e5b3c32bf252562_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy01LTEtMS0xNDA1MjM_bddefab6-9755-424d-9c27-f2826526d2dd">584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7584d2566eb4f808e5b3c32bf252562_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy03LTEtMS0xNDA1MjM_f838577e-4a85-4ac4-97f8-64c2aebd3ad5">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e32fde2d0c74321a6ffc1d2e7fcfab3_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy05LTEtMS0xNDA1MjM_0de45ab5-cf2a-4ee7-83bf-13daa3b8330f">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e32fde2d0c74321a6ffc1d2e7fcfab3_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy0xMS0xLTEtMTQwNTIz_a240ba72-6137-4a64-a422-f745e3492001">573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e32fde2d0c74321a6ffc1d2e7fcfab3_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy0xMy0xLTEtMTQwNTIz_5964d723-9814-4de0-973e-3e037cad6bc0">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b0754d6d499499ea1f08e091a6e4313_D20220401-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS0xLTEtMS0xNDA1MjM_361bc8f4-d727-4266-b879-c78d66b0748a">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0dcd0a8f12f4512a836f6114659037f_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS0zLTEtMS0xNDA1MjM_8ab8c1c1-10fc-47fc-97b8-76ea5d147302">802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0dcd0a8f12f4512a836f6114659037f_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS01LTEtMS0xNDA1MjM_5e88a246-3385-4832-93c6-1b4e41ba7ced">397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0dcd0a8f12f4512a836f6114659037f_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS03LTEtMS0xNDA1MjM_3966c2b9-1670-4bae-a52e-64190d5bc5f7">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bee33b48ae745368d813bb179998562_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS05LTEtMS0xNDA1MjM_960b5cab-1c2b-4146-8c3a-ac7947a0d30f">819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bee33b48ae745368d813bb179998562_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS0xMS0xLTEtMTQwNTIz_cee9ad89-df28-4c57-adf1-4da4863ffce6">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bee33b48ae745368d813bb179998562_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS0xMy0xLTEtMTQwNTIz_bc7c48cf-c46d-44d7-ae77-a71a5083cd2c">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1884f32c95e4196b9733d13eed48df6_D20220401-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi0xLTEtMS0xNDA1MjM_f57ddb4d-ea4c-4cc4-af52-69a10181cb04">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5a01c7f75b4124be2e8212faabad25_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi0zLTEtMS0xNDA1MjM_af666da6-78d3-495e-ab2f-5a658ce7ec38">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5a01c7f75b4124be2e8212faabad25_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi01LTEtMS0xNDA1MjM_3342610c-8635-44b9-bc16-2a3fe658f9c7">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5a01c7f75b4124be2e8212faabad25_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi03LTEtMS0xNDA1MjM_277be7f0-0b5b-45cb-95fb-e3fe622f8a76">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id45be366e31e4b0eb3bb557a83a956d4_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi05LTEtMS0xNDA1MjM_f0f71fbd-211c-4b63-8205-a3c3528689b3">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id45be366e31e4b0eb3bb557a83a956d4_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi0xMS0xLTEtMTQwNTIz_331a64c0-dff5-4bf6-bf11-bc9563fe180b">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id45be366e31e4b0eb3bb557a83a956d4_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi0xMy0xLTEtMTQwNTIz_c8daf544-c099-4618-8781-4340ee9298e3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8aeceba0472c4993b4306ff3c946485a_D20220401-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy0xLTEtMS0xNDA1MjM_12384bf7-afb6-4a45-8e89-67ddce0f2e6b">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93d8e3ed6e654406a8a87749f03f9693_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy0zLTEtMS0xNDA1MjM_ba01b03f-e8fa-458e-927c-b1f1f73d0f9c">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93d8e3ed6e654406a8a87749f03f9693_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy01LTEtMS0xNDA1MjM_8886c88e-7153-4c11-8f1e-6775be645ac8">172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93d8e3ed6e654406a8a87749f03f9693_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy03LTEtMS0xNDA1MjM_430b3705-18aa-4521-8b58-52eab52966b8">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1e9f681efc9418e8d647ad3a6c73873_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy05LTEtMS0xNDA1MjM_8dd18612-81a9-45b2-9dd9-c2c512c41f08">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1e9f681efc9418e8d647ad3a6c73873_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy0xMS0xLTEtMTQwNTIz_b9cadd5e-d1e7-4701-9363-ba14e927a17c">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1e9f681efc9418e8d647ad3a6c73873_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy0xMy0xLTEtMTQwNTIz_495187e0-0a83-4509-942d-044d4ae1c219">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC0zLTEtMS0xNDA1MjM_5686fcb1-7be4-4040-9f09-4a37f8c5de66">4,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC01LTEtMS0xNDA1MjM_bbfc911d-bc05-4de5-8595-d3b1eb8e7d2c">2,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC03LTEtMS0xNDA1MjM_a0c50cf8-5460-4e80-a619-9519fe3bb33b">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC05LTEtMS0xNDA1MjM_1901b036-59da-48e7-8489-632deb85692f">4,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC0xMS0xLTEtMTQwNTIz_586704b8-66c6-47cb-8537-03323a626e88">2,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC0xMy0xLTEtMTQwNTIz_e4a2eb29-5478-4356-bcfe-e50d51ccbfda">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifff85063e4f8476ba7c91d9560b517b0">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTU5Ng_96f7f9d7-b4ff-4da8-8f16-15119ee7502d">56</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTYzOQ_ad2970c9-86eb-425c-9cb5-bd4eeb915c40">98</ix:nonFraction> million during the three months ended June 30, 2022 and 2021, respectively. Estimated amortization expense of these assets is as follows: $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc0MA_ec114483-9819-4b99-9e88-7aa841386f8b">166</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc0NA_9a1630d6-02b7-4685-83d2-d1ad5396c1cf">211</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc0OA_a940f6f1-7fc7-4998-9415-1833c3604235">206</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc1Mg_12278112-53c5-4104-be87-6fb0a83779d4">174</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc2MA_afa8c842-d635-40f1-8ae4-2a5e183450e9">168</ix:nonFraction> million for the remainder of fiscal 2023 and each of the succeeding years through fiscal 2027, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-8" name="mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTg1MA_93b368a9-fd57-4f88-a7e4-61935f9e8352">1.1</ix:nonFraction> billion thereafter. All intangible assets were subject to amortization as of June 30, 2022 and March 31, 2022. Amortization of intangible assets of the E.U. disposal group classified as held for sale ceased in the second quarter of fiscal 2022.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjIxMA_643d28df-805f-49f3-8134-d7fded335f58" continuedAt="ib43182c0070d459e9d85c30eecf0f886" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="ib43182c0070d459e9d85c30eecf0f886" continuedAt="i2e9dc10a488c49b59e7df29029674368"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjIxNA_31525e6e-c119-4803-b51a-101cda1dd901" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff711db73c6f4c5e9f9a44b9edfa2c8f_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMi0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjpmNzE1MGQ5MTJjZGI0MmFmYTY4MmIwNTk1NDZjMTE3ZV80_de4dca4f-26bc-4dd4-9b27-7fc0a4f66620">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff711db73c6f4c5e9f9a44b9edfa2c8f_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMi0xLTEtMS0xNDA1MjM_1ae7ee75-7e15-41fb-978c-7947dc8cce94">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964e360bb5304a7a91cbb307fe41a400_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMi0zLTEtMS0xNDA1MjM_7e7c4f0b-cb63-4ab7-b79d-ed490ba0a803">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iefc091ee1ba943d9bd16e2df30bb21cb_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMy0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjo2NzcwYWZkMmJiNTM0ZDU3ODJkN2YzZWFlYzVhMzI5MV80_9ae8a2eb-59e3-4e93-b800-0bc6e7c02b63">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc091ee1ba943d9bd16e2df30bb21cb_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMy0xLTEtMS0xNDA1MjM_3ff03d70-f07b-4aa5-ad73-1f6594b1094a">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32ca5071eb44a8fafb2dc2af15d5f2a_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMy0zLTEtMS0xNDA1MjM_9d896a51-5e0c-446a-a11a-97033a826389">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4cd5447a107486e8828badac335b9ea_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNC0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjo2Y2NkZjIzZmE1Yjg0Njc3ODJmNGI0MWIzZmRhOWUzNl80_20c4796a-db34-4dcf-a408-70dc2ec06e5e">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4cd5447a107486e8828badac335b9ea_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNC0xLTEtMS0xNDA1MjM_2b56c634-8021-401b-9f82-2f7763f126f4">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b43926998845dbb130d523377325ab_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNC0zLTEtMS0xNDA1MjM_ea6909e9-8a9e-4a20-84e9-c6fd4b4bec35">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3167bf1182f948fdba7729ff76cf27b3_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNS0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjpkYjdiYTE2ZWQwYzg0MjQ0YWM5MjQ1MDg4ZTNhMGZjNl80_4e122d7a-74bf-4c3a-aedb-c3c315a43366">0.90</ix:nonFraction>% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3167bf1182f948fdba7729ff76cf27b3_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNS0xLTEtMS0xNDA1MjM_916517a1-8c9f-46f8-9bc5-40d68cd5de65">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfe85e7a9b641a78490906855cf69b3_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNS0zLTEtMS0xNDA1MjM_d84761a3-7921-45f2-8868-a722967a1588">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a0b0abcd2744a1582bac3909196080c_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNi0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjo0OGVmNTNlOWZkYTI0YjZhODVhYTFlN2JhMGQ3MjQ2OF80_0f03c137-ecc0-4b94-95e6-bcd3fe5ff3ad">1.30</ix:nonFraction>% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0b0abcd2744a1582bac3909196080c_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNi0xLTEtMS0xNDA1MjM_1379e20a-82df-4824-bdae-0d5033de16c8">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6328397e5e846f2926603d07bf5629f_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNi0zLTEtMS0xNDA1MjM_117f4d5b-4c45-4012-89b5-02e897750739">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i565074a91efd4e2baba451998e9fe4e9_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNy0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjo2ZWJlNTE5ZTUxZGQ0YTdlOWNlZmNkN2VlZTNlMTEzYV80_882e72c7-7762-4b5f-ab80-10ea6a2ea60b">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565074a91efd4e2baba451998e9fe4e9_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNy0xLTEtMS0xNDA1MjM_bd577cf9-89eb-4527-a092-e4fa8f46ee18">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafef158a41cf4048baa5a93cb0b6620d_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNy0zLTEtMS0xNDA1MjM_54df560a-9313-40b1-9314-18ccf58651b6">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b7fb8d52da24328b8964b016e0c3351_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOC0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjowMzM1OGRkYzkzNTI0M2ZmYTIwZjllYTA5NGE5NWYxMl80_e3ea76c2-f993-4d0a-a118-0bf0f0a67fd1">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7fb8d52da24328b8964b016e0c3351_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOC0xLTEtMS0xNDA1MjM_d84efede-6d3a-4f75-a8c8-096636dde710">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab1fe3e771e4795b92c3519d4aa2a57_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOC0zLTEtMS0xNDA1MjM_1d17c0b1-9895-4955-9ff6-5c0b618bb023">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9575f4f1c94440dbcd550e774d94cf2_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOS0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjpjMDZjYzQ1NGNhMTQ0YTM5OGY3OGQ4MjEyZjY3NDkzN180_9671dc89-9500-4f86-8507-2b960a4ecc3f">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9575f4f1c94440dbcd550e774d94cf2_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOS0xLTEtMS0xNDA1MjM_a568e8a2-3280-4770-ac75-4d87d089da9b">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c01fc67d7d4672a61f5062adaa04d9_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOS0zLTEtMS0xNDA1MjM_6fa4fc66-c74b-4462-a07e-fd6ffa224eed">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c6e596876c14eceb35218c7197c764c_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTAtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NGMwYjA5MDMzZDUwNDVjOWJkM2I5OWQxYTlmMDgwYjBfNA_c14d5d48-3b6f-4120-8821-ff22baf38ebd">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c6e596876c14eceb35218c7197c764c_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTAtMS0xLTEtMTQwNTIz_8803f380-09db-4c9b-88f7-e7dfe5729ebb">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24aabefa576e4aa09449e0603fd27472_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTAtMy0xLTEtMTQwNTIz_54664c77-7120-4877-a797-f7712bb6bbd4">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0e935c6a9174c0198aeceebe6d8008b_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTEtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246MjEzMGUzZWI2ZTMyNGI0NDhiNzBlYTNjMWVjODFjNzVfNA_5b2df197-a562-429b-a8dc-7b2a9aa69569">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e935c6a9174c0198aeceebe6d8008b_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTEtMS0xLTEtMTQwNTIz_5508b01c-3ab8-44fc-8965-d1dc093cdeaf">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb8a57a80a64603b803e2b679fdc63b_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTEtMy0xLTEtMTQwNTIz_86395680-bef1-42f1-af12-9a1d8c9da070">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id3d0ea03571840b0b0defd993f65540b_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246MGY4MDk5NGMwZTA2NDJiZmI4ZDc3MjlmZTYwYjE1YjhfNA_528d0c82-6321-4f3f-8e42-1d11e992797b">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d0ea03571840b0b0defd993f65540b_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTQtMS0xLTEtMTQwNTIz_2f79d8ef-d4df-4cc6-8c5b-919e2b3d5e1f">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac3251871f54afb9e05a2dd9845dd86_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTQtMy0xLTEtMTQwNTIz_5235a949-e81b-42ce-9445-0faf612cf267">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8e2051458de4ca3b3ff972dc1e5df47_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTUtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246OTQ4OTJiMGQwNDJlNDE1NDkyMTViYTg2MzEwZTcxMTJfNA_3a360c2d-022a-4ae5-bb6a-8037b66549e3">1.63</ix:nonFraction>% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e2051458de4ca3b3ff972dc1e5df47_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTUtMS0xLTEtMTQwNTIz_caa4be6b-7b02-4e6d-a0a1-4de9949a8cf6">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i466138b603084d54be88ad1a34567c8b_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTUtMy0xLTEtMTQwNTIz_6b9a055d-ad67-4323-9576-124aac4d88c7">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i752a8a7f16074f689ee9d1b4892d270f_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTYtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246MDhjYWQ5MTRjMDQxNGRhNThhY2Y3ODk1MmJhMWVjM2VfNA_8f6fc337-9fca-4822-b323-8f9f89aa7fef">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752a8a7f16074f689ee9d1b4892d270f_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTYtMS0xLTEtMTQwNTIz_0b04e8fa-3e18-4182-b8cc-9bd3f066e04b">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2166a8ac1e96401c8f1600c898c367ac_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTYtMy0xLTEtMTQwNTIz_2f7a09ab-cd61-4de8-8d3d-eadb932a6bc0">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTgtMS0xLTEtMTQwNTIz_85841e4c-de4c-472c-9086-8103bad96428">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTgtMy0xLTEtMTQwNTIz_2eb817ec-2b48-42fd-90da-310291fa7143">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTktMS0xLTEtMTQwNTIz_2aefbf4c-2118-4b1a-8bdf-b8f2d4186be0">5,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTktMy0xLTEtMTQwNTIz_1168560a-8d71-4e8d-8941-706982c9bab7">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMjAtMS0xLTEtMTQwNTIz_cde9a9f9-83e7-4493-abed-fefb0f3e144f">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMjAtMy0xLTEtMTQwNTIz_c680d512-1df0-4f7d-9ceb-31a665a7207a">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMjEtMS0xLTEtMTQwNTIz_9f42e971-a308-4da9-93f8-0561249b097b">4,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMjEtMy0xLTEtMTQwNTIz_4c0e6634-c5d1-4ad5-ac2c-b4e8cb868fbe">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjcw_79a7f0c5-9752-4fd5-8de1-1081735bf0f9">5.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjc3_59558f85-8bdf-41a6-9e9c-84d375bf049f">5.9</ix:nonFraction> billion at June 30, 2022 and March 31, 2022, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNzE3_2247d530-673c-4c41-8a5a-4e170841a8e2">799</ix:nonFraction> million, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets at each of June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Credit Agreement, dated as of September 25, 2019, as amended (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $<ix:nonFraction unitRef="usd" contextRef="ieb8a1defb0594686a254e66fc7830f7d_I20190925" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDA5NA_199f0106-7311-4831-9ba7-0e8358e19cea">4.0</ix:nonFraction> billion <ix:nonNumeric contextRef="if7e42ec92f674a79afbd81e8fb750262_D20190925-20190925" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjIwNg_68d19784-e277-4aa9-b4e2-a97c7ccd1ce3">five-year</ix:nonNumeric> senior unsecured credit facility with a $<ix:nonFraction unitRef="usd" contextRef="ib12270524a7b4cc6b7b87975f0b31013_I20190925" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDE0NQ_a42166fc-68d0-46be-ab8c-61d4f4182791">3.6</ix:nonFraction> billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had <ix:nonFraction unitRef="usd" contextRef="i1ce62c7971874b97a640c6606962ea01_D20210401-20210630" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDU3NA_17f63054-72f3-455a-9f48-5ab8bdf8deaf"><ix:nonFraction unitRef="usd" contextRef="icefd77afd24c4487924437959cfe8fbc_D20220401-20220630" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDU3NA_63f6832b-6918-4d70-a133-cfd001b6031a">no</ix:nonFraction></ix:nonFraction> borrowings during the three months ended June 30, 2022 and 2021 and <ix:nonFraction unitRef="usd" contextRef="iece544191d5240e3b1283537222c41a8_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDYxNg_76fd939b-690b-480e-9064-e099a1b54859"><ix:nonFraction unitRef="usd" contextRef="i044fe80187ac47b3b779f3f5fa0c3a15_I20220630" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDYxNg_b474bd46-f583-4c79-9865-57ecca6d62e8">no</ix:nonFraction></ix:nonFraction> amounts outstanding as of June 30, 2022 and March 31, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i2e9dc10a488c49b59e7df29029674368"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At June 30, 2022, the Company was in compliance with all covenants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $<ix:nonFraction unitRef="usd" contextRef="ib3341b4ea67b4eb1bfc0be50fbf79480_I20220630" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNTQ0Mg_5b641a0a-1f2c-4468-9d7a-306686bbcf22">1</ix:nonFraction> million and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="ib8185c82e2434a0c84ff562df7ae24ab_I20220630" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNTQ3NA_890070c9-5023-4403-80d5-ead6b5ef7b03">105</ix:nonFraction> million as of June 30, 2022. Borrowings and repayments were not material during the three months ended June 30, 2022 and 2021. Amounts outstanding under these credit lines were not material as of June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="i03515862174f44c7b695b85111ea920d_I20220630" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNTgzNQ_4581ebc3-8d71-402f-9db4-db179bb03ba7">4.0</ix:nonFraction> billion in outstanding commercial paper notes. During the three months ended June 30, 2022 and 2021, there were <ix:nonFraction unitRef="usd" contextRef="iec54ae004102491b9606ef01cb1fdf20_D20210401-20210630" decimals="INF" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:fixed-zero" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjAxNw_06bc97d2-32a1-4cae-abca-2088494dcd2b"><ix:nonFraction unitRef="usd" contextRef="i8ae8a14adb19498bb9dded3088ccc4a5_D20220401-20220630" decimals="INF" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:fixed-zero" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjAxNw_418b0098-4e41-4b39-a9a6-69a8a754e7b2">no</ix:nonFraction></ix:nonFraction> material borrowings under the program. At June 30, 2022 and March 31, 2022, there were <ix:nonFraction unitRef="usd" contextRef="i03515862174f44c7b695b85111ea920d_I20220630" decimals="INF" name="us-gaap:LongTermCommercialPaperCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjE2OQ_3fa04e5f-a238-4933-a13a-2f045209138c"><ix:nonFraction unitRef="usd" contextRef="i98edbf2764e9413891b48258d46b8d5a_I20220331" decimals="INF" name="us-gaap:LongTermCommercialPaperCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjE2OQ_993d48e1-0ba2-4921-9c9a-c60d95fc1424">no</ix:nonFraction></ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_58"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTAwOA_0bac2193-5844-43a8-b50c-4864eef7b248" continuedAt="ie678f12722f24312b00a40b075c0dd92" escape="true">Pension Benefits</ix:nonNumeric></span></div><ix:continuation id="ie678f12722f24312b00a40b075c0dd92"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was not material for each of the three months ended June 30, 2022 and 2021. Cash contributions to these plans were $<ix:nonFraction unitRef="usd" contextRef="idd567c67685b42aba4f0f9ef5b214c07_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMjEx_b6f92ef8-1549-49ae-82bd-2b41ed5d3056">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3d909bc2a8994f798b89f3084cf96826_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTY0OTI2NzQ0NDI5OA_bdfd1ed3-fbf6-4052-8e0c-91692c413e8e">14</ix:nonFraction> million for the three months ended June 30, 2022 and 2021, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="i8767bea4ed9b4241b64e9c77192c274d_I20220630" decimals="INF" name="us-gaap:DefinedBenefitPlanFundedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfNTQz_567c1ea0-c0ec-422c-bca7-51b782346012">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale,&#8221; pension liabilities of $<ix:nonFraction unitRef="usd" contextRef="i51ae381b635041b2a03df829498f103d_I20220630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTY0OTI2NzQ0NDExMQ_e377036b-0810-4996-b383-e8a8a81d658b">79</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i695dd9f4cbbd46edaa4b764478844aa6_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfODg5_55ee9842-b20a-4be7-ae23-213184387206">85</ix:nonFraction>&#160;million as of June 30, 2022 and March 31, 2022, respectively, were included under the caption &#8220;Liabilities held for sale,&#8221; in the Condensed Consolidated Balance Sheets as part of the E.U. disposal group. During the first quarter of fiscal 2023, the Company derecognized pension assets of $<ix:nonFraction unitRef="usd" contextRef="i1628a1ef0d3b482691b8aa3e61736647_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTY0OTI2NzQ0MzQ4Mg_00d86104-238e-4708-998d-f80b21f6279e">49</ix:nonFraction>&#160;million and released $<ix:nonFraction unitRef="usd" contextRef="i24e204f409be4b29a94900362c7cef4e_D20220401-20220630" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTY0OTI2NzQ0Mzg2Nw_9dcaa59f-5386-4011-bf1d-64ff37da1287">30</ix:nonFraction>&#160;million of accumulated other comprehensive loss related to the sale of its U.K. disposal group. The pension assets were included within &#8220;Assets held for sale&#8221; in the Condensed Consolidated Balance Sheet as of March 31, 2022.</span></div></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_6597069767980"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ2MTYx_7284ad7e-dcf7-4a8b-8c74-1ca2273d50f4" continuedAt="id3860c22fc2b4d738fee2f58ef1d5e9f" escape="true">Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="id3860c22fc2b4d738fee2f58ef1d5e9f" continuedAt="ibd63bc68b8134c9d931dda5a59bc3604"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. Subsequent to the completion of the U.K. divestiture in April 2022 as discussed in Financial Note 2, &#8220;Held for Sale,&#8221; the Company&#8217;s foreign currency exchange rate risk is limited to the Euro and Canadian dollar.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ibd63bc68b8134c9d931dda5a59bc3604" continuedAt="ic46f6a1ee9b94d98b96618945b95448f"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="ie3254c69cbee481f97c6743efa9150c3_I20220331" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xNTEw_1bdd12ff-49e5-4dd8-a8a7-7fc4df4acc74"><ix:nonFraction unitRef="eur" contextRef="ie6f9d6fa7ca7441e8a4987577b13651e_I20220630" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xNTEw_cde65b9a-10c3-4d48-baa1-97003419659a">1.1</ix:nonFraction></ix:nonFraction> billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded as foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the U.K. disposal group as discussed in more detail in Financial Note 2, &#8220;Held for Sale,&#8221; the Company reclassified $<ix:nonFraction unitRef="usd" contextRef="i372251adcd1648eab091c52b5f01446e_D20220406-20220406" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ2Nzc5_ba1fa03a-8190-4b6b-86e1-b5b383232af3">26</ix:nonFraction>&#160;million of gains from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. This amount related to the Company&#8217;s &#163;<ix:nonFraction unitRef="gbp" contextRef="if2af5ce20fb04be99d4d91c3837262bd_I20220406" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xNjQ5MjY3NDg5MDIx_722ba681-fa43-4654-8248-f65902ee41ff">450</ix:nonFraction> million British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell.</span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ2MTYy_220e4f4e-f9c0-4395-b53c-e0b78889a0ab" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ebb607246c4e2991322746c42fa818_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6M2ZiYmNjZGUwODRjNGMzYjlhZmQwZGZmOGNiYmNiZmIvdGFibGVyYW5nZTozZmJiY2NkZTA4NGM0YzNiOWFmZDBkZmY4Y2JiY2JmYl8zLTEtMS0xLTE1NDQzOQ_871a28d1-678e-4897-af68-35995ec5e1c7">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic770e7e260c6494e91714f00ee4061af_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6M2ZiYmNjZGUwODRjNGMzYjlhZmQwZGZmOGNiYmNiZmIvdGFibGVyYW5nZTozZmJiY2NkZTA4NGM0YzNiOWFmZDBkZmY4Y2JiY2JmYl8zLTMtMS0xLTE1NDQzOQ_1e616fbc-313e-4399-b303-e28aea8824d9">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ2MTY0_e275f758-e09e-494c-814e-ba0f0b512963" continuedAt="ib26b77eb5d3c438bb422551f9f21f03a" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="ia9200147039b4d23906d2205705299fd_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF8zLTMtMS0xLTE1NDUzMA_da9eeb96-4abf-4e19-becf-f7bd825c65ad">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="ic0f94a4fe40647dcad8d868e1ecf16d5_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF8zLTctMS0xLTE1NDYzOQ_097ac4a6-bac7-4a53-8d2d-72e811a8793b">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="ie2122223b4e24f6a94b2791de320374a_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF81LTMtMS0xLTE1NDUzNg_7050f7e8-8148-44d7-9cff-69e655f12ec5">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="icaedc0e4a45e442fa6d6beac1dcb1ca9_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF82LTctMS0xLTE1NDY0Nw_01c3abff-0655-4ae2-95c3-20769f8e8526">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-27</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727c52e939144af4b31c1f88bc2836cc_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF83LTUtMS0xLTE2MDg3OQ_a0dab14e-752b-4ac6-a261-94de381ede99">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a2f796909a429daa27355e79f80ddd_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF83LTctMS0xLTE2MDg3OQ_4bfc342b-0410-48b3-b973-e5a6d8897985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jul-22 to Jan-24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="i864b745cf60843c5aaf96b4cc4f1a217_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF85LTUtMS0xLTE1NDY2Ng_bcab49e3-b55b-43a8-a785-67f77089d15c">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="ic5d560c2041344ab9c85f9e013cc904f_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF85LTctMS0xLTE1NDY3MQ_4aedaaa9-fa36-44f3-b6da-c598052fcf2f">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mar-23</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66b4897d62c94e129073ebc6630ec481_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF8xMS01LTEtMS0xNTQ3NTk_1086fd64-4594-4bfc-91ca-5ffafac37a01">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ef45188f1b4c4fae080a330a7456bf_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF8xMS03LTEtMS0xNTQ3ODA_7024f4af-bfe4-463b-871f-46041c1c221c">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ic46f6a1ee9b94d98b96618945b95448f" continuedAt="ie82e8b7044854923a213561b1ea7521d"><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="ib26b77eb5d3c438bb422551f9f21f03a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge the changes in the fair value of British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#8217;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2023, the Company entered into floating interest rate swaps to convert $<ix:nonFraction unitRef="usd" contextRef="i727c52e939144af4b31c1f88bc2836cc_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ5NTA0_519f749f-955e-4d2f-89d6-496c4994bac1">180</ix:nonFraction>&#160;million of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in earnings.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations were not material for the three months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are mark-to-market at the end of each accounting period with the change in fair value included in earnings. From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material for the three months ended June 30, 2022 and 2021. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ie82e8b7044854923a213561b1ea7521d"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information on Derivative Instruments</span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xMzc0Mzg5NTM5NjE0OQ_4471db45-017f-4da0-979f-04e9b1baf530" escape="true"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xMzc0Mzg5NTM5NjE0OQ_99064130-b425-4e87-8b9c-252affb0e98d" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedcceae98f1745c18c291607c35f1154_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV8zLTEtMS0xLTE1NzUyNQ_7469232a-b03c-4e89-ab69-15ca36df953a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7abd9fb0b51412e99b4001e9c3d02c3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV8zLTMtMS0xLTE1NzUyNQ_4f5ed696-eb87-4583-81ac-a5ba11a11604">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib695670fac054a96998413f0f81621bf_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV82LTEtMS0xLTE1NzUyNQ_af8172e5-abed-4190-84c6-026b5932093c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0d302cd168e4ac5b3e8c93a2b801655_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV82LTMtMS0xLTE1NzUyNQ_b3acd207-6fce-4643-9aac-cb3b5ecf231b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf70302177a746cfb31a8c813fc9e576_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV83LTEtMS0xLTE1OTU0MQ_7345da4b-1363-4614-a6c2-c8879d043d56">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2567e9d256a74d91967a6dcec0897b06_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV83LTMtMS0xLTE1OTU1MQ_152d2290-7a10-4383-b32c-fb58f8044333">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xMzc0Mzg5NTM5NjE1MA_290f78e9-4341-4ff0-9f32-a685acec7c0d" escape="true"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614af20eb8bf45108edd1be8b5e30eb7_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTItMS0xLTE1NDM4OA_a327f18e-5da3-490c-9d17-110663b079d7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614af20eb8bf45108edd1be8b5e30eb7_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTQtMS0xLTE1NDM4OA_e720a3ac-acfe-433a-a957-a97a204ba693">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614af20eb8bf45108edd1be8b5e30eb7_I20220630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTUtMS0xLTE1NDM4OA_a1ec987f-5159-4495-8c0b-cefba68daedd">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93afc9722af414ebd768788768bc773_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTctMS0xLTE1NDM4OA_260713c9-9d64-41ad-9d8f-1a3f384bb878">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93afc9722af414ebd768788768bc773_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTktMS0xLTE1NDM4OA_e17f2eea-9106-4de6-b9f1-a577e793f547">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93afc9722af414ebd768788768bc773_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTEwLTEtMS0xNTQzODg_8b97ab3f-2daf-4ae5-a98b-d8463b586028">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d25f973adc48d18bbace1d7f69620e_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTItMS0xLTE1NDM4OA_3bc90768-f9e0-4b24-9124-47c02812207c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d25f973adc48d18bbace1d7f69620e_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTQtMS0xLTE1NDM4OA_2790c7dc-5223-4b7c-9b21-fe982d36adac">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d25f973adc48d18bbace1d7f69620e_I20220630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTUtMS0xLTE1NDM4OA_4fd44901-ca3e-4313-b35a-29a9d1f2747b">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06c2da02d95474691982974e55aa7cc_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTctMS0xLTE1NDM4OA_8e929520-c957-4b84-a1ec-ed442d35f054">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06c2da02d95474691982974e55aa7cc_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTktMS0xLTE1NDM4OA_0d35b5e1-e1f6-439f-bf15-c0664cd486cd">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06c2da02d95474691982974e55aa7cc_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTEwLTEtMS0xNTQzODg_c9751391-39b3-42de-a210-ac54d8db67ee">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae6d3027e7b40d19a5f999387bb5a94_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTItMS0xLTE1NDM4OA_43ea1755-cfba-47a7-b77a-7a1d2052b966">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae6d3027e7b40d19a5f999387bb5a94_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTQtMS0xLTE1NDM4OA_51c03089-a636-4e94-808b-be9aff62cde9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae6d3027e7b40d19a5f999387bb5a94_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTUtMS0xLTE1NDM4OA_f2b41ee0-7cbd-4cea-bd66-4fb56e897e2d">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7702e8b3e0242449e9281863062b488_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTctMS0xLTE1NDM4OA_068df36e-994e-409c-883a-f4040c633a7f">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7702e8b3e0242449e9281863062b488_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTktMS0xLTE1NDM4OA_645cdd3f-4852-49d6-a761-914d34fe0e5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7702e8b3e0242449e9281863062b488_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTEwLTEtMS0xNTQzODg_b254890d-5ac4-4774-854f-03f947d2f4be">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c492e20719648568963f8577647d24f_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC0yLTEtMS0xNjI3ODE_35904ec1-85e8-41d4-8028-5078c673f117">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c492e20719648568963f8577647d24f_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC00LTEtMS0xNjI3OTQ_7f966d62-78a2-49c1-a1a9-8ea23d509985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c492e20719648568963f8577647d24f_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC02LTEtMS0xNjI4MDE_ca51dc50-3e33-4f39-a6ed-e96693564ac7">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4228622f82ae4dcd8f033204a9968b56_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC04LTEtMS0xNjI4MTA_343659ad-e923-42f6-a951-0e7de3b71eff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4228622f82ae4dcd8f033204a9968b56_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC0xMC0xLTEtMTYyODE3_9dcc1875-ba58-47af-b411-7be7f4c9817f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4228622f82ae4dcd8f033204a9968b56_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC0xMi0xLTEtMTYyODI0_e9da2eef-ff7d-4819-97e3-c203176ecfb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f56ba1a598a4a829b10b8749df60caf_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF85LTItMS0xLTE1NDM4OA_c45bd3ec-a97c-484a-9778-995dc928c4b2">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f56ba1a598a4a829b10b8749df60caf_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF85LTQtMS0xLTE1NDM4OA_b0f4e2a4-3e88-401d-97d4-65025ae30ee3">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f0747ce2512401a84d2048c76eb4934_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF85LTctMS0xLTE1NDM4OA_55a182f8-8967-4665-8471-0d957c4702ba">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f0747ce2512401a84d2048c76eb4934_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF85LTktMS0xLTE1NDM4OA_42e73bd2-6412-45c9-b679-70c79a545509">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfODM4MA_f8af7369-bb42-4fac-b41c-5e664eb88cd5" continuedAt="i67f5919b7c5e45b3b45440d584216ea8" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i67f5919b7c5e45b3b45440d584216ea8" continuedAt="i61a0bd672ec24c94bb218e3690232fac"><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at June 30, 2022 and March 31, 2022 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="ibf4b0c9f108245a0ab670e3765ab193c_I20220630" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfNzY4_587933f4-3ac0-46f1-83c0-09d883c8d9d4">547</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6d2ebfdac84e4abbb90a1e8f5ae7e490_I20220331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfNzc1_9fc471c3-82e6-437d-8422-bf79e6224244">981</ix:nonFraction> million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the assets and liabilities associated with the disposal groups in Europe held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale." At March 31, 2022, assets measured at fair value on a nonrecurring basis also included certain long-lived assets within the International segment related to the Company&#8217;s operations in Denmark and its retail pharmacy businesses in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other material liabilities measured at fair value on a nonrecurring basis at June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i61a0bd672ec24c94bb218e3690232fac"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfODM3OQ_6fc9407b-87f3-4374-9680-8381b7af3fe7" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6628b987433540f19ebb8c735161874b_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RhYmxlOmYwNmQ2Mzg0ZGVjYTQ1OGRhOWI3MjhlZmEzODIzNTZkL3RhYmxlcmFuZ2U6ZjA2ZDYzODRkZWNhNDU4ZGE5YjcyOGVmYTM4MjM1NmRfMi0xLTEtMS0xNDA1MjM_a956a697-dd5b-45ba-8c32-e242cef97bc8">5,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6628b987433540f19ebb8c735161874b_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RhYmxlOmYwNmQ2Mzg0ZGVjYTQ1OGRhOWI3MjhlZmEzODIzNTZkL3RhYmxlcmFuZ2U6ZjA2ZDYzODRkZWNhNDU4ZGE5YjcyOGVmYTM4MjM1NmRfMi0zLTEtMS0xNDA1MjM_8964451e-4368-400c-ace0-c83bf2ddb0ca">5,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0efcc5cada804b01af7a7152f7f15ce1_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RhYmxlOmYwNmQ2Mzg0ZGVjYTQ1OGRhOWI3MjhlZmEzODIzNTZkL3RhYmxlcmFuZ2U6ZjA2ZDYzODRkZWNhNDU4ZGE5YjcyOGVmYTM4MjM1NmRfMi01LTEtMS0xNDA1MjM_b9a895f0-daa7-4dfe-a2b3-d3fec2c33462">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0efcc5cada804b01af7a7152f7f15ce1_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RhYmxlOmYwNmQ2Mzg0ZGVjYTQ1OGRhOWI3MjhlZmEzODIzNTZkL3RhYmxlcmFuZ2U6ZjA2ZDYzODRkZWNhNDU4ZGE5YjcyOGVmYTM4MjM1NmRfMi03LTEtMS0xNDA1MjM_f0e83780-81c0-49b7-8e6e-a2a1ed2314b7">5,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within &#8220;Prepaid expenses and other&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets primarily consists of $<ix:nonFraction unitRef="usd" contextRef="ib9dcecf8036248a0a44938b3a51b3d54_I20220630" decimals="-6" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfMTY0OTI2NzQ1NTU5MA_a5e360f6-0977-4ed7-b022-07fb67ec77cc">100</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic42ce3a7a52742d682e55d121a735789_I20220331" decimals="-6" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfNjQyNw_be41ce1f-685c-4e8d-b3bb-ddfaf7237d94">395</ix:nonFraction>&#160;million as of June 30, 2022 and March 31, 2022, respectively, held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221; </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_67"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDc4MDA2Nw_5d77723a-1a46-47e1-b63e-652513150e7b" continuedAt="ie0a8176daf824f7da4168fb8bb1697dd" escape="true">Commitments and Contingent Liabilities</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:continuation id="ie0a8176daf824f7da4168fb8bb1697dd" continuedAt="i7f04406a2006478bbd4c2f1650bf56ed"><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjA2MTU_2c1fda74-6426-42f8-af40-9954be4ed6d6" continuedAt="ic92df040ad2f46e0959941802801fb57" escape="true"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163">Financial Note 18 to the Company&#8217;s 2022 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></ix:nonNumeric></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i7f04406a2006478bbd4c2f1650bf56ed" continuedAt="ia61e8e494a2942d3b30731c601c04b7e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic92df040ad2f46e0959941802801fb57">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and the <ix:nonFraction unitRef="distributor" contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNDU3NQ_0dda3cf3-c341-4320-829b-03ca0b778879">two</ix:nonFraction> other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) settled with <ix:nonFraction unitRef="state" contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTc5NDEyMw_0d68fdb9-b4d9-4fbf-9ab4-cb7ec4518f00">46</ix:nonFraction> of <ix:nonFraction unitRef="state" contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402" decimals="INF" name="mck:LossContingencyNumberOfEligibleStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTc5NDEzMA_25280d92-29b2-44c9-830e-cfdbdb1a7764">49</ix:nonFraction> eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#8220;Settling Governmental Entities&#8221;) effective on April 2, 2022 (&#8220;Settlement&#8221;). If all conditions to the Settlement are satisfied, including the receipt of approval by relevant courts of consent decrees to dismiss the lawsuits, the Distributors would pay the Settling Governmental Entities up to approximately $<ix:nonFraction unitRef="usd" contextRef="idd41c4e1c30c44259a7ba92d433dfc8a_D20220402-20220402" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNTAwMw_d98e1d45-ffcf-40b1-a587-8014bd03159c">19.5</ix:nonFraction> billion over <ix:nonNumeric contextRef="idd41c4e1c30c44259a7ba92d433dfc8a_D20220402-20220402" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDgwMTA4OA_30b6f975-58d8-4f39-9016-8ca03f104e34">18</ix:nonNumeric> years, with up to approximately $<ix:nonFraction unitRef="usd" contextRef="ia25c48fcadfa411c87b9b338ed7c17cf_D20220402-20220402" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNTAyNg_6e0fc6e0-6886-4cf1-b03d-94d47282dcd7">7.4</ix:nonFraction> billion to be paid by the Company for its <ix:nonFraction unitRef="number" contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNTA2Mw_8aa0c0da-d5ad-4404-bed5-ca6710939e15">38.1</ix:nonFraction>% portion. Under the Settlement, a minimum of <ix:nonFraction unitRef="number" contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402" decimals="2" name="mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNTA4OA_3f2e0039-8da0-43e0-8177-5f43a95e98fe">85</ix:nonFraction>% of the settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three eligible states, Alabama, Washington, and Oklahoma did not join the Settlement, but they have all now reached agreements in principle with the Company. With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement in principle under which the Company will pay $<ix:nonFraction unitRef="usd" contextRef="i91fd5b95930f48feafff5e007780cca1_D20220402-20220402" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0ODk0NA_e15cc137-6f1b-4187-aa36-d6b38f98e57c">141</ix:nonFraction>&#160;million in <ix:nonFraction unitRef="installment" contextRef="i91fd5b95930f48feafff5e007780cca1_D20220402-20220402" decimals="INF" name="mck:LossContingencySettlementNumberOfInstallmentPayments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0ODk1Nw_5cb3a147-beda-48b5-84a2-fc5375f4d909">ten</ix:nonFraction> equal annual installments and an additional approximately $<ix:nonFraction unitRef="usd" contextRef="i91fd5b95930f48feafff5e007780cca1_D20220402-20220402" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDA1Mg_ec0be2ee-6ae8-4ed8-aa87-87ad72e2e0f3">33</ix:nonFraction>&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $<ix:nonFraction unitRef="usd" contextRef="i7cce7634359c49e6bb6d0498ed0e65cb_D20220503-20220503" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDAzOA_1507f9ae-778e-4f52-8699-f15fe530bbd0">518</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="i7cce7634359c49e6bb6d0498ed0e65cb_D20220503-20220503" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDgwMTA3OA_f79a920b-b546-4f4b-926a-75a1e236a928">18</ix:nonNumeric> years, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="ib624e26e3984429eb8c566e69a33ac6a_I20220503" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDAxNw_dba03836-3ae5-412d-b024-393143008918">38.1</ix:nonFraction>% (or approximately $<ix:nonFraction unitRef="usd" contextRef="ib6347fef3d684c6884e7d1d8b83e0f28_D20220503-20220503" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDAyNA_155b7069-d090-4b40-8dea-01cd3b4eaf1b">197</ix:nonFraction>&#160;million), consistent with Washington&#8217;s allocation under the comprehensive framework, as well as certain additional attorneys&#8217; fees and costs. On June 27, 2022, an agreement was announced between the Distributors and the attorney general of Oklahoma to settle claims of the state of Oklahoma and its subdivisions. Under that agreement, Oklahoma and its subdivisions would be paid up to $<ix:nonFraction unitRef="usd" contextRef="ief5af3b3c7d04f4b9061d24c01dfc96a_D20220627-20220627" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM0MTgwNQ_904d489f-1cac-4318-a450-b40784d9cb00">250</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="ief5af3b3c7d04f4b9061d24c01dfc96a_D20220627-20220627" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjMyNw_d23e24f7-b802-41d4-87a1-ecd33c5431b7">18</ix:nonNumeric> years, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i1c5c1f1d6da349fcbcbcc5d4ee10b2db_I20220627" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM0MTg5NA_0199e8d2-1f07-42f8-a191-0d84210131a5">38.1</ix:nonFraction>%, consistent with Oklahoma&#8217;s allocation under the comprehensive framework, as well as certain additional attorneys&#8217; fees and costs. The Company&#8217;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements in principle.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ia61e8e494a2942d3b30731c601c04b7e" continuedAt="ie2b1caca81ed426d968d6c6245511ec9"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Claims of various West Virginia subdivisions remain pending in both state and federal courts. Trial in the case of Cabell County and City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. On July 4, 2022, the court entered judgment in defendants&#8217; favor. On August 2, 2022, the plaintiffs filed an appeal. The claims of certain other West Virginia subdivisions are pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Distributors for July 5, 2022. On July 5, 2022, the Mass Litigation Panel entered an order postponing the trial in light of an agreement in principle between a group of plaintiffs&#8217; attorneys representing the municipalities and the three companies. Under that agreement in principle, the three companies would pay $<ix:nonFraction unitRef="usd" contextRef="i9c9164e71857427a9e3f6fb313e6f958_D20220705-20220705" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjI3NA_a9303a8e-5684-4cdf-af58-4e7307fb8e46">400</ix:nonFraction>&#160;million over approximately <ix:nonNumeric contextRef="i9c9164e71857427a9e3f6fb313e6f958_D20220705-20220705" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjI4Nw_c9379166-284d-44ec-9b17-0e4399b07bfe">11</ix:nonNumeric> years, with the Company responsible for <ix:nonFraction unitRef="number" contextRef="ic78671dfdbde4f1da51669767a156413_I20220705" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjI4OQ_0ef70688-3f05-46ca-a1b7-6dc4eec3b78a">38.1</ix:nonFraction>% of the total amount (or approximately $<ix:nonFraction unitRef="usd" contextRef="i88b0d90d6afe4e72801e173856f8f730_D20220705-20220705" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjI5Ng_ec26d221-7607-43b9-bc4b-89227b5f1f5a">152</ix:nonFraction>&#160;million). The agreement in principle is contingent on participation of certain litigating subdivisions in West Virginia, but does not include school districts or the claims of Cabell County and the City of Huntington. The Company&#8217;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of June 30, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $<ix:nonFraction unitRef="usd" contextRef="i8dd43cb0b7cc4ad7a6b61b07881c8a2a_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDEwMA_39e04592-00e0-4ca8-b7ce-4d2269a37aa3">75</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="i49d09f3e82e04ef68ecb9c2396cd73c1_D20210928-20210928" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDExMw_137b869a-a2a7-4336-b436-0db4a42b35a6">6.5</ix:nonNumeric> years to resolve opioid-related claims, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="ie80fd48f4e8d4c678b4ce9cef44086f1_I20210928" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDEyMw_3d3ce0b7-53cd-4399-95c7-0fe86a880e9d">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i49d09f3e82e04ef68ecb9c2396cd73c1_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDEzMA_5448b620-c78b-4739-91bb-6a52cfc63942">29</ix:nonFraction>&#160;million). The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Distributors would pay the Native American tribes, other than the Cherokee Nation, approximately $<ix:nonFraction unitRef="usd" contextRef="i2f19aed3491848fe9a6318bd365640c4_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDA3OQ_e78f74f9-e3ab-44eb-abc1-1bd409a4dd3b">440</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="ib15c8902459948b8800a989e5b1ee1ab_D20210928-20210928" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDA5Mw_6c7d48d8-8fd6-44eb-a928-223b06ec26af">6</ix:nonNumeric> years, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i20b65fe316bc46c7a65913e0e73468b4_I20210928" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE0Mw_1519d902-ab3d-450e-ac87-d5719a068839">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="ib15c8902459948b8800a989e5b1ee1ab_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDA2NQ_64a4879c-1bde-4087-8b27-83adb8f03345">167</ix:nonFraction>&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Distributors. Under these agreements, a minimum of <ix:nonFraction unitRef="number" contextRef="i20b65fe316bc46c7a65913e0e73468b4_I20210928" decimals="2" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE1MA_d19c1834-98b0-4f3e-ad1d-733fa030e865">85</ix:nonFraction>% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#8217;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of June 30, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Settlement terminated the substantial majority of opioid-related suits by governmental entities pending against the Company, a small number of subdivisions in participating states have opted not to participate in the comprehensive settlement, and other suits brought by subdivisions in non-participating states remain pending. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#8217;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the first quarter of fiscal 2023, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i55b70e47e8e34b20ab513c75c1bd8f1a_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE1NQ_f5edc1d7-c69d-4592-ac3a-803c977df420">375</ix:nonFraction>&#160;million, and in July 2022 paid an additional $<ix:nonFraction unitRef="usd" contextRef="ibacb5dc687fb421890cdd8812f84593a_D20220701-20220731" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjYwNA_1a4d3437-646f-4ea0-88ee-249dcda4b4ca">470</ix:nonFraction>&#160;million, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes.</span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjA2Mjk_55493d2b-9965-4a98-8d62-186a6767611f" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785cd0fca728419db26ae24ee9b6d389_I20220630" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfMS0xLTEtMS0xNDA1MjM_c8632f32-dc3e-437d-9fd2-f1bf096393ee">759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc26f3e4e9d14faaaf590fbb3e98fd58_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfMS0zLTEtMS0xNTk4Njc_9a8d2928-8944-49cf-99e9-f173ff355af7">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785cd0fca728419db26ae24ee9b6d389_I20220630" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfMi0xLTEtMS0xNDA1MjM_a3786005-cc96-4f69-bef6-ce690e4d0903">7,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc26f3e4e9d14faaaf590fbb3e98fd58_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfMi0zLTEtMS0xNTk4Njc_664ac320-7975-46f2-9e1d-4db88b8336a6">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785cd0fca728419db26ae24ee9b6d389_I20220630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfNC0xLTEtMS0xNDA1MjM_c7246c6e-409f-4db8-87e8-bbaedf2a65c2">7,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc26f3e4e9d14faaaf590fbb3e98fd58_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfNC0zLTEtMS0xNTcwNTE_c2a4c29a-6357-486f-b077-e69d28715752">8,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts as of June 30, 2022 and March 31, 2022, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the terms of the Settlement and a separate agreement with the Alabama attorney general, the Company placed approximately $<ix:nonFraction unitRef="usd" contextRef="ib182ad32ae1a4140ba81d1576ebb67fd_I20220331" decimals="-6" name="us-gaap:EscrowDeposit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE3MQ_dd4c04cd-dbb2-4eab-a94c-1318bcf28ea0">395</ix:nonFraction>&#160;million into escrow during the fiscal year ended March 31, 2022. During the period ended June 30, 2022, the Company released $<ix:nonFraction unitRef="usd" contextRef="i3a1aa40a3d3642ff855da782b897135b_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE4NQ_e2215022-7b24-4319-9f3b-d2ae3886ec5d">296</ix:nonFraction>&#160;million from escrow consistent with the terms of the opioid settlement agreements. The remaining escrow amounts were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in our Condensed Consolidated Balance Sheet as of June 30, 2022. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ie2b1caca81ed426d968d6c6245511ec9" continuedAt="idb037318ba754cbb8edfb2c20a20ae47"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as <ix:nonFraction unitRef="case" contextRef="ia2ca6a0d3d4048d7928d1ed7a412b532_I20220630" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQxNw_911f4562-c471-4e2b-81ad-7800c5f0b28a">four</ix:nonFraction> cases brought in Canada (<ix:nonFraction unitRef="case" contextRef="i583c48262f76490389c5bfa859e9c30c_I20220630" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQxOA_80627d73-f240-419e-88b1-3d698bf8ce46">three</ix:nonFraction> by governmental or tribal entities and <ix:nonFraction unitRef="case" contextRef="idf2512ace2434b2992e2e25b1b514696_I20220630" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQxOQ_0e2d6d01-adef-4fcb-af60-3f0e55a550b0">one</ix:nonFraction> by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CE19-00472. Although trial began in this case on July 18, 2022, the court declared a mistrial on July 22, 2022; no new trial date has been set. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. CV-13-02219 (HG). Plaintiffs seek statutory damages from $<ix:nonFraction unitRef="usd" contextRef="iefa43f959af643fa81156301548309e0_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ2Nw_e55493ed-c020-493d-9847-5b8e34e423e4">500</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i0d1725cc0bf34e1b9b6258af7a6286da_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ3Mw_b2c56c04-eaa5-4958-b446-22ae06ed3e23">1,500</ix:nonFraction> per violation plus injunctive relief. Plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, <ix:nonFraction unitRef="faxnumber" contextRef="ia156720ce72f43da8c988dd169e9286f_I20190813" decimals="INF" name="mck:LossContingencyClassActionNumberofFaxesRemainingintheClass" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ4MQ_4f4c5935-77f6-4c45-a484-4046315a876c">9,490</ix:nonFraction> fax numbers remain in the class, representing <ix:nonFraction unitRef="fax" contextRef="ia156720ce72f43da8c988dd169e9286f_I20190813" decimals="INF" name="mck:LossContingencyClassActionNumberofFaxesReceived" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ4OA_48ad6ae6-5ef9-40fc-afa9-8cf0abed95b1">48,769</ix:nonFraction> faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving two named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $<ix:nonFraction unitRef="usd" contextRef="i95823add3af04d3eb3962971d102762c_D20220427-20220427" decimals="INF" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ5Ng_06e640bb-60b5-4a4f-ae29-31d5a8642dce">6,500</ix:nonFraction>. The Company appealed the finding of liability and the plaintiffs cross-appealed the denial of class certification and the ruling denying treble damages.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of a complaint filed by a relator, purportedly on behalf of the United States, <ix:nonFraction unitRef="state" contextRef="ifa5a8bf25a1c492f8877a4d52f7a8892_D20191209-20191209" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDgwMTEyMA_ab23e7dc-8eb1-4659-af3d-71e4fea8d177">30</ix:nonFraction> states, the District of Columbia, and <ix:nonFraction unitRef="city" contextRef="ifa5a8bf25a1c492f8877a4d52f7a8892_D20191209-20191209" decimals="0" name="mck:LossContingencyNumberOfCitiesFiledOnBehalfOf" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDgwMTEyMw_44889859-ade1-4c35-905d-2c6dfe7313a8">two</ix:nonFraction> cities, against US Oncology, Inc. alleging that from 2001 through 2010 the Company repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-05125. The United States and the named states declined to intervene in the case. On July 21, 2022, US Oncology, Inc.&#8217;s motion to dismiss was granted without prejudice. The related case against other Company defendants remains pending, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 12-CV-06440 (NG).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. On May 25, 2022, the district court granted distributor defendants&#8217; motion to dismiss the complaint, but granted the plaintiffs leave to amend the complaint. Plaintiffs filed an amended complaint on July 1, 2022. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="idb037318ba754cbb8edfb2c20a20ae47"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company was served with a first amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., <ix:nonFraction unitRef="state" contextRef="id32341657ec2405d904a9a2b92c4f261_D20200701-20200731" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTUwNA_ea04a41d-cbd0-4003-86a9-02f0a32277c6">27</ix:nonFraction> states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hart v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#8217;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint. The relator filed the second amended complaint on June 7, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $<ix:nonFraction unitRef="usd" contextRef="ie9db5a1c9a3b4448b90e7d790fddd929_I20180430" decimals="-6" name="mck:OpioidStewardshipActNewYorkAnnualSurcharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDMyMw_59d14e48-0554-4e35-84e8-43cc4eb64dfb">100</ix:nonFraction>&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $<ix:nonFraction unitRef="usd" contextRef="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDMzOA_4eabab30-f588-4556-82f8-e44a881901be"><ix:nonFraction unitRef="usd" contextRef="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDMzOA_e9b9c19d-d4bd-402d-9160-35e2fd6e2dcc">50</ix:nonFraction></ix:nonFraction>&#160;million pre-tax charge ($<ix:nonFraction unitRef="usd" contextRef="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331" decimals="-6" name="mck:LossContingencyAccrualProvisionAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDM1MQ_0f960824-9258-4663-81c4-2bf704e0db3d"><ix:nonFraction unitRef="usd" contextRef="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331" decimals="-6" name="mck:LossContingencyAccrualProvisionAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDM1MQ_4c9796c9-8f85-456a-8a19-89e43c336852">37</ix:nonFraction></ix:nonFraction>&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. That petition was denied on October 4, 2021. In December 2021, McKesson paid $<ix:nonFraction unitRef="usd" contextRef="if5b8f534c4f94a2286245c2844a0b617_D20211201-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDQ1OQ_5bfcef80-a309-4bb7-9c39-b8c0fb6d294e">26</ix:nonFraction>&#160;million for the assessment for calendar year 2017 while reserving all rights to challenge the constitutionality of the assessment. McKesson filed a new lawsuit challenging the constitutionality of the OSA on May 18, 2022.</span></div></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_70"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDk0NA_1418d40c-0b6d-4f83-aabe-87380bd0339e" continuedAt="i3bcb4935aa3243e78ed250af6901d2d2" escape="true">Stockholders' Equity (Deficit) </ix:nonNumeric></span></div><ix:continuation id="i3bcb4935aa3243e78ed250af6901d2d2" continuedAt="ibdedd6b9ef354e1f99cc78960870a0ca"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="INF" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNzk_62e2c683-fb1a-45e2-9d97-5e6f436e0868">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the quarterly dividend was raised from $<ix:nonFraction unitRef="usdPerShare" contextRef="iae2bcb78271948b4a1ebf3f41dcd15bf_D20220630-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMzAy_60903bfa-eef7-4501-aab1-2b13f89c697b">0.47</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="i2151c060ee864dcf9cc0a315dedcb4bc_D20220701-20220731" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMzA4_0e4a60a7-2556-4ee3-b5b3-48874635a4c3">0.54</ix:nonFraction> per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ibdedd6b9ef354e1f99cc78960870a0ca" continuedAt="id5e4e473be2043c8ac68a53ef4341f10"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NzMwNw_b305b8dc-4ea2-4148-9574-87d780a17625">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMTY0OTI2NzQ1MjY5Ng_b305b8dc-4ea2-4148-9574-87d780a17625">1.0</ix:nonFraction>&#160;billion to the financial institution and received an initial delivery of <ix:nonFraction unitRef="shares" contextRef="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NzQ4OQ_807b65d4-203c-43b2-8b37-4175887dfe85">2.6</ix:nonFraction> million shares in May 2022. The transaction will be completed during the second quarter of fiscal 2023, at which point the Company expects to receive additional shares. The final number of shares repurchased and the average price per share paid will be determined based on the volume-weighted average price of the Company&#8217;s common stock during the term of the ASR program, less a pre-negotiated discount.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="ifef2c199d98e42be9e9661e3aba687b3_D20220201-20220228" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDQ5OQ_46d6df2e-0f9d-4be9-a461-74554f1f84c4">1.5</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was <ix:nonFraction unitRef="shares" contextRef="ifef2c199d98e42be9e9661e3aba687b3_D20220201-20220228" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDQ3OA_36d76833-e4f2-457d-90ba-86be0962c962">5.1</ix:nonFraction> million shares at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="ifef2c199d98e42be9e9661e3aba687b3_D20220201-20220228" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDUxMg_2ae1e72f-e8f0-4475-89bb-7ef6e3ad03b0">295.16</ix:nonFraction>. The Company received <ix:nonFraction unitRef="shares" contextRef="i8c0920ece63d40bcb5b7571d38f78484_D20220101-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDU1OQ_f17cdd30-1857-4803-ac32-c555ebbedd27">4.8</ix:nonFraction> million shares as the initial share settlement during the fourth quarter of fiscal 2022 and, in May 2022, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDU3OQ_ecd9d117-eda0-465d-b169-ca7677f09a0e">0.3</ix:nonFraction> million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMTQ1MQ_70c86f44-6077-408d-82f5-670f91f66a0e">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was <ix:nonFraction unitRef="shares" contextRef="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMTU1MQ_da572f26-6914-4a31-a7ef-224395d7b540">5.2</ix:nonFraction> million shares at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMTU5NA_7f586fac-c5cd-496f-a767-87c19fd5fa1b">193.22</ix:nonFraction>. The Company received <ix:nonFraction unitRef="shares" contextRef="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDUyMQ_0888628e-2772-4015-8846-2aa120a3c2e3">4.3</ix:nonFraction> million shares as the initial share settlement during the first quarter of fiscal 2022 and, in August 2021, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="i2221b7fadd8a4d1f9694fd8e401e6039_D20210801-20210831" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDUyOQ_d91c8183-ab5b-4966-b14d-a15efcb15a5e">0.9</ix:nonFraction> million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other shares repurchased during the three months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at June 30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMjYwMQ_2490441c-4fe5-4d66-9400-2ce4f0457864">2.3</ix:nonFraction> billion. In July 2022, the Board approved an increase of $<ix:nonFraction unitRef="usd" contextRef="iacb94994718b406dbc1a53f8dab8d938_I20220731" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3OTIwNQ_865ca8cb-7c50-4466-a818-079375b7ef09">4.0</ix:nonFraction> billion in the authorization for repurchase of McKesson&#8217;s common stock.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id5e4e473be2043c8ac68a53ef4341f10" continuedAt="i7094c61ce8d34413bfcffc64f3773c0d"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss </span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDkzMw_a60144e6-1be7-43e5-80ba-2101098c8b54" continuedAt="iddcc5450047743a49f61b6f6a650c7a3" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three months ended June 30, 2022 and 2021 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04054837ec0342f9b8450625e682723a_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi0xLTEtMS0xNDA1MjM_58a5138f-df2e-49f7-b74a-2da616fcdc2a">1,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d27ffef9104861bb0e13a1caea6f92_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi0zLTEtMS0xNDA1MjM_5332c0de-7076-429d-adf2-b668e52a9a4a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142d11dab4f1472296e0e34a0a568a1c_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi01LTEtMS0xNDA1MjM_b65a553b-1fc6-461b-a567-5edd2fcff059">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae923b8233e9431eb94789aba9fc18b0_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi03LTEtMS0xNDA1MjM_8e95603c-7ad9-4283-b160-9fb8f3646751">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i778742d22ea2469ba0d763c4abaf0a0e_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi05LTEtMS0xNDA1MjM_539a9540-cddb-47b0-b969-48086c9fc7af">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy0xLTEtMS0xNDA1MjM_265d2d4d-afe3-4779-8efe-7f81cce224cf">176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy0zLTEtMS0xNDA1MjM_264df7ef-fd77-4d9e-96bb-08f957ed527a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy01LTEtMS0xNDA1MjM_86a4ee77-e3a6-4eee-9a7d-03c48f0433a7">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy03LTEtMS0xNDA1MjM_2c746a82-c029-4e59-97dc-20e2cb108fad">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy05LTEtMS0xNDA1MjM_65fe186c-6796-4078-8146-4f8362b86fcb">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC0xLTEtMS0xNDA1MjM_1a267a33-f34b-4e27-8228-7834b7abfcab">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC0zLTEtMS0xNDA1MjM_a9f52360-b0a7-426b-b28c-7db2ed5559d1">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC01LTEtMS0xNDA1MjM_86f7a083-4c93-4dd3-86eb-b98f43eb9f6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC03LTEtMS0xNDA1MjM_bb254138-e0f2-4a15-b65e-478f1482d42f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC05LTEtMS0xNDA1MjM_82fe7246-97d2-4858-be5b-043e73ff3408">737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS0xLTEtMS0xNDA1MjM_bd26ccab-e1f8-47d4-a5f2-7ec30eb7de4f">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS0zLTEtMS0xNDA1MjM_b02967c7-db67-4e00-8fb8-e1b5ad9f682b">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS01LTEtMS0xNDA1MjM_532be715-92ee-490e-9a42-34d07e77a852">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS03LTEtMS0xNDA1MjM_c7e1a0c2-afed-49f8-8f11-076dea759cf9">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS05LTEtMS0xNDA1MjM_464f8c02-e344-44e3-992d-5bf5fc1bab1d">636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi0xLTEtMS0xNDA1MjM_45b5fc8c-2525-4ea6-bd53-8b578255cb25">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi0zLTEtMS0xNDA1MjM_9532c625-5add-4f91-a17d-7dedb1dba312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi01LTEtMS0xNDA1MjM_fb1e7e6a-d263-4064-b074-be10c9b7cc69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi03LTEtMS0xNDA1MjM_2639eebb-2207-4016-9378-a151ef45fd1c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi05LTEtMS0xNDA1MjM_37e10775-11dd-4fe8-a00e-264d3718f215">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy0xLTEtMS0xNDA1MjM_52a9f9e4-de44-4cbb-b286-767b165e20e2">507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy0zLTEtMS0xNDA1MjM_92d0f6ab-d5f6-454d-a094-4653eb0e7916">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy01LTEtMS0xNDA1MjM_ca256bb3-b8a3-40ae-9924-a23f9acd1fa9">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy03LTEtMS0xNDA1MjM_b6376ad5-abe1-4bed-9f52-922db1aa304d">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy05LTEtMS0xNDA1MjM_86d119dc-af4e-42b9-8971-6169756182cc">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37c3f3f9cc2a4fe5809c48e5837aa33b_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS0xLTEtMS0xNDA1MjM_c5f57cd2-a7aa-4ab8-86f9-2ecfaba1af82">997</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia153c233c3224f40b8bee60f5ca03330_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS0zLTEtMS0xNDA1MjM_88cb56f1-b82f-42b4-aeac-829d62458a91">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3b36ae57df4556b852d256a5051b7c_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS01LTEtMS0xNDA1MjM_900ac49f-cdeb-4010-9661-69c694b529ab">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834def9396054b11a7467a8892ddc33e_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS03LTEtMS0xNDA1MjM_9081b5e6-45eb-473d-b29a-78a1f57ef11e">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i826edda2198046dba4823c7a7d93044e_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS05LTEtMS0xNDA1MjM_6c3c1f16-ada7-425e-85dd-bf4069cb1013">948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended June 30, 2022 include gains of $<ix:nonFraction unitRef="usd" contextRef="i41ebb607246c4e2991322746c42fa818_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3OTM3Ng_871a28d1-678e-4897-af68-35995ec5e1c7">64</ix:nonFraction> million related to net investment hedges from Euro-denominated notes and gains of $<ix:nonFraction unitRef="usd" contextRef="iedcceae98f1745c18c291607c35f1154_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3OTQwNQ_7469232a-b03c-4e89-ab69-15ca36df953a">12</ix:nonFraction> million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMzY3NQ_005c50cc-e44e-4d48-a642-f88fce5348d7">31</ix:nonFraction> million.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i7094c61ce8d34413bfcffc64f3773c0d"><ix:continuation id="iddcc5450047743a49f61b6f6a650c7a3"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586dbdd097949bc84d2b6538b7c21a1_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi0xLTEtMS0xNDA1MjM_e0199cce-c9e1-4634-9a5f-b667a889fa4d">1,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibea2a408cb5143869cd6f99a7f554856_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi0zLTEtMS0xNDA1MjM_cebadf1e-fe98-477d-a14d-8c3863eef943">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f74d47337f44069d4abbae67a7e76f_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi01LTEtMS0xNDA1MjM_cd7f75a4-d711-4383-80db-9c8e138afcb6">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i812bd8eaa6f848db94fa9829cb892c51_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi03LTEtMS0xNDA1MjM_5abb0a37-1b05-4bb9-9f59-00b4d17c9827">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37c280e5ed9e46c793e2b72e48c5aa9b_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi05LTEtMS0xNDA1MjM_42da4b5c-89a7-47a2-96a4-ad4472aee17e">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy0xLTEtMS0xNDA1MjM_5deb5020-0f46-4f3f-83cd-61df5dbe6b56">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy0zLTEtMS0xNDA1MjM_a405bc70-d13e-4bd5-acbe-a3e86ee1f6b1">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy01LTEtMS0xNDA1MjM_d7306d20-9705-4666-85ff-053341f4a083">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy03LTEtMS0xNDA1MjM_e8d7a10f-c875-44df-90dd-dcb509944725">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy05LTEtMS0xNDA1MjM_17dc6117-0d0c-4e81-8ae7-a09227c6bf83">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC0xLTEtMS0xNDA1MjM_b4bedf37-e44d-49f8-acd8-33aeb61528d9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC0zLTEtMS0xNDA1MjM_f9593eda-dce6-4a2a-89b0-c80741b11cc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC01LTEtMS0xNDA1MjM_ea000518-a950-43eb-9322-8bb116df7734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC03LTEtMS0xNDA1MjM_e24e4f7e-b535-4baa-b79b-4007e89e5c46">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC05LTEtMS0xNDA1MjM_ea2ab4b5-0476-42df-a4bd-0e921f6e0f1e">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS0xLTEtMS0xNDA1MjM_a3399204-3c67-4577-8000-e2992c906deb">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS0zLTEtMS0xNDA1MjM_5371680b-7e6e-4904-92a5-42a5e5b3df29">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS01LTEtMS0xNDA1MjM_de0f9bfd-317c-4e9e-b881-88509769f191">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS03LTEtMS0xNDA1MjM_cd50c416-de0e-4030-b274-d097bafffd42">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS05LTEtMS0xNDA1MjM_09551afd-48d1-4cc2-9efb-e53a13f24347">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi0xLTEtMS0xNDA1MjM_a1861a4b-810f-4ae9-ab2c-91779a324bb0">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi0zLTEtMS0xNDA1MjM_70428d8b-d476-4208-9ffc-bd5eac4fdd1b">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi01LTEtMS0xNDA1MjM_ec3e72e3-2cb5-422d-99aa-897a22f2697e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi03LTEtMS0xNDA1MjM_f0cba52a-87e6-498e-b1c1-551065d3b1cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi05LTEtMS0xNDA1MjM_e32f477a-e256-43b7-b1f8-d7a0744f2d3c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy0xLTEtMS0xNDA1MjM_4b72dc40-0d00-4e02-9521-155843b800a7">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy0zLTEtMS0xNDA1MjM_13023e93-ab2e-41d8-9ef8-29be183e13a5">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy01LTEtMS0xNDA1MjM_2a77fc77-1784-4dd9-9c41-5f920ab1a64c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy03LTEtMS0xNDA1MjM_ee0250f0-59f4-436c-8670-97ff482912b2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy05LTEtMS0xNDA1MjM_f821314f-4e44-4077-bd7a-04a70ffaf627">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC0xLTEtMS0xNTE1OTE_909deb4a-7f38-42e4-adb6-5ddf1cef91b7">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC0zLTEtMS0xNTE1OTg_0200f09e-4dee-4bc6-984b-fedc130c3a17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC01LTEtMS0xNTE2MDU_01c307e7-bdfb-4d5a-adfc-41640d318787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC03LTEtMS0xNTE2MTI_a1be618a-c9f8-448e-999d-29044e1c46a0">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC05LTEtMS0xNTE2MTk_d8259ce4-aebb-4a16-a998-df4d1feec530">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a1ba08501874acda7d8038964225375_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC0xLTEtMS0xNDA1MjM_bfc8d102-e9d9-46ee-89f6-37299a6b5bf0">1,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfb860711704471396b6ab18f5a00a89_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC0zLTEtMS0xNDA1MjM_ac0e34c2-a431-4ccd-bf26-8516abd9d51a">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f48074346a94363895ed8e84a8026ab_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC01LTEtMS0xNDA1MjM_017b9356-4f2a-476e-af5d-eabf928f3985">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4499ac651c794efc9fddcb3b54af3036_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC03LTEtMS0xNDA1MjM_7601dad3-46e3-4a89-a2c6-7fbc39ecb385">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7db9df2543f7470aae07e22c69f7fa2a_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC05LTEtMS0xNDA1MjM_078f197f-2f8b-43ce-ac52-ed28035c90a5">1,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended June 30, 2021 include losses of $<ix:nonFraction unitRef="usd" contextRef="ic770e7e260c6494e91714f00ee4061af_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDMyNA_241938f6-30bd-441e-bd34-93cee3236034">22</ix:nonFraction>&#160;million related to net investment hedges from Euro-denominated notes and losses of $<ix:nonFraction unitRef="usd" contextRef="if7abd9fb0b51412e99b4001e9c3d02c3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDQwMg_bef11259-8663-4592-a87a-72e9564da86b">5</ix:nonFraction>&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDUxMg_91335204-8fa8-4e9d-8837-3388deaa0b15">6</ix:nonFraction>&#160;million.</span></div></ix:continuation></ix:continuation><div id="ida37730e58094407b89f4630fc6c6b2d_73"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNzYxOA_4c5b200d-568f-4af1-a4ac-c15311d154d5" continuedAt="ibb0c7feb05fd4904821b1b117fe8fb4e" escape="true">Segments of Business</ix:nonNumeric></span></div><ix:continuation id="ibb0c7feb05fd4904821b1b117fe8fb4e" continuedAt="i061f8d60b65d4eaa95f47fb621c58066"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNTc_2d330914-5886-4c28-a337-261240bb4b12">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment serves McKesson&#8217;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than <ix:nonFraction unitRef="product" contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630" decimals="INF" name="mck:NumberOfNationalBrandMedicalSurgicalProducts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc3NTQzOQ_c6697b49-7fd7-419a-a868-1ff3d0a3b904">285,000</ix:nonFraction> national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i061f8d60b65d4eaa95f47fb621c58066" continuedAt="i4fbe534f05524e98a28ae33f808bc369"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in <ix:nonFraction unitRef="country" contextRef="i2c6e06d925d44f989655a7673bdde907_I20220630" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMjU5OQ_3609a219-aa77-48f6-beec-8d8030c8a7cb">10</ix:nonFraction> European countries where it owns, partners, or franchises with retail pharmacies and operates through <ix:nonFraction unitRef="business_operation" contextRef="i2c6e06d925d44f989655a7673bdde907_I20220630" decimals="INF" name="mck:NumberOfBusinessOperations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMjcwNA_4c04eb51-89f6-4a44-b596-b7dff35410fb">two</ix:nonFraction> businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of fiscal 2022, the Company entered into an agreement to sell the E.U. disposal group which is anticipated to close within the second half of fiscal 2023. International segment assets at June 30, 2022 were $<ix:nonFraction unitRef="usd" contextRef="i403f9ff68d8c4127940b5ac3bf567cb2_I20220630" decimals="-8" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc4MDQxOA_7e35d47f-0e0d-4154-a4a2-4bc0b99d0846">10.9</ix:nonFraction> billion, a decrease during the first quarter of fiscal 2023 primarily due to the completed the sale of the U.K. disposal group. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div><ix:nonNumeric contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNzU4Nw_8a86aced-f76b-4e28-b693-b2286b5fd06a" continuedAt="i9f6147a43b9d4b6b9826f9112ae76c30" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e71847d225b4930bef9de929f3f2a3c_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMy0xLTEtMS0xNDA1MjM_b2d9481e-78bb-4a19-9c8c-e5256c1fc1a0">56,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de3e5bddea84662aeab82793750ac17_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMy0zLTEtMS0xNDA1MjM_9344bddf-f947-4a9d-913c-81616f6103a5">50,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9167671dc7c472eb51af611bf7cc7e4_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNC0xLTEtMS0xNDA1MjM_0a8865bc-20ee-4142-ab46-15d6390fdf79">1,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1577c607c8ab49f392ecdd91decbed0f_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNC0zLTEtMS0xNDA1MjM_24e16ab9-de8d-4cb6-9a46-d46fa3fffcc6">881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c30ffbc257945ba83eb82993a8be420_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNS0xLTEtMS0xNDA1MjM_9771a063-31fe-4662-9f99-9c19ea2ca22e">2,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4001c0764b641b489a0e6a821b1bc2a_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNS0zLTEtMS0xNDA1MjM_605ec906-a4aa-49c4-899c-6030a9d50a38">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b46e42465d84c47a2183912a0e10716_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNi0xLTEtMS0xNDA1MjM_edd7e390-f265-4fb3-b93f-1b6e71043a15">6,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb05392f0a4c4daea446534a262c49ce_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNi0zLTEtMS0xNDA1MjM_471fbe98-5650-49ac-9105-8a5de66955f2">9,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfOC0xLTEtMS0xNDA1MjM_72ecd8e6-47eb-46a0-bb72-072b31151865">67,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfOC0zLTEtMS0xNDA1MjM_aece903d-490d-46c5-b083-a67437222a85">62,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTEtMS0xLTEtMTQwNTIz_cfc2b1b9-b0bb-48c7-9f8d-f048665d248e">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTEtMy0xLTEtMTQwNTIz_3e49565f-9f0c-4bf1-a32c-ca7885653922">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTItMS0xLTEtMTQwNTIz_16caf4f2-d60d-4b62-a43e-ddd5f8987bb8">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTItMy0xLTEtMTQwNTIz_ba282d4c-9279-4a61-ab46-71158ca9ac68">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTMtMS0xLTEtMTQwNTIz_c83851fe-9c91-4a32-ba2e-6dc1d58e7f48">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTMtMy0xLTEtMTQwNTIz_f012af7e-a24c-4975-a9f5-fc79e09ce6dc">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTQtMS0xLTEtMTQwNTIz_08f41dd9-3360-4e43-acb0-1e11212ebeaf">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTQtMy0xLTEtMTQwNTIz_dcc3672b-2834-4a03-92b8-52b56e278746">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac647f2ab1ea4e1aab5af149078db642_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTYtMS0xLTEtMTQwNTIz_2e2276e7-f718-4e12-90a0-d724a987e661">1,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aebb076b6b54144a3cd96e1ece30f3b_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTYtMy0xLTEtMTQwNTIz_e2b3bfac-7c66-4680-a0d4-3b80f145bda5">914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTctMS0xLTEtMTQwNTIz_b3138afc-68f6-402c-88bf-d99032e81391">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTctMy0xLTEtMTQwNTIz_fd0e09ed-2ccc-42f1-bf63-8105d70315c5">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTktMS0xLTEtMTQwNTIz_b231418d-b62b-4ebf-97b7-38d0df4bfa0c">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTktMy0xLTEtMTQwNTIz_d6100681-be18-4bcd-a2ed-e502bdbd4794">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMjAtMS0xLTEtMTQwNTIz_7ee8eee9-6df8-4082-a201-dcfc1f1afdb5">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMjAtMy0xLTEtMTQwNTIz_03857324-e32d-45d3-8009-c114b77d385e">562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzQzNQ_ed491ba7-d861-4a43-8d74-14a4bcfe1499">1</ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzUwMQ_28eecc11-83a6-45fc-b80d-264b9589502c">35</ix:nonFraction>% of the RxTS segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzU1Mg_b877f328-972c-4b16-b6dc-b4a753481138">1</ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than <ix:nonFraction unitRef="number" contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzYyOQ_bb8db312-6601-47e1-803f-972e16f7098e">8</ix:nonFraction>% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining <ix:nonFraction unitRef="segment" contextRef="i507200d519254ee5b810cc4ba9c9eb26_D20220401-20220630" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzc1OQ_0b3603e5-6dd1-4cae-b3d4-9bcf6df24a9c">three</ix:nonFraction> reportable segments are derived in the U.S.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three months ended June 30, 2022 and 2021 includes $<ix:nonFraction unitRef="usd" contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNDAzNA_ead8fe34-56ce-4f41-bcce-37fe62e6dfca">13</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNDA4Mw_d2d21aa0-2857-44c0-a03d-b7a9623f557c">23</ix:nonFraction> million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three months ended June 30, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNDU1NQ_cf02ed5d-a421-4f7b-8a4a-a675c1b17c66">164</ix:nonFraction> million of inventory charges on certain personal protective equipment and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three months ended June 30, 2022 includes charges of $<ix:nonFraction unitRef="usd" contextRef="ia2177f40437f42b6809296d7905c7869_D20220401-20220630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNDk2Mw_0e9461d1-da76-4967-8e9b-62763ac6dd91">94</ix:nonFraction> million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">gains of $<ix:nonFraction unitRef="usd" contextRef="i8cd60915c3dd465caaf23b140f67daf3_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc3ODgxNw_b44b71bd-9a0b-40da-a602-45a7dfdc0621">106</ix:nonFraction> million for the three months ended June 30, 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="i4588d9a710614530af4777a0d6ec981e_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc3OTE3Nw_3992d362-91a3-4bb5-9d27-91ce7053881f">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie6158e4d86384dd3835014e2ff918ab3_D20210401-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc3OTE4NQ_fda9d42f-936f-4294-9dfa-0f2b43e1108e">74</ix:nonFraction> million for the three months ended June 30, 2022 and 2021, respectively, related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities;&#8221; </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i4fbe534f05524e98a28ae33f808bc369"><ix:continuation id="i9f6147a43b9d4b6b9826f9112ae76c30"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="i7cb66cdf2011438e8e70e27b549a9862_D20220401-20220630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjY2NA_e8560d60-1bc5-4503-9325-b746e06669ab">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3b9d7a308dd141549bede7bfa3e5cbf0_D20210401-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjcwOQ_be9a4d67-5dd8-4411-9ce0-837f54f0b2b1">35</ix:nonFraction> million for the three months ended June 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfODc5NjA5MzAzNzIxNA_bbdc54e6-ca76-4d0e-8df0-feae4c52c490">62</ix:nonFraction> million for the three months ended June 30, 2021 primarily due to the transition to a partial remote work model for certain employees.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ida37730e58094407b89f4630fc6c6b2d_79"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt;padding-left:27pt;padding-right:27pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Section</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_82">General</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_82">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_85">Overview of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_85">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_85">ur Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_85">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_88">Executive Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_88">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_91">Trends and Uncertainties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_91">35</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_94">Overview of Consolidated Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_94">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_97">Overview of Segment Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_97">42</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_106">New Accounting Pronouncements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_106">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_109">Financial Condition, Liquidity, and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_109">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_115">Cautionary Notice About Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_115">48</a></span></div></td></tr></table></div><div id="ida37730e58094407b89f4630fc6c6b2d_82"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;McKesson,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying financial notes in Item 1 of Part I of this Quarterly Report on Form 10-Q (&#8220;Quarterly Report&#8221;) and in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 previously filed with the Securities and Exchange Commission on May&#160;9, 2022 (&#8220;2022 Annual Report&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this report constitute forward-looking statements. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Cautionary Notice About Forward-Looking Statements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Quarterly Report.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_85"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for further information regarding our reportable segments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a reportable segment that combines automation and our ability to navigate the healthcare ecosystem to connect pharmacies, providers, payers, and biopharma companies to address patients&#8217; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the United States (&#8220;U.S.&#8221;).</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. During fiscal 2022, we entered into agreements to sell certain of our businesses in the European Union (&#8220;E.U.&#8221;) and our retail and distribution businesses in the United Kingdom (&#8220;U.K.&#8221;), as well as completed the sale of our Austrian business. During the three months ended June 30, 2022, we completed the sale of our retail and distribution businesses in the U.K. These divestitures are further described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;European Divestiture Activities&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, we entered into an agreement to sell certain of our businesses in the E.U. located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with our German headquarters and wound-care business, part of a shared services center in Lithuania, and our ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2 billion (or, approximately $1.3 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. We recorded a gain of $12 million for the three months ended June 30, 2022 in total operating expenses to remeasure the E.U. disposal group to fair value less costs to sell, of which gains of $106 million are included within Corporate expenses, net, partially offset by charges of $94 million included within our International segment. The transaction is anticipated to close within the second half of fiscal 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, we completed the previously announced sale of our retail and distribution businesses in the U.K. (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;110&#160;million (or, approximately $144&#160;million), including certain adjustments. As part of the transaction, we divested net assets of $615&#160;million and released $731&#160;million of accumulated other comprehensive loss. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, we had $3.2 billion of assets and $2.3 billion of liabilities classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet primarily related to the pending sale of our E.U. disposal group described above. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_88"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the three months ended June 30, 2022. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The pandemic disease caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;) impacted our results of operations for the three months ended June 30, 2022. For a more in-depth discussion of how COVID-19 impacted our business, operations, and outlook, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For the three months ended June 30, 2022 compared to the prior year, revenues increased by 7%, gross profit was flat, total operating expenses decreased by 19%, and other income, net decreased by 65%. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Overview of Consolidated Results&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below for an analysis of these changes;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted earnings per common share from continuing operations attributable to McKesson Corporation for the three months ended June 30, 2022 increased 70% to $5.25, primarily driven by reduced corporate expenses, growth across our North American businesses, and a lower share count compared to the prior year due to the cumulative effect of share repurchases; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">We returned $1.1 billion of cash to shareholders during the three months ended June 30, 2022 through $1.0 billion of common stock repurchases under an accelerated share repurchase (&#8220;ASR&#8221;) program entered into in May 2022 and $71 million of dividend payments. In July 2022, our Board of Directors (the &#8220;Board&#8221;) approved an increase of $4.0 billion in the authorization for repurchases of McKesson&#8217;s common stock and raised our quarterly dividend from $0.47 to $0.54 per common share.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_91"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Impact of Inflationary and Global Events </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and results of operations, financial condition, and liquidity are impacted by broad economic conditions including inflation, increased competition for talent, and disruption of the supply chain, as well as by political or civil unrest or military action, including indirect results such as commodity price increases from the conflict between Russia and Ukraine (&#8220;Russo-Ukrainian War&#8221;). Cost inflation generally affects us by increasing transportation, operational, and other administrative costs associated with our business operations which we might not be able to fully pass along to our customers. Although it is difficult to predict the impact that these factors may have on our business in the future, they did not have a material effect on our results of operations, financial condition, or liquidity for the three months ended June 30, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has continued to evolve since it was declared a global pandemic by the World Health Organization on March 11, 2020. We continue to evaluate the nature and extent of the ongoing impacts of COVID-19 on our business, operations, and financial results. Refer to Item 7 - Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II of our 2022 Annual Report for additional disclosure of trends and uncertainties due to COVID-19. The disclosures below include significant updates that occurred during the first quarter of fiscal 2023 and the financial impacts compared to fiscal 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Role in the Distribution of COVID-19 Vaccines and Ancillary Supply Kits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a diversified healthcare services leader, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe. We work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (&#8220;PPE&#8221;), and medicine reach our customers and their patients. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we began distributing certain COVID-19 vaccines in support of the U.S. government through a contract with the Centers for Disease Control and Prevention (&#8220;CDC&#8221;). In July 2022, we renewed our relationship with the CDC, under which we serve as a centralized distributor of COVID-19 vaccines and ancillary supplies used to administer vaccines. The results of operations related to our vaccine distribution are reflected in our U.S. Pharmaceutical segment. We also extended our contract to manage the assembly, storage, and distribution of ancillary supply kits as directed by the Department of Health and Human Services (&#8220;HHS&#8221;), the results of which are reflected in our Medical-Surgical Solutions segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada and McKesson Europe support governments and public health entities through distributing COVID-19 vaccines and administering them in pharmacies as well as distributing COVID-19 tests and certain PPE.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We observed increases in prescription volumes within our U.S. Pharmaceutical segment and favorability in our primary care business within our Medical-Surgical Solutions segment during the three months ended June 30, 2022 compared to the same prior year period. The contributions from COVID-19 tests and our vaccine and related kitting distribution programs have decreased year over year primarily driven by lower demand. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impacts to our Supply Chain </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor and address the COVID-19 pandemic impacts on our supply chain. Although the availability of various products is dependent on our suppliers, their locations, and the extent to which they are impacted by the COVID-19 pandemic, we proactively work with manufacturers, industry partners, and government agencies to meet the needs of our customers. During the quarter, we had an increase in supply chain costs primarily related to transportation and labor; however, this did not materially impact our results of operations for the three months ended June 30, 2022. As potential shortages or disruptions of any products are identified, we address supply continuity which includes securing additional products when available, sourcing back-up products when needed, and following allocation procedures to maintain and protect supply as much as possible. We utilize business continuity action planning to maintain and protect operations across all locations and facilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Results of Operations, Financial Condition, and Liquidity</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2022, COVID-19 tests and the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately $201 million and $49 million to segment revenues and segment operating profit, respectively. For the three months ended June 30, 2021, the contribution was approximately $323 million to segment revenues and including total inventory charges that are further described below, reduced our segment operating profit by approximately $90 million.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of COVID-19 vaccines in our U.S. Pharmaceutical segment decreased during the first quarter of fiscal 2023 when compared to the same prior year period. The contribution was less than 10% to segment operating profit for each of the three months ended June 30, 2022 and 2021. The financial impact from our COVID-19 response efforts in the International segment during the three months ended June 30, 2022 and 2021 was not material to our consolidated results, but favorably contributed to our segment operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Additionally, we recorded inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment during the three months ended June 30, 2021. We have taken measures to mitigate risks for market price volatility and changes to anticipated customer demand that may require additional write-downs in future periods of other PPE and related product categories.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These COVID-19 related items had a net favorable impact on consolidated income from continuing operations before income taxes for the three months ended June 30, 2022 compared to the same prior year period, primarily due to prior year inventory charges on certain PPE and other related products as mentioned above. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022 and 2021, we maintained appropriate labor and overall vendor supply levels and experienced no material impacts to our liquidity or net working capital due to the COVID-19 pandemic. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in many legal proceedings asserting claims related to the distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. The plaintiffs in these actions have included state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2022, the Company and two other United States pharmaceutical distribution companies (collectively, "Distributors") determined that there was sufficient State and subdivision participation to proceed with an agreement ("Settlement") to settle a substantial majority of opioids-related lawsuits filed against the Distributors by U.S. states, territories and local governmental entities. Under the Settlement, 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, "Settling Governmental Entities"), have agreed to join the Settlement. The Settlement became effective on April 2, 2022. If all conditions to the Settlement are satisfied, including the receipt of approval by relevant courts of consent decrees to dismiss the lawsuits, the Distributors would pay the Settling Governmental Entities up to approximately $19.5 billion over 18 years, with up to approximately $7.4 billion to be paid by the Company for its 38.1% portion. Under the Settlement, a minimum of 85% of the settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Settlement provides that the Distributors do not admit liability or wrongdoing and do not waive any defenses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement only addresses the claims of attorneys general of U.S. states and territories and political subdivisions in participating states and territories. Governmental entities not participating in the Settlement may continue to pursue their claims. The states of Alabama, Oklahoma and Washington chose not to participate in the Settlement, but, since the announcement of the Settlement, we have reached separate agreements in principle with the attorneys general of these states to settle the claims of the states and their subdivisions. The Distributors previously settled with the Cherokee Nation and reached a separate agreement in principle to settle the claims of the remaining federally recognized Native American Tribes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a charge of $8.3 billion during the year ended March 31, 2022 related to our estimated liability to U.S. governmental entities, including those expected to participate in the Settlement, the states and subdivisions that were not expected to participate or were not eligible, and the Native American tribes. Our total estimated liability for opioid-related claims was $7.9 billion as of June 30, 2022, of which $759 million was included in &#8220;Other accrued liabilities&#8221; for the amount estimated to be paid within the next twelve months, and the remaining liability was included in &#8220;Long-term litigation liabilities&#8221; in our Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private individuals or entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with ongoing opioid-related litigation matters, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. In light of the uncertainty, the amount of any ultimate loss may differ materially from the amount accrued.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the Settlement, we also continue to prepare for trial in pending matters. We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Forward-Looking Information </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent events such as the COVID-19 pandemic, the Russo-Ukrainian War, and associated economic impacts have disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments, and assumptions used in our forecasts. We have experienced and may experience difficulties in sourcing products and changes in costs and pricing due to the effects of these events on supply chains. Our participation in government-sponsored vaccination distribution and related ancillary supply kit programs with the CDC and HHS exposes us to various uncertainties, such as the scope and length of related agreements and the amount of COVID-19 vaccines and ancillary supply kits that we are contracted to distribute, which could materially impact our future financial performance. Additionally, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Key assumptions and estimates about future values in our impairment assessments can be affected by a variety of factors, including the impacts of socio-political events on industry and economic trends as well as on our business strategy and internal forecasts. Impairment charges have been recognized in prior periods due to the impact from the COVID-19 pandemic. Material changes to key assumptions and estimates could decrease the projected cash flows or increase the discount rates that could potentially result in future impairment charges. Refer to Item 1A - Risk Factors in Part I of our 2022 Annual Report for a discussion of risk factors that could cause our actual results to differ materially from our projections.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_94"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions, except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,032&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the three months ended June 30, 2022 compared to the same prior year period primarily due to market growth in our U.S. Pharmaceutical segment. This was partially offset by lower revenues in our International segment driven by the completed divestiture of our U.K. disposal group in April 2022 and unfavorable effects of foreign currency exchange fluctuations. Market growth includes growing drug utilization, price increases, and newly launched products, partially offset by price deflation associated with branded to generic drug conversion.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit was flat for the three months ended June 30, 2022 compared to the same prior year period. Gross profit decreased in our International segment primarily driven by the completed divestiture of our U.K. disposal group in April 2022 and unfavorable effects of foreign currency exchange fluctuations. This was partially offset by an increase in gross profit in our Medical-Surgical Solutions segment due to prior year inventory charges on PPE and other related products as well as growth in our primary care business. Gross profit was also favorably impacted by growth of specialty pharmaceuticals in our U.S. Pharmaceutical segment as well as increased volume with new and existing customers in our RxTS segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Last-in, first-out (&#8220;LIFO&#8221;) inventory credits were $13 million and $23 million for the three months ended June 30, 2022 and 2021, respectively. LIFO credits were lower in the first quarter of fiscal 2023 compared to the same prior year period primarily due to higher expected brand inflation. Our U.S. Pharmaceutical business uses the LIFO method of accounting for the majority of its inventories, which results in cost of sales that more closely reflects replacement cost than under other accounting methods. The business&#8217; practice is to pass on to customers published price changes from suppliers. Manufacturers generally provide us with price protection, which limits price related inventory losses. A LIFO expense is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Our quarterly LIFO credit is based on our estimates of the annual LIFO credit which is impacted by expected changes in year-end inventory quantities, product mix, and manufacturer pricing practices, which may be influenced by market and other external factors. Changes to any of the above factors could have a material impact to our annual LIFO credit. The actual valuation of inventory under the LIFO method is calculated at the end of the fiscal year. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the components of our total operating expenses for the three months ended June 30, 2022 and 2021 is as follows: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Selling, distribution, general, and administrative expenses (&#8220;SDG&amp;A&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SDG&amp;A consists of personnel costs, transportation costs, depreciation and amortization, lease costs, professional fee expenses, administrative expenses, remeasurement charges to the lower of carrying value or fair value less costs to sell, and other general charges.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Claims and litigation charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates. Legal fees to defend claims, which are expensed as incurred, are included within SDG&amp;A.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Restructuring, impairment, and related charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restructuring charges are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.973%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2022, total operating expenses and total operating expenses as a percentage of revenues decreased compared to the same prior year period. Total operating expenses were impacted by the following significant items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three months ended June 30, 2022 reflects lower operating expenses due to the completed divestiture of our U.K. disposal group in April 2022;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net for the three months ended June 30, 2022 and 2021 includes charges of $5 million and $74 million, respectively, related to our estimated liability for opioid-related claims as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section;  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Restructuring, impairment, and related charges, net for the three months ended June 30, 2021 includes charges of $158&#160;million primarily related to our transition to a partial remote work model approved during the first quarter of fiscal 2022 and costs for optimization programs in Canada; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were favorably impacted by foreign currency exchange fluctuations for the three months ended June 30, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. We voluntarily changed our annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with the change in timing of our annual long-term planning process. This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. Refer to Financial Note 7, &#8220;Goodwill and Intangible Assets, Net,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed in fiscal 2023 and fiscal 2022 did not indicate any impairment of goodwill and no goodwill impairment charges were recorded during the three months ended June 30, 2022 and 2021. However, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment, where the risk of a material goodwill impairment is higher than other reporting units. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives and Long-Lived Asset Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of our office space in North America. Where we ceased using office space, we exited the portion of the facility no longer used. We also retained and repurposed certain other office locations. We recorded charges of $95 million for the three months ended June 30, 2021 primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 and remaining costs we expect to record under this initiative are not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for further information on our restructuring initiatives.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net decreased for the three months ended June 30, 2022 compared to the same prior year period primarily due to unfavorability from our equity investments and lower net equity in earnings. This was partially offset by the payment from a tax receivable agreement related to our previous joint venture with Change Healthcare, Inc., which was split-off in March 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, we exited one of our investments in equity securities for proceeds of $179 million. We expect to recognize a gain within &#8220;Other income, net&#8221; in our Condensed Consolidated Statement of Operations for the second quarter of fiscal 2023 related to the disposition. The cost basis of the investment was $38 million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased for the three months ended June 30, 2022 when compared to the same prior year period. Interest expense may fluctuate based on timing, amounts, and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022 and 2021, we recorded an income tax expense of $199 million and $26 million, respectively. Our reported income tax rates were 19.8% and 4.6% for the three months ended June 30, 2022 and 2021, respectively. Fluctuations in our reported income tax rates are primarily due to discrete benefits recognized in the quarter. Refer to Financial Note 4, &#8220;Income Taxes,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests for the three months ended June 30, 2022 and 2021 primarily represents ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe share that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;). Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests.&#160;Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Selected Measures of Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 5, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information on changes to our redeemable and noncontrolling interests that occurred during the first quarter of fiscal 2022. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to McKesson Corporation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to McKesson Corporation was $768 million and $486 million for the three months ended June 30, 2022 and 2021, respectively. Diluted earnings per common share attributable to McKesson Corporation was $5.26 and $3.07 for the three months ended June 30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares Outstanding</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per common share was calculated based on a weighted-average number of shares outstanding of 145.9 million and 158.1 million for the three months ended June 30, 2022 and 2021, respectively. Weighted-average diluted shares outstanding for the three months ended June 30, 2022 decreased from the same prior year period primarily due to the cumulative effect of shares repurchases.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.973%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,154&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the three months ended June 30, 2022 increased $6.9 billion or</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14% compared to the same prior year period. Within the segment, sales to pharmacies and institutional healthcare providers increased $6.6 billion and sales to specialty practices and other increased $315 million compared to the same prior year period. Other includes the results for the distribution of COVID-19 vaccines. Overall, these increases were primarily due to market growth, including growth in specialty pharmaceuticals driven by higher volumes from retail national account customers, and branded pharmaceutical price increases, partially offset by branded to generic drug conversions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the three months ended June 30, 2022 increased $185 million or 21% compared to the same prior year period. This increase was due to increased volumes with new and existing customers primarily in our third-party logistics and wholesale distribution services as well as higher technology service revenues.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the three months ended June 30, 2022 increased $64 million or 3% compared to the same prior year period. Within the segment, sales to primary care and extended care customers increased $87 million and $10 million, respectively, partially offset by a $33 million decline in sales primarily related to the results of the kitting and distribution of ancillary supply kits used to administer COVID-19 vaccines. The increase in our primary care business was driven by underlying revenue growth from physician office customers, partially offset by lower sales of COVID-19 tests. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the three months ended June 30, 2022 decreased $2.7 billion or 29% compared to the same prior year period. Within the segment, foreign currency exchange fluctuations were unfavorable by $574 million and sales in Europe declined by $2.3 billion, partially offset by increased sales in Canada of $169 million compared to the same prior year period. Excluding the unfavorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 23% largely due to the completed divestitures of our U.K. disposal group in April 2022 and Austrian business in January 2022. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.973%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for our reportable segments. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our Medical-Surgical Solutions segment for the three months ended June 30, 2021 includes $164 million of inventory charges on certain PPE and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for our International segment for the three months ended June 30, 2022 includes charges of $94 million to remeasure our E.U. disposal group to fair value less costs to sell.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">gains of $106 million for the three months ended June 30, 2022 primarily related to the effect of accumulated other comprehensive loss components from our E.U. disposal group;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $5 million and $74 million for the three months ended June 30, 2022 and 2021, respectively, related to our estimated liability for opioid-related claims; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $19 million and $35 million for the three months ended June 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; and</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $62 million for the three months ended June 30, 2021 primarily due to the transition to a partial remote work model for certain employees.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for this segment for the three months ended June 30, 2022 compared to the same prior year period primarily due to growth in specialty pharmaceuticals, partially offset by a decrease in the contribution from our COVID-19 vaccine distribution program.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the three months ended June 30, 2022 compared to the same prior year period primarily driven by increased volumes with new and existing customers due to growth in our access, affordability, and adherence solutions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the three months ended June 30, 2022 compared to the same prior year period primarily due to prior year inventory charges on certain PPE and other related products. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss for this segment for the three months ended June 30, 2022 compared to operating profit for the same prior year period was largely due to fair value remeasurement charges recorded during the first quarter of fiscal 2023 related to our E.U. disposal group, partially offset by the cessation of depreciation and amortization expenses from its assets classified as held for sale, as well as unfavorable impacts from the completed divestitures of our Austrian business and U.K. disposal group. These impacts were partially offset by lower restructuring expenses primarily due to optimization programs in Canada. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Expenses, Net</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net decreased for the three months ended June 30, 2022 compared to the same prior year period primarily due to fair value remeasurement gains recognized during the first quarter of fiscal 2023 related to our E.U. disposal group, lower charges related to our estimated liability for opioid-related claims, and prior year restructuring charges for the transition to a partial remote work model for certain employees.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_106"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted as well as those that have been recently issued but not yet adopted by us are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_109"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. We remain adequately capitalized with access to liquidity from our $4.0 billion revolving credit facility. At June 30, 2022, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,595)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,861)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This change reflects a reversal of cash, cash equivalents, and restricted cash previously classified within assets held for sale at March 31, 2022 as part of the U.K. disposal group and is offset by cash outflows primarily related to the settlement of liabilities which is reflected in operating activities. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for further information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities used cash of $941 million and $1.6 billion during the three months ended June 30, 2022 and 2021, respectively. Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers, inventory receipts, and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities for the three months ended June 30, 2022 were affected by net income adjusted for non-cash items and changes in receivables, drafts and accounts payables, and inventories classified as held for sale. Refer to the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selected Measures of Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below of this Financial Review and Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for further information. Operating activities for the three months ended June 30, 2022 were affected by increases in receivables of $1.6 billion, drafts and accounts payable of $1.0 billion, and inventory of $955 million, all primarily driven by higher revenues and timing. Our litigation liabilities also decreased by $370 million primarily driven by payments made during the first quarter of fiscal 2023 associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities for the three months ended June 30, 2021 were affected by increases in receivables of $1.0 billion and inventory of $901 million, both primarily due to timing and higher revenues. Other non-cash items for the three months ended June 30, 2021 includes non-cash inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities provided cash of $39 million and used cash of $99 million during the three months ended June 30, 2022 and 2021, respectively. Investing activities for the three months ended June 30, 2022 includes proceeds from sales of businesses and investments of $240 million, primarily due to the completed divestiture of our U.K. disposal group in April 2022. Investing activities for the three months ended June 30, 2022 and 2021 includes $100 million and $159 million, respectively, in capital expenditures for property, plant, and equipment, and capitalized software.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used cash of $1.2 billion and $2.2 billion during the three months ended June 30, 2022 and 2021, respectively. Financing activities for each of the three months ended June 30, 2022 and 2021 includes $1.0 billion of cash paid for share repurchases as well as $71 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $69 million of cash paid for dividends, respectively. Financing activities for the three months ended June 30, 2021 includes a payment of $1.0&#160;billion to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders. The put right option expired on June 15, 2021 as further described below. Cash used for other financing activities generally includes shares surrendered for tax withholding and payments to noncontrolling interests.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans </span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock from time-to-time in open market transactions, privately negotiated transactions, through ASR programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, we entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, we paid $1.0&#160;billion to the financial institution and received an initial delivery of 2.6 million shares in May 2022. The transaction will be completed during the second quarter of fiscal 2023, at which point we expect to receive additional shares. The final number of shares repurchased and the average price per share paid will be determined based on the volume-weighted average price of the Company&#8217;s common stock during the term of the ASR program, less a pre-negotiated discount.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, we entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. We received 4.8 million shares as the initial share settlement, and in May 2022, we received an additional 0.3 million shares upon the completion of this ASR program. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. We received 4.3 million shares as the initial share settlement, and in August 2021, we received an additional 0.9 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other shares repurchased during the three months ended June 30, 2022 and 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at June 30, 2022 was $2.3 billion. In July 2022, the Board approved an increase of $4.0 billion in the authorization for repurchase of McKesson&#8217;s common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected Measures of Liquidity and Capital Resources</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,235)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling interests and accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of June 30, 2022 and March 31, 2022 included approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$821 million and $1.5 billion of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, inventories, and net current assets or liabilities classified as held for sale, net of drafts and accounts payable, current portion of long-term debt, and other accrued liabilities. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital improved at June 30, 2022 compared to March 31, 2022 primarily due to increases in receivables, net assets classified as held for sale related to our European divestiture activities, and inventory, partially offset by an increase in drafts and accounts payable and a decrease in cash and cash equivalents. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio increased for the three months ended June 30, 2022 primarily due to share repurchases, partially offset by net income for the quarter. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, we raised our quarterly dividend from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our previously recognized redeemable noncontrolling interests primarily related to our consolidated subsidiary, McKesson Europe. Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published semi-annually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid by McKesson (&#8220;Put Amount&#8221;). During the three months ended June 30, 2021, we paid $1.0 billion to purchase 34.5&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders, which reduced the balance of our redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, valued at $287 million, were transferred from redeemable noncontrolling interests to noncontrolling interests and as a result, we no longer have redeemable noncontrolling interests presented in our condensed consolidated balance sheets at June 30, 2022 or March 31, 2022. Our noncontrolling interest in McKesson Europe will be included in the sale of our E.U. disposal group.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_76">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount is recognized ratably during the applicable annual period. The Domination Agreement does not expire, but it may be terminated at the end of any fiscal year by giving at least six months&#8217; advance notice. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 5, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for additional information on redeemable noncontrolling interests. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our credit facilities and commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements, including any future payments that may be made related to our total estimated litigation liability of $7.9 billion as of June 30, 2022 payable under the Settlement terms for opioid-related claims, are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, are open and accessible to us should we decide to access those markets. Detailed information regarding our debt and financing activities is included in Financial Note 8, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing. </span></div><div id="ida37730e58094407b89f4630fc6c6b2d_115"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTICE ABOUT FORWARD-LOOKING STATEMENTS </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 2 of Part I of this report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Some of these statements can be identified by the use of terminology such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or the negative of these words and other comparable terminology. The discussion of financial trends, strategy, plans, assumptions, or intentions may also include forward-looking statements. Readers should not place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by law, we undertake no obligation to update or revise our forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, factors described in the Risk Factors discussion in Item 1A of Part I of our most recently filed Annual Report. </span></div><div id="ida37730e58094407b89f4630fc6c6b2d_118"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe there has been no material change in our exposure to risks associated with fluctuations in interest and foreign currency exchange rates as disclosed in our 2022 Annual Report. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Controls and Procedures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;)) as of the end of the period covered by this quarterly report, and our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our &#8220;internal control over financial reporting&#8221; (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that occurred during the three months ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_124"></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_127"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Legal Proceedings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, and in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, is incorporated herein by reference. Disclosure of an environmental proceeding with a governmental agency generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_130"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.8pt">Risk Factors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than factual updates discussed in this Quarterly Report on Form 10-Q, there have been no material changes for the period covered by this Quarterly Report on Form 10-Q to the risk factors disclosed in Part I, Item 1A, of our 2022 Annual Report on Form 10-K.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_133"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, the Company paid $1.0&#160;billion to the financial institution and received an initial delivery of 2.6 million shares in May 2022. The transaction will be completed during the second quarter of fiscal 2023, at which point the Company expects to receive additional shares. The final number of shares repurchased and the average price per share paid will be determined based on the volume-weighted average price of the Company&#8217;s common stock during the term of the ASR program, less a pre-negotiated discount.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. The Company received 4.8 million shares as the initial share settlement, and in May 2022, the Company received an additional 0.3 million shares upon the completion of this ASR program. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. The Company received 4.3 million shares as the initial share settlement, and in August 2021, the Company received an additional 0.9 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other shares repurchased during the three months ended June 30, 2022 and 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at June 30, 2022 was $2.3 billion. In July 2022, the Board approved an increase of $4.0 billion in the authorization for repurchase of McKesson&#8217;s common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the Company&#8217;s share repurchases during the three months ended June 30, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased<br/>As Part of Publicly<br/>Announced<br/>Program</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate<br/>Dollar&#160;Value&#160;of<br/>Shares&#160;that&#160;May<br/>Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2022 &#8211; April 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2022 &#8211; May 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2022 &#8211; June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes shares received upon the completion of the February 2022 ASR program, and the initial delivery of shares under the May 2022 ASR program at a reference price of $326.47, as discussed above. These amounts under the May 2022 ASR program are estimates and may differ from the total number of shares purchased and average price paid per share under the ASR program upon its final settlement in the second quarter of fiscal 2023.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_136"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Defaults Upon Senior Securities.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_139"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Mine Safety Disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ida37730e58094407b89f4630fc6c6b2d_142"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Other Information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_145"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Exhibits.</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified in parentheses below are on file with the SEC and are incorporated by reference as exhibits hereto. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">McKesson Corporation 2022 Stock Plan, effective July </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">22</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">, 2022 (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm"> of the Company&#8217;s Registration Statement on Form S-8 filed with the SEC on July </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">27</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_ex102xstockplantermsan.htm">Forms of Statement of Terms and Conditions and Grant Notices Applicable to Awards Pursuant to the McKesson Corporation 2022 Stock Plan.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#8224;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit311x630202210-q.htm">Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#8224;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit312x630202210-q.htm">Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit32x630202210-q.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit), (v) Condensed Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensation plan or arrangement in which directors and/or executive officers are eligible to participate.</span></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="ida37730e58094407b89f4630fc6c6b2d_148"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ida37730e58094407b89f4630fc6c6b2d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:207.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:207.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Napoleon B. Rutledge Jr.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Napoleon B. Rutledge Jr.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>mck_ex102xstockplantermsan.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibd561b47d4184a839c90169cfcfff003_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">OUTSIDE DIRECTOR<br>Div Equiv Cash</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION<br>STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO<br>RESTRICTED STOCK UNITS GRANTED TO<br>OUTSIDE DIRECTORS PURSUANT TO THE 2022 STOCK PLAN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:28.34pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:23.68pt">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Outside Director&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards. With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders. An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Number of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Board or the Governance Committee of the Board (the &#8220;Governance Committee&#8221;), the number of Restricted Stock Units (&#8220;Units&#8221;) granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $&#91;__&#93; (with any fractional </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2022 Stock Plan STC (Outside Director)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unit rounded up to the nearest whole Unit). In addition to such grant, unless otherwise determined by the Board or the Governance Committee, the Independent Chair shall be granted an annual meeting grant determined by dividing the Fair Market Value of a Share on the date of grant into $&#91;__&#93; (with any fractional Unit rounded up to the nearest whole Unit).  Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to any Outside Director pursuant to such annual meeting grant or grants exceed 5,000. A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director&#8217;s election to the Board.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">No Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be credited on behalf of an Outside Director to a deferred cash account until such time as the underlying Shares are issued.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Outside Director shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither an Outside Director nor any person entitled to exercise an Outside Director&#8217;s rights in the event of the Outside Director&#8217;s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as noted in Section II.7 below, Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director&#8217;s separation of service with the Corporation (&#8220;Automatic Deferral Requirement&#8221;). &#8220;Separation from service&#8221; shall have the meaning provided under the McKesson Corporation Deferred Compensation Administration Plan III (&#8220;DCAP&#160;III&#8221;).  Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Outside Director&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Satisfaction of Director Stock Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For those Outside Directors who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director&#59; provided, however, that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Deferrals of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.02pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Terms of Service with the Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation&#8217;s right to terminate the service of any Outside Director.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Grants to Outside Directors in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If an Outside Director is not a United States citizen or resident, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director&#8217;s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director&#8217;s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein. Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Nothing herein contained shall affect an Outside Director&#8217;s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state or local income tax withholding requirements or payroll tax requirements, if any is required.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27pt">Data Privacy Information and Consent.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Data Collection and Usage.  The Corporation may collect, process and use certain personal information about the Outside Director, including, but not limited to, the Outside Director&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares held in the Corporation, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Outside Director&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Outside Director may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Outside Director&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19.36pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Outside Director&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Outside Director understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Outside Director&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Outside Director&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Outside Director&#8217;s Data for any of the above purposes, the Outside Director understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Outside Director is providing the consents herein on a purely voluntary basis.  If the Outside Director does not consent, or if the Outside Director later seeks to revoke the Outside Director&#8217;s consent, the Outside Director&#8217;s retainer and fees from or services with the Corporation will not be affected&#59; the only consequence of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">refusing or withdrawing the Outside Director&#8217;s consent is that the Corporation would not be able to grant Awards to the Outside Director or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Data Subject Rights.  The Outside Director may have a number of rights under data privacy laws in the Outside Director&#8217;s jurisdiction.  Depending on where the Outside Director is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Outside Director and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Outside Director that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Outside Director&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Outside Director feels its processing is inappropriate, (v) request portability of the Outside Director&#8217;s Data that the Outside Director has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Outside Director&#8217;s service on the Board and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Outside Director&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Outside Director can contact the Corporate Secretary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Outside Director is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;Outside Director&#8221; as used herein shall include the Outside Director&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><div id="ibd561b47d4184a839c90169cfcfff003_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">OUTSIDE DIRECTOR<br>Div Equiv Units</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION<br>STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO<br>RESTRICTED STOCK UNITS GRANTED TO<br>OUTSIDE DIRECTORS PURSUANT TO THE 2022 STOCK PLAN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:28.34pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:23.68pt">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Outside Director&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards. With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders. An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Number of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Board or the Governance Committee of the Board (the &#8220;Governance Committee&#8221;), the number of Restricted Stock Units (&#8220;Units&#8221;) granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $&#91;__&#93; (with any fractional </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2022 Stock Plan STC (Outside Director)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unit rounded up to the nearest whole Unit).  In addition to such grant, unless otherwise determined by the Board or the Governance Committee, the Independent Chair shall be granted an annual meeting grant determined by dividing the Fair Market Value of a Share on the date of grant into $&#91;__&#93; (with any fractional Unit rounded up to the nearest whole Unit).  Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to any Outside Director pursuant to such annual meeting grant or grants exceed 5,000.  A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director&#8217;s election to the Board.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">No Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award. The number of such additional Restricted Stock Units shall be calculated by dividing (a)&#160;the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b)&#160;the Fair Market Value per Share on the payment date for such dividend. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Outside Director shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither an Outside Director nor any person entitled to exercise an Outside Director&#8217;s rights in the event of the Outside Director&#8217;s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as noted in Section II.7 below, Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director&#8217;s separation of service with the Corporation (&#8220;Automatic Deferral Requirement&#8221;). &#8220;Separation from service&#8221; shall have the meaning provided under the McKesson Corporation Deferred Compensation Administration Plan III (&#8220;DCAP&#160;III&#8221;). Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Outside Director&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award. Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Satisfaction of Director Stock Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For those Outside Directors who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director&#59; provided, however, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Deferrals of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.02pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Terms of Service with the Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation&#8217;s right to terminate the service of any Outside Director.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Grants to Outside Directors in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If an Outside Director is not a United States citizen or resident, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director&#8217;s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director&#8217;s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein. Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Nothing herein contained shall affect an Outside Director&#8217;s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state or local income tax withholding requirements or payroll tax requirements, if any is required.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27pt">Data Privacy Information and Consent.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Data Collection and Usage.  The Corporation may collect, process and use certain personal information about the Outside Director, including, but not limited to, the Outside Director&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares held in the Corporation, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Outside Director&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Outside Director may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Outside Director&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19.36pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Outside Director&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws. In the latter case, the Outside Director understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Outside Director&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Outside Director&#8217;s interests, rights or freedoms. When the Corporation no longer needs the Outside Director&#8217;s Data for any of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">above purposes, the Outside Director understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Outside Director is providing the consents herein on a purely voluntary basis. If the Outside Director does not consent, or if the Outside Director later seeks to revoke the Outside Director&#8217;s consent, the Outside Director&#8217;s retainer and fees from or services with the Corporation will not be affected&#59; the only consequence of refusing or withdrawing the Outside Director&#8217;s consent is that the Corporation would not be able to grant Awards to the Outside Director or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Data Subject Rights.  The Outside Director may have a number of rights under data privacy laws in the Outside Director&#8217;s jurisdiction. Depending on where the Outside Director is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Outside Director and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Outside Director that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Outside Director&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Outside Director feels its processing is inappropriate, (v) request portability of the Outside Director&#8217;s Data that the Outside Director has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Outside Director&#8217;s service on the Board and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Outside Director&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Outside Director can contact the Corporate Secretary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Outside Director is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Corporation. &#8220;Outside Director&#8221; as used herein shall include the Outside Director&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of Delaware. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><div id="ibd561b47d4184a839c90169cfcfff003_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE OFFICERS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AND PERFORMANCE STOCK UNITS GRANTED TO EXECUTIVE OFFICERS<br>PURSUANT TO THE 2022 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:28.34pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:23.68pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI. The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI. No Option may be exercised for less than 5% of the total number of Shares </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2022 Stock Plan STC (Outside Director)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.32pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date. Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised. Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise.  The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check.  Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant. No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing&#58; (A)&#160;unless otherwise determined by the Administrator in its sole discretion, a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity. In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.02pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement.  The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any Participant who is a U.S. taxpayer validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units.  Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">PERFORMANCE STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Performance Awards&#8221; as provided under Section 10 of the Plan.  Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement. Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period. Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved, and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section&#160;V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restriction on Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives with respect to the settlement of a Performance Stock Unit Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A. Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.  In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise.  In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.</font><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know-how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.02pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:10.36pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance contributions, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting, settlement or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">applicable&#59; or (4) any other method of withholding determined by the Corporation and to the extent required by applicable law or the Plan, approved by the Compensation Committee. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates in the Participant&#8217;s jurisdictions(s). If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund. In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Corporation and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.36pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">the Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19.36pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Stock Units, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19.36pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.69pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21.35pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language, or has consulted with an advisor who is sufficiently proficient in the English language, and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions. If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Unit Award, Performance Stock Unit Award or Other Share-Based Award, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)-1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;Any change in the person to whom the Participant reports, as this relationship existed immediately prior to a Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan or the McKesson Corporation Severance Policy for Executive Employees, as applicable, in accordance with the terms and conditions of such plans. A Participant outside the United States who is not qualified for participation in and entitlement to the benefits under such plans will nonetheless be treated for the limited purposes of his or her Awards, and subject to the provisions of Section VIII.9 of this Statement of Terms and Conditions, as terminated by reason of Severance to the extent his or her employment with the Corporation or an affiliate is terminated and he or she would satisfy the conditions for termination for reason of Severance but for the fact that such plan is only applicable to employees of the Corporation or an affiliate in the United States who qualify for participation in that plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet. A Participant or a Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039 or emailing CorpSecretary&#64;McKesson.com. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><div id="ibd561b47d4184a839c90169cfcfff003_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EMPLOYEES SUBJECT TO STOCK OWNERSHIP POLICY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AND PERFORMANCE STOCK UNITS GRANTED TO EMPLOYEES SUBJECT TO STOCK OWNERSHIP POLICY PURSUANT TO THE 2022 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:28.34pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:23.68pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI. The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI. No Option may be exercised for less than 5% of the total number of Shares </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2022 Stock Plan STC (Outside Director)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.32pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date. Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised.  Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise. The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check. Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant.  No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing&#58; (A)&#160;unless otherwise determined by the Administrator in its sole discretion, a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity.  In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.02pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement. The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any Participant who is a U.S. taxpayer validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">PERFORMANCE STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Performance Awards&#8221; as provided under Section 10 of the Plan. Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement. Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period. Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved, and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restriction on Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives with respect to the settlement of a Performance Stock Unit Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A. Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation. In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise. In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.</font><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know-how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.02pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:10.36pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance contributions, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting, settlement or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">applicable&#59; or (4) any other method of withholding determined by the Corporation and to the extent required by applicable law or the Plan, approved by the Compensation Committee. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates in the Participant&#8217;s jurisdiction(s). If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund. In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Corporation and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.36pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">the Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19.36pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Stock Units, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19.36pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms. When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.69pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21.35pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language, or has consulted with an advisor who is sufficiently proficient in the English language, and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions.  If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Unit Award, Performance Stock Unit Award or Other Share-Based Award, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)-1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59; provided, however, that, any such change attributable to the Corporation&#8217;s no longer being a company with publicly traded common stock shall not constitute Good Reason&#59; and provided, further, that a reduction in the Participant&#8217;s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant&#8217;s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation&#8217;s business) shall not constitute Good Reason&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan or the McKesson Corporation Severance Policy for Executive Employees, as applicable, in accordance with the terms and conditions of such plans. A Participant outside the United States who is not qualified for participation in and entitlement to the benefits under such plans will nonetheless be treated for the limited purposes of his or her Awards, and subject to the provisions of Section VIII.9 of this Statement of Terms and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Conditions, as terminated by reason of Severance to the extent his or her employment with the Corporation or an affiliate is terminated and he or she would satisfy the conditions for termination for reason of Severance but for the fact that such plan is only applicable to employees of the Corporation or an affiliate in the United States who qualify for participation in that plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet. A Participant or a Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039 or emailing CorpSecretary&#64;McKesson.com.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><div id="ibd561b47d4184a839c90169cfcfff003_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMPLOYEES</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND PERFORMANCE STOCK UNITS GRANTED TO EMPLOYEES<br>PURSUANT TO THE 2022 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:28.34pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan.  This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:23.68pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option.  Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement.  The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI.  The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2022 Stock Plan STC (Employee)</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI.  No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.32pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date.  Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised.  Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States.  Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise.  The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check.  Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant.  No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.  Notwithstanding the foregoing&#58; (A)&#160;unless otherwise determined by the Administrator in its sole discretion, a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity.  In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.02pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award.  Each </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement.  The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock.  From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any Participant who is a U.S. taxpayer validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units.  Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stock Unit Award, and to which the cash dividends relate, are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">PERFORMANCE STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Performance Awards&#8221; as provided under Section 10 of the Plan.  Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">documents shall constitute the Performance Stock Unit Agreement.  Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period.  Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved, and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.  In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise.  In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.</font><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know-how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.02pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:10.36pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance contributions, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting, settlement or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable&#59; or (4) any other method of withholding determined by the Corporation and to the extent required by applicable law or the Plan, approved by the Compensation Committee. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates in the Participant&#8217;s jurisdiction(s). If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund. In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Corporation and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.36pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">the Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19.36pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Stock Units, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.02pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19.36pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:20.69pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21.35pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language, or has consulted with an advisor who is sufficiently proficient in the English language, and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions.  If the Participant has received this Statement of Terms and Conditions or any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Stock Unit Award or Other Share-Based Award, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)-1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59; provided, however, that, any such change attributable to the Corporation&#8217;s no longer being a company with publicly traded common stock shall not constitute Good Reason&#59; and provided, further, that a reduction in the Participant&#8217;s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant&#8217;s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation&#8217;s business) shall not constitute Good Reason&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan or the McKesson Corporation Severance Policy for Executive Employees, as applicable, in accordance with the terms and conditions of such plans. A Participant outside the United States who is not qualified for participation in and entitlement to the benefits under such plans will nonetheless be treated for the limited purposes of his or her Awards, and subject to the provisions of Section VIII.9 of this Statement of Terms and Conditions, as terminated by reason of Severance to the extent his or her employment with the Corporation or an affiliate is terminated and he or she would satisfy the conditions for termination for reason of Severance but for the fact that such plan is only applicable to employees of the Corporation or an affiliate in the United States who qualify for participation in that plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><div id="ibd561b47d4184a839c90169cfcfff003_16"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUTSIDE DIRECTOR</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MCKESSON CORPORATION 2022 STOCK PLAN </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:77.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.048%"><tr><td style="width:1.0%"></td><td style="width:54.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Number of RSUs Granted&#58;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100% vested on grant date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2022 Stock Plan, as may be amended from time to time (the &#8220;Plan&#8221;) to receive shares of common stock of the Company (&#8220;Shares&#8221;). This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Restricted Stock Unit Agreement, which along with the Plan set forth the terms of your grant.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investors section of the McKesson website at www.mckesson.com&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-855-466-2547)&#59; and </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The Plan and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;The Company recommends that the Grantee consult with a tax advisor prior to accepting this grant of RSUs&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;I accept ALL the terms and conditions as set forth in the Plan and the ST&#38;Cs applicable to this grant of RSUs.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;   </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.549%"><tr><td style="width:1.0%"></td><td style="width:40.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.170%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brian S. Tyler&#160;&#160;&#160;&#160;Grantee Signature                             Date</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ATTACHMENTS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* 2022 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* 2022 Stock Plan Prospectus for Non-Employee Directors</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* ST&#38;Cs </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. - country specific)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">August 2022 </font></div><div style="height:44.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ibd561b47d4184a839c90169cfcfff003_19"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #4f81bd;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#17365d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MCKESSON CORPORATION 2022 STOCK PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:104.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.859%"><tr><td style="width:1.0%"></td><td style="width:44.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs Granted&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Please see Appendix</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2022 Stock Plan (the &#8220;Plan&#8221;) which represent the contingent right to receive shares of common stock of the Company (&#8220;Shares&#8221;). This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Restricted Stock Unit Agreement. Your Restricted Stock Unit Agreement and your RSUs are subject to the terms of the Plan, which incorporates by reference the Company&#8217;s Compensation Recoupment Policy (the &#8220;Recoupment Policy&#8221;) and the Company&#8217;s Stock Ownership Policy (the &#8220;Stock Ownership Policy&#8221;), as both are amended from time to time).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company&#8217;s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investors section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-855-466-2547)&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company recommends that the Grantee consult with a tax advisor prior to accepting this grant of RSUs&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I accept ALL the terms and conditions as set forth in the Plan and ST&#38;Cs applicable to this grant of RSUs.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.924%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brian S. Tyler&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Grantee Signature&#160;&#160;&#160;&#160;                 Date</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ATTACHMENTS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* 2022 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* 2022 Stock Plan Prospectus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* ST&#38;Cs Applicable to __________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Compensation Recoupment Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy (Section 16 only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Stock Ownership Policy (EOT only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. &#8211; country-specific)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">August 2022</font></div><div style="height:44.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ibd561b47d4184a839c90169cfcfff003_22"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #4f81bd;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MCKESSON CORPORATION 2022 STOCK PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PERFORMANCE STOCK UNIT GRANT NOTICE</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:80.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.688%"><tr><td style="width:1.0%"></td><td style="width:44.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target PSUs Granted&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Period&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY&#160;20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">__</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> - FY&#160;20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">__</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you target performance stock units (&#8220;PSUs&#8221;) under the Company&#8217;s 2022 Stock Plan (the &#8220;Plan&#8221;). This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided with this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Performance Stock Unit Agreement. Your Performance Stock Unit Agreement and your PSUs are subject to the terms of the Plan, which incorporates by reference the Company&#8217;s Compensation Recoupment Policy (the &#8220;Recoupment Policy&#8221;), and the Company&#8217;s Stock Ownership Policy (the &#8220;Stock Ownership Policy&#8221;), as both are amended from time to time.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your PSUs will be earned subject to the Company&#8217;s attainment of performance goals that have been pre-established by the Compensation and Talent Committee (the &#8220;Committee&#8221;) of the Company&#8217;s Board of Directors. You may receive 0% - 200% of the target number of PSUs set forth above. PSUs, if earned, will be paid in the form of shares of the Company&#8217;s Common Stock (&#8220;Shares&#8221;) that are not subject to any further vesting restrictions. The Committee has the sole discretion to determine the Company&#8217;s performance against the pre-established goals after completion of the performance period, and to authorize the grant of Shares.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company&#8217;s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investors section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-855-466-2547)&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I accept ALL the terms and conditions as set forth in the Plan and ST&#38;Cs applicable to this grant of PSUs.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.924%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brian S. Tyler&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Grantee Signature&#160;&#160;&#160;&#160;                 Date</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Documents and Related Policies</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* 2022 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* 2022 Stock Plan Prospectus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* ST&#38;Cs Applicable to __________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Compensation Recoupment Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy (Section 16 only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Stock Ownership Policy (EOT only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. - country specific)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">August 2022</font></div><div style="height:44.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>mck_exhibit311x630202210-q.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iebaf98ed5a28461295159aa9bd31f9c6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>mck_exhibit312x630202210-q.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic3a98b22068b4971aef17ede8130488a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>mck_exhibit32x630202210-q.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i84b7985bd9494a4f820aa8eaa0cab9a0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the quarterly report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended June 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:24pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160; Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:36pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mck-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18507b8d-c172-4d9a-9fef-a030c1e6a2f5,g:26ea8e13-0c76-4471-91f9-3ae4cfe6c737-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://mckesson123.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSale" roleURI="http://mckesson123.com/role/HeldforSale">
        <link:definition>2104102 - Disclosure - Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleTables" roleURI="http://mckesson123.com/role/HeldforSaleTables">
        <link:definition>2305301 - Disclosure - Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleNarrativeDetails" roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails">
        <link:definition>2406402 - Disclosure - Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>2407403 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedCharges" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges">
        <link:definition>2108103 - Disclosure - Restructuring, Impairment, and Related Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables">
        <link:definition>2309302 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails">
        <link:definition>2410404 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
        <link:definition>2411405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
        <link:definition>2412406 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>2113104 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesDetails">
        <link:definition>2414407 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>2115105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>2316303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>2417408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
        <link:definition>2418409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShare" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare">
        <link:definition>2119106 - Disclosure - Earnings (Loss) Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareTables" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables">
        <link:definition>2320304 - Disclosure - Earnings (Loss) Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareAdditionalInformationDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails">
        <link:definition>2421410 - Disclosure - Earnings (Loss) Per Common Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails">
        <link:definition>2422411 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>2123107 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>2324305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>2425412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>2426413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetNarrativeDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails">
        <link:definition>2427414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>2128108 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>2329306 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>2430415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1">
        <link:definition>2430415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
        <link:definition>2431416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails">
        <link:definition>2432417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesCommercialPaperNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails">
        <link:definition>2433418 - Disclosure - Debt and Financing Activities - Commercial Paper Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementofIncomeIncludingGrossMarginStatement" roleURI="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement">
        <link:definition>1008009 - Statement - Statement of Income (Including Gross Margin) (Statement)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>2134109 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>2435419 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>2136110 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>2337307 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>2438420 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails">
        <link:definition>2439421 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails">
        <link:definition>2440422 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails">
        <link:definition>2441423 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesScheduleofFairValueofDerivativesDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails">
        <link:definition>2442424 - Disclosure - Hedging Activities - Schedule of Fair Value of Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>2143111 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://mckesson123.com/role/FairValueMeasurementsTables">
        <link:definition>2344308 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2445425 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails">
        <link:definition>2446426 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>2147112 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesTables" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables">
        <link:definition>2348309 - Disclosure - Commitments and Contingent Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesNarrativeDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails">
        <link:definition>2449427 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
        <link:definition>2450428 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficit" roleURI="http://mckesson123.com/role/StockholdersEquityDeficit">
        <link:definition>2151113 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitTables" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables">
        <link:definition>2352310 - Disclosure - Stockholders' Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails">
        <link:definition>2453429 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
        <link:definition>2454430 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>2155114 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>2356311 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessNarrativeDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails">
        <link:definition>2457431 - Disclosure - Segments of Business - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessReportableoperatingsegmentDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails">
        <link:definition>2458432 - Disclosure - Segments of Business - Reportable operating segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_OtherNonCurrentAssetsMember" abstract="true" name="OtherNonCurrentAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A380NotesDueMarch152024Member" abstract="true" name="A380NotesDueMarch152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_CherokeeNationMember" abstract="true" name="CherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyDamagesSoughtPerViolationValue" abstract="false" name="LossContingencyDamagesSoughtPerViolationValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" abstract="true" name="AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NumberOfBusinessOperations" abstract="false" name="NumberOfBusinessOperations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_RestructuringPlanRemoteWorkTransitioningMember" abstract="true" name="RestructuringPlanRemoteWorkTransitioningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" abstract="false" name="NoncontrollingInterestDecreaseForExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A475NotesDueMay302029Member" abstract="true" name="A475NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMember" abstract="true" name="AcceleratedShareRepurchaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" abstract="true" name="ThreeLargestU.S.PharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfAlabamaAndSubdivisionsMember" abstract="true" name="StateOfAlabamaAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NationalPrescriptionOpiateLitigationMember" abstract="true" name="NationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencySettlementInstallmentPaymentsTerm" abstract="false" name="LossContingencySettlementInstallmentPaymentsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_InternallyDevelopedSoftwareMember" abstract="true" name="InternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" abstract="false" name="LossContingencyClassActionNumberofFaxesRemainingintheClass" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" abstract="true" name="UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" abstract="false" name="NoncontrollingInterestDecreaseFromReclassificationToLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_UncommittedMember" abstract="true" name="UncommittedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NumberOfNationalBrandMedicalSurgicalProducts" abstract="false" name="NumberOfNationalBrandMedicalSurgicalProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" abstract="false" name="CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" abstract="false" name="LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_OtherNonCurrentLiabilitiesMember" abstract="true" name="OtherNonCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DistributorsMember" abstract="true" name="DistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" abstract="false" name="ReclassificationOfTemporaryEquityToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfOtherDefendants" abstract="false" name="LossContingencyNumberOfOtherDefendants" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PrepaidExpensesAndOtherMember" abstract="true" name="PrepaidExpensesAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" abstract="true" name="UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FixedInterestRateSwapMember" abstract="true" name="FixedInterestRateSwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_A270NotesDueDecember152022Member" abstract="true" name="A270NotesDueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OpioidStewardshipActNewYorkAnnualSurcharge" abstract="false" name="OpioidStewardshipActNewYorkAnnualSurcharge" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" abstract="false" name="DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" abstract="true" name="TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ThreeNationalPharmaceuticalDistributorsMember" abstract="true" name="ThreeNationalPharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfOklahomaAndSubdivisionsMember" abstract="true" name="StateOfOklahomaAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A600NotesDueMarch12041Member" abstract="true" name="A600NotesDueMarch12041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EUBusinessesDisposalGroupMember" abstract="true" name="EUBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IndividualClaimantMember" abstract="true" name="IndividualClaimantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A395NotesDueFebruary162028Member" abstract="true" name="A395NotesDueFebruary162028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember" abstract="true" name="SettlingGovernmentalEntitiesAndStateOfAlabamaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberOfCitiesFiledOnBehalfOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NativeAmericanTribesOtherThanCherokeeNationMember" abstract="true" name="NativeAmericanTribesOtherThanCherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A285NotesDueMarch152023Member" abstract="true" name="A285NotesDueMarch152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A765DebenturesDueMarch12027Member" abstract="true" name="A765DebenturesDueMarch12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementNumberOfInstallmentPayments" abstract="false" name="LossContingencySettlementNumberOfInstallmentPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_GovernmentalEntitiesMember" abstract="true" name="GovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OpioidStewardshipActStateOfNewYorkMember" abstract="true" name="OpioidStewardshipActStateOfNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_HeldForSalePolicyTextBlock" abstract="false" name="HeldForSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_LossContingencyNumberOfEligibleStates" abstract="false" name="LossContingencyNumberOfEligibleStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A3125NotesDue2029Member" abstract="true" name="A3125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A150EuroNotesDueNovember172025Member" abstract="true" name="A150EuroNotesDueNovember172025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" abstract="false" name="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_A313SterlingNotesDueFebruary172029Member" abstract="true" name="A313SterlingNotesDueFebruary172029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyAccrualProvisionAfterTax" abstract="false" name="LossContingencyAccrualProvisionAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SettlingGovernmentalEntitiesMember" abstract="true" name="SettlingGovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A1500NotesDue2025Member" abstract="true" name="A1500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IncreaseDecreaseInLitigationReserve" abstract="false" name="IncreaseDecreaseInLitigationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A130NotesDueAugust152026Member" abstract="true" name="A130NotesDueAugust152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AureliusElephantLimitedMember" abstract="true" name="AureliusElephantLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CommittedMember" abstract="true" name="CommittedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofStatesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberofStatesFiledOnBehalfOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A163EuroNotesDueOctober302026Member" abstract="true" name="A163EuroNotesDueOctober302026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EPSBasicAndDilutedAbstract" abstract="true" name="EPSBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A090NotesDueDecember32025Member" abstract="true" name="A090NotesDueDecember32025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UKBusinessesDisposalGroupMember" abstract="true" name="UKBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_VantageandClarusOneSourcingServicesLLCMember" abstract="true" name="VantageandClarusOneSourcingServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A488NotesDueMarch152044Member" abstract="true" name="A488NotesDueMarch152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfWashingtonAndSubdivisionsMember" abstract="true" name="StateOfWashingtonAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfWestVirginiaAndSubdivisionsMember" abstract="true" name="StateOfWestVirginiaAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CurrentAssetLiabilityMember" abstract="true" name="CurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" abstract="false" name="StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsMember" abstract="true" name="PrescriptionTechnologySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesReceived" abstract="false" name="LossContingencyClassActionNumberofFaxesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementAwardPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementAwardPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_A1625NotesDue2026Member" abstract="true" name="A1625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>mck-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18507b8d-c172-4d9a-9fef-a030c1e6a2f5,g:26ea8e13-0c76-4471-91f9-3ae4cfe6c737-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e91d26ec-9fc4-47fa-9c35-e39a61367a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1ba6e3ad-2739-4dde-999e-7dd5352fc4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e91d26ec-9fc4-47fa-9c35-e39a61367a7d" xlink:to="loc_us-gaap_ProfitLoss_1ba6e3ad-2739-4dde-999e-7dd5352fc4e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e4132f61-fef9-4a17-ad08-b111ee0d5eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e91d26ec-9fc4-47fa-9c35-e39a61367a7d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e4132f61-fef9-4a17-ad08-b111ee0d5eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_74b26932-8d05-429e-a878-ecedbb8909d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_394f47f1-f66c-4338-9692-c626e2192cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_74b26932-8d05-429e-a878-ecedbb8909d4" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_394f47f1-f66c-4338-9692-c626e2192cbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0bd2df38-e4e8-473a-84c2-6cbc7c0d2986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_74b26932-8d05-429e-a878-ecedbb8909d4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0bd2df38-e4e8-473a-84c2-6cbc7c0d2986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_978a5c44-4765-431f-abe8-a40e1807b55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_74b26932-8d05-429e-a878-ecedbb8909d4" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_978a5c44-4765-431f-abe8-a40e1807b55a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f902774-6420-4227-ba77-dccf79954579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b8cbab03-a9fb-487e-b59e-78013939fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f902774-6420-4227-ba77-dccf79954579" xlink:to="loc_us-gaap_OperatingIncomeLoss_b8cbab03-a9fb-487e-b59e-78013939fd3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bc600972-45d1-4026-8faf-5b3121c6fcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f902774-6420-4227-ba77-dccf79954579" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bc600972-45d1-4026-8faf-5b3121c6fcdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_18942a7a-b7aa-41b5-bf75-ac3bab02aa61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f902774-6420-4227-ba77-dccf79954579" xlink:to="loc_us-gaap_InterestExpense_18942a7a-b7aa-41b5-bf75-ac3bab02aa61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2b080501-69b5-4f05-94b0-7ae1bb1d312d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_49692c15-2a85-45ca-aa2a-59178bb74c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_2b080501-69b5-4f05-94b0-7ae1bb1d312d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_49692c15-2a85-45ca-aa2a-59178bb74c47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a0865150-3ec6-4acb-8385-b012c3faed10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_2b080501-69b5-4f05-94b0-7ae1bb1d312d" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a0865150-3ec6-4acb-8385-b012c3faed10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f3ebafc3-4eb1-4f3e-b42d-48d7dc505d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fdb94cd-fe41-4f32-a119-b594c733540e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f3ebafc3-4eb1-4f3e-b42d-48d7dc505d27" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fdb94cd-fe41-4f32-a119-b594c733540e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c315c3ea-67ce-496b-812e-f152e9b54422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f3ebafc3-4eb1-4f3e-b42d-48d7dc505d27" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c315c3ea-67ce-496b-812e-f152e9b54422" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fce78d17-6ad6-405e-bf76-d9966c37f842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_068d6a02-5c48-4e78-9122-c6e7a34dce5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fce78d17-6ad6-405e-bf76-d9966c37f842" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_068d6a02-5c48-4e78-9122-c6e7a34dce5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f443909e-573e-430f-af5c-f9895270e766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fce78d17-6ad6-405e-bf76-d9966c37f842" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f443909e-573e-430f-af5c-f9895270e766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5d71438f-bc72-4a7a-8da1-ce923d226380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_45126b7b-225f-4130-be81-0f599f1133db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_5d71438f-bc72-4a7a-8da1-ce923d226380" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_45126b7b-225f-4130-be81-0f599f1133db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_aa9d7498-e193-4556-bac6-845a35318e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_5d71438f-bc72-4a7a-8da1-ce923d226380" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_aa9d7498-e193-4556-bac6-845a35318e19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cdb3b1e8-a40f-45bd-9f6f-d8f06278618c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a301c18e-aa9a-4b5c-9720-efb9d979103c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_cdb3b1e8-a40f-45bd-9f6f-d8f06278618c" xlink:to="loc_us-gaap_OperatingExpenses_a301c18e-aa9a-4b5c-9720-efb9d979103c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_61aaeeda-8ed7-4a8f-b27c-ade48caae92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_cdb3b1e8-a40f-45bd-9f6f-d8f06278618c" xlink:to="loc_us-gaap_GrossProfit_61aaeeda-8ed7-4a8f-b27c-ade48caae92b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_faa1da1a-692b-4fce-9f88-135813e7bf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b7a6db43-c97a-4f79-a37d-2ed35d5e0229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_faa1da1a-692b-4fce-9f88-135813e7bf03" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b7a6db43-c97a-4f79-a37d-2ed35d5e0229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_4e732d10-7805-4150-8963-a0cdde51c0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_faa1da1a-692b-4fce-9f88-135813e7bf03" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_4e732d10-7805-4150-8963-a0cdde51c0ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_601c8c1c-b713-4450-9cfd-16857bc11b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4d1217c8-b750-493f-92b3-071d0428312f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_601c8c1c-b713-4450-9cfd-16857bc11b52" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4d1217c8-b750-493f-92b3-071d0428312f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_dcebc6de-0227-4b5f-bd8a-7e73a869ef91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_601c8c1c-b713-4450-9cfd-16857bc11b52" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_dcebc6de-0227-4b5f-bd8a-7e73a869ef91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9de1755-69d4-4742-bdaa-e0cc16769de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1fd8032a-0f98-436c-8845-8bf6c0a8b862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9de1755-69d4-4742-bdaa-e0cc16769de1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1fd8032a-0f98-436c-8845-8bf6c0a8b862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4c1c0dbe-5077-406c-84bf-ca749fca602a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9de1755-69d4-4742-bdaa-e0cc16769de1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4c1c0dbe-5077-406c-84bf-ca749fca602a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5c07e885-b7a3-42e0-9755-d00fed88b928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9de1755-69d4-4742-bdaa-e0cc16769de1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5c07e885-b7a3-42e0-9755-d00fed88b928" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3f4f6ee3-3ad9-4ac9-a41e-0bf7db688c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9f7e06b2-8f69-4042-80a9-819570344587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3f4f6ee3-3ad9-4ac9-a41e-0bf7db688c79" xlink:to="loc_us-gaap_ProfitLoss_9f7e06b2-8f69-4042-80a9-819570344587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_858a7c7a-2870-4b59-bea0-ca57355afc36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3f4f6ee3-3ad9-4ac9-a41e-0bf7db688c79" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_858a7c7a-2870-4b59-bea0-ca57355afc36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3ef9a5ba-e6bb-4dc0-9d99-b765e2fbf413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_04fdb35c-a24d-489f-9c96-2c39e25ac0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ef9a5ba-e6bb-4dc0-9d99-b765e2fbf413" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_04fdb35c-a24d-489f-9c96-2c39e25ac0aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2115eccd-aa5f-4ded-a743-84bafcfcaa81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ef9a5ba-e6bb-4dc0-9d99-b765e2fbf413" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2115eccd-aa5f-4ded-a743-84bafcfcaa81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_17dac091-246a-4a1f-885d-26d7a5e7a806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ef9a5ba-e6bb-4dc0-9d99-b765e2fbf413" xlink:to="loc_us-gaap_AccountsPayableCurrent_17dac091-246a-4a1f-885d-26d7a5e7a806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_24d6475b-a473-461b-b3f8-4bfefcf70b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ef9a5ba-e6bb-4dc0-9d99-b765e2fbf413" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_24d6475b-a473-461b-b3f8-4bfefcf70b23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cf1589ea-66c5-4ae0-ba31-31510cf602e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ef9a5ba-e6bb-4dc0-9d99-b765e2fbf413" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cf1589ea-66c5-4ae0-ba31-31510cf602e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6159b49f-a4f1-480f-b29a-ab8786119574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5013e676-e9ce-4a16-b796-3b7c67d3c7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6159b49f-a4f1-480f-b29a-ab8786119574" xlink:to="loc_us-gaap_LiabilitiesCurrent_5013e676-e9ce-4a16-b796-3b7c67d3c7b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7dacbfcf-fe12-41eb-bfce-456a2db55b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6159b49f-a4f1-480f-b29a-ab8786119574" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7dacbfcf-fe12-41eb-bfce-456a2db55b7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3d3dc22e-ec16-4a46-bce4-23d0d88fe55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6159b49f-a4f1-480f-b29a-ab8786119574" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3d3dc22e-ec16-4a46-bce4-23d0d88fe55a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d8c61e3a-2d4b-4b0c-b121-bc3c0b46d30a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6159b49f-a4f1-480f-b29a-ab8786119574" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d8c61e3a-2d4b-4b0c-b121-bc3c0b46d30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_55424618-f294-4908-8b17-bce7f4f92f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6159b49f-a4f1-480f-b29a-ab8786119574" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_55424618-f294-4908-8b17-bce7f4f92f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ce32484-3040-4c96-b9bb-b599649b3fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6159b49f-a4f1-480f-b29a-ab8786119574" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ce32484-3040-4c96-b9bb-b599649b3fcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_769f914d-02f4-4ed1-9df9-6d68ff10f055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6159b49f-a4f1-480f-b29a-ab8786119574" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_769f914d-02f4-4ed1-9df9-6d68ff10f055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b51f4ec4-9358-46c0-9abf-009476ef9b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ae083488-5648-4466-a9c5-611bcd389f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b51f4ec4-9358-46c0-9abf-009476ef9b33" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ae083488-5648-4466-a9c5-611bcd389f1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_81c096a1-62f5-4606-b291-903d033a0649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b51f4ec4-9358-46c0-9abf-009476ef9b33" xlink:to="loc_us-gaap_ReceivablesNetCurrent_81c096a1-62f5-4606-b291-903d033a0649" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3e22aafa-8482-41b2-b664-62a2a7f663e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b51f4ec4-9358-46c0-9abf-009476ef9b33" xlink:to="loc_us-gaap_InventoryNet_3e22aafa-8482-41b2-b664-62a2a7f663e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_524c5e24-f836-4c34-8e3b-4f1149ca24de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b51f4ec4-9358-46c0-9abf-009476ef9b33" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_524c5e24-f836-4c34-8e3b-4f1149ca24de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b76af763-ba5f-4c1b-8c80-72fb3779e8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b51f4ec4-9358-46c0-9abf-009476ef9b33" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b76af763-ba5f-4c1b-8c80-72fb3779e8c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4df4d2a8-4307-4f32-83e5-8f60992a9d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2c4c30f2-1e64-468c-b19d-ec47dfb5d04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4df4d2a8-4307-4f32-83e5-8f60992a9d4d" xlink:to="loc_us-gaap_AssetsCurrent_2c4c30f2-1e64-468c-b19d-ec47dfb5d04d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_eb6713d1-d212-451c-b9dc-6b04c05f88ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4df4d2a8-4307-4f32-83e5-8f60992a9d4d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_eb6713d1-d212-451c-b9dc-6b04c05f88ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_09145795-1ac1-4930-a4c3-2707d0040d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4df4d2a8-4307-4f32-83e5-8f60992a9d4d" xlink:to="loc_us-gaap_Goodwill_09145795-1ac1-4930-a4c3-2707d0040d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c9caa562-798d-4520-b69d-cc08864593c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4df4d2a8-4307-4f32-83e5-8f60992a9d4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c9caa562-798d-4520-b69d-cc08864593c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d73585f6-a556-4e53-a064-b7cefaa3d3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4df4d2a8-4307-4f32-83e5-8f60992a9d4d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d73585f6-a556-4e53-a064-b7cefaa3d3fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_851c37f1-d4aa-4a64-a03b-a97389c293bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4df4d2a8-4307-4f32-83e5-8f60992a9d4d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_851c37f1-d4aa-4a64-a03b-a97389c293bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0296bad3-0e59-42b9-bb0a-bded815af1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_59285298-fb9d-4e01-a31e-fd3120f0842b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0296bad3-0e59-42b9-bb0a-bded815af1cc" xlink:to="loc_us-gaap_AdditionalPaidInCapital_59285298-fb9d-4e01-a31e-fd3120f0842b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f3a3398c-a171-4f8b-b79b-286ddf4da58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0296bad3-0e59-42b9-bb0a-bded815af1cc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f3a3398c-a171-4f8b-b79b-286ddf4da58f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8d056b83-1856-4066-bd44-6bd016015ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0296bad3-0e59-42b9-bb0a-bded815af1cc" xlink:to="loc_us-gaap_TreasuryStockValue_8d056b83-1856-4066-bd44-6bd016015ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_292553b2-9060-41fd-97b2-e13eef37e751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0296bad3-0e59-42b9-bb0a-bded815af1cc" xlink:to="loc_us-gaap_PreferredStockValue_292553b2-9060-41fd-97b2-e13eef37e751" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f46f9e13-00ff-4dbe-9885-79c185a74453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0296bad3-0e59-42b9-bb0a-bded815af1cc" xlink:to="loc_us-gaap_CommonStockValue_f46f9e13-00ff-4dbe-9885-79c185a74453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1f8fb5f1-a67a-4e33-a4c3-f1ee18816f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0296bad3-0e59-42b9-bb0a-bded815af1cc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1f8fb5f1-a67a-4e33-a4c3-f1ee18816f86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_af58f983-09e9-40a5-9787-204e6ba1e538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_99639290-e5c3-4b27-9c4a-b9eb1c17b04e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_af58f983-09e9-40a5-9787-204e6ba1e538" xlink:to="loc_us-gaap_StockholdersEquity_99639290-e5c3-4b27-9c4a-b9eb1c17b04e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_459b1ee8-ff36-4455-911a-5ab4fa36d5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_af58f983-09e9-40a5-9787-204e6ba1e538" xlink:to="loc_us-gaap_MinorityInterest_459b1ee8-ff36-4455-911a-5ab4fa36d5d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4ad94932-fb48-49eb-bdc1-6e06012d3ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6c963f9e-bfc4-4d75-bbf7-42c5ebae4344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4ad94932-fb48-49eb-bdc1-6e06012d3ba2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6c963f9e-bfc4-4d75-bbf7-42c5ebae4344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_3ba94674-9725-4fd2-b834-dec74752c350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4ad94932-fb48-49eb-bdc1-6e06012d3ba2" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_3ba94674-9725-4fd2-b834-dec74752c350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_20982796-7ce9-4212-a989-cc8dbd2272cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4ad94932-fb48-49eb-bdc1-6e06012d3ba2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_20982796-7ce9-4212-a989-cc8dbd2272cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_c35cd8bf-2c94-4a8f-8b4c-8afc2a432572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4ad94932-fb48-49eb-bdc1-6e06012d3ba2" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_c35cd8bf-2c94-4a8f-8b4c-8afc2a432572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_239f9895-1b8e-4665-a90d-e9ae426e1eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4ad94932-fb48-49eb-bdc1-6e06012d3ba2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_239f9895-1b8e-4665-a90d-e9ae426e1eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9089d94b-be2b-4425-824d-7b01a72c87c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0bc0df04-7d2f-4f17-8490-6753a56e90ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9089d94b-be2b-4425-824d-7b01a72c87c8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0bc0df04-7d2f-4f17-8490-6753a56e90ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_b1efaac6-c1b8-4901-9f89-8b44b5809ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9089d94b-be2b-4425-824d-7b01a72c87c8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_b1efaac6-c1b8-4901-9f89-8b44b5809ea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_2cd24a6c-f8c3-4207-9fff-4c763b41898b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9089d94b-be2b-4425-824d-7b01a72c87c8" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_2cd24a6c-f8c3-4207-9fff-4c763b41898b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_76b846ff-6653-405d-9fda-2afa02e695dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9089d94b-be2b-4425-824d-7b01a72c87c8" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_76b846ff-6653-405d-9fda-2afa02e695dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2ce09c0b-d0f4-4b67-8ccb-9685678c5864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9089d94b-be2b-4425-824d-7b01a72c87c8" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2ce09c0b-d0f4-4b67-8ccb-9685678c5864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0cf68402-246b-49c8-9ae2-79732a27b45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9089d94b-be2b-4425-824d-7b01a72c87c8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0cf68402-246b-49c8-9ae2-79732a27b45b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f58505dd-b8f9-4b86-b5af-2c713877fac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f58505dd-b8f9-4b86-b5af-2c713877fac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c3680f07-3fc5-49a6-9c4b-799a11544f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c3680f07-3fc5-49a6-9c4b-799a11544f28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_91f4f139-0e0b-4f8e-a8ec-2d411bc03ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_91f4f139-0e0b-4f8e-a8ec-2d411bc03ead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_d1d710c9-2d70-4d40-b006-9027b6ee4fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_AdjustmentForAmortization_d1d710c9-2d70-4d40-b006-9027b6ee4fb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d3d3d86d-58f9-4265-a660-069555b7dd72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_ProfitLoss_d3d3d86d-58f9-4265-a660-069555b7dd72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_6738283b-6858-4ea9-9067-8f51dc37b1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_6738283b-6858-4ea9-9067-8f51dc37b1f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_384c09a2-0d27-40c7-80f2-03ec7b87399b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_Depreciation_384c09a2-0d27-40c7-80f2-03ec7b87399b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_d223ba32-c31f-48e1-8af1-18df66da399e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_d223ba32-c31f-48e1-8af1-18df66da399e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_88176685-513e-4332-8109-c701cf470028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_88176685-513e-4332-8109-c701cf470028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_a56b8d70-9a97-4ddc-8bee-4bac245cf2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_a56b8d70-9a97-4ddc-8bee-4bac245cf2d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7c6ac01f-71ae-44c7-bcfb-85cf0bbdcaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7c6ac01f-71ae-44c7-bcfb-85cf0bbdcaa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_760d90cc-891f-4203-b8fa-de5ddfeb83a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_760d90cc-891f-4203-b8fa-de5ddfeb83a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_63a2af08-a314-4234-ad86-796382deb2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_OperatingLeaseExpense_63a2af08-a314-4234-ad86-796382deb2b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_5eb71796-170c-4709-832b-a103bac992c9" xlink:href="mck-20220630.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_5eb71796-170c-4709-832b-a103bac992c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_da3e5251-994b-4470-8492-8cdb6656ff63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_da3e5251-994b-4470-8492-8cdb6656ff63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9e9afec5-8788-4ed0-99ab-d841e94601ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9e9afec5-8788-4ed0-99ab-d841e94601ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_12fae695-f6c9-4e48-bd84-c824b0961cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36bcdd80-e669-45cb-a5ee-5e552b781d47" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_12fae695-f6c9-4e48-bd84-c824b0961cb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f206a18f-3977-4e25-8f49-6ca19b180187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_48e98f5e-8ae7-4c25-988a-6229ee20b874" xlink:href="mck-20220630.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f206a18f-3977-4e25-8f49-6ca19b180187" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_48e98f5e-8ae7-4c25-988a-6229ee20b874" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1e9506b4-5150-4ed3-8673-8a66ca03a515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f206a18f-3977-4e25-8f49-6ca19b180187" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1e9506b4-5150-4ed3-8673-8a66ca03a515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_264640ed-bd5d-4913-adee-068354c5d404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f206a18f-3977-4e25-8f49-6ca19b180187" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_264640ed-bd5d-4913-adee-068354c5d404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e65e2c12-be2f-4160-b409-b5eaeebc550b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f206a18f-3977-4e25-8f49-6ca19b180187" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e65e2c12-be2f-4160-b409-b5eaeebc550b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f23a1cd-b184-409d-ae73-1332364b09c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f206a18f-3977-4e25-8f49-6ca19b180187" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f23a1cd-b184-409d-ae73-1332364b09c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9faccc73-431b-4a1f-bfc2-f469dbbdec5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_b2b720b9-305f-4290-a8ce-c56ada45f9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9faccc73-431b-4a1f-bfc2-f469dbbdec5f" xlink:to="loc_us-gaap_RestrictedCashCurrent_b2b720b9-305f-4290-a8ce-c56ada45f9e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5afcddf3-80d8-4171-a705-549f6ed0150a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9faccc73-431b-4a1f-bfc2-f469dbbdec5f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5afcddf3-80d8-4171-a705-549f6ed0150a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_1df80ad4-8ba5-4fb7-acf2-089b33f91aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_1df80ad4-8ba5-4fb7-acf2-089b33f91aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_5c13e227-070c-442e-8b1b-b3c4aed55120" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_5c13e227-070c-442e-8b1b-b3c4aed55120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_2494b5a2-7cc7-49eb-8491-4340dffa5900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_2494b5a2-7cc7-49eb-8491-4340dffa5900" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ce5b9dee-7261-4e4b-9a99-663ede0e236c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ce5b9dee-7261-4e4b-9a99-663ede0e236c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_c0a652e2-42e5-4070-97b8-b49a85af1ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_c0a652e2-42e5-4070-97b8-b49a85af1ca8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_751fc5c5-0961-45b4-b8a7-43b92c0757c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_751fc5c5-0961-45b4-b8a7-43b92c0757c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_9ffb3879-fe56-4db6-bf88-ad233263fdfe" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_9ffb3879-fe56-4db6-bf88-ad233263fdfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_75f2cd00-e390-4ec6-be57-2ebc94c17e23" xlink:href="mck-20220630.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_75f2cd00-e390-4ec6-be57-2ebc94c17e23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_437cd1bf-e616-4e5f-b823-fbdcd3aed232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a520a59a-9333-4074-a486-7f16733bffca" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_437cd1bf-e616-4e5f-b823-fbdcd3aed232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_1761987a-f066-4df3-9229-443482910092" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_1761987a-f066-4df3-9229-443482910092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_4ddbff62-98ae-4161-bc72-7e96127db29d" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_4ddbff62-98ae-4161-bc72-7e96127db29d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_901a657f-88f1-42d4-8d9a-ddc294760d05" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_901a657f-88f1-42d4-8d9a-ddc294760d05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_27cfc922-e617-4b4a-a848-1ce5cd5c7fc3" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_27cfc922-e617-4b4a-a848-1ce5cd5c7fc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_34f8de3f-7200-4c6e-85d4-efa204d413de" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_34f8de3f-7200-4c6e-85d4-efa204d413de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_eab9eae4-c6f3-47f5-a6c2-d82b8a417220" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_eab9eae4-c6f3-47f5-a6c2-d82b8a417220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_830b854e-cad4-483c-9bd2-7d23755caf09" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_830b854e-cad4-483c-9bd2-7d23755caf09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_e95ac16d-3e65-45e9-81e2-a915b40abc5a" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ca6caa39-fb48-4e74-a49f-b0a46613ef6e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_e95ac16d-3e65-45e9-81e2-a915b40abc5a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_03de2a6b-fc66-4188-a650-55077d05b516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_5c6469e2-e15a-467f-95f6-3f86b1b1b061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_03de2a6b-fc66-4188-a650-55077d05b516" xlink:to="loc_us-gaap_SeveranceCosts1_5c6469e2-e15a-467f-95f6-3f86b1b1b061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_a3f357d9-015f-4878-bbb4-3f2b1fa109cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_03de2a6b-fc66-4188-a650-55077d05b516" xlink:to="loc_us-gaap_BusinessExitCosts1_a3f357d9-015f-4878-bbb4-3f2b1fa109cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_4ccd8a98-e5c6-42cf-9aed-e3c4916e4fe5" xlink:href="mck-20220630.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_03de2a6b-fc66-4188-a650-55077d05b516" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_4ccd8a98-e5c6-42cf-9aed-e3c4916e4fe5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_bd85bc34-8c4c-47f3-a2e3-e9a0cc1642b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d5a5216d-9272-4a75-a03a-3a6cbd631d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_bd85bc34-8c4c-47f3-a2e3-e9a0cc1642b6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d5a5216d-9272-4a75-a03a-3a6cbd631d59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_81601358-afc7-45d8-ad81-04d151df3f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_bd85bc34-8c4c-47f3-a2e3-e9a0cc1642b6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_81601358-afc7-45d8-ad81-04d151df3f94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79891c07-c713-4129-98cc-41ab85d49bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_61b32c3b-b7fa-4188-b479-1cc3aa140787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79891c07-c713-4129-98cc-41ab85d49bed" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_61b32c3b-b7fa-4188-b479-1cc3aa140787" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f17f7a42-85e8-4cf2-8e0f-925e7959d13d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79891c07-c713-4129-98cc-41ab85d49bed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f17f7a42-85e8-4cf2-8e0f-925e7959d13d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f5876c87-b63d-42e8-bde0-d04b1fc31175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_617e879f-94eb-40b7-865b-f145330ee409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f5876c87-b63d-42e8-bde0-d04b1fc31175" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_617e879f-94eb-40b7-865b-f145330ee409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b2e427b0-c12f-423e-a0f0-8af8843742b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f5876c87-b63d-42e8-bde0-d04b1fc31175" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b2e427b0-c12f-423e-a0f0-8af8843742b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b83e09c0-af54-4844-9e0a-2936407eca8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_97c2c5f1-fa98-4b1f-ae80-704312427dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b83e09c0-af54-4844-9e0a-2936407eca8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_97c2c5f1-fa98-4b1f-ae80-704312427dc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d93f46b1-78a5-4599-a767-a4fa185ebbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b83e09c0-af54-4844-9e0a-2936407eca8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d93f46b1-78a5-4599-a767-a4fa185ebbdf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_323bfd73-6e86-47c0-a75d-c22213d0840a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6382494b-9f47-41cc-a02c-b9df2cafbae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_323bfd73-6e86-47c0-a75d-c22213d0840a" xlink:to="loc_us-gaap_FinanceLeaseLiability_6382494b-9f47-41cc-a02c-b9df2cafbae0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1db22440-6d9e-475a-9670-a8cb475c9d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_323bfd73-6e86-47c0-a75d-c22213d0840a" xlink:to="loc_us-gaap_LongTermDebt_1db22440-6d9e-475a-9670-a8cb475c9d59" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_7d0a4021-9bce-413c-8fca-7efa8fb0c04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c32c21ae-6d70-48c0-a46e-183278a4232d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_7d0a4021-9bce-413c-8fca-7efa8fb0c04c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c32c21ae-6d70-48c0-a46e-183278a4232d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0b00bec2-f0fd-4b98-90a3-b6491f2f6039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_7d0a4021-9bce-413c-8fca-7efa8fb0c04c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0b00bec2-f0fd-4b98-90a3-b6491f2f6039" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_cce31f5a-5096-41d8-90f7-2517651de3db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_87208f56-2107-4c0a-ae74-366b23da770d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_cce31f5a-5096-41d8-90f7-2517651de3db" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_87208f56-2107-4c0a-ae74-366b23da770d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_d831e8ed-fa41-4686-9371-9276f06dbd55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_cce31f5a-5096-41d8-90f7-2517651de3db" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_d831e8ed-fa41-4686-9371-9276f06dbd55" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_21f748fc-d5a6-498e-aa07-1e9e8e8b53eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0b5b7ebd-0762-4585-8403-a24bf5a8af74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_21f748fc-d5a6-498e-aa07-1e9e8e8b53eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0b5b7ebd-0762-4585-8403-a24bf5a8af74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a136bd68-8bf0-4a81-b147-fe5a21e7c633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_21f748fc-d5a6-498e-aa07-1e9e8e8b53eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a136bd68-8bf0-4a81-b147-fe5a21e7c633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_813509fc-ff95-49f4-b4db-378a7dfd5b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1684ca10-a8dc-4213-99a0-8b1116ccfa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_813509fc-ff95-49f4-b4db-378a7dfd5b27" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1684ca10-a8dc-4213-99a0-8b1116ccfa1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_191c1cb5-3f3a-47ec-ad17-570a6c0c12d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_813509fc-ff95-49f4-b4db-378a7dfd5b27" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_191c1cb5-3f3a-47ec-ad17-570a6c0c12d1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>mck-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18507b8d-c172-4d9a-9fef-a030c1e6a2f5,g:26ea8e13-0c76-4471-91f9-3ae4cfe6c737-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/Cover" xlink:type="simple" xlink:href="mck-20220630.xsd#Cover"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/Cover" xlink:type="extended" id="i01e5abde1ca64b3d8cc96c97c476201a_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_73052264-ed6d-44ee-917e-6ae38445c7e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentType_73052264-ed6d-44ee-917e-6ae38445c7e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5a2f6fb9-30f3-4e16-a83c-f37c7752d7d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentQuarterlyReport_5a2f6fb9-30f3-4e16-a83c-f37c7752d7d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_82aab958-25e0-4fb6-b7d6-11eb0ef045cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentTransitionReport_82aab958-25e0-4fb6-b7d6-11eb0ef045cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_6feb0100-e79a-4388-8fdf-006ec6d736ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityFileNumber_6feb0100-e79a-4388-8fdf-006ec6d736ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fd06c8d2-b740-42f0-8292-411889f1adb2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityRegistrantName_fd06c8d2-b740-42f0-8292-411889f1adb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2717142b-11bb-4561-a9d6-d1194aa47545" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2717142b-11bb-4561-a9d6-d1194aa47545" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cbaab7be-20b5-44f0-8b1f-dcfaababc8ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityTaxIdentificationNumber_cbaab7be-20b5-44f0-8b1f-dcfaababc8ce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9e810de9-6534-41f0-8516-b4c08b9d4810" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityAddressAddressLine1_9e810de9-6534-41f0-8516-b4c08b9d4810" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_aa70f9ec-69b1-4b12-8535-82150dddd79c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityAddressCityOrTown_aa70f9ec-69b1-4b12-8535-82150dddd79c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6743896d-4ad9-47a7-909e-7119afbe55bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityAddressStateOrProvince_6743896d-4ad9-47a7-909e-7119afbe55bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_07b1549b-ee33-4437-a88a-65b5eaf088a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityAddressPostalZipCode_07b1549b-ee33-4437-a88a-65b5eaf088a3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f67dcdd9-64dc-4012-a49b-23466187040f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_CityAreaCode_f67dcdd9-64dc-4012-a49b-23466187040f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ef63f1ee-8bf9-4a0d-bed6-5e9d1fd25434" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_LocalPhoneNumber_ef63f1ee-8bf9-4a0d-bed6-5e9d1fd25434" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_585cd4ba-4abc-44ae-98c7-d4f1b725ea76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_Security12bTitle_585cd4ba-4abc-44ae-98c7-d4f1b725ea76" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_efd3e6fd-eb8d-4dff-94a1-425f40f860b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_TradingSymbol_efd3e6fd-eb8d-4dff-94a1-425f40f860b8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_27cbc8fb-6acf-40f3-bed3-32a27cd1db85" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_SecurityExchangeName_27cbc8fb-6acf-40f3-bed3-32a27cd1db85" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2de986c5-028f-4787-aaa1-0f67c9b43df8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityCurrentReportingStatus_2de986c5-028f-4787-aaa1-0f67c9b43df8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_09b38f8b-1cfa-42f8-939f-845428184d23" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityInteractiveDataCurrent_09b38f8b-1cfa-42f8-939f-845428184d23" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_462502e5-4f95-48a8-b3d1-c76abf6997d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityFilerCategory_462502e5-4f95-48a8-b3d1-c76abf6997d2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_415054ac-90c5-4f2d-9791-3da4bfa2e230" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntitySmallBusiness_415054ac-90c5-4f2d-9791-3da4bfa2e230" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_627be232-173b-42ab-bfa5-cc703281bb6c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityEmergingGrowthCompany_627be232-173b-42ab-bfa5-cc703281bb6c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cd6cb330-cd49-4a70-9556-f1962f959ad7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityShellCompany_cd6cb330-cd49-4a70-9556-f1962f959ad7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7d55f6c3-ba67-4c44-834c-229d290d3df2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7d55f6c3-ba67-4c44-834c-229d290d3df2" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ffb73a12-3c27-4956-bfc2-97ec1f008a65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityCentralIndexKey_ffb73a12-3c27-4956-bfc2-97ec1f008a65" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4ec83697-f958-4157-82d7-d784f50aaa88" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentFiscalYearFocus_4ec83697-f958-4157-82d7-d784f50aaa88" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c3c2d306-dca9-4ea6-b8bb-2e927b3e1fca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c3c2d306-dca9-4ea6-b8bb-2e927b3e1fca" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_004f68d6-cf2f-45e0-be1f-e615d412f68b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_AmendmentFlag_004f68d6-cf2f-45e0-be1f-e615d412f68b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_df3f4a6e-2178-4e2a-856f-8c862d8f2a67" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_CurrentFiscalYearEndDate_df3f4a6e-2178-4e2a-856f-8c862d8f2a67" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6a8fb2de-b2ba-4157-8dbd-bbcd89f579a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentPeriodEndDate_6a8fb2de-b2ba-4157-8dbd-bbcd89f579a2" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5547ddc1-f87f-4bf9-bbc1-107f5bb2511e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntitiesTable_5547ddc1-f87f-4bf9-bbc1-107f5bb2511e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_553a7b4c-4216-4110-8669-d0972d602529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_5547ddc1-f87f-4bf9-bbc1-107f5bb2511e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_553a7b4c-4216-4110-8669-d0972d602529" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_553a7b4c-4216-4110-8669-d0972d602529_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_553a7b4c-4216-4110-8669-d0972d602529" xlink:to="loc_us-gaap_ClassOfStockDomain_553a7b4c-4216-4110-8669-d0972d602529_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_553a7b4c-4216-4110-8669-d0972d602529" xlink:to="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_700f9bf2-c026-4b74-aa02-22cfccaa3ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:to="loc_us-gaap_CommonStockMember_700f9bf2-c026-4b74-aa02-22cfccaa3ed2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_2c188ec2-824f-431a-8bed-3e570d29626b" xlink:href="mck-20220630.xsd#mck_A1500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:to="loc_mck_A1500NotesDue2025Member_2c188ec2-824f-431a-8bed-3e570d29626b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_a03e1a1a-2d52-46fe-b72a-ea4c2fcb8442" xlink:href="mck-20220630.xsd#mck_A1625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:to="loc_mck_A1625NotesDue2026Member_a03e1a1a-2d52-46fe-b72a-ea4c2fcb8442" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_573d41e7-e7ba-4404-a26f-99f039c62edd" xlink:href="mck-20220630.xsd#mck_A3125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:to="loc_mck_A3125NotesDue2029Member_573d41e7-e7ba-4404-a26f-99f039c62edd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="i2fb519d3b6e4429388b6524477e3183e_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_989f4c80-9298-4edf-9f9b-a168fc9f3855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_989f4c80-9298-4edf-9f9b-a168fc9f3855" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2aa241d7-5099-4190-989b-008f86d15c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_SharesOutstanding_2aa241d7-5099-4190-989b-008f86d15c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_2ad51dd4-204c-4cb9-81c6-228f4251f3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_2ad51dd4-204c-4cb9-81c6-228f4251f3cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54616ad5-616b-4ded-9940-0080947f1fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54616ad5-616b-4ded-9940-0080947f1fa0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_b033a9f3-3959-44bf-bde6-2b4d1b77dd29" xlink:href="mck-20220630.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_b033a9f3-3959-44bf-bde6-2b4d1b77dd29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_c8337ddd-4160-4a14-9523-3059c39ef8cd" xlink:href="mck-20220630.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_c8337ddd-4160-4a14-9523-3059c39ef8cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_20f9b5af-6c8a-49fd-b6ac-6c71f3461aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_20f9b5af-6c8a-49fd-b6ac-6c71f3461aa2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0a7cff7e-b320-4ead-ad0d-df34ae1b77a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0a7cff7e-b320-4ead-ad0d-df34ae1b77a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3f575d36-abc1-4a03-9ac4-8b3f09ebbaca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3f575d36-abc1-4a03-9ac4-8b3f09ebbaca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_2bf8f508-88a3-47fc-8609-f3ec2b3e88cc" xlink:href="mck-20220630.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_2bf8f508-88a3-47fc-8609-f3ec2b3e88cc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_28bd4061-cb7e-44b0-81f7-35653d3c3a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_28bd4061-cb7e-44b0-81f7-35653d3c3a8a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_b81ffdce-d8e4-4b19-9fbd-cb781a21ebed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_b81ffdce-d8e4-4b19-9fbd-cb781a21ebed" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_cff512d2-668a-4e21-8821-c0793c876c4e" xlink:href="mck-20220630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_cff512d2-668a-4e21-8821-c0793c876c4e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_2c6703d5-e726-4834-89dc-809758985095" xlink:href="mck-20220630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_2c6703d5-e726-4834-89dc-809758985095" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_611c4e6c-ae11-4be2-9c70-10249cef70a1" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_611c4e6c-ae11-4be2-9c70-10249cef70a1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_ebbd1e35-b4d7-4948-9e02-724721cb4775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_DividendsCommonStockCash_ebbd1e35-b4d7-4948-9e02-724721cb4775" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_2aa59fcb-e850-481b-8d3f-8ca410da4bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockholdersEquityOther_2aa59fcb-e850-481b-8d3f-8ca410da4bb1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_21170d4b-5e54-4435-95f9-15829b7e04a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_9b7804a9-0448-454f-8104-0f7992b521ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2408e180-8fda-467f-884f-4d8d5cf425a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ea5180c6-ece1-4ee0-8816-1efd478a8dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_989f4c80-9298-4edf-9f9b-a168fc9f3855" xlink:to="loc_us-gaap_StatementTable_ea5180c6-ece1-4ee0-8816-1efd478a8dcc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e5807de1-8f77-440a-a0ff-21a2e22eba16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ea5180c6-ece1-4ee0-8816-1efd478a8dcc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e5807de1-8f77-440a-a0ff-21a2e22eba16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e5807de1-8f77-440a-a0ff-21a2e22eba16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e5807de1-8f77-440a-a0ff-21a2e22eba16" xlink:to="loc_us-gaap_EquityComponentDomain_e5807de1-8f77-440a-a0ff-21a2e22eba16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e5807de1-8f77-440a-a0ff-21a2e22eba16" xlink:to="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4f93b422-df1e-465f-bb44-b4c22cd849bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_CommonStockMember_4f93b422-df1e-465f-bb44-b4c22cd849bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_14d7dfe0-cc14-4640-8546-1055b1eb5a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_14d7dfe0-cc14-4640-8546-1055b1eb5a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_897159e1-2d69-4f63-ab14-a18202f2ee3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_RetainedEarningsMember_897159e1-2d69-4f63-ab14-a18202f2ee3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7c84c952-c923-4d58-bebf-0c77140e2ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7c84c952-c923-4d58-bebf-0c77140e2ec3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_3c9df9e4-c706-4f32-aa2c-05823ee53399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_TreasuryStockCommonMember_3c9df9e4-c706-4f32-aa2c-05823ee53399" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_dbe754dd-fca8-4b8f-a968-29e455e8ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_NoncontrollingInterestMember_dbe754dd-fca8-4b8f-a968-29e455e8ad6d" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="id92ed3c4f4924404b7172a7bb4de5668_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_6bb60108-460d-4c44-84f0-c348b53e1a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:to="loc_us-gaap_NumberOfReportableSegments_6bb60108-460d-4c44-84f0-c348b53e1a5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_34bd0174-f1a2-4242-a668-a1b5068bc0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_34bd0174-f1a2-4242-a668-a1b5068bc0ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_25b93f20-42e0-4260-85ab-76f5de2ce89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_25b93f20-42e0-4260-85ab-76f5de2ce89a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_839d6249-77ce-45b7-8e5f-d306500d5375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:to="loc_us-gaap_SubsequentEventTable_839d6249-77ce-45b7-8e5f-d306500d5375" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f5929c3a-fd89-40fb-aad4-3707ed3e253c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_839d6249-77ce-45b7-8e5f-d306500d5375" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f5929c3a-fd89-40fb-aad4-3707ed3e253c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f5929c3a-fd89-40fb-aad4-3707ed3e253c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f5929c3a-fd89-40fb-aad4-3707ed3e253c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f5929c3a-fd89-40fb-aad4-3707ed3e253c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ea1277a3-7d3c-4822-82a9-09d4f0fee4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f5929c3a-fd89-40fb-aad4-3707ed3e253c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ea1277a3-7d3c-4822-82a9-09d4f0fee4fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8eaea6c4-950f-4331-807f-0ce6813e3234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ea1277a3-7d3c-4822-82a9-09d4f0fee4fc" xlink:to="loc_us-gaap_SubsequentEventMember_8eaea6c4-950f-4331-807f-0ce6813e3234" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended" id="ia539841e539d4d5dba553a9f369a4363_HeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_25dd8749-5e66-4d05-8143-17433a5ad9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_25dd8749-5e66-4d05-8143-17433a5ad9a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_94646633-7152-42bf-bc37-903c3be790ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_94646633-7152-42bf-bc37-903c3be790ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_161cf931-4676-40de-a9e1-795947724148" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_161cf931-4676-40de-a9e1-795947724148" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_2e30fea6-cbe7-4038-88be-40811f76ad40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_2e30fea6-cbe7-4038-88be-40811f76ad40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_ffb95cd0-0388-40dd-8e2b-bf87d4966966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_ffb95cd0-0388-40dd-8e2b-bf87d4966966" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_5c66c53d-f2ea-4a3f-bb4c-e1c8c07cb3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_5c66c53d-f2ea-4a3f-bb4c-e1c8c07cb3a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ba5c2d8c-e415-438c-bd08-149c085354d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ba5c2d8c-e415-438c-bd08-149c085354d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_bac1e4ae-436b-4a17-b623-f185c847fecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_bac1e4ae-436b-4a17-b623-f185c847fecc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_497f3411-4595-4f16-883a-222b6c3a2a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_497f3411-4595-4f16-883a-222b6c3a2a37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_497f3411-4595-4f16-883a-222b6c3a2a37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_497f3411-4595-4f16-883a-222b6c3a2a37" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_497f3411-4595-4f16-883a-222b6c3a2a37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_497f3411-4595-4f16-883a-222b6c3a2a37" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_d86cf25d-0410-4b2d-84e3-fe9ee1fd8811" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_d86cf25d-0410-4b2d-84e3-fe9ee1fd8811" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_6a56bf96-6aba-469f-ad3f-0778bf2d347e" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_6a56bf96-6aba-469f-ad3f-0778bf2d347e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7d2ecc4e-4f02-475e-8d18-33c60a53423c" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:to="loc_mck_InternationalSegmentMember_7d2ecc4e-4f02-475e-8d18-33c60a53423c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c3f43c54-e4f9-4148-ad7c-2db999ee9c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c3f43c54-e4f9-4148-ad7c-2db999ee9c35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c3f43c54-e4f9-4148-ad7c-2db999ee9c35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c3f43c54-e4f9-4148-ad7c-2db999ee9c35" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c3f43c54-e4f9-4148-ad7c-2db999ee9c35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3e332c6b-27fc-40f0-b742-1272c933238a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c3f43c54-e4f9-4148-ad7c-2db999ee9c35" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3e332c6b-27fc-40f0-b742-1272c933238a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_313b23c7-8eb3-4117-96a8-ae0e34f87713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3e332c6b-27fc-40f0-b742-1272c933238a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_313b23c7-8eb3-4117-96a8-ae0e34f87713" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_79d72c1c-171b-42b9-8604-f15e4567d680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3e332c6b-27fc-40f0-b742-1272c933238a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_79d72c1c-171b-42b9-8604-f15e4567d680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9a9b3015-a76b-40be-9b67-8ceac70f349d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:to="loc_dei_LegalEntityAxis_9a9b3015-a76b-40be-9b67-8ceac70f349d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9a9b3015-a76b-40be-9b67-8ceac70f349d_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_9a9b3015-a76b-40be-9b67-8ceac70f349d" xlink:to="loc_dei_EntityDomain_9a9b3015-a76b-40be-9b67-8ceac70f349d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7a586d2b-fe67-4fd6-9e3b-80a42bec56d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_9a9b3015-a76b-40be-9b67-8ceac70f349d" xlink:to="loc_dei_EntityDomain_7a586d2b-fe67-4fd6-9e3b-80a42bec56d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember_ccaba33d-0cb0-42a3-bfbb-c21baa2c2d6d" xlink:href="mck-20220630.xsd#mck_AureliusElephantLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_7a586d2b-fe67-4fd6-9e3b-80a42bec56d8" xlink:to="loc_mck_AureliusElephantLimitedMember_ccaba33d-0cb0-42a3-bfbb-c21baa2c2d6d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="i22b8d3b9ec6f46f1b6de565826daba69_HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_d2680e0d-1115-402f-9d1d-e791c2868ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_d2680e0d-1115-402f-9d1d-e791c2868ab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a404d84f-0d8d-47d8-a28a-9bc432799980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a404d84f-0d8d-47d8-a28a-9bc432799980" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ba85089f-3c34-414b-afe0-2d3de861f19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ba85089f-3c34-414b-afe0-2d3de861f19c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_b021cdab-4f35-4152-bb27-5bd57da2e16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_b021cdab-4f35-4152-bb27-5bd57da2e16f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_ec900790-5581-426c-b25f-3a42b1b879f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_ec900790-5581-426c-b25f-3a42b1b879f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_64aeb0ef-3b3a-49d6-a460-33d2b48f5513" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_64aeb0ef-3b3a-49d6-a460-33d2b48f5513" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d3272295-080f-4556-a6c6-ab411171900e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d3272295-080f-4556-a6c6-ab411171900e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_a1a8cdcc-9b03-417f-bc11-8827efa88abe" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_a1a8cdcc-9b03-417f-bc11-8827efa88abe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_e2d417aa-f2ad-4bc9-a3be-c0811dca30f6" xlink:href="mck-20220630.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_e2d417aa-f2ad-4bc9-a3be-c0811dca30f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a73163b3-e011-4faa-80ca-a450ac98d378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a73163b3-e011-4faa-80ca-a450ac98d378" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_61e4580f-589d-4382-b34f-80f18eb95b5d" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_61e4580f-589d-4382-b34f-80f18eb95b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_57e9d7c5-0b9f-4b15-9733-361250788762" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_57e9d7c5-0b9f-4b15-9733-361250788762" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_587e5f88-eea7-40e2-b46f-7a93c5a4b51c" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_587e5f88-eea7-40e2-b46f-7a93c5a4b51c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_5a28a39e-7bf9-4efd-b049-708fe2610ac3" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_5a28a39e-7bf9-4efd-b049-708fe2610ac3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_9401f989-87df-48a8-99a9-7edfcdd61dfb" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_9401f989-87df-48a8-99a9-7edfcdd61dfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_06a7df63-f631-41a4-90b3-457ead5494d4" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_06a7df63-f631-41a4-90b3-457ead5494d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_58bb3582-959b-41e9-acac-6de4bddba88b" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_58bb3582-959b-41e9-acac-6de4bddba88b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_b1753a14-44b6-4ab4-86e9-9c08f8a44619" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_b1753a14-44b6-4ab4-86e9-9c08f8a44619" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a7365556-1a91-4f43-880c-777e44513860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a7365556-1a91-4f43-880c-777e44513860" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_ca0c8c67-b37a-4a47-822b-5172940644b8" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_ca0c8c67-b37a-4a47-822b-5172940644b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3bf9731e-6a0b-4c0a-ae04-286ef1c76545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3bf9731e-6a0b-4c0a-ae04-286ef1c76545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3bf9731e-6a0b-4c0a-ae04-286ef1c76545_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3bf9731e-6a0b-4c0a-ae04-286ef1c76545" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3bf9731e-6a0b-4c0a-ae04-286ef1c76545_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3bf9731e-6a0b-4c0a-ae04-286ef1c76545" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_8fb5922e-9e38-46eb-b0c2-a85b28420363" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_8fb5922e-9e38-46eb-b0c2-a85b28420363" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_6f92e091-00aa-4586-818e-16d038b38fc8" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_6f92e091-00aa-4586-818e-16d038b38fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_8741569f-f4d6-4e1d-ba65-7a61f087b065" xlink:href="mck-20220630.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_8741569f-f4d6-4e1d-ba65-7a61f087b065" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_59dec6d1-8c6e-43b5-9a63-72dad00b415b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_59dec6d1-8c6e-43b5-9a63-72dad00b415b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7752cddd-242a-46d7-afb0-bfa2a1136992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_59dec6d1-8c6e-43b5-9a63-72dad00b415b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7752cddd-242a-46d7-afb0-bfa2a1136992" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended" id="id7a7d3bc864141b9a31f8c0d4504f8fc_RestructuringImpairmentandRelatedChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a1dda5f0-c327-40b0-baf0-f408c532b1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_40db1ca7-7378-43d5-a000-54c6a8e875d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a1dda5f0-c327-40b0-baf0-f408c532b1c6" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_40db1ca7-7378-43d5-a000-54c6a8e875d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_792d47ab-ff7b-4e38-93d1-0e85965466c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a1dda5f0-c327-40b0-baf0-f408c532b1c6" xlink:to="loc_us-gaap_RestructuringCharges_792d47ab-ff7b-4e38-93d1-0e85965466c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_888fe8ec-17ac-4291-a2a5-6e230f900082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a1dda5f0-c327-40b0-baf0-f408c532b1c6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_888fe8ec-17ac-4291-a2a5-6e230f900082" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_43298035-0ba4-4e22-9569-acccb440ec90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_888fe8ec-17ac-4291-a2a5-6e230f900082" xlink:to="loc_us-gaap_RestructuringPlanAxis_43298035-0ba4-4e22-9569-acccb440ec90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_43298035-0ba4-4e22-9569-acccb440ec90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_43298035-0ba4-4e22-9569-acccb440ec90" xlink:to="loc_us-gaap_RestructuringPlanDomain_43298035-0ba4-4e22-9569-acccb440ec90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9001c470-0ebc-4ef9-b00c-4bd43566f843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_43298035-0ba4-4e22-9569-acccb440ec90" xlink:to="loc_us-gaap_RestructuringPlanDomain_9001c470-0ebc-4ef9-b00c-4bd43566f843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_a7d191b3-42e3-42f9-9fb0-a99f6b106d8a" xlink:href="mck-20220630.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9001c470-0ebc-4ef9-b00c-4bd43566f843" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_a7d191b3-42e3-42f9-9fb0-a99f6b106d8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended" id="i4dab9525dc954f9392257ec9ce0ac91f_RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_f158e717-895c-4236-9882-2add84c8d96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_us-gaap_SeveranceCosts1_f158e717-895c-4236-9882-2add84c8d96a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_444e570d-3394-4995-bf27-3b677f70309e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_us-gaap_BusinessExitCosts1_444e570d-3394-4995-bf27-3b677f70309e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_5bf353be-f679-4fd4-9637-bb73d6f7b90b" xlink:href="mck-20220630.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_5bf353be-f679-4fd4-9637-bb73d6f7b90b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_73f95e6c-a470-491c-b489-6393118e0288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_us-gaap_RestructuringCharges_73f95e6c-a470-491c-b489-6393118e0288" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_85121956-fafb-45e2-b20d-0da582fd544e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:to="loc_srt_ConsolidationItemsAxis_85121956-fafb-45e2-b20d-0da582fd544e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_85121956-fafb-45e2-b20d-0da582fd544e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_85121956-fafb-45e2-b20d-0da582fd544e" xlink:to="loc_srt_ConsolidationItemsDomain_85121956-fafb-45e2-b20d-0da582fd544e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_83e4cc1b-77ed-4b34-996c-d13dcbb39ef1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_85121956-fafb-45e2-b20d-0da582fd544e" xlink:to="loc_srt_ConsolidationItemsDomain_83e4cc1b-77ed-4b34-996c-d13dcbb39ef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b7b9f41e-16a6-4c4d-a629-3a5468820d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_83e4cc1b-77ed-4b34-996c-d13dcbb39ef1" xlink:to="loc_us-gaap_OperatingSegmentsMember_b7b9f41e-16a6-4c4d-a629-3a5468820d6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_8c6daf8f-d820-4778-b22b-878f9edd532d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_83e4cc1b-77ed-4b34-996c-d13dcbb39ef1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_8c6daf8f-d820-4778-b22b-878f9edd532d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_05ff427f-398f-4df4-9ebd-6e58c2da65cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_05ff427f-398f-4df4-9ebd-6e58c2da65cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_05ff427f-398f-4df4-9ebd-6e58c2da65cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_05ff427f-398f-4df4-9ebd-6e58c2da65cb" xlink:to="loc_us-gaap_SegmentDomain_05ff427f-398f-4df4-9ebd-6e58c2da65cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_05ff427f-398f-4df4-9ebd-6e58c2da65cb" xlink:to="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_d54ddb22-f7c8-45ee-8211-c18ca31f20c8" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:to="loc_mck_USPharmaceuticalSegmentMember_d54ddb22-f7c8-45ee-8211-c18ca31f20c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_2511ca87-e97d-45e0-90aa-2107b3feb213" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_2511ca87-e97d-45e0-90aa-2107b3feb213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_1dd56021-6a91-4156-be89-1b64f70fb6e2" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_1dd56021-6a91-4156-be89-1b64f70fb6e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_dc646aea-cf67-4602-9fa9-04bfc02b8d4c" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:to="loc_mck_InternationalSegmentMember_dc646aea-cf67-4602-9fa9-04bfc02b8d4c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended" id="iae3e0fad61bf415f8f36595c08773337_RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_24ba7398-8c6c-4ba3-92d0-fc7599788b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_24ba7398-8c6c-4ba3-92d0-fc7599788b42" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f4313e74-f8f4-4124-9613-9dbbaf8a8aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringReserve_f4313e74-f8f4-4124-9613-9dbbaf8a8aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_da90e6f5-4746-42c3-8814-7391790aeaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringCharges_da90e6f5-4746-42c3-8814-7391790aeaba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_99fd7a60-991e-4ebf-b56b-c5cbf939bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_99fd7a60-991e-4ebf-b56b-c5cbf939bc65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_8ba55482-3f7c-4048-9d1b-485cac5463e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_PaymentsForRestructuring_8ba55482-3f7c-4048-9d1b-485cac5463e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_39e44fa1-c993-4d39-a61e-8002ffe7206c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_39e44fa1-c993-4d39-a61e-8002ffe7206c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_90e821df-3198-4e84-ba91-f42bcdf48a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_24ba7398-8c6c-4ba3-92d0-fc7599788b42" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5d86c265-7b0f-492e-ad2b-2101ad131cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5d86c265-7b0f-492e-ad2b-2101ad131cf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5d86c265-7b0f-492e-ad2b-2101ad131cf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5d86c265-7b0f-492e-ad2b-2101ad131cf5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5d86c265-7b0f-492e-ad2b-2101ad131cf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5d86c265-7b0f-492e-ad2b-2101ad131cf5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_83312fc6-5d82-4a77-acd3-0a408a65027f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_83312fc6-5d82-4a77-acd3-0a408a65027f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_ed5995cd-9389-4bbd-808e-832d8d003ae9" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_ed5995cd-9389-4bbd-808e-832d8d003ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c23a2fee-f2b1-488e-96e9-786aff30d6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c23a2fee-f2b1-488e-96e9-786aff30d6bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:to="loc_srt_ConsolidationItemsAxis_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269" xlink:to="loc_srt_ConsolidationItemsDomain_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7afc6361-b79e-4129-afa3-1fbfab02f0dd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269" xlink:to="loc_srt_ConsolidationItemsDomain_7afc6361-b79e-4129-afa3-1fbfab02f0dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6522b176-0d5e-44c0-a1a6-ceb86b63845f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7afc6361-b79e-4129-afa3-1fbfab02f0dd" xlink:to="loc_us-gaap_OperatingSegmentsMember_6522b176-0d5e-44c0-a1a6-ceb86b63845f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6fef9ccc-91d3-40fe-a4ee-054aa693b666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7afc6361-b79e-4129-afa3-1fbfab02f0dd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_6fef9ccc-91d3-40fe-a4ee-054aa693b666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_74626b56-9543-4e5d-b20e-555e45c0718a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_74626b56-9543-4e5d-b20e-555e45c0718a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_74626b56-9543-4e5d-b20e-555e45c0718a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_74626b56-9543-4e5d-b20e-555e45c0718a" xlink:to="loc_us-gaap_SegmentDomain_74626b56-9543-4e5d-b20e-555e45c0718a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_74626b56-9543-4e5d-b20e-555e45c0718a" xlink:to="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_e0a1a3a5-54b7-4ad7-979b-c5c859c071d0" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:to="loc_mck_USPharmaceuticalSegmentMember_e0a1a3a5-54b7-4ad7-979b-c5c859c071d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_a9e95a15-d8d8-41a7-a123-32f05f7c64fb" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_a9e95a15-d8d8-41a7-a123-32f05f7c64fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_79eda308-b22d-40f3-88be-381490ae197c" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_79eda308-b22d-40f3-88be-381490ae197c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_a1ee5df8-4439-4856-95e7-67a9608a0060" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:to="loc_mck_InternationalSegmentMember_a1ee5df8-4439-4856-95e7-67a9608a0060" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended" id="ibfc295d3c79141f1a7b3b2eb46028732_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8f17bff4-7552-45f9-8335-f3ef734cfb58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8f17bff4-7552-45f9-8335-f3ef734cfb58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_75aa1b92-a82d-4b52-9023-592b73a1bd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_75aa1b92-a82d-4b52-9023-592b73a1bd53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_20f5e33e-c852-496d-8249-0320b9105527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_20f5e33e-c852-496d-8249-0320b9105527" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_00fb6303-9b16-4734-b2ac-c4e002c1e17e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_00fb6303-9b16-4734-b2ac-c4e002c1e17e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_5c52c6d4-c10e-42da-94f4-61288327ce58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_5c52c6d4-c10e-42da-94f4-61288327ce58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_803334e9-7f2c-4c33-8d46-8fd926cd9600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_803334e9-7f2c-4c33-8d46-8fd926cd9600" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_4a2bd6c6-b00d-47b4-9477-2ff2f7ccfb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_4a2bd6c6-b00d-47b4-9477-2ff2f7ccfb3a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_8e795c1c-2452-4c58-a43b-4ca897ac5aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_8e795c1c-2452-4c58-a43b-4ca897ac5aff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f9948981-a02f-49f9-87b9-aaf1bac45b0b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8e795c1c-2452-4c58-a43b-4ca897ac5aff" xlink:to="loc_srt_RangeAxis_f9948981-a02f-49f9-87b9-aaf1bac45b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f9948981-a02f-49f9-87b9-aaf1bac45b0b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f9948981-a02f-49f9-87b9-aaf1bac45b0b" xlink:to="loc_srt_RangeMember_f9948981-a02f-49f9-87b9-aaf1bac45b0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7d7ce22c-81bc-4559-8334-e1aaeb9e8a8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f9948981-a02f-49f9-87b9-aaf1bac45b0b" xlink:to="loc_srt_RangeMember_7d7ce22c-81bc-4559-8334-e1aaeb9e8a8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a26b9562-487e-4679-b1c7-1baf9bfdf975" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7d7ce22c-81bc-4559-8334-e1aaeb9e8a8d" xlink:to="loc_srt_MinimumMember_a26b9562-487e-4679-b1c7-1baf9bfdf975" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c8d2506c-9c1f-421c-8167-23af86e51949" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7d7ce22c-81bc-4559-8334-e1aaeb9e8a8d" xlink:to="loc_srt_MaximumMember_c8d2506c-9c1f-421c-8167-23af86e51949" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="idb267372a62b49fb8b571dff488fb9e6_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_55305aeb-fa1e-41da-8ac2-96ccf3c2054a" xlink:href="mck-20220630.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_55305aeb-fa1e-41da-8ac2-96ccf3c2054a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_eb514dd8-b22e-49f9-8215-46fa38e6ec56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_eb514dd8-b22e-49f9-8215-46fa38e6ec56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_39ccf289-2c04-4295-9c45-5600c31039cf" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_39ccf289-2c04-4295-9c45-5600c31039cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_c2fb8bb6-5f16-4d48-b284-8f81242f3b6b" xlink:href="mck-20220630.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_PutRightValueInterestRateSpread_c2fb8bb6-5f16-4d48-b284-8f81242f3b6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f699a59e-d3a9-4d78-a215-7249ce4d3f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f699a59e-d3a9-4d78-a215-7249ce4d3f82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_4479b46d-bc89-4044-820f-e86ab2d322b3" xlink:href="mck-20220630.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_4479b46d-bc89-4044-820f-e86ab2d322b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_29ffdef0-26d7-4e9a-8339-8d08eee8c07b" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_29ffdef0-26d7-4e9a-8339-8d08eee8c07b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_4db77cb1-f0dd-4722-9dcd-fc99c667b6b7" xlink:href="mck-20220630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_4db77cb1-f0dd-4722-9dcd-fc99c667b6b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_1f9a1dc6-b6ed-4cfc-b63d-4ad3cb63947b" xlink:href="mck-20220630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_1f9a1dc6-b6ed-4cfc-b63d-4ad3cb63947b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c06c2a24-88d3-44b5-94bf-cfa12c2ae39c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c06c2a24-88d3-44b5-94bf-cfa12c2ae39c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_578d3097-7c5e-4602-8a8a-fe6a06081d8b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:to="loc_srt_OwnershipAxis_578d3097-7c5e-4602-8a8a-fe6a06081d8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_578d3097-7c5e-4602-8a8a-fe6a06081d8b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_578d3097-7c5e-4602-8a8a-fe6a06081d8b" xlink:to="loc_srt_OwnershipDomain_578d3097-7c5e-4602-8a8a-fe6a06081d8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d688b3e6-0278-4936-8f35-207071bfd12b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_578d3097-7c5e-4602-8a8a-fe6a06081d8b" xlink:to="loc_srt_OwnershipDomain_d688b3e6-0278-4936-8f35-207071bfd12b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_b1d25a11-2485-46d7-99ff-8970a9cf2ee2" xlink:href="mck-20220630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_d688b3e6-0278-4936-8f35-207071bfd12b" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_b1d25a11-2485-46d7-99ff-8970a9cf2ee2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_39e3bdff-a48c-495d-b572-d2cd71984a31" xlink:href="mck-20220630.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_d688b3e6-0278-4936-8f35-207071bfd12b" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_39e3bdff-a48c-495d-b572-d2cd71984a31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_563acf8c-5a8a-4d14-92b4-2fed876d8bd7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:to="loc_dei_LegalEntityAxis_563acf8c-5a8a-4d14-92b4-2fed876d8bd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_563acf8c-5a8a-4d14-92b4-2fed876d8bd7_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_563acf8c-5a8a-4d14-92b4-2fed876d8bd7" xlink:to="loc_dei_EntityDomain_563acf8c-5a8a-4d14-92b4-2fed876d8bd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fff4587d-ecea-4fb9-a7b9-0a4497441329" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_563acf8c-5a8a-4d14-92b4-2fed876d8bd7" xlink:to="loc_dei_EntityDomain_fff4587d-ecea-4fb9-a7b9-0a4497441329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_5249f185-dfeb-41db-ac83-330059471785" xlink:href="mck-20220630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fff4587d-ecea-4fb9-a7b9-0a4497441329" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_5249f185-dfeb-41db-ac83-330059471785" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8f934658-e933-4d60-8d92-7a6dab7a23b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8f934658-e933-4d60-8d92-7a6dab7a23b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8f934658-e933-4d60-8d92-7a6dab7a23b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f934658-e933-4d60-8d92-7a6dab7a23b7" xlink:to="loc_us-gaap_EquityComponentDomain_8f934658-e933-4d60-8d92-7a6dab7a23b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f934658-e933-4d60-8d92-7a6dab7a23b7" xlink:to="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_090a3f0f-9e2f-4e70-ab9c-799c89844ff8" xlink:href="mck-20220630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_090a3f0f-9e2f-4e70-ab9c-799c89844ff8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7db42564-b934-4ce0-b0a9-7a8ded66dc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7db42564-b934-4ce0-b0a9-7a8ded66dc21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_41151f2b-cdd3-4a14-88ac-f7b3952c2e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:to="loc_us-gaap_NoncontrollingInterestMember_41151f2b-cdd3-4a14-88ac-f7b3952c2e77" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended" id="i8d06e58310834afb9c52620ef541bba1_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_44016068-62e7-496d-89b2-89d40d9e9b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_44016068-62e7-496d-89b2-89d40d9e9b04" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c29e73bb-b4b3-41ab-9c17-fda7d86f62d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_MinorityInterest_c29e73bb-b4b3-41ab-9c17-fda7d86f62d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89527ca1-addd-4e1f-91a6-c2b9ad3aa57d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89527ca1-addd-4e1f-91a6-c2b9ad3aa57d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9a2b239-7b6e-49f4-be31-db12fdc45316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9a2b239-7b6e-49f4-be31-db12fdc45316" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_4df56eec-f393-4b7d-b019-81b63c2e32e7" xlink:href="mck-20220630.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_4df56eec-f393-4b7d-b019-81b63c2e32e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_97848b6b-195d-4fde-ac2d-3e00bc4856f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_97848b6b-195d-4fde-ac2d-3e00bc4856f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_5d9a2a79-c51f-44b0-83a8-86763336a348" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_5d9a2a79-c51f-44b0-83a8-86763336a348" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e7d4184b-8cbe-4e8d-91fd-e1ae2a6940e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_44016068-62e7-496d-89b2-89d40d9e9b04" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f3bc635e-d91f-4950-939a-82f5fda09694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f3bc635e-d91f-4950-939a-82f5fda09694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_00540ca7-6a8a-4f7a-920d-8f2795fec284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_00540ca7-6a8a-4f7a-920d-8f2795fec284" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_88d5c611-5621-4bf6-b8dc-47a262e1ab2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_70223588-14c3-4a7b-9064-8c1b585aabca" xlink:href="mck-20220630.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_9e2b0771-5870-4b24-ad3e-218b6c7ce724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_95c51088-b39c-4464-8d11-d895ce72710f" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_95c51088-b39c-4464-8d11-d895ce72710f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_643be020-bb4a-401a-b541-8ae2374a1d88" xlink:href="mck-20220630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_643be020-bb4a-401a-b541-8ae2374a1d88" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_36e63686-218a-43e8-bcb2-548e6017e0e7" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_845ba166-f431-4e1b-876c-808a1a67a74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_7d2c1534-27d8-4e56-a0bd-814ca72cfa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_44016068-62e7-496d-89b2-89d40d9e9b04" xlink:to="loc_us-gaap_MinorityInterestTable_7d2c1534-27d8-4e56-a0bd-814ca72cfa4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4c95582f-8265-4907-82f2-0dd8e1467736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_7d2c1534-27d8-4e56-a0bd-814ca72cfa4b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4c95582f-8265-4907-82f2-0dd8e1467736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4c95582f-8265-4907-82f2-0dd8e1467736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4c95582f-8265-4907-82f2-0dd8e1467736" xlink:to="loc_us-gaap_EquityComponentDomain_4c95582f-8265-4907-82f2-0dd8e1467736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_023d3cc2-bd7f-45f2-8a12-7b2bbe78c371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4c95582f-8265-4907-82f2-0dd8e1467736" xlink:to="loc_us-gaap_EquityComponentDomain_023d3cc2-bd7f-45f2-8a12-7b2bbe78c371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_e4b78782-9ea7-431e-9a20-f3f88853dfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_023d3cc2-bd7f-45f2-8a12-7b2bbe78c371" xlink:to="loc_us-gaap_NoncontrollingInterestMember_e4b78782-9ea7-431e-9a20-f3f88853dfa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_f39dcf2c-d2c7-412c-a6da-8d044bd4eb5a" xlink:href="mck-20220630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_023d3cc2-bd7f-45f2-8a12-7b2bbe78c371" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_f39dcf2c-d2c7-412c-a6da-8d044bd4eb5a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended" id="i60d91b169da840f99fa08663c17e0262_EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_46e59dc6-c8a0-4472-858b-53c91120f9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_46e59dc6-c8a0-4472-858b-53c91120f9b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_580ab97b-ce4e-4e0d-a6ba-5ee1dd9e2e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_580ab97b-ce4e-4e0d-a6ba-5ee1dd9e2e4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_a3e5ee3d-6a95-4b03-ad8e-6ad5f4c49115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_a3e5ee3d-6a95-4b03-ad8e-6ad5f4c49115" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_06cf60a7-7914-44e8-a71c-c8c7323777bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_06cf60a7-7914-44e8-a71c-c8c7323777bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4792c1d7-8e50-4227-badb-9e1a36c8fb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_NetIncomeLoss_4792c1d7-8e50-4227-badb-9e1a36c8fb57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ef6d8b5e-245e-45c6-8727-4fa6f2d76e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ef6d8b5e-245e-45c6-8727-4fa6f2d76e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_72fe40f4-deb9-47bd-b6af-599359d5fa26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_72fe40f4-deb9-47bd-b6af-599359d5fa26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_eba45f08-65c6-45d8-aba4-a94733deef40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_72fe40f4-deb9-47bd-b6af-599359d5fa26" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_eba45f08-65c6-45d8-aba4-a94733deef40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ecf02cea-a7ca-41d6-a6c9-ff3b485061ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ecf02cea-a7ca-41d6-a6c9-ff3b485061ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract_0c73104b-6dfc-4644-9d82-28bb889a4537" xlink:href="mck-20220630.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_mck_EPSBasicAndDilutedAbstract_0c73104b-6dfc-4644-9d82-28bb889a4537" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_0c73104b-6dfc-4644-9d82-28bb889a4537" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_862e88d9-102e-4cba-9a6e-57f045ef9806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_862e88d9-102e-4cba-9a6e-57f045ef9806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_79fe071e-453c-4365-b106-6fc982ecc103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_79fe071e-453c-4365-b106-6fc982ecc103" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1be55aaf-f0a8-4a04-a05b-983e38c60c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1be55aaf-f0a8-4a04-a05b-983e38c60c01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_0c73104b-6dfc-4644-9d82-28bb889a4537" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4ddcac98-64b8-4cf1-ba23-be85dcede4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4ddcac98-64b8-4cf1-ba23-be85dcede4c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_26d0c542-b5e3-45a8-b3f6-172666376eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_26d0c542-b5e3-45a8-b3f6-172666376eb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_385c7066-c5a8-412e-982d-5cecfaa0ec11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:to="loc_us-gaap_EarningsPerShareBasic_385c7066-c5a8-412e-982d-5cecfaa0ec11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_801fa746-974f-446f-9e1a-02ea6d3b91ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_801fa746-974f-446f-9e1a-02ea6d3b91ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5b205c97-aea1-4c42-b0fe-db0c6175f1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_801fa746-974f-446f-9e1a-02ea6d3b91ba" xlink:to="loc_us-gaap_AwardTypeAxis_5b205c97-aea1-4c42-b0fe-db0c6175f1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5b205c97-aea1-4c42-b0fe-db0c6175f1b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5b205c97-aea1-4c42-b0fe-db0c6175f1b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5b205c97-aea1-4c42-b0fe-db0c6175f1b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eba6a0b-ac36-419b-9a2a-d4601ae0c3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5b205c97-aea1-4c42-b0fe-db0c6175f1b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eba6a0b-ac36-419b-9a2a-d4601ae0c3ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2ed575a8-df1d-4d20-baea-b154bbdf5fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eba6a0b-ac36-419b-9a2a-d4601ae0c3ad" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2ed575a8-df1d-4d20-baea-b154bbdf5fc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_265c4659-2465-4a7e-bf39-7075a2abce55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eba6a0b-ac36-419b-9a2a-d4601ae0c3ad" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_265c4659-2465-4a7e-bf39-7075a2abce55" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="if3fba4dc1eb04df5bc4923bda78eb32d_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f08b7572-480d-4576-b9e9-08cff73aae98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f08b7572-480d-4576-b9e9-08cff73aae98" xlink:to="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9af0c46b-52fc-4148-b0c7-65d97fc6f7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:to="loc_us-gaap_Goodwill_9af0c46b-52fc-4148-b0c7-65d97fc6f7c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dee2273c-97dc-4c2e-bc8d-650ac24d9f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dee2273c-97dc-4c2e-bc8d-650ac24d9f85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_14d0ebe3-de50-4463-b413-bd9ce82d164b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_14d0ebe3-de50-4463-b413-bd9ce82d164b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fc20f6f7-df1b-49a8-a632-9536898536ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f35090eb-85b2-41cc-9d42-be443848d414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_f08b7572-480d-4576-b9e9-08cff73aae98" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f35090eb-85b2-41cc-9d42-be443848d414" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b142ec29-df77-4cd1-bd7f-5314d3744c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f35090eb-85b2-41cc-9d42-be443848d414" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b142ec29-df77-4cd1-bd7f-5314d3744c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b142ec29-df77-4cd1-bd7f-5314d3744c6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b142ec29-df77-4cd1-bd7f-5314d3744c6e" xlink:to="loc_us-gaap_SegmentDomain_b142ec29-df77-4cd1-bd7f-5314d3744c6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b142ec29-df77-4cd1-bd7f-5314d3744c6e" xlink:to="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_18667094-8e9e-4369-922f-4fa3e3eb3eb9" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:to="loc_mck_USPharmaceuticalSegmentMember_18667094-8e9e-4369-922f-4fa3e3eb3eb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_a3c3cdaf-325f-4c11-a8b2-fac8ab64a1b9" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_a3c3cdaf-325f-4c11-a8b2-fac8ab64a1b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_1956dd2d-3308-418d-aff6-95aa5f086dbd" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_1956dd2d-3308-418d-aff6-95aa5f086dbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_f7c327bf-a45b-4297-897e-a0fe5f42d0fe" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:to="loc_mck_InternationalSegmentMember_f7c327bf-a45b-4297-897e-a0fe5f42d0fe" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="ifd42cbd6a02e45c1a7fd941da39184bf_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a462ab88-f1ff-4725-9849-42ff124e4e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a462ab88-f1ff-4725-9849-42ff124e4e08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_befb07b0-8256-42a7-9279-a6f8346d13af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_befb07b0-8256-42a7-9279-a6f8346d13af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d820772e-1669-4e59-bc1c-4c3b8c6228b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d820772e-1669-4e59-bc1c-4c3b8c6228b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_61ec8829-3743-42d4-871f-c1fc6dd741e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_61ec8829-3743-42d4-871f-c1fc6dd741e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_96b82cce-001b-4b3c-88e0-1de4e7567f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_96b82cce-001b-4b3c-88e0-1de4e7567f52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8d7565e7-76d8-4157-8848-c90709a35599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_96b82cce-001b-4b3c-88e0-1de4e7567f52" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8d7565e7-76d8-4157-8848-c90709a35599" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d7565e7-76d8-4157-8848-c90709a35599_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8d7565e7-76d8-4157-8848-c90709a35599" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d7565e7-76d8-4157-8848-c90709a35599_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8d7565e7-76d8-4157-8848-c90709a35599" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ca83e494-b6ec-494e-8db4-c92a8e16541e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ca83e494-b6ec-494e-8db4-c92a8e16541e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_5055a205-10b5-48bf-bc15-e4d47c85988f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_ServiceAgreementsMember_5055a205-10b5-48bf-bc15-e4d47c85988f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_d30eaf6a-a70a-4f40-bbe4-d5afafcfd855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_d30eaf6a-a70a-4f40-bbe4-d5afafcfd855" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_895e685d-3f6c-4426-b0f8-569c2f50efd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_895e685d-3f6c-4426-b0f8-569c2f50efd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_ffa7753a-1749-4c83-bd8b-986ea4384680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_ffa7753a-1749-4c83-bd8b-986ea4384680" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="i74f696e9dbb94a738e7eb7bde0fe03b7_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0308a54-9b12-49a5-a7b2-06f54cca9858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0308a54-9b12-49a5-a7b2-06f54cca9858" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d94a49a8-8a42-4a8c-aa99-6d3bb54261d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_LongTermDebt_d94a49a8-8a42-4a8c-aa99-6d3bb54261d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_37c1311a-a0f2-4318-89cd-c4962b5d9496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_FinanceLeaseLiability_37c1311a-a0f2-4318-89cd-c4962b5d9496" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_0d0ae766-4fba-4b38-9b8d-4fce790a6f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_0d0ae766-4fba-4b38-9b8d-4fce790a6f04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_39576998-b1b0-423f-a6fb-cf12cd26633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_39576998-b1b0-423f-a6fb-cf12cd26633d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_47c2c443-5446-4ed2-a2e5-9c347f4023e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_47c2c443-5446-4ed2-a2e5-9c347f4023e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9a1bd680-dcb2-4188-a697-14cec1045dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:to="loc_us-gaap_DebtInstrumentAxis_9a1bd680-dcb2-4188-a697-14cec1045dc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9a1bd680-dcb2-4188-a697-14cec1045dc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a1bd680-dcb2-4188-a697-14cec1045dc6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9a1bd680-dcb2-4188-a697-14cec1045dc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a1bd680-dcb2-4188-a697-14cec1045dc6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_0ad5359e-5137-4d9b-86be-c10c29549077" xlink:href="mck-20220630.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A270NotesDueDecember152022Member_0ad5359e-5137-4d9b-86be-c10c29549077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_6c0193c5-80f8-4528-ba74-b43711acdcf3" xlink:href="mck-20220630.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A285NotesDueMarch152023Member_6c0193c5-80f8-4528-ba74-b43711acdcf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_17bb5ecf-69f3-4660-8a2d-a1b5dda31754" xlink:href="mck-20220630.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A380NotesDueMarch152024Member_17bb5ecf-69f3-4660-8a2d-a1b5dda31754" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_4c98533f-0e59-4e2c-ad72-c5ffb6b893a9" xlink:href="mck-20220630.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A090NotesDueDecember32025Member_4c98533f-0e59-4e2c-ad72-c5ffb6b893a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_b249a744-b172-4897-bb48-e931eaea0964" xlink:href="mck-20220630.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A130NotesDueAugust152026Member_b249a744-b172-4897-bb48-e931eaea0964" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_3df1931a-5a8e-4174-9594-1dbb42884263" xlink:href="mck-20220630.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_3df1931a-5a8e-4174-9594-1dbb42884263" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_a9643b2f-d2f9-460d-8311-0f956e68cfaf" xlink:href="mck-20220630.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A395NotesDueFebruary162028Member_a9643b2f-d2f9-460d-8311-0f956e68cfaf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_250e1960-8842-488c-a6c4-d21a48604164" xlink:href="mck-20220630.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A475NotesDueMay302029Member_250e1960-8842-488c-a6c4-d21a48604164" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_122927d5-5698-4427-ad51-1e89dff116a2" xlink:href="mck-20220630.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A600NotesDueMarch12041Member_122927d5-5698-4427-ad51-1e89dff116a2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_33f66418-a32b-4a9b-9c28-f0ef5601d9d6" xlink:href="mck-20220630.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A488NotesDueMarch152044Member_33f66418-a32b-4a9b-9c28-f0ef5601d9d6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_62168d7a-2929-47b3-93a8-030bdd753f99" xlink:href="mck-20220630.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_62168d7a-2929-47b3-93a8-030bdd753f99" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_b9b562b7-ba1e-4556-9f22-dc71722f2a52" xlink:href="mck-20220630.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_b9b562b7-ba1e-4556-9f22-dc71722f2a52" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_1109c0e8-f124-4975-b1f3-302bb464859a" xlink:href="mck-20220630.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_1109c0e8-f124-4975-b1f3-302bb464859a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0568d62d-efbf-48ce-bdcf-50ce0491e715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0568d62d-efbf-48ce-bdcf-50ce0491e715" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0568d62d-efbf-48ce-bdcf-50ce0491e715_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0568d62d-efbf-48ce-bdcf-50ce0491e715" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0568d62d-efbf-48ce-bdcf-50ce0491e715_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_618f8342-1970-4811-89b5-f15669bc5c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0568d62d-efbf-48ce-bdcf-50ce0491e715" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_618f8342-1970-4811-89b5-f15669bc5c06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_fd6bbe90-09e5-4235-b40f-24a4a0ef5889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_618f8342-1970-4811-89b5-f15669bc5c06" xlink:to="loc_us-gaap_LoansPayableMember_fd6bbe90-09e5-4235-b40f-24a4a0ef5889" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" xlink:type="extended" id="i88ab21e6b29145738ead395fba9ec810_DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ccbd5cc5-c326-4bc3-8d8b-831fce7a72ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ccbd5cc5-c326-4bc3-8d8b-831fce7a72ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_f29b4a00-abd8-4137-aff4-19f89049efc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_DebtInstrumentTerm_f29b4a00-abd8-4137-aff4-19f89049efc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ad721b25-d8d8-40a9-9a1a-3f78e8c2d674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ad721b25-d8d8-40a9-9a1a-3f78e8c2d674" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c8180724-5fe3-44d6-aec7-b51cd1facb70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c8180724-5fe3-44d6-aec7-b51cd1facb70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ae10e3f1-0cff-43da-b7b0-564e21f31d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_LineOfCredit_ae10e3f1-0cff-43da-b7b0-564e21f31d4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5c990145-a4f0-4877-891b-899cc04af82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5c990145-a4f0-4877-891b-899cc04af82a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c990145-a4f0-4877-891b-899cc04af82a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c990145-a4f0-4877-891b-899cc04af82a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c990145-a4f0-4877-891b-899cc04af82a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9dd6f27d-7986-45dd-ab67-18665009d560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c990145-a4f0-4877-891b-899cc04af82a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9dd6f27d-7986-45dd-ab67-18665009d560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_9ebe2efe-cd41-4bf9-88a8-9293eb975370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9dd6f27d-7986-45dd-ab67-18665009d560" xlink:to="loc_us-gaap_UnsecuredDebtMember_9ebe2efe-cd41-4bf9-88a8-9293eb975370" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d04fa914-d275-412c-8312-61f60b088eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:to="loc_us-gaap_CreditFacilityAxis_d04fa914-d275-412c-8312-61f60b088eae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d04fa914-d275-412c-8312-61f60b088eae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d04fa914-d275-412c-8312-61f60b088eae" xlink:to="loc_us-gaap_CreditFacilityDomain_d04fa914-d275-412c-8312-61f60b088eae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_15ed06d8-19ee-416c-8e4e-e666fc6e881d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d04fa914-d275-412c-8312-61f60b088eae" xlink:to="loc_us-gaap_CreditFacilityDomain_15ed06d8-19ee-416c-8e4e-e666fc6e881d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_24c7a71b-372e-45d9-a535-faf557c442d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_15ed06d8-19ee-416c-8e4e-e666fc6e881d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_24c7a71b-372e-45d9-a535-faf557c442d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9bb61464-aae0-4f08-9783-30d7a8e3aa03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_15ed06d8-19ee-416c-8e4e-e666fc6e881d" xlink:to="loc_us-gaap_LineOfCreditMember_9bb61464-aae0-4f08-9783-30d7a8e3aa03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_797c9875-f584-4b62-9160-7b752da2c800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:to="loc_us-gaap_DebtInstrumentAxis_797c9875-f584-4b62-9160-7b752da2c800" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_797c9875-f584-4b62-9160-7b752da2c800_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_797c9875-f584-4b62-9160-7b752da2c800" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_797c9875-f584-4b62-9160-7b752da2c800_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_797c9875-f584-4b62-9160-7b752da2c800" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_ef7bf145-39f2-42f8-bd79-bde8b0db00e7" xlink:href="mck-20220630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_ef7bf145-39f2-42f8-bd79-bde8b0db00e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_bc4edf2d-b488-4a59-b7d2-e09e73d3ff2f" xlink:href="mck-20220630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_bc4edf2d-b488-4a59-b7d2-e09e73d3ff2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommittedMember_17814cff-285c-4c5b-8a08-7a5655427a7a" xlink:href="mck-20220630.xsd#mck_CommittedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:to="loc_mck_CommittedMember_17814cff-285c-4c5b-8a08-7a5655427a7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UncommittedMember_3628875b-6fc7-47a2-92df-05b8f43b00e3" xlink:href="mck-20220630.xsd#mck_UncommittedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:to="loc_mck_UncommittedMember_3628875b-6fc7-47a2-92df-05b8f43b00e3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesCommercialPaperNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails" xlink:type="extended" id="i10eb751fd8494e8f86775c80821dfa39_DebtandFinancingActivitiesCommercialPaperNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b09c76f8-7b23-4a92-8dd1-fe057d3d1f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b09c76f8-7b23-4a92-8dd1-fe057d3d1f0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_cd57fc5e-3c52-4c5a-b92f-f3508966712a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_cd57fc5e-3c52-4c5a-b92f-f3508966712a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_1344ceb7-6b77-46c0-a2a8-431985a81473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_1344ceb7-6b77-46c0-a2a8-431985a81473" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7f2d2d12-6823-4075-9e89-dca86915a134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:to="loc_us-gaap_DebtInstrumentTable_7f2d2d12-6823-4075-9e89-dca86915a134" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4b027427-01df-4248-9fb7-455e593a075f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7f2d2d12-6823-4075-9e89-dca86915a134" xlink:to="loc_us-gaap_CreditFacilityAxis_4b027427-01df-4248-9fb7-455e593a075f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4b027427-01df-4248-9fb7-455e593a075f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4b027427-01df-4248-9fb7-455e593a075f" xlink:to="loc_us-gaap_CreditFacilityDomain_4b027427-01df-4248-9fb7-455e593a075f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4e03043b-420e-4450-97fb-c4a843107df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4b027427-01df-4248-9fb7-455e593a075f" xlink:to="loc_us-gaap_CreditFacilityDomain_4e03043b-420e-4450-97fb-c4a843107df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_68c67d12-43a5-498d-aa87-6d38450d6cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_4e03043b-420e-4450-97fb-c4a843107df7" xlink:to="loc_us-gaap_CommercialPaperMember_68c67d12-43a5-498d-aa87-6d38450d6cd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="i762bc5c62cfd4e7db8556de09ecae9d8_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a1ea3caa-46f9-49fd-a80c-4b866241a6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a1ea3caa-46f9-49fd-a80c-4b866241a6a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_502bf051-6580-4fbe-a31d-76155d53f5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_502bf051-6580-4fbe-a31d-76155d53f5b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_1b7a95d4-1ca4-41be-88a9-063e0a0c1f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_1b7a95d4-1ca4-41be-88a9-063e0a0c1f16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_e2372dff-14ff-417a-b2e8-488eadb7fa06" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_e2372dff-14ff-417a-b2e8-488eadb7fa06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_c7bddd65-61c7-4908-9078-3f6b116a6f38" xlink:href="mck-20220630.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_c7bddd65-61c7-4908-9078-3f6b116a6f38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0229034a-4302-4b8b-bdb2-8b2d178387a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0229034a-4302-4b8b-bdb2-8b2d178387a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0229034a-4302-4b8b-bdb2-8b2d178387a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0229034a-4302-4b8b-bdb2-8b2d178387a6" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0229034a-4302-4b8b-bdb2-8b2d178387a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_05ddf351-e300-4f02-a00b-13ad4dd3698a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0229034a-4302-4b8b-bdb2-8b2d178387a6" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_05ddf351-e300-4f02-a00b-13ad4dd3698a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ebcee50f-32a2-473d-a1c6-55afdb631334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_05ddf351-e300-4f02-a00b-13ad4dd3698a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ebcee50f-32a2-473d-a1c6-55afdb631334" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1277aff6-c0bc-4441-a7c4-b62fd092b7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1277aff6-c0bc-4441-a7c4-b62fd092b7d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1277aff6-c0bc-4441-a7c4-b62fd092b7d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1277aff6-c0bc-4441-a7c4-b62fd092b7d2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1277aff6-c0bc-4441-a7c4-b62fd092b7d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bc2f58a3-e88f-40da-9a66-a6cbeed08fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1277aff6-c0bc-4441-a7c4-b62fd092b7d2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bc2f58a3-e88f-40da-9a66-a6cbeed08fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4a78b2d1-6822-4ac8-a019-dd4e7299dcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bc2f58a3-e88f-40da-9a66-a6cbeed08fff" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4a78b2d1-6822-4ac8-a019-dd4e7299dcab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9a52574b-466a-4860-9cc9-58546c11dc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9a52574b-466a-4860-9cc9-58546c11dc6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9a52574b-466a-4860-9cc9-58546c11dc6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9a52574b-466a-4860-9cc9-58546c11dc6b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9a52574b-466a-4860-9cc9-58546c11dc6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d7c62d29-b429-49fc-994f-50fa3bd9ecc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9a52574b-466a-4860-9cc9-58546c11dc6b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d7c62d29-b429-49fc-994f-50fa3bd9ecc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_47aab1f0-e6cc-45e8-9f77-1d1b2ae6dd51" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d7c62d29-b429-49fc-994f-50fa3bd9ecc7" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_47aab1f0-e6cc-45e8-9f77-1d1b2ae6dd51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_8abae1f3-3257-439b-aba3-8cfb3d2bbf4f" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d7c62d29-b429-49fc-994f-50fa3bd9ecc7" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_8abae1f3-3257-439b-aba3-8cfb3d2bbf4f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="i8f46ebf98e924c5ab88a921400bba96e_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4cc09742-c5d8-4e75-9bd6-92cc417b44e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4d10d465-bd8f-4984-97e6-def9400c1238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4cc09742-c5d8-4e75-9bd6-92cc417b44e5" xlink:to="loc_us-gaap_LongTermDebt_4d10d465-bd8f-4984-97e6-def9400c1238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_20cb40a2-4d0f-4474-9971-59cdb5856534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4cc09742-c5d8-4e75-9bd6-92cc417b44e5" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_20cb40a2-4d0f-4474-9971-59cdb5856534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4cc09742-c5d8-4e75-9bd6-92cc417b44e5" xlink:to="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13aa4c05-8dba-4157-b64e-1665500399cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_DebtInstrumentAxis_13aa4c05-8dba-4157-b64e-1665500399cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_13aa4c05-8dba-4157-b64e-1665500399cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_13aa4c05-8dba-4157-b64e-1665500399cd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_13aa4c05-8dba-4157-b64e-1665500399cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7ff91513-5260-4fba-a4d6-04fbb75d8886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_13aa4c05-8dba-4157-b64e-1665500399cd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7ff91513-5260-4fba-a4d6-04fbb75d8886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_d44e662a-6967-47dd-b51e-6ce09ed38de0" xlink:href="mck-20220630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7ff91513-5260-4fba-a4d6-04fbb75d8886" xlink:to="loc_mck_EuroDenominatedNotesMember_d44e662a-6967-47dd-b51e-6ce09ed38de0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_36a85450-46ca-4f5c-bacc-075ae87a9d44" xlink:href="mck-20220630.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7ff91513-5260-4fba-a4d6-04fbb75d8886" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_36a85450-46ca-4f5c-bacc-075ae87a9d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_174275af-d1b2-457f-bd46-dbd057c8e7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_174275af-d1b2-457f-bd46-dbd057c8e7c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_174275af-d1b2-457f-bd46-dbd057c8e7c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_174275af-d1b2-457f-bd46-dbd057c8e7c5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_174275af-d1b2-457f-bd46-dbd057c8e7c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e0d58839-c5e8-4f08-80be-b3d8ff32910a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_174275af-d1b2-457f-bd46-dbd057c8e7c5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e0d58839-c5e8-4f08-80be-b3d8ff32910a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_7bb5d36e-7840-4dcb-8e56-e0f0aea85e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e0d58839-c5e8-4f08-80be-b3d8ff32910a" xlink:to="loc_us-gaap_LoansPayableMember_7bb5d36e-7840-4dcb-8e56-e0f0aea85e98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_38f567e1-db80-4f48-ab27-5569543e58ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_38f567e1-db80-4f48-ab27-5569543e58ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_38f567e1-db80-4f48-ab27-5569543e58ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_38f567e1-db80-4f48-ab27-5569543e58ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_38f567e1-db80-4f48-ab27-5569543e58ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_991e7f1e-a9fb-4d92-ac9f-d0fc6826cc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_38f567e1-db80-4f48-ab27-5569543e58ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_991e7f1e-a9fb-4d92-ac9f-d0fc6826cc1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d7699698-58a8-4190-ba53-e36a8f190c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_991e7f1e-a9fb-4d92-ac9f-d0fc6826cc1e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d7699698-58a8-4190-ba53-e36a8f190c8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a1f82369-2394-4e10-86d1-e525346654f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a1f82369-2394-4e10-86d1-e525346654f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a1f82369-2394-4e10-86d1-e525346654f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a1f82369-2394-4e10-86d1-e525346654f0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a1f82369-2394-4e10-86d1-e525346654f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_109e14e1-5fd3-4118-818f-37548113f715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a1f82369-2394-4e10-86d1-e525346654f0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_109e14e1-5fd3-4118-818f-37548113f715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6586cd9d-00bf-465f-8982-f6a86ed39c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_109e14e1-5fd3-4118-818f-37548113f715" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6586cd9d-00bf-465f-8982-f6a86ed39c01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91466863-9b51-48ca-8be2-00c1c62be25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91466863-9b51-48ca-8be2-00c1c62be25b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_91466863-9b51-48ca-8be2-00c1c62be25b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91466863-9b51-48ca-8be2-00c1c62be25b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_91466863-9b51-48ca-8be2-00c1c62be25b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b0e50b1-4f61-4be8-91f8-ccbe185bd327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91466863-9b51-48ca-8be2-00c1c62be25b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b0e50b1-4f61-4be8-91f8-ccbe185bd327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_5b9b139d-4787-4c34-8bad-5b6203679aee" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b0e50b1-4f61-4be8-91f8-ccbe185bd327" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_5b9b139d-4787-4c34-8bad-5b6203679aee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="extended" id="i74113bd5d0564c6fa7265e5e48de54e9_HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_19701731-17be-44b2-b837-a1e1ea4b24c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_b79e05bd-ff71-4839-b95b-421a684c0528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_19701731-17be-44b2-b837-a1e1ea4b24c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_b79e05bd-ff71-4839-b95b-421a684c0528" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_19701731-17be-44b2-b837-a1e1ea4b24c4" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6845cbac-f9b7-4711-a327-dbbc3e2dd87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:to="loc_us-gaap_HedgingDesignationAxis_6845cbac-f9b7-4711-a327-dbbc3e2dd87a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6845cbac-f9b7-4711-a327-dbbc3e2dd87a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_6845cbac-f9b7-4711-a327-dbbc3e2dd87a" xlink:to="loc_us-gaap_HedgingDesignationDomain_6845cbac-f9b7-4711-a327-dbbc3e2dd87a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_df19ea34-e472-4725-9831-c11781d200d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_6845cbac-f9b7-4711-a327-dbbc3e2dd87a" xlink:to="loc_us-gaap_HedgingDesignationDomain_df19ea34-e472-4725-9831-c11781d200d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e1d3cb74-421e-41f7-9ae0-e00e89705b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_df19ea34-e472-4725-9831-c11781d200d9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e1d3cb74-421e-41f7-9ae0-e00e89705b38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_166a74d3-b51b-4aa5-8642-5592a0deae06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_166a74d3-b51b-4aa5-8642-5592a0deae06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_166a74d3-b51b-4aa5-8642-5592a0deae06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_166a74d3-b51b-4aa5-8642-5592a0deae06" xlink:to="loc_us-gaap_HedgingRelationshipDomain_166a74d3-b51b-4aa5-8642-5592a0deae06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6a7cabe2-9d6c-4a23-9c3d-22af5b67fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_166a74d3-b51b-4aa5-8642-5592a0deae06" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6a7cabe2-9d6c-4a23-9c3d-22af5b67fd36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_94235be8-8ffb-438a-bfaa-941442cbcedd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6a7cabe2-9d6c-4a23-9c3d-22af5b67fd36" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_94235be8-8ffb-438a-bfaa-941442cbcedd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3df0d972-d41d-47b2-8123-8e3c8ebc276d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:to="loc_us-gaap_DebtInstrumentAxis_3df0d972-d41d-47b2-8123-8e3c8ebc276d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3df0d972-d41d-47b2-8123-8e3c8ebc276d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3df0d972-d41d-47b2-8123-8e3c8ebc276d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3df0d972-d41d-47b2-8123-8e3c8ebc276d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9ceb8fda-633e-4cb8-8426-bbe0e9b4e990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3df0d972-d41d-47b2-8123-8e3c8ebc276d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9ceb8fda-633e-4cb8-8426-bbe0e9b4e990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_a5392c3d-bf6c-45ab-8be2-b4373b61e354" xlink:href="mck-20220630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9ceb8fda-633e-4cb8-8426-bbe0e9b4e990" xlink:to="loc_mck_EuroDenominatedNotesMember_a5392c3d-bf6c-45ab-8be2-b4373b61e354" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="extended" id="i3ac9308789864ec99afd8360c3bdc54d_HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_44c3447c-61af-4fc9-a727-fd76fe416c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_bdc4ecb0-8bb1-45a0-9368-f1d193298d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_44c3447c-61af-4fc9-a727-fd76fe416c0c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_bdc4ecb0-8bb1-45a0-9368-f1d193298d0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_44c3447c-61af-4fc9-a727-fd76fe416c0c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8d8c3e83-506a-4757-bee5-5b18963f36dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_HedgingDesignationAxis_8d8c3e83-506a-4757-bee5-5b18963f36dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8d8c3e83-506a-4757-bee5-5b18963f36dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_8d8c3e83-506a-4757-bee5-5b18963f36dc" xlink:to="loc_us-gaap_HedgingDesignationDomain_8d8c3e83-506a-4757-bee5-5b18963f36dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2ca91f99-bd19-4d82-8608-e53e402b9a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_8d8c3e83-506a-4757-bee5-5b18963f36dc" xlink:to="loc_us-gaap_HedgingDesignationDomain_2ca91f99-bd19-4d82-8608-e53e402b9a9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_02be6f53-bd32-49ac-86df-fd4feeb66624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2ca91f99-bd19-4d82-8608-e53e402b9a9f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_02be6f53-bd32-49ac-86df-fd4feeb66624" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9e387d0a-05c0-4c83-b31e-71543ccdb16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9e387d0a-05c0-4c83-b31e-71543ccdb16d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9e387d0a-05c0-4c83-b31e-71543ccdb16d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9e387d0a-05c0-4c83-b31e-71543ccdb16d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9e387d0a-05c0-4c83-b31e-71543ccdb16d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9e387d0a-05c0-4c83-b31e-71543ccdb16d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_42d7d7c0-ec9e-40f9-aa27-5db914cb39dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:to="loc_us-gaap_CurrencySwapMember_42d7d7c0-ec9e-40f9-aa27-5db914cb39dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0b9c6af6-1648-4e84-b165-4bcc97b5796f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:to="loc_us-gaap_InterestRateSwapMember_0b9c6af6-1648-4e84-b165-4bcc97b5796f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_b70ab813-37d5-48e7-8961-ef85b4615dea" xlink:href="mck-20220630.xsd#mck_FixedInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:to="loc_mck_FixedInterestRateSwapMember_b70ab813-37d5-48e7-8961-ef85b4615dea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_efd85e43-a442-46e3-a112-c7c9d34b5c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_efd85e43-a442-46e3-a112-c7c9d34b5c09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_efd85e43-a442-46e3-a112-c7c9d34b5c09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_efd85e43-a442-46e3-a112-c7c9d34b5c09" xlink:to="loc_us-gaap_HedgingRelationshipDomain_efd85e43-a442-46e3-a112-c7c9d34b5c09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_efd85e43-a442-46e3-a112-c7c9d34b5c09" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_533205bb-3809-44da-bb8a-a1c5b053a726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_533205bb-3809-44da-bb8a-a1c5b053a726" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_61172587-9d1b-4786-8ec7-b72471669d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:to="loc_us-gaap_CashFlowHedgingMember_61172587-9d1b-4786-8ec7-b72471669d4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_705b87bb-fae8-45e7-a13d-eed07e624a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:to="loc_us-gaap_FairValueHedgingMember_705b87bb-fae8-45e7-a13d-eed07e624a79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3528c4f8-67d8-4d3b-84a5-5580babf9d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_DebtInstrumentAxis_3528c4f8-67d8-4d3b-84a5-5580babf9d8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3528c4f8-67d8-4d3b-84a5-5580babf9d8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3528c4f8-67d8-4d3b-84a5-5580babf9d8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3528c4f8-67d8-4d3b-84a5-5580babf9d8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c3c71b49-1038-4cf3-a440-1e9814565fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3528c4f8-67d8-4d3b-84a5-5580babf9d8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c3c71b49-1038-4cf3-a440-1e9814565fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_8e5db68e-3d3a-47b8-a753-e19cf4978444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c3c71b49-1038-4cf3-a440-1e9814565fa3" xlink:to="loc_us-gaap_CurrencySwapMember_8e5db68e-3d3a-47b8-a753-e19cf4978444" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_srt_CurrencyAxis_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d" xlink:to="loc_currency_AllCurrenciesDomain_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d" xlink:to="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_cc27e999-14ac-45a6-8ff8-2af4531bd50d" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:to="loc_currency_CAD_cc27e999-14ac-45a6-8ff8-2af4531bd50d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_51be720e-3699-4ae7-a4be-16d2ea5f782a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:to="loc_currency_GBP_51be720e-3699-4ae7-a4be-16d2ea5f782a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_71e4f861-0478-47f8-a485-e7cf1c0fbe84" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:to="loc_currency_USD_71e4f861-0478-47f8-a485-e7cf1c0fbe84" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="extended" id="ib668434cb5ec4faca8d9a7c880a58286_HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_fb245ab8-6573-4cdd-944b-cce51e38ae71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_0319d4b8-1b0f-46cf-aa0a-73d42fa9f5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fb245ab8-6573-4cdd-944b-cce51e38ae71" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_0319d4b8-1b0f-46cf-aa0a-73d42fa9f5bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_53e98e44-1e10-407a-83d8-4b4936d0716c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fb245ab8-6573-4cdd-944b-cce51e38ae71" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_53e98e44-1e10-407a-83d8-4b4936d0716c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fb245ab8-6573-4cdd-944b-cce51e38ae71" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f098b5f7-50d7-4538-8629-5d320b7d4779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:to="loc_us-gaap_HedgingDesignationAxis_f098b5f7-50d7-4538-8629-5d320b7d4779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f098b5f7-50d7-4538-8629-5d320b7d4779_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f098b5f7-50d7-4538-8629-5d320b7d4779" xlink:to="loc_us-gaap_HedgingDesignationDomain_f098b5f7-50d7-4538-8629-5d320b7d4779_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7726a809-955a-4a0e-9458-7172294f2c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f098b5f7-50d7-4538-8629-5d320b7d4779" xlink:to="loc_us-gaap_HedgingDesignationDomain_7726a809-955a-4a0e-9458-7172294f2c64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8734855f-03b8-4dc9-b74d-12d15ddc8a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_7726a809-955a-4a0e-9458-7172294f2c64" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8734855f-03b8-4dc9-b74d-12d15ddc8a9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_04bf9249-489a-43b1-90fb-cfc60f52f712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_04bf9249-489a-43b1-90fb-cfc60f52f712" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_04bf9249-489a-43b1-90fb-cfc60f52f712_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_04bf9249-489a-43b1-90fb-cfc60f52f712" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_04bf9249-489a-43b1-90fb-cfc60f52f712_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_862c37ae-cd77-4256-9f2d-a42e944de87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_04bf9249-489a-43b1-90fb-cfc60f52f712" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_862c37ae-cd77-4256-9f2d-a42e944de87c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_6833bcb9-bc42-4839-8af2-3a72a36683aa" xlink:href="mck-20220630.xsd#mck_FixedInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_862c37ae-cd77-4256-9f2d-a42e944de87c" xlink:to="loc_mck_FixedInterestRateSwapMember_6833bcb9-bc42-4839-8af2-3a72a36683aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_c140640e-8715-4132-abab-f9dceaaffdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_862c37ae-cd77-4256-9f2d-a42e944de87c" xlink:to="loc_us-gaap_CurrencySwapMember_c140640e-8715-4132-abab-f9dceaaffdc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2597dcf-d711-46a0-acf7-90408ea9e55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2597dcf-d711-46a0-acf7-90408ea9e55b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d2597dcf-d711-46a0-acf7-90408ea9e55b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2597dcf-d711-46a0-acf7-90408ea9e55b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d2597dcf-d711-46a0-acf7-90408ea9e55b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_21b00304-6056-4f37-af7d-7b3cb406d32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2597dcf-d711-46a0-acf7-90408ea9e55b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_21b00304-6056-4f37-af7d-7b3cb406d32d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_e396ee0d-8d0a-4dc0-9036-97e5016c4b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_21b00304-6056-4f37-af7d-7b3cb406d32d" xlink:to="loc_us-gaap_CurrencySwapMember_e396ee0d-8d0a-4dc0-9036-97e5016c4b2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c06f2a23-1de1-4b6f-a658-7eac02e2666d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_21b00304-6056-4f37-af7d-7b3cb406d32d" xlink:to="loc_us-gaap_CashFlowHedgingMember_c06f2a23-1de1-4b6f-a658-7eac02e2666d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesScheduleofFairValueofDerivativesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails" xlink:type="extended" id="i035bcf4aa83a414ba18c85210048d259_HedgingActivitiesScheduleofFairValueofDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ec55dffe-9151-46ac-b1c7-29be72deba04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ec55dffe-9151-46ac-b1c7-29be72deba04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a3497875-1e1c-4a68-b98b-01eb09da5213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a3497875-1e1c-4a68-b98b-01eb09da5213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_81683484-6853-4455-9700-be5efcbaff98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_81683484-6853-4455-9700-be5efcbaff98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_1b0417b5-237b-4b66-be89-6c689545592a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_1b0417b5-237b-4b66-be89-6c689545592a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7bb6c948-34cc-4156-ace2-3ce609b621b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:to="loc_us-gaap_HedgingDesignationAxis_7bb6c948-34cc-4156-ace2-3ce609b621b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7bb6c948-34cc-4156-ace2-3ce609b621b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7bb6c948-34cc-4156-ace2-3ce609b621b6" xlink:to="loc_us-gaap_HedgingDesignationDomain_7bb6c948-34cc-4156-ace2-3ce609b621b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bfd81c8d-6a05-4ef4-9cea-90dab177106b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7bb6c948-34cc-4156-ace2-3ce609b621b6" xlink:to="loc_us-gaap_HedgingDesignationDomain_bfd81c8d-6a05-4ef4-9cea-90dab177106b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9a2ab3f2-d06f-4d63-b3e8-b541eec7f456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_bfd81c8d-6a05-4ef4-9cea-90dab177106b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9a2ab3f2-d06f-4d63-b3e8-b541eec7f456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bb5abfd1-5c05-4541-89b6-4b643ca5588f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bb5abfd1-5c05-4541-89b6-4b643ca5588f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bb5abfd1-5c05-4541-89b6-4b643ca5588f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bb5abfd1-5c05-4541-89b6-4b643ca5588f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bb5abfd1-5c05-4541-89b6-4b643ca5588f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_352e5e87-d4f5-4c64-976a-477f2c3867e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bb5abfd1-5c05-4541-89b6-4b643ca5588f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_352e5e87-d4f5-4c64-976a-477f2c3867e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_cfaaa0df-f67d-484f-bcdf-06d9ea933d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_352e5e87-d4f5-4c64-976a-477f2c3867e8" xlink:to="loc_us-gaap_CurrencySwapMember_cfaaa0df-f67d-484f-bcdf-06d9ea933d57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0e5a8242-240d-4602-8cef-a300b2e6addb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_352e5e87-d4f5-4c64-976a-477f2c3867e8" xlink:to="loc_us-gaap_InterestRateSwapMember_0e5a8242-240d-4602-8cef-a300b2e6addb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_f898af05-54b6-43be-a3aa-5050baa1683c" xlink:href="mck-20220630.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:to="loc_mck_CurrentAssetLiabilityMember_f898af05-54b6-43be-a3aa-5050baa1683c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentLiabilitiesMember_1d500606-ac2a-4fd4-b9f3-c76a859e8557" xlink:href="mck-20220630.xsd#mck_OtherNonCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:to="loc_mck_OtherNonCurrentLiabilitiesMember_1d500606-ac2a-4fd4-b9f3-c76a859e8557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember_642d0b71-4714-4e15-b358-0af93afcf585" xlink:href="mck-20220630.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:to="loc_mck_PrepaidExpensesAndOtherMember_642d0b71-4714-4e15-b358-0af93afcf585" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsMember_359266cc-b403-4f1e-867e-371acc02540d" xlink:href="mck-20220630.xsd#mck_OtherNonCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:to="loc_mck_OtherNonCurrentAssetsMember_359266cc-b403-4f1e-867e-371acc02540d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="ic8434d5795794996990a83a8ee15a286_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7a8652be-44e9-4554-9657-a6645b8a4633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_321aeac9-8f71-498a-a64a-da21496d5703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7a8652be-44e9-4554-9657-a6645b8a4633" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_321aeac9-8f71-498a-a64a-da21496d5703" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_7d92ab3e-f160-4b77-b491-95c1df6d1a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7a8652be-44e9-4554-9657-a6645b8a4633" xlink:to="loc_us-gaap_RestrictedCash_7d92ab3e-f160-4b77-b491-95c1df6d1a9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7a8652be-44e9-4554-9657-a6645b8a4633" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a546ca0-4850-43a7-9e69-a19e844fab47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a546ca0-4850-43a7-9e69-a19e844fab47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a546ca0-4850-43a7-9e69-a19e844fab47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a546ca0-4850-43a7-9e69-a19e844fab47" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a546ca0-4850-43a7-9e69-a19e844fab47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbef6e74-331c-49a8-a129-ee0a9f5c136b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a546ca0-4850-43a7-9e69-a19e844fab47" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbef6e74-331c-49a8-a129-ee0a9f5c136b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_01a5733b-5c37-4da1-8c08-2971a9949670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbef6e74-331c-49a8-a129-ee0a9f5c136b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_01a5733b-5c37-4da1-8c08-2971a9949670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40968281-f3cb-4706-80e7-1917f5981707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40968281-f3cb-4706-80e7-1917f5981707" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_40968281-f3cb-4706-80e7-1917f5981707_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40968281-f3cb-4706-80e7-1917f5981707" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_40968281-f3cb-4706-80e7-1917f5981707_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_851cb86e-0c8c-4b5c-83cd-ea322f1c347c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40968281-f3cb-4706-80e7-1917f5981707" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_851cb86e-0c8c-4b5c-83cd-ea322f1c347c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_faa231fb-78ac-41b9-99a7-63b210a9e717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_851cb86e-0c8c-4b5c-83cd-ea322f1c347c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_faa231fb-78ac-41b9-99a7-63b210a9e717" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b1b7a3ef-8229-4f43-849a-77a3949a2115" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:to="loc_srt_LitigationCaseAxis_b1b7a3ef-8229-4f43-849a-77a3949a2115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b1b7a3ef-8229-4f43-849a-77a3949a2115_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_b1b7a3ef-8229-4f43-849a-77a3949a2115" xlink:to="loc_srt_LitigationCaseTypeDomain_b1b7a3ef-8229-4f43-849a-77a3949a2115_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_17961f88-0f6b-49dc-9d22-d2ebb5ddd828" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_b1b7a3ef-8229-4f43-849a-77a3949a2115" xlink:to="loc_srt_LitigationCaseTypeDomain_17961f88-0f6b-49dc-9d22-d2ebb5ddd828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_a9cf4031-8427-4647-bb62-100fdbd50c20" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_17961f88-0f6b-49dc-9d22-d2ebb5ddd828" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_a9cf4031-8427-4647-bb62-100fdbd50c20" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="extended" id="i257acb3538c949c1b456b6b6a28a984c_FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f46d10e6-905e-42c4-bb55-967ed8bb574b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_53b2a4ae-950f-4f92-8101-23de25171a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f46d10e6-905e-42c4-bb55-967ed8bb574b" xlink:to="loc_us-gaap_LongTermDebt_53b2a4ae-950f-4f92-8101-23de25171a91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_c19c476c-d99e-4fc9-bb36-f340a4b04525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f46d10e6-905e-42c4-bb55-967ed8bb574b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_c19c476c-d99e-4fc9-bb36-f340a4b04525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f46d10e6-905e-42c4-bb55-967ed8bb574b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6d403526-c269-45e0-87fe-befdf6b42181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6d403526-c269-45e0-87fe-befdf6b42181" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6d403526-c269-45e0-87fe-befdf6b42181_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6d403526-c269-45e0-87fe-befdf6b42181" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6d403526-c269-45e0-87fe-befdf6b42181_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d6dee6e9-b12c-407a-a430-ef316e60fa33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6d403526-c269-45e0-87fe-befdf6b42181" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d6dee6e9-b12c-407a-a430-ef316e60fa33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a4cae162-8304-44a7-986a-18e67c9ed9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d6dee6e9-b12c-407a-a430-ef316e60fa33" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a4cae162-8304-44a7-986a-18e67c9ed9f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1516c642-0688-485f-9999-212cea7c84de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1516c642-0688-485f-9999-212cea7c84de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1516c642-0688-485f-9999-212cea7c84de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1516c642-0688-485f-9999-212cea7c84de" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1516c642-0688-485f-9999-212cea7c84de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_652fb4bd-ad89-4b77-8de5-ebb58c8adf87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1516c642-0688-485f-9999-212cea7c84de" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_652fb4bd-ad89-4b77-8de5-ebb58c8adf87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3006a09a-63af-4a81-9938-94904beba608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_652fb4bd-ad89-4b77-8de5-ebb58c8adf87" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3006a09a-63af-4a81-9938-94904beba608" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended" id="ie4120978ef984c178c175c863d2700dc_CommitmentsandContingentLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_31c6eb31-e131-4980-9898-72781bce4823" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_31c6eb31-e131-4980-9898-72781bce4823" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_ccfd8022-4f58-4629-9f6b-dcdf3eacc0b9" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberofStates_ccfd8022-4f58-4629-9f6b-dcdf3eacc0b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates_6ae6631c-b5c5-4f45-8140-e8265618326d" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberOfEligibleStates_6ae6631c-b5c5-4f45-8140-e8265618326d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_29aa5e4a-22ce-49ba-abcd-512c2c218aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_29aa5e4a-22ce-49ba-abcd-512c2c218aa9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_3e402dac-dca8-461f-bd00-e79b271f9449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_3e402dac-dca8-461f-bd00-e79b271f9449" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_a342775b-38ce-4ec3-b375-3ed75200f3fd" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_a342775b-38ce-4ec3-b375-3ed75200f3fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_0bf2cb1e-9b03-48f7-b0f4-382a49d1ae8d" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_0bf2cb1e-9b03-48f7-b0f4-382a49d1ae8d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8626a1a7-4f44-4dc6-8212-3bb3d6bb9762" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8626a1a7-4f44-4dc6-8212-3bb3d6bb9762" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_f486d311-7cc2-4dec-b7e0-5c86ada6d227" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_f486d311-7cc2-4dec-b7e0-5c86ada6d227" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_80ed3c1d-aced-4aee-8571-8a8fed05c484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LitigationSettlementExpense_80ed3c1d-aced-4aee-8571-8a8fed05c484" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_7d452079-bdd5-4867-ad19-27d87f992a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_7d452079-bdd5-4867-ad19-27d87f992a4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_a861966c-1ec3-4636-9512-ba953c8b1287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_a861966c-1ec3-4636-9512-ba953c8b1287" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_34fa5663-2a96-4040-9dbe-daaa7fec32fb" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_34fa5663-2a96-4040-9dbe-daaa7fec32fb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_5427e309-ac57-4f66-9de2-3cd00c554b6a" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_5427e309-ac57-4f66-9de2-3cd00c554b6a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_d66fe125-816f-42c3-ba26-fce866ff718c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_EscrowDeposit_d66fe125-816f-42c3-ba26-fce866ff718c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_f14c994f-d380-49c4-8b61-03482fe53a30" xlink:href="mck-20220630.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_f14c994f-d380-49c4-8b61-03482fe53a30" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_4e2b3269-dc45-4777-ada2-8abce305350d" xlink:href="mck-20220630.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_4e2b3269-dc45-4777-ada2-8abce305350d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_b9de8f92-7ec2-46dd-820e-f35aeba7645d" xlink:href="mck-20220630.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_b9de8f92-7ec2-46dd-820e-f35aeba7645d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_927f7c62-6e98-43f1-951e-58ad7dca75c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_927f7c62-6e98-43f1-951e-58ad7dca75c4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_5b44d97e-a13a-40a2-915f-d0c2c9b3e48d" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_5b44d97e-a13a-40a2-915f-d0c2c9b3e48d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_833759f6-1816-4c0c-986c-b075a3f9d356" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_833759f6-1816-4c0c-986c-b075a3f9d356" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_716b69da-2ac7-4dfc-b746-c51de3cbff6a" xlink:href="mck-20220630.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_716b69da-2ac7-4dfc-b746-c51de3cbff6a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_145b72fa-cf18-4d42-b0e9-5a0a381f542f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_145b72fa-cf18-4d42-b0e9-5a0a381f542f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax_2e365b78-db83-4313-b47c-85f4db369d91" xlink:href="mck-20220630.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyAccrualProvisionAfterTax_2e365b78-db83-4313-b47c-85f4db369d91" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_9347516f-1c47-4572-ba6d-e65a1d2afa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_9347516f-1c47-4572-ba6d-e65a1d2afa4d" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_30dfc9f1-7e53-4005-a632-10bdcc238693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_us-gaap_LitigationStatusAxis_30dfc9f1-7e53-4005-a632-10bdcc238693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_30dfc9f1-7e53-4005-a632-10bdcc238693_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_30dfc9f1-7e53-4005-a632-10bdcc238693" xlink:to="loc_us-gaap_LitigationStatusDomain_30dfc9f1-7e53-4005-a632-10bdcc238693_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c622ac9e-7f46-4c7d-a289-ab61ee0ad317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_30dfc9f1-7e53-4005-a632-10bdcc238693" xlink:to="loc_us-gaap_LitigationStatusDomain_c622ac9e-7f46-4c7d-a289-ab61ee0ad317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_fdcbdda6-6f96-47c5-b497-d4d322ce1849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_c622ac9e-7f46-4c7d-a289-ab61ee0ad317" xlink:to="loc_us-gaap_PendingLitigationMember_fdcbdda6-6f96-47c5-b497-d4d322ce1849" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_6aef9acf-bce2-4e92-ba45-e6130064fd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_c622ac9e-7f46-4c7d-a289-ab61ee0ad317" xlink:to="loc_us-gaap_SettledLitigationMember_6aef9acf-bce2-4e92-ba45-e6130064fd5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_13ffc664-8d0e-4ec5-a5d2-5ca92770a674" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_dei_LegalEntityAxis_13ffc664-8d0e-4ec5-a5d2-5ca92770a674" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_13ffc664-8d0e-4ec5-a5d2-5ca92770a674_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_13ffc664-8d0e-4ec5-a5d2-5ca92770a674" xlink:to="loc_dei_EntityDomain_13ffc664-8d0e-4ec5-a5d2-5ca92770a674_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_13ffc664-8d0e-4ec5-a5d2-5ca92770a674" xlink:to="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_7e979ec1-3c3c-415b-a6b4-f530c10912b3" xlink:href="mck-20220630.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_7e979ec1-3c3c-415b-a6b4-f530c10912b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_0f8dc73b-8f9a-4019-9151-3f828a366365" xlink:href="mck-20220630.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_0f8dc73b-8f9a-4019-9151-3f828a366365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember_d9ebc89f-3d1f-41a0-9e9c-bd19efebc9e2" xlink:href="mck-20220630.xsd#mck_DistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:to="loc_mck_DistributorsMember_d9ebc89f-3d1f-41a0-9e9c-bd19efebc9e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_14ed2592-8dd0-4cd3-b889-2bcc58ee5953" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_srt_StatementGeographicalAxis_14ed2592-8dd0-4cd3-b889-2bcc58ee5953" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_14ed2592-8dd0-4cd3-b889-2bcc58ee5953_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_14ed2592-8dd0-4cd3-b889-2bcc58ee5953" xlink:to="loc_srt_SegmentGeographicalDomain_14ed2592-8dd0-4cd3-b889-2bcc58ee5953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bfc597e4-9ffa-4f70-b6ed-a54b8f7b476f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_14ed2592-8dd0-4cd3-b889-2bcc58ee5953" xlink:to="loc_srt_SegmentGeographicalDomain_bfc597e4-9ffa-4f70-b6ed-a54b8f7b476f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_2c2a50e4-efb7-4aeb-b7bb-767182411e68" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bfc597e4-9ffa-4f70-b6ed-a54b8f7b476f" xlink:to="loc_country_CA_2c2a50e4-efb7-4aeb-b7bb-767182411e68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_771bad60-d831-4741-b8f0-511971de063a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_srt_LitigationCaseAxis_771bad60-d831-4741-b8f0-511971de063a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_771bad60-d831-4741-b8f0-511971de063a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_771bad60-d831-4741-b8f0-511971de063a" xlink:to="loc_srt_LitigationCaseTypeDomain_771bad60-d831-4741-b8f0-511971de063a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_771bad60-d831-4741-b8f0-511971de063a" xlink:to="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_6f2299b1-e9fd-47d2-b1b5-18fa26f8e82e" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_6f2299b1-e9fd-47d2-b1b5-18fa26f8e82e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_c716b7a4-2dff-4787-8899-041b0e79cbf5" xlink:href="mck-20220630.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_c716b7a4-2dff-4787-8899-041b0e79cbf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_2b0ab41f-eb06-40b6-8d6a-a7fc5bfe9e79" xlink:href="mck-20220630.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:to="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_2b0ab41f-eb06-40b6-8d6a-a7fc5bfe9e79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_9f01b9a9-d544-4350-914e-ca2d01984913" xlink:href="mck-20220630.xsd#mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:to="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_9f01b9a9-d544-4350-914e-ca2d01984913" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c0e6ddc-69ca-4861-b9d3-80dbabaece65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c0e6ddc-69ca-4861-b9d3-80dbabaece65" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_3c0e6ddc-69ca-4861-b9d3-80dbabaece65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c0e6ddc-69ca-4861-b9d3-80dbabaece65" xlink:to="loc_us-gaap_LossContingencyNatureDomain_3c0e6ddc-69ca-4861-b9d3-80dbabaece65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d9589602-7092-4827-a722-246d56101cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c0e6ddc-69ca-4861-b9d3-80dbabaece65" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d9589602-7092-4827-a722-246d56101cbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_bf1f5f76-f753-4b73-9625-f59cc627cc72" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_d9589602-7092-4827-a722-246d56101cbd" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_bf1f5f76-f753-4b73-9625-f59cc627cc72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActStateOfNewYorkMember_ae36c7cb-92a7-4800-beba-5c0552cd1a9b" xlink:href="mck-20220630.xsd#mck_OpioidStewardshipActStateOfNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_d9589602-7092-4827-a722-246d56101cbd" xlink:to="loc_mck_OpioidStewardshipActStateOfNewYorkMember_ae36c7cb-92a7-4800-beba-5c0552cd1a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8ada517f-13d1-4776-b69e-6aba122e53fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_srt_CounterpartyNameAxis_8ada517f-13d1-4776-b69e-6aba122e53fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8ada517f-13d1-4776-b69e-6aba122e53fe_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_8ada517f-13d1-4776-b69e-6aba122e53fe" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8ada517f-13d1-4776-b69e-6aba122e53fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_8ada517f-13d1-4776-b69e-6aba122e53fe" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_0124e9e6-df49-4a86-885a-419f7a45b2ce" xlink:href="mck-20220630.xsd#mck_CherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_CherokeeNationMember_0124e9e6-df49-4a86-885a-419f7a45b2ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_430b20eb-09fb-4566-89be-71628056f9ab" xlink:href="mck-20220630.xsd#mck_GovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_GovernmentalEntitiesMember_430b20eb-09fb-4566-89be-71628056f9ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_ca90507d-577b-47cd-933a-95cfe6d2fa9a" xlink:href="mck-20220630.xsd#mck_IndividualClaimantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_IndividualClaimantMember_ca90507d-577b-47cd-933a-95cfe6d2fa9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_2df310e9-056d-42f2-9853-6e4e94cd9629" xlink:href="mck-20220630.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_2df310e9-056d-42f2-9853-6e4e94cd9629" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember_bf179780-2df9-4c51-84c7-e22be5dcc9e8" xlink:href="mck-20220630.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_StateOfAlabamaAndSubdivisionsMember_bf179780-2df9-4c51-84c7-e22be5dcc9e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember_b46a8f50-d8ef-43c5-81eb-633d59f1a99e" xlink:href="mck-20220630.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_StateOfWashingtonAndSubdivisionsMember_b46a8f50-d8ef-43c5-81eb-633d59f1a99e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOklahomaAndSubdivisionsMember_f6fb6030-124a-4c30-a2bf-368c60c0cad9" xlink:href="mck-20220630.xsd#mck_StateOfOklahomaAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_StateOfOklahomaAndSubdivisionsMember_f6fb6030-124a-4c30-a2bf-368c60c0cad9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember_06666c7b-71f2-479a-9b8f-40d3d09b83ce" xlink:href="mck-20220630.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_SettlingGovernmentalEntitiesMember_06666c7b-71f2-479a-9b8f-40d3d09b83ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember_6ab7014b-b94e-437a-95c8-4dd372bf75b9" xlink:href="mck-20220630.xsd#mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember_6ab7014b-b94e-437a-95c8-4dd372bf75b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_b75e553d-727d-4a44-b65d-29fdf53538a5" xlink:href="mck-20220630.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_b75e553d-727d-4a44-b65d-29fdf53538a5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_151e75bc-040b-477f-b150-dc405c30dd43" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_srt_RangeAxis_151e75bc-040b-477f-b150-dc405c30dd43" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_151e75bc-040b-477f-b150-dc405c30dd43_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_151e75bc-040b-477f-b150-dc405c30dd43" xlink:to="loc_srt_RangeMember_151e75bc-040b-477f-b150-dc405c30dd43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c567db66-8a88-4f6a-99e3-f65cccbd7846" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_151e75bc-040b-477f-b150-dc405c30dd43" xlink:to="loc_srt_RangeMember_c567db66-8a88-4f6a-99e3-f65cccbd7846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_835eeaf2-6311-4de0-be05-21cf4b7890b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c567db66-8a88-4f6a-99e3-f65cccbd7846" xlink:to="loc_srt_MinimumMember_835eeaf2-6311-4de0-be05-21cf4b7890b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9f387f4d-7796-491b-9e8e-d79b871983ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c567db66-8a88-4f6a-99e3-f65cccbd7846" xlink:to="loc_srt_MaximumMember_9f387f4d-7796-491b-9e8e-d79b871983ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_30fffb92-2700-48ec-8af1-baec0c2f150e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_30fffb92-2700-48ec-8af1-baec0c2f150e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_30fffb92-2700-48ec-8af1-baec0c2f150e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_30fffb92-2700-48ec-8af1-baec0c2f150e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_30fffb92-2700-48ec-8af1-baec0c2f150e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5416a4bb-3545-43ef-8b94-c02d1ab1b571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_30fffb92-2700-48ec-8af1-baec0c2f150e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5416a4bb-3545-43ef-8b94-c02d1ab1b571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ea53dd10-2744-4a0f-af0c-19160b927666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5416a4bb-3545-43ef-8b94-c02d1ab1b571" xlink:to="loc_us-gaap_SubsequentEventMember_ea53dd10-2744-4a0f-af0c-19160b927666" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended" id="iae1021c603704e5ab49ea00d744e8174_CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_6939e3bb-c393-404d-b358-7466ee7ff933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_6939e3bb-c393-404d-b358-7466ee7ff933" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_e7d8257b-7ffe-4c17-86d7-4efe82223019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_e7d8257b-7ffe-4c17-86d7-4efe82223019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_857cf613-aef5-4128-965d-bb3e1ccc6213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_857cf613-aef5-4128-965d-bb3e1ccc6213" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b58e8aff-4d28-405e-9082-b0e6f9199372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:to="loc_us-gaap_LossContingenciesTable_b58e8aff-4d28-405e-9082-b0e6f9199372" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e99f5c62-11a5-4a54-8223-89645c14a75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b58e8aff-4d28-405e-9082-b0e6f9199372" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e99f5c62-11a5-4a54-8223-89645c14a75c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e99f5c62-11a5-4a54-8223-89645c14a75c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e99f5c62-11a5-4a54-8223-89645c14a75c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e99f5c62-11a5-4a54-8223-89645c14a75c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_394724bb-13e0-4adf-95f5-ed7f0955e225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e99f5c62-11a5-4a54-8223-89645c14a75c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_394724bb-13e0-4adf-95f5-ed7f0955e225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_87e10e71-dc91-407a-8015-aa7feb703536" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_394724bb-13e0-4adf-95f5-ed7f0955e225" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_87e10e71-dc91-407a-8015-aa7feb703536" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended" id="i82c4fe9172024746bb40d56de86baeaa_StockholdersEquityDeficitNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_44830c45-dd5a-46f6-8675-b28b3592638c" xlink:href="mck-20220630.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_44830c45-dd5a-46f6-8675-b28b3592638c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b857a70f-cff9-49be-83fe-9cc420ed4047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b857a70f-cff9-49be-83fe-9cc420ed4047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_f6211a05-1c92-41ff-bd34-3f5557171e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_f6211a05-1c92-41ff-bd34-3f5557171e22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_4979739f-3ab2-4984-bb3d-3f1c635261ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_4979739f-3ab2-4984-bb3d-3f1c635261ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_aefed9b8-761e-4321-b2f8-c1d96edce2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_aefed9b8-761e-4321-b2f8-c1d96edce2f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_eff3d393-53c5-418a-a187-b052e437323c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_eff3d393-53c5-418a-a187-b052e437323c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_69cdc4a1-cc5a-4c5d-a8b1-07fa97357d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_69cdc4a1-cc5a-4c5d-a8b1-07fa97357d94" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_7d257387-9dc9-45f5-954f-eee04e07f4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_7d257387-9dc9-45f5-954f-eee04e07f4a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7c7f362d-3643-4b67-8bae-18d15c982faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7c7f362d-3643-4b67-8bae-18d15c982faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7c7f362d-3643-4b67-8bae-18d15c982faf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7c7f362d-3643-4b67-8bae-18d15c982faf" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7c7f362d-3643-4b67-8bae-18d15c982faf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f511d6db-d63f-43eb-8ac9-f79f9be503f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7c7f362d-3643-4b67-8bae-18d15c982faf" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f511d6db-d63f-43eb-8ac9-f79f9be503f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_83460835-3572-4d74-b4f0-1b33fc417e64" xlink:href="mck-20220630.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f511d6db-d63f-43eb-8ac9-f79f9be503f4" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_83460835-3572-4d74-b4f0-1b33fc417e64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7fcced1d-2673-4efc-bb17-321342cc08ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7fcced1d-2673-4efc-bb17-321342cc08ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7fcced1d-2673-4efc-bb17-321342cc08ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7fcced1d-2673-4efc-bb17-321342cc08ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7fcced1d-2673-4efc-bb17-321342cc08ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_472cbebe-d7ee-4155-8882-45a072dcbd41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7fcced1d-2673-4efc-bb17-321342cc08ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_472cbebe-d7ee-4155-8882-45a072dcbd41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e3b7d21c-ff36-4b55-9859-5061f5d46931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_472cbebe-d7ee-4155-8882-45a072dcbd41" xlink:to="loc_us-gaap_SubsequentEventMember_e3b7d21c-ff36-4b55-9859-5061f5d46931" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended" id="i2d8e49a3af81421cb9de7190c0b5424a_StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5904638e-516f-442d-9d95-8565e324b436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5904638e-516f-442d-9d95-8565e324b436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b0786716-d531-4965-b250-5e69fb4e4409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b0786716-d531-4965-b250-5e69fb4e4409" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_173b5c03-92ff-41d4-8fd8-e3d7269e1a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_173b5c03-92ff-41d4-8fd8-e3d7269e1a06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9feef468-7a50-485e-bf23-d9ffbc80ffb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9feef468-7a50-485e-bf23-d9ffbc80ffb9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_14e51786-ce03-46ca-801d-76a7384dec35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_14e51786-ce03-46ca-801d-76a7384dec35" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f146174-a4af-4e76-a89f-55a8c9d722eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f146174-a4af-4e76-a89f-55a8c9d722eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_b75894c8-0b83-4a16-84a1-8a96f388960d" xlink:href="mck-20220630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_b75894c8-0b83-4a16-84a1-8a96f388960d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd53650-7fd4-4519-96ab-97842a22c754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_79180723-6a35-4655-b28c-68c7898e1ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_79180723-6a35-4655-b28c-68c7898e1ba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b668699a-38c4-49eb-875c-fa9b710ded05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b668699a-38c4-49eb-875c-fa9b710ded05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d" xlink:to="loc_us-gaap_EquityComponentDomain_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_231e3cba-e15d-44fd-8332-bdb3a487d1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d" xlink:to="loc_us-gaap_EquityComponentDomain_231e3cba-e15d-44fd-8332-bdb3a487d1ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_231e3cba-e15d-44fd-8332-bdb3a487d1ba" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_87a53c4c-cfcf-4609-b967-9eacbada30e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_87a53c4c-cfcf-4609-b967-9eacbada30e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_5f352c04-263b-484d-8f3c-b55bdc66b737" xlink:href="mck-20220630.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_5f352c04-263b-484d-8f3c-b55bdc66b737" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_2cbb9002-a293-4c83-9266-3b778eb820ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_2cbb9002-a293-4c83-9266-3b778eb820ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_75ce292b-fe39-40b4-93d6-b3758fbbd584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_75ce292b-fe39-40b4-93d6-b3758fbbd584" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociAttributableToNoncontrollingInterestMember_edb196cc-8f1a-45f0-830e-33a879e4dd31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_231e3cba-e15d-44fd-8332-bdb3a487d1ba" xlink:to="loc_us-gaap_AociAttributableToNoncontrollingInterestMember_edb196cc-8f1a-45f0-830e-33a879e4dd31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a8851c0e-0539-421f-ac12-15d2c2deb038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_HedgingDesignationAxis_a8851c0e-0539-421f-ac12-15d2c2deb038" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a8851c0e-0539-421f-ac12-15d2c2deb038_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a8851c0e-0539-421f-ac12-15d2c2deb038" xlink:to="loc_us-gaap_HedgingDesignationDomain_a8851c0e-0539-421f-ac12-15d2c2deb038_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4f29a5b4-7be8-4b70-89f9-e59322234d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a8851c0e-0539-421f-ac12-15d2c2deb038" xlink:to="loc_us-gaap_HedgingDesignationDomain_4f29a5b4-7be8-4b70-89f9-e59322234d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_18681a50-2283-424b-9b35-81ccc8b4c5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4f29a5b4-7be8-4b70-89f9-e59322234d40" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_18681a50-2283-424b-9b35-81ccc8b4c5f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f1e15d39-8065-4e2e-904c-03c3bd942769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f1e15d39-8065-4e2e-904c-03c3bd942769" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f1e15d39-8065-4e2e-904c-03c3bd942769_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f1e15d39-8065-4e2e-904c-03c3bd942769" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f1e15d39-8065-4e2e-904c-03c3bd942769_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_67e37349-7a56-4efc-b2a8-969fef27c529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f1e15d39-8065-4e2e-904c-03c3bd942769" xlink:to="loc_us-gaap_HedgingRelationshipDomain_67e37349-7a56-4efc-b2a8-969fef27c529" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a51fbe9e-8b46-49cd-97a6-f45b9ff94258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_67e37349-7a56-4efc-b2a8-969fef27c529" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a51fbe9e-8b46-49cd-97a6-f45b9ff94258" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_1ae972d0-9431-469b-86e5-4b8aff0dac77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_67e37349-7a56-4efc-b2a8-969fef27c529" xlink:to="loc_us-gaap_CurrencySwapMember_1ae972d0-9431-469b-86e5-4b8aff0dac77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_621b5ed6-4b78-4655-871f-91f506dc3ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_DebtInstrumentAxis_621b5ed6-4b78-4655-871f-91f506dc3ef4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_621b5ed6-4b78-4655-871f-91f506dc3ef4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_621b5ed6-4b78-4655-871f-91f506dc3ef4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_621b5ed6-4b78-4655-871f-91f506dc3ef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2e71a726-6f52-4fa5-aa4f-94f9f74fa9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_621b5ed6-4b78-4655-871f-91f506dc3ef4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2e71a726-6f52-4fa5-aa4f-94f9f74fa9e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_38d590bd-6092-4c10-8238-4b932bf91176" xlink:href="mck-20220630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2e71a726-6f52-4fa5-aa4f-94f9f74fa9e1" xlink:to="loc_mck_EuroDenominatedNotesMember_38d590bd-6092-4c10-8238-4b932bf91176" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended" id="ib39fb775c97a4783bcb8dad0b532d9be_SegmentsofBusinessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b3e5ecb8-d9b3-424b-8d8d-3c2f47d14607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_us-gaap_NumberOfReportableSegments_b3e5ecb8-d9b3-424b-8d8d-3c2f47d14607" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_ee3ada35-8c3a-4d88-b37f-95ba4ab3c20b" xlink:href="mck-20220630.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_ee3ada35-8c3a-4d88-b37f-95ba4ab3c20b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_0847bf0d-93c6-4693-a836-dde73d187f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_0847bf0d-93c6-4693-a836-dde73d187f9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_60b97ee0-6c57-4c95-b993-24d0a876462c" xlink:href="mck-20220630.xsd#mck_NumberOfBusinessOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_mck_NumberOfBusinessOperations_60b97ee0-6c57-4c95-b993-24d0a876462c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6b11a509-ba26-41c4-90b6-87d744c192b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_us-gaap_Assets_6b11a509-ba26-41c4-90b6-87d744c192b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c7deda8d-5b40-438a-8869-19e5cdc9b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c7deda8d-5b40-438a-8869-19e5cdc9b239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c7deda8d-5b40-438a-8869-19e5cdc9b239_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c7deda8d-5b40-438a-8869-19e5cdc9b239" xlink:to="loc_us-gaap_SegmentDomain_c7deda8d-5b40-438a-8869-19e5cdc9b239_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1a2e3993-bfe6-4308-926d-162d6e1bf7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c7deda8d-5b40-438a-8869-19e5cdc9b239" xlink:to="loc_us-gaap_SegmentDomain_1a2e3993-bfe6-4308-926d-162d6e1bf7b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_dce4ed3d-be74-43dc-8417-a8500183b2ac" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1a2e3993-bfe6-4308-926d-162d6e1bf7b3" xlink:to="loc_mck_InternationalSegmentMember_dce4ed3d-be74-43dc-8417-a8500183b2ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2be01a2a-d62b-4f43-b61e-60cd929182ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:to="loc_srt_StatementGeographicalAxis_2be01a2a-d62b-4f43-b61e-60cd929182ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2be01a2a-d62b-4f43-b61e-60cd929182ac_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2be01a2a-d62b-4f43-b61e-60cd929182ac" xlink:to="loc_srt_SegmentGeographicalDomain_2be01a2a-d62b-4f43-b61e-60cd929182ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ce8f3c3a-ca40-4653-ba32-933a6f684fad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2be01a2a-d62b-4f43-b61e-60cd929182ac" xlink:to="loc_srt_SegmentGeographicalDomain_ce8f3c3a-ca40-4653-ba32-933a6f684fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c3629cad-5a91-4135-95c4-eb398c4988ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce8f3c3a-ca40-4653-ba32-933a6f684fad" xlink:to="loc_srt_EuropeMember_c3629cad-5a91-4135-95c4-eb398c4988ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#SegmentsofBusinessReportableoperatingsegmentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="extended" id="i54e901805e2942e0af68434c66d7703d_SegmentsofBusinessReportableoperatingsegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_28afc3cb-e782-453d-a618-855597169349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_us-gaap_RevenuesAbstract_28afc3cb-e782-453d-a618-855597169349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_321d5e6e-17a0-4bff-b913-c8e2e18b8e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_28afc3cb-e782-453d-a618-855597169349" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_321d5e6e-17a0-4bff-b913-c8e2e18b8e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_6c811c0d-53e4-4906-a08a-7e9225e6c8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_6c811c0d-53e4-4906-a08a-7e9225e6c8cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_49abe257-a034-4b76-8632-c3aab5158007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_6c811c0d-53e4-4906-a08a-7e9225e6c8cf" xlink:to="loc_us-gaap_OperatingIncomeLoss_49abe257-a034-4b76-8632-c3aab5158007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_8249ab60-65b2-4111-b9a5-3492c34ef804" xlink:href="mck-20220630.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_8249ab60-65b2-4111-b9a5-3492c34ef804" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b7d649bd-0923-4911-9626-9b1908f3ca79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_us-gaap_InterestExpense_b7d649bd-0923-4911-9626-9b1908f3ca79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e945d3d-6a91-4086-ae17-2af86804efe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e945d3d-6a91-4086-ae17-2af86804efe0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_7b418135-b37b-43d6-99ff-88c97285e76b" xlink:href="mck-20220630.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_7b418135-b37b-43d6-99ff-88c97285e76b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2c86018c-2b38-498d-a7ea-ad0a433c2432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_NumberOfReportableSegments_2c86018c-2b38-498d-a7ea-ad0a433c2432" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_b6cfb422-e317-4228-882d-9bfa9db90ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_b6cfb422-e317-4228-882d-9bfa9db90ebf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9b5d2d58-d1df-48a5-a2fe-0aa0cf3fc4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_InventoryWriteDown_9b5d2d58-d1df-48a5-a2fe-0aa0cf3fc4d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_6fe19208-14dc-4e99-a595-e21cc188e9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_6fe19208-14dc-4e99-a595-e21cc188e9be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a43a72d6-6abc-4d21-bf05-62a17be05abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a43a72d6-6abc-4d21-bf05-62a17be05abf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_9a53e2e8-6018-4c57-a2dc-32bf63ed5ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_LitigationSettlementExpense_9a53e2e8-6018-4c57-a2dc-32bf63ed5ccf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d817dba3-c9da-41d5-8ec9-405079c6d3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d817dba3-c9da-41d5-8ec9-405079c6d3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d817dba3-c9da-41d5-8ec9-405079c6d3c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d817dba3-c9da-41d5-8ec9-405079c6d3c0" xlink:to="loc_us-gaap_SegmentDomain_d817dba3-c9da-41d5-8ec9-405079c6d3c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d817dba3-c9da-41d5-8ec9-405079c6d3c0" xlink:to="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_0f30badf-d936-4026-9041-8da32719fa82" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:to="loc_mck_USPharmaceuticalSegmentMember_0f30badf-d936-4026-9041-8da32719fa82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_a586fbf6-8487-436d-9774-581a5649a00c" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_a586fbf6-8487-436d-9774-581a5649a00c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e859d058-a154-48e2-86eb-380a91814585" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e859d058-a154-48e2-86eb-380a91814585" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_0c779098-b1b4-4b33-b9c6-1975ea274590" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:to="loc_mck_InternationalSegmentMember_0c779098-b1b4-4b33-b9c6-1975ea274590" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d635fc19-5c1a-452d-ad77-dc4d2df54b2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_srt_LitigationCaseAxis_d635fc19-5c1a-452d-ad77-dc4d2df54b2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d635fc19-5c1a-452d-ad77-dc4d2df54b2a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_d635fc19-5c1a-452d-ad77-dc4d2df54b2a" xlink:to="loc_srt_LitigationCaseTypeDomain_d635fc19-5c1a-452d-ad77-dc4d2df54b2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d5fa96d9-77cf-40be-a281-d29a98fe8aa7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_d635fc19-5c1a-452d-ad77-dc4d2df54b2a" xlink:to="loc_srt_LitigationCaseTypeDomain_d5fa96d9-77cf-40be-a281-d29a98fe8aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_d97f61c5-ed03-4376-a173-b74c229b6a10" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_d5fa96d9-77cf-40be-a281-d29a98fe8aa7" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_d97f61c5-ed03-4376-a173-b74c229b6a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_77c38058-f8b0-45c7-8504-a8cf5e0726c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_srt_ConsolidationItemsAxis_77c38058-f8b0-45c7-8504-a8cf5e0726c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_77c38058-f8b0-45c7-8504-a8cf5e0726c3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_77c38058-f8b0-45c7-8504-a8cf5e0726c3" xlink:to="loc_srt_ConsolidationItemsDomain_77c38058-f8b0-45c7-8504-a8cf5e0726c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e0ef034b-2ff0-41d2-bb07-4afc7abd6308" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_77c38058-f8b0-45c7-8504-a8cf5e0726c3" xlink:to="loc_srt_ConsolidationItemsDomain_e0ef034b-2ff0-41d2-bb07-4afc7abd6308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_27b5ffa4-e477-4f06-ae87-a47e724e5ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e0ef034b-2ff0-41d2-bb07-4afc7abd6308" xlink:to="loc_us-gaap_OperatingSegmentsMember_27b5ffa4-e477-4f06-ae87-a47e724e5ed9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ea36d8ca-587c-46d3-8f7d-83a7d282f989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e0ef034b-2ff0-41d2-bb07-4afc7abd6308" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ea36d8ca-587c-46d3-8f7d-83a7d282f989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_776a52f8-fbf3-4a15-bf34-cd73f327a43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_776a52f8-fbf3-4a15-bf34-cd73f327a43b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d29f2ef2-3e24-44bb-a681-1986bbc985f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_776a52f8-fbf3-4a15-bf34-cd73f327a43b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d29f2ef2-3e24-44bb-a681-1986bbc985f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6e00c6ed-335b-486f-baa3-bedddc524d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6e00c6ed-335b-486f-baa3-bedddc524d88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_6e00c6ed-335b-486f-baa3-bedddc524d88_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6e00c6ed-335b-486f-baa3-bedddc524d88" xlink:to="loc_us-gaap_LossContingencyNatureDomain_6e00c6ed-335b-486f-baa3-bedddc524d88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b6ff1e88-7522-4227-8760-8cb2cd8648e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6e00c6ed-335b-486f-baa3-bedddc524d88" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b6ff1e88-7522-4227-8760-8cb2cd8648e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_a16053e9-71b7-47e7-836f-f07026a26122" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_b6ff1e88-7522-4227-8760-8cb2cd8648e7" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_a16053e9-71b7-47e7-836f-f07026a26122" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd02647a-5365-4742-b638-71329210f1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd02647a-5365-4742-b638-71329210f1c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cd02647a-5365-4742-b638-71329210f1c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd02647a-5365-4742-b638-71329210f1c8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cd02647a-5365-4742-b638-71329210f1c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_92f5ac03-f0e8-49bc-945f-cb3a74153036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd02647a-5365-4742-b638-71329210f1c8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_92f5ac03-f0e8-49bc-945f-cb3a74153036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_c8a02ace-3ff8-4f9b-ba38-ddb2ca8cdd88" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_92f5ac03-f0e8-49bc-945f-cb3a74153036" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_c8a02ace-3ff8-4f9b-ba38-ddb2ca8cdd88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_db7ecf82-1d9f-433d-85b4-d0a8072132e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_srt_StatementGeographicalAxis_db7ecf82-1d9f-433d-85b4-d0a8072132e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_db7ecf82-1d9f-433d-85b4-d0a8072132e2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_db7ecf82-1d9f-433d-85b4-d0a8072132e2" xlink:to="loc_srt_SegmentGeographicalDomain_db7ecf82-1d9f-433d-85b4-d0a8072132e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1e17c440-f94d-47ef-912c-21677482e20d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_db7ecf82-1d9f-433d-85b4-d0a8072132e2" xlink:to="loc_srt_SegmentGeographicalDomain_1e17c440-f94d-47ef-912c-21677482e20d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f94b9f98-079a-4b21-a7c8-2b3b981eaf84" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1e17c440-f94d-47ef-912c-21677482e20d" xlink:to="loc_country_US_f94b9f98-079a-4b21-a7c8-2b3b981eaf84" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>mck-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18507b8d-c172-4d9a-9fef-a030c1e6a2f5,g:26ea8e13-0c76-4471-91f9-3ae4cfe6c737-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8d6585b2-f4bf-4a6a-9c64-167a1059c409_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to earnings and other</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ca806b41-5c10-4f7c-b203-a27e59e6ec9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_17e8c4dd-29de-42bc-9176-a7930d1985ea_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_a226b7bb-8090-45f4-a9cb-208f6c70b5ce_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_8064f0c3-28f1-4770-9b53-e8fe4e97b978_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_672b82c0-69e2-4878-82f9-331ad9b853a7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complaints filed against the entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_ff95c92d-2a8e-4982-bf6a-a74176b6f3b9_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GBP</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_547a4c7f-051f-4ae4-ad85-495de63a7073_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_546339a7-dcb0-4baa-8389-f5f1f2c41a83_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_815dc8ed-4dc5-431e-9bdb-3806f7bc1084_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</link:label>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_label_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:href="mck-20220630.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:to="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_737ba9f1-3474-466f-b20b-fc7f1a3179c5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_fffac095-61b0-42cd-82f7-7ae385daa592_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and other-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_73a0bb9b-20a6-4ad4-8aa0-8bad808000f6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_ef01469f-7290-4c79-b0ef-a928f52f9c56_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_9bfa650b-f0bb-458d-b530-b5a714db139a_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and other obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_b1a5e74e-3cda-48f5-b109-900d27e1fe76_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bb2a63bf-ff27-438f-b31c-f8356c8e1429_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4115b989-1704-4180-8d7d-f5879217a312_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding notes (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e0180bf3-7c06-491d-8a03-678c4f1b801b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8b318969-ae20-4774-9849-b21940560618_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c25cdb4f-7611-4aad-b3fb-c0b79f4aee69_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_c30ae689-9846-43f8-859d-bb53e7e5a1e9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair values of liabilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FixedInterestRateSwapMember_de93e95b-8ac0-45bf-84ae-86249e066253_terseLabel_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate swaps</link:label>
    <link:label id="lab_mck_FixedInterestRateSwapMember_label_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate Swap [Member]</link:label>
    <link:label id="lab_mck_FixedInterestRateSwapMember_documentation_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate Swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember" xlink:href="mck-20220630.xsd#mck_FixedInterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FixedInterestRateSwapMember" xlink:to="lab_mck_FixedInterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_c4571606-4356-4018-9751-704b42e8a20f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts awarded to plaintiff</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_771b32f2-cd18-4d93-9285-8ddc4d87b2a9_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_2f4fa8dc-fd98-48ae-b0f4-93c4a75bb81e_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_77ac227c-97d7-4632-9c49-d55cd2d07bd4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_c7443e90-3c20-4792-a712-0cdfbd03dfbb_terseLabel_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_label_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other [Member]</link:label>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_documentation_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember" xlink:href="mck-20220630.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrepaidExpensesAndOtherMember" xlink:to="lab_mck_PrepaidExpensesAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_87139389-afc2-4cde-830e-0b2db94fcfc0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_dac071e0-7006-4abe-a20e-decadbfb33f7_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_62fa9753-f362-44b6-83aa-43087be6a83e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae291c97-f764-4818-8b98-e12d7e73472c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on debt instrument (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_f3f5bfdc-6e2c-49a7-ab90-404b6d10c7d7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit recognized due to statute of limitation expirations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpioidStewardshipActStateOfNewYorkMember_1177cbf1-fafd-4629-83a1-69ae8af2cbc7_terseLabel_en-US" xlink:label="lab_mck_OpioidStewardshipActStateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, State of New York</link:label>
    <link:label id="lab_mck_OpioidStewardshipActStateOfNewYorkMember_label_en-US" xlink:label="lab_mck_OpioidStewardshipActStateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, State of New York [Member]</link:label>
    <link:label id="lab_mck_OpioidStewardshipActStateOfNewYorkMember_documentation_en-US" xlink:label="lab_mck_OpioidStewardshipActStateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, State of New York</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActStateOfNewYorkMember" xlink:href="mck-20220630.xsd#mck_OpioidStewardshipActStateOfNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpioidStewardshipActStateOfNewYorkMember" xlink:to="lab_mck_OpioidStewardshipActStateOfNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_eb50bba7-0dc2-4ec1-b9cc-0ef7c9a87bf2_terseLabel_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:href="mck-20220630.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:to="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bc105a12-2707-40cd-9f24-716ec846edd4_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (in shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20220630.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_07a67a05-3016-4634-89e9-7a0e0ecde65b_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_9dcb40d2-a380-45e0-a0c6-6fa986e30756_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_15588af0-d6f5-49e3-8704-50e66e38866a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_70fc3311-a74b-414d-9fcd-7e14f92275d2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2bf72c3c-62d3-4e2d-9082-8e40629fa5f5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities (shares) (fewer than)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_7209cf7f-09ae-484d-98c5-485cd9dae8a3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_6a976d62-b119-4fa5-b52c-35456c51e082_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of States Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of States Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_bea5edbe-a0d2-4344-899e-08d37b11ecf0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_444b4e7f-cc1e-42d7-bd96-f8e4534ea102_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_84a1ae81-3735-45ad-97ac-cbbe415a6ef1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_da09dca7-feb5-4624-a9f2-ee827ad66e43_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_16d8a105-a7a4-4b25-89eb-84e2b050ede9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_650d4267-4b1e-4b86-81f0-2ab825945385_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_4b3354be-5b45-4d6d-a289-b229f3d0db94_terseLabel_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_label_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024 [Member]</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_documentation_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member" xlink:href="mck-20220630.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A380NotesDueMarch152024Member" xlink:to="lab_mck_A380NotesDueMarch152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_72056879-918f-4776-8eb2-921abdb835a4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_1bfae974-ecf2-46f6-8b0d-c01a09b02fe8_terseLabel_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures (in shares)</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_label_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_documentation_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:href="mck-20220630.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:to="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_5905760d-c5c4-468e-ae19-eecc03b278e0_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_b4b70173-5bc0-4520-935b-3b5088dd474f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_60d0d71d-d9a5-4d18-991e-32298db4424f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_bec8996f-2a67-4c5a-9cf1-c601d35239ae_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax credits related to LIFO accounting</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_a200b4a8-7035-4df9-ad0e-580f7d18ed41_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125</link:label>
    <link:label id="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_label_en-US" xlink:label="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125 [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:href="mck-20220630.xsd#mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:to="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_a2a3a677-640f-4bf7-a3ba-60ee5d3bdaac_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_42d74483-c152-4ae0-b920-d736f8d6f460_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_4608dfc1-c23b-4d63-873a-df1ac832a85a_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share of common stock permitted on proposals presented to stockholders (vote)</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20220630.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_a6f2abbd-7d82-4f5d-9563-5346c5a3457f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4c25e430-0327-490a-bf59-bb3c13050979_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_a24f9e52-e36a-4c38-be59-c1fb2e2774de_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_2586be1e-1144-4469-a981-cdcd49bc78d7_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_0b47629c-4223-4a49-ba34-f886da25adb3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_618e8e0b-3df7-42f0-83a8-434d81860e2e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ec7bcb9c-2319-4a14-95a5-973ebb4ee2c0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_b0878611-4dbf-40c2-9985-df9ede8b248b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts outstanding under facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dad69357-b8af-4966-b38f-3cbf77ddf57c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1ca6bf76-791b-4ae6-b249-b2df77b7b1d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_6d863a5c-cc79-49ff-bf00-b8d2ba5f6731_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMay302029Member_5674e4ef-1095-4b1a-b138-649466f9b5a8_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member" xlink:href="mck-20220630.xsd#mck_A475NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMay302029Member" xlink:to="lab_mck_A475NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e4dcac1d-2bc0-44b4-ba31-4dc0d4783e26_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_0b353ef0-a8b3-427f-9912-dd85993206d5_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cf1412b8-1262-4501-8535-c0f0aecd7221_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_08d04e37-5c44-475e-aa39-a7c2825e5c0f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_cf293746-e239-4450-962a-2e9eb7d877cd_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring dividend (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20220630.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a3546f7e-0e17-4a3a-955b-b63478469220_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax expenses related to estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IndividualClaimantMember_688a60ed-3ea2-4089-ba75-5c1e5d2a7a31_terseLabel_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An individual</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_label_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant [Member]</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_documentation_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember" xlink:href="mck-20220630.xsd#mck_IndividualClaimantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IndividualClaimantMember" xlink:to="lab_mck_IndividualClaimantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_85ad3a6a-5a8e-47ba-a49d-3bacfd37762e_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_51e732c8-4dac-44d6-a730-b77a65def2e3_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_26b4ee13-ee83-4ed4-8eb3-e2ae695a74cf_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of settlement award to be used by state and local government for remediation (percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_label_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:to="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_783be2f1-56de-4879-bb84-96bec4264939_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_7017e2b8-3822-4a08-9e06-7ff60c38d5ff_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_7e5b0188-6db1-44dc-929a-6a0840641cc3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as cash flow hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_3de0c0d2-0849-4cb7-b70e-32ed4b326edb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_483f890a-950b-430c-bb50-76d6f794b3ed_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_45ecfcc5-0dc1-45d2-b6c9-458518bf6477_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1b334f5f-8df0-4db7-94b4-f5e630717e5a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2e9297df-bf9f-4ee7-ab0a-039fd9d683d5_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_506b8287-9afe-417b-a424-e6e0cfd8ed99_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_4becf69f-ec9f-47b0-a99a-2db9a1cab32d_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_ce3316b4-a573-4288-9fa5-ce50b40f05d8_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_efff31f0-a2fd-4b53-a458-85f56daebd60_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d1afb217-f143-4da8-b19f-83e91762c3d2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12ba32ae-280f-4f06-81f7-dd0ab58640ad_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_b2d1e5a5-ee80-4dd0-9430-624f45ddb4b9_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_5b7ce0ec-8e74-4262-8e7e-ead51005cdbd_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7e2b046d-722d-48aa-942b-cf443ca1f07f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_b1bdc37f-e483-4b19-90a1-1cda30af0f95_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_080aa13a-a60a-4cf5-bef0-a93a29e66103_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_5749e39f-782b-4e64-91da-c3611cd4ea65_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_265669b7-13aa-4c96-87d6-346d35161319_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_415e4ff2-d7d5-4bd6-8a89-aba97c039286_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_287747ea-503a-4b66-916f-79c99cc6dd4a_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_59fe2954-73dc-443b-a5fa-20acbf113548_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_dc908580-b2fb-4b0d-a2b6-fea67fad5745_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_96de56bb-feca-448e-8800-16675fa5d067_terseLabel_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes due August 15, 2026</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_label_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026 [Member]</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_documentation_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member" xlink:href="mck-20220630.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A130NotesDueAugust152026Member" xlink:to="lab_mck_A130NotesDueAugust152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_4db80458-1e2c-4476-8531-0f59f4201c05_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Credit Facility</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20220630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d1e5fb2e-838e-4e63-9405-17661ad4379c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4c1d2a53-7261-432d-8d5a-bff97a0ba5fc_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_47cad817-e9b0-4d46-9cdf-5631feae6e5a_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_379f645a-c44b-45d9-85d1-83d37112a7cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_4f805d7b-fcb3-42da-af64-a92cfb5c59f2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges, net</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8c253fb9-151e-45e4-9255-698a34fa0a1a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_2557cf64-7f8d-44be-8628-eb9b31317327_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash contributions to the plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_94d8b959-a2a2-4e0c-9e04-03ba8d04db69_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, settlement, number of installment payments</link:label>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_label_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Number of Installment Payments</link:label>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Number of Installment Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:to="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_abea8eed-94ba-4b84-be85-0b4c7350d107_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating interest rate swaps (4)</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_56898714-040b-410c-85bf-3a1b003b66ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_892ced0e-07c1-4cfe-8007-87b79a255089_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_61f4057e-c910-45ee-be84-6e4c07221913_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_cefe0106-e534-4edc-b9f5-ff6093f9cbf4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_d885f40e-ea53-44b7-b4f2-1887a34f104f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_31afd54d-86f3-4797-a618-df1e182501b0_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_1921abec-e736-4fd6-81ed-fb344a530bca_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_7db581e4-c125-440b-8561-ab6748c85c97_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized repurchase amount (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_94122704-a328-4e81-85d7-b5825bb9f1d3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b67b7324-f710-4002-994d-af16a2b06c90_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fc4ba7d7-046a-4311-b46d-133789e4179a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aee05106-3f60-4608-b569-fdcf75abb738_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b7ebf524-198f-4483-9bc8-3e547cde62ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_68b1ae85-1bc6-489a-939c-680909070c65_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_d39a951b-416a-4fd6-8583-8e0fb51e5bf7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_e7a7df0b-aa90-4f50-a9b4-17155f4a684d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_803bd4b9-cb73-45ef-af6d-38060900b148_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_123f9384-603a-4c8f-941c-b8fb18421afd_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f333717-6f75-473c-8078-2718273ecf01_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_5442d490-8438-4e60-bd70-a86061d3c05d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_d31e8ece-b1c3-4023-b712-96d95e9354a8_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_f6c438be-a9b3-4d5b-ba24-aeb7a85fa1ae_negatedLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3677415e-a125-43b7-8c88-f3f66554a3ff_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_e8211aff-2643-417c-bcd7-24106e7e5f4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_664d0cb2-36e3-401c-9b11-c472fc5c04b3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fcbf22d-48cb-41f0-9c89-3c85fe554589_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_f551da75-5b1b-43a5-b6d8-7f60c7526c4c_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_38e79417-6ffd-4dde-90d5-037e86d51afa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_9d1bb809-e7e0-4b59-86ae-db99612acc0c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_f216dff7-79b2-4dba-bb96-3b643a537806_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_72d605d1-2103-4fad-98d4-be2b82e90779_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_473a952b-a3eb-4891-b63a-75d41d72abc9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_2ab2c3a6-d021-4450-823f-6c0bfc0b7a9e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Derivatives</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_29f9ed73-bda0-4e64-a98b-ad13054980c1_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Europe Subsidiary</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20220630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_14491b0b-f75a-45fb-81f8-53e4de1b13e5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_10f12a72-299d-42ee-ae6a-75ef5857f873_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_bd95877c-d690-406e-9cfd-3c718f996bc1_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_332fb22c-c90e-494b-ac86-06939f2545c4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_bd7413b6-ed05-4589-b028-9dd6b332f6f5_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20220630.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_33755df1-a2db-4074-8d65-2543e4403fcf_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ec054c28-5af6-4130-a5aa-8362bb08cd04_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_f4156c29-7235-43ef-897d-777c50367c50_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_5aaae14d-0d74-424f-895a-2176fb515fa0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_9ca0c1b3-746b-4491-b754-2386747a92e9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_5aee1995-c13c-436c-b4df-416eb7a545bc_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ee3db7ff-accb-4b1c-af83-085c6989d784_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f838212c-da6a-438f-a589-8a083ddf5ded_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_19876f5f-30da-4c63-8332-abcadcd557a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f6594b3d-162e-41d5-b0ef-d6af5c38dde0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for purchase shares of McKesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_c3bd9807-265e-4d61-9a50-ca4aa00c26b7_terseLabel_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes due December 3, 2025</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_label_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025 [Member]</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_documentation_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member" xlink:href="mck-20220630.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A090NotesDueDecember32025Member" xlink:to="lab_mck_A090NotesDueDecember32025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c5e51e71-58d1-4e24-ac16-6a1dbb604d53_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2873874a-6d56-42b8-af83-2298e3356b39_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_19968a1b-54a8-4fcc-ba9c-61745872dc36_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_941bb6f3-97f2-4aa9-8f9e-652f810478dc_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_892509ff-f4bb-412e-a893-d803db74e465_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_cf428869-0964-4132-8ae8-636477814e37_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_d9a6ab05-22b5-4f2f-8285-9578f8d78020_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_bce32b12-7db9-4b23-9ff6-1495afb5892f_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_c53bb47d-954c-45ba-9418-35481f7acec3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified pension liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_82eff9ec-d84a-48e0-970a-63069baeb298_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a5af9192-e4d8-4975-b743-5feb90b086be_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6f846610-f851-469a-8592-d68ffc30bce1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_406bdcdc-c6c4-484b-8a4f-0f28c9aa25f8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory charges</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_386dae3a-fc4d-4357-b384-9181155ee419_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b73520b8-44ce-46ec-b237-2f6afedc24e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c47f3149-ce96-4238-8cc5-49809a58bef9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_fb566f88-7387-43ce-b95f-3703aeaec52d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_a00f818f-6477-4eda-a347-d52f35b139fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_7958cb00-7d76-45f0-8629-99f9d0685aa7_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComparabilityOfPriorYearFinancialData_357572db-3e3e-41fa-9128-3420b5704294_terseLabel_en-US" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Results of Operations</link:label>
    <link:label id="lab_us-gaap_ComparabilityOfPriorYearFinancialData_label_en-US" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comparability of Prior Year Financial Data, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComparabilityOfPriorYearFinancialData"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:to="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_83d25456-4401-49e1-acd6-e1e579890041_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f3c79ef4-1175-42c7-a9da-34bcd44d5b4f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_025b9bf3-3d96-4f5a-90bc-3f24cb99f88e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price of shares repurchased (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_698799f6-46ac-4370-b0b1-516156a4c2dd_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_f18d7880-4736-498f-9554-edce66aaa3db_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_539591ad-9f6c-40af-b570-3561fc0e4dea_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss adjustment</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c5d06933-30cc-4d3e-b835-3215fa874095_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_36f6f5bd-d31e-427e-9b3e-12e10363d8c5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_c1b218d3-318d-4b57-89ed-99d137b5c6f5_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c22f2865-b773-42b7-8993-7d3a1285989c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_1a5d4352-76ca-4332-9205-e8ef1bf38864_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_0b15c330-c799-4d90-a36c-ffba30952716_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_621e2951-a7a8-4e8b-b673-78a6135ebcdd_terseLabel_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:href="mck-20220630.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:to="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8c60a9ae-c948-443f-b3e9-1db44b2afe71_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_ce538eff-a5ab-4ecf-b9ad-7b7502d00b76_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4a7d9ea4-56a6-48d7-9e76-97c4a09f3ddf_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported income tax expense (benefit) rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_ea4dfb69-087f-4a3e-bc99-11dae4ba21ee_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_081ff91b-cbaa-442f-b924-f74056b0b92c_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_06a48f1d-ebf5-4f35-8711-f8c4987d9f11_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar, notional amount, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_eb5643a0-6c31-4f53-9427-5b900a03cf8f_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember" xlink:href="mck-20220630.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMember" xlink:to="lab_mck_AcceleratedShareRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_da7b48bf-3c5b-412e-a993-1fdf092335cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7288be1f-c863-4a64-a7f4-c997698bb9db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_76ff877a-e006-4a78-9bbb-e85a5c18df33_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_1163b496-9133-4866-a3da-460d0e21e2fd_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_991fe253-c0a5-4c15-b456-859630f8dd56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_a286102a-5f09-4a1a-a73f-a0b8090e8ecf_terseLabel_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_label_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_documentation_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:href="mck-20220630.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:to="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_c6b51d16-bda8-4324-98a6-9714906dd208_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_09ff9b2b-d42d-41c1-9ba3-80066c125189_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_2a1ac1ba-ab5f-48b3-8f01-57560a9238da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d12c7e35-5f46-4e70-8b06-0fa1d5d40eca_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_16659eeb-c498-45af-a85a-9ad4f55db1a4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_69992ec8-e53e-4795-b678-6142bcf319f6_terseLabel_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid stewardship act, new york, annual surcharge</link:label>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_label_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, New York, Annual Surcharge</link:label>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_documentation_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, New York, Annual Surcharge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:href="mck-20220630.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:to="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_da2f633f-49ab-4dfe-a04f-7167c4031511_terseLabel_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:href="mck-20220630.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_85828eb2-1b14-47bd-b01d-72e4e71c5ccd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_06d443c6-cee8-4f13-be57-58eb72281f4d_terseLabel_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson:</link:label>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_label_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS, Basic and Diluted [Abstract]</link:label>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract" xlink:href="mck-20220630.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EPSBasicAndDilutedAbstract" xlink:to="lab_mck_EPSBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_06a08ef9-f2c9-43d0-b7a0-357acfb162c0_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested net liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_74951585-cd9f-4362-b4f1-1e703752929c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_f841b74b-028f-45b7-b7c9-f675398e2da1_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_2f08f87d-eeea-4e97-8077-513e56ce4f72_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_4e0336b2-45f4-47a1-a8e1-ffd9d93d454a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_db6272dc-7bcf-435c-a6fd-28cabd42af7e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_a5027359-f9dd-4f88-9dfc-12a119159f42_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_3af68f7c-79c0-4533-a1b7-8a6ea639515d_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_f84835c2-34a0-41ff-97be-1d0497be7e9e_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_6de47e46-deb1-4198-a65f-81609c59ff68_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_17eac9ee-8dcc-4e75-8243-bdddbc0706e5_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ff2cd049-4e77-4602-8d8f-9adc0626dffc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_94a96d13-1cdf-408a-9cbe-2de9dd3b8128_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_dc0dd56f-9984-45a7-920f-1aac8e7f4e19_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_0bd6d561-fa8e-4ca5-b4de-05ce32ad9a0b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_b6623233-573b-4989-926d-af3f846c3eb9_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims and litigation charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_f9a7226f-92b0-4dda-8905-03b73e5cf08a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_07b6011d-a3cc-4182-9aa9-0c83878bdffb_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_1639c1bd-d231-4870-8323-6f78806e977b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_14544426-3266-408d-8702-fe6ca36a517d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_8491a50c-add0-435c-b5b1-220b7732748b_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds at carrying value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a6eeb205-d262-4e06-b8c3-29af93604508_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_92c946db-4335-4982-88f8-505d224a96e6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_956c61d3-a939-48ca-b251-705ac1b10118_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_8ebde4bd-ee3a-4be5-b2ab-3a817269274a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_94468a0c-18e8-453c-a6ad-f0376aab668a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_0cd0c9a1-16f7-4832-8e44-8e5f42821c5b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_1a8cfefa-7c3e-4368-b40e-a595ebf31480_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_c097730d-c915-4126-a84c-b7d461edf5a6_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_48063cc5-4e36-435f-8c9f-c2ffaba6556d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_b8bd1e3a-7edf-48fa-b917-7cd1c8ea000a_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European businesses held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_4c08e523-9040-4992-973d-50529cd5a335_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain to remeasure disposal group to fair value</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_049e10b1-3233-4140-b2e2-3086de95fd4d_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_84078cf0-b349-49ea-8cda-09f1e94be6f6_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bd25a8c5-ed5b-4c8b-9159-fd88b8c015b5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ab7e2d49-fc82-4b9b-b726-c5bb58daa081_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d3142c8c-b4a3-4699-bacc-f9f44f87293c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6443ce2c-3683-4949-8603-057562292682_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_555ab5e8-dc78-4f83-86d4-383826f17847_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_5a6a8674-7ea1-4acd-b4f6-0bb3a839d2be_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f3e51123-c118-428d-ac87-88d19d983c36_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_8f3f6922-fff0-4bd5-89d2-50b2c3493585_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of eligible states</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfEligibleStates" xlink:to="lab_mck_LossContingencyNumberOfEligibleStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4bc6baec-3c07-4154-ad8c-b2582c4ed240_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_0ef02e91-f0f5-4d59-8425-4f58a2e6cdd3_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember_c9a76604-6d21-4b67-9fe6-2da11e61c07a_terseLabel_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and State of Alabama</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember_label_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and State of Alabama [Member]</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember_documentation_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and State of Alabama</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember" xlink:href="mck-20220630.xsd#mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember" xlink:to="lab_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3d0b3679-2d88-44f5-a29a-4e48bb5fbe79_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_1c5a0780-bf92-47ae-841c-41ea81b89fd5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_dc925e57-9636-4ff2-907b-4e1a57feff34_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_af43d0c8-ed89-4400-acb7-12c496478afe_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_aa3681f4-916b-4c13-a8ac-2848b2987416_terseLabel_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_label_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041 [Member]</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_documentation_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member" xlink:href="mck-20220630.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A600NotesDueMarch12041Member" xlink:to="lab_mck_A600NotesDueMarch12041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6f928fed-8167-4142-93d7-b235bf9e2359_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_88ae5012-cdaa-410f-ae1a-d4145b6f4b39_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_09977724-e843-45a0-bdea-f2b6ae197769_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_00dc09dc-3701-4de7-af74-6c4b76842e67_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20220630.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_16be3120-3e8e-4631-8549-c278b8babdd4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4e849078-a648-43e3-b503-f0c577c8c4cb_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_8c588e51-e353-4a2e-9438-911d216576e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, distribution, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_5502dae1-11f4-4965-a7ce-a27f018261a9_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAD</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_dfbe5f1f-ba96-42c5-a1f6-7cc8a5e25658_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_badaa3cd-cee8-47bc-937e-aa2d80b74f49_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f5182a66-b95c-4f53-a399-c662351ef15c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherNonCurrentLiabilitiesMember_5d014968-272f-4e36-8936-4755e6ecad22_terseLabel_en-US" xlink:label="lab_mck_OtherNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_mck_OtherNonCurrentLiabilitiesMember_label_en-US" xlink:label="lab_mck_OtherNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities [Member]</link:label>
    <link:label id="lab_mck_OtherNonCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_OtherNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentLiabilitiesMember" xlink:href="mck-20220630.xsd#mck_OtherNonCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherNonCurrentLiabilitiesMember" xlink:to="lab_mck_OtherNonCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_b59b6e0d-56a4-4529-bed8-261623e42079_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_dcd86170-75a8-41d6-897c-d4608dfb89e2_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0be5f638-19db-413c-a812-8d3a697c89c5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_e7627157-5c49-42d1-b84e-730afe78c3fd_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of gains from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_55bc9572-61b3-404d-97b1-7889b2edd308_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_dca6b949-5dcc-43d8-bde2-fea129607042_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bab021e5-a073-4384-bad2-2c897c2be8a0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3be66db6-1902-4e9e-83e9-925c7b81de0d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c50df9bf-400f-41c8-83cc-03e16b492e07_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_cb57860d-b0df-406c-86de-ee0012153714_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9035d63a-b9a9-4531-8a54-437bc5e51cbc_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_88b29135-fd01-48b6-bcea-d36d36483d77_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_cae61492-dffd-40a1-8176-8a2b8c7540a0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_151502ea-b836-4235-87cd-1776afb3410e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_62778254-bd5e-489e-a7d8-8b06f0a62a5a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_55b83c92-2b72-41c4-b1b8-55101ce78edc_terseLabel_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember" xlink:href="mck-20220630.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfWashingtonAndSubdivisionsMember" xlink:to="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_01f4ae71-2e14-4695-8bb4-50b3c4126140_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_25e8ab24-bc9d-4013-9e3a-98c042f47b65_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_b2a247a3-13d7-4e5a-99fe-8cf88400d140_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_0f1ab516-0120-4a09-b4a8-b54889816eed_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency number of cities filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Cities Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Cities Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_f8d7d815-4576-41c6-82bf-18563b1b7615_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_c84bd9b8-db40-46cc-aefd-aa3cf47d2873_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_c238968e-a8dc-4ac8-9dfd-73836bdeb6e6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_42407f83-d56f-4a59-bd2e-45aa723a06c6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_81093c7c-8918-4607-9796-2044396b0981_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_7bb20046-b874-402d-8be9-cda49e90517e_terseLabel_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember" xlink:href="mck-20220630.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SettlingGovernmentalEntitiesMember" xlink:to="lab_mck_SettlingGovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eaaba95c-0dbc-493e-8257-ecc91a1893c4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_56ec326d-9592-4d50-9a77-8c377ef59b97_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1500NotesDue2025Member_491c8947-51d0-4acf-97e3-302a1d293c67_terseLabel_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member" xlink:href="mck-20220630.xsd#mck_A1500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1500NotesDue2025Member" xlink:to="lab_mck_A1500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_82892644-af07-4159-8484-626298a31a69_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b73a5f3a-f532-475f-8c8d-e09682b822dd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_3a89e025-bfa7-47d4-aaab-ac39e7db7f61_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_deb5f495-2172-4f76-91df-fc88c29de732_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_27fbcfec-efba-4118-a585-8c91d81be0b7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b6fbccae-630b-4d9c-85f2-8c70521827d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f9efd50e-eead-4a4a-ae3f-2c036b8b2f62_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b1de29fc-27fb-4b65-8d00-5f5aad475b4f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_975da7a8-9ae9-42bd-9412-bff3fb4a9798_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_9b7ad094-0a80-4d35-af84-b5c5cbd0632e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_a657046b-623b-419d-8d2e-6a3a5d027124_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_1a0267ef-e61c-4fd9-82f7-d1564a099230_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_d63a2f52-dd54-4bb9-be25-8496ac8319f3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfOklahomaAndSubdivisionsMember_3ad18b91-2bf9-4346-8053-f1933813f5a0_terseLabel_en-US" xlink:label="lab_mck_StateOfOklahomaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Oklahoma and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfOklahomaAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfOklahomaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Oklahoma and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfOklahomaAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfOklahomaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Oklahoma and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOklahomaAndSubdivisionsMember" xlink:href="mck-20220630.xsd#mck_StateOfOklahomaAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfOklahomaAndSubdivisionsMember" xlink:to="lab_mck_StateOfOklahomaAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_4c5505e3-5108-46da-aea7-d486157c4a9e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_26f7c3be-b0a0-4fbd-a950-68580ed6f8d1_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right redemption price per share (in euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fbfcbeed-9e26-4859-8375-b214e20798fa_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0c6caf13-ac30-4287-a83b-e4e822f90ba1_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_e8da86a3-4a00-42b9-ba98-33fa0506b9e7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_c23f8c6e-71b3-441d-bbcb-7f4ee2743861_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_3df63299-8f66-41bb-9c11-ae5d0eccb53d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_2be6f391-3e9b-42ac-a024-07e6115fc495_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_23f763c2-2591-4c19-98df-4e53f83eb060_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity segment operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_5e2b8554-bdb8-4574-825b-5dc574cbcc80_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized and 277 and 275 shares issued at June 30, 2022 and March 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_784ff6af-cc5f-4652-81be-dd3ff42c3899_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate income (expenses), net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20220630.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_2db9cc06-e129-476d-91f4-849a8e15e664_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_92bc98b6-7262-430a-ac24-d0707bddbc21_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_7af263b5-f0fe-4c38-9cbe-22c2d18d0c9b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_fe7c35d9-01ac-4dd5-84e8-327558338c7e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_578b1d14-7a1e-4047-ba1f-d3c80919c405_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_3aa85d57-2737-4dcd-bd49-3555c5e22101_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c945349f-ab25-4268-adc2-625e3de3bbcd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_4a6a5c7b-bb30-46dd-a7b3-565f73155410_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_147bcca6-2b2b-4052-9558-e3676e9d56a7_terseLabel_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember" xlink:href="mck-20220630.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfAlabamaAndSubdivisionsMember" xlink:to="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_fb36407a-127d-45f9-b73b-16cc07b64459_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_5e41cf3d-5b48-4dd0-82c5-73fdfef1a769_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_78812ad7-cefd-4aaa-96dc-df4a595484bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_10ea78f9-9d80-47ae-8bcc-e7836afec9f8_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible decrease in unrecognized tax benefits during the next twelve months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2b9e4698-5155-477b-86bd-93a4d3a64bb2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f0d7ff3-037c-44c2-9edc-6170452a4862_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_18cde6c5-699f-4ba9-84f7-dd23e5aa5591_terseLabel_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_label_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_documentation_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:href="mck-20220630.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:to="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_11e4a576-c6ae-4915-bb57-6fae0054117a_terseLabel_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_label_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027 [Member]</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_documentation_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member" xlink:href="mck-20220630.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A765DebenturesDueMarch12027Member" xlink:to="lab_mck_A765DebenturesDueMarch12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d7b1c0f-0db8-4f62-95c4-acec0edecc9f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_c76497be-cdc0-4491-83f5-37fc7f8c8947_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in noncontrolling interest</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_7c7f8b40-7bca-4834-a2c2-c7e581bde8fa_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:to="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStates_fb428fbb-ec25-4132-ad31-74161cc027a6_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which court cases are pending</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStates" xlink:to="lab_mck_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CherokeeNationMember_9491285f-301b-40da-8407-0dc8ad1f87c8_terseLabel_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:label id="lab_mck_CherokeeNationMember_label_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_CherokeeNationMember_documentation_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember" xlink:href="mck-20220630.xsd#mck_CherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CherokeeNationMember" xlink:to="lab_mck_CherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_e7d2e9b7-8e4b-4abd-9956-21e39b69b3f6_verboseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_5f99b0cd-c1a2-4256-b7e3-53e32f03e50c_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b0a9cf8f-ed81-48f8-bf1e-e071498a5961_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c9b2528e-7880-4c0d-b84b-3e91cff414b0_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_41494b30-fa94-4248-99e7-400760bdf549_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4921afcf-044d-493a-a2d8-7e127f2a29d1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6899e04a-f2e2-441b-9c4e-1a6b699ad5a8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_45845564-eacd-427e-9568-f62bade758fc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_5fcbd3c6-2f52-4dc6-b829-92e5cb4ecc80_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_bec9b5ad-dfca-4259-b359-8338f5fda9be_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross purchase price</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_c8a22bb1-9ce3-460c-9213-90f8ee5e25bb_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_93b31207-2593-4dc6-9fcf-3e0844befd8c_terseLabel_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_label_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software [Member]</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_documentation_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember" xlink:href="mck-20220630.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternallyDevelopedSoftwareMember" xlink:to="lab_mck_InternallyDevelopedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_925e7373-bc5d-48d4-8598-848caa98d0d8_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_f5f019e2-dc86-4488-a493-399c66333797_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as cash flow hedges:</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ff8c4047-6910-4dc1-9101-94a1020cc9f9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8f90b8b2-dba8-41aa-8d80-4947db53d6e4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_fa3bf26e-13ee-41a7-9606-4128e6091a99_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_e30f8881-cccd-4a3a-aa16-a3378d890b5a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a1eb95f0-01d9-4860-88e7-2b23174d350c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_924fbe57-d86a-468b-b57e-4d62afef2d21_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e5f19564-df28-4fe5-b605-30a9290be3a9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_ac073783-a737-4ffc-bfa0-a568d529e326_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, class action, number of faxes received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:href="mck-20220630.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_342e26c6-9175-4a9b-8cdc-eba55f3d7d0a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0239144d-3613-415f-b42a-753c7def4819_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_7f4566f2-ecdf-42d8-9eae-b081e8bc1649_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9751513b-051e-4641-aecf-0bc03ad01cac_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_ba414ac4-070e-4a6e-8066-a3fae8fa0f70_terseLabel_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opioid Litigation</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_f3f56ffd-f8e0-413e-9c06-36e70006be1f_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20220630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_76a23903-f675-4a5f-b2ec-514989ade52f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_43701af5-b7f4-422c-ae61-59b25a3ec6ef_terseLabel_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of national brand medical-surgical products offered (more than)</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_label_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_documentation_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:href="mck-20220630.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:to="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_510b21a5-9692-4922-bbae-419f644e5d5a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c7dbb95-67be-470d-9b3b-ed4f9e6c2a4c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_08ab9124-3b78-448f-9893-8246dade8ebc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7e590b82-bc28-4591-b0ef-6e3f6a18aa4d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_e4e7b949-2127-4964-9342-8d059f4e312b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_49a8510a-65bc-41d0-9241-a46d67bf19e4_terseLabel_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_label_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:href="mck-20220630.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:to="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GovernmentalEntitiesMember_cefd3289-f564-4299-a8b5-95e0677b7678_terseLabel_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental entities</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember" xlink:href="mck-20220630.xsd#mck_GovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GovernmentalEntitiesMember" xlink:to="lab_mck_GovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_1dc424bc-e035-47b3-bbee-0464bf8f48ae_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3125NotesDue2029Member_709b99c0-cd4b-4fbd-9b85-8799cbabe9d5_terseLabel_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member" xlink:href="mck-20220630.xsd#mck_A3125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3125NotesDue2029Member" xlink:to="lab_mck_A3125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_8532c42c-7bd7-4451-9688-722d94a99467_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_2038965f-b878-4842-95ca-d6e40e06cf3b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_13dbdb64-c7d1-4d42-97fd-c6ce1580d07a_negatedTerseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of assets of business held for sale to fair value less costs to sell</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:href="mck-20220630.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0f28e9f1-a270-4931-85a6-31476c6a4801_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_93898c82-67b5-4b2a-a505-8c854b5abdb3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Accrual Liability</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_ccf8605e-a8f1-4b51-a2f8-7ef824dca39a_terseLabel_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan - Remote Work Transitioning</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_label_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning [Member]</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_documentation_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:href="mck-20220630.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:to="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_fe8b00b9-9685-4969-a0c9-b2f7c5cb2ba2_terseLabel_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EUBusinessesDisposalGroupMember" xlink:to="lab_mck_EUBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fdd2a6a4-206b-406a-acad-42d75f5d7d32_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_2f1aaf1d-aa70-48e9-9fee-54a43260c5e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_454d1626-cb31-495d-808e-0f8617ab0643_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_13324276-c9d1-47ac-a598-900d0d1476eb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_8c66d9af-3a30-4cb2-a3cd-6d8c1540b2a3_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_e3c0958f-3a21-4908-a25d-549bc0878824_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_2fd48863-0e8e-437c-8383-6bb226ea4927_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_08aa7baf-79bb-4bfb-88fe-1a44b2f8edc6_terseLabel_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_label_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_documentation_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:href="mck-20220630.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:to="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_6a636d33-8571-4ad3-9566-d71697f41964_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_e32c309d-2577-40d8-a69c-86c8b7fdceed_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 133 and 130 shares at June 30, 2022 and March 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommittedMember_dca8baaa-c60c-4577-8b6f-d09c125d5b1a_terseLabel_en-US" xlink:label="lab_mck_CommittedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed</link:label>
    <link:label id="lab_mck_CommittedMember_label_en-US" xlink:label="lab_mck_CommittedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed [Member]</link:label>
    <link:label id="lab_mck_CommittedMember_documentation_en-US" xlink:label="lab_mck_CommittedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommittedMember" xlink:href="mck-20220630.xsd#mck_CommittedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommittedMember" xlink:to="lab_mck_CommittedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_62472fef-c250-44e3-8b33-bbd556cbe6d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_c7a0634f-4e8f-4799-b0bd-d113a81a1305_terseLabel_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_label_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026 [Member]</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_documentation_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member" xlink:href="mck-20220630.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A163EuroNotesDueOctober302026Member" xlink:to="lab_mck_A163EuroNotesDueOctober302026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_b65715ca-7ae1-449c-8a77-d25448b4d295_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognized pension assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_a6e00c1e-8154-4c6a-8382-c42d980cb0dc_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, provision, after tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision, After Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax" xlink:href="mck-20220630.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualProvisionAfterTax" xlink:to="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_34ea57f6-5eaf-476e-8edc-fe5892e98dfe_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_45df7514-d86f-48f7-ba72-ad0f459b6aa4_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of liabilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6a60d58e-aba0-4645-b8a1-90bd4b2fce29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_b6079d81-3c0b-4375-8e3b-25e2e6553759_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_be4b65e8-da15-4534-9767-e1ec294696bb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_d4a169b5-7935-4b76-b7d5-48f7e0af45db_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b38ed916-3d8b-4063-ae6f-e64be36bf4b4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_f92a4b3e-d6cd-49c2-88c0-826d79098b91_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a4e06c11-d835-4740-907f-8784d6e674fd_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ae7d674a-becb-4a7a-bdf2-5c9446625d17_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_0c88845e-49e6-49bb-8b07-43b0ae6c2736_terseLabel_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_label_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044 [Member]</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_documentation_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member" xlink:href="mck-20220630.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A488NotesDueMarch152044Member" xlink:to="lab_mck_A488NotesDueMarch152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_c7f5a788-5b68-4f21-b26f-a5c3c619239c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_2c20ea4f-07a0-4fe4-ad1c-5bd986e3c327_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2676d15f-236b-4dbc-a148-42f7e27aae0f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1fe39419-5396-4f3b-8c43-9a452068b509_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_4174add3-cce6-461a-bf31-37145078df6f_terseLabel_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_label_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028 [Member]</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_documentation_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member" xlink:href="mck-20220630.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A395NotesDueFebruary162028Member" xlink:to="lab_mck_A395NotesDueFebruary162028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_65af6772-d938-4d96-853c-a5cb0a5a3d4b_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_145d70fe-1f7f-49ca-94d4-169013c5c07e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_f76ca1f3-8b19-45e4-a56c-a19ceacbb52c_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_03ecb396-b81f-46e6-95c2-b468e32d3c01_terseLabel_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_label_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_documentation_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldForSalePolicyTextBlock" xlink:href="mck-20220630.xsd#mck_HeldForSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HeldForSalePolicyTextBlock" xlink:to="lab_mck_HeldForSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_44901d26-ebe5-4aaf-a81b-660cc5590414_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement payment</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_9aaae6bf-ef58-4d8f-a2cd-8b34698b48e1_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f1422da4-fd2f-43e5-bc50-38dd9f34d444_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DistributorsMember_a8fbdb3a-5d99-45ce-97f5-5bdf7779cbb2_terseLabel_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:label id="lab_mck_DistributorsMember_label_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors [Member]</link:label>
    <link:label id="lab_mck_DistributorsMember_documentation_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember" xlink:href="mck-20220630.xsd#mck_DistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DistributorsMember" xlink:to="lab_mck_DistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_45320292-87fd-4219-9ede-31409e2ec142_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_db8cfc76-6746-48b6-ac21-80d41f7a1247_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cb5b600b-e0eb-46a4-b601-3400c1bc1ff6_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_4869962b-14a4-455e-bd8f-0aa521da36a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_55fd1e4d-e01c-4c70-ab5b-4336891ce3ab_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_8d5d34ce-0d84-4d95-ab4e-f2df140271a0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_7437d104-00fa-46bf-94bd-7da473e07405_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_f40b8ec5-359b-461e-8a94-da3a439450ec_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_a5c2cad1-21a5-4f6e-8f20-0dc045f8748b_terseLabel_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages sought per violation, value (per violation)</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_label_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_documentation_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:href="mck-20220630.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:to="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_2073faaf-d866-47a6-9999-705baf132ac5_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_d0369a48-05a1-4dfd-b8d4-ae4ac0f3740f_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_0f073e6f-361d-4612-a9f2-659669d39021_verboseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated increase in Company's ownership interest on its equity</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20220630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_64da84fa-5e8e-49e9-9623-b2425a89b00b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_ee80ef68-e696-4de5-b3b0-edb63b8d6ffc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_1a505dd1-0bb4-430b-88f4-4d0c11d9cd54_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_f0b1deef-1db1-462f-85c9-3459a243c8e5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_06e6bef3-b7e0-4c5f-b95f-183544a34d51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_76de457a-01ae-441b-833b-3a85f502cbb7_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_539db673-b762-44c3-967c-e4d43d7b7938_terseLabel_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_label_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025 [Member]</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_documentation_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member" xlink:href="mck-20220630.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A150EuroNotesDueNovember172025Member" xlink:to="lab_mck_A150EuroNotesDueNovember172025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9e19a455-5158-4693-a944-cba9d12a0a89_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_d4c26b97-f6da-45fd-8c9e-7a56e64a0b58_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar notional amount, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_bdf58db8-0e5b-4ea5-8387-f639f0889091_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, settlement, installment payments, term</link:label>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_label_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Installment Payments, Term</link:label>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Installment Payments, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:to="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4aeb25b1-c47a-4629-843a-56601cca3690_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f86dcf14-b666-4fa0-bf07-fe486f08fdfb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_51d286ca-44f3-41b1-955f-7a2f25c73442_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_e54c41b6-38d5-4b11-850a-43f3a43ecbf7_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which award would be payable under proposed framework</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:to="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_f96fa315-b9dc-4134-9fd5-e899346f72b5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_a597ba2d-21ce-4a77-84f3-1313a7ab270c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f26e1f89-d993-46ab-9530-abbcee4032cb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_c1b44c54-16a0-4a8b-a649-0d5b67f4c132_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_0da50f40-00b7-4b61-89f9-f14d1b73e6db_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_40618302-632b-4e1d-8496-f05ddbaadba3_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20220630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_b97ff5cd-b72f-4f81-811a-1e5c6e56211a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, tax (benefit), share-based payment arrangement, amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_aa69d2bf-3825-413b-9e69-152adc7dd73d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_9fd3624d-1a76-4d9d-a9e3-cbf85ebab5a4_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_3747ed26-851e-427a-9aa8-2854079adccb_terseLabel_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Disposal Group (Disposal Group)</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKBusinessesDisposalGroupMember" xlink:to="lab_mck_UKBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe17bfb3-a512-42ce-8c86-f1d4699ecc4b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND DEFICIT</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c72d65a1-1437-4330-a452-c9097accc64a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherNonCurrentAssetsMember_51a12ecc-7d3a-4be4-a823-af4003b3e921_terseLabel_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_mck_OtherNonCurrentAssetsMember_label_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets [Member]</link:label>
    <link:label id="lab_mck_OtherNonCurrentAssetsMember_documentation_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsMember" xlink:href="mck-20220630.xsd#mck_OtherNonCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherNonCurrentAssetsMember" xlink:to="lab_mck_OtherNonCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_788b2427-2f71-4913-96f4-b5d71c90e817_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20220630.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_3b53bc60-1e6b-49ae-94c6-007e3e843394_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award payable under proposed framework</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_b06e3609-2c67-46e8-a2b3-24fa719dd64b_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of other national distributors named in suit</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:to="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1b4b183-fb15-400b-a112-bff8269d2ab3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e99c94c0-f98f-45d8-8911-ae28186c9592_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_2c269316-2974-4be9-b383-72caa61a1ed4_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_d5fb94ee-71ad-44dd-b084-7ee64a2d6e10_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_9f2775d5-8f1d-49a4-8188-37a78a2faf93_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_06cb6cc5-d130-44be-a3ee-31772ab4da48_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_8c84de7e-035a-48f8-b0b5-0a473cc9f383_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_43c05fd4-f481-45ae-ad1f-7ce319d1e26e_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4a629edc-86e0-4572-a0d4-3872e02a6142_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_ecd490fe-1e35-42e6-90da-be48aacf991e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_832657d1-2981-46c2-aabb-dcb8136b48b1_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_d583f9ef-5b1e-4fae-9005-246f1c1eaeb0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_96121285-5d52-4984-821a-b97ee95945a8_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1ab9e72c-e11a-4849-af0e-ba0995a44c3e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociAttributableToNoncontrollingInterestMember_47a00c91-e075-4d14-8bda-c7b0cf5b25bd_terseLabel_en-US" xlink:label="lab_us-gaap_AociAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_502305db-dc90-4452-940a-c63aefec8a61_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20220630.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_b91f2e9d-a557-4e5c-b1f3-dafd7b356367_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_939e5720-8157-491c-988c-276432f6660c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_44030d01-b280-49a7-b3ef-35304ca9fd6f_terseLabel_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:href="mck-20220630.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_b4866d18-a9bc-4817-bb82-949b36074e22_terseLabel_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember" xlink:href="mck-20220630.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CurrentAssetLiabilityMember" xlink:to="lab_mck_CurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_0064dc8f-7632-44ad-af54-0ef4a5913538_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_a96f47c5-6bac-439e-b1aa-fab7bd4d2ab6_totalLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_e660c1fe-6ae8-43c2-bb4b-a9a1247349e1_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_4d6a38e6-153c-404b-827d-845d8ce39add_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue derived from services, percentage (less than)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20220630.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2ed94292-7b77-4aea-9489-436ac3adadca_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_01a8e384-b673-4c61-a2b5-a377e7641aaa_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_36a74ced-00ab-4205-a15e-2a550b1e3987_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_873a0cac-1e09-4ee5-a86d-a4cc899362cf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4c5e4082-5379-4d0c-960f-3d55e82b5f90_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_115bddd7-b7c0-40bb-b1ee-af0d63b46220_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_09ff1759-6b2a-4727-844d-6fe0dc99d9bc_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_426d627c-eb3a-4171-8caa-ee3b88ab6d69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe853250-1937-4c5c-9c7d-bdc6a8702f0e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f155a7d6-8634-47a3-a6af-77754ac435fd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_02ecacd6-0c2e-4a62-b62d-b7c58f6d35dc_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_680d3f03-c4ea-4bfb-9223-a1f7faeb0662_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e2b61a28-ce0d-479d-9f48-046aa74096fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1625NotesDue2026Member_4adafe35-c10d-4658-ae90-4355050376d5_terseLabel_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member" xlink:href="mck-20220630.xsd#mck_A1625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1625NotesDue2026Member" xlink:to="lab_mck_A1625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_c5f1c382-cb46-451d-a49a-562b2e96b7ea_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_085db6f2-7a17-41d7-b9e9-2056e0de39ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_e50c4366-9bef-49b2-9179-8650f9597efc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_eb079b98-ca40-4122-bd06-8426e274ee12_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_f4f122a5-db0b-4f28-bac5-1ea083951eec_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:to="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_f6dfffc7-ee58-4c20-b8b8-f50b4e371d72_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_0a09be5e-300e-405e-87eb-091a07f71d0b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Commercial Paper, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:to="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_568fa49c-c67e-436a-af15-f52b447c53b8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge recorded related to Company's share of the litigation settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_96288928-85eb-458f-a887-73d6f28db295_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_38384049-00b9-4517-a419-42a579d69c42_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe AG redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_0fc91e52-217d-43f6-85da-67b96c5ec0da_terseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of temporary equity to noncontrolling interest</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_label_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:href="mck-20220630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:to="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_ac7e0752-a934-4416-81a5-41c69eae2a8d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_324231cc-0264-4ef4-a96f-632be80a8348_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_853e3c77-2a9a-4af6-a119-b0f044bb663a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_838af771-8e29-4195-aad1-bb6135ef4e01_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_95ebaa33-bf50-43ab-98e4-7ff816e224a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized amount available for future repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_963dcdf5-3291-4211-9f6b-d4ca35479628_terseLabel_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_label_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_documentation_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:href="mck-20220630.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:to="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_af4a4a70-3346-4c46-88ba-dc9557f472fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_9d508365-464f-4308-9a95-0df336646251_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_ac73f61c-f4fc-43da-ae4c-3db84ede38ee_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e3fdc624-dc95-4645-be00-6bf34176a462_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_45ffc46d-6a9a-467b-9d68-60d3fc2f9925_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a3a1bf43-60a6-486f-8508-ba5d77622f4a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_54b9b00c-193c-4e9a-ac7d-0216f08ea277_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, class action, number of faxes remaining in the class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:href="mck-20220630.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_4ebf611a-2a12-4ef0-a656-21222fea7799_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_331281bf-bb8e-4c21-95dc-2344d7563cd0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collection of notes receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3876e5eb-82b9-4e9b-8a56-713f22680823_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5e9b9ec2-35f3-4cc5-94fa-97ae8e530cf2_terseLabel_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, thereafter</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="mck-20220630.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a84c20a2-92b6-4c9c-83e1-5f52fab2ee16_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_a619a0fd-4156-4582-950d-e9856ddb669b_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_20c06a9e-5067-473d-85bc-c481b0e12204_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_98327b79-4f5b-412f-aadf-7acaf056e60d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_cc5359c1-649f-449d-8cd0-1efc7e38f122_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested net assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_6f08d2af-2cbf-460d-81b5-5dde91b4b4a4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7e98de03-9699-42f5-8cbd-1e477385cbad_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_217e9a91-53a8-4912-b0c4-476158f7a81c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_94f96964-20ce-482a-be8e-df4f40dc2fa4_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AureliusElephantLimitedMember_2cf61d07-3529-4567-aafc-420da716ec2a_terseLabel_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited</link:label>
    <link:label id="lab_mck_AureliusElephantLimitedMember_label_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited [Member]</link:label>
    <link:label id="lab_mck_AureliusElephantLimitedMember_documentation_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember" xlink:href="mck-20220630.xsd#mck_AureliusElephantLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AureliusElephantLimitedMember" xlink:to="lab_mck_AureliusElephantLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_07bb980b-dfe4-4543-bc18-a86f15df8c1f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UncommittedMember_e09752c0-5a21-4e43-948a-7d6777b6c2cb_terseLabel_en-US" xlink:label="lab_mck_UncommittedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted</link:label>
    <link:label id="lab_mck_UncommittedMember_label_en-US" xlink:label="lab_mck_UncommittedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted [Member]</link:label>
    <link:label id="lab_mck_UncommittedMember_documentation_en-US" xlink:label="lab_mck_UncommittedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UncommittedMember" xlink:href="mck-20220630.xsd#mck_UncommittedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UncommittedMember" xlink:to="lab_mck_UncommittedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_5114d945-b89b-433e-844e-8d949b936eb7_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_19434e3e-f8b5-49c9-ace7-cdbf8e979ed0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_53295424-c89b-456f-9ac1-89920bff943e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_01a263a8-f992-4cd0-b0b0-83c2ac34db10_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_0b80b557-6922-47fc-9990-de9a522cdb4f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived asset impairment charges</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_901b81d2-78aa-4a65-b2e7-892fc0059aa1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_e08e601a-1393-47c3-881f-520428de4ce4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8aae3dfc-240e-424d-985a-ed1294341c3d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b796cd9f-dea9-406c-8232-dc7a4f9b9016_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_6a952e16-98b4-4f4b-a1c2-46e638a079df_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8616b9f2-84d3-4232-be29-5db229905a02_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_8436f5a1-2034-4f89-8bf9-6c8163515c78_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_7f37efa2-6f2f-464d-a5c2-2d55ff0f09ab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_547a1aca-1bf4-4623-a075-04a1c4ac0793_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_56675a40-c38a-4727-a86a-3fab17d93a4d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_3fabfc7b-7ec0-493a-8417-5566d6c372fc_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_753b2e40-0f51-4a9c-ad2c-f8000054e735_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_002503bc-620f-4ded-9eb6-c45a8b50dc63_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of settlement to be paid by the Company (percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_9176a33f-5113-425f-acd6-25a90bfd0055_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_293aa4a2-fa6f-4ff3-a689-0eabb9bcdbd3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as net investment hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_f9900336-8478-41a3-994e-fc88ef3840a2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net investment hedge, gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_ee662f27-8c3a-45f8-a458-d17c87b3eb72_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_91937c5c-3507-4f6c-8f02-3349e3190746_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_a82eca0c-64fe-4d92-be1b-e18d0a5d803d_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_aa35e1d8-f93a-4aba-9f31-4bcba6f8bb80_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_296e4164-0e79-47d2-8154-4295c7f5380f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfBusinessOperations_6c7f088b-422f-48d1-8c84-87fba0a7577f_terseLabel_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_label_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_documentation_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations" xlink:href="mck-20220630.xsd#mck_NumberOfBusinessOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfBusinessOperations" xlink:to="lab_mck_NumberOfBusinessOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_5bf2532a-2de8-4642-9749-3322ddbe7f36_terseLabel_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_label_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029 [Member]</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_documentation_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:href="mck-20220630.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:to="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_fd12e94c-3e0f-4d76-82d6-4ebf12a57e17_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_f4d2ca52-1d69-4c11-9e63-54b3f06e6310_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_6a76a660-a496-491b-9c09-fca9e6a72b56_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_d0057c74-03d2-4f70-9b4d-7b2f464d2170_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_0c7d026a-850b-46d9-8777-846c400b31f7_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_b1dbdaed-eda8-4841-b228-5e9a304ba43f_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_812695ef-e8a8-4c4d-ad7e-782d58ef3612_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_f0aa90a9-b789-478c-b7d1-e1145771cb4a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5a8c0fca-6d93-4fb9-a65e-8d2338e11edb_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_e86a82f7-716f-4b2f-82df-12fd71d7becd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d6bed259-254d-4b13-ab3e-3173a9e8a249_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_abf1ee9d-d86d-489b-b5dc-659492634b06_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, remainder of 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_c38716df-99bc-4909-9408-77457dd02c5c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains on Cash Flow Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_e50d5ab2-5cf4-45be-886a-c880068ebb08_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_1b1af910-0105-4bc0-b4da-263423e2b3b4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as net investment hedges:</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_bb6b8f81-be80-451d-ad29-f1121529995b_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swaps</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3fd08f9a-0734-4e9a-9161-99bec6b5575e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_db2fe3f1-2649-45ed-a0df-acafb2d507c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8869078f-a53b-43d0-84f4-db5956e75718_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_be6875b3-1daa-41c4-bbbb-1787f8e8941d_terseLabel_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_label_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022 [Member]</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_documentation_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member" xlink:href="mck-20220630.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A270NotesDueDecember152022Member" xlink:to="lab_mck_A270NotesDueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_bca9b3c2-6478-4c6d-8745-77031a266f75_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b5d156a6-c691-4211-abc0-58480f55accc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_456502bb-0bf3-4615-bc61-59a73f814875_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_66578782-ccaf-4457-af46-8506f92696e6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_f6fc11e8-36a4-4a78-a53b-127ccb0ed241_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_53d6574e-240a-44ac-932a-2a2520bb37b1_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_cf06289c-5e1c-47fd-919e-eb2dba532ede_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:href="mck-20220630.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c0428d26-2e1d-4417-91a1-b47c1263c817_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_99f4d5e8-259a-4266-8ece-a86cf42283e8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_94113a26-206f-42e3-be96-7efc3f0efc56_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_355ff2ff-7f76-4c1c-92db-f65594d69bb2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_e257b3d9-40a1-465b-bf00-5bc2b88efad3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7394bf40-0f40-4263-b447-36c23ef60185_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_403ac1b7-bfd1-49a6-a296-711a712fc3c5_terseLabel_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_label_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023 [Member]</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_documentation_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member" xlink:href="mck-20220630.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A285NotesDueMarch152023Member" xlink:to="lab_mck_A285NotesDueMarch152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_da6332a8-4e13-4b17-9284-89b99ecc11e9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9fe9c48d-6188-4a24-a2c4-76a598b26240_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_312a8350-047c-46f9-be86-7294fc42a5d8_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:href="mck-20220630.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:to="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d414b844-8290-460f-8508-5c394208db4d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_3cf42197-b968-4124-a6e3-730296579bb8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_c0e51540-4113-4290-970d-c8b8522384ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_0389ec0c-b0fb-4473-ac43-ab6e94ad3560_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_0ffed868-1095-4ea4-a8e3-692549315bb3_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right value, interest rate spread (as a percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20220630.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e758bdc0-7562-4c2f-9a06-bf3f3e339797_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EscrowDeposit_fe976efd-e48a-4bf5-a12c-89004b4abe4c_terseLabel_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow deposit</link:label>
    <link:label id="lab_us-gaap_EscrowDeposit_label_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EscrowDeposit" xlink:to="lab_us-gaap_EscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a720bcbc-cacf-4311-9883-25ce4df67f04_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3a6d2e31-be66-4b4a-af62-5c070ef6a86b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computations for basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_9348c339-993c-4a03-98e9-37d97661ec9b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost basis of investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_b8f4bcf1-12b0-4f83-8ada-e22f95c41a45_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20220630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>mck-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18507b8d-c172-4d9a-9fef-a030c1e6a2f5,g:26ea8e13-0c76-4471-91f9-3ae4cfe6c737-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/Cover" xlink:type="simple" xlink:href="mck-20220630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5c53bade-c50a-4b63-9f1a-3fb0d6f1ed1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5547ddc1-f87f-4bf9-bbc1-107f5bb2511e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c53bade-c50a-4b63-9f1a-3fb0d6f1ed1f" xlink:to="loc_dei_EntitiesTable_5547ddc1-f87f-4bf9-bbc1-107f5bb2511e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_553a7b4c-4216-4110-8669-d0972d602529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5547ddc1-f87f-4bf9-bbc1-107f5bb2511e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_553a7b4c-4216-4110-8669-d0972d602529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_553a7b4c-4216-4110-8669-d0972d602529" xlink:to="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_700f9bf2-c026-4b74-aa02-22cfccaa3ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:to="loc_us-gaap_CommonStockMember_700f9bf2-c026-4b74-aa02-22cfccaa3ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_2c188ec2-824f-431a-8bed-3e570d29626b" xlink:href="mck-20220630.xsd#mck_A1500NotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:to="loc_mck_A1500NotesDue2025Member_2c188ec2-824f-431a-8bed-3e570d29626b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_a03e1a1a-2d52-46fe-b72a-ea4c2fcb8442" xlink:href="mck-20220630.xsd#mck_A1625NotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:to="loc_mck_A1625NotesDue2026Member_a03e1a1a-2d52-46fe-b72a-ea4c2fcb8442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_573d41e7-e7ba-4404-a26f-99f039c62edd" xlink:href="mck-20220630.xsd#mck_A3125NotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a262a6e-0c01-434e-853b-602a177ea834" xlink:to="loc_mck_A3125NotesDue2029Member_573d41e7-e7ba-4404-a26f-99f039c62edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5547ddc1-f87f-4bf9-bbc1-107f5bb2511e" xlink:to="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_73052264-ed6d-44ee-917e-6ae38445c7e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentType_73052264-ed6d-44ee-917e-6ae38445c7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5a2f6fb9-30f3-4e16-a83c-f37c7752d7d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentQuarterlyReport_5a2f6fb9-30f3-4e16-a83c-f37c7752d7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_82aab958-25e0-4fb6-b7d6-11eb0ef045cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentTransitionReport_82aab958-25e0-4fb6-b7d6-11eb0ef045cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_6feb0100-e79a-4388-8fdf-006ec6d736ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityFileNumber_6feb0100-e79a-4388-8fdf-006ec6d736ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fd06c8d2-b740-42f0-8292-411889f1adb2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityRegistrantName_fd06c8d2-b740-42f0-8292-411889f1adb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2717142b-11bb-4561-a9d6-d1194aa47545" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2717142b-11bb-4561-a9d6-d1194aa47545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cbaab7be-20b5-44f0-8b1f-dcfaababc8ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityTaxIdentificationNumber_cbaab7be-20b5-44f0-8b1f-dcfaababc8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9e810de9-6534-41f0-8516-b4c08b9d4810" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityAddressAddressLine1_9e810de9-6534-41f0-8516-b4c08b9d4810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_aa70f9ec-69b1-4b12-8535-82150dddd79c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityAddressCityOrTown_aa70f9ec-69b1-4b12-8535-82150dddd79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6743896d-4ad9-47a7-909e-7119afbe55bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityAddressStateOrProvince_6743896d-4ad9-47a7-909e-7119afbe55bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_07b1549b-ee33-4437-a88a-65b5eaf088a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityAddressPostalZipCode_07b1549b-ee33-4437-a88a-65b5eaf088a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f67dcdd9-64dc-4012-a49b-23466187040f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_CityAreaCode_f67dcdd9-64dc-4012-a49b-23466187040f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ef63f1ee-8bf9-4a0d-bed6-5e9d1fd25434" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_LocalPhoneNumber_ef63f1ee-8bf9-4a0d-bed6-5e9d1fd25434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_585cd4ba-4abc-44ae-98c7-d4f1b725ea76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_Security12bTitle_585cd4ba-4abc-44ae-98c7-d4f1b725ea76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_efd3e6fd-eb8d-4dff-94a1-425f40f860b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_TradingSymbol_efd3e6fd-eb8d-4dff-94a1-425f40f860b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_27cbc8fb-6acf-40f3-bed3-32a27cd1db85" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_SecurityExchangeName_27cbc8fb-6acf-40f3-bed3-32a27cd1db85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2de986c5-028f-4787-aaa1-0f67c9b43df8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityCurrentReportingStatus_2de986c5-028f-4787-aaa1-0f67c9b43df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_09b38f8b-1cfa-42f8-939f-845428184d23" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityInteractiveDataCurrent_09b38f8b-1cfa-42f8-939f-845428184d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_462502e5-4f95-48a8-b3d1-c76abf6997d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityFilerCategory_462502e5-4f95-48a8-b3d1-c76abf6997d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_415054ac-90c5-4f2d-9791-3da4bfa2e230" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntitySmallBusiness_415054ac-90c5-4f2d-9791-3da4bfa2e230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_627be232-173b-42ab-bfa5-cc703281bb6c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityEmergingGrowthCompany_627be232-173b-42ab-bfa5-cc703281bb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cd6cb330-cd49-4a70-9556-f1962f959ad7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityShellCompany_cd6cb330-cd49-4a70-9556-f1962f959ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7d55f6c3-ba67-4c44-834c-229d290d3df2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7d55f6c3-ba67-4c44-834c-229d290d3df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ffb73a12-3c27-4956-bfc2-97ec1f008a65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_EntityCentralIndexKey_ffb73a12-3c27-4956-bfc2-97ec1f008a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4ec83697-f958-4157-82d7-d784f50aaa88" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentFiscalYearFocus_4ec83697-f958-4157-82d7-d784f50aaa88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c3c2d306-dca9-4ea6-b8bb-2e927b3e1fca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c3c2d306-dca9-4ea6-b8bb-2e927b3e1fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_004f68d6-cf2f-45e0-be1f-e615d412f68b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_AmendmentFlag_004f68d6-cf2f-45e0-be1f-e615d412f68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_df3f4a6e-2178-4e2a-856f-8c862d8f2a67" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_CurrentFiscalYearEndDate_df3f4a6e-2178-4e2a-856f-8c862d8f2a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6a8fb2de-b2ba-4157-8dbd-bbcd89f579a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_504f1171-1286-4f78-970a-94bced705ffd" xlink:to="loc_dei_DocumentPeriodEndDate_6a8fb2de-b2ba-4157-8dbd-bbcd89f579a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_67eaf025-cc34-4eb5-b4b8-54e9b9d18650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_67eaf025-cc34-4eb5-b4b8-54e9b9d18650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_817ac6df-6ae5-4c07-b1a4-391a68771f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_817ac6df-6ae5-4c07-b1a4-391a68771f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_70dbce29-10e0-46ae-94f5-caecd84058f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_GrossProfit_70dbce29-10e0-46ae-94f5-caecd84058f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e000f973-209c-435e-a391-a23f583ccb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e000f973-209c-435e-a391-a23f583ccb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_a58ad348-7876-49a0-b842-3788bfbb7305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_a58ad348-7876-49a0-b842-3788bfbb7305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_33619767-dc37-49b1-9fa3-8da291d334dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_33619767-dc37-49b1-9fa3-8da291d334dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_45d510e5-7e8f-4c3d-bf7e-f7c53b9fd79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_OperatingExpenses_45d510e5-7e8f-4c3d-bf7e-f7c53b9fd79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_31929cf5-32d3-4e9b-b25a-46fae760ca33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_OperatingIncomeLoss_31929cf5-32d3-4e9b-b25a-46fae760ca33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_173ef1e7-bf6e-4915-8111-ad71d3922323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_173ef1e7-bf6e-4915-8111-ad71d3922323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e3c18510-dc92-475d-a49c-b52d152436d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_InterestExpense_e3c18510-dc92-475d-a49c-b52d152436d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_56138730-0ad8-4d8c-9b2c-2f7a5fd8a851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_56138730-0ad8-4d8c-9b2c-2f7a5fd8a851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_36fd041b-238d-4c7a-b245-413499f19061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_36fd041b-238d-4c7a-b245-413499f19061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_85cf7e3c-b72a-4b8a-897c-06192ab3f67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_85cf7e3c-b72a-4b8a-897c-06192ab3f67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b69c66fe-35d5-425e-bbee-980f0baafe89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b69c66fe-35d5-425e-bbee-980f0baafe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9cb1fc32-02bb-4569-8d9f-c58c41a4231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_ProfitLoss_9cb1fc32-02bb-4569-8d9f-c58c41a4231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ba63f1e-662d-4f55-b441-6244db1b4ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ba63f1e-662d-4f55-b441-6244db1b4ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6e099551-56bc-4511-8d19-2aab1680aed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_NetIncomeLoss_6e099551-56bc-4511-8d19-2aab1680aed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dc95d4aa-8081-4a1e-a95c-f00ff78624b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_EarningsPerShareAbstract_dc95d4aa-8081-4a1e-a95c-f00ff78624b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_40441c8f-f199-4676-b762-0b1d9b175423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dc95d4aa-8081-4a1e-a95c-f00ff78624b6" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_40441c8f-f199-4676-b762-0b1d9b175423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9eb44c3e-b0a2-4428-9068-523b6c95049f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_40441c8f-f199-4676-b762-0b1d9b175423" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9eb44c3e-b0a2-4428-9068-523b6c95049f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_9d318de2-c5b9-40c2-918e-1ac7bac0ec15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_40441c8f-f199-4676-b762-0b1d9b175423" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_9d318de2-c5b9-40c2-918e-1ac7bac0ec15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c25b8d98-320b-4b3d-8e5c-16fa32743723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_40441c8f-f199-4676-b762-0b1d9b175423" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c25b8d98-320b-4b3d-8e5c-16fa32743723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_bb580e9e-4567-446f-9885-06348b0a8b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dc95d4aa-8081-4a1e-a95c-f00ff78624b6" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_bb580e9e-4567-446f-9885-06348b0a8b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a2bf0b2f-b5eb-47fe-ad72-7572602ecc17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bb580e9e-4567-446f-9885-06348b0a8b86" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a2bf0b2f-b5eb-47fe-ad72-7572602ecc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a200007c-b838-4e88-a1a8-9e6903dadd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bb580e9e-4567-446f-9885-06348b0a8b86" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a200007c-b838-4e88-a1a8-9e6903dadd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a177d82b-1506-482e-9dc5-de9aa53dcd51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bb580e9e-4567-446f-9885-06348b0a8b86" xlink:to="loc_us-gaap_EarningsPerShareBasic_a177d82b-1506-482e-9dc5-de9aa53dcd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5c91dfe-c33e-44af-87da-807cf201fbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1a734dd1-2edc-4168-affe-89cb52177649" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5c91dfe-c33e-44af-87da-807cf201fbd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9f64fca2-281b-4809-82ff-dbf29700a730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5c91dfe-c33e-44af-87da-807cf201fbd8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9f64fca2-281b-4809-82ff-dbf29700a730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_40fe036b-b617-4a3b-85f4-024335ffd7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d5c91dfe-c33e-44af-87da-807cf201fbd8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_40fe036b-b617-4a3b-85f4-024335ffd7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_577a5558-4396-4918-acf0-27e9c1474d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_736823e1-e8b8-4e54-ac9d-47c1430e8d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_577a5558-4396-4918-acf0-27e9c1474d11" xlink:to="loc_us-gaap_ProfitLoss_736823e1-e8b8-4e54-ac9d-47c1430e8d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d8ae1c76-ea22-4578-a457-7aa94f943ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_577a5558-4396-4918-acf0-27e9c1474d11" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d8ae1c76-ea22-4578-a457-7aa94f943ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b6c8a968-2af5-437c-ac90-44d8ccf6d84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d8ae1c76-ea22-4578-a457-7aa94f943ec1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b6c8a968-2af5-437c-ac90-44d8ccf6d84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d35e0089-f950-4ef3-879c-f6222eb8218d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d8ae1c76-ea22-4578-a457-7aa94f943ec1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d35e0089-f950-4ef3-879c-f6222eb8218d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7ab13fe5-a77a-463b-af59-c2253653fb60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d8ae1c76-ea22-4578-a457-7aa94f943ec1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7ab13fe5-a77a-463b-af59-c2253653fb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_94b5c0c5-eaa9-4add-a251-444109b61952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d8ae1c76-ea22-4578-a457-7aa94f943ec1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_94b5c0c5-eaa9-4add-a251-444109b61952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ac3ec272-835d-45b2-87cf-5fef61df5ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_577a5558-4396-4918-acf0-27e9c1474d11" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ac3ec272-835d-45b2-87cf-5fef61df5ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_690b922d-260e-4b95-92b5-cd51aad9abd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_577a5558-4396-4918-acf0-27e9c1474d11" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_690b922d-260e-4b95-92b5-cd51aad9abd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_82a4cee8-d8ef-43cc-9bd8-4942701858aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_577a5558-4396-4918-acf0-27e9c1474d11" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_82a4cee8-d8ef-43cc-9bd8-4942701858aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f9eea93f-7ab8-446b-a3df-8a350bc0ba53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f9eea93f-7ab8-446b-a3df-8a350bc0ba53" xlink:to="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3be0c853-d420-4fb9-82d1-8481c9181353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3be0c853-d420-4fb9-82d1-8481c9181353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_727d3b70-d0ca-4d88-839c-3491abc2eaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3be0c853-d420-4fb9-82d1-8481c9181353" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_727d3b70-d0ca-4d88-839c-3491abc2eaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_2ecfe119-0e81-4c68-8a6d-e65513288c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3be0c853-d420-4fb9-82d1-8481c9181353" xlink:to="loc_us-gaap_ReceivablesNetCurrent_2ecfe119-0e81-4c68-8a6d-e65513288c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a7ce47bf-ad8f-4060-aaaa-1c3833d42330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3be0c853-d420-4fb9-82d1-8481c9181353" xlink:to="loc_us-gaap_InventoryNet_a7ce47bf-ad8f-4060-aaaa-1c3833d42330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_97ba84a0-c5d0-44a5-9d5b-ea0278ac8e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3be0c853-d420-4fb9-82d1-8481c9181353" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_97ba84a0-c5d0-44a5-9d5b-ea0278ac8e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_38b6b15c-6bbc-4a97-9ab6-21b1bdc81cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3be0c853-d420-4fb9-82d1-8481c9181353" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_38b6b15c-6bbc-4a97-9ab6-21b1bdc81cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1e231790-b6ab-4b4d-96b0-ac4b3b8118d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3be0c853-d420-4fb9-82d1-8481c9181353" xlink:to="loc_us-gaap_AssetsCurrent_1e231790-b6ab-4b4d-96b0-ac4b3b8118d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_69eda88e-c28d-49ad-9462-679755efd261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_69eda88e-c28d-49ad-9462-679755efd261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e7a7ba95-8c07-42b6-8c47-c894c06d99d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e7a7ba95-8c07-42b6-8c47-c894c06d99d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0e41e2b6-73ac-4243-9be9-d8800c0e03c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:to="loc_us-gaap_Goodwill_0e41e2b6-73ac-4243-9be9-d8800c0e03c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_741b51a5-33f5-421a-8132-f7a23c39ea85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_741b51a5-33f5-421a-8132-f7a23c39ea85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_079ce32c-9181-4e4d-8f7c-02b625b084ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_079ce32c-9181-4e4d-8f7c-02b625b084ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_89f8187a-446e-4bb9-8ebf-b6c796f64360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f2f04ae-66c4-4ffa-a067-5857d6eefc07" xlink:to="loc_us-gaap_Assets_89f8187a-446e-4bb9-8ebf-b6c796f64360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f9eea93f-7ab8-446b-a3df-8a350bc0ba53" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_31d4aede-3d1f-4c76-b539-0fe2342db071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:to="loc_us-gaap_AccountsPayableCurrent_31d4aede-3d1f-4c76-b539-0fe2342db071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_3a2d194c-3168-4ba8-bfc6-f15bf22ace96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_3a2d194c-3168-4ba8-bfc6-f15bf22ace96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9cfe4bd8-e4a1-422d-9b72-1f413964cf61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9cfe4bd8-e4a1-422d-9b72-1f413964cf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6d5db086-808a-40d7-bba6-1ffb8c946b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6d5db086-808a-40d7-bba6-1ffb8c946b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f4b7f497-dfd2-44d1-be49-be07c63d726d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f4b7f497-dfd2-44d1-be49-be07c63d726d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0a711af7-7fc5-48e7-8909-8628e4b50492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:to="loc_us-gaap_LiabilitiesCurrent_0a711af7-7fc5-48e7-8909-8628e4b50492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_08da06f3-344d-4303-ae36-c326b8b9bec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fa6dc13-642d-44fb-8e5d-a80ac9fc22af" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_08da06f3-344d-4303-ae36-c326b8b9bec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_50459718-585a-4fa3-bfbe-b93e5725b856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_50459718-585a-4fa3-bfbe-b93e5725b856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8481598d-88c4-4dd4-a67d-e1dc0069c1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8481598d-88c4-4dd4-a67d-e1dc0069c1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_b4182d28-b1d0-4773-8c96-1cf4a9aba804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_b4182d28-b1d0-4773-8c96-1cf4a9aba804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cf4f46e9-b27e-4fc3-a6f9-649826bfcd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cf4f46e9-b27e-4fc3-a6f9-649826bfcd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:to="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_dc091e35-ffd9-432f-a9b2-3fcc333c04a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_PreferredStockValue_dc091e35-ffd9-432f-a9b2-3fcc333c04a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_46687403-76d1-434e-9309-3e97360de173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_CommonStockValue_46687403-76d1-434e-9309-3e97360de173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4f7fae4f-c2c8-4bc4-884a-66044fc70cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4f7fae4f-c2c8-4bc4-884a-66044fc70cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aab938ce-0550-4ef9-a7a8-4766ae5a957f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aab938ce-0550-4ef9-a7a8-4766ae5a957f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dccb784a-422a-4a8d-b8b2-fa759a8f8771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dccb784a-422a-4a8d-b8b2-fa759a8f8771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_a93ee37a-7479-45a0-8580-383d03996a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_TreasuryStockValue_a93ee37a-7479-45a0-8580-383d03996a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e749685b-220d-4d92-a438-ea77af5b6244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_StockholdersEquity_e749685b-220d-4d92-a438-ea77af5b6244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_43d49753-6849-4077-a252-da42f1371159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_MinorityInterest_43d49753-6849-4077-a252-da42f1371159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32d08a0a-83f4-4298-ba02-3354f202ea02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_183d5761-1d5f-4603-aaa6-a22faf940220" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32d08a0a-83f4-4298-ba02-3354f202ea02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4073043f-41e4-4362-a9f4-d7e3f3181be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_359064b2-2149-4f15-aadb-6ec0e484490d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4073043f-41e4-4362-a9f4-d7e3f3181be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ee857b82-da40-4dc8-8fcb-812a0ef87cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ee857b82-da40-4dc8-8fcb-812a0ef87cf2" xlink:to="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c5f0fe04-f14e-4185-b4bc-c3f91aa0e201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c5f0fe04-f14e-4185-b4bc-c3f91aa0e201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b5af7c2f-edf2-4de3-8129-6f5b4a89e5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b5af7c2f-edf2-4de3-8129-6f5b4a89e5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f89d438e-aaf0-4f8a-b1a6-b625ae11e06a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f89d438e-aaf0-4f8a-b1a6-b625ae11e06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_efd2f699-19ed-416d-804b-a785f471c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_efd2f699-19ed-416d-804b-a785f471c1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b3a9d459-6993-4294-ac97-63bcb31e6c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b3a9d459-6993-4294-ac97-63bcb31e6c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d3ac9be8-78c5-4d9d-9e4e-bc415db34709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d3ac9be8-78c5-4d9d-9e4e-bc415db34709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8d5acb12-9251-4117-a11a-6dc2942ed141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:to="loc_us-gaap_CommonStockSharesIssued_8d5acb12-9251-4117-a11a-6dc2942ed141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_9f2dee29-1756-4fbb-8607-4c32e064c70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_00428bef-6939-4fe8-a4d6-e699358cb475" xlink:to="loc_us-gaap_TreasuryStockShares_9f2dee29-1756-4fbb-8607-4c32e064c70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_37032dae-a5d8-4956-9c63-d3cfe18a206d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ea5180c6-ece1-4ee0-8816-1efd478a8dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_37032dae-a5d8-4956-9c63-d3cfe18a206d" xlink:to="loc_us-gaap_StatementTable_ea5180c6-ece1-4ee0-8816-1efd478a8dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e5807de1-8f77-440a-a0ff-21a2e22eba16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ea5180c6-ece1-4ee0-8816-1efd478a8dcc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e5807de1-8f77-440a-a0ff-21a2e22eba16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e5807de1-8f77-440a-a0ff-21a2e22eba16" xlink:to="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4f93b422-df1e-465f-bb44-b4c22cd849bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_CommonStockMember_4f93b422-df1e-465f-bb44-b4c22cd849bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_14d7dfe0-cc14-4640-8546-1055b1eb5a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_14d7dfe0-cc14-4640-8546-1055b1eb5a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_897159e1-2d69-4f63-ab14-a18202f2ee3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_RetainedEarningsMember_897159e1-2d69-4f63-ab14-a18202f2ee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7c84c952-c923-4d58-bebf-0c77140e2ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7c84c952-c923-4d58-bebf-0c77140e2ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_3c9df9e4-c706-4f32-aa2c-05823ee53399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_TreasuryStockCommonMember_3c9df9e4-c706-4f32-aa2c-05823ee53399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_dbe754dd-fca8-4b8f-a968-29e455e8ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_23aaf12a-1945-45e2-81d4-132746101a32" xlink:to="loc_us-gaap_NoncontrollingInterestMember_dbe754dd-fca8-4b8f-a968-29e455e8ad6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_989f4c80-9298-4edf-9f9b-a168fc9f3855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ea5180c6-ece1-4ee0-8816-1efd478a8dcc" xlink:to="loc_us-gaap_StatementLineItems_989f4c80-9298-4edf-9f9b-a168fc9f3855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_989f4c80-9298-4edf-9f9b-a168fc9f3855" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2aa241d7-5099-4190-989b-008f86d15c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_SharesOutstanding_2aa241d7-5099-4190-989b-008f86d15c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_2ad51dd4-204c-4cb9-81c6-228f4251f3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_2ad51dd4-204c-4cb9-81c6-228f4251f3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54616ad5-616b-4ded-9940-0080947f1fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54616ad5-616b-4ded-9940-0080947f1fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_b033a9f3-3959-44bf-bde6-2b4d1b77dd29" xlink:href="mck-20220630.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_b033a9f3-3959-44bf-bde6-2b4d1b77dd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_c8337ddd-4160-4a14-9523-3059c39ef8cd" xlink:href="mck-20220630.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_c8337ddd-4160-4a14-9523-3059c39ef8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_20f9b5af-6c8a-49fd-b6ac-6c71f3461aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_20f9b5af-6c8a-49fd-b6ac-6c71f3461aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0a7cff7e-b320-4ead-ad0d-df34ae1b77a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_0a7cff7e-b320-4ead-ad0d-df34ae1b77a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3f575d36-abc1-4a03-9ac4-8b3f09ebbaca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3f575d36-abc1-4a03-9ac4-8b3f09ebbaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_2bf8f508-88a3-47fc-8609-f3ec2b3e88cc" xlink:href="mck-20220630.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_2bf8f508-88a3-47fc-8609-f3ec2b3e88cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_28bd4061-cb7e-44b0-81f7-35653d3c3a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_28bd4061-cb7e-44b0-81f7-35653d3c3a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_b81ffdce-d8e4-4b19-9fbd-cb781a21ebed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_b81ffdce-d8e4-4b19-9fbd-cb781a21ebed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_cff512d2-668a-4e21-8821-c0793c876c4e" xlink:href="mck-20220630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_cff512d2-668a-4e21-8821-c0793c876c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_2c6703d5-e726-4834-89dc-809758985095" xlink:href="mck-20220630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_2c6703d5-e726-4834-89dc-809758985095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_611c4e6c-ae11-4be2-9c70-10249cef70a1" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_611c4e6c-ae11-4be2-9c70-10249cef70a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_ebbd1e35-b4d7-4948-9e02-724721cb4775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_DividendsCommonStockCash_ebbd1e35-b4d7-4948-9e02-724721cb4775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_2aa59fcb-e850-481b-8d3f-8ca410da4bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockholdersEquityOther_2aa59fcb-e850-481b-8d3f-8ca410da4bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_21170d4b-5e54-4435-95f9-15829b7e04a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_SharesOutstanding_21170d4b-5e54-4435-95f9-15829b7e04a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_9b7804a9-0448-454f-8104-0f7992b521ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_9b7804a9-0448-454f-8104-0f7992b521ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2408e180-8fda-467f-884f-4d8d5cf425a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_67c445b1-1aa2-4f4a-ace8-ab8319dab08f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2408e180-8fda-467f-884f-4d8d5cf425a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_94922e85-d8b7-42c4-a040-90f5b7fcf1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_255f37a7-a212-4dcd-911e-7359d00e3ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_94922e85-d8b7-42c4-a040-90f5b7fcf1d8" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_255f37a7-a212-4dcd-911e-7359d00e3ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d350c0e-b507-4fa0-968f-ef64d50a1a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d350c0e-b507-4fa0-968f-ef64d50a1a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9b134324-1a8f-4c11-9837-d97af6de1ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d350c0e-b507-4fa0-968f-ef64d50a1a5e" xlink:to="loc_us-gaap_ProfitLoss_9b134324-1a8f-4c11-9837-d97af6de1ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d350c0e-b507-4fa0-968f-ef64d50a1a5e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_36fe33ad-d34f-4b12-a9f3-bc11ca682b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_Depreciation_36fe33ad-d34f-4b12-a9f3-bc11ca682b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_7f5c5d99-88ef-4e1a-ba20-987e656e4950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_AdjustmentForAmortization_7f5c5d99-88ef-4e1a-ba20-987e656e4950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_6211bacc-ba0e-4ce4-afbe-e2cf6295d176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_6211bacc-ba0e-4ce4-afbe-e2cf6295d176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a4fcad47-be9a-44ce-8f15-8c15a14981bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a4fcad47-be9a-44ce-8f15-8c15a14981bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_c884d239-5617-4ce8-9b0b-b8050262ead4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_c884d239-5617-4ce8-9b0b-b8050262ead4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_cb9c73d3-577b-4c6b-b8ae-980dc7c870d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_OperatingLeaseExpense_cb9c73d3-577b-4c6b-b8ae-980dc7c870d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_b0662dd8-0b6c-4dcb-a8e5-119146a31936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_b0662dd8-0b6c-4dcb-a8e5-119146a31936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_ebbc0aaf-9e46-4340-9f57-3cb6f3dd6f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_ebbc0aaf-9e46-4340-9f57-3cb6f3dd6f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_7aad0b62-3c28-404b-b665-761fa0678710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_7aad0b62-3c28-404b-b665-761fa0678710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c7a8d4c9-44b8-4501-83e0-374c062356a7" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_9f14b230-9edf-40ae-a455-2d251067a794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_9f14b230-9edf-40ae-a455-2d251067a794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_231a53f1-8ab9-418a-9412-f91490e608bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_231a53f1-8ab9-418a-9412-f91490e608bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_33fc99b0-8de6-4a23-b841-c21414db4e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_33fc99b0-8de6-4a23-b841-c21414db4e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8f27308b-5590-405f-a5ef-ae41ad461224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8f27308b-5590-405f-a5ef-ae41ad461224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_352c20a5-f9c6-4529-92d8-d11e02b4cd58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_352c20a5-f9c6-4529-92d8-d11e02b4cd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_5049709a-82b3-4690-90f4-173010196d46" xlink:href="mck-20220630.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_5049709a-82b3-4690-90f4-173010196d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e313ba43-db11-4d79-9ead-16abcb9673ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_44f588fe-f3d6-4ad1-ba3a-4b780a5b311e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e313ba43-db11-4d79-9ead-16abcb9673ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea793b78-e08b-45df-acf6-425b1da8ae5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d350c0e-b507-4fa0-968f-ef64d50a1a5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea793b78-e08b-45df-acf6-425b1da8ae5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52d63870-207b-41f8-8707-f2634f27f19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52d63870-207b-41f8-8707-f2634f27f19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a7aa68ce-9808-4363-828f-10befa169132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52d63870-207b-41f8-8707-f2634f27f19f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a7aa68ce-9808-4363-828f-10befa169132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_c6949df9-c0a2-40ef-8fc2-8f38e2615ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52d63870-207b-41f8-8707-f2634f27f19f" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_c6949df9-c0a2-40ef-8fc2-8f38e2615ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0ef0376d-72c1-4c3d-8c63-dae6406c48eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52d63870-207b-41f8-8707-f2634f27f19f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0ef0376d-72c1-4c3d-8c63-dae6406c48eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_f8faa506-877b-4c53-bc8e-f8e515d4f514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52d63870-207b-41f8-8707-f2634f27f19f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_f8faa506-877b-4c53-bc8e-f8e515d4f514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_21d8074f-e7cd-4cdb-bd51-c37e7b5bb391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52d63870-207b-41f8-8707-f2634f27f19f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_21d8074f-e7cd-4cdb-bd51-c37e7b5bb391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fca2596c-a02e-4370-846d-91c4230fa5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52d63870-207b-41f8-8707-f2634f27f19f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fca2596c-a02e-4370-846d-91c4230fa5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62b8b052-28c3-40ac-8537-f352b6b1e803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62b8b052-28c3-40ac-8537-f352b6b1e803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a5d4112c-b826-47b7-af06-d2479749ec9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62b8b052-28c3-40ac-8537-f352b6b1e803" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a5d4112c-b826-47b7-af06-d2479749ec9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_98f8dca5-6750-4b52-aeba-4c060f3e5549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62b8b052-28c3-40ac-8537-f352b6b1e803" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_98f8dca5-6750-4b52-aeba-4c060f3e5549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6a82198f-fd91-4bdf-8283-149c0da518ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_98f8dca5-6750-4b52-aeba-4c060f3e5549" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6a82198f-fd91-4bdf-8283-149c0da518ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ed7aa9d1-55fd-448b-bcff-aba938250738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_98f8dca5-6750-4b52-aeba-4c060f3e5549" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ed7aa9d1-55fd-448b-bcff-aba938250738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_cb7c8359-a681-43e1-bf12-3d2b04ef898f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62b8b052-28c3-40ac-8537-f352b6b1e803" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_cb7c8359-a681-43e1-bf12-3d2b04ef898f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_6d144010-a1d3-465d-bc5b-d7b6107b0cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62b8b052-28c3-40ac-8537-f352b6b1e803" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_6d144010-a1d3-465d-bc5b-d7b6107b0cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f7c9cb37-ee8f-4781-8512-cde3bdb2c487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62b8b052-28c3-40ac-8537-f352b6b1e803" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f7c9cb37-ee8f-4781-8512-cde3bdb2c487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed76d230-327f-46c7-8002-d183070a9649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62b8b052-28c3-40ac-8537-f352b6b1e803" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed76d230-327f-46c7-8002-d183070a9649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f453ec63-1452-4525-9131-e4c8161701ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f453ec63-1452-4525-9131-e4c8161701ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_14ea97e0-9f4c-4bc0-a19a-58ca0460e6e8" xlink:href="mck-20220630.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_14ea97e0-9f4c-4bc0-a19a-58ca0460e6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6f96df02-e7b8-42fe-b9f5-e7e7e85e6156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6f96df02-e7b8-42fe-b9f5-e7e7e85e6156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5c8b9343-dcc2-4bc7-831b-746d2ddc6873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5c8b9343-dcc2-4bc7-831b-746d2ddc6873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7135300-aed7-4ef3-8e0d-590516dfc119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7135300-aed7-4ef3-8e0d-590516dfc119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_65619681-0fe1-40ea-8ccb-e37f42b2c5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_RestrictedCashCurrent_65619681-0fe1-40ea-8ccb-e37f42b2c5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_462ba116-90a4-458c-80b5-32298f309580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_375e3881-0412-4219-b9b4-83042fd015a8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_462ba116-90a4-458c-80b5-32298f309580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20220630.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2539c1c7-7e90-4d5a-858e-3a255a73e996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_1b849ce4-cd61-4149-8aa2-bb10c3405578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2539c1c7-7e90-4d5a-858e-3a255a73e996" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_1b849ce4-cd61-4149-8aa2-bb10c3405578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20220630.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a29d404f-d8aa-48a8-a850-26e705f1ca05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a29d404f-d8aa-48a8-a850-26e705f1ca05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_921cf572-b771-4ee5-94b3-d41b77684f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_us-gaap_FiscalPeriod_921cf572-b771-4ee5-94b3-d41b77684f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_999c91ef-b91f-4f95-ad74-10433f7f565e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_999c91ef-b91f-4f95-ad74-10433f7f565e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_37d151dd-f0d8-40d0-8c03-f40b09ecc666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_us-gaap_UseOfEstimates_37d151dd-f0d8-40d0-8c03-f40b09ecc666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData_52aad82a-2164-4702-9968-e1ad4a557672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComparabilityOfPriorYearFinancialData"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_us-gaap_ComparabilityOfPriorYearFinancialData_52aad82a-2164-4702-9968-e1ad4a557672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0cb99095-6a0d-4f0c-87f3-c4f376ea6cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0cb99095-6a0d-4f0c-87f3-c4f376ea6cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldForSalePolicyTextBlock_09061256-e71e-437c-849b-2e14000a6a94" xlink:href="mck-20220630.xsd#mck_HeldForSalePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_mck_HeldForSalePolicyTextBlock_09061256-e71e-437c-849b-2e14000a6a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_d58f84af-5ad8-43d6-b25e-1981124f7244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_d58f84af-5ad8-43d6-b25e-1981124f7244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_3bbc525e-85c8-4490-8e31-a710a3c07ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77841074-7d1a-441d-b2a6-428f77eaaf3b" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_3bbc525e-85c8-4490-8e31-a710a3c07ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_99802fa3-6fe7-4cc2-bb9b-8765fe6066b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_839d6249-77ce-45b7-8e5f-d306500d5375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_99802fa3-6fe7-4cc2-bb9b-8765fe6066b9" xlink:to="loc_us-gaap_SubsequentEventTable_839d6249-77ce-45b7-8e5f-d306500d5375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f5929c3a-fd89-40fb-aad4-3707ed3e253c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_839d6249-77ce-45b7-8e5f-d306500d5375" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f5929c3a-fd89-40fb-aad4-3707ed3e253c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ea1277a3-7d3c-4822-82a9-09d4f0fee4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f5929c3a-fd89-40fb-aad4-3707ed3e253c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ea1277a3-7d3c-4822-82a9-09d4f0fee4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8eaea6c4-950f-4331-807f-0ce6813e3234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ea1277a3-7d3c-4822-82a9-09d4f0fee4fc" xlink:to="loc_us-gaap_SubsequentEventMember_8eaea6c4-950f-4331-807f-0ce6813e3234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_839d6249-77ce-45b7-8e5f-d306500d5375" xlink:to="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_6bb60108-460d-4c44-84f0-c348b53e1a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:to="loc_us-gaap_NumberOfReportableSegments_6bb60108-460d-4c44-84f0-c348b53e1a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_34bd0174-f1a2-4242-a668-a1b5068bc0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_34bd0174-f1a2-4242-a668-a1b5068bc0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_25b93f20-42e0-4260-85ab-76f5de2ce89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5a754b49-9379-449d-bdcc-2eca997fdd1d" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_25b93f20-42e0-4260-85ab-76f5de2ce89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20220630.xsd#HeldforSale"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c3f5764c-9464-4e31-a8e2-c27cbd4dd244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_9c286e9d-00fd-4bce-9ff1-fd256aa12405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c3f5764c-9464-4e31-a8e2-c27cbd4dd244" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_9c286e9d-00fd-4bce-9ff1-fd256aa12405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20220630.xsd#HeldforSaleTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a4f277d4-9ce6-4201-9101-a0ded2227084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b4740e0f-df5a-4bdf-922f-94f5c0fc5af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a4f277d4-9ce6-4201-9101-a0ded2227084" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b4740e0f-df5a-4bdf-922f-94f5c0fc5af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3d633be9-853a-44ca-96c0-51519f0cabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3d633be9-853a-44ca-96c0-51519f0cabfd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_497f3411-4595-4f16-883a-222b6c3a2a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_497f3411-4595-4f16-883a-222b6c3a2a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_497f3411-4595-4f16-883a-222b6c3a2a37" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_d86cf25d-0410-4b2d-84e3-fe9ee1fd8811" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_d86cf25d-0410-4b2d-84e3-fe9ee1fd8811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_6a56bf96-6aba-469f-ad3f-0778bf2d347e" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_6a56bf96-6aba-469f-ad3f-0778bf2d347e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7d2ecc4e-4f02-475e-8d18-33c60a53423c" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0717b76c-360d-4aee-a003-48592b2e48a9" xlink:to="loc_mck_InternationalSegmentMember_7d2ecc4e-4f02-475e-8d18-33c60a53423c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c3f43c54-e4f9-4148-ad7c-2db999ee9c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c3f43c54-e4f9-4148-ad7c-2db999ee9c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3e332c6b-27fc-40f0-b742-1272c933238a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c3f43c54-e4f9-4148-ad7c-2db999ee9c35" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3e332c6b-27fc-40f0-b742-1272c933238a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_313b23c7-8eb3-4117-96a8-ae0e34f87713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3e332c6b-27fc-40f0-b742-1272c933238a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_313b23c7-8eb3-4117-96a8-ae0e34f87713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_79d72c1c-171b-42b9-8604-f15e4567d680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3e332c6b-27fc-40f0-b742-1272c933238a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_79d72c1c-171b-42b9-8604-f15e4567d680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9a9b3015-a76b-40be-9b67-8ceac70f349d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:to="loc_dei_LegalEntityAxis_9a9b3015-a76b-40be-9b67-8ceac70f349d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7a586d2b-fe67-4fd6-9e3b-80a42bec56d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_9a9b3015-a76b-40be-9b67-8ceac70f349d" xlink:to="loc_dei_EntityDomain_7a586d2b-fe67-4fd6-9e3b-80a42bec56d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember_ccaba33d-0cb0-42a3-bfbb-c21baa2c2d6d" xlink:href="mck-20220630.xsd#mck_AureliusElephantLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7a586d2b-fe67-4fd6-9e3b-80a42bec56d8" xlink:to="loc_mck_AureliusElephantLimitedMember_ccaba33d-0cb0-42a3-bfbb-c21baa2c2d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e12f837d-6cf8-43a8-9a4f-08184130c902" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_25dd8749-5e66-4d05-8143-17433a5ad9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_25dd8749-5e66-4d05-8143-17433a5ad9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_94646633-7152-42bf-bc37-903c3be790ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_94646633-7152-42bf-bc37-903c3be790ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_161cf931-4676-40de-a9e1-795947724148" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_161cf931-4676-40de-a9e1-795947724148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_2e30fea6-cbe7-4038-88be-40811f76ad40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_2e30fea6-cbe7-4038-88be-40811f76ad40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_ffb95cd0-0388-40dd-8e2b-bf87d4966966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_ffb95cd0-0388-40dd-8e2b-bf87d4966966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_5c66c53d-f2ea-4a3f-bb4c-e1c8c07cb3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_5c66c53d-f2ea-4a3f-bb4c-e1c8c07cb3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ba5c2d8c-e415-438c-bd08-149c085354d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ba5c2d8c-e415-438c-bd08-149c085354d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_bac1e4ae-436b-4a17-b623-f185c847fecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_14c6f1e4-0f70-4664-9243-0596db025a0c" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_bac1e4ae-436b-4a17-b623-f185c847fecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_40d32096-4cb2-4652-9c04-d459b5de5cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_40d32096-4cb2-4652-9c04-d459b5de5cbb" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3bf9731e-6a0b-4c0a-ae04-286ef1c76545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3bf9731e-6a0b-4c0a-ae04-286ef1c76545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3bf9731e-6a0b-4c0a-ae04-286ef1c76545" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_8fb5922e-9e38-46eb-b0c2-a85b28420363" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_8fb5922e-9e38-46eb-b0c2-a85b28420363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_6f92e091-00aa-4586-818e-16d038b38fc8" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_6f92e091-00aa-4586-818e-16d038b38fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_8741569f-f4d6-4e1d-ba65-7a61f087b065" xlink:href="mck-20220630.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_36cdeff1-8cc5-4f27-807e-18147cbc33c5" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_8741569f-f4d6-4e1d-ba65-7a61f087b065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_59dec6d1-8c6e-43b5-9a63-72dad00b415b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e6c5c3d3-34df-45e4-94dc-165ed3a59ec3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_59dec6d1-8c6e-43b5-9a63-72dad00b415b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7752cddd-242a-46d7-afb0-bfa2a1136992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_59dec6d1-8c6e-43b5-9a63-72dad00b415b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7752cddd-242a-46d7-afb0-bfa2a1136992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd30a5d6-0f06-4c75-bfa9-2a4b641249e5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_d2680e0d-1115-402f-9d1d-e791c2868ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_d2680e0d-1115-402f-9d1d-e791c2868ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a404d84f-0d8d-47d8-a28a-9bc432799980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a404d84f-0d8d-47d8-a28a-9bc432799980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ba85089f-3c34-414b-afe0-2d3de861f19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ba85089f-3c34-414b-afe0-2d3de861f19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_b021cdab-4f35-4152-bb27-5bd57da2e16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_b021cdab-4f35-4152-bb27-5bd57da2e16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_ec900790-5581-426c-b25f-3a42b1b879f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_ec900790-5581-426c-b25f-3a42b1b879f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_64aeb0ef-3b3a-49d6-a460-33d2b48f5513" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_64aeb0ef-3b3a-49d6-a460-33d2b48f5513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d3272295-080f-4556-a6c6-ab411171900e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d3272295-080f-4556-a6c6-ab411171900e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_a1a8cdcc-9b03-417f-bc11-8827efa88abe" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_a1a8cdcc-9b03-417f-bc11-8827efa88abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_e2d417aa-f2ad-4bc9-a3be-c0811dca30f6" xlink:href="mck-20220630.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_e2d417aa-f2ad-4bc9-a3be-c0811dca30f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a73163b3-e011-4faa-80ca-a450ac98d378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_77d632e0-7dbf-4412-b4bd-67575e3fd658" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a73163b3-e011-4faa-80ca-a450ac98d378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_61e4580f-589d-4382-b34f-80f18eb95b5d" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_61e4580f-589d-4382-b34f-80f18eb95b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_57e9d7c5-0b9f-4b15-9733-361250788762" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_57e9d7c5-0b9f-4b15-9733-361250788762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_587e5f88-eea7-40e2-b46f-7a93c5a4b51c" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_587e5f88-eea7-40e2-b46f-7a93c5a4b51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_5a28a39e-7bf9-4efd-b049-708fe2610ac3" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_5a28a39e-7bf9-4efd-b049-708fe2610ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_9401f989-87df-48a8-99a9-7edfcdd61dfb" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_9401f989-87df-48a8-99a9-7edfcdd61dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_06a7df63-f631-41a4-90b3-457ead5494d4" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_06a7df63-f631-41a4-90b3-457ead5494d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_58bb3582-959b-41e9-acac-6de4bddba88b" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_58bb3582-959b-41e9-acac-6de4bddba88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_b1753a14-44b6-4ab4-86e9-9c08f8a44619" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_b1753a14-44b6-4ab4-86e9-9c08f8a44619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a7365556-1a91-4f43-880c-777e44513860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_73cf36ab-b9f4-4903-a825-a87d0f97bb52" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a7365556-1a91-4f43-880c-777e44513860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_ca0c8c67-b37a-4a47-822b-5172940644b8" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_174f425a-d854-440e-b3e2-3aa834af5bc6" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_ca0c8c67-b37a-4a47-822b-5172940644b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5b615e5f-acfd-4341-9100-cad5cc779d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8445a3e8-e0b6-4356-a8b4-bc06cbf59bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5b615e5f-acfd-4341-9100-cad5cc779d33" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8445a3e8-e0b6-4356-a8b4-bc06cbf59bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d201987b-dd52-41a5-bdb1-171e0876c20a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_3a6b8677-2fce-424b-84d2-fedca79f70cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d201987b-dd52-41a5-bdb1-171e0876c20a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_3a6b8677-2fce-424b-84d2-fedca79f70cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_28c8290e-1584-4042-820f-941c37532a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d201987b-dd52-41a5-bdb1-171e0876c20a" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_28c8290e-1584-4042-820f-941c37532a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_27c835dd-2c61-4dc0-aa3b-84e48eec16fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_888fe8ec-17ac-4291-a2a5-6e230f900082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_27c835dd-2c61-4dc0-aa3b-84e48eec16fd" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_888fe8ec-17ac-4291-a2a5-6e230f900082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_43298035-0ba4-4e22-9569-acccb440ec90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_888fe8ec-17ac-4291-a2a5-6e230f900082" xlink:to="loc_us-gaap_RestructuringPlanAxis_43298035-0ba4-4e22-9569-acccb440ec90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9001c470-0ebc-4ef9-b00c-4bd43566f843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_43298035-0ba4-4e22-9569-acccb440ec90" xlink:to="loc_us-gaap_RestructuringPlanDomain_9001c470-0ebc-4ef9-b00c-4bd43566f843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_a7d191b3-42e3-42f9-9fb0-a99f6b106d8a" xlink:href="mck-20220630.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9001c470-0ebc-4ef9-b00c-4bd43566f843" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_a7d191b3-42e3-42f9-9fb0-a99f6b106d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a1dda5f0-c327-40b0-baf0-f408c532b1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_888fe8ec-17ac-4291-a2a5-6e230f900082" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_a1dda5f0-c327-40b0-baf0-f408c532b1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_40db1ca7-7378-43d5-a000-54c6a8e875d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a1dda5f0-c327-40b0-baf0-f408c532b1c6" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_40db1ca7-7378-43d5-a000-54c6a8e875d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_792d47ab-ff7b-4e38-93d1-0e85965466c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a1dda5f0-c327-40b0-baf0-f408c532b1c6" xlink:to="loc_us-gaap_RestructuringCharges_792d47ab-ff7b-4e38-93d1-0e85965466c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d6f076ce-0dad-41a0-846f-ca29896187d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d6f076ce-0dad-41a0-846f-ca29896187d2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_85121956-fafb-45e2-b20d-0da582fd544e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:to="loc_srt_ConsolidationItemsAxis_85121956-fafb-45e2-b20d-0da582fd544e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_83e4cc1b-77ed-4b34-996c-d13dcbb39ef1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_85121956-fafb-45e2-b20d-0da582fd544e" xlink:to="loc_srt_ConsolidationItemsDomain_83e4cc1b-77ed-4b34-996c-d13dcbb39ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b7b9f41e-16a6-4c4d-a629-3a5468820d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_83e4cc1b-77ed-4b34-996c-d13dcbb39ef1" xlink:to="loc_us-gaap_OperatingSegmentsMember_b7b9f41e-16a6-4c4d-a629-3a5468820d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_8c6daf8f-d820-4778-b22b-878f9edd532d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_83e4cc1b-77ed-4b34-996c-d13dcbb39ef1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_8c6daf8f-d820-4778-b22b-878f9edd532d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_05ff427f-398f-4df4-9ebd-6e58c2da65cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_05ff427f-398f-4df4-9ebd-6e58c2da65cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_05ff427f-398f-4df4-9ebd-6e58c2da65cb" xlink:to="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_d54ddb22-f7c8-45ee-8211-c18ca31f20c8" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:to="loc_mck_USPharmaceuticalSegmentMember_d54ddb22-f7c8-45ee-8211-c18ca31f20c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_2511ca87-e97d-45e0-90aa-2107b3feb213" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_2511ca87-e97d-45e0-90aa-2107b3feb213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_1dd56021-6a91-4156-be89-1b64f70fb6e2" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_1dd56021-6a91-4156-be89-1b64f70fb6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_dc646aea-cf67-4602-9fa9-04bfc02b8d4c" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6004ad5-a8a8-4928-bc46-8bf216b69f56" xlink:to="loc_mck_InternationalSegmentMember_dc646aea-cf67-4602-9fa9-04bfc02b8d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_21aa5c64-744c-4752-9477-679efa37b54d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_f158e717-895c-4236-9882-2add84c8d96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_us-gaap_SeveranceCosts1_f158e717-895c-4236-9882-2add84c8d96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_444e570d-3394-4995-bf27-3b677f70309e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_us-gaap_BusinessExitCosts1_444e570d-3394-4995-bf27-3b677f70309e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_5bf353be-f679-4fd4-9637-bb73d6f7b90b" xlink:href="mck-20220630.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_5bf353be-f679-4fd4-9637-bb73d6f7b90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_73f95e6c-a470-491c-b489-6393118e0288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_172a42a3-d9df-4708-ab54-e1a774e32b03" xlink:to="loc_us-gaap_RestructuringCharges_73f95e6c-a470-491c-b489-6393118e0288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_71069e50-318a-443f-ae15-27a490badff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_71069e50-318a-443f-ae15-27a490badff2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5d86c265-7b0f-492e-ad2b-2101ad131cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5d86c265-7b0f-492e-ad2b-2101ad131cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5d86c265-7b0f-492e-ad2b-2101ad131cf5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_83312fc6-5d82-4a77-acd3-0a408a65027f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_83312fc6-5d82-4a77-acd3-0a408a65027f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_ed5995cd-9389-4bbd-808e-832d8d003ae9" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_ed5995cd-9389-4bbd-808e-832d8d003ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c23a2fee-f2b1-488e-96e9-786aff30d6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a4a02a8-1396-4580-89bf-13ef6ac78577" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c23a2fee-f2b1-488e-96e9-786aff30d6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:to="loc_srt_ConsolidationItemsAxis_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7afc6361-b79e-4129-afa3-1fbfab02f0dd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a5f1c9b3-1b5c-4117-b4a8-d2839f2ef269" xlink:to="loc_srt_ConsolidationItemsDomain_7afc6361-b79e-4129-afa3-1fbfab02f0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6522b176-0d5e-44c0-a1a6-ceb86b63845f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7afc6361-b79e-4129-afa3-1fbfab02f0dd" xlink:to="loc_us-gaap_OperatingSegmentsMember_6522b176-0d5e-44c0-a1a6-ceb86b63845f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6fef9ccc-91d3-40fe-a4ee-054aa693b666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7afc6361-b79e-4129-afa3-1fbfab02f0dd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_6fef9ccc-91d3-40fe-a4ee-054aa693b666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_74626b56-9543-4e5d-b20e-555e45c0718a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_74626b56-9543-4e5d-b20e-555e45c0718a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_74626b56-9543-4e5d-b20e-555e45c0718a" xlink:to="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_e0a1a3a5-54b7-4ad7-979b-c5c859c071d0" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:to="loc_mck_USPharmaceuticalSegmentMember_e0a1a3a5-54b7-4ad7-979b-c5c859c071d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_a9e95a15-d8d8-41a7-a123-32f05f7c64fb" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_a9e95a15-d8d8-41a7-a123-32f05f7c64fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_79eda308-b22d-40f3-88be-381490ae197c" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_79eda308-b22d-40f3-88be-381490ae197c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_a1ee5df8-4439-4856-95e7-67a9608a0060" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6507f09f-830d-4402-b996-cfcfaa957fe3" xlink:to="loc_mck_InternationalSegmentMember_a1ee5df8-4439-4856-95e7-67a9608a0060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_24ba7398-8c6c-4ba3-92d0-fc7599788b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7e320c8d-2872-4066-9f87-46908d31fad6" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_24ba7398-8c6c-4ba3-92d0-fc7599788b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_24ba7398-8c6c-4ba3-92d0-fc7599788b42" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f4313e74-f8f4-4124-9613-9dbbaf8a8aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringReserve_f4313e74-f8f4-4124-9613-9dbbaf8a8aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_da90e6f5-4746-42c3-8814-7391790aeaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringCharges_da90e6f5-4746-42c3-8814-7391790aeaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_99fd7a60-991e-4ebf-b56b-c5cbf939bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_99fd7a60-991e-4ebf-b56b-c5cbf939bc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_8ba55482-3f7c-4048-9d1b-485cac5463e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_PaymentsForRestructuring_8ba55482-3f7c-4048-9d1b-485cac5463e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_39e44fa1-c993-4d39-a61e-8002ffe7206c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_39e44fa1-c993-4d39-a61e-8002ffe7206c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_90e821df-3198-4e84-ba91-f42bcdf48a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e9b53983-0158-4dda-acc9-f93773365de9" xlink:to="loc_us-gaap_RestructuringReserve_90e821df-3198-4e84-ba91-f42bcdf48a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20220630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_17e6d8e4-730a-407a-b906-93fe408a717c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_526c263e-e88d-4a7e-824c-a7c96d126dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_17e6d8e4-730a-407a-b906-93fe408a717c" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_526c263e-e88d-4a7e-824c-a7c96d126dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a1aa1046-523c-4d7d-83a7-71da3c874be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_8e795c1c-2452-4c58-a43b-4ca897ac5aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a1aa1046-523c-4d7d-83a7-71da3c874be7" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_8e795c1c-2452-4c58-a43b-4ca897ac5aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f9948981-a02f-49f9-87b9-aaf1bac45b0b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8e795c1c-2452-4c58-a43b-4ca897ac5aff" xlink:to="loc_srt_RangeAxis_f9948981-a02f-49f9-87b9-aaf1bac45b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7d7ce22c-81bc-4559-8334-e1aaeb9e8a8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f9948981-a02f-49f9-87b9-aaf1bac45b0b" xlink:to="loc_srt_RangeMember_7d7ce22c-81bc-4559-8334-e1aaeb9e8a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a26b9562-487e-4679-b1c7-1baf9bfdf975" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7d7ce22c-81bc-4559-8334-e1aaeb9e8a8d" xlink:to="loc_srt_MinimumMember_a26b9562-487e-4679-b1c7-1baf9bfdf975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c8d2506c-9c1f-421c-8167-23af86e51949" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7d7ce22c-81bc-4559-8334-e1aaeb9e8a8d" xlink:to="loc_srt_MaximumMember_c8d2506c-9c1f-421c-8167-23af86e51949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8e795c1c-2452-4c58-a43b-4ca897ac5aff" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8f17bff4-7552-45f9-8335-f3ef734cfb58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8f17bff4-7552-45f9-8335-f3ef734cfb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_75aa1b92-a82d-4b52-9023-592b73a1bd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_75aa1b92-a82d-4b52-9023-592b73a1bd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_20f5e33e-c852-496d-8249-0320b9105527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_20f5e33e-c852-496d-8249-0320b9105527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_00fb6303-9b16-4734-b2ac-c4e002c1e17e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_00fb6303-9b16-4734-b2ac-c4e002c1e17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_5c52c6d4-c10e-42da-94f4-61288327ce58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_5c52c6d4-c10e-42da-94f4-61288327ce58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_803334e9-7f2c-4c33-8d46-8fd926cd9600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_803334e9-7f2c-4c33-8d46-8fd926cd9600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_4a2bd6c6-b00d-47b4-9477-2ff2f7ccfb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d5a79b26-221d-4837-b73a-0af1c94d0ad9" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_4a2bd6c6-b00d-47b4-9477-2ff2f7ccfb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20220630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_e4e5732b-af73-41b5-9351-45fc4ee670de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_40a5a727-7dbf-4d68-8f79-e1109419325a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_e4e5732b-af73-41b5-9351-45fc4ee670de" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_40a5a727-7dbf-4d68-8f79-e1109419325a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20220630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_7e614098-1af4-41cd-8cd3-22233f0dd4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_c16a3a32-b1ca-4f20-9648-f9dc419a2288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_7e614098-1af4-41cd-8cd3-22233f0dd4e8" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_c16a3a32-b1ca-4f20-9648-f9dc419a2288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_a2ffcdcb-48dd-46dd-832a-273e87c51a67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_a2ffcdcb-48dd-46dd-832a-273e87c51a67" xlink:to="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_578d3097-7c5e-4602-8a8a-fe6a06081d8b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:to="loc_srt_OwnershipAxis_578d3097-7c5e-4602-8a8a-fe6a06081d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d688b3e6-0278-4936-8f35-207071bfd12b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_578d3097-7c5e-4602-8a8a-fe6a06081d8b" xlink:to="loc_srt_OwnershipDomain_d688b3e6-0278-4936-8f35-207071bfd12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_b1d25a11-2485-46d7-99ff-8970a9cf2ee2" xlink:href="mck-20220630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_d688b3e6-0278-4936-8f35-207071bfd12b" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_b1d25a11-2485-46d7-99ff-8970a9cf2ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_39e3bdff-a48c-495d-b572-d2cd71984a31" xlink:href="mck-20220630.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_d688b3e6-0278-4936-8f35-207071bfd12b" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_39e3bdff-a48c-495d-b572-d2cd71984a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_563acf8c-5a8a-4d14-92b4-2fed876d8bd7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:to="loc_dei_LegalEntityAxis_563acf8c-5a8a-4d14-92b4-2fed876d8bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fff4587d-ecea-4fb9-a7b9-0a4497441329" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_563acf8c-5a8a-4d14-92b4-2fed876d8bd7" xlink:to="loc_dei_EntityDomain_fff4587d-ecea-4fb9-a7b9-0a4497441329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_5249f185-dfeb-41db-ac83-330059471785" xlink:href="mck-20220630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fff4587d-ecea-4fb9-a7b9-0a4497441329" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_5249f185-dfeb-41db-ac83-330059471785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8f934658-e933-4d60-8d92-7a6dab7a23b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8f934658-e933-4d60-8d92-7a6dab7a23b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f934658-e933-4d60-8d92-7a6dab7a23b7" xlink:to="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_090a3f0f-9e2f-4e70-ab9c-799c89844ff8" xlink:href="mck-20220630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_090a3f0f-9e2f-4e70-ab9c-799c89844ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7db42564-b934-4ce0-b0a9-7a8ded66dc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7db42564-b934-4ce0-b0a9-7a8ded66dc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_41151f2b-cdd3-4a14-88ac-f7b3952c2e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cfedd69-b6da-4692-a6bc-2c3015047714" xlink:to="loc_us-gaap_NoncontrollingInterestMember_41151f2b-cdd3-4a14-88ac-f7b3952c2e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_89991a16-8e25-4110-b633-dea17fe87a8f" xlink:to="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_55305aeb-fa1e-41da-8ac2-96ccf3c2054a" xlink:href="mck-20220630.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_55305aeb-fa1e-41da-8ac2-96ccf3c2054a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_eb514dd8-b22e-49f9-8215-46fa38e6ec56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_eb514dd8-b22e-49f9-8215-46fa38e6ec56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_39ccf289-2c04-4295-9c45-5600c31039cf" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_39ccf289-2c04-4295-9c45-5600c31039cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_c2fb8bb6-5f16-4d48-b284-8f81242f3b6b" xlink:href="mck-20220630.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_PutRightValueInterestRateSpread_c2fb8bb6-5f16-4d48-b284-8f81242f3b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f699a59e-d3a9-4d78-a215-7249ce4d3f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f699a59e-d3a9-4d78-a215-7249ce4d3f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_4479b46d-bc89-4044-820f-e86ab2d322b3" xlink:href="mck-20220630.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_4479b46d-bc89-4044-820f-e86ab2d322b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_29ffdef0-26d7-4e9a-8339-8d08eee8c07b" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_29ffdef0-26d7-4e9a-8339-8d08eee8c07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_4db77cb1-f0dd-4722-9dcd-fc99c667b6b7" xlink:href="mck-20220630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_4db77cb1-f0dd-4722-9dcd-fc99c667b6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_1f9a1dc6-b6ed-4cfc-b63d-4ad3cb63947b" xlink:href="mck-20220630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_1f9a1dc6-b6ed-4cfc-b63d-4ad3cb63947b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c06c2a24-88d3-44b5-94bf-cfa12c2ae39c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c80da60f-4d8d-43aa-9299-d5d8fb3f06c5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c06c2a24-88d3-44b5-94bf-cfa12c2ae39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_ab08b7b2-cc4b-4c0c-b31a-23de3634a8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_7d2c1534-27d8-4e56-a0bd-814ca72cfa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_ab08b7b2-cc4b-4c0c-b31a-23de3634a8b6" xlink:to="loc_us-gaap_MinorityInterestTable_7d2c1534-27d8-4e56-a0bd-814ca72cfa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4c95582f-8265-4907-82f2-0dd8e1467736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_7d2c1534-27d8-4e56-a0bd-814ca72cfa4b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4c95582f-8265-4907-82f2-0dd8e1467736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_023d3cc2-bd7f-45f2-8a12-7b2bbe78c371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4c95582f-8265-4907-82f2-0dd8e1467736" xlink:to="loc_us-gaap_EquityComponentDomain_023d3cc2-bd7f-45f2-8a12-7b2bbe78c371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_e4b78782-9ea7-431e-9a20-f3f88853dfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_023d3cc2-bd7f-45f2-8a12-7b2bbe78c371" xlink:to="loc_us-gaap_NoncontrollingInterestMember_e4b78782-9ea7-431e-9a20-f3f88853dfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_f39dcf2c-d2c7-412c-a6da-8d044bd4eb5a" xlink:href="mck-20220630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_023d3cc2-bd7f-45f2-8a12-7b2bbe78c371" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_f39dcf2c-d2c7-412c-a6da-8d044bd4eb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_44016068-62e7-496d-89b2-89d40d9e9b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_7d2c1534-27d8-4e56-a0bd-814ca72cfa4b" xlink:to="loc_us-gaap_MinorityInterestLineItems_44016068-62e7-496d-89b2-89d40d9e9b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_44016068-62e7-496d-89b2-89d40d9e9b04" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c29e73bb-b4b3-41ab-9c17-fda7d86f62d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_MinorityInterest_c29e73bb-b4b3-41ab-9c17-fda7d86f62d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89527ca1-addd-4e1f-91a6-c2b9ad3aa57d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89527ca1-addd-4e1f-91a6-c2b9ad3aa57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9a2b239-7b6e-49f4-be31-db12fdc45316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9a2b239-7b6e-49f4-be31-db12fdc45316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_4df56eec-f393-4b7d-b019-81b63c2e32e7" xlink:href="mck-20220630.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_4df56eec-f393-4b7d-b019-81b63c2e32e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_97848b6b-195d-4fde-ac2d-3e00bc4856f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_97848b6b-195d-4fde-ac2d-3e00bc4856f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_5d9a2a79-c51f-44b0-83a8-86763336a348" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_5d9a2a79-c51f-44b0-83a8-86763336a348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e7d4184b-8cbe-4e8d-91fd-e1ae2a6940e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_62abb5e4-4f8d-493e-b8b8-1ce6eacb0ccc" xlink:to="loc_us-gaap_MinorityInterest_e7d4184b-8cbe-4e8d-91fd-e1ae2a6940e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_44016068-62e7-496d-89b2-89d40d9e9b04" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f3bc635e-d91f-4950-939a-82f5fda09694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f3bc635e-d91f-4950-939a-82f5fda09694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_00540ca7-6a8a-4f7a-920d-8f2795fec284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_00540ca7-6a8a-4f7a-920d-8f2795fec284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_88d5c611-5621-4bf6-b8dc-47a262e1ab2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_88d5c611-5621-4bf6-b8dc-47a262e1ab2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_70223588-14c3-4a7b-9064-8c1b585aabca" xlink:href="mck-20220630.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_70223588-14c3-4a7b-9064-8c1b585aabca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_9e2b0771-5870-4b24-ad3e-218b6c7ce724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_9e2b0771-5870-4b24-ad3e-218b6c7ce724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_95c51088-b39c-4464-8d11-d895ce72710f" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_95c51088-b39c-4464-8d11-d895ce72710f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_643be020-bb4a-401a-b541-8ae2374a1d88" xlink:href="mck-20220630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_643be020-bb4a-401a-b541-8ae2374a1d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_36e63686-218a-43e8-bcb2-548e6017e0e7" xlink:href="mck-20220630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_36e63686-218a-43e8-bcb2-548e6017e0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_845ba166-f431-4e1b-876c-808a1a67a74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9ec3df78-088f-48ac-ae83-d5b65193411a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_845ba166-f431-4e1b-876c-808a1a67a74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="simple" xlink:href="mck-20220630.xsd#EarningsLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cf869b6e-3096-4898-b3f9-545708d54fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_92108448-853b-4df7-a227-38baab8f1b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cf869b6e-3096-4898-b3f9-545708d54fb8" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_92108448-853b-4df7-a227-38baab8f1b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="simple" xlink:href="mck-20220630.xsd#EarningsLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5d0454ed-8ceb-40b1-85ba-a3895419b0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_42e33136-c9ed-4770-9e3f-f53d95e7cac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5d0454ed-8ceb-40b1-85ba-a3895419b0c8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_42e33136-c9ed-4770-9e3f-f53d95e7cac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#EarningsLossPerCommonShareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_12ba1853-1b72-4b3e-8a4f-366befc98960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ad4b5102-48f6-4db1-9228-ff5be7f76c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12ba1853-1b72-4b3e-8a4f-366befc98960" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ad4b5102-48f6-4db1-9228-ff5be7f76c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_aa319b5c-87c1-4802-bcf9-2230bad165c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_801fa746-974f-446f-9e1a-02ea6d3b91ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aa319b5c-87c1-4802-bcf9-2230bad165c4" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_801fa746-974f-446f-9e1a-02ea6d3b91ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5b205c97-aea1-4c42-b0fe-db0c6175f1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_801fa746-974f-446f-9e1a-02ea6d3b91ba" xlink:to="loc_us-gaap_AwardTypeAxis_5b205c97-aea1-4c42-b0fe-db0c6175f1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eba6a0b-ac36-419b-9a2a-d4601ae0c3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5b205c97-aea1-4c42-b0fe-db0c6175f1b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eba6a0b-ac36-419b-9a2a-d4601ae0c3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2ed575a8-df1d-4d20-baea-b154bbdf5fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eba6a0b-ac36-419b-9a2a-d4601ae0c3ad" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2ed575a8-df1d-4d20-baea-b154bbdf5fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_265c4659-2465-4a7e-bf39-7075a2abce55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eba6a0b-ac36-419b-9a2a-d4601ae0c3ad" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_265c4659-2465-4a7e-bf39-7075a2abce55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_801fa746-974f-446f-9e1a-02ea6d3b91ba" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_46e59dc6-c8a0-4472-858b-53c91120f9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_46e59dc6-c8a0-4472-858b-53c91120f9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_580ab97b-ce4e-4e0d-a6ba-5ee1dd9e2e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_580ab97b-ce4e-4e0d-a6ba-5ee1dd9e2e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_a3e5ee3d-6a95-4b03-ad8e-6ad5f4c49115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_a3e5ee3d-6a95-4b03-ad8e-6ad5f4c49115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_06cf60a7-7914-44e8-a71c-c8c7323777bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_06cf60a7-7914-44e8-a71c-c8c7323777bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4792c1d7-8e50-4227-badb-9e1a36c8fb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_NetIncomeLoss_4792c1d7-8e50-4227-badb-9e1a36c8fb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ef6d8b5e-245e-45c6-8727-4fa6f2d76e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ef6d8b5e-245e-45c6-8727-4fa6f2d76e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_72fe40f4-deb9-47bd-b6af-599359d5fa26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_72fe40f4-deb9-47bd-b6af-599359d5fa26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_eba45f08-65c6-45d8-aba4-a94733deef40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_72fe40f4-deb9-47bd-b6af-599359d5fa26" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_eba45f08-65c6-45d8-aba4-a94733deef40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ecf02cea-a7ca-41d6-a6c9-ff3b485061ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c112856f-6516-434e-915c-2a2402e6352b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ecf02cea-a7ca-41d6-a6c9-ff3b485061ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract_0c73104b-6dfc-4644-9d82-28bb889a4537" xlink:href="mck-20220630.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_dbfa5dae-e779-4307-a71e-c750aee41f50" xlink:to="loc_mck_EPSBasicAndDilutedAbstract_0c73104b-6dfc-4644-9d82-28bb889a4537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_0c73104b-6dfc-4644-9d82-28bb889a4537" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_862e88d9-102e-4cba-9a6e-57f045ef9806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_862e88d9-102e-4cba-9a6e-57f045ef9806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_79fe071e-453c-4365-b106-6fc982ecc103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_79fe071e-453c-4365-b106-6fc982ecc103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1be55aaf-f0a8-4a04-a05b-983e38c60c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_07e29e36-989a-444b-8586-bf104fbfeb93" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1be55aaf-f0a8-4a04-a05b-983e38c60c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_0c73104b-6dfc-4644-9d82-28bb889a4537" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4ddcac98-64b8-4cf1-ba23-be85dcede4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4ddcac98-64b8-4cf1-ba23-be85dcede4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_26d0c542-b5e3-45a8-b3f6-172666376eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_26d0c542-b5e3-45a8-b3f6-172666376eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_385c7066-c5a8-412e-982d-5cecfaa0ec11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_5e66f61d-e9d1-40ee-afe9-0a612e867f12" xlink:to="loc_us-gaap_EarningsPerShareBasic_385c7066-c5a8-412e-982d-5cecfaa0ec11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20220630.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_56134dc4-8f84-42e1-a588-b42096564d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_69dffbbf-ae54-4014-b2b2-5fa63ad856da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_56134dc4-8f84-42e1-a588-b42096564d3b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_69dffbbf-ae54-4014-b2b2-5fa63ad856da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20220630.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_060f3884-7e25-4a87-a6ae-5c233ddb3be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9a5e45dd-206b-4c34-8437-c54deb7f422d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_060f3884-7e25-4a87-a6ae-5c233ddb3be7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9a5e45dd-206b-4c34-8437-c54deb7f422d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1313ea06-07f6-4c51-a5ff-965c45047909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_060f3884-7e25-4a87-a6ae-5c233ddb3be7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1313ea06-07f6-4c51-a5ff-965c45047909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c5eeb93c-80c1-41cb-97eb-4bf56fb05233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f35090eb-85b2-41cc-9d42-be443848d414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c5eeb93c-80c1-41cb-97eb-4bf56fb05233" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f35090eb-85b2-41cc-9d42-be443848d414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b142ec29-df77-4cd1-bd7f-5314d3744c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f35090eb-85b2-41cc-9d42-be443848d414" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b142ec29-df77-4cd1-bd7f-5314d3744c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b142ec29-df77-4cd1-bd7f-5314d3744c6e" xlink:to="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_18667094-8e9e-4369-922f-4fa3e3eb3eb9" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:to="loc_mck_USPharmaceuticalSegmentMember_18667094-8e9e-4369-922f-4fa3e3eb3eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_a3c3cdaf-325f-4c11-a8b2-fac8ab64a1b9" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_a3c3cdaf-325f-4c11-a8b2-fac8ab64a1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_1956dd2d-3308-418d-aff6-95aa5f086dbd" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_1956dd2d-3308-418d-aff6-95aa5f086dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_f7c327bf-a45b-4297-897e-a0fe5f42d0fe" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_affe6d48-f8bc-4da7-a198-82314f4cf7ad" xlink:to="loc_mck_InternationalSegmentMember_f7c327bf-a45b-4297-897e-a0fe5f42d0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f08b7572-480d-4576-b9e9-08cff73aae98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f35090eb-85b2-41cc-9d42-be443848d414" xlink:to="loc_us-gaap_GoodwillLineItems_f08b7572-480d-4576-b9e9-08cff73aae98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f08b7572-480d-4576-b9e9-08cff73aae98" xlink:to="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9af0c46b-52fc-4148-b0c7-65d97fc6f7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:to="loc_us-gaap_Goodwill_9af0c46b-52fc-4148-b0c7-65d97fc6f7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dee2273c-97dc-4c2e-bc8d-650ac24d9f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dee2273c-97dc-4c2e-bc8d-650ac24d9f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_14d0ebe3-de50-4463-b413-bd9ce82d164b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_14d0ebe3-de50-4463-b413-bd9ce82d164b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fc20f6f7-df1b-49a8-a632-9536898536ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6ed33a80-c05e-489c-994c-58cfca85fe11" xlink:to="loc_us-gaap_Goodwill_fc20f6f7-df1b-49a8-a632-9536898536ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25defeda-332c-4334-918f-2b1cb4b03c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_96b82cce-001b-4b3c-88e0-1de4e7567f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25defeda-332c-4334-918f-2b1cb4b03c58" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_96b82cce-001b-4b3c-88e0-1de4e7567f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8d7565e7-76d8-4157-8848-c90709a35599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_96b82cce-001b-4b3c-88e0-1de4e7567f52" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8d7565e7-76d8-4157-8848-c90709a35599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8d7565e7-76d8-4157-8848-c90709a35599" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ca83e494-b6ec-494e-8db4-c92a8e16541e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ca83e494-b6ec-494e-8db4-c92a8e16541e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_5055a205-10b5-48bf-bc15-e4d47c85988f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_ServiceAgreementsMember_5055a205-10b5-48bf-bc15-e4d47c85988f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_d30eaf6a-a70a-4f40-bbe4-d5afafcfd855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_d30eaf6a-a70a-4f40-bbe4-d5afafcfd855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_895e685d-3f6c-4426-b0f8-569c2f50efd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_895e685d-3f6c-4426-b0f8-569c2f50efd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_ffa7753a-1749-4c83-bd8b-986ea4384680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_262f9068-6d63-4a91-9555-0690660becbb" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_ffa7753a-1749-4c83-bd8b-986ea4384680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_96b82cce-001b-4b3c-88e0-1de4e7567f52" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a462ab88-f1ff-4725-9849-42ff124e4e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a462ab88-f1ff-4725-9849-42ff124e4e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_befb07b0-8256-42a7-9279-a6f8346d13af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_befb07b0-8256-42a7-9279-a6f8346d13af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d820772e-1669-4e59-bc1c-4c3b8c6228b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d820772e-1669-4e59-bc1c-4c3b8c6228b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_61ec8829-3743-42d4-871f-c1fc6dd741e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cce0dea1-d481-4b17-875a-d87da3081c1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_61ec8829-3743-42d4-871f-c1fc6dd741e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#GoodwillandIntangibleAssetsNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d48ac2b-5e57-4af4-b678-611322e360d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e67f3634-60ee-48ce-b8de-d392fac67f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d48ac2b-5e57-4af4-b678-611322e360d6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e67f3634-60ee-48ce-b8de-d392fac67f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_4ab6cef3-2893-4138-8133-ab2f449e080a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d48ac2b-5e57-4af4-b678-611322e360d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_4ab6cef3-2893-4138-8133-ab2f449e080a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2833752f-df01-4708-8230-cb01758835cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_4ab6cef3-2893-4138-8133-ab2f449e080a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2833752f-df01-4708-8230-cb01758835cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_63d6263e-8a15-41d0-866e-1028a663a728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_4ab6cef3-2893-4138-8133-ab2f449e080a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_63d6263e-8a15-41d0-866e-1028a663a728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ab59c585-2548-405e-8bbf-95fa6ed9129a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_4ab6cef3-2893-4138-8133-ab2f449e080a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ab59c585-2548-405e-8bbf-95fa6ed9129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f1952105-b983-4bb2-ac96-a4e93ba5dfac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_4ab6cef3-2893-4138-8133-ab2f449e080a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f1952105-b983-4bb2-ac96-a4e93ba5dfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_121aa6c4-76b3-45b5-8933-0ebdffb6b78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_4ab6cef3-2893-4138-8133-ab2f449e080a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_121aa6c4-76b3-45b5-8933-0ebdffb6b78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_2c00fcc8-08be-47f7-974e-31bbeea10678" xlink:href="mck-20220630.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_4ab6cef3-2893-4138-8133-ab2f449e080a" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_2c00fcc8-08be-47f7-974e-31bbeea10678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_66157821-8a49-4a13-9c47-daff01f09d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_9833e15d-4c6d-4c69-85aa-19e770daa981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_66157821-8a49-4a13-9c47-daff01f09d90" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_9833e15d-4c6d-4c69-85aa-19e770daa981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_97f0da58-4083-4171-ad57-d443de72ceb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_ed5790a8-ffae-443b-942a-2fa458b9044f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_97f0da58-4083-4171-ad57-d443de72ceb3" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_ed5790a8-ffae-443b-942a-2fa458b9044f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8e8a00b7-aba5-42c4-9423-b12a2bb9a322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8e8a00b7-aba5-42c4-9423-b12a2bb9a322" xlink:to="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9a1bd680-dcb2-4188-a697-14cec1045dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:to="loc_us-gaap_DebtInstrumentAxis_9a1bd680-dcb2-4188-a697-14cec1045dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a1bd680-dcb2-4188-a697-14cec1045dc6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_0ad5359e-5137-4d9b-86be-c10c29549077" xlink:href="mck-20220630.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A270NotesDueDecember152022Member_0ad5359e-5137-4d9b-86be-c10c29549077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_6c0193c5-80f8-4528-ba74-b43711acdcf3" xlink:href="mck-20220630.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A285NotesDueMarch152023Member_6c0193c5-80f8-4528-ba74-b43711acdcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_17bb5ecf-69f3-4660-8a2d-a1b5dda31754" xlink:href="mck-20220630.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A380NotesDueMarch152024Member_17bb5ecf-69f3-4660-8a2d-a1b5dda31754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_4c98533f-0e59-4e2c-ad72-c5ffb6b893a9" xlink:href="mck-20220630.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A090NotesDueDecember32025Member_4c98533f-0e59-4e2c-ad72-c5ffb6b893a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_b249a744-b172-4897-bb48-e931eaea0964" xlink:href="mck-20220630.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A130NotesDueAugust152026Member_b249a744-b172-4897-bb48-e931eaea0964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_3df1931a-5a8e-4174-9594-1dbb42884263" xlink:href="mck-20220630.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_3df1931a-5a8e-4174-9594-1dbb42884263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_a9643b2f-d2f9-460d-8311-0f956e68cfaf" xlink:href="mck-20220630.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A395NotesDueFebruary162028Member_a9643b2f-d2f9-460d-8311-0f956e68cfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_250e1960-8842-488c-a6c4-d21a48604164" xlink:href="mck-20220630.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A475NotesDueMay302029Member_250e1960-8842-488c-a6c4-d21a48604164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_122927d5-5698-4427-ad51-1e89dff116a2" xlink:href="mck-20220630.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A600NotesDueMarch12041Member_122927d5-5698-4427-ad51-1e89dff116a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_33f66418-a32b-4a9b-9c28-f0ef5601d9d6" xlink:href="mck-20220630.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A488NotesDueMarch152044Member_33f66418-a32b-4a9b-9c28-f0ef5601d9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_62168d7a-2929-47b3-93a8-030bdd753f99" xlink:href="mck-20220630.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_62168d7a-2929-47b3-93a8-030bdd753f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_b9b562b7-ba1e-4556-9f22-dc71722f2a52" xlink:href="mck-20220630.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_b9b562b7-ba1e-4556-9f22-dc71722f2a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_1109c0e8-f124-4975-b1f3-302bb464859a" xlink:href="mck-20220630.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c0a01f5b-279d-46cd-8c1f-05878c151559" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_1109c0e8-f124-4975-b1f3-302bb464859a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0568d62d-efbf-48ce-bdcf-50ce0491e715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0568d62d-efbf-48ce-bdcf-50ce0491e715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_618f8342-1970-4811-89b5-f15669bc5c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0568d62d-efbf-48ce-bdcf-50ce0491e715" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_618f8342-1970-4811-89b5-f15669bc5c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_fd6bbe90-09e5-4235-b40f-24a4a0ef5889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_618f8342-1970-4811-89b5-f15669bc5c06" xlink:to="loc_us-gaap_LoansPayableMember_fd6bbe90-09e5-4235-b40f-24a4a0ef5889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3b4e05f4-5d25-4160-a168-ec16a8160cff" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0308a54-9b12-49a5-a7b2-06f54cca9858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0308a54-9b12-49a5-a7b2-06f54cca9858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d94a49a8-8a42-4a8c-aa99-6d3bb54261d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_LongTermDebt_d94a49a8-8a42-4a8c-aa99-6d3bb54261d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_37c1311a-a0f2-4318-89cd-c4962b5d9496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_FinanceLeaseLiability_37c1311a-a0f2-4318-89cd-c4962b5d9496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_0d0ae766-4fba-4b38-9b8d-4fce790a6f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_0d0ae766-4fba-4b38-9b8d-4fce790a6f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_39576998-b1b0-423f-a6fb-cf12cd26633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_39576998-b1b0-423f-a6fb-cf12cd26633d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_47c2c443-5446-4ed2-a2e5-9c347f4023e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7ff884fc-a157-44b5-95de-2fa730bc6b34" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_47c2c443-5446-4ed2-a2e5-9c347f4023e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_15e31a05-1074-4c22-9402-950a38718e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_17585be7-1e1e-4ea5-8cad-e5bd5b9886ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15e31a05-1074-4c22-9402-950a38718e81" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_17585be7-1e1e-4ea5-8cad-e5bd5b9886ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6015caa9-6a57-4a2e-a06e-a9b947d01901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15e31a05-1074-4c22-9402-950a38718e81" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6015caa9-6a57-4a2e-a06e-a9b947d01901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0a3d74eb-f503-4e3c-8be2-d28748785459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0a3d74eb-f503-4e3c-8be2-d28748785459" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5c990145-a4f0-4877-891b-899cc04af82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5c990145-a4f0-4877-891b-899cc04af82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9dd6f27d-7986-45dd-ab67-18665009d560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c990145-a4f0-4877-891b-899cc04af82a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9dd6f27d-7986-45dd-ab67-18665009d560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_9ebe2efe-cd41-4bf9-88a8-9293eb975370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9dd6f27d-7986-45dd-ab67-18665009d560" xlink:to="loc_us-gaap_UnsecuredDebtMember_9ebe2efe-cd41-4bf9-88a8-9293eb975370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d04fa914-d275-412c-8312-61f60b088eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:to="loc_us-gaap_CreditFacilityAxis_d04fa914-d275-412c-8312-61f60b088eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_15ed06d8-19ee-416c-8e4e-e666fc6e881d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d04fa914-d275-412c-8312-61f60b088eae" xlink:to="loc_us-gaap_CreditFacilityDomain_15ed06d8-19ee-416c-8e4e-e666fc6e881d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_24c7a71b-372e-45d9-a535-faf557c442d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_15ed06d8-19ee-416c-8e4e-e666fc6e881d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_24c7a71b-372e-45d9-a535-faf557c442d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9bb61464-aae0-4f08-9783-30d7a8e3aa03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_15ed06d8-19ee-416c-8e4e-e666fc6e881d" xlink:to="loc_us-gaap_LineOfCreditMember_9bb61464-aae0-4f08-9783-30d7a8e3aa03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_797c9875-f584-4b62-9160-7b752da2c800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:to="loc_us-gaap_DebtInstrumentAxis_797c9875-f584-4b62-9160-7b752da2c800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_797c9875-f584-4b62-9160-7b752da2c800" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_ef7bf145-39f2-42f8-bd79-bde8b0db00e7" xlink:href="mck-20220630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_ef7bf145-39f2-42f8-bd79-bde8b0db00e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_bc4edf2d-b488-4a59-b7d2-e09e73d3ff2f" xlink:href="mck-20220630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_bc4edf2d-b488-4a59-b7d2-e09e73d3ff2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommittedMember_17814cff-285c-4c5b-8a08-7a5655427a7a" xlink:href="mck-20220630.xsd#mck_CommittedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:to="loc_mck_CommittedMember_17814cff-285c-4c5b-8a08-7a5655427a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UncommittedMember_3628875b-6fc7-47a2-92df-05b8f43b00e3" xlink:href="mck-20220630.xsd#mck_UncommittedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc6a56c-4d6f-47bd-9b27-634a2530350b" xlink:to="loc_mck_UncommittedMember_3628875b-6fc7-47a2-92df-05b8f43b00e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cdc39778-a0db-491b-ad2e-e53072bd45b7" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ccbd5cc5-c326-4bc3-8d8b-831fce7a72ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ccbd5cc5-c326-4bc3-8d8b-831fce7a72ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_f29b4a00-abd8-4137-aff4-19f89049efc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_DebtInstrumentTerm_f29b4a00-abd8-4137-aff4-19f89049efc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ad721b25-d8d8-40a9-9a1a-3f78e8c2d674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ad721b25-d8d8-40a9-9a1a-3f78e8c2d674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c8180724-5fe3-44d6-aec7-b51cd1facb70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c8180724-5fe3-44d6-aec7-b51cd1facb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ae10e3f1-0cff-43da-b7b0-564e21f31d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_160dca6c-66b2-4d30-a685-925b84355436" xlink:to="loc_us-gaap_LineOfCredit_ae10e3f1-0cff-43da-b7b0-564e21f31d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#DebtandFinancingActivitiesCommercialPaperNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5ff65849-83ac-44f2-bef9-0b8b2755151c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7f2d2d12-6823-4075-9e89-dca86915a134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5ff65849-83ac-44f2-bef9-0b8b2755151c" xlink:to="loc_us-gaap_DebtInstrumentTable_7f2d2d12-6823-4075-9e89-dca86915a134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4b027427-01df-4248-9fb7-455e593a075f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f2d2d12-6823-4075-9e89-dca86915a134" xlink:to="loc_us-gaap_CreditFacilityAxis_4b027427-01df-4248-9fb7-455e593a075f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4e03043b-420e-4450-97fb-c4a843107df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4b027427-01df-4248-9fb7-455e593a075f" xlink:to="loc_us-gaap_CreditFacilityDomain_4e03043b-420e-4450-97fb-c4a843107df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_68c67d12-43a5-498d-aa87-6d38450d6cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_4e03043b-420e-4450-97fb-c4a843107df7" xlink:to="loc_us-gaap_CommercialPaperMember_68c67d12-43a5-498d-aa87-6d38450d6cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f2d2d12-6823-4075-9e89-dca86915a134" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b09c76f8-7b23-4a92-8dd1-fe057d3d1f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b09c76f8-7b23-4a92-8dd1-fe057d3d1f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_cd57fc5e-3c52-4c5a-b92f-f3508966712a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_cd57fc5e-3c52-4c5a-b92f-f3508966712a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_1344ceb7-6b77-46c0-a2a8-431985a81473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b2d741d-1d8e-4955-bf95-c7c5555daf87" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_1344ceb7-6b77-46c0-a2a8-431985a81473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement" xlink:type="simple" xlink:href="mck-20220630.xsd#StatementofIncomeIncludingGrossMarginStatement"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_32ad172e-050a-4566-afe5-d258787f90be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20220630.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6812bd48-fc58-4089-a431-128845e5b50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_a4106418-df18-4377-9fb6-45cc433e0ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6812bd48-fc58-4089-a431-128845e5b50d" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_a4106418-df18-4377-9fb6-45cc433e0ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_18b2afb4-5f33-4f8f-bfcc-58c5d0232597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_18b2afb4-5f33-4f8f-bfcc-58c5d0232597" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0229034a-4302-4b8b-bdb2-8b2d178387a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0229034a-4302-4b8b-bdb2-8b2d178387a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_05ddf351-e300-4f02-a00b-13ad4dd3698a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0229034a-4302-4b8b-bdb2-8b2d178387a6" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_05ddf351-e300-4f02-a00b-13ad4dd3698a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ebcee50f-32a2-473d-a1c6-55afdb631334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_05ddf351-e300-4f02-a00b-13ad4dd3698a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ebcee50f-32a2-473d-a1c6-55afdb631334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1277aff6-c0bc-4441-a7c4-b62fd092b7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1277aff6-c0bc-4441-a7c4-b62fd092b7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bc2f58a3-e88f-40da-9a66-a6cbeed08fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1277aff6-c0bc-4441-a7c4-b62fd092b7d2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bc2f58a3-e88f-40da-9a66-a6cbeed08fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4a78b2d1-6822-4ac8-a019-dd4e7299dcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bc2f58a3-e88f-40da-9a66-a6cbeed08fff" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4a78b2d1-6822-4ac8-a019-dd4e7299dcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9a52574b-466a-4860-9cc9-58546c11dc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9a52574b-466a-4860-9cc9-58546c11dc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d7c62d29-b429-49fc-994f-50fa3bd9ecc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9a52574b-466a-4860-9cc9-58546c11dc6b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d7c62d29-b429-49fc-994f-50fa3bd9ecc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_47aab1f0-e6cc-45e8-9f77-1d1b2ae6dd51" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d7c62d29-b429-49fc-994f-50fa3bd9ecc7" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_47aab1f0-e6cc-45e8-9f77-1d1b2ae6dd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_8abae1f3-3257-439b-aba3-8cfb3d2bbf4f" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d7c62d29-b429-49fc-994f-50fa3bd9ecc7" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_8abae1f3-3257-439b-aba3-8cfb3d2bbf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_05f42766-d933-4840-97b8-6aa22bd236aa" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a1ea3caa-46f9-49fd-a80c-4b866241a6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a1ea3caa-46f9-49fd-a80c-4b866241a6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_502bf051-6580-4fbe-a31d-76155d53f5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_502bf051-6580-4fbe-a31d-76155d53f5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_1b7a95d4-1ca4-41be-88a9-063e0a0c1f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_1b7a95d4-1ca4-41be-88a9-063e0a0c1f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_e2372dff-14ff-417a-b2e8-488eadb7fa06" xlink:href="mck-20220630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_e2372dff-14ff-417a-b2e8-488eadb7fa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_c7bddd65-61c7-4908-9078-3f6b116a6f38" xlink:href="mck-20220630.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_935d9e54-ade3-428b-b945-7c137f5949b7" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_c7bddd65-61c7-4908-9078-3f6b116a6f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ae173c00-9a63-4d39-aca1-a6007470ec16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_88fe6a09-dbae-4ef5-8634-8b85dc4e6206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ae173c00-9a63-4d39-aca1-a6007470ec16" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_88fe6a09-dbae-4ef5-8634-8b85dc4e6206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2da05e8-67ca-43e8-b323-7f0ad6f7a90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_d9fcdd20-c214-4cae-a08a-db8ab3c71cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2da05e8-67ca-43e8-b323-7f0ad6f7a90c" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_d9fcdd20-c214-4cae-a08a-db8ab3c71cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_9bd2dd00-e762-4f66-bfb5-ca72d9f7621d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2da05e8-67ca-43e8-b323-7f0ad6f7a90c" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_9bd2dd00-e762-4f66-bfb5-ca72d9f7621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_04325cc0-bc90-49cf-b81f-ca7e649cc0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2da05e8-67ca-43e8-b323-7f0ad6f7a90c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_04325cc0-bc90-49cf-b81f-ca7e649cc0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_19d71bf5-6cda-4e28-8281-70e05fa1ef6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2da05e8-67ca-43e8-b323-7f0ad6f7a90c" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_19d71bf5-6cda-4e28-8281-70e05fa1ef6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_33c3b2e5-6513-4c3a-99fa-87b9364d2966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2da05e8-67ca-43e8-b323-7f0ad6f7a90c" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_33c3b2e5-6513-4c3a-99fa-87b9364d2966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_98677c33-66fe-4d1f-a66e-a0429aba1d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_98677c33-66fe-4d1f-a66e-a0429aba1d0d" xlink:to="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13aa4c05-8dba-4157-b64e-1665500399cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_DebtInstrumentAxis_13aa4c05-8dba-4157-b64e-1665500399cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7ff91513-5260-4fba-a4d6-04fbb75d8886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_13aa4c05-8dba-4157-b64e-1665500399cd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7ff91513-5260-4fba-a4d6-04fbb75d8886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_d44e662a-6967-47dd-b51e-6ce09ed38de0" xlink:href="mck-20220630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7ff91513-5260-4fba-a4d6-04fbb75d8886" xlink:to="loc_mck_EuroDenominatedNotesMember_d44e662a-6967-47dd-b51e-6ce09ed38de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_36a85450-46ca-4f5c-bacc-075ae87a9d44" xlink:href="mck-20220630.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7ff91513-5260-4fba-a4d6-04fbb75d8886" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_36a85450-46ca-4f5c-bacc-075ae87a9d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_174275af-d1b2-457f-bd46-dbd057c8e7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_174275af-d1b2-457f-bd46-dbd057c8e7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e0d58839-c5e8-4f08-80be-b3d8ff32910a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_174275af-d1b2-457f-bd46-dbd057c8e7c5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e0d58839-c5e8-4f08-80be-b3d8ff32910a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_7bb5d36e-7840-4dcb-8e56-e0f0aea85e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e0d58839-c5e8-4f08-80be-b3d8ff32910a" xlink:to="loc_us-gaap_LoansPayableMember_7bb5d36e-7840-4dcb-8e56-e0f0aea85e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_38f567e1-db80-4f48-ab27-5569543e58ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_38f567e1-db80-4f48-ab27-5569543e58ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_991e7f1e-a9fb-4d92-ac9f-d0fc6826cc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_38f567e1-db80-4f48-ab27-5569543e58ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_991e7f1e-a9fb-4d92-ac9f-d0fc6826cc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d7699698-58a8-4190-ba53-e36a8f190c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_991e7f1e-a9fb-4d92-ac9f-d0fc6826cc1e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d7699698-58a8-4190-ba53-e36a8f190c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a1f82369-2394-4e10-86d1-e525346654f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a1f82369-2394-4e10-86d1-e525346654f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_109e14e1-5fd3-4118-818f-37548113f715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a1f82369-2394-4e10-86d1-e525346654f0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_109e14e1-5fd3-4118-818f-37548113f715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6586cd9d-00bf-465f-8982-f6a86ed39c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_109e14e1-5fd3-4118-818f-37548113f715" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6586cd9d-00bf-465f-8982-f6a86ed39c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91466863-9b51-48ca-8be2-00c1c62be25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91466863-9b51-48ca-8be2-00c1c62be25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b0e50b1-4f61-4be8-91f8-ccbe185bd327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91466863-9b51-48ca-8be2-00c1c62be25b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b0e50b1-4f61-4be8-91f8-ccbe185bd327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_5b9b139d-4787-4c34-8bad-5b6203679aee" xlink:href="mck-20220630.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b0e50b1-4f61-4be8-91f8-ccbe185bd327" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_5b9b139d-4787-4c34-8bad-5b6203679aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4cc09742-c5d8-4e75-9bd6-92cc417b44e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_978ce75f-b9da-4752-a334-b2cf7c72bc03" xlink:to="loc_us-gaap_DerivativeLineItems_4cc09742-c5d8-4e75-9bd6-92cc417b44e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4d10d465-bd8f-4984-97e6-def9400c1238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4cc09742-c5d8-4e75-9bd6-92cc417b44e5" xlink:to="loc_us-gaap_LongTermDebt_4d10d465-bd8f-4984-97e6-def9400c1238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_20cb40a2-4d0f-4474-9971-59cdb5856534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4cc09742-c5d8-4e75-9bd6-92cc417b44e5" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_20cb40a2-4d0f-4474-9971-59cdb5856534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c452a307-3171-47e9-a4b2-e5142df371e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c452a307-3171-47e9-a4b2-e5142df371e5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6845cbac-f9b7-4711-a327-dbbc3e2dd87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:to="loc_us-gaap_HedgingDesignationAxis_6845cbac-f9b7-4711-a327-dbbc3e2dd87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_df19ea34-e472-4725-9831-c11781d200d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_6845cbac-f9b7-4711-a327-dbbc3e2dd87a" xlink:to="loc_us-gaap_HedgingDesignationDomain_df19ea34-e472-4725-9831-c11781d200d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e1d3cb74-421e-41f7-9ae0-e00e89705b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_df19ea34-e472-4725-9831-c11781d200d9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e1d3cb74-421e-41f7-9ae0-e00e89705b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_166a74d3-b51b-4aa5-8642-5592a0deae06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_166a74d3-b51b-4aa5-8642-5592a0deae06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6a7cabe2-9d6c-4a23-9c3d-22af5b67fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_166a74d3-b51b-4aa5-8642-5592a0deae06" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6a7cabe2-9d6c-4a23-9c3d-22af5b67fd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_94235be8-8ffb-438a-bfaa-941442cbcedd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6a7cabe2-9d6c-4a23-9c3d-22af5b67fd36" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_94235be8-8ffb-438a-bfaa-941442cbcedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3df0d972-d41d-47b2-8123-8e3c8ebc276d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:to="loc_us-gaap_DebtInstrumentAxis_3df0d972-d41d-47b2-8123-8e3c8ebc276d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9ceb8fda-633e-4cb8-8426-bbe0e9b4e990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3df0d972-d41d-47b2-8123-8e3c8ebc276d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9ceb8fda-633e-4cb8-8426-bbe0e9b4e990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_a5392c3d-bf6c-45ab-8be2-b4373b61e354" xlink:href="mck-20220630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9ceb8fda-633e-4cb8-8426-bbe0e9b4e990" xlink:to="loc_mck_EuroDenominatedNotesMember_a5392c3d-bf6c-45ab-8be2-b4373b61e354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_19701731-17be-44b2-b837-a1e1ea4b24c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4c8744dc-3944-40a2-abb4-4d8f0e044fd8" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_19701731-17be-44b2-b837-a1e1ea4b24c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_b79e05bd-ff71-4839-b95b-421a684c0528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_19701731-17be-44b2-b837-a1e1ea4b24c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_b79e05bd-ff71-4839-b95b-421a684c0528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_104514a0-be94-4956-aad6-a4288ce0271a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_104514a0-be94-4956-aad6-a4288ce0271a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8d8c3e83-506a-4757-bee5-5b18963f36dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_HedgingDesignationAxis_8d8c3e83-506a-4757-bee5-5b18963f36dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2ca91f99-bd19-4d82-8608-e53e402b9a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_8d8c3e83-506a-4757-bee5-5b18963f36dc" xlink:to="loc_us-gaap_HedgingDesignationDomain_2ca91f99-bd19-4d82-8608-e53e402b9a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_02be6f53-bd32-49ac-86df-fd4feeb66624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2ca91f99-bd19-4d82-8608-e53e402b9a9f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_02be6f53-bd32-49ac-86df-fd4feeb66624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9e387d0a-05c0-4c83-b31e-71543ccdb16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9e387d0a-05c0-4c83-b31e-71543ccdb16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9e387d0a-05c0-4c83-b31e-71543ccdb16d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_42d7d7c0-ec9e-40f9-aa27-5db914cb39dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:to="loc_us-gaap_CurrencySwapMember_42d7d7c0-ec9e-40f9-aa27-5db914cb39dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0b9c6af6-1648-4e84-b165-4bcc97b5796f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:to="loc_us-gaap_InterestRateSwapMember_0b9c6af6-1648-4e84-b165-4bcc97b5796f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_b70ab813-37d5-48e7-8961-ef85b4615dea" xlink:href="mck-20220630.xsd#mck_FixedInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_158dea1c-cab5-4e5f-9a56-abf0d3aeefed" xlink:to="loc_mck_FixedInterestRateSwapMember_b70ab813-37d5-48e7-8961-ef85b4615dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_efd85e43-a442-46e3-a112-c7c9d34b5c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_efd85e43-a442-46e3-a112-c7c9d34b5c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_efd85e43-a442-46e3-a112-c7c9d34b5c09" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_533205bb-3809-44da-bb8a-a1c5b053a726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_533205bb-3809-44da-bb8a-a1c5b053a726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_61172587-9d1b-4786-8ec7-b72471669d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:to="loc_us-gaap_CashFlowHedgingMember_61172587-9d1b-4786-8ec7-b72471669d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_705b87bb-fae8-45e7-a13d-eed07e624a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d22253d-9d27-4208-910f-eebd88c3ee4a" xlink:to="loc_us-gaap_FairValueHedgingMember_705b87bb-fae8-45e7-a13d-eed07e624a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3528c4f8-67d8-4d3b-84a5-5580babf9d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_DebtInstrumentAxis_3528c4f8-67d8-4d3b-84a5-5580babf9d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c3c71b49-1038-4cf3-a440-1e9814565fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3528c4f8-67d8-4d3b-84a5-5580babf9d8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c3c71b49-1038-4cf3-a440-1e9814565fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_8e5db68e-3d3a-47b8-a753-e19cf4978444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c3c71b49-1038-4cf3-a440-1e9814565fa3" xlink:to="loc_us-gaap_CurrencySwapMember_8e5db68e-3d3a-47b8-a753-e19cf4978444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_srt_CurrencyAxis_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_3c8ab6e1-fe47-4625-99df-ff2ea0dd9d1d" xlink:to="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_cc27e999-14ac-45a6-8ff8-2af4531bd50d" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:to="loc_currency_CAD_cc27e999-14ac-45a6-8ff8-2af4531bd50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_51be720e-3699-4ae7-a4be-16d2ea5f782a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:to="loc_currency_GBP_51be720e-3699-4ae7-a4be-16d2ea5f782a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_71e4f861-0478-47f8-a485-e7cf1c0fbe84" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_994fe2a7-740e-4f5f-8b12-4a69d4239bb2" xlink:to="loc_currency_USD_71e4f861-0478-47f8-a485-e7cf1c0fbe84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_44c3447c-61af-4fc9-a727-fd76fe416c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c7bc6a6-12ae-47d6-b1cb-187461285bfe" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_44c3447c-61af-4fc9-a727-fd76fe416c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_bdc4ecb0-8bb1-45a0-9368-f1d193298d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_44c3447c-61af-4fc9-a727-fd76fe416c0c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_bdc4ecb0-8bb1-45a0-9368-f1d193298d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_48177cb5-5a3a-43c4-a2b9-a0fec6e8b367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_48177cb5-5a3a-43c4-a2b9-a0fec6e8b367" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f098b5f7-50d7-4538-8629-5d320b7d4779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:to="loc_us-gaap_HedgingDesignationAxis_f098b5f7-50d7-4538-8629-5d320b7d4779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7726a809-955a-4a0e-9458-7172294f2c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f098b5f7-50d7-4538-8629-5d320b7d4779" xlink:to="loc_us-gaap_HedgingDesignationDomain_7726a809-955a-4a0e-9458-7172294f2c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8734855f-03b8-4dc9-b74d-12d15ddc8a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_7726a809-955a-4a0e-9458-7172294f2c64" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8734855f-03b8-4dc9-b74d-12d15ddc8a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_04bf9249-489a-43b1-90fb-cfc60f52f712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_04bf9249-489a-43b1-90fb-cfc60f52f712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_862c37ae-cd77-4256-9f2d-a42e944de87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_04bf9249-489a-43b1-90fb-cfc60f52f712" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_862c37ae-cd77-4256-9f2d-a42e944de87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_6833bcb9-bc42-4839-8af2-3a72a36683aa" xlink:href="mck-20220630.xsd#mck_FixedInterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_862c37ae-cd77-4256-9f2d-a42e944de87c" xlink:to="loc_mck_FixedInterestRateSwapMember_6833bcb9-bc42-4839-8af2-3a72a36683aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_c140640e-8715-4132-abab-f9dceaaffdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_862c37ae-cd77-4256-9f2d-a42e944de87c" xlink:to="loc_us-gaap_CurrencySwapMember_c140640e-8715-4132-abab-f9dceaaffdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2597dcf-d711-46a0-acf7-90408ea9e55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2597dcf-d711-46a0-acf7-90408ea9e55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_21b00304-6056-4f37-af7d-7b3cb406d32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2597dcf-d711-46a0-acf7-90408ea9e55b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_21b00304-6056-4f37-af7d-7b3cb406d32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_e396ee0d-8d0a-4dc0-9036-97e5016c4b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_21b00304-6056-4f37-af7d-7b3cb406d32d" xlink:to="loc_us-gaap_CurrencySwapMember_e396ee0d-8d0a-4dc0-9036-97e5016c4b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c06f2a23-1de1-4b6f-a658-7eac02e2666d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_21b00304-6056-4f37-af7d-7b3cb406d32d" xlink:to="loc_us-gaap_CashFlowHedgingMember_c06f2a23-1de1-4b6f-a658-7eac02e2666d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_fb245ab8-6573-4cdd-944b-cce51e38ae71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_126a849c-78c8-4508-a5a2-d9e31c55ef8e" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_fb245ab8-6573-4cdd-944b-cce51e38ae71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_0319d4b8-1b0f-46cf-aa0a-73d42fa9f5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fb245ab8-6573-4cdd-944b-cce51e38ae71" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_0319d4b8-1b0f-46cf-aa0a-73d42fa9f5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_53e98e44-1e10-407a-83d8-4b4936d0716c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fb245ab8-6573-4cdd-944b-cce51e38ae71" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_53e98e44-1e10-407a-83d8-4b4936d0716c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#HedgingActivitiesScheduleofFairValueofDerivativesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d2aaa52-f9dd-45e5-a5ad-805409df48c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d2aaa52-f9dd-45e5-a5ad-805409df48c3" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7bb6c948-34cc-4156-ace2-3ce609b621b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:to="loc_us-gaap_HedgingDesignationAxis_7bb6c948-34cc-4156-ace2-3ce609b621b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bfd81c8d-6a05-4ef4-9cea-90dab177106b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7bb6c948-34cc-4156-ace2-3ce609b621b6" xlink:to="loc_us-gaap_HedgingDesignationDomain_bfd81c8d-6a05-4ef4-9cea-90dab177106b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9a2ab3f2-d06f-4d63-b3e8-b541eec7f456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_bfd81c8d-6a05-4ef4-9cea-90dab177106b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9a2ab3f2-d06f-4d63-b3e8-b541eec7f456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bb5abfd1-5c05-4541-89b6-4b643ca5588f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bb5abfd1-5c05-4541-89b6-4b643ca5588f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_352e5e87-d4f5-4c64-976a-477f2c3867e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bb5abfd1-5c05-4541-89b6-4b643ca5588f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_352e5e87-d4f5-4c64-976a-477f2c3867e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_cfaaa0df-f67d-484f-bcdf-06d9ea933d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_352e5e87-d4f5-4c64-976a-477f2c3867e8" xlink:to="loc_us-gaap_CurrencySwapMember_cfaaa0df-f67d-484f-bcdf-06d9ea933d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0e5a8242-240d-4602-8cef-a300b2e6addb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_352e5e87-d4f5-4c64-976a-477f2c3867e8" xlink:to="loc_us-gaap_InterestRateSwapMember_0e5a8242-240d-4602-8cef-a300b2e6addb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4166d2b0-e018-4bf9-b2b2-a9e06e8fca60" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_f898af05-54b6-43be-a3aa-5050baa1683c" xlink:href="mck-20220630.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:to="loc_mck_CurrentAssetLiabilityMember_f898af05-54b6-43be-a3aa-5050baa1683c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentLiabilitiesMember_1d500606-ac2a-4fd4-b9f3-c76a859e8557" xlink:href="mck-20220630.xsd#mck_OtherNonCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:to="loc_mck_OtherNonCurrentLiabilitiesMember_1d500606-ac2a-4fd4-b9f3-c76a859e8557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember_642d0b71-4714-4e15-b358-0af93afcf585" xlink:href="mck-20220630.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:to="loc_mck_PrepaidExpensesAndOtherMember_642d0b71-4714-4e15-b358-0af93afcf585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsMember_359266cc-b403-4f1e-867e-371acc02540d" xlink:href="mck-20220630.xsd#mck_OtherNonCurrentAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f8e66c0-eb87-4368-ae60-32512d11a65b" xlink:to="loc_mck_OtherNonCurrentAssetsMember_359266cc-b403-4f1e-867e-371acc02540d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b58c0ae4-ed7b-4a55-965b-385c74dc526c" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ec55dffe-9151-46ac-b1c7-29be72deba04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ec55dffe-9151-46ac-b1c7-29be72deba04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a3497875-1e1c-4a68-b98b-01eb09da5213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a3497875-1e1c-4a68-b98b-01eb09da5213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_81683484-6853-4455-9700-be5efcbaff98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_81683484-6853-4455-9700-be5efcbaff98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_1b0417b5-237b-4b66-be89-6c689545592a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_26f44964-3ae9-465f-8e0b-c01143e79945" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_1b0417b5-237b-4b66-be89-6c689545592a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20220630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3a8a49fc-ce16-4765-a199-31ce79130901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_d4def0f4-8202-4631-8627-939a212d5c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3a8a49fc-ce16-4765-a199-31ce79130901" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_d4def0f4-8202-4631-8627-939a212d5c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20220630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4c33d3b2-a724-4b6c-8d17-21905364ac71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_33f7ded3-b157-48e6-a469-8845eec01e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4c33d3b2-a724-4b6c-8d17-21905364ac71" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_33f7ded3-b157-48e6-a469-8845eec01e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7302a3b7-26f5-48d6-8b16-102a1422e404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7302a3b7-26f5-48d6-8b16-102a1422e404" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a546ca0-4850-43a7-9e69-a19e844fab47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a546ca0-4850-43a7-9e69-a19e844fab47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbef6e74-331c-49a8-a129-ee0a9f5c136b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a546ca0-4850-43a7-9e69-a19e844fab47" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbef6e74-331c-49a8-a129-ee0a9f5c136b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_01a5733b-5c37-4da1-8c08-2971a9949670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbef6e74-331c-49a8-a129-ee0a9f5c136b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_01a5733b-5c37-4da1-8c08-2971a9949670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40968281-f3cb-4706-80e7-1917f5981707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40968281-f3cb-4706-80e7-1917f5981707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_851cb86e-0c8c-4b5c-83cd-ea322f1c347c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40968281-f3cb-4706-80e7-1917f5981707" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_851cb86e-0c8c-4b5c-83cd-ea322f1c347c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_faa231fb-78ac-41b9-99a7-63b210a9e717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_851cb86e-0c8c-4b5c-83cd-ea322f1c347c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_faa231fb-78ac-41b9-99a7-63b210a9e717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b1b7a3ef-8229-4f43-849a-77a3949a2115" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:to="loc_srt_LitigationCaseAxis_b1b7a3ef-8229-4f43-849a-77a3949a2115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_17961f88-0f6b-49dc-9d22-d2ebb5ddd828" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_b1b7a3ef-8229-4f43-849a-77a3949a2115" xlink:to="loc_srt_LitigationCaseTypeDomain_17961f88-0f6b-49dc-9d22-d2ebb5ddd828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_a9cf4031-8427-4647-bb62-100fdbd50c20" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_17961f88-0f6b-49dc-9d22-d2ebb5ddd828" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_a9cf4031-8427-4647-bb62-100fdbd50c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7a8652be-44e9-4554-9657-a6645b8a4633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b347eca8-34bb-4eed-9a46-417e905a1782" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7a8652be-44e9-4554-9657-a6645b8a4633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_321aeac9-8f71-498a-a64a-da21496d5703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7a8652be-44e9-4554-9657-a6645b8a4633" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_321aeac9-8f71-498a-a64a-da21496d5703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_7d92ab3e-f160-4b77-b491-95c1df6d1a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7a8652be-44e9-4554-9657-a6645b8a4633" xlink:to="loc_us-gaap_RestrictedCash_7d92ab3e-f160-4b77-b491-95c1df6d1a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2615c520-d77f-4c37-93de-76d336c8263c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2615c520-d77f-4c37-93de-76d336c8263c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6d403526-c269-45e0-87fe-befdf6b42181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6d403526-c269-45e0-87fe-befdf6b42181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d6dee6e9-b12c-407a-a430-ef316e60fa33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6d403526-c269-45e0-87fe-befdf6b42181" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d6dee6e9-b12c-407a-a430-ef316e60fa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a4cae162-8304-44a7-986a-18e67c9ed9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d6dee6e9-b12c-407a-a430-ef316e60fa33" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a4cae162-8304-44a7-986a-18e67c9ed9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1516c642-0688-485f-9999-212cea7c84de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1516c642-0688-485f-9999-212cea7c84de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_652fb4bd-ad89-4b77-8de5-ebb58c8adf87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1516c642-0688-485f-9999-212cea7c84de" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_652fb4bd-ad89-4b77-8de5-ebb58c8adf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3006a09a-63af-4a81-9938-94904beba608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_652fb4bd-ad89-4b77-8de5-ebb58c8adf87" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3006a09a-63af-4a81-9938-94904beba608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f46d10e6-905e-42c4-bb55-967ed8bb574b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9a2aaeca-9d87-4328-863b-4babc19673a0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f46d10e6-905e-42c4-bb55-967ed8bb574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_53b2a4ae-950f-4f92-8101-23de25171a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f46d10e6-905e-42c4-bb55-967ed8bb574b" xlink:to="loc_us-gaap_LongTermDebt_53b2a4ae-950f-4f92-8101-23de25171a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_c19c476c-d99e-4fc9-bb36-f340a4b04525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f46d10e6-905e-42c4-bb55-967ed8bb574b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_c19c476c-d99e-4fc9-bb36-f340a4b04525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20220630.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dfc7349d-49c8-49d2-a9e4-e99caf363e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_af0b8f2e-c96c-4f47-929e-8bc633c3b2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dfc7349d-49c8-49d2-a9e4-e99caf363e9a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_af0b8f2e-c96c-4f47-929e-8bc633c3b2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="simple" xlink:href="mck-20220630.xsd#CommitmentsandContingentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4bb4d84-0aa5-4d08-9056-46f392e9df9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_f5e2e948-c691-4e88-a110-70f2a16c7f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4bb4d84-0aa5-4d08-9056-46f392e9df9d" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_f5e2e948-c691-4e88-a110-70f2a16c7f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f32be07c-6ed6-43ed-aecd-b1ed22548b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f32be07c-6ed6-43ed-aecd-b1ed22548b96" xlink:to="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_30dfc9f1-7e53-4005-a632-10bdcc238693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_us-gaap_LitigationStatusAxis_30dfc9f1-7e53-4005-a632-10bdcc238693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c622ac9e-7f46-4c7d-a289-ab61ee0ad317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_30dfc9f1-7e53-4005-a632-10bdcc238693" xlink:to="loc_us-gaap_LitigationStatusDomain_c622ac9e-7f46-4c7d-a289-ab61ee0ad317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_fdcbdda6-6f96-47c5-b497-d4d322ce1849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_c622ac9e-7f46-4c7d-a289-ab61ee0ad317" xlink:to="loc_us-gaap_PendingLitigationMember_fdcbdda6-6f96-47c5-b497-d4d322ce1849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_6aef9acf-bce2-4e92-ba45-e6130064fd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_c622ac9e-7f46-4c7d-a289-ab61ee0ad317" xlink:to="loc_us-gaap_SettledLitigationMember_6aef9acf-bce2-4e92-ba45-e6130064fd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_13ffc664-8d0e-4ec5-a5d2-5ca92770a674" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_dei_LegalEntityAxis_13ffc664-8d0e-4ec5-a5d2-5ca92770a674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_13ffc664-8d0e-4ec5-a5d2-5ca92770a674" xlink:to="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_7e979ec1-3c3c-415b-a6b4-f530c10912b3" xlink:href="mck-20220630.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_7e979ec1-3c3c-415b-a6b4-f530c10912b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_0f8dc73b-8f9a-4019-9151-3f828a366365" xlink:href="mck-20220630.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_0f8dc73b-8f9a-4019-9151-3f828a366365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember_d9ebc89f-3d1f-41a0-9e9c-bd19efebc9e2" xlink:href="mck-20220630.xsd#mck_DistributorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8471a543-e08f-426f-b387-9f8d51d3d425" xlink:to="loc_mck_DistributorsMember_d9ebc89f-3d1f-41a0-9e9c-bd19efebc9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_14ed2592-8dd0-4cd3-b889-2bcc58ee5953" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_srt_StatementGeographicalAxis_14ed2592-8dd0-4cd3-b889-2bcc58ee5953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bfc597e4-9ffa-4f70-b6ed-a54b8f7b476f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_14ed2592-8dd0-4cd3-b889-2bcc58ee5953" xlink:to="loc_srt_SegmentGeographicalDomain_bfc597e4-9ffa-4f70-b6ed-a54b8f7b476f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_2c2a50e4-efb7-4aeb-b7bb-767182411e68" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bfc597e4-9ffa-4f70-b6ed-a54b8f7b476f" xlink:to="loc_country_CA_2c2a50e4-efb7-4aeb-b7bb-767182411e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_771bad60-d831-4741-b8f0-511971de063a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_srt_LitigationCaseAxis_771bad60-d831-4741-b8f0-511971de063a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_771bad60-d831-4741-b8f0-511971de063a" xlink:to="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_6f2299b1-e9fd-47d2-b1b5-18fa26f8e82e" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_6f2299b1-e9fd-47d2-b1b5-18fa26f8e82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_c716b7a4-2dff-4787-8899-041b0e79cbf5" xlink:href="mck-20220630.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_c716b7a4-2dff-4787-8899-041b0e79cbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_2b0ab41f-eb06-40b6-8d6a-a7fc5bfe9e79" xlink:href="mck-20220630.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:to="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_2b0ab41f-eb06-40b6-8d6a-a7fc5bfe9e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_9f01b9a9-d544-4350-914e-ca2d01984913" xlink:href="mck-20220630.xsd#mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_488d4b41-d80a-4f0f-bde5-e466c720581f" xlink:to="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_9f01b9a9-d544-4350-914e-ca2d01984913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c0e6ddc-69ca-4861-b9d3-80dbabaece65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c0e6ddc-69ca-4861-b9d3-80dbabaece65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d9589602-7092-4827-a722-246d56101cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3c0e6ddc-69ca-4861-b9d3-80dbabaece65" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d9589602-7092-4827-a722-246d56101cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_bf1f5f76-f753-4b73-9625-f59cc627cc72" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_d9589602-7092-4827-a722-246d56101cbd" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_bf1f5f76-f753-4b73-9625-f59cc627cc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActStateOfNewYorkMember_ae36c7cb-92a7-4800-beba-5c0552cd1a9b" xlink:href="mck-20220630.xsd#mck_OpioidStewardshipActStateOfNewYorkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_d9589602-7092-4827-a722-246d56101cbd" xlink:to="loc_mck_OpioidStewardshipActStateOfNewYorkMember_ae36c7cb-92a7-4800-beba-5c0552cd1a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8ada517f-13d1-4776-b69e-6aba122e53fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_srt_CounterpartyNameAxis_8ada517f-13d1-4776-b69e-6aba122e53fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_8ada517f-13d1-4776-b69e-6aba122e53fe" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_0124e9e6-df49-4a86-885a-419f7a45b2ce" xlink:href="mck-20220630.xsd#mck_CherokeeNationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_CherokeeNationMember_0124e9e6-df49-4a86-885a-419f7a45b2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_430b20eb-09fb-4566-89be-71628056f9ab" xlink:href="mck-20220630.xsd#mck_GovernmentalEntitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_GovernmentalEntitiesMember_430b20eb-09fb-4566-89be-71628056f9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_ca90507d-577b-47cd-933a-95cfe6d2fa9a" xlink:href="mck-20220630.xsd#mck_IndividualClaimantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_IndividualClaimantMember_ca90507d-577b-47cd-933a-95cfe6d2fa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_2df310e9-056d-42f2-9853-6e4e94cd9629" xlink:href="mck-20220630.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_2df310e9-056d-42f2-9853-6e4e94cd9629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember_bf179780-2df9-4c51-84c7-e22be5dcc9e8" xlink:href="mck-20220630.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_StateOfAlabamaAndSubdivisionsMember_bf179780-2df9-4c51-84c7-e22be5dcc9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember_b46a8f50-d8ef-43c5-81eb-633d59f1a99e" xlink:href="mck-20220630.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_StateOfWashingtonAndSubdivisionsMember_b46a8f50-d8ef-43c5-81eb-633d59f1a99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOklahomaAndSubdivisionsMember_f6fb6030-124a-4c30-a2bf-368c60c0cad9" xlink:href="mck-20220630.xsd#mck_StateOfOklahomaAndSubdivisionsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_StateOfOklahomaAndSubdivisionsMember_f6fb6030-124a-4c30-a2bf-368c60c0cad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember_06666c7b-71f2-479a-9b8f-40d3d09b83ce" xlink:href="mck-20220630.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_SettlingGovernmentalEntitiesMember_06666c7b-71f2-479a-9b8f-40d3d09b83ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember_6ab7014b-b94e-437a-95c8-4dd372bf75b9" xlink:href="mck-20220630.xsd#mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember_6ab7014b-b94e-437a-95c8-4dd372bf75b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_b75e553d-727d-4a44-b65d-29fdf53538a5" xlink:href="mck-20220630.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4eaee3b4-e715-4193-be10-0a765827cd95" xlink:to="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_b75e553d-727d-4a44-b65d-29fdf53538a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_151e75bc-040b-477f-b150-dc405c30dd43" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_srt_RangeAxis_151e75bc-040b-477f-b150-dc405c30dd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c567db66-8a88-4f6a-99e3-f65cccbd7846" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_151e75bc-040b-477f-b150-dc405c30dd43" xlink:to="loc_srt_RangeMember_c567db66-8a88-4f6a-99e3-f65cccbd7846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_835eeaf2-6311-4de0-be05-21cf4b7890b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c567db66-8a88-4f6a-99e3-f65cccbd7846" xlink:to="loc_srt_MinimumMember_835eeaf2-6311-4de0-be05-21cf4b7890b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9f387f4d-7796-491b-9e8e-d79b871983ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c567db66-8a88-4f6a-99e3-f65cccbd7846" xlink:to="loc_srt_MaximumMember_9f387f4d-7796-491b-9e8e-d79b871983ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_30fffb92-2700-48ec-8af1-baec0c2f150e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_30fffb92-2700-48ec-8af1-baec0c2f150e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5416a4bb-3545-43ef-8b94-c02d1ab1b571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_30fffb92-2700-48ec-8af1-baec0c2f150e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5416a4bb-3545-43ef-8b94-c02d1ab1b571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ea53dd10-2744-4a0f-af0c-19160b927666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5416a4bb-3545-43ef-8b94-c02d1ab1b571" xlink:to="loc_us-gaap_SubsequentEventMember_ea53dd10-2744-4a0f-af0c-19160b927666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_50ba3f4d-27f8-41c4-93e0-7c6581d06d74" xlink:to="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_31c6eb31-e131-4980-9898-72781bce4823" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_31c6eb31-e131-4980-9898-72781bce4823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_ccfd8022-4f58-4629-9f6b-dcdf3eacc0b9" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberofStates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberofStates_ccfd8022-4f58-4629-9f6b-dcdf3eacc0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates_6ae6631c-b5c5-4f45-8140-e8265618326d" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberOfEligibleStates_6ae6631c-b5c5-4f45-8140-e8265618326d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_29aa5e4a-22ce-49ba-abcd-512c2c218aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_29aa5e4a-22ce-49ba-abcd-512c2c218aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_3e402dac-dca8-461f-bd00-e79b271f9449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_3e402dac-dca8-461f-bd00-e79b271f9449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_a342775b-38ce-4ec3-b375-3ed75200f3fd" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_a342775b-38ce-4ec3-b375-3ed75200f3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_0bf2cb1e-9b03-48f7-b0f4-382a49d1ae8d" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_0bf2cb1e-9b03-48f7-b0f4-382a49d1ae8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8626a1a7-4f44-4dc6-8212-3bb3d6bb9762" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8626a1a7-4f44-4dc6-8212-3bb3d6bb9762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_f486d311-7cc2-4dec-b7e0-5c86ada6d227" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_f486d311-7cc2-4dec-b7e0-5c86ada6d227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_80ed3c1d-aced-4aee-8571-8a8fed05c484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LitigationSettlementExpense_80ed3c1d-aced-4aee-8571-8a8fed05c484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_7d452079-bdd5-4867-ad19-27d87f992a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_7d452079-bdd5-4867-ad19-27d87f992a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_a861966c-1ec3-4636-9512-ba953c8b1287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_a861966c-1ec3-4636-9512-ba953c8b1287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_34fa5663-2a96-4040-9dbe-daaa7fec32fb" xlink:href="mck-20220630.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_34fa5663-2a96-4040-9dbe-daaa7fec32fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_5427e309-ac57-4f66-9de2-3cd00c554b6a" xlink:href="mck-20220630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_5427e309-ac57-4f66-9de2-3cd00c554b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_d66fe125-816f-42c3-ba26-fce866ff718c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_EscrowDeposit_d66fe125-816f-42c3-ba26-fce866ff718c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_f14c994f-d380-49c4-8b61-03482fe53a30" xlink:href="mck-20220630.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_f14c994f-d380-49c4-8b61-03482fe53a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_4e2b3269-dc45-4777-ada2-8abce305350d" xlink:href="mck-20220630.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_4e2b3269-dc45-4777-ada2-8abce305350d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_b9de8f92-7ec2-46dd-820e-f35aeba7645d" xlink:href="mck-20220630.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_b9de8f92-7ec2-46dd-820e-f35aeba7645d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_927f7c62-6e98-43f1-951e-58ad7dca75c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_927f7c62-6e98-43f1-951e-58ad7dca75c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_5b44d97e-a13a-40a2-915f-d0c2c9b3e48d" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_5b44d97e-a13a-40a2-915f-d0c2c9b3e48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_833759f6-1816-4c0c-986c-b075a3f9d356" xlink:href="mck-20220630.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_833759f6-1816-4c0c-986c-b075a3f9d356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_716b69da-2ac7-4dfc-b746-c51de3cbff6a" xlink:href="mck-20220630.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_716b69da-2ac7-4dfc-b746-c51de3cbff6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_145b72fa-cf18-4d42-b0e9-5a0a381f542f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_145b72fa-cf18-4d42-b0e9-5a0a381f542f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax_2e365b78-db83-4313-b47c-85f4db369d91" xlink:href="mck-20220630.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_mck_LossContingencyAccrualProvisionAfterTax_2e365b78-db83-4313-b47c-85f4db369d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_9347516f-1c47-4572-ba6d-e65a1d2afa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4060aaef-1b33-4711-8345-a8bbe6098c7a" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_9347516f-1c47-4572-ba6d-e65a1d2afa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d279e1a2-a90a-4810-a3c7-67fcf6c72a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b58e8aff-4d28-405e-9082-b0e6f9199372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d279e1a2-a90a-4810-a3c7-67fcf6c72a07" xlink:to="loc_us-gaap_LossContingenciesTable_b58e8aff-4d28-405e-9082-b0e6f9199372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e99f5c62-11a5-4a54-8223-89645c14a75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b58e8aff-4d28-405e-9082-b0e6f9199372" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e99f5c62-11a5-4a54-8223-89645c14a75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_394724bb-13e0-4adf-95f5-ed7f0955e225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e99f5c62-11a5-4a54-8223-89645c14a75c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_394724bb-13e0-4adf-95f5-ed7f0955e225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_87e10e71-dc91-407a-8015-aa7feb703536" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_394724bb-13e0-4adf-95f5-ed7f0955e225" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_87e10e71-dc91-407a-8015-aa7feb703536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b58e8aff-4d28-405e-9082-b0e6f9199372" xlink:to="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_6939e3bb-c393-404d-b358-7466ee7ff933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_6939e3bb-c393-404d-b358-7466ee7ff933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_e7d8257b-7ffe-4c17-86d7-4efe82223019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_e7d8257b-7ffe-4c17-86d7-4efe82223019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_857cf613-aef5-4128-965d-bb3e1ccc6213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_80e34972-ffe4-473c-bca6-473cd49d883a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_857cf613-aef5-4128-965d-bb3e1ccc6213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="mck-20220630.xsd#StockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8eef72ae-ee11-4caf-9071-7caba2c06831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e5442945-7d04-44e7-9bb9-43d968f5d6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8eef72ae-ee11-4caf-9071-7caba2c06831" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e5442945-7d04-44e7-9bb9-43d968f5d6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="mck-20220630.xsd#StockholdersEquityDeficitTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_097f961f-da09-489a-a2c2-2474818ec110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_57b4d20e-362c-4c9a-9b2b-ac0909b093c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_097f961f-da09-489a-a2c2-2474818ec110" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_57b4d20e-362c-4c9a-9b2b-ac0909b093c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_bb43221a-ae48-4787-b5f6-e264384e0bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bb43221a-ae48-4787-b5f6-e264384e0bdb" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7c7f362d-3643-4b67-8bae-18d15c982faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7c7f362d-3643-4b67-8bae-18d15c982faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f511d6db-d63f-43eb-8ac9-f79f9be503f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7c7f362d-3643-4b67-8bae-18d15c982faf" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f511d6db-d63f-43eb-8ac9-f79f9be503f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_83460835-3572-4d74-b4f0-1b33fc417e64" xlink:href="mck-20220630.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f511d6db-d63f-43eb-8ac9-f79f9be503f4" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_83460835-3572-4d74-b4f0-1b33fc417e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7fcced1d-2673-4efc-bb17-321342cc08ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7fcced1d-2673-4efc-bb17-321342cc08ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_472cbebe-d7ee-4155-8882-45a072dcbd41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7fcced1d-2673-4efc-bb17-321342cc08ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_472cbebe-d7ee-4155-8882-45a072dcbd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e3b7d21c-ff36-4b55-9859-5061f5d46931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_472cbebe-d7ee-4155-8882-45a072dcbd41" xlink:to="loc_us-gaap_SubsequentEventMember_e3b7d21c-ff36-4b55-9859-5061f5d46931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_c3d9e65b-c544-408d-aded-72c0730ec43b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_44830c45-dd5a-46f6-8675-b28b3592638c" xlink:href="mck-20220630.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_44830c45-dd5a-46f6-8675-b28b3592638c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b857a70f-cff9-49be-83fe-9cc420ed4047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b857a70f-cff9-49be-83fe-9cc420ed4047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_f6211a05-1c92-41ff-bd34-3f5557171e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_f6211a05-1c92-41ff-bd34-3f5557171e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_4979739f-3ab2-4984-bb3d-3f1c635261ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_4979739f-3ab2-4984-bb3d-3f1c635261ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_aefed9b8-761e-4321-b2f8-c1d96edce2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_aefed9b8-761e-4321-b2f8-c1d96edce2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_eff3d393-53c5-418a-a187-b052e437323c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_eff3d393-53c5-418a-a187-b052e437323c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_69cdc4a1-cc5a-4c5d-a8b1-07fa97357d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_69cdc4a1-cc5a-4c5d-a8b1-07fa97357d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_7d257387-9dc9-45f5-954f-eee04e07f4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_c92e8aa4-cae5-497c-80b2-75852561e222" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_7d257387-9dc9-45f5-954f-eee04e07f4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9ea5823e-a18d-40d2-9533-0bbc68e5de43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9ea5823e-a18d-40d2-9533-0bbc68e5de43" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_231e3cba-e15d-44fd-8332-bdb3a487d1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a4b9a0a-9d3a-4220-9a11-c41ead52c32d" xlink:to="loc_us-gaap_EquityComponentDomain_231e3cba-e15d-44fd-8332-bdb3a487d1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_231e3cba-e15d-44fd-8332-bdb3a487d1ba" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_87a53c4c-cfcf-4609-b967-9eacbada30e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_87a53c4c-cfcf-4609-b967-9eacbada30e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_5f352c04-263b-484d-8f3c-b55bdc66b737" xlink:href="mck-20220630.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_5f352c04-263b-484d-8f3c-b55bdc66b737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_2cbb9002-a293-4c83-9266-3b778eb820ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_2cbb9002-a293-4c83-9266-3b778eb820ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_75ce292b-fe39-40b4-93d6-b3758fbbd584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_fb6e16c2-3a8b-4e99-bf46-8a216badbd19" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_75ce292b-fe39-40b4-93d6-b3758fbbd584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociAttributableToNoncontrollingInterestMember_edb196cc-8f1a-45f0-830e-33a879e4dd31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_231e3cba-e15d-44fd-8332-bdb3a487d1ba" xlink:to="loc_us-gaap_AociAttributableToNoncontrollingInterestMember_edb196cc-8f1a-45f0-830e-33a879e4dd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a8851c0e-0539-421f-ac12-15d2c2deb038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_HedgingDesignationAxis_a8851c0e-0539-421f-ac12-15d2c2deb038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4f29a5b4-7be8-4b70-89f9-e59322234d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a8851c0e-0539-421f-ac12-15d2c2deb038" xlink:to="loc_us-gaap_HedgingDesignationDomain_4f29a5b4-7be8-4b70-89f9-e59322234d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_18681a50-2283-424b-9b35-81ccc8b4c5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4f29a5b4-7be8-4b70-89f9-e59322234d40" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_18681a50-2283-424b-9b35-81ccc8b4c5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f1e15d39-8065-4e2e-904c-03c3bd942769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f1e15d39-8065-4e2e-904c-03c3bd942769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_67e37349-7a56-4efc-b2a8-969fef27c529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f1e15d39-8065-4e2e-904c-03c3bd942769" xlink:to="loc_us-gaap_HedgingRelationshipDomain_67e37349-7a56-4efc-b2a8-969fef27c529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a51fbe9e-8b46-49cd-97a6-f45b9ff94258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_67e37349-7a56-4efc-b2a8-969fef27c529" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a51fbe9e-8b46-49cd-97a6-f45b9ff94258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_1ae972d0-9431-469b-86e5-4b8aff0dac77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_67e37349-7a56-4efc-b2a8-969fef27c529" xlink:to="loc_us-gaap_CurrencySwapMember_1ae972d0-9431-469b-86e5-4b8aff0dac77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_621b5ed6-4b78-4655-871f-91f506dc3ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_DebtInstrumentAxis_621b5ed6-4b78-4655-871f-91f506dc3ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2e71a726-6f52-4fa5-aa4f-94f9f74fa9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_621b5ed6-4b78-4655-871f-91f506dc3ef4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2e71a726-6f52-4fa5-aa4f-94f9f74fa9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_38d590bd-6092-4c10-8238-4b932bf91176" xlink:href="mck-20220630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2e71a726-6f52-4fa5-aa4f-94f9f74fa9e1" xlink:to="loc_mck_EuroDenominatedNotesMember_38d590bd-6092-4c10-8238-4b932bf91176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_89de23b9-e867-4086-be8b-b4f2c66391ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5904638e-516f-442d-9d95-8565e324b436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5904638e-516f-442d-9d95-8565e324b436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b0786716-d531-4965-b250-5e69fb4e4409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b0786716-d531-4965-b250-5e69fb4e4409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_173b5c03-92ff-41d4-8fd8-e3d7269e1a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_173b5c03-92ff-41d4-8fd8-e3d7269e1a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9feef468-7a50-485e-bf23-d9ffbc80ffb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9feef468-7a50-485e-bf23-d9ffbc80ffb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_14e51786-ce03-46ca-801d-76a7384dec35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_14e51786-ce03-46ca-801d-76a7384dec35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f146174-a4af-4e76-a89f-55a8c9d722eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f146174-a4af-4e76-a89f-55a8c9d722eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_b75894c8-0b83-4a16-84a1-8a96f388960d" xlink:href="mck-20220630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_b75894c8-0b83-4a16-84a1-8a96f388960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd53650-7fd4-4519-96ab-97842a22c754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ad5d8038-c150-4759-a7d3-3c9fb942199f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd53650-7fd4-4519-96ab-97842a22c754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_79180723-6a35-4655-b28c-68c7898e1ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_79180723-6a35-4655-b28c-68c7898e1ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b668699a-38c4-49eb-875c-fa9b710ded05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_486efc49-1435-4512-870f-60b5ede48a47" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b668699a-38c4-49eb-875c-fa9b710ded05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20220630.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_58d18c55-267b-4173-a7f8-0fb4a81e6a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0cecd2de-089d-422d-b99d-921194bd44a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_58d18c55-267b-4173-a7f8-0fb4a81e6a30" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0cecd2de-089d-422d-b99d-921194bd44a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20220630.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_96514f5e-a8f4-4077-aeac-6e2c8ae66727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b1d2c483-d7fe-4bf4-ba46-9a47c6f4573b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_96514f5e-a8f4-4077-aeac-6e2c8ae66727" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b1d2c483-d7fe-4bf4-ba46-9a47c6f4573b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7d8fc046-5dea-4085-8f42-f33c42b6c350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7d8fc046-5dea-4085-8f42-f33c42b6c350" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c7deda8d-5b40-438a-8869-19e5cdc9b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c7deda8d-5b40-438a-8869-19e5cdc9b239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1a2e3993-bfe6-4308-926d-162d6e1bf7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c7deda8d-5b40-438a-8869-19e5cdc9b239" xlink:to="loc_us-gaap_SegmentDomain_1a2e3993-bfe6-4308-926d-162d6e1bf7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_dce4ed3d-be74-43dc-8417-a8500183b2ac" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1a2e3993-bfe6-4308-926d-162d6e1bf7b3" xlink:to="loc_mck_InternationalSegmentMember_dce4ed3d-be74-43dc-8417-a8500183b2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2be01a2a-d62b-4f43-b61e-60cd929182ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:to="loc_srt_StatementGeographicalAxis_2be01a2a-d62b-4f43-b61e-60cd929182ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ce8f3c3a-ca40-4653-ba32-933a6f684fad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2be01a2a-d62b-4f43-b61e-60cd929182ac" xlink:to="loc_srt_SegmentGeographicalDomain_ce8f3c3a-ca40-4653-ba32-933a6f684fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c3629cad-5a91-4135-95c4-eb398c4988ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce8f3c3a-ca40-4653-ba32-933a6f684fad" xlink:to="loc_srt_EuropeMember_c3629cad-5a91-4135-95c4-eb398c4988ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b47397e-f6f4-431d-a92e-d16b88766791" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b3e5ecb8-d9b3-424b-8d8d-3c2f47d14607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_us-gaap_NumberOfReportableSegments_b3e5ecb8-d9b3-424b-8d8d-3c2f47d14607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_ee3ada35-8c3a-4d88-b37f-95ba4ab3c20b" xlink:href="mck-20220630.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_ee3ada35-8c3a-4d88-b37f-95ba4ab3c20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_0847bf0d-93c6-4693-a836-dde73d187f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_0847bf0d-93c6-4693-a836-dde73d187f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_60b97ee0-6c57-4c95-b993-24d0a876462c" xlink:href="mck-20220630.xsd#mck_NumberOfBusinessOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_mck_NumberOfBusinessOperations_60b97ee0-6c57-4c95-b993-24d0a876462c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6b11a509-ba26-41c4-90b6-87d744c192b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_454004b9-6dab-452e-8b6b-6e48354e298b" xlink:to="loc_us-gaap_Assets_6b11a509-ba26-41c4-90b6-87d744c192b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="simple" xlink:href="mck-20220630.xsd#SegmentsofBusinessReportableoperatingsegmentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_559f262c-5986-4aaf-b48e-a813272052bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_559f262c-5986-4aaf-b48e-a813272052bc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d817dba3-c9da-41d5-8ec9-405079c6d3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d817dba3-c9da-41d5-8ec9-405079c6d3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d817dba3-c9da-41d5-8ec9-405079c6d3c0" xlink:to="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_0f30badf-d936-4026-9041-8da32719fa82" xlink:href="mck-20220630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:to="loc_mck_USPharmaceuticalSegmentMember_0f30badf-d936-4026-9041-8da32719fa82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_a586fbf6-8487-436d-9774-581a5649a00c" xlink:href="mck-20220630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_a586fbf6-8487-436d-9774-581a5649a00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e859d058-a154-48e2-86eb-380a91814585" xlink:href="mck-20220630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e859d058-a154-48e2-86eb-380a91814585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_0c779098-b1b4-4b33-b9c6-1975ea274590" xlink:href="mck-20220630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e01134da-376c-4ebe-876f-c78f243884da" xlink:to="loc_mck_InternationalSegmentMember_0c779098-b1b4-4b33-b9c6-1975ea274590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d635fc19-5c1a-452d-ad77-dc4d2df54b2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_srt_LitigationCaseAxis_d635fc19-5c1a-452d-ad77-dc4d2df54b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d5fa96d9-77cf-40be-a281-d29a98fe8aa7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_d635fc19-5c1a-452d-ad77-dc4d2df54b2a" xlink:to="loc_srt_LitigationCaseTypeDomain_d5fa96d9-77cf-40be-a281-d29a98fe8aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_d97f61c5-ed03-4376-a173-b74c229b6a10" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_d5fa96d9-77cf-40be-a281-d29a98fe8aa7" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_d97f61c5-ed03-4376-a173-b74c229b6a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_77c38058-f8b0-45c7-8504-a8cf5e0726c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_srt_ConsolidationItemsAxis_77c38058-f8b0-45c7-8504-a8cf5e0726c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e0ef034b-2ff0-41d2-bb07-4afc7abd6308" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_77c38058-f8b0-45c7-8504-a8cf5e0726c3" xlink:to="loc_srt_ConsolidationItemsDomain_e0ef034b-2ff0-41d2-bb07-4afc7abd6308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_27b5ffa4-e477-4f06-ae87-a47e724e5ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e0ef034b-2ff0-41d2-bb07-4afc7abd6308" xlink:to="loc_us-gaap_OperatingSegmentsMember_27b5ffa4-e477-4f06-ae87-a47e724e5ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ea36d8ca-587c-46d3-8f7d-83a7d282f989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e0ef034b-2ff0-41d2-bb07-4afc7abd6308" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ea36d8ca-587c-46d3-8f7d-83a7d282f989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_776a52f8-fbf3-4a15-bf34-cd73f327a43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ffed8023-839a-40b7-a67d-e0bfc2bc1d3b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_776a52f8-fbf3-4a15-bf34-cd73f327a43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d29f2ef2-3e24-44bb-a681-1986bbc985f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_776a52f8-fbf3-4a15-bf34-cd73f327a43b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d29f2ef2-3e24-44bb-a681-1986bbc985f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6e00c6ed-335b-486f-baa3-bedddc524d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6e00c6ed-335b-486f-baa3-bedddc524d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b6ff1e88-7522-4227-8760-8cb2cd8648e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6e00c6ed-335b-486f-baa3-bedddc524d88" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b6ff1e88-7522-4227-8760-8cb2cd8648e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_a16053e9-71b7-47e7-836f-f07026a26122" xlink:href="mck-20220630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_b6ff1e88-7522-4227-8760-8cb2cd8648e7" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_a16053e9-71b7-47e7-836f-f07026a26122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd02647a-5365-4742-b638-71329210f1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd02647a-5365-4742-b638-71329210f1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_92f5ac03-f0e8-49bc-945f-cb3a74153036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd02647a-5365-4742-b638-71329210f1c8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_92f5ac03-f0e8-49bc-945f-cb3a74153036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_c8a02ace-3ff8-4f9b-ba38-ddb2ca8cdd88" xlink:href="mck-20220630.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_92f5ac03-f0e8-49bc-945f-cb3a74153036" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_c8a02ace-3ff8-4f9b-ba38-ddb2ca8cdd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_db7ecf82-1d9f-433d-85b4-d0a8072132e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_srt_StatementGeographicalAxis_db7ecf82-1d9f-433d-85b4-d0a8072132e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1e17c440-f94d-47ef-912c-21677482e20d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_db7ecf82-1d9f-433d-85b4-d0a8072132e2" xlink:to="loc_srt_SegmentGeographicalDomain_1e17c440-f94d-47ef-912c-21677482e20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f94b9f98-079a-4b21-a7c8-2b3b981eaf84" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1e17c440-f94d-47ef-912c-21677482e20d" xlink:to="loc_country_US_f94b9f98-079a-4b21-a7c8-2b3b981eaf84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_17437243-bf54-4667-ada6-e808fcdff00b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_28afc3cb-e782-453d-a618-855597169349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_us-gaap_RevenuesAbstract_28afc3cb-e782-453d-a618-855597169349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_321d5e6e-17a0-4bff-b913-c8e2e18b8e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_28afc3cb-e782-453d-a618-855597169349" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_321d5e6e-17a0-4bff-b913-c8e2e18b8e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_6c811c0d-53e4-4906-a08a-7e9225e6c8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_6c811c0d-53e4-4906-a08a-7e9225e6c8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_49abe257-a034-4b76-8632-c3aab5158007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_6c811c0d-53e4-4906-a08a-7e9225e6c8cf" xlink:to="loc_us-gaap_OperatingIncomeLoss_49abe257-a034-4b76-8632-c3aab5158007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_8249ab60-65b2-4111-b9a5-3492c34ef804" xlink:href="mck-20220630.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_8249ab60-65b2-4111-b9a5-3492c34ef804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b7d649bd-0923-4911-9626-9b1908f3ca79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_us-gaap_InterestExpense_b7d649bd-0923-4911-9626-9b1908f3ca79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e945d3d-6a91-4086-ae17-2af86804efe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_76b19a33-a6c1-431f-935c-bd738355ad3d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e945d3d-6a91-4086-ae17-2af86804efe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_7b418135-b37b-43d6-99ff-88c97285e76b" xlink:href="mck-20220630.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_7b418135-b37b-43d6-99ff-88c97285e76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2c86018c-2b38-498d-a7ea-ad0a433c2432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_NumberOfReportableSegments_2c86018c-2b38-498d-a7ea-ad0a433c2432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_b6cfb422-e317-4228-882d-9bfa9db90ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_b6cfb422-e317-4228-882d-9bfa9db90ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9b5d2d58-d1df-48a5-a2fe-0aa0cf3fc4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_InventoryWriteDown_9b5d2d58-d1df-48a5-a2fe-0aa0cf3fc4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_6fe19208-14dc-4e99-a595-e21cc188e9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_6fe19208-14dc-4e99-a595-e21cc188e9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a43a72d6-6abc-4d21-bf05-62a17be05abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a43a72d6-6abc-4d21-bf05-62a17be05abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_9a53e2e8-6018-4c57-a2dc-32bf63ed5ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7311ae56-4759-440c-a4c6-2379832dea38" xlink:to="loc_us-gaap_LitigationSettlementExpense_9a53e2e8-6018-4c57-a2dc-32bf63ed5ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>mck-20220630_g1.jpg
<TEXT>
begin 644 mck-20220630_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
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M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
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MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
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MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
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M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
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M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
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M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
M9"IG_?%>F_\ !1?X1S^,OAO8>*]/@,M[X>D9I@HY^SR8#_D0I_.O!]K3P^;N
MVS/HO8U<5D:3U:U^2/SB\(ZW_P (UXJT76,%O[/O8+K:O4[)%?'XXK]RM%U.
M#7-&L=0M95GM[J!)XI$.5964$$'T((K\'Z^U?V1OVX+'X=^'+7P9XZ,YTNT^
M2QU2-?,,,><B)UZ[5YP1G P,<"O0SS!3Q,(U*2NT>;P]F%/"5)4JSLI'Z,]*
M\0_;.\80>#_V<_%[RR*DVH6W]G0*>KM,=A _X"7/X4W4OVU/@[INFF['C&VN
MAMW+#;Q2-(W? 7;P?KBO@+]K']J6Z_:$UVVM;"&33_"VGLS6UO*1OF<\&5QZ
MX' [ GO7S>79=7K5XN4;),^LS7-</1PTHPDG)H^?ATK])_\ @F3H<MC\*_$.
MIR*0E]JA$9]0D:J?US7YQ:;IUSK&I6MA9PM<7EU*L$,,8)9W8A54#U)(K]G_
M -GSX8I\(?A+H'AK"_:;>#?=,O\ %,WS.?S./PKZ3/ZT84%2OJSY7AK#RGB7
M6MHD?%7_  4^_P"2B^#_ /L&/_Z-:OD;P/\ \CIX?_["%O\ ^C5KZY_X*??\
ME%\'_P#8,?\ ]&M7R-X'_P"1T\/_ /80M_\ T:M=>6_\BZ/HSS\U_P"1I+U7
MZ'[%_'WX0V/QL^%^I^'+M5%P\?G6<QZQ3J"4;\^#[$U^-.OZ#>^&=<O])U&%
MK>_LIF@FB8$%64X(_,5^[R_ZL?2OSY_X*-? 7[#J%M\2]&MML5QMMM72,<!^
MD<Q'N/E/T4]S7SN1XWV-1T)[2V]3ZKB'+_;4EB8;QW]#Y?\ !WQ@O/#WPI\7
M^!+@O-I6L".>!>HAN%8$D>S ?H*\X]:!17W<*<:;DXK5GYS.K.HHJ3O8_7C]
MA_\ Y-=\$?\ 7*X_]*I:*/V'_P#DUWP1_P!<KC_TJEHK\DQ7^\5/5_F?MV!_
MW6GZ(Q_V_P!6;]F[60H)_P!*MN!_UT%?E%Y$G/[MO^^37[QWFGVVI6Y@NK>*
MY@/)CF0.I_ UG?\ "%^'^G]B:?\ ^ L?^%>OE^;?4:3I\M[GA9GDCS"LJO/;
M0X+]E4%?V>? H(Q_Q+D[>YK\_P#]O[X=MX0^/-WJ5O"PM-=MTO591G]X/E<?
M7*Y_$5^J,-O#90I#!$D$*#:D<:A54>@ Z55U'0].U9D-]86UX5'RF>)7QGTR
M*Y,)CWAL2ZZ5[WT._'98L7A8X=RLXVU/R0_8U^'+_$+]H#PY;RP,]EI[-J5S
MN7Y=D6, ^Q<JOXU^LGC1?^*-US _Y<9__1;59T_P_IFDS-+9:=:VDK#:7@A5
M"5)Z$@=./TK09%DC*L RL,$'H<T8['2QM95&K)!EN6K 4)4KW;/P;NH9/M4_
M[M_OG^'W-?H/_P $O8V3PCXX#*5S>V_48_@:OL5O!>@=]$TXG_KU3_"KFG:1
M8Z2CK8V5O9JQRP@C5 3[X'-=^-SCZU0]AR6V/,R_(G@L2J_M+_(X#]HI=WPM
MU, 9^9/_ $(5\9>6W]P_E7Z*W%O%=1F.:-94/57&15+_ (1[3,C_ $"V_P"_
M2_X5^)\0\)SSS$K$*KRV5MC]DR7B)930=%T^:[ON?GOY;?W#^5-,;\?*WY&O
MT,_X1[3?^?"V_P"_2_X4?\([IG_/A;_]^E_PKY7_ (AS4_Z"/P_X)]#_ *[K
M_GQ^/_ /._V; 5^%UD""/WLG_H5?)7_!4"-V\2>"-JLV+6XZ#/\ $M?H';V\
M5K$(X(UB0<A4&!5;4=#T[5F0WUA;7A7[IN(E?&?3(K]NR-?V/3I0?O<BMZGY
M%G=/^U_:V]WG=S\-?#$,G_"2Z3\C_P#'W#V/]]:_='3_ /CPMO\ KFO\A6:O
M@W048,NBZ>"#D$6J9_E6R%XP.!7N9EF/U]Q?+:QXV4Y6\M4KRO<^*_\ @H!^
MS6?%6DM\1?#UIG5[",)J<,*?-<0+TDQW9!^:@>E?G/Y,G_/-OR-?O3)&LD;1
MR*'5A@J1D'V-9'_"%Z!U_L33O_ 6/_"NS YU+"TO93CS=C@S#A^&,K>VA+EO
MN?G1^PY^U%+\-=7@\#^)[AAX7OI<6=Q-]VRF8]">R,3] 3GN:]S_ ."E2F7X
M-Z,4!<'5$/R\_P #5]2_\(7H&W/]AZ=_X"I_A5Z\TFRU*W2&[M(+J%>5CFC#
MJ,<< BN.>.@\5'%0A8[J>6U8X*6$J5+I[/L?@_Y$G_/-_P#ODT>1+_<;_ODU
M^Z/_  A?A_\ Z >G_P#@*G^%'_"%^'_^@'I__@*G^%>[_K'_ -._Q/GO]59?
M\_?P/PN\B3_GF_\ WR:/(D_YYO\ ]\FOW1_X0OP__P! /3__  %3_"C_ (0O
MP_\ ] /3_P#P%3_"E_K$O^??XA_JK+_G[^!\<?\ !+V-E\+^.-RLO^FP8R,?
M\LVKI_\ @H/\-_B!\3/#7ART\)Z--K&D6,TMW?0VKJ9C)M"QD1YRP ,G"Y/S
M=*^K].T>PTA76QL[>S5SEA!$J GWP*N;:^>ECG];^M1CKV/IX9:OJ*P4Y?,_
M!W5M#U+0+R2TU33[K3KJ,X>&[A:)U]BK '\ZI<5^Z_B#PAH?BJ 0ZSH]CJL7
M9+RV24#_ +Z!Q7!W?[+7PGOIS+-X%TDN?[L.T?D"!7TD.(H-?O*>I\I4X7J)
M_NJGWGXR=2 .:]-^$?[.?COXT:C%%H.B7"Z>S8DU2ZC,=K&,\G>1\Q']U<FO
MU=T/]GCX:^'9%DL/!.BPR*<JSVBR$>X+ UZ!#!';PI'%&L<: *J*N !T  ]*
MQK<0MQM1A;U-\/PO:2=>I?T/-?V?_@3HWP#\#Q:'IA-S>2D2WU\PPUQ+C!/L
M!T [5\O_ /!0GX5_$?X@^)-)U#0_#UUK/AK3+0C_ $#][*)6;YB8A\YX Y4'
M@5]W4<=,5\Y0QE2C7^L/67F?58C+Z5?#?55[L?(_!>\L;G3;AX+NVFM9XSM>
M.:,HRD=001UJ&OW/\1> ?#7C! -;T'3=5P, WEJDI'T+ D5Q$W[*OPFN)#(_
M@722Q_NQ$#\@:^JAQ%3:]^GJ?'5.%JJ?[NHK'XSJ"S8')] *]H^"/[)OCSXU
M:A ]MI<^CZ 2#+K%_$8XRN>?+SS(?]T8SU-?J5X=^!'P]\*S1RZ5X.T:UF3E
M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
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HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096172814784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,730,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member', window );">1.500% Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member', window );">1.625% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member', window );">3.125% Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169139568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 67,154<span></span>
</td>
<td class="nump">$ 62,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(64,131)<span></span>
</td>
<td class="num">(59,642)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,023<span></span>
</td>
<td class="nump">3,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, distribution, general, and administrative expenses</a></td>
<td class="num">(1,959)<span></span>
</td>
<td class="num">(2,232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Claims and litigation charges, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(1,987)<span></span>
</td>
<td class="num">(2,464)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">1,006<span></span>
</td>
<td class="nump">562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(199)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">809<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to McKesson Corporation</a></td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in usd per share)</a></td>
<td class="nump">$ 5.25<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">5.26<span></span>
</td>
<td class="nump">3.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in usd per share)</a></td>
<td class="nump">5.31<span></span>
</td>
<td class="nump">3.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 5.32<span></span>
</td>
<td class="nump">$ 3.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in usd per share)</a></td>
<td class="nump">145.9<span></span>
</td>
<td class="nump">158.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">144.2<span></span>
</td>
<td class="nump">156.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096172750928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 809<span></span>
</td>
<td class="nump">$ 533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Other comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains on cash flow hedges</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">1,445<span></span>
</td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to McKesson Corporation</a></td>
<td class="nump">$ 1,354<span></span>
</td>
<td class="nump">$ 509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096168919504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,233<span></span>
</td>
<td class="nump">$ 3,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">19,900<span></span>
</td>
<td class="nump">18,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">19,505<span></span>
</td>
<td class="nump">18,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">3,155<span></span>
</td>
<td class="nump">4,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">45,383<span></span>
</td>
<td class="nump">46,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,083<span></span>
</td>
<td class="nump">2,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,368<span></span>
</td>
<td class="nump">9,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,887<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">62,295<span></span>
</td>
<td class="nump">63,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">39,708<span></span>
</td>
<td class="nump">38,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">2,324<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">4,077<span></span>
</td>
<td class="nump">4,543<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">47,201<span></span>
</td>
<td class="nump">48,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">4,976<span></span>
</td>
<td class="nump">5,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">1,541<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,364<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">7,132<span></span>
</td>
<td class="nump">7,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,553<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized and 277 and 275 shares issued at June 30, 2022 and March 31, 2022, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">7,350<span></span>
</td>
<td class="nump">7,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">9,732<span></span>
</td>
<td class="nump">9,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(948)<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 133 and 130 shares at June 30, 2022 and March 31, 2022, respectively</a></td>
<td class="num">(18,141)<span></span>
</td>
<td class="num">(17,045)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; deficit</a></td>
<td class="num">(2,004)<span></span>
</td>
<td class="num">(2,272)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total deficit</a></td>
<td class="num">(1,472)<span></span>
</td>
<td class="num">(1,792)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and deficit</a></td>
<td class="nump">$ 62,295<span></span>
</td>
<td class="nump">$ 63,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096171701392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">277,000,000<span></span>
</td>
<td class="nump">275,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">133,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096172989920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,925<span></span>
</td>
<td class="nump">$ 8,202<span></span>
</td>
<td class="num">$ (1,480)<span></span>
</td>
<td class="num">$ (13,670)<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (850)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,057<span></span>
</td>
<td class="nump">8,618<span></span>
</td>
<td class="num">(1,627)<span></span>
</td>
<td class="num">$ (14,579)<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="num">(1,792)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,275<span></span>
</td>
<td class="nump">9,030<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
<td class="num">$ (17,045)<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="num">(60)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (152)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (944)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="num">$ (1,472)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 7,350<span></span>
</td>
<td class="nump">$ 9,732<span></span>
</td>
<td class="num">$ (948)<span></span>
</td>
<td class="num">$ (18,141)<span></span>
</td>
<td class="nump">$ 532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease from Reclassification to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseFromReclassificationToLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096171301776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096171909088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 809<span></span>
</td>
<td class="nump">$ 533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Long-lived asset impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain from sales of businesses and investments</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(1,584)<span></span>
</td>
<td class="num">(1,045)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(955)<span></span>
</td>
<td class="num">(901)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="nump">1,006<span></span>
</td>
<td class="num">(609)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="nump">37<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseInLitigationReserve', window );">Litigation liabilities</a></td>
<td class="num">(370)<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(941)<span></span>
</td>
<td class="num">(1,622)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">39<span></span>
</td>
<td class="num">(99)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(1,008)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(199)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,181)<span></span>
</td>
<td class="num">(2,151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease', window );">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(1,595)<span></span>
</td>
<td class="num">(3,861)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">6,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">2,340<span></span>
</td>
<td class="nump">2,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of period included in Prepaid expenses and other</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 2,233<span></span>
</td>
<td class="nump">$ 2,423<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInLitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Litigation Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInLitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096172811792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain prior period amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;), and therefore the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#8220;2022 Annual Report&#8221;). </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during the first quarter of fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of this guidance but does not expect it to have a material impact on its consolidated financial statements or related disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company exited one of its investments in equity securities for proceeds of $179&#160;million. The Company expects to recognize a gain within &#8220;Other income, net&#8221; in its Condensed Consolidated Statement of Operations for the second quarter of fiscal 2023 related to the disposition. The cost basis of the investment was $38&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096174696576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale</a></td>
<td class="text">Held for Sale<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe resulting in classification of certain assets and liabilities as held for sale. Assets and liabilities of $3.2 billion and $2.3 billion, respectively, at June 30, 2022, and $4.5 billion and $4.7 billion, respectively, at March 31, 2022, met the criteria for classification as held for sale, primarily consisting of disposal groups related to the Company&#8217;s European divestiture activities discussed below. The decrease in assets and liabilities held for sale during the first quarter of fiscal 2023 was primarily due to the divestiture of the Company&#8217;s U.K. disposal group in April 2022, as discussed in more detail below.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2 billion (or, approximately $1.3 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. The transaction is anticipated to close within the second half of fiscal 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. As of June 30, 2022 and March 31, 2022, the E.U. disposal group within the Company&#8217;s International segment, was classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022, the Company recorded a gain of $12&#160;million to remeasure the E.U. disposal group to fair value less costs to sell. This amount was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;110&#160;million (or, approximately $144&#160;million), including certain adjustments. As part of the transaction, the Company divested net assets of $615&#160;million and released $731&#160;million of accumulated other comprehensive loss, within the International segment, and the buyer assumed and repaid a note payable to the Company of approximately $118&#160;million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the transaction on April 6, 2022, there were no assets or liabilities of the U.K. disposal group classified as held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet. The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096168999536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment, and Related Charges</a></td>
<td class="text">Restructuring, Impairment, and Related Charges, Net<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges, net of $23 million and $158 million for the three months ended June 30, 2022 and 2021, respectively. These charges were included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Condensed Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#8217;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $95 million for the three months ended June 30, 2021 primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 and remaining costs the Company expects to record under this initiative are not material.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the three months ended June 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above and U.K. operating model and cost optimization efforts, as well as costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the liabilities associated with the Company&#8217;s restructuring initiatives for the three months ended June 30, 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#8220;Other accrued liabilities,&#8221; $36 million was recorded in &#8220;Liabilities held for sale,&#8221; and $36 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily includes cumulative translation adjustments and transfers to certain other liabilities.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of June 30, 2022, the total reserve balance was $116 million, of which $62 million was recorded in &#8220;Other accrued liabilities,&#8221; $26 million was recorded in &#8220;Liabilities held for sale,&#8221; and $28 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096174768704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022 and 2021, the Company recorded income tax expense of $199 million and $26 million, respectively. The Company&#8217;s reported income tax expense rate was 19.8% and 4.6% for the three months ended June 30, 2022 and 2021, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to discrete benefits recognized in the quarter. During the three months ended June 30, 2022, the Company recognized a net discrete tax benefit of $45 million primarily related to the tax impact of share-based compensation. During the three months ended June 30, 2021, the Company recognized a net discrete tax benefit of $97&#160;million primarily related to statute of limitation expirations in various taxing jurisdictions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the Company had $1.5 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that our unrecognized tax benefits may decrease by as much as $150&#160;million to $190&#160;million due to settlements of tax examinations and statute of limitation expirations based on the information currently available. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year or statute of limitations expire, and if the ultimate resolution of unrecognized tax benefits differs from this estimated range, the Company will record any additional income tax expense or benefit as necessary in the appropriate period. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096168999536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s previously recognized redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million during the three months ended June 30, 2021. This amount was recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statement of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). During the three months ended June 30, 2021, the Company paid $1.0&#160;billion to purchase 34.5&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $983 million for the three months ended June 30, 2021, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $178 million as an increase to McKesson stockholders&#8217; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. The Company&#8217;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221; The Company allocated $41 million and $39 million of net income to noncontrolling interests during the during the three months ended June 30, 2022 and 2021, respectively, which was recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in noncontrolling interests for the three months ended June 30, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096170083872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Common Share</a></td>
<td class="text">Earnings (Loss) Per Common ShareBasic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Fewer than 1 million potentially dilutive securities for each of the three months ended June 30, 2022 and 2021, respectively, were excluded from the computation of diluted earnings per common share as they were anti-dilutive.<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096255529040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. The Company voluntarily changed its annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with a change in timing of the Company&#8217;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#8217;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. The annual impairment testing performed as of April 1, 2022 did not indicate an impairment of goodwill.</span><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,368&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,966)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,937)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Amortization expense of intangible assets was $56 million and $98 million during the three months ended June 30, 2022 and 2021, respectively. Estimated amortization expense of these assets is as follows: $166 million, $211 million, $206 million, $174 million, and $168 million for the remainder of fiscal 2023 and each of the succeeding years through fiscal 2027, respectively, and $1.1 billion thereafter. All intangible assets were subject to amortization as of June 30, 2022 and March 31, 2022. Amortization of intangible assets of the E.U. disposal group classified as held for sale ceased in the second quarter of fiscal 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096170110432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,976&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $5.8 billion and $5.9 billion at June 30, 2022 and March 31, 2022, respectively, of which $799 million, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets at each of June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Credit Agreement, dated as of September 25, 2019, as amended (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no borrowings during the three months ended June 30, 2022 and 2021 and no amounts outstanding as of June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At June 30, 2022, the Company was in compliance with all covenants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $1 million and an uncommitted amount of $105 million as of June 30, 2022. Borrowings and repayments were not material during the three months ended June 30, 2022 and 2021. Amounts outstanding under these credit lines were not material as of June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the three months ended June 30, 2022 and 2021, there were no material borrowings under the program. At June 30, 2022 and March 31, 2022, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096174768704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was not material for each of the three months ended June 30, 2022 and 2021. Cash contributions to these plans were $3 million and $14 million for the three months ended June 30, 2022 and 2021, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale,&#8221; pension liabilities of $79&#160;million and $85&#160;million as of June 30, 2022 and March 31, 2022, respectively, were included under the caption &#8220;Liabilities held for sale,&#8221; in the Condensed Consolidated Balance Sheets as part of the E.U. disposal group. During the first quarter of fiscal 2023, the Company derecognized pension assets of $49&#160;million and released $30&#160;million of accumulated other comprehensive loss related to the sale of its U.K. disposal group. The pension assets were included within &#8220;Assets held for sale&#8221; in the Condensed Consolidated Balance Sheet as of March 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096170110432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging Activities<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. Subsequent to the completion of the U.K. divestiture in April 2022 as discussed in Financial Note 2, &#8220;Held for Sale,&#8221; the Company&#8217;s foreign currency exchange rate risk is limited to the Euro and Canadian dollar.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the Company had &#8364;1.1 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded as foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the U.K. disposal group as discussed in more detail in Financial Note 2, &#8220;Held for Sale,&#8221; the Company reclassified $26&#160;million of gains from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. This amount related to the Company&#8217;s &#163;450 million British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-27</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jul-22 to Jan-24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mar-23</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge the changes in the fair value of British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#8217;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2023, the Company entered into floating interest rate swaps to convert $180&#160;million of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in earnings.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations were not material for the three months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are mark-to-market at the end of each accounting period with the change in fair value included in earnings. From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material for the three months ended June 30, 2022 and 2021. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information on Derivative Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096163892400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at June 30, 2022 and March 31, 2022 included investments in money market funds of $547 million and $981 million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the assets and liabilities associated with the disposal groups in Europe held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale." At March 31, 2022, assets measured at fair value on a nonrecurring basis also included certain long-lived assets within the International segment related to the Company&#8217;s operations in Denmark and its retail pharmacy businesses in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other material liabilities measured at fair value on a nonrecurring basis at June 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within &#8220;Prepaid expenses and other&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets primarily consists of $100&#160;million and $395&#160;million as of June 30, 2022 and March 31, 2022, respectively, held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221; </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169758048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities<span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 18 to the Company&#8217;s 2022 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and the two other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) settled with 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#8220;Settling Governmental Entities&#8221;) effective on April 2, 2022 (&#8220;Settlement&#8221;). If all conditions to the Settlement are satisfied, including the receipt of approval by relevant courts of consent decrees to dismiss the lawsuits, the Distributors would pay the Settling Governmental Entities up to approximately $19.5 billion over 18 years, with up to approximately $7.4 billion to be paid by the Company for its 38.1% portion. Under the Settlement, a minimum of 85% of the settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three eligible states, Alabama, Washington, and Oklahoma did not join the Settlement, but they have all now reached agreements in principle with the Company. With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement in principle under which the Company will pay $141&#160;million in ten equal annual installments and an additional approximately $33&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $518&#160;million over 18 years, of which the Company&#8217;s portion would be 38.1% (or approximately $197&#160;million), consistent with Washington&#8217;s allocation under the comprehensive framework, as well as certain additional attorneys&#8217; fees and costs. On June 27, 2022, an agreement was announced between the Distributors and the attorney general of Oklahoma to settle claims of the state of Oklahoma and its subdivisions. Under that agreement, Oklahoma and its subdivisions would be paid up to $250&#160;million over 18 years, of which the Company&#8217;s portion would be 38.1%, consistent with Oklahoma&#8217;s allocation under the comprehensive framework, as well as certain additional attorneys&#8217; fees and costs. The Company&#8217;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements in principle.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Claims of various West Virginia subdivisions remain pending in both state and federal courts. Trial in the case of Cabell County and City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. On July 4, 2022, the court entered judgment in defendants&#8217; favor. On August 2, 2022, the plaintiffs filed an appeal. The claims of certain other West Virginia subdivisions are pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Distributors for July 5, 2022. On July 5, 2022, the Mass Litigation Panel entered an order postponing the trial in light of an agreement in principle between a group of plaintiffs&#8217; attorneys representing the municipalities and the three companies. Under that agreement in principle, the three companies would pay $400&#160;million over approximately 11 years, with the Company responsible for 38.1% of the total amount (or approximately $152&#160;million). The agreement in principle is contingent on participation of certain litigating subdivisions in West Virginia, but does not include school districts or the claims of Cabell County and the City of Huntington. The Company&#8217;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of June 30, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $75&#160;million over 6.5 years to resolve opioid-related claims, of which the Company&#8217;s portion would be 38.1% (or, approximately $29&#160;million). The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Distributors would pay the Native American tribes, other than the Cherokee Nation, approximately $440&#160;million over 6 years, of which the Company&#8217;s portion would be 38.1% (or, approximately $167&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Distributors. Under these agreements, a minimum of 85% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#8217;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of June 30, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Settlement terminated the substantial majority of opioid-related suits by governmental entities pending against the Company, a small number of subdivisions in participating states have opted not to participate in the comprehensive settlement, and other suits brought by subdivisions in non-participating states remain pending. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#8217;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the first quarter of fiscal 2023, the Company paid $375&#160;million, and in July 2022 paid an additional $470&#160;million, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts as of June 30, 2022 and March 31, 2022, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the terms of the Settlement and a separate agreement with the Alabama attorney general, the Company placed approximately $395&#160;million into escrow during the fiscal year ended March 31, 2022. During the period ended June 30, 2022, the Company released $296&#160;million from escrow consistent with the terms of the opioid settlement agreements. The remaining escrow amounts were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in our Condensed Consolidated Balance Sheet as of June 30, 2022. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CE19-00472. Although trial began in this case on July 18, 2022, the court declared a mistrial on July 22, 2022; no new trial date has been set. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. CV-13-02219 (HG). Plaintiffs seek statutory damages from $500 to $1,500 per violation plus injunctive relief. Plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving two named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $6,500. The Company appealed the finding of liability and the plaintiffs cross-appealed the denial of class certification and the ruling denying treble damages.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of a complaint filed by a relator, purportedly on behalf of the United States, 30 states, the District of Columbia, and two cities, against US Oncology, Inc. alleging that from 2001 through 2010 the Company repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-05125. The United States and the named states declined to intervene in the case. On July 21, 2022, US Oncology, Inc.&#8217;s motion to dismiss was granted without prejudice. The related case against other Company defendants remains pending, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 12-CV-06440 (NG).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. On May 25, 2022, the district court granted distributor defendants&#8217; motion to dismiss the complaint, but granted the plaintiffs leave to amend the complaint. Plaintiffs filed an amended complaint on July 1, 2022. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company was served with a first amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., 27 states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hart v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#8217;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint. The relator filed the second amended complaint on June 7, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. That petition was denied on October 4, 2021. In December 2021, McKesson paid $26&#160;million for the assessment for calendar year 2017 while reserving all rights to challenge the constitutionality of the assessment. McKesson filed a new lawsuit challenging the constitutionality of the OSA on May 18, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169796192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text">Stockholders' Equity (Deficit) <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the quarterly dividend was raised from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, the Company paid $1.0&#160;billion to the financial institution and received an initial delivery of 2.6 million shares in May 2022. The transaction will be completed during the second quarter of fiscal 2023, at which point the Company expects to receive additional shares. The final number of shares repurchased and the average price per share paid will be determined based on the volume-weighted average price of the Company&#8217;s common stock during the term of the ASR program, less a pre-negotiated discount.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. The Company received 4.8 million shares as the initial share settlement during the fourth quarter of fiscal 2022 and, in May 2022, the Company received an additional 0.3 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. The Company received 4.3 million shares as the initial share settlement during the first quarter of fiscal 2022 and, in August 2021, the Company received an additional 0.9 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other shares repurchased during the three months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at June 30, 2022 was $2.3 billion. In July 2022, the Board approved an increase of $4.0 billion in the authorization for repurchase of McKesson&#8217;s common stock.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three months ended June 30, 2022 and 2021 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(997)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended June 30, 2022 include gains of $64 million related to net investment hedges from Euro-denominated notes and gains of $12 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $31 million.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,627)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended June 30, 2021 include losses of $22&#160;million related to net investment hedges from Euro-denominated notes and losses of $5&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $6&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169837568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment serves McKesson&#8217;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 285,000 national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 10 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of fiscal 2022, the Company entered into an agreement to sell the E.U. disposal group which is anticipated to close within the second half of fiscal 2023. International segment assets at June 30, 2022 were $10.9 billion, a decrease during the first quarter of fiscal 2023 primarily due to the completed the sale of the U.K. disposal group. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 35% of the RxTS segment&#8217;s total revenues, less than 1% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are derived in the U.S.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three months ended June 30, 2022 and 2021 includes $13 million and $23 million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three months ended June 30, 2021 includes $164 million of inventory charges on certain personal protective equipment and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three months ended June 30, 2022 includes charges of $94 million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">gains of $106 million for the three months ended June 30, 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $5 million and $74 million for the three months ended June 30, 2022 and 2021, respectively, related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $19 million and $35 million for the three months ended June 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $62 million for the three months ended June 30, 2021 primarily due to the transition to a partial remote work model for certain employees.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096172760160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. </span></div>The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain prior period amounts have been reclassified to conform to the current year presentation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;), and therefore the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComparabilityOfPriorYearFinancialData', window );">Results of Operations</a></td>
<td class="text">The results of operations for the three months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#8220;2022 Annual Report&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during the first quarter of fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div>Recently Issued Accounting Pronouncements Not Yet Adopted<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span>, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of this guidance but does not expect it to have a material impact on its consolidated financial statements or related disclosures<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_HeldForSalePolicyTextBlock', window );">Held for Sale</a></td>
<td class="text">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 18 to the Company&#8217;s 2022 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span>Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company exited one of its investments in equity securities for proceeds of $179&#160;million. The Company expects to recognize a gain within &#8220;Other income, net&#8221; in its Condensed Consolidated Statement of Operations for the second quarter of fiscal 2023 related to the disposition. The cost basis of the investment was $38&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HeldForSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Held for Sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HeldForSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComparabilityOfPriorYearFinancialData">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting any exceptions to the comparability of prior year financial data with data shown for the most recent accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124429468&amp;loc=d3e288-107754<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComparabilityOfPriorYearFinancialData</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096163892400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div>The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169857968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring, Impairment, and Related Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the three months ended June 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above and U.K. operating model and cost optimization efforts, as well as costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring and Asset Impairment Charges</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the liabilities associated with the Company&#8217;s restructuring initiatives for the three months ended June 30, 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#8220;Other accrued liabilities,&#8221; $36 million was recorded in &#8220;Liabilities held for sale,&#8221; and $36 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily includes cumulative translation adjustments and transfers to certain other liabilities.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of June 30, 2022, the total reserve balance was $116 million, of which $62 million was recorded in &#8220;Other accrued liabilities,&#8221; $26 million was recorded in &#8220;Liabilities held for sale,&#8221; and $28 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169837568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in noncontrolling interests for the three months ended June 30, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169758048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computations for basic and diluted earnings per common share</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169964048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,368&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,966)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,937)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169810672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,976&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096172749440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and March 31, 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-27</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jul-22 to Jan-24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mar-23</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value of Derivatives</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169810672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096170192240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Estimated Accrual Liability</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts as of June 30, 2022 and March 31, 2022, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096170016064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three months ended June 30, 2022 and 2021 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(997)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended June 30, 2022 include gains of $64 million related to net investment hedges from Euro-denominated notes and gains of $12 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $31 million.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,627)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended June 30, 2021 include losses of $22&#160;million related to net investment hedges from Euro-denominated notes and losses of $5&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $6&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169990320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 35% of the RxTS segment&#8217;s total revenues, less than 1% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are derived in the U.S.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three months ended June 30, 2022 and 2021 includes $13 million and $23 million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three months ended June 30, 2021 includes $164 million of inventory charges on certain personal protective equipment and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three months ended June 30, 2022 includes charges of $94 million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">gains of $106 million for the three months ended June 30, 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $5 million and $74 million for the three months ended June 30, 2022 and 2021, respectively, related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $19 million and $35 million for the three months ended June 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $62 million for the three months ended June 30, 2021 primarily due to the transition to a partial remote work model for certain employees.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096171888624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>segment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity securities</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Cost basis of investment</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165912896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Narrative (Details)<br> &#163; in Millions, $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Gain to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Disposal Group (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Disposal Group (Disposal Group) | Disposed of by sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of notes receivable</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">&#8364; 1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Gain to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember', window );">International | Disposed of by sale | Aurelius Elephant Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Accumulated other comprehensive loss adjustment</a></td>
<td class="nump">$ 731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Expected</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_AureliusElephantLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_AureliusElephantLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165441488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Assets and Liabilities Held for Sale (Details) - Held-for-sale - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less costs to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,159)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,277<span></span>
</td>
<td class="nump">1,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less costs to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="num">(302)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,982<span></span>
</td>
<td class="nump">3,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
<td class="nump">1,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,204<span></span>
</td>
<td class="nump">$ 2,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware', window );">Impairment charge</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096173047696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan - Remote Work Transitioning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165622192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165368320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other accrued liabilities, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096171165104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit) related to continuing operations</a></td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported income tax expense (benefit) rates (percent)</a></td>
<td class="nump">19.80%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Effective income tax rate reconciliation, tax (benefit), share-based payment arrangement, amount</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Discrete tax benefit recognized due to statute of limitation expirations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Possible decrease in unrecognized tax benefits during the next twelve months</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Possible decrease in unrecognized tax benefits during the next twelve months</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165199728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right redemption price per share (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Put right value, interest rate spread (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of McKesson Europe</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of temporary equity to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of temporary equity to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of temporary equity to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring dividend (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember', window );">Vantage and ClarusOne Sourcing Services LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165991616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096169971232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share - Additional Information (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (shares) (fewer than)</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165916512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">$ 807<span></span>
</td>
<td class="nump">$ 536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations attributable to McKesson Corporation</a></td>
<td class="nump">766<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to McKesson Corporation</a></td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">144.2<span></span>
</td>
<td class="nump">156.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">145.9<span></span>
</td>
<td class="nump">158.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in usd per share)</a></td>
<td class="nump">$ 5.25<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">5.26<span></span>
</td>
<td class="nump">3.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in usd per share)</a></td>
<td class="nump">5.31<span></span>
</td>
<td class="nump">3.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 5.32<span></span>
</td>
<td class="nump">$ 3.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096168943056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 9,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">9,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">3,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">3,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 1,486<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165227728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 4,942<span></span>
</td>
<td class="nump">$ 4,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,966)<span></span>
</td>
<td class="num">(2,937)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,976<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,747<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,695)<span></span>
</td>
<td class="num">(1,691)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,052<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,078<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(584)<span></span>
</td>
<td class="num">(573)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 802<span></span>
</td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(397)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165227744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Estimated annual amortization expense, remainder of 2023</a></td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2026</a></td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2027</a></td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Estimated annual amortization expense, thereafter</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096163967280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease and other obligations</a></td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="nump">5,775<span></span>
</td>
<td class="nump">5,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">$ 4,976<span></span>
</td>
<td class="nump">5,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member', window );">2.70% Notes due December 15, 2022 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 360<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 918<span></span>
</td>
<td class="nump">918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member', window );">1.30% Notes due August 15, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member', window );">1.50% Euro Notes due November 17, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 627<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member', window );">1.63% Euro Notes due October 30, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 524<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member', window );">3.13% Sterling Notes due February 17, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 548<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096170159456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 5,775<span></span>
</td>
<td class="nump">$ 5,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 799<span></span>
</td>
<td class="nump">$ 799<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165920112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Committed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Uncommitted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | The 2020 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Syndicated senior unsecured revolving credit facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | Canadian Dollar, British Pound Sterling, and Euros Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amounts outstanding under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_CommittedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_CommittedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_UncommittedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_UncommittedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096171114160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Commercial Paper Narrative (Details) - Commercial Paper - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Outstanding notes (up to)</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from issuance of commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermCommercialPaperCurrent', window );">Commercial paper</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermCommercialPaperCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermCommercialPaperCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096171884000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive loss derecognized</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Cash contributions to the plans</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedPercentage', window );">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation', window );">Reclassified pension liabilities</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Held-for-sale | U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized', window );">Derecognized pension assets</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of plan assets to benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096171165872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#163; in Millions, $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by sale | U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification of gains from AOCI | $</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096172977520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Net Investment Hedging | Euro Denominated Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as net investment hedges:</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="num">$ (22)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165980032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details) - Derivatives designated for hedge accounting<br> &#163; in Millions, $ in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fair Value Hedging | Derivatives designated as net investment hedges: | GBP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as net investment hedges: | Net Investment Hedging | CAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as net investment hedges: | Cash Flow Hedging | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional</a></td>
<td class="nump">$ 1,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Floating interest rate swaps (4) | Fair Value Hedging | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fixed interest rate swaps | Cash Flow Hedging | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096164065024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details) - Derivatives designated for hedge accounting - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as net investment hedges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as net investment hedges:</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fixed interest rate swaps | Derivatives designated as cash flow hedges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as cash flow hedges:</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as net investment hedges: | Derivatives designated as cash flow hedges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as cash flow hedges:</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165347472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Schedule of Fair Value of Derivatives (Details) - Derivatives designated for hedge accounting - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as net investment hedges: | Prepaid expenses and other/Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as net investment hedges: | Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Floating interest rate swaps (4) | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Floating interest rate swaps (4) | Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096265736672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair value, inputs, level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds at carrying value</a></td>
<td class="nump">$ 547<span></span>
</td>
<td class="nump">$ 981<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096170046096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details) - Recurring - Fair value, inputs, level 2 - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount of liabilities</a></td>
<td class="nump">$ 5,775<span></span>
</td>
<td class="nump">$ 5,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of liabilities</a></td>
<td class="nump">$ 5,674<span></span>
</td>
<td class="nump">$ 5,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096157898832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 27, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 03, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($) </div>
<div>distributor </div>
<div>installment </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 09, 2019 </div>
<div>city </div>
<div>state</div>
</th>
<th class="th">
<div>May 17, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>state</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>case</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 13, 2019 </div>
<div>faxNumber </div>
<div>fax</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,891,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,266,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_OpioidStewardshipActStateOfNewYorkMember', window );">Opioid Stewardship Act, State of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OpioidStewardshipActNewYorkAnnualSurcharge', window );">Opioid stewardship act, new york, annual surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualProvisionAfterTax', window );">Loss contingency accrual, provision, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Loss contingency accrual, payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states in which court cases are pending | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfEligibleStates', window );">Number of eligible states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment', window );">Portion of settlement award to be used by state and local government for remediation (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages', window );">Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | State of West Virginia and Subdivisions | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="nump">$ 152,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass', window );">Loss contingency, class action, number of faxes remaining in the class | faxNumber</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesReceived', window );">Loss contingency, class action, number of faxes received | fax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Amounts awarded to plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Loss contingency, damages sought per violation, value (per violation)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Loss contingency, damages sought per violation, value (per violation)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember', window );">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Loss contingency, number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member', window );">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Loss contingency, number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf', window );">Loss contingency number of cities filed on behalf of | city</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation | Governmental entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation | An individual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember', window );">Three Largest U.S. Pharmaceutical Distributors | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | State of West Virginia and Subdivisions | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | National Prescription Opioid Litigation | State of Alabama and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementNumberOfInstallmentPayments', window );">Loss contingency, settlement, number of installment payments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | State of Washington and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | State of Oklahoma and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | Settling Governmental Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | Settling Governmental Entities | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 470,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | Settling Governmental Entities and State of Alabama</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 296,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | Distributors | National Prescription Opioid Litigation | State of Washington and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 518,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | Distributors | National Prescription Opioid Litigation | State of Oklahoma and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Award Amount To Be Used by State and Local Government</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualProvisionAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Provision, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualProvisionAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Remaining in the Class</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesRemainingintheClass</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyDamagesSoughtPerViolationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Sought Per Violation, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyDamagesSoughtPerViolationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of Cities Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfCitiesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfEligibleStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Eligible States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfEligibleStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfOtherDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Other Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfOtherDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of States Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStatesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Award Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementAwardPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementInstallmentPaymentsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement, Installment Payments, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementInstallmentPaymentsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementNumberOfInstallmentPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement, Number of Installment Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementNumberOfInstallmentPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OpioidStewardshipActNewYorkAnnualSurcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Stewardship Act, New York, Annual Surcharge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OpioidStewardshipActNewYorkAnnualSurcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_OpioidStewardshipActStateOfNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_OpioidStewardshipActStateOfNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_CherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_CherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_IndividualClaimantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_IndividualClaimantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfWashingtonAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfWashingtonAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfOklahomaAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfOklahomaAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_DistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_DistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096172736992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details) - National Prescription Opioid Litigation - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Current litigation liabilities</a></td>
<td class="nump">$ 759<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">7,132<span></span>
</td>
<td class="nump">7,220<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="nump">$ 7,891<span></span>
</td>
<td class="nump">$ 8,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096164076448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Narrative (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes per share of common stock permitted on proposals presented to stockholders (vote) | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Authorized amount available for future repurchases</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized repurchase amount (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember', window );">Accelerated Share Repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Share repurchases (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of shares repurchased (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096164707552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (1,792)<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,472)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Net Investment Hedging | Euro Denominated Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss)</a></td>
<td class="nump">64<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss)</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Total Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,534)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(948)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,504)<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(176)<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">730<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(997)<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember', window );">Unrealized Gains on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">45<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">28<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">28<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">38<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (34)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociAttributableToNoncontrollingInterestMember', window );">AOCI Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,627)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096165184176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>country </div>
<div>product </div>
<div>business_operation </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfNationalBrandMedicalSurgicalProducts', window );">Number of national brand medical-surgical products offered (more than) | product</a></td>
<td class="nump">285,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">International segment assets</a></td>
<td class="nump">$ 62,295<span></span>
</td>
<td class="nump">$ 63,298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">International segment assets</a></td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity segment operates | country</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfBusinessOperations', window );">Number of business operations | business_operation</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfBusinessOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Business Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfBusinessOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfNationalBrandMedicalSurgicalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of National Brand Medical-Surgical Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfNationalBrandMedicalSurgicalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140096164976480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Reportable operating segment (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 67,154<span></span>
</td>
<td class="nump">$ 62,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate income (expenses), net</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(303)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="nump">562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Gain to remeasure disposal group to fair value</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Gain to remeasure disposal group to fair value</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">1,090<span></span>
</td>
<td class="nump">914<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Gain to remeasure disposal group to fair value</a></td>
<td class="num">(106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">56,947<span></span>
</td>
<td class="nump">50,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">$ 696<span></span>
</td>
<td class="nump">682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,066<span></span>
</td>
<td class="nump">881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 2,592<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 6,549<span></span>
</td>
<td class="nump">9,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Gain to remeasure disposal group to fair value</a></td>
<td class="nump">$ 94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>mck-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20220630"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mck-20220630.xsd" xlink:type="simple"/>
    <context id="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i74fd4c8aee6d4010ab7706397f856ed2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id6f9902a7b234823ae104e7c4f2c65de_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib5786b575ab14c9086b23a1d0e5b5366_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3438dd3f84f74a70a816f4abae28fdd4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3006488f024c45fcaf5dbd509e6c0e56_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4f241c72875e4d98bd23bb25744707d7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i34daad1897684d7cb9165b77d17ca934_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibc276c29bee440b1be1ec46674de1a06_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i151489c821d34264ba84b7c360fadace_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i24ead1497b6d497b80e44b48146936b5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i65ab8217fe89483e8a1f4f965ba5729e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8f0afdd8a78b4984a7c33d73ebec78e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8fd9d9552a334e37b133dfa12dc23516_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iae2638ed49674216b6fc56801fe2326f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i183a8c52537c45628ea1a4b23722e45c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iba579ff5d35d41aea8face8b5fd431db_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1df9375c53a54770836b443aebe65d3b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaa15a292151249278a75938323d1968f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i965a6647bfcc4c34af4e145de7a94e66_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibb0e60dee72643d9b8f7da1912eb9d0c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifc273f7fc5b247c0846600e051da1759_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5026063ddbbd426490dc361b9a57ba33_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8f79f8849ffd4f6d92a5100af46ef410_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i302a7aa1b388436ba21034ef5118cefb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic25a09d084d74900927f8d3b2d327f34_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib222089abc8b4a0984b44963c8a6da6c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if0356030a71f4cedad29132c59391b27_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i31619d5dfb2942f181793348c62fa60a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifd8f1ea1e497400f8334891264c28e85_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibacc7e1f23d649749320d4f48e0caff5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2bf29a8b64e74d7c8e6324067684ba02_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i943ab72fcf1e488daa35869380273a79_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id9d4cc7ccee34f9a8a8f2544e232a63f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i12ff8ccdcd1d43578af7654618f2847f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if7f38fed308149759889e7a524621b45_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i06e4115630544b9a8ecb71896a8d29ae_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic6a849346f984ba7a24863f281ff99ca_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1257a17abb1d49209b1ecf7010d647c4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i915d93beb3944977a2b115e5a05ff593_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i97688416d8624c10a48f226d71563b9e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i52e0da06428444108f6f30cfdedaf625_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2151c060ee864dcf9cc0a315dedcb4bc_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="iacb94994718b406dbc1a53f8dab8d938_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i184217f9158a415e9fe088348387b9e9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icd5d065ca8604d0bbd24e8e67b95eb01_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5150b5ddba2945abbc839f1edd5fea5f_I20210705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-05</instant>
        </period>
    </context>
    <context id="i8c16ef6d38344729a8077cc7cfbddb3e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie89d0240cac14cacaec39c08ee9b4a63_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5403be05c92b4345b8c30e84ad1ccc67_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i24d358bf2d514516969073c17eb16cab_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i966d0672f94e47d48297a66c14bc69ae_I20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-06</instant>
        </period>
    </context>
    <context id="i393f7b257bbf4a2fb7a4b7d3c3e8cc5b_I20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-06</instant>
        </period>
    </context>
    <context id="i3cd413ff00624a0d8270f7ea278d9a55_D20220406-20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="i372251adcd1648eab091c52b5f01446e_D20220406-20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="i1cc8fba8571641aeaca7afef9370cf88_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8810900c5c324fd89fbada461816423d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9aac3ab068164da3a45be34214805860_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4bd299c03b254bf08ef56a66adc41c05_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i160ffe77823e4333a979c33b283947f8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i18e67fe7460b4e2ea12fbbd5167e3238_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i41993913d47d47799af347f96dffc5fa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6ca90c76b5f8423db112b3afece54ca7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6171834fcd894e66b9bdf8b9a377ecff_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaf9d9c26183c4805bf511847202547f9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9c025968801c4a25945836d01ed6ac95_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i08861b972b284eedaa85076ea9b4829f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if4d963bead34459498d2d03f537cf122_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i88d93fed8d3a43138335a08e977df9ef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6d022b083bbc45939920f85e12d37954_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i216779d361ff48b8b7d99ea6028d66c7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib92e13fab3344b80882529369055d140_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if81042ef89a44749b328252179e501f0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6e446b32652445c78cd737bf63c505d0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icb71f08be1794969b42bcb9fbb8584e9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i555ad7eb9be24508ab277351083f8b95_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i71f3011cbd3947f88570706f2746d1cd_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i97348d9c0c3c492caee0d7de4e918481_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i62f4dfc0153d46679ff78f542f7e14de_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i17aa11bc6b1c4164b6719d0eae227c3b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i83027e4dbfea4e06a441bc5aa8dc605f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iffeb32001f68497d8267ddc9ae2c0968_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i64e32cd74f0c4010a3e8e787177c3aaa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i82d9a039d97f4e1f810d8c8939c48515_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3c9753fdbc8c42afa67a387dbdc341f2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iac0f191ee9524cc4a123dca1beca64b2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if0d41c1016b54583a7525969593331c4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib1603e72ed6c4daa8b8ca5a07fbd1091_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia1f27ef316774f2ebcc0ec59b1f39297_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib406df4db52b4b27b436c0fc953e4a8e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i79bce56293174c7db4e539b562cc2526_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4e71847d225b4930bef9de929f3f2a3c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id9167671dc7c472eb51af611bf7cc7e4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5c30ffbc257945ba83eb82993a8be420_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b46e42465d84c47a2183912a0e10716_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2973547bb0b04222a89b6729430ffa65_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i80b7ea531f5944e9a9d6f976d44806d0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i19e7f49efd664e9eb7c79c6728a445c6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i403f9ff68d8c4127940b5ac3bf567cb2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8356415b26f44a79a7bef9dd35e8c8c6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i37712c0066f64e0bb1e51fcf34f13275_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iebea36d3b82e4242a79f2cb24837bf11_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56b572e5f85647c2bb4157a3e9274374_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia7584d2566eb4f808e5b3c32bf252562_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4e32fde2d0c74321a6ffc1d2e7fcfab3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0b0754d6d499499ea1f08e091a6e4313_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id0dcd0a8f12f4512a836f6114659037f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5bee33b48ae745368d813bb179998562_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id1884f32c95e4196b9733d13eed48df6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9f5a01c7f75b4124be2e8212faabad25_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id45be366e31e4b0eb3bb557a83a956d4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8aeceba0472c4993b4306ff3c946485a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i93d8e3ed6e654406a8a87749f03f9693_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id1e9f681efc9418e8d647ad3a6c73873_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iff711db73c6f4c5e9f9a44b9edfa2c8f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i964e360bb5304a7a91cbb307fe41a400_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iefc091ee1ba943d9bd16e2df30bb21cb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if32ca5071eb44a8fafb2dc2af15d5f2a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia4cd5447a107486e8828badac335b9ea_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib9b43926998845dbb130d523377325ab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3167bf1182f948fdba7729ff76cf27b3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9cfe85e7a9b641a78490906855cf69b3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2a0b0abcd2744a1582bac3909196080c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if6328397e5e846f2926603d07bf5629f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i565074a91efd4e2baba451998e9fe4e9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iafef158a41cf4048baa5a93cb0b6620d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7b7fb8d52da24328b8964b016e0c3351_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaab1fe3e771e4795b92c3519d4aa2a57_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia9575f4f1c94440dbcd550e774d94cf2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if1c01fc67d7d4672a61f5062adaa04d9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1c6e596876c14eceb35218c7197c764c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i24aabefa576e4aa09449e0603fd27472_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id0e935c6a9174c0198aeceebe6d8008b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8cb8a57a80a64603b803e2b679fdc63b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id3d0ea03571840b0b0defd993f65540b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaac3251871f54afb9e05a2dd9845dd86_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if8e2051458de4ca3b3ff972dc1e5df47_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i466138b603084d54be88ad1a34567c8b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i752a8a7f16074f689ee9d1b4892d270f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2166a8ac1e96401c8f1600c898c367ac_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieb8a1defb0594686a254e66fc7830f7d_I20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-25</instant>
        </period>
    </context>
    <context id="if7e42ec92f674a79afbd81e8fb750262_D20190925-20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-25</startDate>
            <endDate>2019-09-25</endDate>
        </period>
    </context>
    <context id="ib12270524a7b4cc6b7b87975f0b31013_I20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-25</instant>
        </period>
    </context>
    <context id="i1ce62c7971874b97a640c6606962ea01_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icefd77afd24c4487924437959cfe8fbc_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iece544191d5240e3b1283537222c41a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i044fe80187ac47b3b779f3f5fa0c3a15_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib3341b4ea67b4eb1bfc0be50fbf79480_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:CommittedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib8185c82e2434a0c84ff562df7ae24ab_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:UncommittedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i03515862174f44c7b695b85111ea920d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iec54ae004102491b9606ef01cb1fdf20_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8ae8a14adb19498bb9dded3088ccc4a5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i98edbf2764e9413891b48258d46b8d5a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idd567c67685b42aba4f0f9ef5b214c07_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3d909bc2a8994f798b89f3084cf96826_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8767bea4ed9b4241b64e9c77192c274d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i51ae381b635041b2a03df829498f103d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i695dd9f4cbbd46edaa4b764478844aa6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1628a1ef0d3b482691b8aa3e61736647_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i24e204f409be4b29a94900362c7cef4e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie3254c69cbee481f97c6743efa9150c3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie6f9d6fa7ca7441e8a4987577b13651e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if2af5ce20fb04be99d4d91c3837262bd_I20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-06</instant>
        </period>
    </context>
    <context id="i41ebb607246c4e2991322746c42fa818_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic770e7e260c6494e91714f00ee4061af_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia9200147039b4d23906d2205705299fd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic0f94a4fe40647dcad8d868e1ecf16d5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie2122223b4e24f6a94b2791de320374a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icaedc0e4a45e442fa6d6beac1dcb1ca9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i727c52e939144af4b31c1f88bc2836cc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie4a2f796909a429daa27355e79f80ddd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i864b745cf60843c5aaf96b4cc4f1a217_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic5d560c2041344ab9c85f9e013cc904f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i66b4897d62c94e129073ebc6630ec481_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i95ef45188f1b4c4fae080a330a7456bf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iedcceae98f1745c18c291607c35f1154_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if7abd9fb0b51412e99b4001e9c3d02c3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib695670fac054a96998413f0f81621bf_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic0d302cd168e4ac5b3e8c93a2b801655_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idf70302177a746cfb31a8c813fc9e576_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2567e9d256a74d91967a6dcec0897b06_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i614af20eb8bf45108edd1be8b5e30eb7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic93afc9722af414ebd768788768bc773_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id1d25f973adc48d18bbace1d7f69620e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib06c2da02d95474691982974e55aa7cc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaae6d3027e7b40d19a5f999387bb5a94_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib7702e8b3e0242449e9281863062b488_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c492e20719648568963f8577647d24f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4228622f82ae4dcd8f033204a9968b56_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9f56ba1a598a4a829b10b8749df60caf_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4f0747ce2512401a84d2048c76eb4934_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibf4b0c9f108245a0ab670e3765ab193c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6d2ebfdac84e4abbb90a1e8f5ae7e490_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6628b987433540f19ebb8c735161874b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0efcc5cada804b01af7a7152f7f15ce1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9dcecf8036248a0a44938b3a51b3d54_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic42ce3a7a52742d682e55d121a735789_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibe98279f3daf4cac829f141c68680c29_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="idd41c4e1c30c44259a7ba92d433dfc8a_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ia25c48fcadfa411c87b9b338ed7c17cf_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i91fd5b95930f48feafff5e007780cca1_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfAlabamaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i7cce7634359c49e6bb6d0498ed0e65cb_D20220503-20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="ib624e26e3984429eb8c566e69a33ac6a_I20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-03</instant>
        </period>
    </context>
    <context id="ib6347fef3d684c6884e7d1d8b83e0f28_D20220503-20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="ief5af3b3c7d04f4b9061d24c01dfc96a_D20220627-20220627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-06-27</endDate>
        </period>
    </context>
    <context id="i1c5c1f1d6da349fcbcbcc5d4ee10b2db_I20220627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-27</instant>
        </period>
    </context>
    <context id="i9c9164e71857427a9e3f6fb313e6f958_D20220705-20220705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-05</startDate>
            <endDate>2022-07-05</endDate>
        </period>
    </context>
    <context id="ic78671dfdbde4f1da51669767a156413_I20220705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-05</instant>
        </period>
    </context>
    <context id="i88b0d90d6afe4e72801e173856f8f730_D20220705-20220705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-05</startDate>
            <endDate>2022-07-05</endDate>
        </period>
    </context>
    <context id="i8dd43cb0b7cc4ad7a6b61b07881c8a2a_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i49d09f3e82e04ef68ecb9c2396cd73c1_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="ie80fd48f4e8d4c678b4ce9cef44086f1_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="i2f19aed3491848fe9a6318bd365640c4_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="ib15c8902459948b8800a989e5b1ee1ab_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i20b65fe316bc46c7a65913e0e73468b4_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="i55b70e47e8e34b20ab513c75c1bd8f1a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibacb5dc687fb421890cdd8812f84593a_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i785cd0fca728419db26ae24ee9b6d389_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifc26f3e4e9d14faaaf590fbb3e98fd58_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib182ad32ae1a4140ba81d1576ebb67fd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndStateOfAlabamaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3a1aa40a3d3642ff855da782b897135b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndStateOfAlabamaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia2ca6a0d3d4048d7928d1ed7a412b532_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i583c48262f76490389c5bfa859e9c30c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idf2512ace2434b2992e2e25b1b514696_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iefa43f959af643fa81156301548309e0_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="i0d1725cc0bf34e1b9b6258af7a6286da_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="ia156720ce72f43da8c988dd169e9286f_I20190813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-13</instant>
        </period>
    </context>
    <context id="i95823add3af04d3eb3962971d102762c_D20220427-20220427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-27</startDate>
            <endDate>2022-04-27</endDate>
        </period>
    </context>
    <context id="ifa5a8bf25a1c492f8877a4d52f7a8892_D20191209-20191209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-09</startDate>
            <endDate>2019-12-09</endDate>
        </period>
    </context>
    <context id="id32341657ec2405d904a9a2b92c4f261_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ie9db5a1c9a3b4448b90e7d790fddd929_I20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:OpioidStewardshipActStateOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:OpioidStewardshipActStateOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if5b8f534c4f94a2286245c2844a0b617_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:OpioidStewardshipActStateOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iae2bcb78271948b4a1ebf3f41dcd15bf_D20220630-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="ifef2c199d98e42be9e9661e3aba687b3_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i8c0920ece63d40bcb5b7571d38f78484_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i2221b7fadd8a4d1f9694fd8e401e6039_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i04054837ec0342f9b8450625e682723a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id6d27ffef9104861bb0e13a1caea6f92_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i142d11dab4f1472296e0e34a0a568a1c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iae923b8233e9431eb94789aba9fc18b0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i778742d22ea2469ba0d763c4abaf0a0e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i37c3f3f9cc2a4fe5809c48e5837aa33b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia153c233c3224f40b8bee60f5ca03330_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6d3b36ae57df4556b852d256a5051b7c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i834def9396054b11a7467a8892ddc33e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i826edda2198046dba4823c7a7d93044e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0586dbdd097949bc84d2b6538b7c21a1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibea2a408cb5143869cd6f99a7f554856_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia8f74d47337f44069d4abbae67a7e76f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i812bd8eaa6f848db94fa9829cb892c51_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i37c280e5ed9e46c793e2b72e48c5aa9b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i48723ecc89164f63a596685462e8682d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3a1ba08501874acda7d8038964225375_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibfb860711704471396b6ab18f5a00a89_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3f48074346a94363895ed8e84a8026ab_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4499ac651c794efc9fddcb3b54af3036_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7db9df2543f7470aae07e22c69f7fa2a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2c6e06d925d44f989655a7673bdde907_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5de3e5bddea84662aeab82793750ac17_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1577c607c8ab49f392ecdd91decbed0f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia4001c0764b641b489a0e6a821b1bc2a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieb05392f0a4c4daea446534a262c49ce_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iac647f2ab1ea4e1aab5af149078db642_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2aebb076b6b54144a3cd96e1ece30f3b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i507200d519254ee5b810cc4ba9c9eb26_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia2177f40437f42b6809296d7905c7869_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8cd60915c3dd465caaf23b140f67daf3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4588d9a710614530af4777a0d6ec981e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie6158e4d86384dd3835014e2ff918ab3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7cb66cdf2011438e8e70e27b549a9862_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3b9d7a308dd141549bede7bfa3e5cbf0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mck:segment</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="distributor">
        <measure>mck:distributor</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="installment">
        <measure>mck:installment</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="faxnumber">
        <measure>mck:faxNumber</measure>
    </unit>
    <unit id="fax">
        <measure>mck:fax</measure>
    </unit>
    <unit id="city">
        <measure>mck:city</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <unit id="product">
        <measure>mck:product</measure>
    </unit>
    <unit id="country">
        <measure>mck:country</measure>
    </unit>
    <unit id="business_operation">
        <measure>mck:business_operation</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV8zLTItMS0xLTE0MDUyMw_f2e5f57b-5e12-4814-89e8-de50691a964a">0000927653</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV80LTQtMS0xLTE0MDUyMw_b033910c-ab02-4eb2-895a-9fdd8b07111a">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV8xMS0yLTEtMS0xNDA1MjM_2b4bbe69-c4b7-4b0e-89bf-c6f765cf2b4b">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV8xMi0yLTEtMS0xNDA1MjM_71b70785-5bab-4651-b25b-57efe6c77e45">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80L2ZyYWc6NjVlMTc3MTVlNzAyNGEzYzhiZTNjMWVjMTFlODZiMTgvdGFibGU6OGQ5OGUwZDRjMDJlNDNiYjkyYmRmNzc1OWNhYzA2MjkvdGFibGVyYW5nZTo4ZDk4ZTBkNGMwMmU0M2JiOTJiZGY3NzU5Y2FjMDYyOV8xMy0yLTEtMS0xNDA1MjM_04916df7-36ed-4e00-9e9f-e05c524b0cb9">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQx_deec14c3-1b69-4420-aac5-c8d49174f832">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzAwNTY0MmRkMWM3NGM1Zjk0YTdjYTAwN2UyZDk3MWUvdGFibGVyYW5nZTo3MDA1NjQyZGQxYzc0YzVmOTRhN2NhMDA3ZTJkOTcxZV8wLTAtMS0xLTE0MDUyMw_aeb453af-fcd1-4435-bfe3-4c136cfe6e75">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8zMjk4NTM0ODg1NjUx_17a322ae-4842-42fe-b946-f397b749bd7f">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6MTVkODI0NWNkMDAzNDBhMzg4ZDczOGMyZjhiOTYyMzYvdGFibGVyYW5nZToxNWQ4MjQ1Y2QwMDM0MGEzODhkNzM4YzJmOGI5NjIzNl8wLTAtMS0xLTE0MDUyMw_639c6eef-0014-488d-ab23-bab8af914036">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTM2_197cd679-55b7-401c-b8f0-6696eb6ce8c3">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQy_5e3e4d7c-e625-4bf4-a0cf-c845c0e81fb1">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NDQwYmIzMDNjZDg3NDQ5MWI5OTM2YjIwMDQ3OWU0MGQvdGFibGVyYW5nZTo0NDBiYjMwM2NkODc0NDkxYjk5MzZiMjAwNDc5ZTQwZF8wLTAtMS0xLTE0MDUyMw_69ea231e-6bf8-4c55-bcf6-e1a52e176465">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NDQwYmIzMDNjZDg3NDQ5MWI5OTM2YjIwMDQ3OWU0MGQvdGFibGVyYW5nZTo0NDBiYjMwM2NkODc0NDkxYjk5MzZiMjAwNDc5ZTQwZF8wLTItMS0xLTE0MDUyMw_c624b6b5-845e-490c-9f96-ddefbe77d6f3">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQz_47e238b0-cb8d-49ea-a778-8f57bac24443">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTM3_334d0e46-32b9-4f58-b28c-8396351bf8fd">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTM4_a5f11564-68bb-4f23-9f43-2b6b7d72f352">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQ0_59b6660e-6395-4730-93f4-b6055c0a59cf">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQ1_82b2cafb-61b7-4bb9-afdf-37a66de0a60d">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQ2_85ba6238-0291-4163-9fae-4e1ad49d276d">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i74fd4c8aee6d4010ab7706397f856ed2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8xLTAtMS0xLTE0MDUyMw_569819e1-fc16-452f-9eee-12cdd85c7ed6">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i74fd4c8aee6d4010ab7706397f856ed2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8xLTEtMS0xLTE0MDUyMw_09c258d8-7b83-4be0-8c2a-4dbf4007bbde">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i74fd4c8aee6d4010ab7706397f856ed2_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8xLTItMS0xLTE0MDUyMw_44ad49fe-3de9-4a6d-89c5-36b367cdc95b">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id6f9902a7b234823ae104e7c4f2c65de_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8yLTAtMS0xLTE0MDUyMw_4dffdad2-63a5-490b-ad04-20a77a16d068">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id6f9902a7b234823ae104e7c4f2c65de_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8yLTEtMS0xLTE0MDUyMw_0d864f7a-4e96-4738-bdfe-0fb27030d509">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id6f9902a7b234823ae104e7c4f2c65de_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8yLTItMS0xLTE0MDUyMw_c8b99359-f282-4bcb-869f-e3ff39c6a047">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib5786b575ab14c9086b23a1d0e5b5366_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8zLTAtMS0xLTE0MDUyMw_3a5aaaac-67c7-48ac-82e8-898219bfcf4c">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib5786b575ab14c9086b23a1d0e5b5366_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8zLTEtMS0xLTE0MDUyMw_2eb5d1f9-5831-4ce5-85cf-8cd41598a7a6">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib5786b575ab14c9086b23a1d0e5b5366_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF8zLTItMS0xLTE0MDUyMw_53166bbe-9ab4-4b10-a40e-b72ef2798e3d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i3438dd3f84f74a70a816f4abae28fdd4_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF80LTAtMS0xLTE0MDUyMw_1ae6ef01-57f0-47e8-8e42-8243ac29ce44">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3438dd3f84f74a70a816f4abae28fdd4_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF80LTEtMS0xLTE0MDUyMw_09d98b70-54ad-4383-9ce3-846b4f08f7bc">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3438dd3f84f74a70a816f4abae28fdd4_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6NzgyZjRhZGVjNGIzNDcxNjkxYjUzYzcwNWRhZDQzMzQvdGFibGVyYW5nZTo3ODJmNGFkZWM0YjM0NzE2OTFiNTNjNzA1ZGFkNDMzNF80LTItMS0xLTE0MDUyMw_2f2eaa88-44cf-4aeb-a949-0111ad55b30c">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQ3_6dcb8bc9-e178-48bf-bbcc-7f8a9c785e6b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTQw_eb17c891-eb18-4aac-9d15-56f28b1fd800">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6MjUwMzUzZWU2MmJkNDFlN2FhNTBmM2E2NDI4ZTE0M2MvdGFibGVyYW5nZToyNTAzNTNlZTYyYmQ0MWU3YWE1MGYzYTY0MjhlMTQzY18wLTAtMS0xLTE0MDUyMw_e19ea9e1-e850-4a28-bf5b-37a6de72897a">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6MjUwMzUzZWU2MmJkNDFlN2FhNTBmM2E2NDI4ZTE0M2MvdGFibGVyYW5nZToyNTAzNTNlZTYyYmQ0MWU3YWE1MGYzYTY0MjhlMTQzY18xLTYtMS0xLTE0MDUyMw_e4bf7514-94e2-4fb2-a434-3b4bf76af48d">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGFibGU6MjUwMzUzZWU2MmJkNDFlN2FhNTBmM2E2NDI4ZTE0M2MvdGFibGVyYW5nZToyNTAzNTNlZTYyYmQ0MWU3YWE1MGYzYTY0MjhlMTQzY18yLTYtMS0xLTE0MDUyMw_8cf38ec0-bb85-482e-bac5-283b014f4d38">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMTM5_a56a8775-3ee6-4651-91a7-b78a9ca4f89e">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i3006488f024c45fcaf5dbd509e6c0e56_I20220729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xL2ZyYWc6YWZmMmY4NWQyZGFjNGMwOGI3YzM0MWJmYTc0NTU1OWUvdGV4dHJlZ2lvbjphZmYyZjg1ZDJkYWM0YzA4YjdjMzQxYmZhNzQ1NTU5ZV8yMDcw_6990d18f-73dd-4346-8497-eb9fe4f031bc"
      unitRef="shares">143730455</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMi01LTEtMS0xNDA1MjM_213c2ed9-3b00-427d-bd77-bb60bb51d2ec"
      unitRef="usd">67154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMi03LTEtMS0xNDA1MjM_1795ae78-8c60-49a9-8162-a4f1955a15dd"
      unitRef="usd">62674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMy01LTEtMS0xNDA1MjM_3b252648-dbe1-4f7c-8b4e-b22bedf39af4"
      unitRef="usd">64131000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMy03LTEtMS0xNDA1MjM_2e2582b3-f667-4862-bead-354e5097ff48"
      unitRef="usd">59642000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNC01LTEtMS0xNDA1MjM_81fcd0f8-6053-4113-8120-2a96e86e45f8"
      unitRef="usd">3023000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNC03LTEtMS0xNDA1MjM_10f5766d-b90b-4a3e-979c-25056c3c8d76"
      unitRef="usd">3032000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNS01LTEtMS0xNDA1MjM_c106f105-f413-4c05-8510-f64e95c51f86"
      unitRef="usd">1959000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNS03LTEtMS0xNDA1MjM_a1de24aa-828c-49c4-8866-3284d403666b"
      unitRef="usd">2232000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNi01LTEtMS0xNDA1MjM_4ac71133-0928-4f1f-aa6d-2ca0e87b3732"
      unitRef="usd">-5000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfNi03LTEtMS0xNDA1MjM_38d34740-1f48-442c-96ee-c6ebde4fdada"
      unitRef="usd">-74000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfOC01LTEtMS0xNDA1MjM_c56da72f-f301-4793-a66a-77863a31078f"
      unitRef="usd">23000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfOC03LTEtMS0xNDA1MjM_312dbb9a-2a20-4958-9cdd-6c6577f496a4"
      unitRef="usd">158000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:OperatingExpenses
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfOS01LTEtMS0xNDA1MjM_e12bc96a-955f-43e5-a97e-e097772f4bb2"
      unitRef="usd">1987000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfOS03LTEtMS0xNDA1MjM_3f31c55d-0a37-454b-855c-e62f18d89979"
      unitRef="usd">2464000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTAtNS0xLTEtMTQwNTIz_8eb15c95-65f6-444e-b977-da4cbe0eb839"
      unitRef="usd">1036000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTAtNy0xLTEtMTQwNTIz_2eaf40da-4081-430a-a70a-21b9c32143e1"
      unitRef="usd">568000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTEtNS0xLTEtMTQwNTIz_c5ca3430-506a-44d6-aa09-0d57c402ef27"
      unitRef="usd">15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTEtNy0xLTEtMTQwNTIz_c33db36b-1570-4595-b371-95996fb6e0e5"
      unitRef="usd">43000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTQtNS0xLTEtMTQwNTIz_0d3cebc3-e180-477d-9132-3d1052820771"
      unitRef="usd">45000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTQtNy0xLTEtMTQwNTIz_8233dce3-1b5e-4788-98b3-d2831c9e7132"
      unitRef="usd">49000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTUtNS0xLTEtMTQwNTIz_bda3ce93-aafa-4b79-bf8e-cb44531910df"
      unitRef="usd">1006000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTUtNy0xLTEtMTQwNTIz_0027ecce-6a95-4ebf-9f52-45b94f53d938"
      unitRef="usd">562000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTYtNS0xLTEtMTQwNTIz_281843c7-fa17-4408-bf70-4c788979b286"
      unitRef="usd">199000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTYtNy0xLTEtMTQwNTIz_677a6a68-6a8c-4773-96dd-43100e2858a0"
      unitRef="usd">26000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTctNS0xLTEtMTQwNTIz_f95fc791-0b42-4987-8187-5e43959fddd7"
      unitRef="usd">807000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTctNy0xLTEtMTQwNTIz_39fd911e-4915-4743-965b-a0f67095efb0"
      unitRef="usd">536000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTgtNS0xLTEtMTQwNTIz_5aeb7b74-a6b3-4096-817e-25a18c2d4c4f"
      unitRef="usd">2000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTgtNy0xLTEtMTQwNTIz_e93678aa-0d4c-455e-b242-6c9727802bed"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTktNS0xLTEtMTQwNTIz_f1fcbf25-e9a9-47c8-86e3-4ea95d36fd43"
      unitRef="usd">809000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMTktNy0xLTEtMTQwNTIz_f1f2ec39-4da5-4730-acf2-8f78c33d5104"
      unitRef="usd">533000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjAtNS0xLTEtMTQwNTIz_9631025b-9053-41c5-bffb-da75e20ef3a3"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjAtNy0xLTEtMTQwNTIz_4bb7d894-4bf1-4ebb-84cf-67ab8bfc4326"
      unitRef="usd">47000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjEtNS0xLTEtMTQwNTIz_74cb5243-0ba2-40bd-994c-3319892664f1"
      unitRef="usd">768000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjEtNy0xLTEtMTQwNTIz_62e26a7c-2865-47c3-847b-9bf4a2e454c4"
      unitRef="usd">486000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjUtNS0xLTEtMTQwNTIz_1da48506-699e-4b31-bb6a-05bb39562d1b"
      unitRef="usdPerShare">5.25</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjUtNy0xLTEtMTQwNTIz_25de7533-0be1-472c-a952-87fd18456291"
      unitRef="usdPerShare">3.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjYtNS0xLTEtMTQwNTIz_1d806951-f367-486f-a687-90f6f0cbb3db"
      unitRef="usdPerShare">0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjYtNy0xLTEtMTQwNTIz_7d0777b9-52e7-4704-8e16-81c92827b817"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjctNS0xLTEtMTQwNTIz_369fb0a8-869b-4b25-a824-6183131388b7"
      unitRef="usdPerShare">5.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjctNy0xLTEtMTQwNTIz_cbbb01d0-39be-4ecf-a80e-9acda2ceb51b"
      unitRef="usdPerShare">3.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjktNS0xLTEtMTQwNTIz_22f17d06-c9a1-4e82-b439-421748631e83"
      unitRef="usdPerShare">5.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMjktNy0xLTEtMTQwNTIz_633be044-61bc-4ff4-b0fa-605bd433d58d"
      unitRef="usdPerShare">3.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzAtNS0xLTEtMTQwNTIz_4fa3ed2f-2fe7-4674-b255-b84bce879acb"
      unitRef="usdPerShare">0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzAtNy0xLTEtMTQwNTIz_5045aefc-52bc-4cc0-984a-24283a36b234"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzEtNS0xLTEtMTQwNTIz_5bbc5452-2d21-44ad-8bcf-df6321c61561"
      unitRef="usdPerShare">5.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzEtNy0xLTEtMTQwNTIz_ca0db8e0-a6bf-4567-811b-a3ef4776a9d7"
      unitRef="usdPerShare">3.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzQtNS0xLTEtMTQwNTIz_e7252a97-1ac5-4274-8256-133f25f466bc"
      unitRef="shares">145900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzQtNy0xLTEtMTQwNTIz_2f79ec5b-4399-4aa5-a847-3c660b496e0e"
      unitRef="shares">158100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzUtNS0xLTEtMTQwNTIz_eeb6a170-05f0-45ca-b0cf-2312958dbc06"
      unitRef="shares">144200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xMy9mcmFnOjI3YzQ4NmI2NWRlMDQ0NTc4MTZjZGMxYjI0MmQ1YmY5L3RhYmxlOmI0OTdhNDk4ZmY2ODRjYzViM2FhZjFkZGUxNjVhNzQwL3RhYmxlcmFuZ2U6YjQ5N2E0OThmZjY4NGNjNWIzYWFmMWRkZTE2NWE3NDBfMzUtNy0xLTEtMTQwNTIz_e78c3a01-9784-47ee-a40e-d7244d1c69e9"
      unitRef="shares">156200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMi01LTEtMS0xNDA1MjM_6e9399fb-6110-4dab-a790-f96d1dc7b912"
      unitRef="usd">809000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMi03LTEtMS0xNDA1MjM_b611828e-324e-4ea8-8c42-d1c74c308952"
      unitRef="usd">533000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNS01LTEtMS0xNDA1MjM_8a05d4cb-7ac6-441b-b44f-23f4eb9af852"
      unitRef="usd">582000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNS03LTEtMS0xNDA1MjM_49b28b76-f9af-4917-8314-95db496cdac6"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNi01LTEtMS0xNDA1MjM_b6840a72-013e-4c00-a294-57e06649cbca"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNi03LTEtMS0xNDA1MjM_b5c0279e-57e8-457b-8c1d-0e15bbf213ac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNy01LTEtMS0xNDA1MjM_f9022c2e-e8d4-4398-9936-d1ecebf12a3e"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfNy03LTEtMS0xNDA1MjM_074c9c18-3658-4225-81a2-7961172b284e"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfOC01LTEtMS0xNDA1MjM_c2819c7a-60c0-41ed-a1ef-a99396b3c09d"
      unitRef="usd">636000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfOC03LTEtMS0xNDA1MjM_43fa290e-23e8-48c8-bfd1-191f390a09c4"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTAtNS0xLTEtMTQwNTIz_e5fae243-0e40-4cb9-92ad-6dae58085938"
      unitRef="usd">1445000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTAtNy0xLTEtMTQwNTIz_e519534f-370e-4a16-a569-9c922205cd89"
      unitRef="usd">559000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTEtNS0xLTEtMTQwNTIz_c5674d90-e7a5-48be-8b5a-a997c72ddaaf"
      unitRef="usd">91000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTEtNy0xLTEtMTQwNTIz_706ebb80-6005-4e5b-94d6-c000b951cbed"
      unitRef="usd">50000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTItNS0xLTEtMTQwNTIz_72950f41-90f9-46fc-8b1c-a52cf612ba92"
      unitRef="usd">1354000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xNi9mcmFnOjUxMjg1OThjZGMxYzQwZWViYmEzZjc4ZTRkZDk5NTc4L3RhYmxlOmM3MDNmOThjZjJkZDRhYWFhYjg3ZTQ0MDU2ZGVhOWI4L3RhYmxlcmFuZ2U6YzcwM2Y5OGNmMmRkNGFhYWFiODdlNDQwNTZkZWE5YjhfMTItNy0xLTEtMTQwNTIz_15861498-1ec0-434e-9412-700b5c1b89fb"
      unitRef="usd">509000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMy0xLTEtMS0xNDA1MjM_b54b676c-54ec-42bf-8fbd-c7fc8f921086"
      unitRef="usd">2233000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMy0zLTEtMS0xNDA1MjM_9cdbbb77-89dd-4b13-9dcb-71b3919d2fc4"
      unitRef="usd">3532000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNC0xLTEtMS0xNDA1MjM_c9f3c55c-fad6-4d8f-be2c-bad063a186de"
      unitRef="usd">19900000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNC0zLTEtMS0xNDA1MjM_13383178-5ef5-4bdc-afcb-5143ef1969a2"
      unitRef="usd">18583000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNS0xLTEtMS0xNDA1MjM_3e2d4da8-a83a-44fe-a7e2-89f714f975d2"
      unitRef="usd">19505000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNS0zLTEtMS0xNDA1MjM_fe246cc1-b86f-4826-86c7-a4de1b3ab554"
      unitRef="usd">18702000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNi0xLTEtMS0xNDA1MjM_a88f18d7-c03b-43dc-b5bc-b6da78b2a567"
      unitRef="usd">3155000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNi0zLTEtMS0xNDA1MjM_59a1e127-a781-4585-866c-01bd284bd329"
      unitRef="usd">4516000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNy0xLTEtMS0xNDA1MjM_1b569a28-dc8a-480f-ada3-c36a626b0bcb"
      unitRef="usd">590000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNy0zLTEtMS0xNDA1MjM_617d279b-4c0c-4524-b4b2-17508da65c7c"
      unitRef="usd">898000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfOC0xLTEtMS0xNDA1MjM_8aeeccbc-58f6-497b-ba85-e6bb1da96e77"
      unitRef="usd">45383000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfOC0zLTEtMS0xNDA1MjM_6648f122-6eff-4085-8147-e3ed015dc31c"
      unitRef="usd">46231000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfOS0xLTEtMS0xNDA1MjM_7e2d13c2-c39b-4dd6-887c-cc97eb30dc77"
      unitRef="usd">2083000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfOS0zLTEtMS0xNDA1MjM_37f2b384-bc51-428f-a899-4d73ed997b44"
      unitRef="usd">2092000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTAtMS0xLTEtMTQwNTIz_5ada50d0-0a41-49aa-9d8d-25a4b84005b3"
      unitRef="usd">1598000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTAtMy0xLTEtMTQwNTIz_b8ddcf81-6a7a-43a1-bee2-fb530b9787f7"
      unitRef="usd">1548000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTEtMS0xLTEtMTQwNTIz_9ed19517-e073-4875-a672-a509a35092f0"
      unitRef="usd">9368000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTEtMy0xLTEtMTQwNTIz_28835702-79e8-4dae-9809-078334150e00"
      unitRef="usd">9451000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTItMS0xLTEtMTQwNTIz_0692e9e1-4003-4a7d-8e06-8853af388bd1"
      unitRef="usd">1976000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTItMy0xLTEtMTQwNTIz_0107f239-040e-4fc7-b794-ee971fbe447d"
      unitRef="usd">2059000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTQtMS0xLTEtMTQwNTIz_9a22262d-0138-4731-8dc4-60a0bd8143a3"
      unitRef="usd">1887000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTQtMy0xLTEtMTQwNTIz_85978cc5-f80d-475f-8be5-66568ab8dc75"
      unitRef="usd">1917000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTUtMS0xLTEtMTQwNTIz_567ad466-838b-4a45-9e6a-2210719de08f"
      unitRef="usd">62295000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTUtMy0xLTEtMTQwNTIz_d874a62a-8e8f-43f9-a263-c8fbaf9ce754"
      unitRef="usd">63298000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTktMS0xLTEtMTQwNTIz_1ec8cb1e-407d-40dd-a6cc-74453ccaad2d"
      unitRef="usd">39708000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMTktMy0xLTEtMTQwNTIz_69948100-e4a5-4371-84e2-f67f2f7d28da"
      unitRef="usd">38086000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjEtMS0xLTEtMTQwNTIz_a66dcce2-bcc5-45e6-b0fa-3b0cc03b9f4c"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjEtMy0xLTEtMTQwNTIz_4ec8e9e0-275e-43cc-8307-3618d3b8305b"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjItMS0xLTEtMTQwNTIz_23e9358d-1c40-420d-8360-d34eacedfe73"
      unitRef="usd">293000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjItMy0xLTEtMTQwNTIz_5beeafa9-8945-4b06-8669-b91f21ec70ad"
      unitRef="usd">297000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjMtMS0xLTEtMTQwNTIz_bc99830f-6acb-4b0d-92d5-4bccd3dadb75"
      unitRef="usd">2324000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjMtMy0xLTEtMTQwNTIz_7803dbf4-2851-4723-b3bf-8362729e8c6c"
      unitRef="usd">4741000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjQtMS0xLTEtMTQwNTIz_5b8831f0-9da4-4bf2-966c-161fbaed017b"
      unitRef="usd">4077000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjQtMy0xLTEtMTQwNTIz_6552751e-eb40-4f4b-bd1a-559e0b81ed06"
      unitRef="usd">4543000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjUtMS0xLTEtMTQwNTIz_c4f6a45c-c6a4-4a1d-9139-78e1e802d3a5"
      unitRef="usd">47201000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjUtMy0xLTEtMTQwNTIz_d2ae62dc-c25e-4093-bee4-9d7375511a1c"
      unitRef="usd">48466000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjYtMS0xLTEtMTQwNTIz_73205358-ce3a-433a-8e61-2e83f1ee730f"
      unitRef="usd">4976000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjYtMy0xLTEtMTQwNTIz_264a60a8-9502-4dc4-a8da-3924416e9d39"
      unitRef="usd">5080000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjctMS0xLTEtMTQwNTIz_df54459f-8d0a-4ae2-814d-ed6586732ea5"
      unitRef="usd">1541000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjctMy0xLTEtMTQwNTIz_aaf21053-1589-4488-b817-661cece08972"
      unitRef="usd">1418000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjgtMS0xLTEtMTQwNTIz_50bcdaa1-17e4-4baa-9381-6641f201ae87"
      unitRef="usd">1364000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjgtMy0xLTEtMTQwNTIz_b52161de-ed6e-4723-b864-b46111eece08"
      unitRef="usd">1366000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjktMS0xLTEtMTQwNTIz_b2b2f38a-ad64-4581-b256-a12c329de294"
      unitRef="usd">7132000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMjktMy0xLTEtMTQwNTIz_bfa5acda-7ea7-47a0-bf2e-f0f546a44b9a"
      unitRef="usd">7220000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzAtMS0xLTEtMTQwNTIz_9ab10e1a-4871-4619-ad37-86962a2c356f"
      unitRef="usd">1553000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzAtMy0xLTEtMTQwNTIz_16ad14eb-a8fc-485d-80aa-81395ba09aa3"
      unitRef="usd">1540000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfMjE_283e2be5-a095-49fe-befe-f39664ff5fb6"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfMjE_fe528565-0b67-4f6d-8c89-b3cf68d2dbba"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfMzU_7796a514-c91f-4754-92ba-999be08c42fb"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfMzU_db45f0df-3271-4dec-849e-4c08387264aa"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfNTc_46eff81d-d708-462d-ad44-4f6846fa2ae9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfNTc_70b5663e-2d04-453d-8156-f23f8a7b9e09"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfNTc_d3bffe25-5a31-4d02-a7dc-ee04aef85a85"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246ZjVlNjM5ZjUyZTBjNDQ3MTkzMmJjNjkxZjYxYjA1ZGFfNTc_e3114b95-e836-4972-b005-a1208edfbafb"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMS0xLTEtMTQwNTIz_7d02d9a6-d197-4b9a-b502-dfa75d1b6192"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzMtMy0xLTEtMTQwNTIz_cffcba4a-33df-439f-85d6-840a1f4c3173"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfMTg_934bf147-6a3f-4914-9fe5-a2522ad8a0e1"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfMTg_e3d5ac4b-44b0-447d-b178-6fd4c0e043c3"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfMzI_24ccafe8-2b08-4863-89ad-841ef6f81d62"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfMzI_5114a3c0-4456-4311-badd-794e3ad469f1"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfNTc_7ac43b6b-f68c-424c-8195-fd4cbcc5560f"
      unitRef="shares">277000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NzFhZTRlNGExMmE3NDYwMGE5NWFiMjA5YzEzMDM1OWVfNjQ_943b6758-6784-4dd9-be9e-34412f24d76e"
      unitRef="shares">275000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMS0xLTEtMTQwNTIz_cbaae212-2e17-45fb-bbd6-e52139ca4170"
      unitRef="usd">3000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzQtMy0xLTEtMTQwNTIz_3931ef09-7c7c-40b6-b15c-0ba7c96a03ef"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzUtMS0xLTEtMTQwNTIz_886cd743-bb59-44b3-85d7-1e9d8064230d"
      unitRef="usd">7350000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzUtMy0xLTEtMTQwNTIz_79cbda3b-bf96-46b6-b488-0e40aa5757fa"
      unitRef="usd">7275000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzYtMS0xLTEtMTQwNTIz_7e134c48-9223-4932-b261-3825bac709c4"
      unitRef="usd">9732000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzYtMy0xLTEtMTQwNTIz_798169b7-7f47-4648-93b2-2b4513a24620"
      unitRef="usd">9030000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzctMS0xLTEtMTQwNTIz_a6c0c820-2692-4074-92b0-560f8573f8b3"
      unitRef="usd">-948000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzctMy0xLTEtMTQwNTIz_7dd0d0ec-94c8-4505-885a-a214d4e240f2"
      unitRef="usd">-1534000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzktMC0xLTEtMTQwNTIzL3RleHRyZWdpb246M2Q1MTdkNmFiMDYwNDI3NmI2MTZmYWI3MjA5YTFhMTlfMzA_1b506d7c-69c9-47f3-a6f8-410b6f79d6e3"
      unitRef="shares">133000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzktMC0xLTEtMTQwNTIzL3RleHRyZWdpb246M2Q1MTdkNmFiMDYwNDI3NmI2MTZmYWI3MjA5YTFhMTlfMzc_276ae702-b66f-4a76-bcda-c74e1297d006"
      unitRef="shares">130000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzktMS0xLTEtMTQwNTIz_73549f85-85c6-4b9f-a13b-0ef75c930044"
      unitRef="usd">18141000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfMzktMy0xLTEtMTQwNTIz_a4a966ee-8fac-4e94-b0e4-18b8b69aaa10"
      unitRef="usd">17045000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDAtMS0xLTEtMTQwNTIz_cbb6b199-05be-4544-b405-4456b35dab9f"
      unitRef="usd">-2004000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDAtMy0xLTEtMTQwNTIz_47c49cc5-c4b6-4624-9730-1c168ff338dd"
      unitRef="usd">-2272000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDEtMS0xLTEtMTQwNTIz_5d7a28aa-c106-4380-957c-5b7d5cb7109a"
      unitRef="usd">532000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDEtMy0xLTEtMTQwNTIz_37b2a48a-d73c-4728-950a-212458572da3"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDItMS0xLTEtMTQwNTIz_0a383910-9fda-41e8-a9e0-50b3303c983e"
      unitRef="usd">-1472000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDItMy0xLTEtMTQwNTIz_c0970d07-5b64-4483-9b97-0607167c31a6"
      unitRef="usd">-1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDMtMS0xLTEtMTQwNTIz_097f36bd-1cc4-4687-93aa-5e448312d9b1"
      unitRef="usd">62295000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8xOS9mcmFnOjU1YTQxOTgzNDIyNzRlZjFiZDE4MDNlNGM3YmM3NzMyL3RhYmxlOmYwOWY3NWZjYzNhMjQ2ZDRhNDI3ZDc2MmE3YzZjNDIxL3RhYmxlcmFuZ2U6ZjA5Zjc1ZmNjM2EyNDZkNGE0MjdkNzYyYTdjNmM0MjFfNDMtMy0xLTEtMTQwNTIz_956ccb2c-cb60-451d-b7e7-188947ad8c48"
      unitRef="usd">63298000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i34daad1897684d7cb9165b77d17ca934_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xLTEtMS0xNDA1MjM_54b9b326-b8f1-46bd-8065-5a9d1f6426ad"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34daad1897684d7cb9165b77d17ca934_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0zLTEtMS0xNDA1MjM_15254d67-c27f-4522-9734-7005f0830458"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc276c29bee440b1be1ec46674de1a06_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy01LTEtMS0xNDA1MjM_a6820f96-f354-44c9-b51f-a67137404d31"
      unitRef="usd">7275000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i151489c821d34264ba84b7c360fadace_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy05LTEtMS0xNDA1MjM_6e9cb05a-2689-4e72-ac78-2a1a305035f1"
      unitRef="usd">9030000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24ead1497b6d497b80e44b48146936b5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xMS0xLTEtMTQwNTIz_6a137951-2f3f-4d70-8ef9-259c35706f8e"
      unitRef="usd">-1534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i65ab8217fe89483e8a1f4f965ba5729e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xMy0xLTEtMTQwNTIz_76ccd318-c7d0-4b9f-9b16-841f960abba3"
      unitRef="shares">130000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65ab8217fe89483e8a1f4f965ba5729e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xNS0xLTEtMTQwNTIz_f00f8066-86c3-4c28-8d17-88107579cbf3"
      unitRef="usd">-17045000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f0afdd8a78b4984a7c33d73ebec78e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xNy0xLTEtMTQwNTIz_7224e876-4d1c-44c6-bdc6-34f36c4dcfc7"
      unitRef="usd">480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMy0xOS0xLTEtMTQwNTIz_98f6dfea-8823-416d-bac9-24b190634f16"
      unitRef="usd">-1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures
      contextRef="i8fd9d9552a334e37b133dfa12dc23516_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC0xLTEtMS0xNDA1MjM_f87f7266-87f6-4048-989d-f7948c3ac924"
      unitRef="shares">2000000</mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i8fd9d9552a334e37b133dfa12dc23516_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC0zLTEtMS0xNDA1MjM_d3ffcba5-e3a6-4f14-b6be-c4c4f42c62e3"
      unitRef="usd">1000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC01LTEtMS0xNDA1MjM_a0a39bbb-0031-4f4a-b3e7-da5706f79884"
      unitRef="usd">91000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="iae2638ed49674216b6fc56801fe2326f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC0xNS0xLTEtMTQwNTIz_5767788b-eb8f-4932-a4f7-cba3469aa3ab"
      unitRef="usd">-152000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNC0xOS0xLTEtMTQwNTIz_3e718a05-4dc9-4d6e-86bb-2b1f896bfe34"
      unitRef="usd">-60000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNS01LTEtMS0xNDA1MjM_ca34bdb8-3221-47b1-80a2-b99c1fda92b2"
      unitRef="usd">40000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNS0xOS0xLTEtMTQwNTIz_958ee3b7-71b2-4b84-abde-872c39295b59"
      unitRef="usd">40000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNi0xNy0xLTEtMTQwNTIz_ffc45c09-3a5c-4252-ab16-afdb7eda2b6d"
      unitRef="usd">36000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNi0xOS0xLTEtMTQwNTIz_7a393951-ce6b-4556-8f19-fa355f5da4b6"
      unitRef="usd">36000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i183a8c52537c45628ea1a4b23722e45c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNy0xMS0xLTEtMTQwNTIz_fb57c4be-f4a2-4f92-9392-8ae8f4bd33b4"
      unitRef="usd">586000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNy0xNy0xLTEtMTQwNTIz_2c6adfe3-af1b-455e-8cf3-b688e436a127"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfNy0xOS0xLTEtMTQwNTIz_841d6b72-b200-4264-8dd4-4ef396fea582"
      unitRef="usd">636000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="iba579ff5d35d41aea8face8b5fd431db_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOC05LTEtMS0xNDA1MjM_b9170422-095d-405a-aa08-95d43605561c"
      unitRef="usd">768000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOC0xNy0xLTEtMTQwNTIz_8b70718c-9aeb-4e06-bff3-410256b15184"
      unitRef="usd">41000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOC0xOS0xLTEtMTQwNTIz_b3946e93-606d-4d49-b1fe-a3b9074398f2"
      unitRef="usd">809000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOS01LTEtMS0xNDA1MjM_7cac02fe-b9cc-4d98-bba1-11882fc76915"
      unitRef="usd">56000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iae2638ed49674216b6fc56801fe2326f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOS0xMy0xLTEtMTQwNTIz_dee3ec4a-90bb-490e-b465-56d4d4bc9454"
      unitRef="shares">3000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iae2638ed49674216b6fc56801fe2326f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOS0xNS0xLTEtMTQwNTIz_697fc3a9-a99b-440c-b0e8-72c9f2618414"
      unitRef="usd">944000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfOS0xOS0xLTEtMTQwNTIz_ce624f94-fe5d-445a-b34e-dafdcd228813"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTItMTctMS0xLTE0MDUyMw_a901e8f2-379c-4167-b48f-9adba304d351"
      unitRef="usd">2000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTItMTktMS0xLTE0MDUyMw_acb4635c-4024-449b-b171-355ac0640ebc"
      unitRef="usd">2000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTMtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246Nzc1YTI2NTRkNmU2NGRkMjhlNDZmMmQwODk3YmQwYjlfMjE5OTAyMzI1NTYwMQ_99b0774a-4a87-4938-98e8-d33679f67bf5"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="iba579ff5d35d41aea8face8b5fd431db_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTMtOS0xLTEtMTQwNTIz_a65dfa7c-a475-43a9-ac5d-6b0d90921707"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTMtMTktMS0xLTE0MDUyMw_7b101a7b-7b3b-442f-8bda-480013389875"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="if1fab88b5e6a417899c5b8cf1af15a53_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTQtNS0xLTEtMTQwNTIz_638da495-66a9-4430-8e3a-e46a7a5883a5"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="iba579ff5d35d41aea8face8b5fd431db_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTQtOS0xLTEtMTQwNTIz_b2f956b2-fd9d-433b-b50f-c5b1eb6a5a94"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTQtMTctMS0xLTE0MDUyMw_8c477b3b-02fa-4326-9101-0229c7387503"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTQtMTktMS0xLTE0MDUyMw_e0f299ee-ba5b-4a10-b02e-ad7b6dbcdbde"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i1df9375c53a54770836b443aebe65d3b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMS0xLTEtMTQwNTIz_96224887-58b4-4fde-92a4-bd6dc223d730"
      unitRef="shares">277000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1df9375c53a54770836b443aebe65d3b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMy0xLTEtMTQwNTIz_d814d444-bef0-4541-8fa6-07400e809aaf"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa15a292151249278a75938323d1968f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtNS0xLTEtMTQwNTIz_1e496a94-314b-41ed-ab11-bda82c91d241"
      unitRef="usd">7350000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i965a6647bfcc4c34af4e145de7a94e66_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtOS0xLTEtMTQwNTIz_aeb2c9bc-e3ba-40c5-83e6-d369a5ebc0ab"
      unitRef="usd">9732000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb0e60dee72643d9b8f7da1912eb9d0c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTEtMS0xLTE0MDUyMw_eae04a42-0585-4495-bd94-774e7dcc1106"
      unitRef="usd">-948000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ifc273f7fc5b247c0846600e051da1759_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTMtMS0xLTE0MDUyMw_6f056045-c964-436a-a8c3-d3336e3ebcbb"
      unitRef="shares">133000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc273f7fc5b247c0846600e051da1759_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTUtMS0xLTE0MDUyMw_9d3bbe1b-eaf9-4c5d-b705-e2cacca0bf8d"
      unitRef="usd">-18141000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5026063ddbbd426490dc361b9a57ba33_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTctMS0xLTE0MDUyMw_95c49a46-b8d9-4128-aad4-a3e3102fb5a2"
      unitRef="usd">532000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOmE0ZWE4YTlmYWE0OTQwNzZhMDhhMjdkMGQ2YzAxZTM1L3RhYmxlcmFuZ2U6YTRlYThhOWZhYTQ5NDA3NmEwOGEyN2QwZDZjMDFlMzVfMTUtMTktMS0xLTE0MDUyMw_94907bdf-090f-4204-ace6-244e6a7e5317"
      unitRef="usd">-1472000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i8f79f8849ffd4f6d92a5100af46ef410_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xLTEtMS0xNDA1MjM_c809f0ee-4c5a-4685-a518-b2a16df768cc"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f79f8849ffd4f6d92a5100af46ef410_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0zLTEtMS0xNDA1MjM_612439e3-1ee9-41b8-852a-9b77596dab94"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i302a7aa1b388436ba21034ef5118cefb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy01LTEtMS0xNDA1MjM_3d996a02-b142-4207-b6fe-0e8896833def"
      unitRef="usd">6925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic25a09d084d74900927f8d3b2d327f34_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy05LTEtMS0xNDA1MjM_1d17511d-59b0-4aec-aa84-fa311bf24198"
      unitRef="usd">8202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib222089abc8b4a0984b44963c8a6da6c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xMS0xLTEtMTQwNTIz_6ecc688f-e7af-4180-a51a-2f510364bf7e"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="if0356030a71f4cedad29132c59391b27_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xMy0xLTEtMTQwNTIz_c39ca7ff-d719-487c-8223-d9e9f797102f"
      unitRef="shares">115000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0356030a71f4cedad29132c59391b27_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xNS0xLTEtMTQwNTIz_1613c806-9ae5-414e-a0d7-a610d8a4e715"
      unitRef="usd">-13670000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31619d5dfb2942f181793348c62fa60a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xNy0xLTEtMTQwNTIz_cde8d456-9c82-4052-a92a-66f2899bcdfd"
      unitRef="usd">196000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd8f1ea1e497400f8334891264c28e85_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMy0xOS0xLTEtMTQwNTIz_045be4c9-9461-43b8-bc6a-e4689b023650"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures
      contextRef="ibacc7e1f23d649749320d4f48e0caff5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNC0xLTEtMS0xNDA1MjM_8fddf6be-188d-4fa4-9762-5100f1d1db97"
      unitRef="shares">1000000</mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNC01LTEtMS0xNDA1MjM_f60c9940-c3ff-4880-950c-967b1c2e9b38"
      unitRef="usd">71000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i2bf29a8b64e74d7c8e6324067684ba02_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNC0xNS0xLTEtMTQwNTIz_65ae4bd0-e431-4d31-9003-9a7b9fd7005e"
      unitRef="usd">-59000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNC0xOS0xLTEtMTQwNTIz_7699d7fc-c487-41b8-8c34-182dc02c1751"
      unitRef="usd">12000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNS01LTEtMS0xNDA1MjM_e2c9d757-39c1-4571-bee3-997e8c1a4c20"
      unitRef="usd">33000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNS0xOS0xLTEtMTQwNTIz_2188b0f2-72f2-4a81-b3ff-88d969561e3e"
      unitRef="usd">33000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNi0xNy0xLTEtMTQwNTIz_613a36c9-c60f-4777-950b-f6fa8659fe74"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNi0xOS0xLTEtMTQwNTIz_3d40b802-72e0-4a32-8e0d-152480434f11"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id9d4cc7ccee34f9a8a8f2544e232a63f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNy0xMS0xLTEtMTQwNTIz_ed1ed3fc-2646-4694-898b-734b88fdfe7d"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfNy0xOS0xLTEtMTQwNTIz_9ed6e012-b958-41d7-8cee-38ea95486acb"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i12ff8ccdcd1d43578af7654618f2847f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOC05LTEtMS0xNDA1MjM_d452fbe4-7b7e-4d3c-8f20-d70487c57451"
      unitRef="usd">486000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOC0xNy0xLTEtMTQwNTIz_4d8a0179-4a08-4af0-a517-71df3f0f497b"
      unitRef="usd">39000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOC0xOS0xLTEtMTQwNTIz_acaa9f6c-5ba2-49a4-b0cd-d27d14fafdee"
      unitRef="usd">525000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOS01LTEtMS0xNDA1MjM_5503c05f-d144-40ad-afec-1d938020738e"
      unitRef="usd">150000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i2bf29a8b64e74d7c8e6324067684ba02_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOS0xMy0xLTEtMTQwNTIz_a92b78e5-2945-4e45-b0c1-c6c0c937d2c4"
      unitRef="shares">4000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i2bf29a8b64e74d7c8e6324067684ba02_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOS0xNS0xLTEtMTQwNTIz_fc68bbbb-2cf3-4806-8820-f63468d92b21"
      unitRef="usd">850000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfOS0xOS0xLTEtMTQwNTIz_014b48b1-2ff3-4bd7-b907-5a764d3bfce3"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTAtNS0xLTEtMTQwNTIz_34167755-113e-4158-b5d7-702debeb61bb"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="id9d4cc7ccee34f9a8a8f2544e232a63f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTAtMTEtMS0xLTE0MDUyMw_58ff1c31-c26e-4240-b727-b17c9f9242b8"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTAtMTktMS0xLTE0MDUyMw_e6fee47a-0fb7-4721-b002-c462de1f5f6f"
      unitRef="usd">8000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtMTctMS0xLTE0MjcxMQ_43a27e9b-7e85-4cca-a3c8-bb5c667c0b69"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtMTktMS0xLTE0MjcxMQ_2881fcd2-be9d-44c6-86f6-219d846cfe90"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246MzU0YzQzMDM1ZjdjNGM0YmIyNzlmNzZkZWRjZmQ4YTJfMjE5OTAyMzI1NTYwNQ_e028c053-9320-4285-ae33-9f9f1b69cc9e"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i12ff8ccdcd1d43578af7654618f2847f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtOS0xLTEtMTQwNTIz_e047a03a-c92c-48b0-9673-f2bdd3a347a8"
      unitRef="usd">65000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTEtMTktMS0xLTE0MDUyMw_94dddc55-88a4-425f-8aff-18234b218070"
      unitRef="usd">65000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i12ff8ccdcd1d43578af7654618f2847f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTItOS0xLTEtMTQwNTIz_48dbc399-4f75-4245-ac0d-0987f9470601"
      unitRef="usd">5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTItMTctMS0xLTE0MDUyMw_24dffae6-6d7b-4416-a13d-0e14f248379a"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTItMTktMS0xLTE0MDUyMw_f3cff37b-a2b4-4462-a16f-d1a0fb1e7e8a"
      unitRef="usd">4000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="if7f38fed308149759889e7a524621b45_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMS0xLTEtMTQwNTIz_d58f8318-93ea-4e4e-aed3-2e14944eb9a2"
      unitRef="shares">274000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7f38fed308149759889e7a524621b45_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMy0xLTEtMTQwNTIz_d48f3d20-3c15-4c8c-9230-850a52dd5cb0"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06e4115630544b9a8ecb71896a8d29ae_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtNS0xLTEtMTQwNTIz_5679bc96-e640-43f5-b0a7-a254d448c4bd"
      unitRef="usd">7057000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6a849346f984ba7a24863f281ff99ca_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtOS0xLTEtMTQwNTIz_6f33df38-766a-40de-aa60-dc086936f933"
      unitRef="usd">8618000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1257a17abb1d49209b1ecf7010d647c4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTEtMS0xLTE0MDUyMw_f1b74b8c-4df4-4691-9336-c30cdcfce489"
      unitRef="usd">-1627000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i915d93beb3944977a2b115e5a05ff593_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTMtMS0xLTE0MDUyMw_4d17e2ae-ff19-42e3-946a-9106b6399a6e"
      unitRef="shares">119000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i915d93beb3944977a2b115e5a05ff593_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTUtMS0xLTE0MDUyMw_ab23776f-7851-4fbb-9383-c9ac46f6b75d"
      unitRef="usd">-14579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i97688416d8624c10a48f226d71563b9e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTctMS0xLTE0MDUyMw_561391d7-14ac-49b0-9c6a-b76271e7139b"
      unitRef="usd">484000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52e0da06428444108f6f30cfdedaf625_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yMi9mcmFnOjgyYTU5Zjk0MjZlZDRiNTc4NGU5ODZhNDUyZDllYTMxL3RhYmxlOjI2NGE0ZjFhYjdkNTQyMjZhNzYxN2QyMzlmYzQ3MThlL3RhYmxlcmFuZ2U6MjY0YTRmMWFiN2Q1NDIyNmE3NjE3ZDIzOWZjNDcxOGVfMTMtMTktMS0xLTE0MDUyMw_6dcca419-ff14-465a-8fa8-2bb4123ce363"
      unitRef="usd">-45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMy0xLTEtMS0xNDA1MjM_8b13cc02-c121-443f-a5c1-4269fcd5a81e"
      unitRef="usd">809000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMy0zLTEtMS0xNDA1MjM_e14d1c32-062c-4c4b-84af-223424f5be4d"
      unitRef="usd">533000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNS0xLTEtMS0xNDA1MjM_03ce0e84-3eeb-40b8-9a1d-53466901ab7c"
      unitRef="usd">61000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNS0zLTEtMS0xNDA1MjM_5e8731bf-50e6-461a-a762-7d88f23718b2"
      unitRef="usd">80000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNi0xLTEtMS0xNDA1MjM_374db198-fe6c-462b-9450-02d45500b969"
      unitRef="usd">87000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNi0zLTEtMS0xNDA1MjM_d25c51bf-8c13-4827-820f-c34440fe08bd"
      unitRef="usd">138000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNy0xLTEtMS0xNDA1MjM_a2fd73f0-f1d0-401c-9e2f-f028bf41aefc"
      unitRef="usd">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNy0zLTEtMS0xNDA1MjM_c744a723-401e-4a7f-b512-377c63afe11c"
      unitRef="usd">104000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfOS0xLTEtMS0xNDA1MjM_591afe81-75b4-4aa3-adf0-3fcf79ee4518"
      unitRef="usd">-109000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfOS0zLTEtMS0xNDA1MjM_d88cdaf6-13fb-44a2-a7f1-2e05c198e1c0"
      unitRef="usd">-36000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTAtMS0xLTEtMTQwNTIz_b3198013-35fb-426a-b9c3-eb7b4840c097"
      unitRef="usd">-13000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTAtMy0xLTEtMTQwNTIz_e778847e-b353-4845-be99-cab262e51b8f"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTEtMS0xLTEtMTQwNTIz_9c775a1f-3469-46e6-aaee-32725f2e5a9c"
      unitRef="usd">63000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTEtMy0xLTEtMTQwNTIz_ef258711-d771-4f2f-ace4-35afb4aa8775"
      unitRef="usd">90000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTItMS0xLTEtMTQwNTIz_f03fd7e8-8429-4801-962f-ca3f4dee7dcb"
      unitRef="usd">33000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTItMy0xLTEtMTQwNTIz_53d78a5b-0801-4a55-81e1-ce424bb77df9"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTMtMS0xLTEtMTQwNTIz_f95253bb-e08e-447b-8eec-b8293e5878a1"
      unitRef="usd">20000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTMtMy0xLTEtMTQwNTIz_50e4d9d7-a563-430e-8d5a-378efdfd7c33"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTQtMS0xLTEtMTQwNTIz_9d5859a7-f113-4b99-abb2-8920e22b1548"
      unitRef="usd">-102000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTQtMy0xLTEtMTQwNTIz_3a194b22-c63a-4ba2-b639-081fb5bd230e"
      unitRef="usd">-194000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTYtMS0xLTEtMTQwNTIz_4aee28b1-5f70-4a4c-9327-1b44b08093de"
      unitRef="usd">1584000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTYtMy0xLTEtMTQwNTIz_1510b006-7657-48ca-a8f9-6ed593e9be4b"
      unitRef="usd">1045000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTctMS0xLTEtMTQwNTIz_b22c5503-4035-4b1d-a138-acd4034ef605"
      unitRef="usd">955000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTctMy0xLTEtMTQwNTIz_23d72ea8-f348-4725-a2ef-2b1de2d77731"
      unitRef="usd">901000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTgtMS0xLTEtMTQwNTIz_51b8108b-5baa-42c1-be56-c888bb050ed8"
      unitRef="usd">1006000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTgtMy0xLTEtMTQwNTIz_a76c47a3-df29-46cb-a1a0-0dbb58407e1b"
      unitRef="usd">-609000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTktMS0xLTEtMTQwNTIz_641514b9-d70c-472a-8f61-7ad862b54696"
      unitRef="usd">-94000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMTktMy0xLTEtMTQwNTIz_81dfb5ef-d8af-4a8a-970d-dbff25ab7b70"
      unitRef="usd">-90000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjAtMS0xLTEtMTQwNTIz_48c17984-393e-4e96-846e-11680511982e"
      unitRef="usd">37000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjAtMy0xLTEtMTQwNTIz_acbbde0d-dabc-408e-8ffe-9efcd03d64c0"
      unitRef="usd">-54000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjEtMS0xLTEtMTQwNTIz_7957005f-6e56-4e87-acc3-2e713ce499ed"
      unitRef="usd">-370000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjEtMy0xLTEtMTQwNTIz_40649795-85e1-4ace-ad02-cae1f38d047a"
      unitRef="usd">74000000</mck:IncreaseDecreaseInLitigationReserve>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjItMS0xLTEtMTQwNTIz_5d0f8399-2c41-46bb-b4db-c858ae30e22f"
      unitRef="usd">186000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjItMy0xLTEtMTQwNTIz_0d0a30ae-033e-4f44-bf90-b2a4e792db02"
      unitRef="usd">149000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjMtMS0xLTEtMTQwNTIz_8c0765f5-394b-431b-88d5-be1bcfeda4b7"
      unitRef="usd">-941000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjMtMy0xLTEtMTQwNTIz_c3d7a1e4-16d4-4048-ad62-5611424e8645"
      unitRef="usd">-1622000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjYtMS0xLTEtMTQwNTIz_2a42bb59-24ff-44b8-bcae-509f7b574025"
      unitRef="usd">71000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjYtMy0xLTEtMTQwNTIz_bcbde926-c012-47bd-ac7a-3ca8f5a6653e"
      unitRef="usd">93000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjctMS0xLTEtMTQwNTIz_d5f4e2e4-9661-4c38-8d4d-0c8f02acc119"
      unitRef="usd">29000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjctMy0xLTEtMTQwNTIz_e7366951-ba4a-4045-8957-463996fbbb54"
      unitRef="usd">66000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjgtMS0xLTEtMTQwNTIz_2b5e18cf-8b4f-4c2f-bb43-80ccb3dc9e7b"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjgtMy0xLTEtMTQwNTIz_de4ecdf3-b053-4c17-bffd-9fe79a081202"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjktMS0xLTEtMTQwNTIz_fcafea40-ba4b-4ca5-a1e1-248880821306"
      unitRef="usd">240000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMjktMy0xLTEtMTQwNTIz_e8719aff-bc30-45f7-bfac-77af2e13e87f"
      unitRef="usd">83000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMzAtMS0xLTEtMTQwNTIz_21df8427-2354-413e-971b-573ba69557c6"
      unitRef="usd">100000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMzAtMy0xLTEtMTQwNTIz_98de40bd-769e-4a05-b64c-00e06b8b9e62"
      unitRef="usd">22000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMzEtMS0xLTEtMTQwNTIz_74e207b8-e428-49a8-b662-ec17d376bdba"
      unitRef="usd">39000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfMzEtMy0xLTEtMTQwNTIz_da0d5e94-fc60-4cb3-8a15-a2b673faebb1"
      unitRef="usd">-99000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDAtMS0xLTEtMTQwNTIz_99964275-543f-4e13-b08f-8a6a8ace6e3f"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDAtMy0xLTEtMTQwNTIz_cfdef47e-e3d7-4795-8b19-05fa863c1144"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDMtMS0xLTEtMTQwNTIz_93ae0b1d-174b-41fb-9549-b96254cf0f68"
      unitRef="usd">91000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDMtMy0xLTEtMTQwNTIz_98e3d54b-826c-4a13-b89c-324a530e6baa"
      unitRef="usd">71000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDQtMS0xLTEtMTQwNTIz_fe922240-cfb0-4f26-bb86-ad6acbf77587"
      unitRef="usd">1000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDQtMy0xLTEtMTQwNTIz_82db5f3a-84f6-4be4-9946-f89957c954ed"
      unitRef="usd">1008000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDUtMS0xLTEtMTQwNTIz_0f08e6e7-0702-4f07-98b4-2ad4bf986b80"
      unitRef="usd">71000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDUtMy0xLTEtMTQwNTIz_db8c799b-33cb-418b-a13c-6570e5ef9d84"
      unitRef="usd">69000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDYtMS0xLTEtMTQwNTIz_6ae56968-b61e-4ef1-9f24-bd7cc2887d60"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDYtMy0xLTEtMTQwNTIz_38ffdfb8-9239-4ff7-b488-727e72f6b05e"
      unitRef="usd">1031000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDctMS0xLTEtMTQwNTIz_0e4f8115-9ee8-4f19-8c5b-9eab436796a2"
      unitRef="usd">-199000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDctMy0xLTEtMTQwNTIz_dcf5141a-97d5-44f6-aec8-eedb498bdadd"
      unitRef="usd">-112000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDgtMS0xLTEtMTQwNTIz_d29524c7-1588-4247-8357-354bc529ee67"
      unitRef="usd">-1181000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDgtMy0xLTEtMTQwNTIz_40d0f0a5-5377-4bca-92a0-948762a9a175"
      unitRef="usd">-2151000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDktMS0xLTEtMTQwNTIz_2fd25dd5-dcd4-478a-8cba-bffb9f044f49"
      unitRef="usd">18000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNDktMy0xLTEtMTQwNTIz_ff8d65fa-0c36-4734-9963-9b1911f0c40c"
      unitRef="usd">11000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTAtMS0xLTEtMTQwNTIz_4dfed151-51d8-4875-8ff0-1769e884433b"
      unitRef="usd">470000000</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTAtMy0xLTEtMTQwNTIz_2f9a355a-b1fb-4c18-a47f-9c3155760d11"
      unitRef="usd">0</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTEtMS0xLTEtMTQwNTIz_57c14943-6f5f-463c-8c85-05760d4173d0"
      unitRef="usd">-1595000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTEtMy0xLTEtMTQwNTIz_fb7e11dd-3d6d-4ed4-be34-2637af0b4bb9"
      unitRef="usd">-3861000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTItMS0xLTEtMTQwNTIz_0756d3a9-758d-42c6-97fe-64deefb76383"
      unitRef="usd">3935000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifd8f1ea1e497400f8334891264c28e85_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTItMy0xLTEtMTQwNTIz_447f6c9a-35dd-47b6-b512-20ab77c4724e"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTMtMS0xLTEtMTQwNTIz_c02a3342-a5be-4fc0-8043-c3ab62b3ed16"
      unitRef="usd">2340000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i52e0da06428444108f6f30cfdedaf625_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTMtMy0xLTEtMTQwNTIz_fbb5316f-4c3a-4caf-bb9d-fa5231a001e0"
      unitRef="usd">2535000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTQtMS0xLTEtMTQwNTIz_e980515f-af8f-43b2-b320-62597190b7bb"
      unitRef="usd">107000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i52e0da06428444108f6f30cfdedaf625_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTQtMy0xLTEtMTQwNTIz_47c2c06d-06f0-4f4b-9253-086621b3eda6"
      unitRef="usd">112000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTYtMS0xLTEtMTQwNTIz_1a3430e4-028c-463e-8f8e-324242f447d8"
      unitRef="usd">2233000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i52e0da06428444108f6f30cfdedaf625_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8yOC9mcmFnOmYzYzdhZmQ0MTgyODQzMjk4MmYxZmI1Yjc5MTk4Y2Q5L3RhYmxlOmE1ZmIxOWZkM2Q2NTQ1OGQ4OTFkZDIwMDA3NmRkN2YwL3RhYmxlcmFuZ2U6YTVmYjE5ZmQzZDY1NDU4ZDg5MWRkMjAwMDc2ZGQ3ZjBfNTYtMy0xLTEtMTQwNTIz_a93ed6d4-9ebe-4479-8fd5-d7df2304f1f4"
      unitRef="usd">2423000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDY5OA_604ab9a0-b56e-45a7-b48b-5261fb6466cb">Significant Accounting Policies&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#x201c;RxTS&#x201d;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#x201c;Segments of Business,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#x201c;COVID-19&#x201d;), and therefore the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#x201c;2022 Annual Report&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no adopted accounting standards during the first quarter of fiscal 2023 that had a material impact to the Company&#x2019;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of this guidance but does not expect it to have a material impact on its consolidated financial statements or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the Company exited one of its investments in equity securities for proceeds of $179&#160;million. The Company expects to recognize a gain within &#x201c;Other income, net&#x201d; in its Condensed Consolidated Statement of Operations for the second quarter of fiscal 2023 related to the disposition. The cost basis of the investment was $38&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNTcx_94fdc16a-0bb9-4750-a14f-616eb0918b98"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDcwMA_e983649b-8df5-4fc9-be65-358a827936ab">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMzg0ODI5MDcxMTIxNA_75eb4ae6-b658-46c3-9222-fcaff2d992b4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMzg0ODI5MDcxMTIxNQ_830db0c9-cf7a-4651-b1b4-6f59ef5c9f41">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDY3Ng_b850864a-6efd-4d99-8a51-088d74cfa7e5">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#x201c;COVID-19&#x201d;), and therefore the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ComparabilityOfPriorYearFinancialData
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDcwNg_516a818f-80fa-493d-8a37-f94823cf5b8b">The results of operations for the three months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#x201c;2022 Annual Report&#x201d;).</us-gaap:ComparabilityOfPriorYearFinancialData>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfNDcwOA_16499c54-9f75-4382-a931-c8578f15796b">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no adopted accounting standards during the first quarter of fiscal 2023 that had a material impact to the Company&#x2019;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.&lt;/span&gt;&lt;/div&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of this guidance but does not expect it to have a material impact on its consolidated financial statements or related disclosures</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMTM3NDM4OTUzNjQ0Njg_30d3b7c1-3874-4690-81b8-f59b98f1da06">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the Company exited one of its investments in equity securities for proceeds of $179&#160;million. The Company expects to recognize a gain within &#x201c;Other income, net&#x201d; in its Condensed Consolidated Statement of Operations for the second quarter of fiscal 2023 related to the disposition. The cost basis of the investment was $38&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMTM3NDM4OTUzNjQ0Njk_d9e22b32-dfb9-484a-917b-c8fef10bdb4c">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the Company exited one of its investments in equity securities for proceeds of $179&#160;million. The Company expects to recognize a gain within &#x201c;Other income, net&#x201d; in its Condensed Consolidated Statement of Operations for the second quarter of fiscal 2023 related to the disposition. The cost basis of the investment was $38&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i2151c060ee864dcf9cc0a315dedcb4bc_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMjE5OTAyMzI3Mjc3Mw_382d2bfa-50c8-4c2d-b3eb-de265e097019"
      unitRef="usd">179000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="iacb94994718b406dbc1a53f8dab8d938_I20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNC9mcmFnOjJhNmNjZTVmZDYxZDQ0YzZiOGQyMmIyODE4M2JhODE3L3RleHRyZWdpb246MmE2Y2NlNWZkNjFkNDRjNmI4ZDIyYjI4MTgzYmE4MTdfMjE5OTAyMzI3Mjc4Nw_8482b785-8a55-4510-a63d-d13930455cbc"
      unitRef="usd">38000000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNzE0OA_9e93e09a-aee0-4018-b3a4-690cbb6f7109">Held for Sale&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company announced its intention to exit its businesses in Europe resulting in classification of certain assets and liabilities as held for sale. Assets and liabilities of $3.2 billion and $2.3 billion, respectively, at June 30, 2022, and $4.5 billion and $4.7 billion, respectively, at March 31, 2022, met the criteria for classification as held for sale, primarily consisting of disposal groups related to the Company&#x2019;s European divestiture activities discussed below. The decrease in assets and liabilities held for sale during the first quarter of fiscal 2023 was primarily due to the divestiture of the Company&#x2019;s U.K. disposal group in April 2022, as discussed in more detail below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;European Divestiture Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#x201c;E.U.&#x201d;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#x201c;E.U. disposal group&#x201d;) to the PHOENIX Group for a purchase price of &#x20ac;1.2 billion (or, approximately $1.3 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;) at the transaction closing date. The transaction is anticipated to close within the second half of fiscal 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. As of June 30, 2022 and March 31, 2022, the E.U. disposal group within the Company&#x2019;s International segment, was classified as &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale,&#x201d; respectively, in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2022, the Company recorded a gain of $12&#160;million to remeasure the E.U. disposal group to fair value less costs to sell. This amount was recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statement of Operations. The Company&#x2019;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges in fiscal 2022 related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#x201c;U.K. disposal group&#x201d;) to Aurelius Elephant Limited for a purchase price of &#xa3;110&#160;million (or, approximately $144&#160;million), including certain adjustments. As part of the transaction, the Company divested net assets of $615&#160;million and released $731&#160;million of accumulated other comprehensive loss, within the International segment, and the buyer assumed and repaid a note payable to the Company of approximately $118&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the completion of the transaction on April 6, 2022, there were no assets or liabilities of the U.K. disposal group classified as held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet. The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i184217f9158a415e9fe088348387b9e9_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1NTUwOA_36dca706-15b1-4bf4-93d1-7c281768cf8b"
      unitRef="usd">3200000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i184217f9158a415e9fe088348387b9e9_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1NTUxOA_e94fedeb-f23e-459f-a026-cdc39c9f1170"
      unitRef="usd">2300000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="icd5d065ca8604d0bbd24e8e67b95eb01_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1NTU3OQ_db143ce2-585b-42f2-b0d3-bf76dd46fe95"
      unitRef="usd">4500000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="icd5d065ca8604d0bbd24e8e67b95eb01_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1NTU4Nw_4f627ac8-c701-4d23-b945-6e9a35d3b5e8"
      unitRef="usd">4700000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <mck:HeldForSalePolicyTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNzE1Mg_9fa05918-a097-406a-9a76-627c8a2b98cc">Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.</mck:HeldForSalePolicyTextBlock>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i5150b5ddba2945abbc839f1edd5fea5f_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMjY4OA_a1c5cfc0-4e7b-4de8-af8d-80f86fb3ff13"
      unitRef="eur">1200000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i5150b5ddba2945abbc839f1edd5fea5f_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMjcxMA_43de0cb7-63af-44be-8f67-5bc18b9bc1f0"
      unitRef="usd">1300000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i8c16ef6d38344729a8077cc7cfbddb3e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ0OTcwOQ_47608615-5667-49ab-a98f-e54cc415a063"
      unitRef="usd">-12000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNzE1MA_664bb01c-7f7b-41df-8377-7ffa079e5e34">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges in fiscal 2022 related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMy0xLTEtMS0xNDgzNjg_858f651f-998e-4933-aaae-bab2ee18364d"
      unitRef="usd">1277000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMy0xLTEtMS0xNDA1MjM_d56ead55-b4fc-432f-aa25-4864da2aaca5"
      unitRef="usd">1322000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNC0xLTEtMS0xNDgzNjg_bdd923d8-08f3-4669-b951-21a3eeeacaf7"
      unitRef="usd">819000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNC0xLTEtMS0xNDA1MjM_ebec8c7b-2847-4fac-a0a7-29b08a1bacfc"
      unitRef="usd">809000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNS0xLTEtMS0xNDgzNjg_e550fcab-f7b2-4195-8298-70320c60d76e"
      unitRef="usd">92000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNS0xLTEtMS0xNDA1MjM_4b562db9-9677-4525-a0e4-399a7b15d51f"
      unitRef="usd">72000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNi0xLTEtMS0xNDgzNjg_25419df7-f463-496b-8c0b-5029f071fc79"
      unitRef="usd">291000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNi0xLTEtMS0xNDA1MjM_9c9285c6-746c-4a11-b6d3-cae433941dcf"
      unitRef="usd">304000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNy0xLTEtMS0xNDgzNjg_8563e113-cb1f-4451-8c3e-c4c196ec3527"
      unitRef="usd">217000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfNy0xLTEtMS0xNDA1MjM_898b43a7-5818-4d94-86c3-78567a63a86c"
      unitRef="usd">224000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfOC0xLTEtMS0xNDgzNjg_1bd4d292-47cb-4a96-a383-319ca5ffd5b0"
      unitRef="usd">253000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfOC0xLTEtMS0xNDA1MjM_ac746ea9-4132-4dec-9083-17a747c53253"
      unitRef="usd">267000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfOS0xLTEtMS0xNDgzNjg_0e18e0f4-3232-4204-9dcd-18651b22920b"
      unitRef="usd">312000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfOS0xLTEtMS0xNDA1MjM_32a38a2a-4242-44be-a7d4-b66c6b676c08"
      unitRef="usd">328000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTAtMS0xLTEtMTQ4MzY4_7e1ddeeb-fb11-4da1-8785-fd9bea1473ee"
      unitRef="usd">279000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTAtMS0xLTEtMTQwNTIz_af5a5c3e-d26f-4b7d-867f-0d10c6018026"
      unitRef="usd">302000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTEtMS0xLTEtMTQ4MzY4_90fae5ee-ec2a-481e-a851-7e58b1ec6058"
      unitRef="usd">2982000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTEtMS0xLTEtMTQwNTIz_6f0b3286-4bac-4675-9184-61d7667db5a3"
      unitRef="usd">3024000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTUtMS0xLTEtMTQ4Mzg3_9f18c076-5628-4a8a-a8c0-f1638c26596d"
      unitRef="usd">1406000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTUtMS0xLTEtMTQwNTIz_b1272146-14a1-4943-9629-6abf1f4f7780"
      unitRef="usd">1826000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTYtMS0xLTEtMTQ4Mzg3_0e8de5b3-e556-4e63-84c6-09eb9d1539e4"
      unitRef="usd">4000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTYtMS0xLTEtMTQwNTIz_dcff6364-1e9f-43cd-90c4-f922412d5180"
      unitRef="usd">4000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTctMS0xLTEtMTQ4Mzg3_123f9dc7-60a2-4347-bfc3-885e21b284db"
      unitRef="usd">30000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTctMS0xLTEtMTQwNTIz_593e63b1-dfbe-4a4c-9531-45e44faade29"
      unitRef="usd">33000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTgtMS0xLTEtMTQ4Mzg3_ad8f9427-8b88-4bb4-a30c-2e963527973c"
      unitRef="usd">403000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTgtMS0xLTEtMTQwNTIz_ab8c4bfd-8d80-4cb3-9986-0be3f7895b42"
      unitRef="usd">473000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTktMS0xLTEtMTQ4Mzg3_bda18a9f-97fe-4c99-b65e-33e1a260f811"
      unitRef="usd">11000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMTktMS0xLTEtMTQwNTIz_2be4d7aa-e105-491c-b9fa-ec18568e1149"
      unitRef="usd">11000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjAtMS0xLTEtMTQ4Mzg3_af08de43-5ab5-49fc-812b-cb531ea4a2d4"
      unitRef="usd">60000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjAtMS0xLTEtMTQwNTIz_20a6fd86-1788-4237-b7a7-3645bc3c057d"
      unitRef="usd">55000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjEtMS0xLTEtMTQ4Mzg3_e3d29a9d-62b8-4f9b-a7c3-e01ad31d72a5"
      unitRef="usd">168000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjEtMS0xLTEtMTQwNTIz_82f31399-c1a7-4637-b5f1-dee218723692"
      unitRef="usd">180000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjItMS0xLTEtMTQ4Mzg3_0c4e80cc-defa-4666-8a54-72ff96d9acd3"
      unitRef="usd">122000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjItMS0xLTEtMTQwNTIz_4f6457b0-e5c4-4ea5-916b-3758b23b0d5c"
      unitRef="usd">138000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ie89d0240cac14cacaec39c08ee9b4a63_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjMtMS0xLTEtMTQ4Mzg3_f045371c-019d-460f-915c-07b2a8bcd14f"
      unitRef="usd">2204000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i5403be05c92b4345b8c30e84ad1ccc67_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOmE5NjUxNWM0Y2E3ZjQ5MDZiMWY5YWRiMDBjZjMyYjkzL3RhYmxlcmFuZ2U6YTk2NTE1YzRjYTdmNDkwNmIxZjlhZGIwMGNmMzJiOTNfMjMtMS0xLTEtMTQwNTIz_0d9b6482-9ba8-49b0-b436-14d6985b0f0a"
      unitRef="usd">2720000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware
      contextRef="i24d358bf2d514516969073c17eb16cab_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNDcwNg_eec5a67d-78e8-4ad4-8fc2-872ccfdf90fe"
      unitRef="usd">113000000</mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i966d0672f94e47d48297a66c14bc69ae_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNTAyMQ_d82900c8-3c79-420f-b2d3-479be5efe57c"
      unitRef="gbp">110000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i966d0672f94e47d48297a66c14bc69ae_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfNTA0Mw_366f504c-7527-4ee7-b52f-c9ab30906499"
      unitRef="usd">144000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i393f7b257bbf4a2fb7a4b7d3c3e8cc5b_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1MjE1Mw_efe20072-42ac-4650-83d9-d0041162faf9"
      unitRef="usd">615000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i3cd413ff00624a0d8270f7ea278d9a55_D20220406-20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1ODUxNA_cfa279f1-ad93-45eb-adc8-e2161ca26246"
      unitRef="usd">731000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i372251adcd1648eab091c52b5f01446e_D20220406-20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RleHRyZWdpb246ZTg4NjY0MTIxYjU0NGQ4MGFiMjJmZWQ4ZWQ4NTE3OTNfMTY0OTI2NzQ1MjE2OQ_fd353c07-70c2-4e08-9517-f23bc51a2926"
      unitRef="usd">118000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMy0xLTEtMS0xNDA1MjM_6d464d66-82e4-4615-90b5-c8ee1fd8d197"
      unitRef="usd">531000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfNC0xLTEtMS0xNDA1MjM_88f4ba5e-f276-4e53-949a-726dcb18dbe7"
      unitRef="usd">931000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfNS0xLTEtMS0xNDA1MjM_33116be0-f26d-4517-b7d0-ad46d2b5634d"
      unitRef="usd">563000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfNi0xLTEtMS0xNDA1MjM_1715ed1e-85b4-47c7-8ef0-83e1ec7b6bbb"
      unitRef="usd">50000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfNy0xLTEtMS0xNDA1MjM_85f1b985-a7d9-410d-b4ca-381e26a4b22a"
      unitRef="usd">91000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfOC0xLTEtMS0xNDA1MjM_84cedb84-5892-4d30-a37a-e7b06a0d3f83"
      unitRef="usd">270000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfOS0xLTEtMS0xNDA1MjM_a8b9952a-6a10-4462-bcce-3857e97bda09"
      unitRef="usd">117000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTAtMS0xLTEtMTQwNTIz_4e9153d2-ba76-4956-9cb7-c8abc413768c"
      unitRef="usd">88000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTEtMS0xLTEtMTQwNTIz_4ebbd378-91a7-4015-b684-2c3e882eeac9"
      unitRef="usd">1159000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTItMS0xLTEtMTQwNTIz_266804a7-722e-480b-a9e5-84d92611a227"
      unitRef="usd">1482000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTYtMS0xLTEtMTQwNTIz_292dad69-aa9f-4142-ae0f-5015c537bef8"
      unitRef="usd">1593000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTgtMS0xLTEtMTQwNTIz_33c99ea3-5449-4b28-9597-f6b4898550e9"
      unitRef="usd">50000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMTktMS0xLTEtMTQwNTIz_78cc86ea-4837-4330-88c7-d6db198efe30"
      unitRef="usd">59000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMjEtMS0xLTEtMTQwNTIz_9bb07f3b-7930-48cd-a043-ac57b1a1b1af"
      unitRef="usd">16000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMjItMS0xLTEtMTQwNTIz_d202a9e8-c563-47ef-977c-357a2808e00d"
      unitRef="usd">262000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMjMtMS0xLTEtMTQwNTIz_aad1a5ee-c33f-4dc8-91e9-98607dc10f71"
      unitRef="usd">38000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1cc8fba8571641aeaca7afef9370cf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF8zNy9mcmFnOmU4ODY2NDEyMWI1NDRkODBhYjIyZmVkOGVkODUxNzkzL3RhYmxlOjRlNTYyNDk0ZGYxNzQ3N2ZhOGIzOGE5MTc4MTE0Mzg3L3RhYmxlcmFuZ2U6NGU1NjI0OTRkZjE3NDc3ZmE4YjM4YTkxNzgxMTQzODdfMjQtMS0xLTEtMTQwNTIz_eaa389c9-be49-4664-8f5d-6c3b83f69ee2"
      unitRef="usd">2018000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNTY0Mw_b8280c52-5601-48fb-b4de-52f21abbc99e">Restructuring, Impairment, and Related Charges, Net&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded restructuring, impairment, and related charges, net of $23 million and $158 million for the three months ended June 30, 2022 and 2021, respectively. These charges were included in &#x201c;Restructuring, impairment, and related charges, net&#x201d; in the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#x2019;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $95 million for the three months ended June 30, 2021 primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 and remaining costs the Company expects to record under this initiative are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net, for the three months ended June 30, 2022 and 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above and U.K. operating model and cost optimization efforts, as well as costs for optimization programs in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the liabilities associated with the Company&#x2019;s restructuring initiatives for the three months ended June 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $36 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $36 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of June 30, 2022, the total reserve balance was $116 million, of which $62 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $26 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $28 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfODM_a2f000a7-7f9e-4746-a441-f5154a191099"
      unitRef="usd">23000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfMTI2_27e8ef37-ef46-49c6-b5e4-4d9785aa7c06"
      unitRef="usd">158000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringCharges
      contextRef="i8810900c5c324fd89fbada461816423d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNjU5NzA2OTc3Mzk0Mw_dc8f1787-39a8-43f9-a3b2-d4c94f9866c8"
      unitRef="usd">95000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNTY0NQ_2e1341be-9cf9-42f0-abab-88cad522277c">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net, for the three months ended June 30, 2022 and 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above and U.K. operating model and cost optimization efforts, as well as costs for optimization programs in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi0xLTEtMS0xNDA1MjM_db62a0a4-255f-4500-bcc0-03575688af25"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi0zLTEtMS0xNDA1MjM_7bb8e5dd-1ec9-4222-962b-76c1b0867eeb"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi01LTEtMS0xNDA1MjM_0096a234-3e48-45f0-b757-576693a4ab05"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi03LTEtMS0xNDA1MjM_efa4528c-560d-4673-98c6-5a92dcd97b63"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi05LTEtMS0xNDA1MjM_95a5ec05-5ea9-499f-bd19-64f714c3240e"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMi0xMS0xLTEtMTQwNTIz_9e414d92-fe10-4b73-8c36-7a4d5849942a"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy0xLTEtMS0xNDA1MjM_962d02ea-ada3-4c12-a16c-c4349b5e7b59"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy0zLTEtMS0xNDA1MjM_6ebd489c-976a-4b5c-b0e9-c3c1ee60e110"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy01LTEtMS0xNDA1MjM_fab2b9c3-bedb-4d50-8ebd-5a695d911c00"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy03LTEtMS0xNDA1MjM_265ea13e-58ed-439b-8447-6784efe93382"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy05LTEtMS0xNDA1MjM_5b4814d4-eca4-4821-86c9-7c1cc3cd9cc1"
      unitRef="usd">15000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfMy0xMS0xLTEtMTQwNTIz_9167a9b7-f58a-42cc-86ca-b1100d041923"
      unitRef="usd">21000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC0xLTEtMS0xNDA1MjM_6524ba35-c5f5-4c9f-83ac-5256c6a4f2d7"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC0zLTEtMS0xNDA1MjM_bf5e1660-441e-4e27-8bbd-0201a878baf1"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC01LTEtMS0xNDA1MjM_207b28bb-ae07-4f6b-ad6e-0679a3d1d1a7"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC03LTEtMS0xNDA1MjM_73b22a84-c406-4bfc-a637-2f9df20a56c0"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC05LTEtMS0xNDA1MjM_cebeb0f0-0fe1-46e0-b24f-1864ac033147"
      unitRef="usd">-5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNC0xMS0xLTEtMTQwNTIz_d4ba5136-3dab-4bef-83bd-fc82238cb7bf"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS0xLTEtMS0xNDA1MjM_7ea29a07-0a81-4b20-8db6-596d265d9650"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS0zLTEtMS0xNDA1MjM_38f425d6-16a4-40a4-a157-40d632a9db8b"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS01LTEtMS0xNDA1MjM_5240a7e9-68e7-4459-ab10-713587e71ec2"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS03LTEtMS0xNDA1MjM_5b4708a5-354e-47e5-b2c2-a41a47b1163f"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS05LTEtMS0xNDA1MjM_486734ac-98e8-4300-908e-1dde5ce0ca4f"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjBhMmJkZGRkOThjMDQwOGVhYjIyYjk2NTExMzcwMmEyL3RhYmxlcmFuZ2U6MGEyYmRkZGQ5OGMwNDA4ZWFiMjJiOTY1MTEzNzAyYTJfNS0xMS0xLTEtMTQwNTIz_f8fd530f-e58f-4ee8-a528-e7d5d3338119"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi0xLTEtMS0xNDA1MjM_7d5d4ef1-c23b-44fa-a8f3-44dd0a13df71"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi0zLTEtMS0xNDA1MjM_c93902eb-31fb-4091-a7f2-1ef8d39a848b"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi01LTEtMS0xNDA1MjM_e84bc8d4-cfa5-46b5-9aa4-f3ccc920f96a"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi03LTEtMS0xNDA1MjM_e5341080-5f7b-4673-872d-b8dd3aa0f206"
      unitRef="usd">12000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi05LTEtMS0xNDA1MjM_1503828a-50ba-4850-afd4-56b6e4d52adb"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMi0xMS0xLTEtMTQwNTIz_5bc4d324-64d1-4b74-b6d1-401e0aea9301"
      unitRef="usd">14000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy0xLTEtMS0xNDA1MjM_fce97ff3-4e5d-472e-9c93-f4a01d30ec40"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy0zLTEtMS0xNDA1MjM_eb47368b-a747-4053-a3bb-6062a6edf038"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy01LTEtMS0xNDA1MjM_c91fdd7c-0158-429d-9a67-ad0004e8e536"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy03LTEtMS0xNDA1MjM_7cfc0654-6e35-47a4-b36a-e0f5397dc2b1"
      unitRef="usd">14000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy05LTEtMS0xNDA1MjM_9f8d8aad-d03d-4ee0-985a-f63595e0ffc9"
      unitRef="usd">21000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfMy0xMS0xLTEtMTQwNTIz_34e5c2cc-90f7-4fb6-a451-3c457763f7a1"
      unitRef="usd">40000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC0xLTEtMS0xNDA1MjM_54554fe5-d1c2-4ca6-97ef-88e961780c99"
      unitRef="usd">8000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC0zLTEtMS0xNDA1MjM_31f3eb68-1e10-4e72-b841-4aa16ed0a7ec"
      unitRef="usd">17000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC01LTEtMS0xNDA1MjM_fa7cb7a4-f514-47a4-be39-0cb13eb42c02"
      unitRef="usd">4000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC03LTEtMS0xNDA1MjM_db1f10aa-032d-4c6b-8c6a-892e510934e8"
      unitRef="usd">34000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC05LTEtMS0xNDA1MjM_5b6d1d6a-f199-4ae3-ab13-16f8f14157b3"
      unitRef="usd">41000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNC0xMS0xLTEtMTQwNTIz_1dd2ad20-af11-4d59-8530-ac28958564b0"
      unitRef="usd">104000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS0xLTEtMS0xNDA1MjM_26290a51-d171-43d9-b408-e9a965f573b3"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS0zLTEtMS0xNDA1MjM_668f2ca0-7f84-483f-ba57-55fb294aa16d"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS01LTEtMS0xNDA1MjM_99d493ce-2abd-4aed-a441-a7f53ad93705"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS03LTEtMS0xNDA1MjM_08ea0e11-6a26-4eb9-9228-a504b1efe51a"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS05LTEtMS0xNDA1MjM_bbdc54e6-ca76-4d0e-8df0-feae4c52c490"
      unitRef="usd">62000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOjkzOTY3ODM1NTYyNjQ2YTZiNTk5N2U2ZGMxZWFmYzQ2L3RhYmxlcmFuZ2U6OTM5Njc4MzU1NjI2NDZhNmI1OTk3ZTZkYzFlYWZjNDZfNS0xMS0xLTEtMTQwNTIz_8f371c8b-d9d2-48cd-b061-2b83e77363e1"
      unitRef="usd">158000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNTYzNQ_cf1e50e8-be2e-4ab0-ad72-d1e3df569376">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the liabilities associated with the Company&#x2019;s restructuring initiatives for the three months ended June 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $36 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $36 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of June 30, 2022, the total reserve balance was $116 million, of which $62 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $26 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $28 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i4bd299c03b254bf08ef56a66adc41c05_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS0xLTEtMS0xNDA1MjM_bd41398e-233b-4fa9-9745-3060b2764df0"
      unitRef="usd">11000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i160ffe77823e4333a979c33b283947f8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS0zLTEtMS0xNDA1MjM_9f86f2d1-6ba6-47db-8407-21ef8d6ba27b"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i18e67fe7460b4e2ea12fbbd5167e3238_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS01LTEtMS0xNDA1MjM_5b02612a-9ad4-4d51-9081-0a851294b87b"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i41993913d47d47799af347f96dffc5fa_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS03LTEtMS0xNDA1MjM_d3a7dc48-47f8-443a-9b06-113a1259f966"
      unitRef="usd">56000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6ca90c76b5f8423db112b3afece54ca7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS05LTEtMS0xNDA1MjM_b3129de3-55ed-4b13-be73-7289fb641c5a"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMS0xMS0xLTEtMTQwNTIz_f3e8249c-d6f8-49a1-9948-03c3e3fbe213"
      unitRef="usd">130000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi0xLTEtMS0xNDA1MjM_b3943928-bffe-483b-8370-45aa0eb6882c"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi0zLTEtMS0xNDA1MjM_b687cfa9-eb06-440e-a9d9-eea5ebfcee07"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi01LTEtMS0xNDA1MjM_9b199791-69e2-4b08-aad1-1f472a2a68ee"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi03LTEtMS0xNDA1MjM_49c0fe5f-21d1-452c-a908-796df4a568b7"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi05LTEtMS0xNDA1MjM_fdcbfa4b-a256-42c2-a028-690b62d16d9c"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMi0xMS0xLTEtMTQwNTIz_6a9982ce-87e4-43f2-a642-1db4e64d0db5"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy0xLTEtMS0xNDA1MjM_f6ebdaac-6f52-4d30-8b5e-52da5ec65a53"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy0zLTEtMS0xNDA1MjM_005248d1-4f72-48a0-bd72-476cd747c8d2"
      unitRef="usd">5000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy01LTEtMS0xNDA1MjM_11cd5ffa-6e7d-45fa-a7c3-f14cbf7404fb"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy03LTEtMS0xNDA1MjM_37006f3f-8c6b-481b-a9d2-5654d9985e40"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy05LTEtMS0xNDA1MjM_57a76983-7b7b-432d-8cfa-2b2474b946e3"
      unitRef="usd">-5000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfMy0xMS0xLTEtMTQwNTIz_47341491-d493-4779-b1b5-6271e33f1c85"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC0xLTEtMS0xNDA1MjM_da2060b7-9992-4a61-aae5-5b8a324dde96"
      unitRef="usd">2000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC0zLTEtMS0xNDA1MjM_e255be03-7115-432e-9908-6e633c5397d3"
      unitRef="usd">2000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC01LTEtMS0xNDA1MjM_8c1544ac-cdef-40ee-a391-6a92cda4cbe5"
      unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC03LTEtMS0xNDA1MjM_b21b493d-91c4-4d1c-b4db-86288901cade"
      unitRef="usd">2000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC05LTEtMS0xNDA1MjM_6ce506f8-af0e-4e5a-84da-e703f01cd7bb"
      unitRef="usd">15000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNC0xMS0xLTEtMTQwNTIz_3b970fd1-1420-47ce-8f3e-0878e6cc5dff"
      unitRef="usd">22000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS0xLTEtMS0xNDA1MjM_facd753c-1cb9-408c-b487-c127c5c42e04"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS0zLTEtMS0xNDA1MjM_19e70442-c016-4ef1-886d-d08f0090d76d"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS01LTEtMS0xNDA1MjM_4948581d-3856-438e-96fc-ff2449dee728"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS03LTEtMS0xNDA1MjM_ea337a3e-8aaf-49c2-84ef-25681e65e3e1"
      unitRef="usd">-15000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i7dea15dda7394600a73a933d1d3b3612_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS05LTEtMS0xNDA1MjM_05207564-1460-4ab3-98ed-37cd18862f65"
      unitRef="usd">1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNS0xMS0xLTEtMTQwNTIz_6e216f2a-8611-42d9-87a7-9c0aec974732"
      unitRef="usd">-15000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i6171834fcd894e66b9bdf8b9a377ecff_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi0xLTEtMS0xNDA1MjM_9b3454a0-6e53-4eb7-bd64-832841b85d8f"
      unitRef="usd">12000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iaf9d9c26183c4805bf511847202547f9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi0zLTEtMS0xNDA1MjM_abf8d8fc-1f85-4da3-b19f-e879b9ce0c72"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9c025968801c4a25945836d01ed6ac95_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi01LTEtMS0xNDA1MjM_94173133-f191-48f9-b588-4fb644235e7d"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i08861b972b284eedaa85076ea9b4829f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi03LTEtMS0xNDA1MjM_49793198-4c06-4511-8818-87d416056291"
      unitRef="usd">41000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if4d963bead34459498d2d03f537cf122_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi05LTEtMS0xNDA1MjM_aa792b20-c4fb-4578-8e5e-1ccdc7fdf4ad"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RhYmxlOmZlNGE3ZGY0MWM4YjRjZTZhMTA2NTZmNTI4NzgxMDQ1L3RhYmxlcmFuZ2U6ZmU0YTdkZjQxYzhiNGNlNmExMDY1NmY1Mjg3ODEwNDVfNi0xMS0xLTEtMTQwNTIz_fbb794cc-b678-4d71-9d6e-3e35bb695f16"
      unitRef="usd">116000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDQ4Mw_eb67454e-6091-4f70-b3ff-348c500997e9"
      unitRef="usd">130000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i88d93fed8d3a43138335a08e977df9ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDQ5Ng_3ea9c089-d000-435f-9621-216132212232"
      unitRef="usd">58000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6d022b083bbc45939920f85e12d37954_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNjU5NzA2OTc3NzEzMg_02ad3755-9193-4de1-9a05-b7167c84e3d9"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i216779d361ff48b8b7d99ea6028d66c7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDUyNA_d548c96c-f4ea-4647-8cc9-e1013b9176d7"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDYzNA_d953eec1-193c-4e41-9363-cad000f4e013"
      unitRef="usd">116000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib92e13fab3344b80882529369055d140_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDY0Nw_1532ac37-d2fd-4417-a9b8-485f86eb5f7d"
      unitRef="usd">62000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if81042ef89a44749b328252179e501f0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDY3Mg_407cf9c6-de97-4775-9656-ae630eef27a6"
      unitRef="usd">26000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6e446b32652445c78cd737bf63c505d0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80MC9mcmFnOmY2NGU5ZmYyODRiMTQzMzI5NDk1MjBkM2QwNGY5MDdiL3RleHRyZWdpb246ZjY0ZTlmZjI4NGIxNDMzMjk0OTUyMGQzZDA0ZjkwN2JfNDcwMQ_cd332634-e45b-45b3-9b0d-5b2a0abb2958"
      unitRef="usd">28000000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfNDAwOA_2527b60f-eaef-4258-ba57-73a3fa328508">Income Taxes &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2022 and 2021, the Company recorded income tax expense of $199 million and $26 million, respectively. The Company&#x2019;s reported income tax expense rate was 19.8% and 4.6% for the three months ended June 30, 2022 and 2021, respectively. Fluctuations in the Company&#x2019;s reported income tax rates are primarily due to discrete benefits recognized in the quarter. During the three months ended June 30, 2022, the Company recognized a net discrete tax benefit of $45 million primarily related to the tax impact of share-based compensation. During the three months ended June 30, 2021, the Company recognized a net discrete tax benefit of $97&#160;million primarily related to statute of limitation expirations in various taxing jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022, the Company had $1.5 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that our unrecognized tax benefits may decrease by as much as $150&#160;million to $190&#160;million due to settlements of tax examinations and statute of limitation expirations based on the information currently available. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year or statute of limitations expire, and if the ultimate resolution of unrecognized tax benefits differs from this estimated range, the Company will record any additional income tax expense or benefit as necessary in the appropriate period. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#x201c;IRS&#x201d;) is currently examining the Company&#x2019;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfOTc_5c975a2f-08c1-450b-a6d3-1cf4ed198731"
      unitRef="usd">199000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMTI5_495f9138-450a-486c-aa78-48b540f91bf4"
      unitRef="usd">26000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMzI5_6d3fbb24-e972-4877-a026-4ffa141ad857"
      unitRef="number">0.198</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMzY2_fd519098-5460-4085-a545-b92050b5ce25"
      unitRef="number">0.046</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfNjU5NzA2OTc3NDU5OA_9a2c27d7-4b64-4a20-853c-dfae158a3748"
      unitRef="usd">-45000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfNjU5NzA2OTc3NTQ3NQ_ed2e6f5e-6b6d-498c-bcda-89a7ed1bb6ac"
      unitRef="usd">97000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMjg3Mw_bb343733-7c9f-4178-94b5-b90527ced1a2"
      unitRef="usd">1500000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMjkxNQ_19bfacbd-2c64-4836-84ac-f2182a1fce8b"
      unitRef="usd">1300000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="icb71f08be1794969b42bcb9fbb8584e9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfMTY0OTI2NzQ1MDk0OQ_a0f4e714-c20d-4ba2-9ed6-2d0a9b5223c2"
      unitRef="usd">150000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i555ad7eb9be24508ab277351083f8b95_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80My9mcmFnOjAzZjkwYzVmOTM3NDQ2YWQ4ZmQyZDUxM2NmZjFlYzI4L3RleHRyZWdpb246MDNmOTBjNWY5Mzc0NDZhZDhmZDJkNTEzY2ZmMWVjMjhfNjU5NzA2OTc3NDQ4Ng_3a8616b0-82e9-4cc4-b55f-0e85477a216b"
      unitRef="usd">190000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfNDYwNQ_cac161fb-d30f-4908-b928-58083b53aac4">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s previously recognized redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million during the three months ended June 30, 2021. This amount was recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Condensed Consolidated Statement of Operations and the corresponding liability balance was recorded in &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). During the three months ended June 30, 2021, the Company paid $1.0&#160;billion to purchase 34.5&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $983 million for the three months ended June 30, 2021, and the Company recorded the associated effect of the increase in the Company&#x2019;s ownership interest of $178 million as an increase to McKesson stockholders&#x2019; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#x201c;Redeemable noncontrolling interests&#x201d; to &#x201c;Noncontrolling interests&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. The Company&#x2019;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#x201c;Held for Sale.&#x201d; The Company allocated $41 million and $39 million of net income to noncontrolling interests during the during the three months ended June 30, 2022 and 2021, respectively, which was recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in noncontrolling interests for the three months ended June 30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i71f3011cbd3947f88570706f2746d1cd_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMzg4_93b1ea95-94a0-4f2e-b814-188be186ac17"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i97348d9c0c3c492caee0d7de4e918481_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfNTI3_be0e7a42-bd04-4ee5-b1cf-7adf1393cd4b"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i62f4dfc0153d46679ff78f542f7e14de_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfOTgx_9510bf7e-b717-420c-b1b9-6a24ab34bb3b"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="i62f4dfc0153d46679ff78f542f7e14de_I20141231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTA0NA_adf24d71-b8c7-4c12-8fa9-c4124a93e25a"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i97348d9c0c3c492caee0d7de4e918481_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMjM2Mg_de0da708-ca6e-4c35-8dab-4e7f59fb43b3"
      unitRef="usd">1000000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="i97348d9c0c3c492caee0d7de4e918481_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMjM5OQ_46e00ad8-c89c-4f15-9b28-4f4f65b0d112"
      unitRef="shares">34500000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMjU5MA_9fc8812a-e288-4cab-b6ce-edbe56da1265"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ie9f164b3366e42c38258b9d42d824ed1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTY0OTI2NzQ0NzY1OQ_34167755-113e-4158-b5d7-702debeb61bb"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTY0OTI2NzQ0NzY2Ng_361a5373-6ec0-4ac1-9bc5-64ccb40f434e"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i17aa11bc6b1c4164b6719d0eae227c3b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTY0OTI2NzQ0NzU0NQ_92d05628-6f8a-4ab7-bd00-270bd746a1e4"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i83027e4dbfea4e06a441bc5aa8dc605f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfMTY0OTI2NzQ0NzUxOA_acf6cd67-9e0d-4bf1-959b-44f84f31fe73"
      unitRef="usd">39000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RleHRyZWdpb246MjhmODEwOTk2OTllNDU0NmEwMWU3YzlkNGQ3ZDYzMWRfNDYwOA_b029e867-70d0-40ea-a1be-9a69796d8770">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in noncontrolling interests for the three months ended June 30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="i8f0afdd8a78b4984a7c33d73ebec78e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfMS0xLTEtMS0xNDA1MjM_619046c3-08f7-485e-bf87-f0ab3bd2bb00"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfMi0xLTEtMS0xNDA1MjM_baee3cf4-b822-43bf-bcb9-053b87d821f7"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfMy0xLTEtMS0xNDA1MjM_89a875a6-c20b-4755-b431-15ada152b42b"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfNC0xLTEtMS0xNDA1MjM_12dd8c7b-52c5-4be8-9adb-53b733499621"
      unitRef="usd">2000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfNS0xLTEtMS0xNDA1MjM_d449f582-7f3e-4bfa-8f76-aec67f779681"
      unitRef="usd">36000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="idf20fec7c00f40ce9144c761f3412edb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfOC0xLTEtMS0xNDA1MjM_5e7c01c1-8328-407f-ad41-311eff514725"
      unitRef="usd">-1000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i5026063ddbbd426490dc361b9a57ba33_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjQ1ZmNjNjA5NWFjZDQ2Njg4ZGE4YmE2MWJlNjc0ZWRkL3RhYmxlcmFuZ2U6NDVmY2M2MDk1YWNkNDY2ODhkYThiYTYxYmU2NzRlZGRfOS0xLTEtMS0xNDA1MjM_d5c156bc-47b5-437a-baeb-6f58b2dae711"
      unitRef="usd">532000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i31619d5dfb2942f181793348c62fa60a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMS0yLTEtMS0xNDA1MjM_7fca2c12-0729-4162-9186-0df0818409f7"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="iffeb32001f68497d8267ddc9ae2c0968_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMS00LTEtMS0xNDA1MjM_bf5a1e70-8e0f-4e88-b755-29d7e56bfe5a"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMi0yLTEtMS0xNDA1MjM_be78f9af-68d0-4e05-836b-b2498d07c7e6"
      unitRef="usd">39000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMi00LTEtMS0xNDA1MjM_4074dd1d-f8a7-461d-b758-1a57ef2c912b"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMy0yLTEtMS0xNDA1MjM_6d397555-4949-4a68-86f2-2fd4350959a4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfMy00LTEtMS0xNDA1MjM_d29235ff-e65e-4ee3-8b01-da894cfbaf41"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNC0yLTEtMS0xNDA1MjM_386f0f0b-16bb-4e97-8adc-432c32a43050"
      unitRef="usd">0</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNC00LTEtMS0xNDA1MjM_1b7d8a5f-d793-4969-8e34-e335f6dc8343"
      unitRef="usd">8000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNS0yLTEtMS0xNDA1MjM_bb1779b1-8035-415e-b739-81c7e58e8a9d"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNS00LTEtMS0xNDA1MjM_0d38c7b8-e103-4729-9379-9848f3e0eae2"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNi0yLTEtMS0xNDA1MjM_b8f65b13-05f2-4779-94d8-651e33b20713"
      unitRef="usd">0</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNi00LTEtMS0xNDA1MjM_9fc8812a-e288-4cab-b6ce-edbe56da1265"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNy0yLTEtMS0xNTQ3Mjc_361a5373-6ec0-4ac1-9bc5-64ccb40f434e"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNy00LTEtMS0xNTQ3MzY_6c389b3c-ce19-4f2e-ad2c-0ee1e9d83fdc"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i943ab72fcf1e488daa35869380273a79_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNy0yLTEtMS0xNDA1MjM_70a47b80-a870-41bb-bb0b-ba943ed04894"
      unitRef="usd">1000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i96929b460c0f46c296665dc3fe8988a6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfNy00LTEtMS0xNDA1MjM_389c7673-59bb-45c6-8221-280312d11a40"
      unitRef="usd">3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i97688416d8624c10a48f226d71563b9e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfOC0yLTEtMS0xNDA1MjM_440c1839-1e05-4caf-91d6-457c70dadb88"
      unitRef="usd">484000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i64e32cd74f0c4010a3e8e787177c3aaa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80Ni9mcmFnOjI4ZjgxMDk5Njk5ZTQ1NDZhMDFlN2M5ZDRkN2Q2MzFkL3RhYmxlOjVhNGQ2ZDllMzZjNDQ0MmM4YTYzOTY2NTcwZDhmNzAxL3RhYmxlcmFuZ2U6NWE0ZDZkOWUzNmM0NDQyYzhhNjM5NjY1NzBkOGY3MDFfOC00LTEtMS0xNDA1MjM_96467a25-f964-47d8-a498-2de6627b38a7"
      unitRef="usd">7000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RleHRyZWdpb246NjVmOTk4YzU0ZjJlNDA4ZWJmYmFjYzNjZmU0N2ZlNGNfMTI3Mg_5d657c45-bd2d-4315-9484-16530de84450">Earnings (Loss) Per Common ShareBasic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Fewer than 1 million potentially dilutive securities for each of the three months ended June 30, 2022 and 2021, respectively, were excluded from the computation of diluted earnings per common share as they were anti-dilutive.&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson Corporation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units and performance-based stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RleHRyZWdpb246NjVmOTk4YzU0ZjJlNDA4ZWJmYmFjYzNjZmU0N2ZlNGNfMTY0OTI2NzQ0MzAzMw_155444f4-875e-423f-ac99-ca8e0de64777"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RleHRyZWdpb246NjVmOTk4YzU0ZjJlNDA4ZWJmYmFjYzNjZmU0N2ZlNGNfMTI3NQ_1a10ed82-ca34-4eb5-8ba4-70f74a39bdb9">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson Corporation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units and performance-based stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMi0xLTEtMS0xNDA1MjM_312ff5ce-b34f-46da-a003-5c3bd299c2a4"
      unitRef="usd">807000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMi0zLTEtMS0xNDA1MjM_187972ae-8337-4eb6-8a2a-acd09acaf320"
      unitRef="usd">536000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMy0xLTEtMS0xNDA1MjM_3578a51e-a642-49d7-b323-26b1ba517fa3"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMy0zLTEtMS0xNDA1MjM_257686ba-b8dc-48c5-9e43-30f626173ced"
      unitRef="usd">47000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNC0xLTEtMS0xNDA1MjM_19869bdd-4bdc-4ac0-8f85-a3baf42fb75c"
      unitRef="usd">766000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNC0zLTEtMS0xNDA1MjM_7e404d90-8d60-4892-ba1b-fb45c16a5a4a"
      unitRef="usd">489000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNS0xLTEtMS0xNDA1MjM_591f0444-9854-4675-9a64-f565fcb4b3e7"
      unitRef="usd">2000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNS0zLTEtMS0xNDA1MjM_81cf4019-2ef8-40c6-b4ba-6d7bbf6a6cce"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNi0xLTEtMS0xNDA1MjM_e89d46e2-ef0b-42d2-beac-630fc303bf34"
      unitRef="usd">768000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfNi0zLTEtMS0xNDA1MjM_b2b76f2f-c4b1-46e7-9f2a-c531de8a318a"
      unitRef="usd">486000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfOS0xLTEtMS0xNDA1MjM_549a0e94-7eae-4337-b47b-f560b6a12207"
      unitRef="shares">144200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfOS0zLTEtMS0xNDA1MjM_8cb35a3b-e378-4eda-b7c1-7dc666e925db"
      unitRef="shares">156200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i82d9a039d97f4e1f810d8c8939c48515_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTEtMS0xLTEtMTQwNTIz_87868986-81e9-4a2f-af72-3f3e8c391dd4"
      unitRef="shares">300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3c9753fdbc8c42afa67a387dbdc341f2_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTEtMy0xLTEtMTQwNTIz_917747bc-a970-40cf-953d-ee54a9d3d125"
      unitRef="shares">100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iac0f191ee9524cc4a123dca1beca64b2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTItMS0xLTEtMTQwNTIz_cec84d04-9ce5-4dd7-960d-aaf95e98fef0"
      unitRef="shares">1400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if0d41c1016b54583a7525969593331c4_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTItMy0xLTEtMTQwNTIz_e8e3449c-eb64-40f0-a566-488f4642b6f1"
      unitRef="shares">1800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTMtMS0xLTEtMTQwNTIz_5d0044b9-b988-4f14-a92a-1777d6b6f4da"
      unitRef="shares">145900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTMtMy0xLTEtMTQwNTIz_f5fd5943-e0dc-43d2-a069-09aba5384f54"
      unitRef="shares">158100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTctMS0xLTEtMTQwNTIz_928190b2-49a3-4c3c-90ca-3081a8b5d1ba"
      unitRef="usdPerShare">5.25</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTctMy0xLTEtMTQwNTIz_8c3cde3c-e414-442d-a50e-01d947c2dca7"
      unitRef="usdPerShare">3.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTgtMS0xLTEtMTQwNTIz_f0e977a6-fdc7-4c2b-8d67-525eeac1860f"
      unitRef="usdPerShare">0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTgtMy0xLTEtMTQwNTIz_d11b337c-0ceb-4f0f-bcb4-cbb65d5166a4"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTktMS0xLTEtMTQwNTIz_5fb7939a-92db-4494-8b4e-541b248c2895"
      unitRef="usdPerShare">5.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMTktMy0xLTEtMTQwNTIz_682a72e9-cbcf-4c2f-bfea-d2ba2c1a175a"
      unitRef="usdPerShare">3.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjEtMS0xLTEtMTQwNTIz_36240e28-0668-4136-b2e0-f2584239a09d"
      unitRef="usdPerShare">5.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjEtMy0xLTEtMTQwNTIz_ad38c9fb-35cb-454b-9036-b17f3a94f402"
      unitRef="usdPerShare">3.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjItMS0xLTEtMTQwNTIz_eb53841e-0677-4e2e-8c93-02095d5af7fc"
      unitRef="usdPerShare">0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjItMy0xLTEtMTQwNTIz_ada368c7-932f-448f-86f7-e503d1ce8b09"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjMtMS0xLTEtMTQwNTIz_5f96ca38-4434-409e-8151-f439914df0c4"
      unitRef="usdPerShare">5.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF80OS9mcmFnOjY1Zjk5OGM1NGYyZTQwOGViZmJhY2MzY2ZlNDdmZTRjL3RhYmxlOjgxNjc4ZTViMTljMTQ3NmZhMmFhOWFlYWUzOWQ2N2YzL3RhYmxlcmFuZ2U6ODE2NzhlNWIxOWMxNDc2ZmEyYWE5YWVhZTM5ZDY3ZjNfMjMtMy0xLTEtMTQwNTIz_c0dd2cb0-f3fc-4369-b814-4a240f4afa9b"
      unitRef="usdPerShare">3.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTk0OA_2a74f095-c9fe-40eb-b4f4-c998a1f3c6a6">Goodwill and Intangible Assets, Net &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. The Company voluntarily changed its annual goodwill impairment testing date from October 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to April 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to align with a change in timing of the Company&#x2019;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#x2019;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. The annual impairment testing performed as of April 1, 2022 did not indicate an impairment of goodwill.&lt;/span&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Amortization expense of intangible assets was $56 million and $98 million during the three months ended June 30, 2022 and 2021, respectively. Estimated amortization expense of these assets is as follows: $166 million, $211 million, $206 million, $174 million, and $168 million for the remainder of fiscal 2023 and each of the succeeding years through fiscal 2027, respectively, and $1.1 billion thereafter. All intangible assets were subject to amortization as of June 30, 2022 and March 31, 2022. Amortization of intangible assets of the E.U. disposal group classified as held for sale ceased in the second quarter of fiscal 2022.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTkzNQ_030166de-8720-4539-81cf-b63fb6d2d7c8">&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ib1603e72ed6c4daa8b8ca5a07fbd1091_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS0xLTEtMS0xNDA1MjM_5efb923d-6cc2-42e0-8b3d-88f1ffe7db8c"
      unitRef="usd">3923000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia1f27ef316774f2ebcc0ec59b1f39297_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS0zLTEtMS0xNDA1MjM_3df21db0-d6fe-402c-aac8-bddec7f7e537"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib406df4db52b4b27b436c0fc953e4a8e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS01LTEtMS0xNDA1MjM_97c083e4-2c9c-4582-b8e9-d18d363ba2df"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i79bce56293174c7db4e539b562cc2526_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS03LTEtMS0xNDA1MjM_a2472b30-5edd-4521-a808-1301122f1f75"
      unitRef="usd">1533000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfMS05LTEtMS0xNDA1MjM_40ce87c0-aacf-44d7-8178-7a7896e5b49e"
      unitRef="usd">9451000000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4e71847d225b4930bef9de929f3f2a3c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi0xLTEtMS0xNDA1MjM_a56b33ca-c233-4b63-8784-418e04fe471f"
      unitRef="usd">-33000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id9167671dc7c472eb51af611bf7cc7e4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi0zLTEtMS0xNDA1MjM_4c96850a-18a4-4108-a471-425357806cc8"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5c30ffbc257945ba83eb82993a8be420_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi01LTEtMS0xNDA1MjM_1c0a0b06-0840-4729-9ca0-7341ea5aca8e"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7b46e42465d84c47a2183912a0e10716_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi03LTEtMS0xNDA1MjM_59141d38-f7ca-4b1d-a831-a5a5346c2e67"
      unitRef="usd">-48000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNi05LTEtMS0xNDA1MjM_f0bb0690-11c0-4694-8b20-b38fd87c610b"
      unitRef="usd">-81000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4e71847d225b4930bef9de929f3f2a3c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy0xLTEtMS0xNjI5Njk_b2134f10-b4aa-4712-934e-38bfcb2a8fa3"
      unitRef="usd">-3000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="id9167671dc7c472eb51af611bf7cc7e4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy0zLTEtMS0xNjI5Njk_a0115323-ac25-44e9-9e75-fcfb1164c3e0"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i5c30ffbc257945ba83eb82993a8be420_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy01LTEtMS0xNjI5Njk_126a805c-cf0e-451c-a018-8800ce2cbd77"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i7b46e42465d84c47a2183912a0e10716_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy03LTEtMS0xNjI5Njk_69108c8f-feb4-48bf-8599-b0b7502e088a"
      unitRef="usd">1000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy05LTEtMS0xNjI5Njk_fc166c71-3f5e-4e68-8f13-fe426d7fda84"
      unitRef="usd">-2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i2973547bb0b04222a89b6729430ffa65_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy0xLTEtMS0xNDA1MjM_c14cd4c2-c48d-44bb-8f70-29a1644aca5d"
      unitRef="usd">3887000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i80b7ea531f5944e9a9d6f976d44806d0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy0zLTEtMS0xNDA1MjM_ccd89322-ffc7-4fa8-8a47-1e0aca0b00ea"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i19e7f49efd664e9eb7c79c6728a445c6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy01LTEtMS0xNDA1MjM_80b93670-8186-484e-a8c5-86094064d432"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i403f9ff68d8c4127940b5ac3bf567cb2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy03LTEtMS0xNDA1MjM_e781be29-51cd-497e-b847-c5ca9a595875"
      unitRef="usd">1486000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOjk1OTZkODdkZDY3YjRmNWRiMGJmMjhmODUyYmI1YmJiL3RhYmxlcmFuZ2U6OTU5NmQ4N2RkNjdiNGY1ZGIwYmYyOGY4NTJiYjViYmJfNy05LTEtMS0xNDA1MjM_15721dab-e078-4943-8b3c-3310382c0b3d"
      unitRef="usd">9368000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTk1Mw_b41c987e-f1ca-4e0f-8f81-085b57c2d870">&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i8356415b26f44a79a7bef9dd35e8c8c6_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi0xLTEtMS0xNDA1MjM_25fe78fd-6cad-4a8e-ab91-0298f893172c">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i37712c0066f64e0bb1e51fcf34f13275_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi0zLTEtMS0xNDA1MjM_edad1a97-8754-425c-9f19-0eff2c03e64a"
      unitRef="usd">2747000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i37712c0066f64e0bb1e51fcf34f13275_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi01LTEtMS0xNDA1MjM_6301e4ac-e55a-4ac9-b551-0aa4f350071a"
      unitRef="usd">1695000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i37712c0066f64e0bb1e51fcf34f13275_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi03LTEtMS0xNDA1MjM_acc67291-096e-4669-a9fb-7b59789c926e"
      unitRef="usd">1052000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iebea36d3b82e4242a79f2cb24837bf11_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi05LTEtMS0xNDA1MjM_4bf8aef5-36c8-469e-98f5-a66de36ba713"
      unitRef="usd">2777000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iebea36d3b82e4242a79f2cb24837bf11_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi0xMS0xLTEtMTQwNTIz_68a0e80e-def0-469f-9ee1-cbf1c52ddb31"
      unitRef="usd">1691000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iebea36d3b82e4242a79f2cb24837bf11_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMi0xMy0xLTEtMTQwNTIz_f90cd998-7e0a-44e5-93f6-99a619868567"
      unitRef="usd">1086000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i56b572e5f85647c2bb4157a3e9274374_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy0xLTEtMS0xNDA1MjM_ccb98979-ad8a-42a3-9d8e-1a8a5c865507">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia7584d2566eb4f808e5b3c32bf252562_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy0zLTEtMS0xNDA1MjM_1194d1c2-be7c-4dab-8ac6-ab3a53577473"
      unitRef="usd">1078000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia7584d2566eb4f808e5b3c32bf252562_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy01LTEtMS0xNDA1MjM_bddefab6-9755-424d-9c27-f2826526d2dd"
      unitRef="usd">584000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia7584d2566eb4f808e5b3c32bf252562_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy03LTEtMS0xNDA1MjM_f838577e-4a85-4ac4-97f8-64c2aebd3ad5"
      unitRef="usd">494000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4e32fde2d0c74321a6ffc1d2e7fcfab3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy05LTEtMS0xNDA1MjM_0de45ab5-cf2a-4ee7-83bf-13daa3b8330f"
      unitRef="usd">1085000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4e32fde2d0c74321a6ffc1d2e7fcfab3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy0xMS0xLTEtMTQwNTIz_a240ba72-6137-4a64-a422-f745e3492001"
      unitRef="usd">573000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4e32fde2d0c74321a6ffc1d2e7fcfab3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfMy0xMy0xLTEtMTQwNTIz_5964d723-9814-4de0-973e-3e037cad6bc0"
      unitRef="usd">512000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i0b0754d6d499499ea1f08e091a6e4313_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS0xLTEtMS0xNDA1MjM_361bc8f4-d727-4266-b879-c78d66b0748a">P11Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id0dcd0a8f12f4512a836f6114659037f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS0zLTEtMS0xNDA1MjM_8ab8c1c1-10fc-47fc-97b8-76ea5d147302"
      unitRef="usd">802000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id0dcd0a8f12f4512a836f6114659037f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS01LTEtMS0xNDA1MjM_5e88a246-3385-4832-93c6-1b4e41ba7ced"
      unitRef="usd">397000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id0dcd0a8f12f4512a836f6114659037f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS03LTEtMS0xNDA1MjM_3966c2b9-1670-4bae-a52e-64190d5bc5f7"
      unitRef="usd">405000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5bee33b48ae745368d813bb179998562_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS05LTEtMS0xNDA1MjM_960b5cab-1c2b-4146-8c3a-ac7947a0d30f"
      unitRef="usd">819000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5bee33b48ae745368d813bb179998562_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS0xMS0xLTEtMTQwNTIz_cee9ad89-df28-4c57-adf1-4da4863ffce6"
      unitRef="usd">386000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5bee33b48ae745368d813bb179998562_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNS0xMy0xLTEtMTQwNTIz_bc7c48cf-c46d-44d7-ae77-a71a5083cd2c"
      unitRef="usd">433000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="id1884f32c95e4196b9733d13eed48df6_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi0xLTEtMS0xNDA1MjM_f57ddb4d-ea4c-4cc4-af52-69a10181cb04">P1Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9f5a01c7f75b4124be2e8212faabad25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi0zLTEtMS0xNDA1MjM_af666da6-78d3-495e-ab2f-5a658ce7ec38"
      unitRef="usd">127000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9f5a01c7f75b4124be2e8212faabad25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi01LTEtMS0xNDA1MjM_3342610c-8635-44b9-bc16-2a3fe658f9c7"
      unitRef="usd">118000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9f5a01c7f75b4124be2e8212faabad25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi03LTEtMS0xNDA1MjM_277be7f0-0b5b-45cb-95fb-e3fe622f8a76"
      unitRef="usd">9000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id45be366e31e4b0eb3bb557a83a956d4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi05LTEtMS0xNDA1MjM_f0f71fbd-211c-4b63-8205-a3c3528689b3"
      unitRef="usd">128000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id45be366e31e4b0eb3bb557a83a956d4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi0xMS0xLTEtMTQwNTIz_331a64c0-dff5-4bf6-bf11-bc9563fe180b"
      unitRef="usd">116000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id45be366e31e4b0eb3bb557a83a956d4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNi0xMy0xLTEtMTQwNTIz_c8daf544-c099-4618-8781-4340ee9298e3"
      unitRef="usd">12000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i8aeceba0472c4993b4306ff3c946485a_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy0xLTEtMS0xNDA1MjM_12384bf7-afb6-4a45-8e89-67ddce0f2e6b">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i93d8e3ed6e654406a8a87749f03f9693_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy0zLTEtMS0xNDA1MjM_ba01b03f-e8fa-458e-927c-b1f1f73d0f9c"
      unitRef="usd">188000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i93d8e3ed6e654406a8a87749f03f9693_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy01LTEtMS0xNDA1MjM_8886c88e-7153-4c11-8f1e-6775be645ac8"
      unitRef="usd">172000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i93d8e3ed6e654406a8a87749f03f9693_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy03LTEtMS0xNDA1MjM_430b3705-18aa-4521-8b58-52eab52966b8"
      unitRef="usd">16000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id1e9f681efc9418e8d647ad3a6c73873_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy05LTEtMS0xNDA1MjM_8dd18612-81a9-45b2-9dd9-c2c512c41f08"
      unitRef="usd">187000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id1e9f681efc9418e8d647ad3a6c73873_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy0xMS0xLTEtMTQwNTIz_b9cadd5e-d1e7-4701-9363-ba14e927a17c"
      unitRef="usd">171000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id1e9f681efc9418e8d647ad3a6c73873_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfNy0xMy0xLTEtMTQwNTIz_495187e0-0a83-4509-942d-044d4ae1c219"
      unitRef="usd">16000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC0zLTEtMS0xNDA1MjM_5686fcb1-7be4-4040-9f09-4a37f8c5de66"
      unitRef="usd">4942000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC01LTEtMS0xNDA1MjM_bbfc911d-bc05-4de5-8595-d3b1eb8e7d2c"
      unitRef="usd">2966000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC03LTEtMS0xNDA1MjM_a0c50cf8-5460-4e80-a619-9519fe3bb33b"
      unitRef="usd">1976000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC05LTEtMS0xNDA1MjM_1901b036-59da-48e7-8489-632deb85692f"
      unitRef="usd">4996000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC0xMS0xLTEtMTQwNTIz_586704b8-66c6-47cb-8537-03323a626e88"
      unitRef="usd">2937000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RhYmxlOmVmNzY3N2Y5NzExODRiNmRiZTczNDI4Mjc1ZDU2M2NkL3RhYmxlcmFuZ2U6ZWY3Njc3Zjk3MTE4NGI2ZGJlNzM0MjgyNzVkNTYzY2RfOC0xMy0xLTEtMTQwNTIz_e4a2eb29-5478-4356-bcfe-e50d51ccbfda"
      unitRef="usd">2059000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTU5Ng_96f7f9d7-b4ff-4da8-8f16-15119ee7502d"
      unitRef="usd">56000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTYzOQ_ad2970c9-86eb-425c-9cb5-bd4eeb915c40"
      unitRef="usd">98000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc0MA_ec114483-9819-4b99-9e88-7aa841386f8b"
      unitRef="usd">166000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc0NA_9a1630d6-02b7-4685-83d2-d1ad5396c1cf"
      unitRef="usd">211000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc0OA_a940f6f1-7fc7-4998-9415-1833c3604235"
      unitRef="usd">206000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc1Mg_12278112-53c5-4104-be87-6fb0a83779d4"
      unitRef="usd">174000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTc2MA_afa8c842-d635-40f1-8ae4-2a5e183450e9"
      unitRef="usd">168000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81Mi9mcmFnOmVhZjIwNjY5Njc5NDQ0MjI4NThjMjgyZDQzODQzNzgwL3RleHRyZWdpb246ZWFmMjA2Njk2Nzk0NDQyMjg1OGMyODJkNDM4NDM3ODBfMTg1MA_93b368a9-fd57-4f88-a7e4-61935f9e8352"
      unitRef="usd">1100000000</mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjIxMA_643d28df-805f-49f3-8134-d7fded335f58">Debt and Financing Activities&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $5.8 billion and $5.9 billion at June 30, 2022 and March 31, 2022, respectively, of which $799 million, was included under the caption &#x201c;Current portion of long-term debt&#x201d; within the Company&#x2019;s Condensed Consolidated Balance Sheets at each of June 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a Credit Agreement, dated as of September 25, 2019, as amended (the &#x201c;2020 Credit Facility&#x201d;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no borrowings during the three months ended June 30, 2022 and 2021 and no amounts outstanding as of June 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At June 30, 2022, the Company was in compliance with all covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $1 million and an uncommitted amount of $105 million as of June 30, 2022. Borrowings and repayments were not material during the three months ended June 30, 2022 and 2021. Amounts outstanding under these credit lines were not material as of June 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the three months ended June 30, 2022 and 2021, there were no material borrowings under the program. At June 30, 2022 and March 31, 2022, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjIxNA_31525e6e-c119-4803-b51a-101cda1dd901">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iff711db73c6f4c5e9f9a44b9edfa2c8f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMi0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjpmNzE1MGQ5MTJjZGI0MmFmYTY4MmIwNTk1NDZjMTE3ZV80_de4dca4f-26bc-4dd4-9b27-7fc0a4f66620"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iff711db73c6f4c5e9f9a44b9edfa2c8f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMi0xLTEtMS0xNDA1MjM_1ae7ee75-7e15-41fb-978c-7947dc8cce94"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i964e360bb5304a7a91cbb307fe41a400_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMi0zLTEtMS0xNDA1MjM_7e7c4f0b-cb63-4ab7-b79d-ed490ba0a803"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iefc091ee1ba943d9bd16e2df30bb21cb_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMy0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjo2NzcwYWZkMmJiNTM0ZDU3ODJkN2YzZWFlYzVhMzI5MV80_9ae8a2eb-59e3-4e93-b800-0bc6e7c02b63"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iefc091ee1ba943d9bd16e2df30bb21cb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMy0xLTEtMS0xNDA1MjM_3ff03d70-f07b-4aa5-ad73-1f6594b1094a"
      unitRef="usd">360000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if32ca5071eb44a8fafb2dc2af15d5f2a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMy0zLTEtMS0xNDA1MjM_9d896a51-5e0c-446a-a11a-97033a826389"
      unitRef="usd">360000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia4cd5447a107486e8828badac335b9ea_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNC0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjo2Y2NkZjIzZmE1Yjg0Njc3ODJmNGI0MWIzZmRhOWUzNl80_20c4796a-db34-4dcf-a408-70dc2ec06e5e"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia4cd5447a107486e8828badac335b9ea_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNC0xLTEtMS0xNDA1MjM_2b56c634-8021-401b-9f82-2f7763f126f4"
      unitRef="usd">918000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib9b43926998845dbb130d523377325ab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNC0zLTEtMS0xNDA1MjM_ea6909e9-8a9e-4a20-84e9-c6fd4b4bec35"
      unitRef="usd">918000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3167bf1182f948fdba7729ff76cf27b3_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNS0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjpkYjdiYTE2ZWQwYzg0MjQ0YWM5MjQ1MDg4ZTNhMGZjNl80_4e122d7a-74bf-4c3a-aedb-c3c315a43366"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3167bf1182f948fdba7729ff76cf27b3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNS0xLTEtMS0xNDA1MjM_916517a1-8c9f-46f8-9bc5-40d68cd5de65"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9cfe85e7a9b641a78490906855cf69b3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNS0zLTEtMS0xNDA1MjM_d84761a3-7921-45f2-8868-a722967a1588"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a0b0abcd2744a1582bac3909196080c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNi0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjo0OGVmNTNlOWZkYTI0YjZhODVhYTFlN2JhMGQ3MjQ2OF80_0f03c137-ecc0-4b94-95e6-bcd3fe5ff3ad"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2a0b0abcd2744a1582bac3909196080c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNi0xLTEtMS0xNDA1MjM_1379e20a-82df-4824-bdae-0d5033de16c8"
      unitRef="usd">498000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if6328397e5e846f2926603d07bf5629f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNi0zLTEtMS0xNDA1MjM_117f4d5b-4c45-4012-89b5-02e897750739"
      unitRef="usd">498000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i565074a91efd4e2baba451998e9fe4e9_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNy0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjo2ZWJlNTE5ZTUxZGQ0YTdlOWNlZmNkN2VlZTNlMTEzYV80_882e72c7-7762-4b5f-ab80-10ea6a2ea60b"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i565074a91efd4e2baba451998e9fe4e9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNy0xLTEtMS0xNDA1MjM_bd577cf9-89eb-4527-a092-e4fa8f46ee18"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iafef158a41cf4048baa5a93cb0b6620d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfNy0zLTEtMS0xNDA1MjM_54df560a-9313-40b1-9314-18ccf58651b6"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7b7fb8d52da24328b8964b016e0c3351_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOC0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjowMzM1OGRkYzkzNTI0M2ZmYTIwZjllYTA5NGE5NWYxMl80_e3ea76c2-f993-4d0a-a118-0bf0f0a67fd1"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7b7fb8d52da24328b8964b016e0c3351_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOC0xLTEtMS0xNDA1MjM_d84efede-6d3a-4f75-a8c8-096636dde710"
      unitRef="usd">343000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iaab1fe3e771e4795b92c3519d4aa2a57_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOC0zLTEtMS0xNDA1MjM_1d17c0b1-9895-4955-9ff6-5c0b618bb023"
      unitRef="usd">343000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia9575f4f1c94440dbcd550e774d94cf2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOS0wLTEtMS0xNDA1MjMvdGV4dHJlZ2lvbjpjMDZjYzQ1NGNhMTQ0YTM5OGY3OGQ4MjEyZjY3NDkzN180_9671dc89-9500-4f86-8507-2b960a4ecc3f"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia9575f4f1c94440dbcd550e774d94cf2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOS0xLTEtMS0xNDA1MjM_a568e8a2-3280-4770-ac75-4d87d089da9b"
      unitRef="usd">196000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if1c01fc67d7d4672a61f5062adaa04d9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfOS0zLTEtMS0xNDA1MjM_6fa4fc66-c74b-4462-a07e-fd6ffa224eed"
      unitRef="usd">196000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1c6e596876c14eceb35218c7197c764c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTAtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246NGMwYjA5MDMzZDUwNDVjOWJkM2I5OWQxYTlmMDgwYjBfNA_c14d5d48-3b6f-4120-8821-ff22baf38ebd"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1c6e596876c14eceb35218c7197c764c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTAtMS0xLTEtMTQwNTIz_8803f380-09db-4c9b-88f7-e7dfe5729ebb"
      unitRef="usd">217000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i24aabefa576e4aa09449e0603fd27472_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTAtMy0xLTEtMTQwNTIz_54664c77-7120-4877-a797-f7712bb6bbd4"
      unitRef="usd">217000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id0e935c6a9174c0198aeceebe6d8008b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTEtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246MjEzMGUzZWI2ZTMyNGI0NDhiNzBlYTNjMWVjODFjNzVfNA_5b2df197-a562-429b-a8dc-7b2a9aa69569"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id0e935c6a9174c0198aeceebe6d8008b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTEtMS0xLTEtMTQwNTIz_5508b01c-3ab8-44fc-8965-d1dc093cdeaf"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8cb8a57a80a64603b803e2b679fdc63b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTEtMy0xLTEtMTQwNTIz_86395680-bef1-42f1-af12-9a1d8c9da070"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id3d0ea03571840b0b0defd993f65540b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTQtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246MGY4MDk5NGMwZTA2NDJiZmI4ZDc3MjlmZTYwYjE1YjhfNA_528d0c82-6321-4f3f-8e42-1d11e992797b"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id3d0ea03571840b0b0defd993f65540b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTQtMS0xLTEtMTQwNTIz_2f79d8ef-d4df-4cc6-8c5b-919e2b3d5e1f"
      unitRef="usd">627000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iaac3251871f54afb9e05a2dd9845dd86_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTQtMy0xLTEtMTQwNTIz_5235a949-e81b-42ce-9445-0faf612cf267"
      unitRef="usd">662000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if8e2051458de4ca3b3ff972dc1e5df47_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTUtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246OTQ4OTJiMGQwNDJlNDE1NDkyMTViYTg2MzEwZTcxMTJfNA_3a360c2d-022a-4ae5-bb6a-8037b66549e3"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if8e2051458de4ca3b3ff972dc1e5df47_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTUtMS0xLTEtMTQwNTIz_caa4be6b-7b02-4e6d-a0a1-4de9949a8cf6"
      unitRef="usd">524000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i466138b603084d54be88ad1a34567c8b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTUtMy0xLTEtMTQwNTIz_6b9a055d-ad67-4323-9576-124aac4d88c7"
      unitRef="usd">554000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i752a8a7f16074f689ee9d1b4892d270f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTYtMC0xLTEtMTQwNTIzL3RleHRyZWdpb246MDhjYWQ5MTRjMDQxNGRhNThhY2Y3ODk1MmJhMWVjM2VfNA_8f6fc337-9fca-4822-b323-8f9f89aa7fef"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i752a8a7f16074f689ee9d1b4892d270f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTYtMS0xLTEtMTQwNTIz_0b04e8fa-3e18-4182-b8cc-9bd3f066e04b"
      unitRef="usd">548000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2166a8ac1e96401c8f1600c898c367ac_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTYtMy0xLTEtMTQwNTIz_2f7a09ab-cd61-4de8-8d3d-eadb932a6bc0"
      unitRef="usd">582000000</us-gaap:LongTermDebt>
    <us-gaap:FinanceLeaseLiability
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTgtMS0xLTEtMTQwNTIz_85841e4c-de4c-472c-9086-8103bad96428"
      unitRef="usd">239000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTgtMy0xLTEtMTQwNTIz_2eb817ec-2b48-42fd-90da-310291fa7143"
      unitRef="usd">244000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTktMS0xLTEtMTQwNTIz_2aefbf4c-2118-4b1a-8bdf-b8f2d4186be0"
      unitRef="usd">5775000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMTktMy0xLTEtMTQwNTIz_1168560a-8d71-4e8d-8941-706982c9bab7"
      unitRef="usd">5879000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMjAtMS0xLTEtMTQwNTIz_cde9a9f9-83e7-4493-abed-fefb0f3e144f"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMjAtMy0xLTEtMTQwNTIz_c680d512-1df0-4f7d-9ceb-31a665a7207a"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMjEtMS0xLTEtMTQwNTIz_9f42e971-a308-4da9-93f8-0561249b097b"
      unitRef="usd">4976000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RhYmxlOmQ3MTAwMjQ2NDg2NDRlNDFiZmVkNTVhMzc0MjdmMzhjL3RhYmxlcmFuZ2U6ZDcxMDAyNDY0ODY0NGU0MWJmZWQ1NWEzNzQyN2YzOGNfMjEtMy0xLTEtMTQwNTIz_4c0e6634-c5d1-4ad5-ac2c-b4e8cb868fbe"
      unitRef="usd">5080000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjcw_79a7f0c5-9752-4fd5-8de1-1081735bf0f9"
      unitRef="usd">5800000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjc3_59558f85-8bdf-41a6-9e9c-84d375bf049f"
      unitRef="usd">5900000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNzE3_2247d530-673c-4c41-8a5a-4e170841a8e2"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ieb8a1defb0594686a254e66fc7830f7d_I20190925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDA5NA_199f0106-7311-4831-9ba7-0e8358e19cea"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="if7e42ec92f674a79afbd81e8fb750262_D20190925-20190925"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjIwNg_68d19784-e277-4aa9-b4e2-a97c7ccd1ce3">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib12270524a7b4cc6b7b87975f0b31013_I20190925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDE0NQ_a42166fc-68d0-46be-ab8c-61d4f4182791"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i1ce62c7971874b97a640c6606962ea01_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDU3NA_17f63054-72f3-455a-9f48-5ab8bdf8deaf"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="icefd77afd24c4487924437959cfe8fbc_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDU3NA_63f6832b-6918-4d70-a133-cfd001b6031a"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="iece544191d5240e3b1283537222c41a8_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDYxNg_76fd939b-690b-480e-9064-e099a1b54859"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i044fe80187ac47b3b779f3f5fa0c3a15_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNDYxNg_b474bd46-f583-4c79-9865-57ecca6d62e8"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ib3341b4ea67b4eb1bfc0be50fbf79480_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNTQ0Mg_5b641a0a-1f2c-4468-9d7a-306686bbcf22"
      unitRef="usd">1000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ib8185c82e2434a0c84ff562df7ae24ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNTQ3NA_890070c9-5023-4403-80d5-ead6b5ef7b03"
      unitRef="usd">105000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i03515862174f44c7b695b85111ea920d_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNTgzNQ_4581ebc3-8d71-402f-9db4-db179bb03ba7"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="iec54ae004102491b9606ef01cb1fdf20_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjAxNw_06bc97d2-32a1-4cae-abca-2088494dcd2b"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i8ae8a14adb19498bb9dded3088ccc4a5_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjAxNw_418b0098-4e41-4b39-a9a6-69a8a754e7b2"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="i03515862174f44c7b695b85111ea920d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjE2OQ_3fa04e5f-a238-4933-a13a-2f045209138c"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="i98edbf2764e9413891b48258d46b8d5a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81NS9mcmFnOjhlZjVkZmZjYTZlYTQ3ZmViOGNmNmZmNjBmZWY5YTk4L3RleHRyZWdpb246OGVmNWRmZmNhNmVhNDdmZWI4Y2Y2ZmY2MGZlZjlhOThfNjE2OQ_993d48e1-0ba2-4921-9c9a-c60d95fc1424"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTAwOA_0bac2193-5844-43a8-b50c-4864eef7b248">Pension Benefits&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic expense for defined benefit pension plans was not material for each of the three months ended June 30, 2022 and 2021. Cash contributions to these plans were $3 million and $14 million for the three months ended June 30, 2022 and 2021, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale,&#x201d; pension liabilities of $79&#160;million and $85&#160;million as of June 30, 2022 and March 31, 2022, respectively, were included under the caption &#x201c;Liabilities held for sale,&#x201d; in the Condensed Consolidated Balance Sheets as part of the E.U. disposal group. During the first quarter of fiscal 2023, the Company derecognized pension assets of $49&#160;million and released $30&#160;million of accumulated other comprehensive loss related to the sale of its U.K. disposal group. The pension assets were included within &#x201c;Assets held for sale&#x201d; in the Condensed Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="idd567c67685b42aba4f0f9ef5b214c07_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMjEx_b6f92ef8-1549-49ae-82bd-2b41ed5d3056"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3d909bc2a8994f798b89f3084cf96826_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTY0OTI2NzQ0NDI5OA_bdfd1ed3-fbf6-4052-8e0c-91692c413e8e"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanFundedPercentage
      contextRef="i8767bea4ed9b4241b64e9c77192c274d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfNTQz_567c1ea0-c0ec-422c-bca7-51b782346012"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanFundedPercentage>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation
      contextRef="i51ae381b635041b2a03df829498f103d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTY0OTI2NzQ0NDExMQ_e377036b-0810-4996-b383-e8a8a81d658b"
      unitRef="usd">79000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation
      contextRef="i695dd9f4cbbd46edaa4b764478844aa6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfODg5_55ee9842-b20a-4be7-ae23-213184387206"
      unitRef="usd">85000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized
      contextRef="i1628a1ef0d3b482691b8aa3e61736647_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTY0OTI2NzQ0MzQ4Mg_00d86104-238e-4708-998d-f80b21f6279e"
      unitRef="usd">49000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i24e204f409be4b29a94900362c7cef4e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF81OC9mcmFnOjE4MmNjYmYxOGQ0ZjQxODk5YmQ5ZTM2NjBmMjczNDJlL3RleHRyZWdpb246MTgyY2NiZjE4ZDRmNDE4OTliZDllMzY2MGYyNzM0MmVfMTY0OTI2NzQ0Mzg2Nw_9dcaa59f-5386-4011-bf1d-64ff37da1287"
      unitRef="usd">30000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ2MTYx_7284ad7e-dcf7-4a8b-8c74-1ca2273d50f4">Hedging Activities&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Exchange Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. Subsequent to the completion of the U.K. divestiture in April 2022 as discussed in Financial Note 2, &#x201c;Held for Sale,&#x201d; the Company&#x2019;s foreign currency exchange rate risk is limited to the Euro and Canadian dollar.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2022 and March 31, 2022, the Company had &#x20ac;1.1 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded as foreign currency translation adjustments in &#x201c;Accumulated other comprehensive loss&#x201d; in the Condensed Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale of the U.K. disposal group as discussed in more detail in Financial Note 2, &#x201c;Held for Sale,&#x201d; the Company reclassified $26&#160;million of gains from accumulated other comprehensive loss and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. This amount related to the Company&#x2019;s &#xa3;450 million British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro-denominated notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2022 and March 31, 2022, the notional amounts of the Company&#x2019;s outstanding derivatives were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nov-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as fair value hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Feb-23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aug-27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jul-22 to Jan-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mar-23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses cross-currency swaps to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses cross-currency swaps to hedge the changes in the fair value of British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#x2019;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2023, the Company entered into floating interest rate swaps to convert $180&#160;million of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations were not material for the three months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are mark-to-market at the end of each accounting period with the change in fair value included in earnings. From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material for the three months ended June 30, 2022 and 2021. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Information on Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated for hedge accounting:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ie3254c69cbee481f97c6743efa9150c3_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xNTEw_1bdd12ff-49e5-4dd8-a8a7-7fc4df4acc74"
      unitRef="eur">1100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie6f9d6fa7ca7441e8a4987577b13651e_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xNTEw_cde65b9a-10c3-4d48-baa1-97003419659a"
      unitRef="eur">1100000000</us-gaap:LongTermDebt>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i372251adcd1648eab091c52b5f01446e_D20220406-20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ2Nzc5_ba1fa03a-8190-4b6b-86e1-b5b383232af3"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:LongTermDebt
      contextRef="if2af5ce20fb04be99d4d91c3837262bd_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xNjQ5MjY3NDg5MDIx_722ba681-fa43-4654-8248-f65902ee41ff"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ2MTYy_220e4f4e-f9c0-4395-b53c-e0b78889a0ab">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro-denominated notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i41ebb607246c4e2991322746c42fa818_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6M2ZiYmNjZGUwODRjNGMzYjlhZmQwZGZmOGNiYmNiZmIvdGFibGVyYW5nZTozZmJiY2NkZTA4NGM0YzNiOWFmZDBkZmY4Y2JiY2JmYl8zLTEtMS0xLTE1NDQzOQ_871a28d1-678e-4897-af68-35995ec5e1c7"
      unitRef="usd">64000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ic770e7e260c6494e91714f00ee4061af_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6M2ZiYmNjZGUwODRjNGMzYjlhZmQwZGZmOGNiYmNiZmIvdGFibGVyYW5nZTozZmJiY2NkZTA4NGM0YzNiOWFmZDBkZmY4Y2JiY2JmYl8zLTMtMS0xLTE1NDQzOQ_1e616fbc-313e-4399-b303-e28aea8824d9"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ2MTY0_e275f758-e09e-494c-814e-ba0f0b512963">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2022 and March 31, 2022, the notional amounts of the Company&#x2019;s outstanding derivatives were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nov-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as fair value hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Feb-23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aug-27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jul-22 to Jan-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mar-23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the three months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.&lt;/span&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia9200147039b4d23906d2205705299fd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF8zLTMtMS0xLTE1NDUzMA_da9eeb96-4abf-4e19-becf-f7bd825c65ad"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic0f94a4fe40647dcad8d868e1ecf16d5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF8zLTctMS0xLTE1NDYzOQ_097ac4a6-bac7-4a53-8d2d-72e811a8793b"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie2122223b4e24f6a94b2791de320374a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF81LTMtMS0xLTE1NDUzNg_7050f7e8-8148-44d7-9cff-69e655f12ec5"
      unitRef="gbp">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icaedc0e4a45e442fa6d6beac1dcb1ca9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF82LTctMS0xLTE1NDY0Nw_01c3abff-0655-4ae2-95c3-20769f8e8526"
      unitRef="gbp">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i727c52e939144af4b31c1f88bc2836cc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF83LTUtMS0xLTE2MDg3OQ_a0dab14e-752b-4ac6-a261-94de381ede99"
      unitRef="usd">180000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie4a2f796909a429daa27355e79f80ddd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF83LTctMS0xLTE2MDg3OQ_4bfc342b-0410-48b3-b973-e5a6d8897985"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i864b745cf60843c5aaf96b4cc4f1a217_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF85LTUtMS0xLTE1NDY2Ng_bcab49e3-b55b-43a8-a785-67f77089d15c"
      unitRef="cad">1678000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic5d560c2041344ab9c85f9e013cc904f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF85LTctMS0xLTE1NDY3MQ_4aedaaa9-fa36-44f3-b6da-c598052fcf2f"
      unitRef="cad">1678000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i66b4897d62c94e129073ebc6630ec481_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF8xMS01LTEtMS0xNTQ3NTk_1086fd64-4594-4bfc-91ca-5ffafac37a01"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i95ef45188f1b4c4fae080a330a7456bf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6NjY2NjAzNDMxNmU0NDU0NWJjYzlkNzQyN2ZjNmJiMzQvdGFibGVyYW5nZTo2NjY2MDM0MzE2ZTQ0NTQ1YmNjOWQ3NDI3ZmM2YmIzNF8xMS03LTEtMS0xNTQ3ODA_7024f4af-bfe4-463b-871f-46041c1c221c"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i727c52e939144af4b31c1f88bc2836cc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18zODQ4MjkwNzQ5NTA0_519f749f-955e-4d2f-89d6-496c4994bac1"
      unitRef="usd">180000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xMzc0Mzg5NTM5NjE0OQ_4471db45-017f-4da0-979f-04e9b1baf530">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xMzc0Mzg5NTM5NjE0OQ_99064130-b425-4e87-8b9c-252affb0e98d">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="iedcceae98f1745c18c291607c35f1154_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV8zLTEtMS0xLTE1NzUyNQ_7469232a-b03c-4e89-ab69-15ca36df953a"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="if7abd9fb0b51412e99b4001e9c3d02c3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV8zLTMtMS0xLTE1NzUyNQ_4f5ed696-eb87-4583-81ac-a5ba11a11604"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib695670fac054a96998413f0f81621bf_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV82LTEtMS0xLTE1NzUyNQ_af8172e5-abed-4190-84c6-026b5932093c"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ic0d302cd168e4ac5b3e8c93a2b801655_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV82LTMtMS0xLTE1NzUyNQ_b3acd207-6fce-4643-9aac-cb3b5ecf231b"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="idf70302177a746cfb31a8c813fc9e576_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV83LTEtMS0xLTE1OTU0MQ_7345da4b-1363-4614-a6c2-c8879d043d56"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2567e9d256a74d91967a6dcec0897b06_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6Y2YwYTlmMDFiMmE0NDYwM2JkZWYwNGI3NmI5Mjc1ZjEvdGFibGVyYW5nZTpjZjBhOWYwMWIyYTQ0NjAzYmRlZjA0Yjc2YjkyNzVmMV83LTMtMS0xLTE1OTU1MQ_152d2290-7a10-4383-b32c-fb58f8044333"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGV4dHJlZ2lvbjoyN2VjYjc0NTg0Y2Q0MjY0OGJjNjIwMTU3ZTQ2YzA4Y18xMzc0Mzg5NTM5NjE1MA_290f78e9-4341-4ff0-9f32-a685acec7c0d">&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated for hedge accounting:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i614af20eb8bf45108edd1be8b5e30eb7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTItMS0xLTE1NDM4OA_a327f18e-5da3-490c-9d17-110663b079d7"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i614af20eb8bf45108edd1be8b5e30eb7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTQtMS0xLTE1NDM4OA_e720a3ac-acfe-433a-a957-a97a204ba693"
      unitRef="usd">30000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i614af20eb8bf45108edd1be8b5e30eb7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTUtMS0xLTE1NDM4OA_a1ec987f-5159-4495-8c0b-cefba68daedd"
      unitRef="usd">1537000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic93afc9722af414ebd768788768bc773_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTctMS0xLTE1NDM4OA_260713c9-9d64-41ad-9d8f-1a3f384bb878"
      unitRef="usd">30000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic93afc9722af414ebd768788768bc773_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTktMS0xLTE1NDM4OA_e17f2eea-9106-4de6-b9f1-a577e793f547"
      unitRef="usd">39000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ic93afc9722af414ebd768788768bc773_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF81LTEwLTEtMS0xNTQzODg_8b97ab3f-2daf-4ae5-a98b-d8463b586028"
      unitRef="usd">1537000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id1d25f973adc48d18bbace1d7f69620e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTItMS0xLTE1NDM4OA_3bc90768-f9e0-4b24-9124-47c02812207c"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id1d25f973adc48d18bbace1d7f69620e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTQtMS0xLTE1NDM4OA_2790c7dc-5223-4b7c-9b21-fe982d36adac"
      unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="id1d25f973adc48d18bbace1d7f69620e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTUtMS0xLTE1NDM4OA_4fd44901-ca3e-4313-b35a-29a9d1f2747b"
      unitRef="usd">679000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib06c2da02d95474691982974e55aa7cc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTctMS0xLTE1NDM4OA_8e929520-c957-4b84-a1ec-ed442d35f054"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib06c2da02d95474691982974e55aa7cc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTktMS0xLTE1NDM4OA_0d35b5e1-e1f6-439f-bf15-c0664cd486cd"
      unitRef="usd">36000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib06c2da02d95474691982974e55aa7cc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF82LTEwLTEtMS0xNTQzODg_c9751391-39b3-42de-a210-ac54d8db67ee"
      unitRef="usd">679000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iaae6d3027e7b40d19a5f999387bb5a94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTItMS0xLTE1NDM4OA_43ea1755-cfba-47a7-b77a-7a1d2052b966"
      unitRef="usd">57000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iaae6d3027e7b40d19a5f999387bb5a94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTQtMS0xLTE1NDM4OA_51c03089-a636-4e94-808b-be9aff62cde9"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="iaae6d3027e7b40d19a5f999387bb5a94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTUtMS0xLTE1NDM4OA_f2b41ee0-7cbd-4cea-bd66-4fb56e897e2d"
      unitRef="usd">500000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib7702e8b3e0242449e9281863062b488_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTctMS0xLTE1NDM4OA_068df36e-994e-409c-883a-f4040c633a7f"
      unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib7702e8b3e0242449e9281863062b488_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTktMS0xLTE1NDM4OA_645cdd3f-4852-49d6-a761-914d34fe0e5c"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ib7702e8b3e0242449e9281863062b488_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF83LTEwLTEtMS0xNTQzODg_b254890d-5ac4-4774-854f-03f947d2f4be"
      unitRef="usd">500000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4c492e20719648568963f8577647d24f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC0yLTEtMS0xNjI3ODE_35904ec1-85e8-41d4-8028-5078c673f117"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4c492e20719648568963f8577647d24f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC00LTEtMS0xNjI3OTQ_7f966d62-78a2-49c1-a1a9-8ea23d509985"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i4c492e20719648568963f8577647d24f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC02LTEtMS0xNjI4MDE_ca51dc50-3e33-4f39-a6ed-e96693564ac7"
      unitRef="usd">180000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4228622f82ae4dcd8f033204a9968b56_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC04LTEtMS0xNjI4MTA_343659ad-e923-42f6-a951-0e7de3b71eff"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4228622f82ae4dcd8f033204a9968b56_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC0xMC0xLTEtMTYyODE3_9dcc1875-ba58-47af-b411-7be7f4c9817f"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i4228622f82ae4dcd8f033204a9968b56_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF8xMC0xMi0xLTEtMTYyODI0_e9da2eef-ff7d-4819-97e3-c203176ecfb1"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9f56ba1a598a4a829b10b8749df60caf_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF85LTItMS0xLTE1NDM4OA_c45bd3ec-a97c-484a-9778-995dc928c4b2"
      unitRef="usd">63000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9f56ba1a598a4a829b10b8749df60caf_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF85LTQtMS0xLTE1NDM4OA_b0f4e2a4-3e88-401d-97d4-65025ae30ee3"
      unitRef="usd">45000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4f0747ce2512401a84d2048c76eb4934_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF85LTctMS0xLTE1NDM4OA_55a182f8-8967-4665-8471-0d957c4702ba"
      unitRef="usd">61000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4f0747ce2512401a84d2048c76eb4934_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NTk3MDY5NzY3OTgwL2ZyYWc6MjdlY2I3NDU4NGNkNDI2NDhiYzYyMDE1N2U0NmMwOGMvdGFibGU6OTQzODM2ZDM0NGY2NGU3N2I3NTUwYjMxOThhZDY1NjAvdGFibGVyYW5nZTo5NDM4MzZkMzQ0ZjY0ZTc3Yjc1NTBiMzE5OGFkNjU2MF85LTktMS0xLTE1NDM4OA_42e73bd2-6412-45c9-b679-70c79a545509"
      unitRef="usd">75000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfODM4MA_f8af7369-bb42-4fac-b41c-5e664eb88cd5">Fair Value Measurements&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - significant other observable market-based inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at June 30, 2022 and March 31, 2022 included investments in money market funds of $547 million and $981 million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#x2019;s marketable securities were not material at June 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#x201c;Hedging Activities,&#x201d; for fair value and other information on the Company&#x2019;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#x2019;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2022 and March 31, 2022, the assets and liabilities associated with the disposal groups in Europe held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale." At March 31, 2022, assets measured at fair value on a nonrecurring basis also included certain long-lived assets within the International segment related to the Company&#x2019;s operations in Denmark and its retail pharmacy businesses in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other material liabilities measured at fair value on a nonrecurring basis at June 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2022 and March 31, 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash, included within &#x201c;Prepaid expenses and other&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets primarily consists of $100&#160;million and $395&#160;million as of June 30, 2022 and March 31, 2022, respectively, held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ibf4b0c9f108245a0ab670e3765ab193c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfNzY4_587933f4-3ac0-46f1-83c0-09d883c8d9d4"
      unitRef="usd">547000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i6d2ebfdac84e4abbb90a1e8f5ae7e490_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfNzc1_9fc471c3-82e6-437d-8422-bf79e6224244"
      unitRef="usd">981000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfODM3OQ_6fc9407b-87f3-4374-9680-8381b7af3fe7">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i6628b987433540f19ebb8c735161874b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RhYmxlOmYwNmQ2Mzg0ZGVjYTQ1OGRhOWI3MjhlZmEzODIzNTZkL3RhYmxlcmFuZ2U6ZjA2ZDYzODRkZWNhNDU4ZGE5YjcyOGVmYTM4MjM1NmRfMi0xLTEtMS0xNDA1MjM_a956a697-dd5b-45ba-8c32-e242cef97bc8"
      unitRef="usd">5775000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6628b987433540f19ebb8c735161874b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RhYmxlOmYwNmQ2Mzg0ZGVjYTQ1OGRhOWI3MjhlZmEzODIzNTZkL3RhYmxlcmFuZ2U6ZjA2ZDYzODRkZWNhNDU4ZGE5YjcyOGVmYTM4MjM1NmRfMi0zLTEtMS0xNDA1MjM_8964451e-4368-400c-ace0-c83bf2ddb0ca"
      unitRef="usd">5674000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i0efcc5cada804b01af7a7152f7f15ce1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RhYmxlOmYwNmQ2Mzg0ZGVjYTQ1OGRhOWI3MjhlZmEzODIzNTZkL3RhYmxlcmFuZ2U6ZjA2ZDYzODRkZWNhNDU4ZGE5YjcyOGVmYTM4MjM1NmRfMi01LTEtMS0xNDA1MjM_b9a895f0-daa7-4dfe-a2b3-d3fec2c33462"
      unitRef="usd">5879000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0efcc5cada804b01af7a7152f7f15ce1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RhYmxlOmYwNmQ2Mzg0ZGVjYTQ1OGRhOWI3MjhlZmEzODIzNTZkL3RhYmxlcmFuZ2U6ZjA2ZDYzODRkZWNhNDU4ZGE5YjcyOGVmYTM4MjM1NmRfMi03LTEtMS0xNDA1MjM_f0e83780-81c0-49b7-8e6e-a2a1ed2314b7"
      unitRef="usd">5999000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:RestrictedCash
      contextRef="ib9dcecf8036248a0a44938b3a51b3d54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfMTY0OTI2NzQ1NTU5MA_a5e360f6-0977-4ed7-b022-07fb67ec77cc"
      unitRef="usd">100000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ic42ce3a7a52742d682e55d121a735789_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82NC9mcmFnOjQzZTE4ODIzMWY5YzQ1NmM4MGJhYzRmMjdjMjE5Mjk1L3RleHRyZWdpb246NDNlMTg4MjMxZjljNDU2YzgwYmFjNGYyN2MyMTkyOTVfNjQyNw_be41ce1f-685c-4e8d-b3bb-ddfaf7237d94"
      unitRef="usd">395000000</us-gaap:RestrictedCash>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDc4MDA2Nw_5d77723a-1a46-47e1-b63e-652513150e7b">Commitments and Contingent Liabilities&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 18 to the Company&#x2019;s 2022 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#x201c;Claims and litigation charges, net&#x201d; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and the two other national pharmaceutical distributors (collectively &#x201c;Distributors&#x201d;) settled with 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#x201c;Settling Governmental Entities&#x201d;) effective on April 2, 2022 (&#x201c;Settlement&#x201d;). If all conditions to the Settlement are satisfied, including the receipt of approval by relevant courts of consent decrees to dismiss the lawsuits, the Distributors would pay the Settling Governmental Entities up to approximately $19.5 billion over 18 years, with up to approximately $7.4 billion to be paid by the Company for its 38.1% portion. Under the Settlement, a minimum of 85% of the settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#x2019; attorneys&#x2019; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three eligible states, Alabama, Washington, and Oklahoma did not join the Settlement, but they have all now reached agreements in principle with the Company. With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement in principle under which the Company will pay $141&#160;million in ten equal annual installments and an additional approximately $33&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $518&#160;million over 18 years, of which the Company&#x2019;s portion would be 38.1% (or approximately $197&#160;million), consistent with Washington&#x2019;s allocation under the comprehensive framework, as well as certain additional attorneys&#x2019; fees and costs. On June 27, 2022, an agreement was announced between the Distributors and the attorney general of Oklahoma to settle claims of the state of Oklahoma and its subdivisions. Under that agreement, Oklahoma and its subdivisions would be paid up to $250&#160;million over 18 years, of which the Company&#x2019;s portion would be 38.1%, consistent with Oklahoma&#x2019;s allocation under the comprehensive framework, as well as certain additional attorneys&#x2019; fees and costs. The Company&#x2019;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements in principle.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Claims of various West Virginia subdivisions remain pending in both state and federal courts. Trial in the case of Cabell County and City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. On July 4, 2022, the court entered judgment in defendants&#x2019; favor. On August 2, 2022, the plaintiffs filed an appeal. The claims of certain other West Virginia subdivisions are pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Distributors for July 5, 2022. On July 5, 2022, the Mass Litigation Panel entered an order postponing the trial in light of an agreement in principle between a group of plaintiffs&#x2019; attorneys representing the municipalities and the three companies. Under that agreement in principle, the three companies would pay $400&#160;million over approximately 11 years, with the Company responsible for 38.1% of the total amount (or approximately $152&#160;million). The agreement in principle is contingent on participation of certain litigating subdivisions in West Virginia, but does not include school districts or the claims of Cabell County and the City of Huntington. The Company&#x2019;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $75&#160;million over 6.5 years to resolve opioid-related claims, of which the Company&#x2019;s portion would be 38.1% (or, approximately $29&#160;million). The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Distributors would pay the Native American tribes, other than the Cherokee Nation, approximately $440&#160;million over 6 years, of which the Company&#x2019;s portion would be 38.1% (or, approximately $167&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Distributors. Under these agreements, a minimum of 85% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#x2019;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Settlement terminated the substantial majority of opioid-related suits by governmental entities pending against the Company, a small number of subdivisions in participating states have opted not to participate in the comprehensive settlement, and other suits brought by subdivisions in non-participating states remain pending. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#x2019;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In the first quarter of fiscal 2023, the Company paid $375&#160;million, and in July 2022 paid an additional $470&#160;million, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These amounts as of June 30, 2022 and March 31, 2022, recorded in &#x201c;Other accrued liabilities&#x201d; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with the terms of the Settlement and a separate agreement with the Alabama attorney general, the Company placed approximately $395&#160;million into escrow during the fiscal year ended March 31, 2022. During the period ended June 30, 2022, the Company released $296&#160;million from escrow consistent with the terms of the opioid settlement agreements. The remaining escrow amounts were presented as restricted cash within &#x201c;Prepaid expenses and other&#x201d; in our Condensed Consolidated Balance Sheet as of June 30, 2022. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#x2019; abuse of prescription opioids. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poppell v. Cardinal Health, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CE19-00472. Although trial began in this case on July 18, 2022, the court declared a mistrial on July 22, 2022; no new trial date has been set. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#x201c;TCPA&#x201d;), as amended by the Junk Fax Protection Act of 2005 or JFPA, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. CV-13-02219 (HG). Plaintiffs seek statutory damages from $500 to $1,500 per violation plus injunctive relief. Plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#x2019; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving two named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $6,500. The Company appealed the finding of liability and the plaintiffs cross-appealed the denial of class certification and the ruling denying treble damages.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of a complaint filed by a relator, purportedly on behalf of the United States, 30 states, the District of Columbia, and two cities, against US Oncology, Inc. alleging that from 2001 through 2010 the Company repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 19-cv-05125. The United States and the named states declined to intervene in the case. On July 21, 2022, US Oncology, Inc.&#x2019;s motion to dismiss was granted without prejudice. The related case against other Company defendants remains pending, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 12-CV-06440 (NG).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reliable Pharmacy, et al. v. Actavis Holdco US, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. On May 25, 2022, the district court granted distributor defendants&#x2019; motion to dismiss the complaint, but granted the plaintiffs leave to amend the complaint. Plaintiffs filed an amended complaint on July 1, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company was served with a first amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., 27 states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Hart v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#x2019;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint. The relator filed the second amended complaint on June 7, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IV. State Opioid Statutes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect the Company&#x2019;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#x201c;OSA&#x201d;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#x2019;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. That petition was denied on October 4, 2021. In December 2021, McKesson paid $26&#160;million for the assessment for calendar year 2017 while reserving all rights to challenge the constitutionality of the assessment. McKesson filed a new lawsuit challenging the constitutionality of the OSA on May 18, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjA2MTU_2c1fda74-6426-42f8-af40-9954be4ed6d6">&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 18 to the Company&#x2019;s 2022 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#x201c;Claims and litigation charges, net&#x201d; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNDU3NQ_0dda3cf3-c341-4320-829b-03ca0b778879"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <mck:LossContingencyNumberofStates
      contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTc5NDEyMw_0d68fdb9-b4d9-4fbf-9ab4-cb7ec4518f00"
      unitRef="state">46</mck:LossContingencyNumberofStates>
    <mck:LossContingencyNumberOfEligibleStates
      contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTc5NDEzMA_25280d92-29b2-44c9-830e-cfdbdb1a7764"
      unitRef="state">49</mck:LossContingencyNumberOfEligibleStates>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="idd41c4e1c30c44259a7ba92d433dfc8a_D20220402-20220402"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNTAwMw_d98e1d45-ffcf-40b1-a587-8014bd03159c"
      unitRef="usd">19500000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="idd41c4e1c30c44259a7ba92d433dfc8a_D20220402-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDgwMTA4OA_30b6f975-58d8-4f39-9016-8ca03f104e34">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ia25c48fcadfa411c87b9b338ed7c17cf_D20220402-20220402"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNTAyNg_6e0fc6e0-6886-4cf1-b03d-94d47282dcd7"
      unitRef="usd">7400000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNTA2Mw_8aa0c0da-d5ad-4404-bed5-ca6710939e15"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
      contextRef="ibe98279f3daf4cac829f141c68680c29_I20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNTA4OA_3f2e0039-8da0-43e0-8177-5f43a95e98fe"
      unitRef="number">0.85</mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i91fd5b95930f48feafff5e007780cca1_D20220402-20220402"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0ODk0NA_e15cc137-6f1b-4187-aa36-d6b38f98e57c"
      unitRef="usd">141000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementNumberOfInstallmentPayments
      contextRef="i91fd5b95930f48feafff5e007780cca1_D20220402-20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0ODk1Nw_5cb3a147-beda-48b5-84a2-fc5375f4d909"
      unitRef="installment">10</mck:LossContingencySettlementNumberOfInstallmentPayments>
    <us-gaap:LitigationSettlementExpense
      contextRef="i91fd5b95930f48feafff5e007780cca1_D20220402-20220402"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDA1Mg_ec0be2ee-6ae8-4ed8-aa87-87ad72e2e0f3"
      unitRef="usd">33000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i7cce7634359c49e6bb6d0498ed0e65cb_D20220503-20220503"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDAzOA_1507f9ae-778e-4f52-8699-f15fe530bbd0"
      unitRef="usd">518000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="i7cce7634359c49e6bb6d0498ed0e65cb_D20220503-20220503"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDgwMTA3OA_f79a920b-b546-4f4b-926a-75a1e236a928">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="ib624e26e3984429eb8c566e69a33ac6a_I20220503"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDAxNw_dba03836-3ae5-412d-b024-393143008918"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ib6347fef3d684c6884e7d1d8b83e0f28_D20220503-20220503"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDAyNA_155b7069-d090-4b40-8dea-01cd3b4eaf1b"
      unitRef="usd">197000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ief5af3b3c7d04f4b9061d24c01dfc96a_D20220627-20220627"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM0MTgwNQ_904d489f-1cac-4318-a450-b40784d9cb00"
      unitRef="usd">250000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="ief5af3b3c7d04f4b9061d24c01dfc96a_D20220627-20220627"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjMyNw_d23e24f7-b802-41d4-87a1-ecd33c5431b7">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i1c5c1f1d6da349fcbcbcc5d4ee10b2db_I20220627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM0MTg5NA_0199e8d2-1f07-42f8-a191-0d84210131a5"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9c9164e71857427a9e3f6fb313e6f958_D20220705-20220705"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjI3NA_a9303a8e-5684-4cdf-af58-4e7307fb8e46"
      unitRef="usd">400000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="i9c9164e71857427a9e3f6fb313e6f958_D20220705-20220705"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjI4Nw_c9379166-284d-44ec-9b17-0e4399b07bfe">P11Y</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="ic78671dfdbde4f1da51669767a156413_I20220705"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjI4OQ_0ef70688-3f05-46ca-a1b7-6dc4eec3b78a"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i88b0d90d6afe4e72801e173856f8f730_D20220705-20220705"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjI5Ng_ec26d221-7607-43b9-bc4b-89227b5f1f5a"
      unitRef="usd">152000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i8dd43cb0b7cc4ad7a6b61b07881c8a2a_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDEwMA_39e04592-00e0-4ca8-b7ce-4d2269a37aa3"
      unitRef="usd">75000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="i49d09f3e82e04ef68ecb9c2396cd73c1_D20210928-20210928"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDExMw_137b869a-a2a7-4336-b436-0db4a42b35a6">P6Y6M</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="ie80fd48f4e8d4c678b4ce9cef44086f1_I20210928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDEyMw_3d3ce0b7-53cd-4399-95c7-0fe86a880e9d"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i49d09f3e82e04ef68ecb9c2396cd73c1_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDEzMA_5448b620-c78b-4739-91bb-6a52cfc63942"
      unitRef="usd">29000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i2f19aed3491848fe9a6318bd365640c4_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDA3OQ_e78f74f9-e3ab-44eb-abc1-1bd409a4dd3b"
      unitRef="usd">440000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="ib15c8902459948b8800a989e5b1ee1ab_D20210928-20210928"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDA5Mw_6c7d48d8-8fd6-44eb-a928-223b06ec26af">P6Y</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i20b65fe316bc46c7a65913e0e73468b4_I20210928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE0Mw_1519d902-ab3d-450e-ac87-d5719a068839"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ib15c8902459948b8800a989e5b1ee1ab_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDA2NQ_64a4879c-1bde-4087-8b27-83adb8f03345"
      unitRef="usd">167000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages
      contextRef="i20b65fe316bc46c7a65913e0e73468b4_I20210928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE1MA_d19c1834-98b0-4f3e-ad1d-733fa030e865"
      unitRef="number">0.85</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i55b70e47e8e34b20ab513c75c1bd8f1a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE1NQ_f5edc1d7-c69d-4592-ac3a-803c977df420"
      unitRef="usd">375000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="ibacb5dc687fb421890cdd8812f84593a_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzU0MjYwNA_1a4d3437-646f-4ea0-88ee-249dcda4b4ca"
      unitRef="usd">470000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjA2Mjk_55493d2b-9965-4a98-8d62-186a6767611f">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These amounts as of June 30, 2022 and March 31, 2022, recorded in &#x201c;Other accrued liabilities&#x201d; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i785cd0fca728419db26ae24ee9b6d389_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfMS0xLTEtMS0xNDA1MjM_c8632f32-dc3e-437d-9fd2-f1bf096393ee"
      unitRef="usd">759000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="ifc26f3e4e9d14faaaf590fbb3e98fd58_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfMS0zLTEtMS0xNTk4Njc_9a8d2928-8944-49cf-99e9-f173ff355af7"
      unitRef="usd">1046000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i785cd0fca728419db26ae24ee9b6d389_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfMi0xLTEtMS0xNDA1MjM_a3786005-cc96-4f69-bef6-ce690e4d0903"
      unitRef="usd">7132000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="ifc26f3e4e9d14faaaf590fbb3e98fd58_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfMi0zLTEtMS0xNTk4Njc_664ac320-7975-46f2-9e1d-4db88b8336a6"
      unitRef="usd">7220000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i785cd0fca728419db26ae24ee9b6d389_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfNC0xLTEtMS0xNDA1MjM_c7246c6e-409f-4db8-87e8-bbaedf2a65c2"
      unitRef="usd">7891000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ifc26f3e4e9d14faaaf590fbb3e98fd58_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RhYmxlOmY4MzljY2YyZmNkZDRkMGU4ZmFkZmZhY2I3OTcwMzVmL3RhYmxlcmFuZ2U6ZjgzOWNjZjJmY2RkNGQwZThmYWRmZmFjYjc5NzAzNWZfNC0zLTEtMS0xNTcwNTE_c2a4c29a-6357-486f-b077-e69d28715752"
      unitRef="usd">8266000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:EscrowDeposit
      contextRef="ib182ad32ae1a4140ba81d1576ebb67fd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE3MQ_dd4c04cd-dbb2-4eab-a94c-1318bcf28ea0"
      unitRef="usd">395000000</us-gaap:EscrowDeposit>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i3a1aa40a3d3642ff855da782b897135b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMTY0OTI2NzUyNDE4NQ_e2215022-7b24-4319-9f3b-d2ae3886ec5d"
      unitRef="usd">296000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia2ca6a0d3d4048d7928d1ed7a412b532_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQxNw_911f4562-c471-4e2b-81ad-7800c5f0b28a"
      unitRef="case">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i583c48262f76490389c5bfa859e9c30c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQxOA_80627d73-f240-419e-88b1-3d698bf8ce46"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="idf2512ace2434b2992e2e25b1b514696_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQxOQ_0e2d6d01-adef-4fcb-af60-3f0e55a550b0"
      unitRef="case">1</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="iefa43f959af643fa81156301548309e0_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ2Nw_e55493ed-c020-493d-9847-5b8e34e423e4"
      unitRef="usd">500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="i0d1725cc0bf34e1b9b6258af7a6286da_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ3Mw_b2c56c04-eaa5-4958-b446-22ae06ed3e23"
      unitRef="usd">1500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyClassActionNumberofFaxesRemainingintheClass
      contextRef="ia156720ce72f43da8c988dd169e9286f_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ4MQ_4f4c5935-77f6-4c45-a484-4046315a876c"
      unitRef="faxnumber">9490</mck:LossContingencyClassActionNumberofFaxesRemainingintheClass>
    <mck:LossContingencyClassActionNumberofFaxesReceived
      contextRef="ia156720ce72f43da8c988dd169e9286f_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ4OA_48ad6ae6-5ef9-40fc-afa9-8cf0abed95b1"
      unitRef="fax">48769</mck:LossContingencyClassActionNumberofFaxesReceived>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i95823add3af04d3eb3962971d102762c_D20220427-20220427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTQ5Ng_06e640bb-60b5-4a4f-ae29-31d5a8642dce"
      unitRef="usd">6500</us-gaap:LossContingencyDamagesAwardedValue>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="ifa5a8bf25a1c492f8877a4d52f7a8892_D20191209-20191209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDgwMTEyMA_ab23e7dc-8eb1-4659-af3d-71e4fea8d177"
      unitRef="state">30</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberOfCitiesFiledOnBehalfOf
      contextRef="ifa5a8bf25a1c492f8877a4d52f7a8892_D20191209-20191209"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMzg0ODI5MDgwMTEyMw_44889859-ade1-4c35-905d-2c6dfe7313a8"
      unitRef="city">2</mck:LossContingencyNumberOfCitiesFiledOnBehalfOf>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="id32341657ec2405d904a9a2b92c4f261_D20200701-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfNjU5NzA2OTg0OTUwNA_ea04a41d-cbd0-4003-86a9-02f0a32277c6"
      unitRef="state">27</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <mck:OpioidStewardshipActNewYorkAnnualSurcharge
      contextRef="ie9db5a1c9a3b4448b90e7d790fddd929_I20180430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDMyMw_59d14e48-0554-4e35-84e8-43cc4eb64dfb"
      unitRef="usd">100000000</mck:OpioidStewardshipActNewYorkAnnualSurcharge>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDMzOA_4eabab30-f588-4556-82f8-e44a881901be"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDMzOA_e9b9c19d-d4bd-402d-9160-35e2fd6e2dcc"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <mck:LossContingencyAccrualProvisionAfterTax
      contextRef="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDM1MQ_0f960824-9258-4663-81c4-2bf704e0db3d"
      unitRef="usd">37000000</mck:LossContingencyAccrualProvisionAfterTax>
    <mck:LossContingencyAccrualProvisionAfterTax
      contextRef="ib7e0a839a0e2482b897f6d805a0ca6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDM1MQ_4c9796c9-8f85-456a-8a19-89e43c336852"
      unitRef="usd">37000000</mck:LossContingencyAccrualProvisionAfterTax>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="if5b8f534c4f94a2286245c2844a0b617_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF82Ny9mcmFnOmE4OWU0MzUwM2UwZTRlNGY4NzUzMzQ0ZmRjYzAyOWY1L3RleHRyZWdpb246YTg5ZTQzNTAzZTBlNGU0Zjg3NTMzNDRmZGNjMDI5ZjVfMjE5OTAyMzM1NDQ1OQ_5bfcef80-a309-4bb7-9c39-b8c0fb6d294e"
      unitRef="usd">26000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDk0NA_1418d40c-0b6d-4f83-aabe-87380bd0339e">Stockholders' Equity (Deficit) &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the quarterly dividend was raised from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#x2019;s common stock. Pursuant to the ASR agreement, the Company paid $1.0&#160;billion to the financial institution and received an initial delivery of 2.6 million shares in May 2022. The transaction will be completed during the second quarter of fiscal 2023, at which point the Company expects to receive additional shares. The final number of shares repurchased and the average price per share paid will be determined based on the volume-weighted average price of the Company&#x2019;s common stock during the term of the ASR program, less a pre-negotiated discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#x2019;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. The Company received 4.8 million shares as the initial share settlement during the fourth quarter of fiscal 2022 and, in May 2022, the Company received an additional 0.3 million shares upon the completion of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#x2019;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. The Company received 4.3 million shares as the initial share settlement during the first quarter of fiscal 2022 and, in August 2021, the Company received an additional 0.9 million shares upon the completion of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other shares repurchased during the three months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total remaining authorization outstanding for repurchases of the Company&#x2019;s common stock at June 30, 2022 was $2.3 billion. In July 2022, the Board approved an increase of $4.0 billion in the authorization for repurchase of McKesson&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three months ended June 30, 2022 and 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the three months ended June 30, 2022 include gains of $64 million related to net investment hedges from Euro-denominated notes and gains of $12 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $31 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the sale of the U.K. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Losses on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the three months ended June 30, 2021 include losses of $22&#160;million related to net investment hedges from Euro-denominated notes and losses of $5&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $6&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNzk_62e2c683-fb1a-45e2-9d97-5e6f436e0868"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iae2bcb78271948b4a1ebf3f41dcd15bf_D20220630-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMzAy_60903bfa-eef7-4501-aab1-2b13f89c697b"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2151c060ee864dcf9cc0a315dedcb4bc_D20220701-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMzA4_0e4a60a7-2556-4ee3-b5b3-48874635a4c3"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NzMwNw_b305b8dc-4ea2-4148-9574-87d780a17625"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMTY0OTI2NzQ1MjY5Ng_b305b8dc-4ea2-4148-9574-87d780a17625"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NzQ4OQ_807b65d4-203c-43b2-8b37-4175887dfe85"
      unitRef="shares">2600000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifef2c199d98e42be9e9661e3aba687b3_D20220201-20220228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDQ5OQ_46d6df2e-0f9d-4be9-a461-74554f1f84c4"
      unitRef="usd">1500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ifef2c199d98e42be9e9661e3aba687b3_D20220201-20220228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDQ3OA_36d76833-e4f2-457d-90ba-86be0962c962"
      unitRef="shares">5100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ifef2c199d98e42be9e9661e3aba687b3_D20220201-20220228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDUxMg_2ae1e72f-e8f0-4475-89bb-7ef6e3ad03b0"
      unitRef="usdPerShare">295.16</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8c0920ece63d40bcb5b7571d38f78484_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDU1OQ_f17cdd30-1857-4803-ac32-c555ebbedd27"
      unitRef="shares">4800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i50caffa774044ac7bd8bd4d19cf3739a_D20220501-20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDU3OQ_ecd9d117-eda0-465d-b169-ca7677f09a0e"
      unitRef="shares">300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMTQ1MQ_70c86f44-6077-408d-82f5-670f91f66a0e"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMTU1MQ_da572f26-6914-4a31-a7ef-224395d7b540"
      unitRef="shares">5200000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMTU5NA_7f586fac-c5cd-496f-a767-87c19fd5fa1b"
      unitRef="usdPerShare">193.22</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if08c7d73dfb148189fb060dd86126d7a_D20210501-20210531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDUyMQ_0888628e-2772-4015-8846-2aa120a3c2e3"
      unitRef="shares">4300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2221b7fadd8a4d1f9694fd8e401e6039_D20210801-20210831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3NDUyOQ_d91c8183-ab5b-4966-b14d-a15efcb15a5e"
      unitRef="shares">900000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMjYwMQ_2490441c-4fe5-4d66-9400-2ce4f0457864"
      unitRef="usd">2300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iacb94994718b406dbc1a53f8dab8d938_I20220731"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3OTIwNQ_865ca8cb-7c50-4466-a818-079375b7ef09"
      unitRef="usd">4000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDkzMw_a60144e6-1be7-43e5-80ba-2101098c8b54">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three months ended June 30, 2022 and 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the three months ended June 30, 2022 include gains of $64 million related to net investment hedges from Euro-denominated notes and gains of $12 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $31 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the sale of the U.K. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Losses on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the three months ended June 30, 2021 include losses of $22&#160;million related to net investment hedges from Euro-denominated notes and losses of $5&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $6&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04054837ec0342f9b8450625e682723a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi0xLTEtMS0xNDA1MjM_58a5138f-df2e-49f7-b74a-2da616fcdc2a"
      unitRef="usd">-1504000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6d27ffef9104861bb0e13a1caea6f92_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi0zLTEtMS0xNDA1MjM_5332c0de-7076-429d-adf2-b668e52a9a4a"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i142d11dab4f1472296e0e34a0a568a1c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi01LTEtMS0xNDA1MjM_b65a553b-1fc6-461b-a567-5edd2fcff059"
      unitRef="usd">27000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae923b8233e9431eb94789aba9fc18b0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi03LTEtMS0xNDA1MjM_8e95603c-7ad9-4283-b160-9fb8f3646751"
      unitRef="usd">-67000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i778742d22ea2469ba0d763c4abaf0a0e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMi05LTEtMS0xNDA1MjM_539a9540-cddb-47b0-b969-48086c9fc7af"
      unitRef="usd">-1534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy0xLTEtMS0xNDA1MjM_265d2d4d-afe3-4779-8efe-7f81cce224cf"
      unitRef="usd">-176000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy0zLTEtMS0xNDA1MjM_264df7ef-fd77-4d9e-96bb-08f957ed527a"
      unitRef="usd">45000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy01LTEtMS0xNDA1MjM_86a4ee77-e3a6-4eee-9a7d-03c48f0433a7"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy03LTEtMS0xNDA1MjM_2c746a82-c029-4e59-97dc-20e2cb108fad"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfMy05LTEtMS0xNDA1MjM_65fe186c-6796-4078-8146-4f8362b86fcb"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC0xLTEtMS0xNDA1MjM_1a267a33-f34b-4e27-8228-7834b7abfcab"
      unitRef="usd">-730000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC0zLTEtMS0xNDA1MjM_a9f52360-b0a7-426b-b28c-7db2ed5559d1"
      unitRef="usd">17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC01LTEtMS0xNDA1MjM_86f7a083-4c93-4dd3-86eb-b98f43eb9f6a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC03LTEtMS0xNDA1MjM_bb254138-e0f2-4a15-b65e-478f1482d42f"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNC05LTEtMS0xNDA1MjM_82fe7246-97d2-4858-be5b-043e73ff3408"
      unitRef="usd">-737000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS0xLTEtMS0xNDA1MjM_bd26ccab-e1f8-47d4-a5f2-7ec30eb7de4f"
      unitRef="usd">554000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS0zLTEtMS0xNDA1MjM_b02967c7-db67-4e00-8fb8-e1b5ad9f682b"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS01LTEtMS0xNDA1MjM_532be715-92ee-490e-9a42-34d07e77a852"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS03LTEtMS0xNDA1MjM_c7e1a0c2-afed-49f8-8f11-076dea759cf9"
      unitRef="usd">36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNS05LTEtMS0xNDA1MjM_464f8c02-e344-44e3-992d-5bf5fc1bab1d"
      unitRef="usd">636000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi0xLTEtMS0xNDA1MjM_45b5fc8c-2525-4ea6-bd53-8b578255cb25"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi0zLTEtMS0xNDA1MjM_9532c625-5add-4f91-a17d-7dedb1dba312"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi01LTEtMS0xNDA1MjM_fb1e7e6a-d263-4064-b074-be10c9b7cc69"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi03LTEtMS0xNDA1MjM_2639eebb-2207-4016-9378-a151ef45fd1c"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNi05LTEtMS0xNDA1MjM_37e10775-11dd-4fe8-a00e-264d3718f215"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7c7300f1bf9f44da849b792b8e11ac41_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy0xLTEtMS0xNDA1MjM_52a9f9e4-de44-4cbb-b286-767b165e20e2"
      unitRef="usd">507000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy0zLTEtMS0xNDA1MjM_92d0f6ab-d5f6-454d-a094-4653eb0e7916"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i37490c23e8cf453285fc4ad132ac43f1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy01LTEtMS0xNDA1MjM_ca256bb3-b8a3-40ae-9924-a23f9acd1fa9"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7533b3ab49714dc1b8a3517100cfd688_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy03LTEtMS0xNDA1MjM_b6376ad5-abe1-4bed-9f52-922db1aa304d"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i26669e4b3ada4d34ab1eb909402db13b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfNy05LTEtMS0xNDA1MjM_86d119dc-af4e-42b9-8971-6169756182cc"
      unitRef="usd">586000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i37c3f3f9cc2a4fe5809c48e5837aa33b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS0xLTEtMS0xNDA1MjM_c5f57cd2-a7aa-4ab8-86f9-2ecfaba1af82"
      unitRef="usd">-997000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia153c233c3224f40b8bee60f5ca03330_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS0zLTEtMS0xNDA1MjM_88cb56f1-b82f-42b4-aeac-829d62458a91"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d3b36ae57df4556b852d256a5051b7c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS01LTEtMS0xNDA1MjM_900ac49f-cdeb-4010-9661-69c694b529ab"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i834def9396054b11a7467a8892ddc33e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS03LTEtMS0xNDA1MjM_9081b5e6-45eb-473d-b29a-78a1f57ef11e"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i826edda2198046dba4823c7a7d93044e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOjdjMTFmZjAxMDU4YjRmMzNiOWY0NWU2ZTcxN2U1YTk4L3RhYmxlcmFuZ2U6N2MxMWZmMDEwNThiNGYzM2I5ZjQ1ZTZlNzE3ZTVhOThfOS05LTEtMS0xNDA1MjM_6c3c1f16-ada7-425e-85dd-bf4069cb1013"
      unitRef="usd">-948000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i41ebb607246c4e2991322746c42fa818_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3OTM3Ng_871a28d1-678e-4897-af68-35995ec5e1c7"
      unitRef="usd">64000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="iedcceae98f1745c18c291607c35f1154_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNjU5NzA2OTc3OTQwNQ_7469232a-b03c-4e89-ab69-15ca36df953a"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i88945fe93d164d4f80415f74b3218fa9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfMzY3NQ_005c50cc-e44e-4d48-a642-f88fce5348d7"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0586dbdd097949bc84d2b6538b7c21a1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi0xLTEtMS0xNDA1MjM_e0199cce-c9e1-4634-9a5f-b667a889fa4d"
      unitRef="usd">-1361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibea2a408cb5143869cd6f99a7f554856_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi0zLTEtMS0xNDA1MjM_cebadf1e-fe98-477d-a14d-8c3863eef943"
      unitRef="usd">-36000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8f74d47337f44069d4abbae67a7e76f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi01LTEtMS0xNDA1MjM_cd7f75a4-d711-4383-80db-9c8e138afcb6"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i812bd8eaa6f848db94fa9829cb892c51_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi03LTEtMS0xNDA1MjM_5abb0a37-1b05-4bb9-9f59-00b4d17c9827"
      unitRef="usd">-96000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i37c280e5ed9e46c793e2b72e48c5aa9b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMi05LTEtMS0xNDA1MjM_42da4b5c-89a7-47a2-96a4-ad4472aee17e"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy0xLTEtMS0xNDA1MjM_5deb5020-0f46-4f3f-83cd-61df5dbe6b56"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy0zLTEtMS0xNDA1MjM_a405bc70-d13e-4bd5-acbe-a3e86ee1f6b1"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy01LTEtMS0xNDA1MjM_d7306d20-9705-4666-85ff-053341f4a083"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy03LTEtMS0xNDA1MjM_e8d7a10f-c875-44df-90dd-dcb509944725"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfMy05LTEtMS0xNDA1MjM_17dc6117-0d0c-4e81-8ae7-a09227c6bf83"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC0xLTEtMS0xNDA1MjM_b4bedf37-e44d-49f8-acd8-33aeb61528d9"
      unitRef="usd">-17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC0zLTEtMS0xNDA1MjM_f9593eda-dce6-4a2a-89b0-c80741b11cc9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC01LTEtMS0xNDA1MjM_ea000518-a950-43eb-9322-8bb116df7734"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC03LTEtMS0xNDA1MjM_e24e4f7e-b535-4baa-b79b-4007e89e5c46"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNC05LTEtMS0xNDA1MjM_ea2ab4b5-0476-42df-a4bd-0e921f6e0f1e"
      unitRef="usd">-14000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS0xLTEtMS0xNDA1MjM_a3399204-3c67-4577-8000-e2992c906deb"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS0zLTEtMS0xNDA1MjM_5371680b-7e6e-4904-92a5-42a5e5b3df29"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS01LTEtMS0xNDA1MjM_de0f9bfd-317c-4e9e-b881-88509769f191"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS03LTEtMS0xNDA1MjM_cd50c416-de0e-4030-b274-d097bafffd42"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNS05LTEtMS0xNDA1MjM_09551afd-48d1-4cc2-9efb-e53a13f24347"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi0xLTEtMS0xNDA1MjM_a1861a4b-810f-4ae9-ab2c-91779a324bb0"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi0zLTEtMS0xNDA1MjM_70428d8b-d476-4208-9ffc-bd5eac4fdd1b"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi01LTEtMS0xNDA1MjM_ec3e72e3-2cb5-422d-99aa-897a22f2697e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi03LTEtMS0xNDA1MjM_f0cba52a-87e6-498e-b1c1-551065d3b1cf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNi05LTEtMS0xNDA1MjM_e32f477a-e256-43b7-b1f8-d7a0744f2d3c"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy0xLTEtMS0xNDA1MjM_4b72dc40-0d00-4e02-9521-155843b800a7"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy0zLTEtMS0xNDA1MjM_13023e93-ab2e-41d8-9ef8-29be183e13a5"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy01LTEtMS0xNDA1MjM_2a77fc77-1784-4dd9-9c41-5f920ab1a64c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy03LTEtMS0xNDA1MjM_ee0250f0-59f4-436c-8670-97ff482912b2"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfNy05LTEtMS0xNDA1MjM_f821314f-4e44-4077-bd7a-04a70ffaf627"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i48723ecc89164f63a596685462e8682d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC0xLTEtMS0xNTE1OTE_909deb4a-7f38-42e4-adb6-5ddf1cef91b7"
      unitRef="usd">-158000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC0zLTEtMS0xNTE1OTg_0200f09e-4dee-4bc6-984b-fedc130c3a17"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i28e9c25bdf914c978eb65f6969dbb281_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC01LTEtMS0xNTE2MDU_01c307e7-bdfb-4d5a-adfc-41640d318787"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i5d261a1721234c73ac0e35c56cf8cfdb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC03LTEtMS0xNTE2MTI_a1be618a-c9f8-448e-999d-29044e1c46a0"
      unitRef="usd">-12000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ie9e80d5161fa452aacace79c9a1a900d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC05LTEtMS0xNTE2MTk_d8259ce4-aebb-4a16-a998-df4d1feec530"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a1ba08501874acda7d8038964225375_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC0xLTEtMS0xNDA1MjM_bfc8d102-e9d9-46ee-89f6-37299a6b5bf0"
      unitRef="usd">-1477000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibfb860711704471396b6ab18f5a00a89_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC0zLTEtMS0xNDA1MjM_ac0e34c2-a431-4ccd-bf26-8516abd9d51a"
      unitRef="usd">-57000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f48074346a94363895ed8e84a8026ab_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC01LTEtMS0xNDA1MjM_017b9356-4f2a-476e-af5d-eabf928f3985"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4499ac651c794efc9fddcb3b54af3036_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC03LTEtMS0xNDA1MjM_7601dad3-46e3-4a89-a2c6-7fbc39ecb385"
      unitRef="usd">-106000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7db9df2543f7470aae07e22c69f7fa2a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RhYmxlOmZkYzIxMjIwZDY1MTQ3NGRhMDExYjQzYTI5NWNkYWY1L3RhYmxlcmFuZ2U6ZmRjMjEyMjBkNjUxNDc0ZGEwMTFiNDNhMjk1Y2RhZjVfOC05LTEtMS0xNDA1MjM_078f197f-2f8b-43ce-ac52-ed28035c90a5"
      unitRef="usd">-1627000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ic770e7e260c6494e91714f00ee4061af_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDMyNA_241938f6-30bd-441e-bd34-93cee3236034"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="if7abd9fb0b51412e99b4001e9c3d02c3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDQwMg_bef11259-8663-4592-a87a-72e9564da86b"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i3d7b696d78ce432f94917b80a35cafd0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83MC9mcmFnOjFjMWVmYjc5YzA0YjRlNWU4NWY2MzkyNjYwMDQ4ZjZmL3RleHRyZWdpb246MWMxZWZiNzljMDRiNGU1ZTg1ZjYzOTI2NjAwNDhmNmZfNDUxMg_91335204-8fa8-4e9d-8837-3388deaa0b15"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNzYxOA_4c5b200d-568f-4af1-a4ac-c15311d154d5">Segments of Business&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment serves McKesson&#x2019;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 285,000 national brand medical-surgical products as well as McKesson&#x2019;s own line of high-quality products through a network of distribution centers within the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#x2019;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 10 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#x2019;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of fiscal 2022, the Company entered into an agreement to sell the E.U. disposal group which is anticipated to close within the second half of fiscal 2023. International segment assets at June 30, 2022 were $10.9 billion, a decrease during the first quarter of fiscal 2023 primarily due to the completed the sale of the U.K. disposal group. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 35% of the RxTS segment&#x2019;s total revenues, less than 1% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are derived in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three months ended June 30, 2022 and 2021 includes $13 million and $23 million, respectively, of credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the three months ended June 30, 2021 includes $164 million of inventory charges on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for the three months ended June 30, 2022 includes charges of $94 million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;gains of $106 million for the three months ended June 30, 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $5 million and $74 million for the three months ended June 30, 2022 and 2021, respectively, related to the Company&#x2019;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $19 million and $35 million for the three months ended June 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;restructuring charges of $62 million for the three months ended June 30, 2021 primarily due to the transition to a partial remote work model for certain employees.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNTc_2d330914-5886-4c28-a337-261240bb4b12"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <mck:NumberOfNationalBrandMedicalSurgicalProducts
      contextRef="i4f241c72875e4d98bd23bb25744707d7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc3NTQzOQ_c6697b49-7fd7-419a-a868-1ff3d0a3b904"
      unitRef="product">285000</mck:NumberOfNationalBrandMedicalSurgicalProducts>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="i2c6e06d925d44f989655a7673bdde907_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMjU5OQ_3609a219-aa77-48f6-beec-8d8030c8a7cb"
      unitRef="country">10</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <mck:NumberOfBusinessOperations
      contextRef="i2c6e06d925d44f989655a7673bdde907_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMjcwNA_4c04eb51-89f6-4a44-b596-b7dff35410fb"
      unitRef="business_operation">2</mck:NumberOfBusinessOperations>
    <us-gaap:Assets
      contextRef="i403f9ff68d8c4127940b5ac3bf567cb2_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc4MDQxOA_7e35d47f-0e0d-4154-a4a2-4bc0b99d0846"
      unitRef="usd">10900000000</us-gaap:Assets>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNzU4Nw_8a86aced-f76b-4e28-b693-b2286b5fd06a">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 35% of the RxTS segment&#x2019;s total revenues, less than 1% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are derived in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three months ended June 30, 2022 and 2021 includes $13 million and $23 million, respectively, of credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the three months ended June 30, 2021 includes $164 million of inventory charges on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for the three months ended June 30, 2022 includes charges of $94 million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;gains of $106 million for the three months ended June 30, 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $5 million and $74 million for the three months ended June 30, 2022 and 2021, respectively, related to the Company&#x2019;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $19 million and $35 million for the three months ended June 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;restructuring charges of $62 million for the three months ended June 30, 2021 primarily due to the transition to a partial remote work model for certain employees.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e71847d225b4930bef9de929f3f2a3c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMy0xLTEtMS0xNDA1MjM_b2d9481e-78bb-4a19-9c8c-e5256c1fc1a0"
      unitRef="usd">56947000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5de3e5bddea84662aeab82793750ac17_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMy0zLTEtMS0xNDA1MjM_9344bddf-f947-4a9d-913c-81616f6103a5"
      unitRef="usd">50019000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9167671dc7c472eb51af611bf7cc7e4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNC0xLTEtMS0xNDA1MjM_0a8865bc-20ee-4142-ab46-15d6390fdf79"
      unitRef="usd">1066000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1577c607c8ab49f392ecdd91decbed0f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNC0zLTEtMS0xNDA1MjM_24e16ab9-de8d-4cb6-9a46-d46fa3fffcc6"
      unitRef="usd">881000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c30ffbc257945ba83eb82993a8be420_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNS0xLTEtMS0xNDA1MjM_9771a063-31fe-4662-9f99-9c19ea2ca22e"
      unitRef="usd">2592000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4001c0764b641b489a0e6a821b1bc2a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNS0zLTEtMS0xNDA1MjM_605ec906-a4aa-49c4-899c-6030a9d50a38"
      unitRef="usd">2528000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b46e42465d84c47a2183912a0e10716_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNi0xLTEtMS0xNDA1MjM_edd7e390-f265-4fb3-b93f-1b6e71043a15"
      unitRef="usd">6549000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb05392f0a4c4daea446534a262c49ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfNi0zLTEtMS0xNDA1MjM_471fbe98-5650-49ac-9105-8a5de66955f2"
      unitRef="usd">9246000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfOC0xLTEtMS0xNDA1MjM_72ecd8e6-47eb-46a0-bb72-072b31151865"
      unitRef="usd">67154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfOC0zLTEtMS0xNDA1MjM_aece903d-490d-46c5-b083-a67437222a85"
      unitRef="usd">62674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTEtMS0xLTEtMTQwNTIz_cfc2b1b9-b0bb-48c7-9f8d-f048665d248e"
      unitRef="usd">696000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTEtMy0xLTEtMTQwNTIz_3e49565f-9f0c-4bf1-a32c-ca7885653922"
      unitRef="usd">682000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTItMS0xLTEtMTQwNTIz_16caf4f2-d60d-4b62-a43e-ddd5f8987bb8"
      unitRef="usd">144000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i69c95d706a9249e89a58327f3f15beff_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTItMy0xLTEtMTQwNTIz_ba282d4c-9279-4a61-ab46-71158ca9ac68"
      unitRef="usd">104000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTMtMS0xLTEtMTQwNTIz_c83851fe-9c91-4a32-ba2e-6dc1d58e7f48"
      unitRef="usd">256000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTMtMy0xLTEtMTQwNTIz_f012af7e-a24c-4975-a9f5-fc79e09ce6dc"
      unitRef="usd">75000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTQtMS0xLTEtMTQwNTIz_08f41dd9-3360-4e43-acb0-1e11212ebeaf"
      unitRef="usd">-6000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie3b7e5ba217f4ed7a9237fbc6f4419a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTQtMy0xLTEtMTQwNTIz_dcc3672b-2834-4a03-92b8-52b56e278746"
      unitRef="usd">53000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iac647f2ab1ea4e1aab5af149078db642_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTYtMS0xLTEtMTQwNTIz_2e2276e7-f718-4e12-90a0-d724a987e661"
      unitRef="usd">1090000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2aebb076b6b54144a3cd96e1ece30f3b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTYtMy0xLTEtMTQwNTIz_e2b3bfac-7c66-4680-a0d4-3b80f145bda5"
      unitRef="usd">914000000</us-gaap:OperatingIncomeLoss>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTctMS0xLTEtMTQwNTIz_b3138afc-68f6-402c-88bf-d99032e81391"
      unitRef="usd">39000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTctMy0xLTEtMTQwNTIz_fd0e09ed-2ccc-42f1-bf63-8105d70315c5"
      unitRef="usd">303000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:InterestExpense
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTktMS0xLTEtMTQwNTIz_b231418d-b62b-4ebf-97b7-38d0df4bfa0c"
      unitRef="usd">45000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMTktMy0xLTEtMTQwNTIz_d6100681-be18-4bcd-a2ed-e502bdbd4794"
      unitRef="usd">49000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMjAtMS0xLTEtMTQwNTIz_7ee8eee9-6df8-4082-a201-dcfc1f1afdb5"
      unitRef="usd">1006000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RhYmxlOjk3YTk0NDBhOTU1YzRlZjI4Nzc1NmEzMTI3MjVhNTA3L3RhYmxlcmFuZ2U6OTdhOTQ0MGE5NTVjNGVmMjg3NzU2YTMxMjcyNWE1MDdfMjAtMy0xLTEtMTQwNTIz_03857324-e32d-45d3-8009-c114b77d385e"
      unitRef="usd">562000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzQzNQ_ed491ba7-d861-4a43-8d74-14a4bcfe1499"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="id61c5d11f2c74f85888d2a277c1cfc43_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzUwMQ_28eecc11-83a6-45fc-b80d-264b9589502c"
      unitRef="number">0.35</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i4d9c1e7245bc47ffa0318c9ef9864058_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzU1Mg_b877f328-972c-4b16-b6dc-b4a753481138"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i9aac3ab068164da3a45be34214805860_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzYyOQ_bb8db312-6601-47e1-803f-972e16f7098e"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:NumberOfReportableSegments
      contextRef="i507200d519254ee5b810cc4ba9c9eb26_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfMzc1OQ_0b3603e5-6dd1-4cae-b3d4-9bcf6df24a9c"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ib92b078a5ebd4294a739596193afc6d7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNDAzNA_ead8fe34-56ce-4f41-bcce-37fe62e6dfca"
      unitRef="usd">-13000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i6296f29ffd714ce28ce3e6f5137232c0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNDA4Mw_d2d21aa0-2857-44c0-a03d-b7a9623f557c"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryWriteDown
      contextRef="i78a5c6ea7c574b1c9c0928ec09ac9f71_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNDU1NQ_cf02ed5d-a421-4f7b-8a4a-a675c1b17c66"
      unitRef="usd">164000000</us-gaap:InventoryWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ia2177f40437f42b6809296d7905c7869_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNDk2Mw_0e9461d1-da76-4967-8e9b-62763ac6dd91"
      unitRef="usd">94000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i8cd60915c3dd465caaf23b140f67daf3_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc3ODgxNw_b44b71bd-9a0b-40da-a602-45a7dfdc0621"
      unitRef="usd">-106000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i4588d9a710614530af4777a0d6ec981e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc3OTE3Nw_3992d362-91a3-4bb5-9d27-91ce7053881f"
      unitRef="usd">5000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ie6158e4d86384dd3835014e2ff918ab3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjU5NzA2OTc3OTE4NQ_fda9d42f-936f-4294-9dfa-0f2b43e1108e"
      unitRef="usd">74000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LitigationSettlementExpense
      contextRef="i7cb66cdf2011438e8e70e27b549a9862_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjY2NA_e8560d60-1bc5-4503-9325-b746e06669ab"
      unitRef="usd">19000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i3b9d7a308dd141549bede7bfa3e5cbf0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfNjcwOQ_be9a4d67-5dd8-4411-9ce0-837f54f0b2b1"
      unitRef="usd">35000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:RestructuringCharges
      contextRef="i2cd0e069c40b44408bffab096f6ad37e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhMzc3MzBlNTgwOTQ0MDdiODlmNDYzMGZjNmM2YjJkL3NlYzpkYTM3NzMwZTU4MDk0NDA3Yjg5ZjQ2MzBmYzZjNmIyZF83My9mcmFnOjRkZGZmNzhhZTBkNzRmNzQ5MTFlN2IzOTQ1M2RkZGQ2L3RleHRyZWdpb246NGRkZmY3OGFlMGQ3NGY3NDkxMWU3YjM5NDUzZGRkZDZfODc5NjA5MzAzNzIxNA_bbdc54e6-ca76-4d0e-8df0-feae4c52c490"
      unitRef="usd">62000000</us-gaap:RestructuringCharges>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>79
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1MG 2WC<;*PF*1)T(*RY"]O)Z]4P&P&WV6KDM*J^+>2[77AK2L-V3BOQ'D7
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MWZ(Q^KKPT)M?WJ)J&96D0FF.+M(LH]JLWJ%?]M^>3&K:Z";T).X:^&G;0.-
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M7-DG6=>QGD.2I=*BJ,%80<%XM=+[>@Y;@'9G#\"O ?Y3P-$>0% #@I=FZ-0
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M2J]U@G(F*TFM#"U**S(SH5&R[#;#OQ!($X#G<R'TQC )FO]:^!=02P,$%
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MIK]$9*K\BYZWMMT62C9*BWS;&!3DO*@^Z<MV(/8:0#_N!GC; #<;Q)X&9-N
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MX1(OOV )\T5RBB',IX^B!V 'CV(&%]-CK""*3C""Y?^,#(RC^>572  :-TC
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MK@24V9 !OE]HI!P_T +;]UL7_P-02P,$%     @ =XP#59WDF])8!   "@H
M !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULG5;;<MLV%/P5#./F2=6%
MDF/7EC1C.<DD;=/QV''[T.D#1!Z):$"  4#+[M=W#WBQ-+$]35\DXG(6>Q:+
M \QWUGWQ!5$0]Z4V?I$4(51GHY'/"BJE']J*#$8VUI4RH.FV(U\YDGD,*O4H
M'8_?C$JI3+*<Q[XKMYS;.FAEZ,H)7Y>E= \KTG:W2"9)UW&MMD7@CM%R7LDM
MW5"XK:X<6J,>)5<E&:^L$8XVB^1B<K::\?PXX7=%.[_W+3B3M;5?N/$Q7R1C
M)D2:LL ($G]W=$E:,Q!H?&TQDWY)#MS_[M#?Q]R1RUIZNK3Z#Y6'8I&<)B*G
MC:QUN+:[#]3F<\QXF=4^_HI=,W>*%;/:!UNVP6B7RC3_\K[582_@=/Q,0-H&
MI)%WLU!D^58&N9P[NQ..9P.-/V*J,1KDE.%-N0D.HPIQ87G5ZKLB0QL5_'P4
M@,ICHZQ%6#4(Z3,(4_')FE!X\<[DE!_&C\"FIY1VE%;IBX _UV8HIN.!2,=I
M^@+>M$]Q&O&FS^!=4U".8*309RG^O%C[X&")OYY*N,&;/8W'Q^3,5S*C18)S
MX,G=4;)\_6KR9GS^ MM9SW;V$OI_VI#O0Q"?"Q(&Y[LBIVRN,D'W.-.>!,XT
M.QCQN5@WLT751E=:&B]VT@MC QP7$"QU#"&9%<)N1 !N*!R1*!L'$#M 8/^H
MWS\A3<X?DZ&XE+X0&68ZM:[Y2'H1+(. 2;L:.1)'4_A<ZWAD$7LTF?5M7OR[
M%AV@;OB*XLG7#\.H1.7LW^A!3&V0;^8HQU])H;"Y4%Z FE;_8%@9]$I?.V6V
MA_IU&G4ZVCMJB%%9:?M Y%^_.DTG)^>"W:$R$EIMJ*=_(/%0W!I'F=V:N"@L
M6<NHM+;>$]*[SP@,06$R_J%3?8OZBPWIFH\I=;MHUUIM9:Q[[:(HN5^0PYW4
M-7&<!#J\(:&X+*T+<7767/#!X%KV(QN+2QY$Z3.4^$"QAJY<\9G6I@XU0+I,
M&Y%\W +6)]**Z3<M:3)LQ(47E72A2^!=[7#-2"-R;)0/*B+&@JV"@@BY\JB%
MOMT4B\&<@E2:F^^5 28K]IL-)-*!8/'3\?D'TGG4_$9J&L3.R7DOOE9RC8V.
M\&!Q=/+3H>U.CQ_;<<:W#OLD'0["=-)T'7IMT)A9F4S7>?1:WBJ8R2KN2\OR
MUST>1<?8[S-&CAQW:0%A6 -\>:M5+EG:E82+H/L-7P&>N1X(.[P=LGJ5!21L
M8^MJ*-XVEN;QC7(^B*^P7&NG#93&3"0T';3+EI4T#Q!\SZ6=B*V)6+_9H7X.
M]ZYDLD?3<3_ MLNRNJQUI&Z![U 12I31@A'O*+J>@^.$ICQ$-3B6:]GM\)=O
M$_J\=ZA:2H?J[U0H5"_Y13/E0.W_(7;KBT,7#)^Z D9[]W-);AM?(1Z9UR8T
M5W7?VS]T+IK[_7%Z\TK":EN%4JEI@]#Q\.0X$:YY>32-8*MXVZ]MP-LA?A9X
MK)'C"1C?6)R2ML$+],^_Y;]02P,$%     @ =XP#51$H>[FM#   U2P  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3@N>&ULU5I;<]LV%OXK&#73L6=L61=?
MTCCQC"]QZV[39N*D^["S#Q )2=A0A J =KR_?K]S0%*@1,J.VVUW7R21 @[.
MY3M7\O6]L9_=7"DOOBRRW+WIS;U?OCHX<,E<+:3KFZ7*\<_4V(7TN+2S [>T
M2J:\:9$=C :#XX.%U'GO[#7?>V_/7IO"9SI7[ZUPQ6(A[<.%RLS]F]ZP5]WX
MH&=S3S<.SEXOY4S=*O]I^=[BZJ"FDNJ%RITVN;!J^J9W/GQU<4CK><&O6MV[
MZ+<@22;&?*:+F_1-;T ,J4PEGBA(?-VI2Y5E1 AL_%;2[-5'TL;X=T7]FF6'
M+!/IU*7)_JY3/W_3>]D3J9K*(O,?S/T/JI3GB.@E)G/\*>[#VF,L3@KGS:+<
M# X6.@_?\DNIAVC#RT''AE&Y8<1\AX.8RROIY=EK:^Z%I=6@1C]85-X-YG1.
M1KGU%O]J[/-G/ZATIO.9."?M:*^5>WW@09?^/4A*&A>!QJB#QEB\,[F?._$V
M3U7:W'\ ?FJF1A53%Z.M!'\L\KX8#_;$:# :;:$WKH4<,[UQ![TK9?6=)/.+
MF]QY6P!5W@F9IV)3?G&E79(95U@E_G$^P7(@YY]M6@F''K8?2M[TRBUEHM[T
MX"Y.V3O5._OVF^'QX'2+2(>U2(?;J#_1;E]+ ^H1?JY$3H#/1&(*ZY0P4S$I
M'#8[M\=_7YK%4N8/0CNAOBR-4ZGP1NC<*PCJA95>L7(1,^ 5.7!LK<J3!ZQ.
MYC*?J;!DFA6)+R1YI^N+<R\\W'WMB$PO-$R%6V#$:O>9?EM3S.:\K CLI;6!
M856'2Y=8/0%;$XHZ?1)+)HFQJ<P3!0_S\_B0;[]Y.1J>G#JQ-)E.'O::Y  #
MDV</=!1+).:EVI:%)=G!^HT7J<':W'CF*-Y/.P"AE';@IUNJI,@"%E<$/D82
M@P DT-,IE)E[L@'I=2DM&XC(D4)61V!%SAAU9 2$"&CLWXKE8^,0CO%'8E6J
M/:L0UHP8EKG7B5Z207*3[R^5Y5!/BIH\E(HO3^^+Z]*BEY5%WU86_4"$8SG
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M*Y#N:-@ZC9JK<7-DUTPQCV06M/MWRGKQ@BJUJ+GF@3H'<EZ?J@G/43O(44D
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MXB_T"JD' 5+(NT,:DB9%9QK%7W0 6S!#78"W:^*X4)V")SD;:660["%20=_
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MJ:C:%K@V:./Z(;\K"EO#F20_Z+)>&95<=^RG:JDP.SY'3W(?$YM9RJEH=$%
M&H9T!N^I:D $F":;GAPJ+!5\V5VRX4))*/TM.B<U9F8E>22;#7S5A[*J2*=N
M$1D4WY[(DQ]932< 74BSR&GD1\DDN?I^=G$XG9Z<]Q(7!M(+\+SP??Q2A;=
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M-1'#1U]R*<+EVLI7 UR73K!<ZY+DVDED[GW[ZI]ZN^.3WF6+GC5<XV>8"AO
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MGNG%]/CPXZ6-/50J'0TYG/<_(NX\RA]\>93>\0V/",_>43S&3XQ5+?Z\=WC
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M +S?&IC1W- "W7?LR_\!4$L#!!0    ( '>, U7"^4TX7@L  )<?   9
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M0(L>*:9$YV,B);&CF=W4EK,+0,76$<L@(.72BRE">U]W>P>^6G>VO[3XAVG
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MOFOME\=7UI@F^5ZX5%MLG5\^?C@1+KX%CE^"K?G-Z\8&H#=_+#!!*T<+\)P
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MFM.O!S1>@,XSK5VW\!=L?X\L_@%02P,$%     @ =XP#5<T#3J;!!0  6!$
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MY!DPD4/.B]I@#GC@5A&WK$FHMA1/\3IO^6&'_\LBN,NJ%70$Z D\[!3B47$
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M!3XJT'W7,?5Z@UQN9U[D[38^MZNUL1O!?+IA*WQ"\V7SJ&@5[%F:MD.A6RE
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MJT#?EY),'Q?V@/T_DOD_4$L#!!0    ( '>, U4QK,GQ@@8  +05   9
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MGWS^0%FF0.ERJ5[XOHD2?;_KL_R@/UP-^J_*-_5JJ1$M50?YE5<;.E;EJC>
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MH_FT5]=^>^/T)KQ,6&KG=!DN"\Y0_GX#GJ\THM;<> /=VZ7#OP!02P,$%
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M[1R-\$=2Y=V@G!B9N_:ZE :;M1NN\#H%RAK@]T1*LYU8!_4%+?P%4$L#!!0
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MMQ?E.)+F0FD>E.9#:0&4%J)HIN--RL&Q;OLNW/B!"ZDTS)3023-W']0/F@^
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ML9J"$WZG0@W[,S74%9N;H6P.9+ZN;JUQFTN9I]7#%6<1+_0)ZOF[/)=/!SK
M]I8TBW\!4$L#!!0    ( '>, U7<BY<U;P<  *4T   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,W+GAM;+V;:V_;-A2&_PKA%4,+Q+%(RK<N,=!$V]JMP8($
MV3XS-AT+E467HG/Y]Z-DQ;0E\MC,V'U)+.OPE<XK7AX=2V=/0GXK%IPK]+S,
M\N*\LU!J];'7*Z8+OF3%J5CQ7.^9"[ED2F_*AUZQDIS-JD;+K$>B:-!;LC3O
M3,ZJ[Z[EY$RL59;F_%JB8KU<,OERP3/Q=-[!G=<O;M*'A2J_Z$W.5NR!WW)U
MM[J6>JNW59FE2YX7J<B1Y//SSB?\,8D'98,JXN^4/Q4[GU&9RKT0W\J-+[/S
M3E2>$<_X5)423/][Y)<\RTHE?1[?:]'.]IAEP]W/K^J_5<GK9.Y9P2]%]D\Z
M4XOSSJB#9GS.UIFZ$4^?>9U0O]2;BJRH_J*G.C;JH.FZ4&)9-]9GL$SSS7_V
M7!NQTP /' U(W8 T&\2.!K1N0(]M$-<-XLJ932J5#PE3;'(FQ1.29;16*S]4
M9E:M=?II7E[W6R7UWE2W4Y///)LAW7W0+<LXZJ)/1<%5@5@^0U]3=I]FJ4IY
M@?;#WB=<L30K/N@&Y9ZNWM,M-@)WMPEZ_^X#>H?2'%VE6::O;G'64_I<RR/V
MIO5Y76S.BSC."Q-T)7*U*-"O^8S/]@5Z.LEMIN0UTPL"*EXQ>8HH/D$D(MAR
M0I=P\S_6N6X>5<V)I7ER_-$)D W=7C=:Z<4.O;O3/T]1DA8KH7U'OTNQ7NG+
MLK?]P>8ZJ%I.,A^+%9OR\XZ>10HN'WEG\O-/>!#]8G,LI%@22&S/S7CK9ERI
M4X>;FUYO\RL.Z5=(L220V)Y?_:U??;#W7;)B4<T1T_(#_[Y.'_7HS^T6@E*^
M%H842S9B@TJL7" ?)WVJIX9'BS.#K3,#T)D;/N7:C/N,%R<HY\IF"*C@:TA(
ML60CUM\Q9.PR9+@U9 @:\B5_U!U#R!0P!%3P-22D6#)L&=(?4+LAHZTA(]"0
M:\E7+)TA_JS9K>";M5:H!9<V:T M7VM"BB6CMC61W9GQUIGQ 6<TSDKU<H)6
M&<O52>5,.;FL-&@J9^\!17TM"BF6C-O#R3&:<&1X+0)-^DM;Q%2:/Z",:]Y%
ML@3;KIAWUWJ#.=<Q6-77I:!J2:VVZQ,9.OH2W@%;?&#B42Q_2/5,7-OB[$"P
MD+<W(=626FW7&XR'#F^(\8; G:B<;E N\NYT+:4>7%#/ :6\W0FIEM1JN^Z,
M1@YS#%EC&*UO^%*/K+7DY:R#Q+SVIOQTORYT<%&@Q>O]4'77HP2:LU0B#4%K
MKL>E#IB*0C?1._0M;F:U-2B)!U5+:K5=6[L8]\<.9PUE8Q!*:\S>-\_J35#J
M#JJ6U&I[ S(>$8<U!JAQ'[P#V;G9MCH2%**#JB6AU/:=,\"-8>).))O7%0LV
MG8JUO@M!*_92(KC5R:#T'50MP6W^UJ/.P9O8$#B&$?RRGN-70E:U-CV1B09%
M9 >Z7U!"#ZJ68 NCN^#!,#J&(7VS0.K^)-=\=M"=H) >5"W!%DQWS>.&TS$,
MZE]%_M!57"[+"BO7G6N&%'L^:%-04 ^JEN VJN.!W29B4)W J&YL\AQNL*ZO
M4T'5$F*!]8%C^2,&U@D,ZVT@/6114&8/JI:0-K-3!Y42@^P$1O;=:OQ!@(*U
MO-T)RNRDS>PDPBY_#+43F-I_/;T[11<UGVN/CBF&PY+>-@5E\%!J^W8:5"=O
MK8B3H' >5"T)I;9OFH%X I?%CRG^PA+>]K5+V)@,37V@MJ7?7MTH<4W:AKP)
M3-['E'9A">]TVX \PN-FMI:@R,$\Q$ T@2':KVP+BWFGW4;<,6EFW8X9NJZP
MP6!RJ%;]IHHLK.J=?1MAR4X=M4Z_'42CV)&_ 5T"@^X;BZVPJG?^;38EN#7$
M+4'$D3\U!$MA@CV^A@H+>?^P;(',/FVD; L:.$JCU) H]251]W6&I;R3MF C
M;@YS6Q!QP!,U<$EAN/Q_2I[P27C;U>;(+ADV%P-;%(T<$R/=>?H"ILUC*YFP
MC'?*[;HL&8]:7:0=I3-VS06&""E,A <JE#0H%@952T*I[3MGL)#"6.A9H835
MO)VTL%\<#9I]QA(U(HX*"#6$2&%"M%0>LYW:T;U]*0F*C+1-@W$S>2AD/W.#
MB_1'UUSA WC;T,9#&C5]L,0XBL_4("0-6$F%M;QS;C-A'+4HPA(T=&5MP)$>
M7R%U]/*@C$@M]<LF(L,Q^\_-&4*,CZUQ^I2"85'OQ^K:(#AH]FU+3+_O2-ZP
M8@RSXIL+O+"N=_Z69P0&HZ8!EJ"1XW>2V(!C[/L@P:',@S)@W*8[3)H\9 MR
MU6-C0X Q3(!>]5A8RSMKVBKZ$!(U5S5;U)"XKOC.D[+P;_CZEI#+G&79BQ[Q
MCSS3/7^&"C%73TS:<P_["&W89VA_!!C&!@SC__2C?QP4!(.J):'4]ITS8!D?
M*#TN5_KNL[I;G2Z8?+#WO$&[.(H;Z_\E?"!O6P*I;6SI[;S7L>0ZR_+]F/)&
M6]]";%[QV'Z[?0?G4_7F2<^$;U[@N=(FI7FAEZ>Y;AJ=#O7UDYMW8C8;2JRJ
MMT3NA5)B67U<<#;CL@S0^^="J->-\@#;-Y,F_P)02P,$%     @ =XP#5<Q9
MBPK8 @  G@D  !D   !X;"]W;W)K<VAE971S+W-H965T,S@N>&ULM59M;YLP
M$/XK%JNF5LH*@;RM2Y":=-,ZK5.4KNN':1]<N 2KQF:V2;I_OS-0EJ0T2Z7T
M"]CF[O%S#W?V#5=2W>L$P)"'E L]<A)CLC/7U5$"*=6G,@.!7^92I=3@5"U<
MG2F@<>&4<M?WO)Z;4B:<<%BL354XE+GA3,!4$9VG*55_QL#E:N2TG<>%&5LD
MQBZXX3"C"[@&<Y--%<[<&B5F*0C-I" *YB/GO'TV&5C[PN '@Y5>&Q,;R9V4
M]W9R&8\<SQ("#I&Q"!1?2Y@ YQ8(:?RN,)UZ2^NX/GY$_U3$CK'<40T3R6]9
M;)*1,W!(#'.:<S.3J\]0Q=.U>)'DNGB2567K.23*M9%IY8P,4B;*-WVH=%AS
M0)QF![]R\+<=.L\X!)5#4 1:,BO"NJ"&AD,E5T19:T2S@T*;PANC8<+^Q6NC
M\"M#/Q/.0!N51R973"Q:Y#+-*%/XETR+4!&3&7!J(":3A*H%:/*.?*-*42L]
M.;X 0QG7)[AZ<WU!CH].R!%A@EPQSO$7Z:%KD*'=QXTJ-N.2C?\,FX!<26$2
M33Z*&.)-?Q<CJ\/S'\,;^SL!O^3BE 1>B_B>[S?PF>SOWMY!)ZC5#@J\8!^U
MR41J4ZFL0:&B/[^B/;DTD.I?3>*5X)UF<%OO9SJC$8P<+.@"T0G?OFGWO ]-
MD1\(;$.'3JU#9Q?Z=M:QK:Q35=9%9=:UB #3I$>Y2:_8Q!Y7R] /ANYR/<JG
M)NWNH+;9(-^MR7</2+Z)=_?_O$N3[CZ\>S7OWOZ\R913@84[@U0:(+=XUI+O
MBN+I;$]7-&CBO1/_I?EW(+ -*?JU%/W7K,/^(74X$-B&#H-:A\$KI_)._)=*
M,7A2%^^[6SGOKEUU*2 KVP%H$LE<F/):J%?K)N.\N%NWUL?8?)2]PC^8LG.Y
MPF"9T(3#'"&]TSY6H2J[@7)B9%9<J'?2X/5<#!-LH$!9 _P^EUA2U<1N4+=D
MX5]02P,$%     @ =XP#50GOL<]C!0  >Q\  !D   !X;"]W;W)K<VAE971S
M+W-H965T,SDN>&ULM5G;;N,V%/P50ET4NT 2BZ0O26H;2)PMFJ)!@WC3/A1]
M4"3:%E8259*.$Z ?7^H2T1(ONV[DET22#T?#0W'.D)SN*/O*-X0(\)(F&9]Y
M&R'RR\& AQN2!OR,YB23OZPH2P,A;]EZP'-&@JALE"8#Y/OC01K$F3>?EL_N
MV7Q*MR*),W+/ -^F:<!>KTE"=S,/>F\/'N+U1A0/!O-I'JS)DHC'_)[)NT&#
M$L4IR7A,,\#(:N9=P<L%GA0-RH@_8K+C>]>@Z,H3I5^+F]MHYOD%(Y*04!00
M@?SW3!8D20HDR>.?&M1KWEDTW+]^0_^Y[+SLS%/ R8(F?\:1V,R\<P]$9!5L
M$_% =[^0ND.C B^D"2__@ET=ZWL@W')!T[JQ9)#&6?4_>*D3L== XI@;H+H!
MZC886AK@N@$N.UHQ*[MU$XA@/F5T!U@1+=&*BS(W96O9FS@KAG$IF/PUENW$
M_(%PP;:AV+(X6Y^ VS0/8B:'29R ((O  TD"02*PV 1L33@X!<MJO %=@5;;
M)N3C#1%!G/!/,OAQ>0,^?O@$/H X W=QDLB1X].!D,2+UP_"FN1U11)92&)P
M1S.QX>!S%I&HW7X@.]ST&KWU^AHY 7_=9F< ^R< ^0@9^"R^OSETT,'-(. 2
M#W_/(( %Y:)./B?LF8"_?I/QX%:0E/]M2EX%/C2#%SIPR?,@)#-/3O02T9O_
M^ ,<^S^9>MX36"L/PR8/0Q?Z?$F>"0NRD)3=)VF>T%="3EG]$88R,?P$9$28
MLE!!CTOH0KR>YW)DG_>[ID? 81/2(CQJ"(^<A#^_Q-504;$AK$W4Q+%"&^US
MA!V2>LC0-Y,<-R3'3I)7G,MR$#<SFY>,@S"46LI*OA&1@QG&02&L)MICC9/?
M8:U'0-^2VTE#>^*D_86*(#&QF>A)Q!TZ>@@<G9OIG#=TSIUT?L^+9!7S<TG6
M51K_!8]GRS-P+X4OE5-B*^+0S-B)?.@$[0FLE82+)@D7QQ2JBS[ST!-8*P_0
M5V73/YY4U=C[WV?W"S:$(/,'#/=*/>Q5K6JXUC3JTM1#;#21HHF.K%?U"UR"
M90BQ" 1451PZBZ-=L>IV+5'O\M%#H"V3JIQ"=STU:M:]G XAB_/217\AX2:C
M"5V_@B5-ML+JSYPO.G3J]H763HLJVG!T3!6#3D]P<"YZ0FOG0GD#Z#8'[].Q
M;QL#9TB;LS(&T.T,#M8Q@V/HTC0X!@M-91B@VS'TH&/G&JM1E[@> B<6YJK*
M0V?Q= C9A?:V29>0'@(MRHI4M47N:FL4LCL2%8;K=+EEZ^+"K6#N-QPZ:_M"
M:^=#57($CZE@R.D3#LY%3VCM7"B[@-QVX5T*AK[M%)PA;<[**2"W4SA4P9#!
M'71IZB$6_X"4?T!N__!^!:M?X,RO'F)9.2)5X9%[76X5,*0OK[5$ZB%C"Q]5
M99&[RAKUZS83A&5EZBQDG: '3].>T-HI4$4;38XJ64Y+<' N>D)KYT(Y ^1V
M!N^3++WB:U/*8 IL8J!, 7*;@H,U2S<"7==E"+'MR&'E%;#;*[Q?M+"^]NYF
MV!"";<Q55<?N];E5M;!KE5T3TD/&EC*%56G%[M*ZH"RG1<Z,I)QM#]YV[@FM
MW=.]#?CC[L#WNP5_C#UXK*H^/N(N/-:K^6FWPAIB;)^JJOBXWYUX;# "W;65
M(0995H5860%\[-UXK"^I3S7J>LS01EV5</P_=^3K=OLG*Q==0GK(N%N2!GO'
MF"EAZ_)TE\LQW&:B.MMKGC8GR%?EN6GG^36\7%3GP JF.I:^"^1:,>,@(2L)
MZ9]-9(98==);W0B:EX>E3U0(FI:7&Q)$A!4!\O<5I>+MIGA!<]X^_P]02P,$
M%     @ =XP#50_K<H\D!P  9#4  !D   !X;"]W;W)K<VAE971S+W-H965T
M-# N>&ULM9M=;]LV%(;_"N$50PLDL46*RL<2 XV[81V6+8C7[6+8!2,SME!9
M]"@Z;H#]^%&R8DJB?.3(U$UK.^(YYSWZ>!]1U/5&R*_I@G.%OBWC)+T9+)1:
M70V':;C@2Y:>B15/]%^>A%PRI;_*^3!=2<YF^:!E/,2C43!<LB@9C*_SW^[E
M^%JL51PE_%ZB=+U<,OERRV.QN1EX@]<?'J+Y0F4_#,?7*S;G4ZZ^K.ZE_C;<
M19E%2YZDD4B0Y$\W@X_>U23(!^1;_!GQ35KZC#(ICT)\S;Y\GMT,1EE%/.:A
MRD(P_=\SG_ XSB+I.OXM@@YV.;.!Y<^OT7_*Q6LQCRSE$Q'_%<W4XF9P,4 S
M_L36L7H0FY]Y(8AF\4(1I_F_:%-L.QJ@<)TJL2P&ZPJ64;+]GWTK&E$:H.,T
M#\#% %P?X.\90(H!)!>ZK2R7]8DI-KZ68H-DMK6.EGW(>Y./UFJB)-N-4R7U
M7R,]3HT?>*KD.E1K&27S$_1YN6*1U+M)G2"6S- #CYGB,S19,#GG*3I%T^W^
M1N()5<:BC]D.B=0+>O^)*Q;%Z0>]]9?I)_3^W0?T#D4)NHOB6.^Z]'JH=.59
M_F%85'F[K1+OJ9*@.Y&H18I^3&9\5AT_U(IWLO&K[%L,!OQEG9PA,CI!>(1Q
M0SV3PX=[0#EDMQ=('H\<LA>ROG+YS-'?#R*.D3Y:-TS._FGJVC:JWQPUNP)<
MI2L6\IN!/L7SF(/Q]]]YP>B')LF.@E4:X.\:X$/1Q[=\'B5))OZ1Q2P)>9/:
M;8@@#Y%=GI[''AE=#Y_+(L T'470G0@*BJB=2U'M7)+%N11NSZ4FA=OXM*00
MDYI :C>!7NRVJ=0=[.H.P+I_$\EIR-(%5%E@55;O/)BC8^?/=PK.0063K/H5
M>\F:W5C^N57^:7;>5P2 *3H*N-@)N  %_*X67#85?F$7[M%:X6#HCH5?[@J_
M! O7%^26L_;24N!Y04T!F*.C F]D+' $-W_%)5.9C"F?YX<0^@]].9N>H7M]
M0BQUXK6*0A8W^A88^JV78%?1JHTHL8#7BPT585TUP5&T:A.P:0(^WHJ*&-6C
MNG90PWFZZC!(X8&&[<"-B@1ED7Y=H[V)AYO=R#,LX,$P<(@?%2$@0X*S=.V_
M@0$/IH%63_)LMS^M>Q*<HZL& P8>3 9[;<FS>>#4.O[[( +/(($',T&[,WDV
M%7C6#NB#"CR#!5X+%S19T[W.%,IHE=\'_\'#12)B,7]!4Q&OU=X;+$>44+2E
M#^;P#'1XE_T8E2/0*)K0![9@@RT8QI:#C*J(43[&ZW<4<)JN,@QT8-#/'?A4
MD:"L\;RNT=[$VW/7A TI8)@4#O$I;(/":9W?X31==X !!0R#0JM18=OD+:."
M<W358) !P\BPUZAP.R? H;N6;C@!PYS0[E/8!@7K'.Z#$[#A!-S""4TV=<=G
MV5W3Z70MY]D'V)_@#&^]-+N*5NV'80]\WHL_84>T432A#W;!AETPS"Z'^9,]
MP5'G2#A-5QF&-3 \P^' GQJF0.H:[4V"9GLBA@\(S >'V!.Q\:!^>82S=&P_
M,7A 8#QH=2=B6[MU*P+GZ*K!@ *!06&O.Q&;#JSV]P$'I/1@ H:#=G<B#5,
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ML@FQ,@2VWA%<^3Y+X9$ W1'FOTT7="1FB@2M?(PN_(VJN:;4FB KBV"/3Y-
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M;^C:NP G(P]Z(RH(+"H.Y3;8;6MH>PL18H0(@86(MVC"[5J';@L.WY3<^&0
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M4TWL T$$GE-74P&LGF\L '1TZW6ZH;DBSNX"1=[ JRW0PJJR0CVOA4'@CD"
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MGQ[G-Y*MLP/8!R8EB[/+%56?P#PU4+\O&),O-^D Y1G^]']02P,$%     @
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M%F92Y95MWC!R[HK#D318:KK'&7X-@+(#\/U$2O/2L!,4WQ?Q'U!+ P04
M" !WC -54R1QNS\'  !_-0  &0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX
M;6RU6UUOVS84_2N$UPTML-KBER1GCH$V6; ,;5<T[?8P[$&V&5NH+'D2G33
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MFYJ\)$G0SI+.!&1@!"0.VWW<!_6!DOM *\/HAL=0P^,8:GF$&AZ;1FIXDJ%
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M-TLA$ZIQ*%>NRB3012&4<#?PO LWH2QUIN-B[DY.QR+7G*5P)XG*DX3*_V;
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M) 2"?9CVP337QB*Q.]MMF;0?O[.3AJ9K.]C2+]1V[IY[[KF+N71G4CWI&-'
M<YH(W?-B8\9'OJ\',:9,[\LQ"GHRE"IEAK9JY.NQ0A8YIS3QPR!H^RGCPNMW
MW=F-ZG?EQ"1<X(T"/4E3IGZ>8")G/:_NS0]N^2@V]L#O=\=LA'=H[L<WBG9^
M@1+Q%(7F4H#"8<\[KA^=UIV#LWC@.-,+:["I/$KY9#>74<\++"-,<& L!*.?
M*9YBDE@DXO$C!_6*F-9Q<3U'/W?)4S*/3..I3+[RR,0][\"#"(=LDIA;.;O
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M4_3Z[]_5V\''5>E7!%82HUF(T73HC;^+L0?GC"MX8,D$X=L5&<*EP51_7R5
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MUX"R ?A\(J593>S16=^4DE]02P,$%     @ =XP#5:R:!#2P @  8 8  !D
M  !X;"]W;W)K<VAE971S+W-H965T-C N>&ULK55=3]LP%/TK5QF:0"HD3;^
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MK38XE\)U.GZ9K6CW!]4<5'-1S4,U']4"5 M1+4(U@6HQI<G7.^^:0D-U4^C
M\SJU/[3+95KDOZ6I%KYYIJ=ZK&-C$]5T5#-0S40U"]5L5'-0S44U#]5\5 M0
M+42U"-4$JL64)J=K5RP:/IZ5#Y[I.41;1:BFHYJ!:B:J6:AFHYJ#:BZJ>:CF
MHUJ :B&J1:@F4"VF-#E#AUV&JIM'WWYX20T?':5H\0C5#%0S4<UJ-:EH..L[
M5&6CXSJHYJ*:AVH^J@6H%J):A&H"U6)*DV.R*Q4-U7<$0@\NJ<<Z.CG1NA&J
M&:AFHIK5:N\=JK+141U4<U'-0S4?U0)4"U$M0C6!:C&ER;G9%8GJAZK<?'GM
MCY.]^#R1[FGX="V0$ZU*BW5O;"J'.CHV24U'-0/53%2SWOG )]I#FA2E-M'6
MNYN']D[8R15R4,U%-0_5?%0+4"U$M0C5!*K%E"8G:M<O&K[3+SKXD%+X> OB
M+^NTR.;)1ONER*[24HMVC<Y?EO4SAQQT0AM(J*:CFH%J)JI9J&:CFH-J+JIY
MJ.:C6H!J(:I%J"90+:8T.7^[KM)P@A]T0IM*J*:CFH%J)JI9J&:CFH-J+JIY
MJ.:C6H!J(:I%J"90+:8T.4.[3M/P>W6:U/#148IVFE#-0#43U:SAZX;48-)[
M75P;'=A!-1?5/%3S42U M1#5(E03J!93FIR37:5I^"^L-*G'.CHZT4H3JAFH
M9J*:-3RL(&6CHSJHYJ*:AVH^J@6H%J):A&H"U6)*DW.SJS0-U94F]*@36E9"
M-1W5#%0S4<UZYP-OCSKU3M31_A*JN:CFH9J/:@&JA:@6H9I M9C2I" ==?VE
MT3MW.NJ[W]N)EJSS[5-']/%^<8^7";U-BJH.VW8K-+EYO&]<7C4WV7RY_;HK
ME=8/GUJCJ;9(UO4BO3<#4:_FL2&,:CJJ&:AFHIK5:E-IT_5E_=1&QW10S44U
M#]5\5 M0+42U"-4$JL64)@=N5VD:J>^5=/C1_:^[,GZ=K_](RTK[>U;<9)LL
MV;7SOVZO%MGC?>B:*^C57Y;I/[=-]!IW;]RO4[U:1P<LVHM"-0/53%2S4,U&
M-0?57%3S4,U'M0#50E2+4$V@6DQI<A /NR >TH?Y1V@A"M5T5#-0S40U"]5L
M5'-0S44U#]5\5 M0+42U"-4$JL64)F=H5YH:J4M3WWZ8OX6E \SC8=\!YDOU
M.AR=DVC]"=5,5+-0S48U!]5<5/-0S4>U -5"5(M03:!:3&ER3G8EJ?JA*B=_
M*;:I9J?)JEIJE\NL3L@BF5?97',V\X\G6EIIR>JC=O=1"^9>6I;U]/\R+V[S
M8K<KH/U^;XHJASUZ@Y34=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C5!*K%
ME"8';=>=&HWQ23W:?T(U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4(U@6HQ
MI<D9VO6?1NI[-;T^MVJ^2NJGFBW69FMT\WPOI^OD]SI@BW2=9)OF/G?99G>R
MZN/+_VB^_7C?I][812M3J*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J"9&
MKV]T-CN?O=A_&%-CRG':5:%&ZBK4\7$Z3[.[=/$8H+W1B5:D4$U'-0/53%2S
M4,U&-0?57%3S4,U'M0#50E2+4$VTFG2/R.G%9/8R.[]'/6K4U:-&ZGK4E]UI
MJ.7^>:BWJWICL\JNKWN3$6U H9J.:D:K[1\_FXQ?'CHST3$M5+-1S4$U%]4\
M5/-1+4"U$-4B5!.H%E.:'(Q=_VFDKL,0!Y3J#<R@GK>OM[VM*/4*'!VE:"L*
MU0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$M0C6!:C&E29%[WC6ESL_H0TOG:*D)
MU714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(U02JQ90F9VA7?CI7EY]>[PMM
M*Z%:F6]OEE53+-7NLGS5;J?>):MZ._<'Z=G>2Y^HQSTZ:=%V$ZH9J&:BFH5J
M-JHYK;:_P^35_A(7'=)#-1_5 E0+42U"-8%J,:7) 3KL E1],R=JWI_\_M:\
M7[T"1R<IVG%"-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4$V@6DQI<N1V':?S
M$3[O1V__A&HZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&H"U6)*DS.TZS_5
M#_]_YOW*<8].6E+34<U -1/5+%2S4<UI-;EH_'KB3X[IH9J/:@&JA:@6H9I
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MH%J(:A&J"52+*4W.X6&7PWAG:8IVEE!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4
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MN0_H4YPQE."-<*4-Y^+Q0LN=*N4!)[MB3\(CX9RDQ<<M#B),Y0GB^PTA_.5
M.JCW"ZW^ U!+ P04    " !WC -5^^_XYQ )   <0@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6S%G%MSV[82@/\*1NV<)C-6) (@:;NV9FPY:=TV
MJ2=.SGGH] &F8(D-!:@D9#N=_O@#4+(@$A>+-L6\V+HL%KL+8/<C0.KDGN=?
MBAFE CS,,U:<]F9"+(X'@R*9T3DIWO %9?*;6Y[/B9!O\^F@6.243,I&\VP
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M.#+&QR(5X-BQLI%&!>1'A<\LIR1+_Y%YZ">2,AE^9MM_ID^R@K^?QJ.Q#U9
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MTJ=9A;S$/R&[%Y7/**-RR_F/[.'C\GSD9!:QB"UD!A&H?W?LDD51AJ3L^*\
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !WC -5>\]LEO0$   *+
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M^3UT(", ,NH$\G8T'RW&4^) Q@!DW"&D%\D$@$RZ;.[(@4P!R+1+R-B!_ 1
M?NH2,G$@/P.0GW$A,[X5W!Y+A2&C/)>U,'9@)DM9\IPS[4!^ 2"_X$+>L[(@
M]I\DH\UEWX;N 31V#W"A'IDVJLY-K6S +LFLVE.NFO]<$BH*=\@)0,4@.V8F
M<EDQLJ(_O-8,(*,$R$IY9 6S)[$7)0MI^81ITHSFN9L)X\L9<DJ +)4I5<)"
M:7(QEUI_($NFR%A6E10DVU$/$[)*@*R5KU(6K[PLV\?.!I"*;4- 1EK;5.K2
MQ82\$B"+9<+6ID6\XX**O&GM49,C<N./,P'DE0!9+$LFM-U&;IE@&VX\+D@E
M ;)+[EFQ?3]BD#\"9('<V5&//-&R9N0;H[I6K/F#AP>9(T!61]-?N6F1VH=O
M+%O!V74RYW3MIMB03$)DF61&YL\[619,Z7_(]+_:3MW(Q<0^@SDW'UQ*R"4A
MLDLRMCU$4F[(;:VY8-IMZ!"<I2 [!4QDO.0ZA)P2(CO%2V7(Q:J1H/8:&%))
MB*P2,*?Q@PBI)$16"9@_^)B03$)DF8#Y@X\)N25$=@N8/_B8D&A"9-& ^0.Y
M<#$AX83H<Y534Y_KY1$DFPA9-N\H^\CI8D*VB;"K8Y"Z_<(3))X(6SR@NMUY
M8 06R)#%<\[=9Y],R#\1LG]@B;O%IPCR3X3L'U_B'\F"*D6;<G?3[H:ZF)!_
M(F3_G&(>)H1M7SK)?2/(/Q&R?^"DPVMTR#\1LG]@3+?F&$'^B9#] V.Z5<<8
M<E",[""W+'7H-;STQJ$84D^,K!XXP70?R1A23]QE'<U[)&-(/7&7=30_FN#;
M&63YP)A>-"'YQ,CR@=-U+YJ0?&)D^<"87C0A^<2=3GZ\X1*23]SIY.>CBPG)
M)T:6#XCIO^&$Y),@RP?&=+M0 EDH0;80C.EVH02R4()LH=.:^4E"[&)"%DK0
M*V]_3,Q=4!<3LE"";*&SF%E=553]M',W%Q/\2@!]"G0.TYZXJ.WH*5U,R$()
M^A0(B*8_($$62O[ZZQTGFCXF9*&DFW<]QW[D8D(62I M]#YF&U+W$Q;(0BFR
MA>#ZEO>E#62AM-,RG&NA%+)0VF49SNM"*62A%+L,!V)ZC0Y9*,4NQ)VK%K[I
MTL6$+)0B6^@=S$>VE\IX%:X4_%JMM5"_/5C?7!>V-00K%O82VF[/:9DO%6D6
MAR]GXJ1YI;VIRW)LMSV(N:3%\5/6XV>X-[\!4$L#!!0    ( '>, U4>WYE>
M' (  #TG   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VDMNHT 4
MA>&M6"P@Y?NJ)*TXHYYDVLH&D%-^*+9!%*U.=M^6,[ /ZD%/(LX(%8C+/^$3
M IY^E4,[[KM3W>W[NO@X'DYUU>S&L?^14EWORK&M=UU?3N<CFVXXMN-Y.6Q3
MWZ[?VVU)NESF--S.:)Z?;F<N7C_[\C\3N\UFORX_N_7O8SF-_QB<_G3#>]V5
M,C:+UW;8EG'5I(_#=7=-EXW<G2<WBY>W53.\O$F3Y@Y2"-+Y@PR";/X@AR"?
M/R@@*.8/RA"4YP^ZAZ#[^8,>(.AA_J!'"'J</TB6*..2(&F"-8'6@EP+@=>"
M8 N!V()D"X'9@F@+@=J"; N!VX)P"X'<@G0+@=V"> N!WHIZ*X'>BGHK@=XZ
M>=@FT%M1;R706U%O)=!;46\ET%M1;R706U%O)=!;46\ET%M1;R70VU!O(]#;
M4&\CT-M0;R/0VR8O2PCT-M3;"/0VU-L(]#;4VPCT-M3;"/0VU-L(]#;4VPCT
M=M3;"?1VU-L)]';4VPGT=M3;"?3VR<MN KT=]78"O1WU=@*]'?5V KT=]78"
MO1WU=@*] _4. KT#]0X"O0/U#@*] _4. KT#]0X"O6/RL9) [T"]@T#O0+V#
M0.] O8- [T"]@T#OC'IG KTSZIT)],ZH=R;0.Z/>F4#OC'IG KTSZIT)],Z3
MGTV^4^\Z?AY*O?9\K?'ZWTGU>#ZW7"]_67[MG-SC%YS3;45]_@M02P,$%
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( '>, U45B.6,[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( '>,
M U697)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ =XP#508WM!H%!P  E2X  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( '>,
M U51[@X=ZP4   X9   8              " @4@/  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " !WC -56U+X<+4#  "^"P  &
M        @(%I%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ =XP#5?"$--;0!@  1!T  !@              ("!5!D  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( '>, U5&.RMH"P,  %\*   8
M              " @5H@  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " !WC -5CXOB4<$)  #150  &               @(&;(P  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ =XP#56DAIHBU @
MXP8  !@              ("!DBT  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( '>, U5),UL4-@@  (PD   8              " @7TP
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !WC -5B-]$
M7< *  #[&@  &               @('I.   >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ =XP#50U,&P=+"P  )2   !D
M ("!WT,  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !W
MC -5PHIA"Q$'  "*%0  &0              @(%A3P  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( '>, U6#4K;.6P4  &X-   9
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M970Q-BYX;6Q02P$"% ,4    " !WC -5G>2;TE@$   *"@  &0
M    @($'=@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M '>, U41*'NYK0P  -4L   9              " @99Z  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ =XP#52[?[ *#"0  *AP  !D
M             ("!>H<  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " !WC -5,?<8_YT<  !W5P  &0              @($TD0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( '>, U4;0Q-MG0H
M !T@   9              " @0BN  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ =XP#58Z_/^=5"P  TQX  !D              ("!
MW+@  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !WC -5
MPOE-.%X+  "7'P  &0              @(%HQ   >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( '>, U4@S^68[ 0  )L,   9
M      " @?W/  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ =XP#5<T#3J;!!0  6!$  !D              ("!(-4  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !WC -5X[F+'40#   K"0
M&0              @($8VP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( '>, U4--9CBT@,    )   9              " @9/>  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ =XP#58^V284
M!   / D  !D              ("!G.(  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " !WC -5Q/78+-T#  "="   &0
M@('3Y@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( '>,
M U4QK,GQ@@8  +05   9              " @>?J  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ =XP#5?R*'SFI @   08  !D
M         ("!H/$  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " !WC -5_+P(WC\#   ,!P  &0              @(& ]   >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( '>, U78L&=<5 8  &D2
M   9              " @?;W  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ =XP#5;[ BI=0!@  9Q$  !D              ("!@?X
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !WC -5)EQ8
M\>X"  "L"0  &0              @($(!0$ >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( '>, U66E.5O9 <  )Y&   9
M  " @2T( 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M=XP#5=R+ES5O!P  I30  !D              ("!R \! 'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " !WC -5S%F+"M@"  ">"0  &0
M            @(%N%P$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( '>, U4)[['/8P4  'L?   9              " @7T: 0!X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ =XP#50_K<H\D!P
M9#4  !D              ("!%R ! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " !WC -5\F1XC0<$   \$   &0              @(%R
M)P$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( '>, U7&
M2]1#2P8  %PK   9              " @; K 0!X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ =XP#58G#/]3"!0  <24  !D
M     ("!,C(! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '>, U71ZF4T3P,  &L,   9              "
M@6Y* 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ =XP#
M55,D<;L_!P  ?S4  !D              ("!]$T! 'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " !WC -5)9\[$5L"  #%!0  &0
M        @(%J50$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( '>, U5#J#O)<@0  & <   9              " @?Q7 0!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ =XP#5;9.B+35 @  ZP@
M !D              ("!I5P! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " !WC -5K\\ 4#P$  #[%   &0              @(&Q7P$
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( '>, U7^\R!.
MK0,  'D2   9              " @21D 0!X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ =XP#50D4F^O3 @  2P<  !D
M ("!"&@! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " !W
MC -5I,SQQZL$  "\)0  &0              @($2:P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( '>, U6WD5J@-P,  /L,   9
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M970V,2YX;6Q02P$"% ,4    " !WC -5WJQS,Y@"  "Y!@  &0
M    @($4G $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M '>, U695Z,21@8  #LT   9              " @>.> 0!X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ =XP#5?OO^.<0"0  '$(  !D
M             ("!8*4! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"
M% ,4    " !WC -59.T,OIL#  !A#@  &0              @(&GK@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( '>, U71XR &0P@
M  @Z   9              " @7FR 0!X;"]W;W)K<VAE971S+W-H965T-C8N
M>&UL4$L! A0#%     @ =XP#52=T^Y)I P  S!4   T              ( !
M\[H! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !WC -5EXJ[',     3 @
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8;6Q02P4&     $H 2@ ]%   !,D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>298</ContextCount>
  <ElementCount>327</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>116</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>20</UnitCount>
  <MyReports>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSale</Role>
      <ShortName>Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Restructuring, Impairment, and Related Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</Role>
      <ShortName>Restructuring, Impairment, and Related Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - Earnings (Loss) Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShare</Role>
      <ShortName>Earnings (Loss) Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2134109 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2136110 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2143111 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2147112 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2151113 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2155114 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleTables</Role>
      <ShortName>Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HeldforSale</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables</Role>
      <ShortName>Restructuring, Impairment, and Related Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - Earnings (Loss) Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareTables</Role>
      <ShortName>Earnings (Loss) Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2324305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2337307 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2344308 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2348309 - Disclosure - Commitments and Contingent Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables</Role>
      <ShortName>Commitments and Contingent Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2352310 - Disclosure - Stockholders' Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitTables</Role>
      <ShortName>Stockholders' Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficit</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2356311 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleNarrativeDetails</Role>
      <ShortName>Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Held for Sale - Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - Earnings (Loss) Per Common Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Debt and Financing Activities - Commercial Paper Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Commercial Paper Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails</Role>
      <ShortName>Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails</Role>
      <ShortName>Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails</Role>
      <ShortName>Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - Hedging Activities - Schedule of Fair Value of Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails</Role>
      <ShortName>Hedging Activities - Schedule of Fair Value of Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2453429 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2454430 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2457431 - Disclosure - Segments of Business - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails</Role>
      <ShortName>Segments of Business - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mck-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2458432 - Disclosure - Segments of Business - Reportable operating segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails</Role>
      <ShortName>Segments of Business - Reportable operating segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mck-20220630.htm">mck-20220630.htm</File>
    <File>mck-20220630.xsd</File>
    <File>mck-20220630_cal.xml</File>
    <File>mck-20220630_def.xml</File>
    <File>mck-20220630_lab.xml</File>
    <File>mck-20220630_pre.xml</File>
    <File>mck_ex102xstockplantermsan.htm</File>
    <File>mck_exhibit311x630202210-q.htm</File>
    <File>mck_exhibit312x630202210-q.htm</File>
    <File>mck_exhibit32x630202210-q.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20220630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="863">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>84
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20220630.htm": {
   "axisCustom": 0,
   "axisStandard": 30,
   "contextCount": 298,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 586,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 54,
   "keyStandard": 273,
   "memberCustom": 60,
   "memberStandard": 50,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://mckesson123.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Held for Sale",
     "role": "http://mckesson123.com/role/HeldforSale",
     "shortName": "Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Restructuring, Impairment, and Related Charges",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges",
     "shortName": "Restructuring, Impairment, and Related Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Income Taxes",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - Earnings (Loss) Per Common Share",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShare",
     "shortName": "Earnings (Loss) Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - Debt and Financing Activities",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134109 - Disclosure - Pension Benefits",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136110 - Disclosure - Hedging Activities",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143111 - Disclosure - Fair Value Measurements",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147112 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151113 - Disclosure - Stockholders' Equity (Deficit)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155114 - Disclosure - Segments of Business",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Held for Sale (Tables)",
     "role": "http://mckesson123.com/role/HeldforSaleTables",
     "shortName": "Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables",
     "shortName": "Restructuring, Impairment, and Related Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - Earnings (Loss) Per Common Share (Tables)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareTables",
     "shortName": "Earnings (Loss) Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - Debt and Financing Activities (Tables)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337307 - Disclosure - Hedging Activities (Tables)",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344308 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348309 - Disclosure - Commitments and Contingent Liabilities (Tables)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables",
     "shortName": "Commitments and Contingent Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352310 - Disclosure - Stockholders' Equity (Deficit) (Tables)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitTables",
     "shortName": "Stockholders' Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2356311 - Disclosure - Segments of Business (Tables)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
       "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i2151c060ee864dcf9cc0a315dedcb4bc_D20220701-20220731",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Held for Sale - Narrative (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
     "shortName": "Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i184217f9158a415e9fe088348387b9e9_I20220630",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i1cc8fba8571641aeaca7afef9370cf88_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i1cc8fba8571641aeaca7afef9370cf88_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i8810900c5c324fd89fbada461816423d_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Income Taxes (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i62f4dfc0153d46679ff78f542f7e14de_I20141231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i62f4dfc0153d46679ff78f542f7e14de_I20141231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i8f0afdd8a78b4984a7c33d73ebec78e1_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - Earnings (Loss) Per Common Share - Additional Information (Details)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails",
     "shortName": "Earnings (Loss) Per Common Share - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i635618c173ca4bacaf9fa6e491adc962_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails",
     "shortName": "Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ib3341b4ea67b4eb1bfc0be50fbf79480_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ib3341b4ea67b4eb1bfc0be50fbf79480_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i03515862174f44c7b695b85111ea920d_I20220630",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Debt and Financing Activities - Commercial Paper Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
     "shortName": "Debt and Financing Activities - Commercial Paper Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i03515862174f44c7b695b85111ea920d_I20220630",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i24e204f409be4b29a94900362c7cef4e_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - Pension Benefits - Narrative (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i24e204f409be4b29a94900362c7cef4e_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i372251adcd1648eab091c52b5f01446e_D20220406-20220406",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Hedging Activities - Narrative (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i372251adcd1648eab091c52b5f01446e_D20220406-20220406",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i41ebb607246c4e2991322746c42fa818_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
     "shortName": "Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ie2122223b4e24f6a94b2791de320374a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbp",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
     "shortName": "Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ie2122223b4e24f6a94b2791de320374a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbp",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "iedcceae98f1745c18c291607c35f1154_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
     "shortName": "Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "idf70302177a746cfb31a8c813fc9e576_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i9f56ba1a598a4a829b10b8749df60caf_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - Hedging Activities - Schedule of Fair Value of Derivatives (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
     "shortName": "Hedging Activities - Schedule of Fair Value of Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i9f56ba1a598a4a829b10b8749df60caf_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ib9dcecf8036248a0a44938b3a51b3d54_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ib9dcecf8036248a0a44938b3a51b3d54_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i8f79f8849ffd4f6d92a5100af46ef410_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i8f79f8849ffd4f6d92a5100af46ef410_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i6628b987433540f19ebb8c735161874b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails",
     "shortName": "Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i6628b987433540f19ebb8c735161874b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i785cd0fca728419db26ae24ee9b6d389_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
     "shortName": "Commitments and Contingent Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ie9db5a1c9a3b4448b90e7d790fddd929_I20180430",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:OpioidStewardshipActNewYorkAnnualSurcharge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i785cd0fca728419db26ae24ee9b6d389_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
     "shortName": "Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i785cd0fca728419db26ae24ee9b6d389_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453429 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails",
     "shortName": "Stockholders' Equity (Deficit) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i2151c060ee864dcf9cc0a315dedcb4bc_D20220701-20220731",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i7dff041ed60b4fc6ab8bad5c0fedc6f1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454430 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i778742d22ea2469ba0d763c4abaf0a0e_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457431 - Disclosure - Segments of Business - Narrative (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
     "shortName": "Segments of Business - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "i4f241c72875e4d98bd23bb25744707d7_I20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mck:NumberOfNationalBrandMedicalSurgicalProducts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "product",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458432 - Disclosure - Segments of Business - Reportable operating segment (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails",
     "shortName": "Segments of Business - Reportable operating segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:CorporateOperatingExpenseandOtherIncomeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "iae2bcb78271948b4a1ebf3f41dcd15bf_D20220630-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220630.htm",
      "contextRef": "ibf448f0a7c8a4eca9f3649a8b979a7e5_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 116,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "CAD"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "GBP"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "USD"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A090NotesDueDecember32025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.90% Notes Due December 3, 2025",
        "label": "0.90% Notes Due December 3, 2025 [Member]",
        "terseLabel": "0.90% Notes due December 3, 2025"
       }
      }
     },
     "localname": "A090NotesDueDecember32025Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A130NotesDueAugust152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.30% Notes Due August 15, 2026",
        "label": "1.30% Notes Due August 15, 2026 [Member]",
        "terseLabel": "1.30% Notes due August 15, 2026"
       }
      }
     },
     "localname": "A130NotesDueAugust152026Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.500% Notes Due 2025",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes Due 2025"
       }
      }
     },
     "localname": "A1500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A150EuroNotesDueNovember172025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.50% Euro Notes Due November 17, 2025",
        "label": "1.50% Euro Notes Due November 17, 2025 [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "A150EuroNotesDueNovember172025Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due 2026",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes Due 2026"
       }
      }
     },
     "localname": "A1625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A163EuroNotesDueOctober302026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.63% Euro Notes Due October 30, 2026",
        "label": "1.63% Euro Notes Due October 30, 2026 [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "A163EuroNotesDueOctober302026Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A270NotesDueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% Notes Due December 15, 2022",
        "label": "2.70% Notes Due December 15, 2022 [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "A270NotesDueDecember152022Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A285NotesDueMarch152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.85% Notes Due March 15, 2023",
        "label": "2.85% Notes Due March 15, 2023 [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "A285NotesDueMarch152023Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Notes Due 2029",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes Due 2029"
       }
      }
     },
     "localname": "A3125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A313SterlingNotesDueFebruary172029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.13% Sterling Notes Due February 17, 2029",
        "label": "3.13% Sterling Notes Due February 17, 2029 [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "A313SterlingNotesDueFebruary172029Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A380NotesDueMarch152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.80% Notes Due March 15, 2024",
        "label": "3.80% Notes Due March 15, 2024 [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "A380NotesDueMarch152024Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A395NotesDueFebruary162028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95% Notes Due February 16, 2028",
        "label": "3.95% Notes Due February 16, 2028 [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "A395NotesDueFebruary162028Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due May 30, 2029",
        "label": "4.75% Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "A475NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A488NotesDueMarch152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.88% Notes Due March 15, 2044",
        "label": "4.88% Notes Due March 15, 2044 [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "A488NotesDueMarch152044Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A600NotesDueMarch12041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.00% Notes Due March 1, 2041",
        "label": "6.00% Notes Due March 1, 2041 [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "A600NotesDueMarch12041Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A765DebenturesDueMarch12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.65% Debentures Due March 1, 2027",
        "label": "7.65% Debentures Due March 1, 2027 [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "A765DebenturesDueMarch12027Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest",
        "label": "AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase [Member]",
        "label": "Accelerated Share Repurchase [Member]",
        "terseLabel": "Accelerated Share Repurchase"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "verboseLabel": "Associated increase in Company's ownership interest on its equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring dividend (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AureliusElephantLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aurelius Elephant Limited",
        "label": "Aurelius Elephant Limited [Member]",
        "terseLabel": "Aurelius Elephant Limited"
       }
      }
     },
     "localname": "AureliusElephantLimitedMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "label": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "terseLabel": "Change in cash, cash equivalents, and restricted cash classified within Assets held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cherokee Nation",
        "label": "Cherokee Nation [Member]",
        "terseLabel": "Cherokee Nation"
       }
      }
     },
     "localname": "CherokeeNationMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommittedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Committed",
        "label": "Committed [Member]",
        "terseLabel": "Committed"
       }
      }
     },
     "localname": "CommittedMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes per share of common stock permitted on proposals presented to stockholders (vote)"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate income (expenses), net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Asset / Liability [Member]",
        "label": "Current Asset / Liability [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "CurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "terseLabel": "Gross purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationExpected",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "label": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "label": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "label": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized",
        "terseLabel": "Derecognized pension assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "label": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "terseLabel": "Accumulated other comprehensive loss derecognized"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "negatedTerseLabel": "Remeasurement of assets of business held for sale to fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainonWritedown1",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributors",
        "label": "Distributors [Member]",
        "terseLabel": "Distributors"
       }
      }
     },
     "localname": "DistributorsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EPSBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted",
        "label": "EPS, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson:"
       }
      }
     },
     "localname": "EPSBasicAndDilutedAbstract",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_EUBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E.U. Businesses (Disposal Group)",
        "label": "E.U. Businesses (Disposal Group) [Member]",
        "terseLabel": "E.U. Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EUBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Estimated annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_FixedInterestRateSwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Interest Rate Swap",
        "label": "Fixed Interest Rate Swap [Member]",
        "terseLabel": "Fixed interest rate swaps"
       }
      }
     },
     "localname": "FixedInterestRateSwapMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Governmental Entities",
        "label": "Governmental Entities [Member]",
        "terseLabel": "Governmental entities"
       }
      }
     },
     "localname": "GovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_HeldForSalePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Held for Sale",
        "label": "Held for Sale [Policy Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "HeldForSalePolicyTextBlock",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_IncreaseDecreaseInLitigationReserve": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Litigation Reserve",
        "label": "Increase (Decrease) in Litigation Reserve",
        "terseLabel": "Litigation liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationReserve",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IndividualClaimantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Claimant",
        "label": "Individual Claimant [Member]",
        "terseLabel": "An individual"
       }
      }
     },
     "localname": "IndividualClaimantMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software",
        "label": "Internally developed software [Member]",
        "terseLabel": "Internally developed software"
       }
      }
     },
     "localname": "InternallyDevelopedSoftwareMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment",
        "label": "International Segment [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "terseLabel": "Portion of settlement to be paid by the Company (percent)"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages",
        "terseLabel": "Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "label": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "terseLabel": "Portion of settlement award to be used by state and local government for remediation (percent)"
       }
      }
     },
     "localname": "LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LossContingencyAccrualProvisionAfterTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, Provision, After Tax",
        "label": "Loss Contingency Accrual, Provision, After Tax",
        "terseLabel": "Loss contingency accrual, provision, after tax"
       }
      }
     },
     "localname": "LossContingencyAccrualProvisionAfterTax",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Received",
        "label": "Loss Contingency, Class Action, Number of Faxes Received",
        "terseLabel": "Loss contingency, class action, number of faxes received"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesReceived",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesRemainingintheClass": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "label": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "terseLabel": "Loss contingency, class action, number of faxes remaining in the class"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesRemainingintheClass",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyDamagesSoughtPerViolationValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Sought Per Violation, Value",
        "label": "Loss Contingency, Damages Sought Per Violation, Value",
        "terseLabel": "Loss contingency, damages sought per violation, value (per violation)"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtPerViolationValue",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyNumberOfCitiesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of Cities Filed On Behalf Of",
        "label": "Loss Contingency Number of Cities Filed On Behalf Of",
        "terseLabel": "Loss contingency number of cities filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberOfCitiesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfEligibleStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Eligible States",
        "label": "Loss Contingency, Number of Eligible States",
        "terseLabel": "Number of eligible states"
       }
      }
     },
     "localname": "LossContingencyNumberOfEligibleStates",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfOtherDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Other Defendants",
        "label": "Loss Contingency, Number of Other Defendants",
        "terseLabel": "Number of other national distributors named in suit"
       }
      }
     },
     "localname": "LossContingencyNumberOfOtherDefendants",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Number of states in which court cases are pending"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStatesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of States Filed On Behalf Of",
        "label": "Loss Contingency Number of States Filed On Behalf Of",
        "terseLabel": "Loss contingency, number of states filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencySettlementAgreementAwardPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "terseLabel": "Period over which award would be payable under proposed framework"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementAwardPaymentPeriod",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementInstallmentPaymentsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement, Installment Payments, Term",
        "label": "Loss Contingency, Settlement, Installment Payments, Term",
        "terseLabel": "Loss contingency, settlement, installment payments, term"
       }
      }
     },
     "localname": "LossContingencySettlementInstallmentPaymentsTerm",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementNumberOfInstallmentPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement, Number of Installment Payments",
        "label": "Loss Contingency, Settlement, Number of Installment Payments",
        "terseLabel": "Loss contingency, settlement, number of installment payments"
       }
      }
     },
     "localname": "LossContingencySettlementNumberOfInstallmentPayments",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "McKesson Europe Subsidiary"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "National Prescription Opiate Litigation [Member]",
        "terseLabel": "National Prescription Opioid Litigation"
       }
      }
     },
     "localname": "NationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NativeAmericanTribesOtherThanCherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Native American Tribes Other Than Cherokee Nation",
        "label": "Native American Tribes Other Than Cherokee Nation [Member]",
        "terseLabel": "Native American Tribes Other Than Cherokee Nation"
       }
      }
     },
     "localname": "NativeAmericanTribesOtherThanCherokeeNationMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseForExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "label": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "negatedTerseLabel": "Exercises of Put Right",
        "terseLabel": "Decrease in noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseForExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseFromReclassificationToLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "label": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromReclassificationToLiability",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "negatedLabel": "Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right redemption price per share (in euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NumberOfBusinessOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Business Operations",
        "label": "Number of Business Operations",
        "terseLabel": "Number of business operations"
       }
      }
     },
     "localname": "NumberOfBusinessOperations",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfNationalBrandMedicalSurgicalProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of National Brand Medical-Surgical Products",
        "label": "Number of National Brand Medical-Surgical Products",
        "terseLabel": "Number of national brand medical-surgical products offered (more than)"
       }
      }
     },
     "localname": "NumberOfNationalBrandMedicalSurgicalProducts",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OpioidStewardshipActNewYorkAnnualSurcharge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Stewardship Act, New York, Annual Surcharge",
        "label": "Opioid Stewardship Act, New York, Annual Surcharge",
        "terseLabel": "Opioid stewardship act, new york, annual surcharge"
       }
      }
     },
     "localname": "OpioidStewardshipActNewYorkAnnualSurcharge",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OpioidStewardshipActStateOfNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Stewardship Act, State of New York",
        "label": "Opioid Stewardship Act, State of New York [Member]",
        "terseLabel": "Opioid Stewardship Act, State of New York"
       }
      }
     },
     "localname": "OpioidStewardshipActStateOfNewYorkMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherNonCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-Current Assets",
        "label": "Other Non-Current Assets [Member]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNonCurrentAssetsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherNonCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-Current Liabilities",
        "label": "Other Non-Current Liabilities [Member]",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherNonCurrentLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrepaidExpensesAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Expenses and Other",
        "label": "Prepaid Expenses and Other [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "Prescription Technology Solutions [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Put right value, interest rate spread (as a percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "label": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "negatedTerseLabel": "Reclassification of McKesson Europe AG redeemable noncontrolling interests",
        "terseLabel": "Reclassification of temporary equity to noncontrolling interest"
       }
      }
     },
     "localname": "ReclassificationOfTemporaryEquityToNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (in shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestructuringPlanRemoteWorkTransitioningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan, Remote Work Transitioning",
        "label": "Restructuring Plan, Remote Work Transitioning [Member]",
        "terseLabel": "Restructuring Plan - Remote Work Transitioning"
       }
      }
     },
     "localname": "RestructuringPlanRemoteWorkTransitioningMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Revenue derived from services, percentage (less than)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "The 2020 Credit Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SettlingGovernmentalEntitiesAndStateOfAlabamaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settling Governmental Entities and State of Alabama",
        "label": "Settling Governmental Entities and State of Alabama [Member]",
        "terseLabel": "Settling Governmental Entities and State of Alabama"
       }
      }
     },
     "localname": "SettlingGovernmentalEntitiesAndStateOfAlabamaMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SettlingGovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settling Governmental Entities",
        "label": "Settling Governmental Entities [Member]",
        "terseLabel": "Settling Governmental Entities"
       }
      }
     },
     "localname": "SettlingGovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfAlabamaAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Alabama and Subdivisions",
        "label": "State of Alabama and Subdivisions [Member]",
        "terseLabel": "State of Alabama and Subdivisions"
       }
      }
     },
     "localname": "StateOfAlabamaAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfOklahomaAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Oklahoma and Subdivisions",
        "label": "State of Oklahoma and Subdivisions [Member]",
        "terseLabel": "State of Oklahoma and Subdivisions"
       }
      }
     },
     "localname": "StateOfOklahomaAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfWashingtonAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Washington and Subdivisions",
        "label": "State of Washington and Subdivisions [Member]",
        "terseLabel": "State of Washington and Subdivisions"
       }
      }
     },
     "localname": "StateOfWashingtonAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfWestVirginiaAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of West Virginia and Subdivisions",
        "label": "State of West Virginia and Subdivisions [Member]",
        "terseLabel": "State of West Virginia and Subdivisions"
       }
      }
     },
     "localname": "StateOfWestVirginiaAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ThreeLargestU.S.PharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "label": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "terseLabel": "Three Largest U.S. Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeLargestU.S.PharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeNationalPharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three National Pharmaceutical Distributors",
        "label": "Three National Pharmaceutical Distributors [Member]",
        "terseLabel": "Three National Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeNationalPharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "label": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "terseLabel": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al"
       }
      }
     },
     "localname": "TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Businesses (Disposal Group)",
        "label": "U.K. Businesses (Disposal Group) [Member]",
        "terseLabel": "U.K. Disposal Group (Disposal Group)"
       }
      }
     },
     "localname": "UKBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UncommittedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncommitted",
        "label": "Uncommitted [Member]",
        "terseLabel": "Uncommitted"
       }
      }
     },
     "localname": "UncommittedMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA",
        "label": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA [Member]",
        "terseLabel": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA"
       }
      }
     },
     "localname": "UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125",
        "label": "United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125 [Member]",
        "terseLabel": "United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125"
       }
      }
     },
     "localname": "UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageandClarusOneSourcingServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "terseLabel": "Vantage and ClarusOne Sourcing Services LLC"
       }
      }
     },
     "localname": "VantageandClarusOneSourcingServicesLLCMember",
     "nsuri": "http://mckesson123.com/20220630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r138",
      "r187",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r207",
      "r211",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302",
      "r304",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r138",
      "r187",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r207",
      "r211",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302",
      "r304",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r63",
      "r65",
      "r136",
      "r137",
      "r313",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r283",
      "r285",
      "r286",
      "r287",
      "r312",
      "r349",
      "r455",
      "r460",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r682",
      "r684",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r283",
      "r285",
      "r286",
      "r287",
      "r312",
      "r349",
      "r455",
      "r460",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r682",
      "r684",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r259",
      "r283",
      "r285",
      "r286",
      "r287",
      "r312",
      "r349",
      "r399",
      "r455",
      "r460",
      "r486",
      "r487",
      "r488",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r682",
      "r684",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r259",
      "r283",
      "r285",
      "r286",
      "r287",
      "r312",
      "r349",
      "r399",
      "r455",
      "r460",
      "r486",
      "r487",
      "r488",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r682",
      "r684",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r64",
      "r65",
      "r136",
      "r137",
      "r313",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r215",
      "r216",
      "r373",
      "r374",
      "r683",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r215",
      "r216",
      "r373",
      "r374",
      "r683",
      "r692",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r50",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r70",
      "r76",
      "r85",
      "r86",
      "r87",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r68",
      "r76",
      "r85",
      "r86",
      "r87",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r69",
      "r76",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains on Cash Flow Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r73",
      "r75",
      "r76",
      "r664",
      "r689",
      "r690"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r85",
      "r86",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r72",
      "r76",
      "r85",
      "r86",
      "r87",
      "r140",
      "r141",
      "r142",
      "r542",
      "r618",
      "r685",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r41",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r491",
      "r492",
      "r493",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r124",
      "r243"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r462",
      "r494",
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r124",
      "r238",
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities (shares) (fewer than)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r72",
      "r76",
      "r85",
      "r86",
      "r87",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r72",
      "r76",
      "r85",
      "r86",
      "r87",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r34",
      "r133",
      "r195",
      "r202",
      "r209",
      "r221",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r535",
      "r545",
      "r597",
      "r619",
      "r621",
      "r640",
      "r661"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "International segment assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r28",
      "r48",
      "r133",
      "r221",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r535",
      "r545",
      "r597",
      "r619",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Assets held for sale",
        "verboseLabel": "Divested net assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r249",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r563",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit and other-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r26",
      "r30",
      "r126"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r120",
      "r126",
      "r127"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r120",
      "r598"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging",
        "verboseLabel": "Derivatives designated as cash flow hedges:"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r130",
      "r133",
      "r155",
      "r159",
      "r160",
      "r162",
      "r164",
      "r172",
      "r173",
      "r174",
      "r221",
      "r294",
      "r299",
      "r300",
      "r301",
      "r307",
      "r308",
      "r347",
      "r348",
      "r352",
      "r356",
      "r362",
      "r597",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r288",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r291",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r40",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized and 277 and 275 shares issued at June 30, 2022 and March 31, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComparabilityOfPriorYearFinancialData": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting any exceptions to the comparability of prior year financial data with data shown for the most recent accounting period.",
        "label": "Comparability of Prior Year Financial Data, Policy [Policy Text Block]",
        "terseLabel": "Results of Operations"
       }
      }
     },
     "localname": "ComparabilityOfPriorYearFinancialData",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r81",
      "r83",
      "r84",
      "r97",
      "r654",
      "r677"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r81",
      "r83",
      "r96",
      "r533",
      "r534",
      "r549",
      "r653",
      "r676"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r81",
      "r83",
      "r95",
      "r532",
      "r549",
      "r652",
      "r675"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r543",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r128",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r211",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r102",
      "r634"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Derivatives designated as net investment hedges:",
        "verboseLabel": "Cross-currency swaps"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r646",
      "r670"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r129",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r326",
      "r333",
      "r334",
      "r336",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r132",
      "r138",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r338",
      "r339",
      "r340",
      "r341",
      "r611",
      "r641",
      "r642",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r324",
      "r338",
      "r339",
      "r595"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair values of liabilities"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r55",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on debt instrument (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r56",
      "r132",
      "r138",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r338",
      "r339",
      "r340",
      "r341",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r56",
      "r132",
      "r138",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r335",
      "r338",
      "r339",
      "r340",
      "r341",
      "r363",
      "r364",
      "r365",
      "r366",
      "r608",
      "r609",
      "r611",
      "r612",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Syndicated senior unsecured revolving credit facility term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Possible decrease in unrecognized tax benefits during the next twelve months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r498",
      "r499"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r392",
      "r400",
      "r402",
      "r443",
      "r445",
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Cash contributions to the plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of plan assets to benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Funded Percentage",
        "terseLabel": "Percentage threshold of greater of projected benefit obligation or market value of assets (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r124",
      "r250"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r554",
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "U.S. Dollar notional amount, asset"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r62",
      "r65",
      "r66",
      "r565",
      "r632"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Fair value of derivative, asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r62",
      "r65",
      "r66",
      "r565",
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Fair value of derivative, liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r65",
      "r564",
      "r566",
      "r571",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r582",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r561",
      "r564",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r554",
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "U.S. Dollar, notional amount, liability"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r553",
      "r556",
      "r557",
      "r561",
      "r562",
      "r568",
      "r571",
      "r578",
      "r579",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r248",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r20",
      "r247",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r249",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation": {
     "auth_ref": [
      "r5",
      "r18",
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation",
        "terseLabel": "Reclassified pension liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r249",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r249",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "auth_ref": [
      "r124",
      "r248",
      "r253"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "terseLabel": "Gain to remeasure disposal group to fair value",
        "verboseLabel": "European businesses held for sale"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r451",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r98",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r153",
      "r155",
      "r162",
      "r163",
      "r164",
      "r168",
      "r169",
      "r585",
      "r586",
      "r655",
      "r678"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Total (in dollars per share)",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r98",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r155",
      "r162",
      "r163",
      "r164",
      "r168",
      "r169",
      "r585",
      "r586",
      "r655",
      "r678"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Total (in dollars per share)",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported income tax expense (benefit) rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r496",
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "negatedTerseLabel": "Effective income tax rate reconciliation, tax (benefit), share-based payment arrangement, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r85",
      "r86",
      "r87",
      "r140",
      "r141",
      "r142",
      "r144",
      "r150",
      "r152",
      "r171",
      "r222",
      "r362",
      "r367",
      "r491",
      "r492",
      "r493",
      "r513",
      "r514",
      "r584",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605",
      "r618",
      "r685",
      "r686",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Cost basis of investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EscrowDeposit": {
     "auth_ref": [
      "r645",
      "r694"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.",
        "label": "Escrow Deposit",
        "terseLabel": "Escrow deposit"
       }
      }
     },
     "localname": "EscrowDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r588",
      "r589",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r588",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Derivatives"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r324",
      "r338",
      "r339",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r445",
      "r589",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r588",
      "r589",
      "r590",
      "r591",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r324",
      "r400",
      "r402",
      "r407",
      "r445",
      "r589",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair value, inputs, level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r324",
      "r338",
      "r339",
      "r400",
      "r402",
      "r407",
      "r445",
      "r589",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair value, inputs, level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r324",
      "r338",
      "r339",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r445",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r592",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r563",
      "r568",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r614",
      "r617"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Lease and other obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r32",
      "r242"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Estimated annual amortization expense, remainder of 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r239",
      "r240",
      "r242",
      "r245",
      "r635",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r242",
      "r636"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r239",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r242",
      "r635"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedTerseLabel": "Gain from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "verboseLabel": "Claims and litigation charges, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r31",
      "r225",
      "r226",
      "r233",
      "r237",
      "r621",
      "r639"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r232",
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r99",
      "r133",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r221",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r597"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r561",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r100",
      "r125",
      "r145",
      "r146",
      "r147",
      "r148",
      "r161",
      "r164",
      "r531"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income from continuing operations attributable to McKesson Corporation"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r91",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r637",
      "r648",
      "r657",
      "r679"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income from continuing operations before income taxes",
        "totalLabel": "Income from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r133",
      "r143",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r221",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r532",
      "r586",
      "r597"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from continuing operations",
        "totalLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r89",
      "r98",
      "r143",
      "r145",
      "r146",
      "r147",
      "r148",
      "r155",
      "r162",
      "r163",
      "r586",
      "r647",
      "r649",
      "r655",
      "r671"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in usd per share)",
        "verboseLabel": "Continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r89",
      "r98",
      "r143",
      "r145",
      "r146",
      "r147",
      "r148",
      "r155",
      "r162",
      "r163",
      "r164",
      "r586",
      "r655",
      "r671",
      "r674",
      "r678"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in usd per share)",
        "verboseLabel": "Continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r21",
      "r24",
      "r519",
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from discontinued operations, net of tax",
        "verboseLabel": "Income (loss) from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r92",
      "r98",
      "r159",
      "r162",
      "r163",
      "r655",
      "r672",
      "r674",
      "r678"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in usd per share)",
        "verboseLabel": "Discontinued operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r159",
      "r162",
      "r163",
      "r551"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in usd per share)",
        "verboseLabel": "Discontinued operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r451",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r5",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r504",
      "r508",
      "r510",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r502",
      "r509",
      "r511",
      "r515",
      "r517",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r151",
      "r152",
      "r193",
      "r500",
      "r516",
      "r518",
      "r680"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r123",
      "r616"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r164",
      "r463"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Restricted stock units (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r90",
      "r189",
      "r607",
      "r610",
      "r656"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Floating interest rate swaps (4)"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "terseLabel": "Credits associated with last-in, first-out inventory method",
        "verboseLabel": "Pre-tax credits related to LIFO accounting"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r27",
      "r47",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory charges"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r46",
      "r133",
      "r221",
      "r597",
      "r621",
      "r644",
      "r667"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r29",
      "r54",
      "r133",
      "r221",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r536",
      "r545",
      "r546",
      "r597",
      "r619",
      "r620",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Liabilities held for sale",
        "verboseLabel": "Divested net liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r249",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r37",
      "r642",
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Amounts outstanding under facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Uncommitted balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "netLabel": "Outstanding notes (up to)",
        "terseLabel": "Syndicated senior unsecured revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r51",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r58",
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Award payable under proposed framework"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermCommercialPaperCurrent": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Long-Term Commercial Paper, Current",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "LongTermCommercialPaperCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r37",
      "r323",
      "r337",
      "r338",
      "r339",
      "r642",
      "r662"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Debt outstanding",
        "verboseLabel": "Carrying amount of liabilities"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Total long-term debt",
        "totalLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current portion",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r56",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r280",
      "r281"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Total litigation liabilities",
        "totalLabel": "Total litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueCurrent": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Current",
        "verboseLabel": "Current litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Noncurrent",
        "verboseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "terseLabel": "Pre-tax expenses related to estimated litigation liability"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "terseLabel": "Loss contingency accrual, payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Charge recorded related to Company's share of the litigation settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r280",
      "r282",
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Amounts awarded to plaintiff"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r282",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Complaints filed against the entity"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r61",
      "r133",
      "r221",
      "r294",
      "r299",
      "r300",
      "r301",
      "r307",
      "r308",
      "r597",
      "r643",
      "r666"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Payments to noncontrolling interests",
        "negatedTerseLabel": "Payments to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r61",
      "r101",
      "r530",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money market funds at carrying value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r120",
      "r122",
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r24",
      "r79",
      "r82",
      "r87",
      "r93",
      "r125",
      "r133",
      "r143",
      "r145",
      "r146",
      "r147",
      "r148",
      "r151",
      "r152",
      "r161",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r221",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r586",
      "r597",
      "r650",
      "r673"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r79",
      "r82",
      "r87",
      "r151",
      "r152",
      "r539",
      "r548"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r367",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity segment operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r195",
      "r201",
      "r205",
      "r208",
      "r211"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating profit (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment operating profit (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r613"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r124",
      "r252"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Long-lived asset impairment charges"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r76",
      "r85",
      "r86",
      "r88",
      "r599",
      "r601",
      "r605"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r74",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r69",
      "r73"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized gains on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r73",
      "r77",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "verboseLabel": "Derivatives designated as cash flow hedges:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r573"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Derivatives designated as net investment hedges:",
        "verboseLabel": "Other comprehensive income (loss), net investment hedge, gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r80",
      "r83",
      "r85",
      "r86",
      "r88",
      "r94",
      "r362",
      "r599",
      "r604",
      "r605",
      "r651",
      "r674"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r83",
      "r532",
      "r533",
      "r541"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Less: amounts attributable to noncontrolling interests",
        "verboseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r80",
      "r83",
      "r532",
      "r533",
      "r541"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive income attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r71",
      "r73"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other accrued liabilities, noncurrent"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Settlement payment"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r108",
      "r111"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "terseLabel": "Payments for purchase shares of McKesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r118",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r399",
      "r401",
      "r407",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r445",
      "r447",
      "r448",
      "r449",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r428",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r450",
      "r456",
      "r457",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r39",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r39",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r39",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Proceeds from collection of notes receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Proceeds from issuance of commercial paper"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r112",
      "r490"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r113",
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r114",
      "r117"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from sale of equity securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r24",
      "r79",
      "r82",
      "r87",
      "r119",
      "r133",
      "r143",
      "r151",
      "r152",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r221",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r532",
      "r538",
      "r540",
      "r548",
      "r549",
      "r586",
      "r597",
      "r657"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r251",
      "r621",
      "r658",
      "r669"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r621",
      "r668",
      "r691"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r76",
      "r85",
      "r86",
      "r88",
      "r599",
      "r603",
      "r605"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to earnings and other"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "terseLabel": "Reclassification of gains from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "verboseLabel": "Accumulated other comprehensive loss adjustment"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r30",
      "r127",
      "r638",
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r30",
      "r127"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of period included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r261",
      "r263",
      "r266",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r124",
      "r260",
      "r269",
      "r272"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r263",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "terseLabel": "Restructuring, impairment, and related charges, net"
       }
      }
     },
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r42",
      "r367",
      "r621",
      "r665",
      "r688",
      "r690"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r140",
      "r141",
      "r142",
      "r144",
      "r150",
      "r152",
      "r222",
      "r491",
      "r492",
      "r493",
      "r513",
      "r514",
      "r584",
      "r685",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r428",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r428",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r186",
      "r187",
      "r200",
      "r206",
      "r207",
      "r214",
      "r215",
      "r218",
      "r372",
      "r373",
      "r634"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r76",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r431",
      "r432",
      "r433",
      "r434",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r5",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computations for basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r155",
      "r159",
      "r162",
      "r164",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r239",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r280",
      "r283",
      "r285",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Estimated Accrual Liability"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.",
        "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r570",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r265",
      "r272",
      "r273",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r267",
      "r268",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r263",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Asset Impairment Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r195",
      "r198",
      "r204",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r195",
      "r198",
      "r204",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r218",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r237",
      "r265",
      "r274",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r182",
      "r184",
      "r185",
      "r195",
      "r199",
      "r205",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r217",
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss) [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, distribution, general, and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r11",
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r218",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r237",
      "r255",
      "r265",
      "r274",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r130",
      "r133",
      "r155",
      "r159",
      "r160",
      "r162",
      "r164",
      "r172",
      "r173",
      "r174",
      "r221",
      "r294",
      "r299",
      "r300",
      "r301",
      "r307",
      "r308",
      "r347",
      "r348",
      "r352",
      "r356",
      "r362",
      "r597",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r60",
      "r85",
      "r86",
      "r87",
      "r140",
      "r141",
      "r142",
      "r144",
      "r150",
      "r152",
      "r171",
      "r222",
      "r362",
      "r367",
      "r491",
      "r492",
      "r493",
      "r513",
      "r514",
      "r584",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605",
      "r618",
      "r685",
      "r686",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r171",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized repurchase amount (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Authorized amount available for future repurchases"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r39",
      "r40",
      "r362",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "terseLabel": "Share repurchases (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r39",
      "r40",
      "r362",
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r40",
      "r44",
      "r45",
      "r133",
      "r220",
      "r221",
      "r597",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r86",
      "r133",
      "r140",
      "r141",
      "r142",
      "r144",
      "r150",
      "r221",
      "r222",
      "r367",
      "r491",
      "r492",
      "r493",
      "r513",
      "r514",
      "r529",
      "r530",
      "r547",
      "r584",
      "r597",
      "r599",
      "r600",
      "r605",
      "r618",
      "r686",
      "r687"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total deficit"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r131",
      "r348",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r367",
      "r371",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r606",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r606",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r606",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r606",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price of shares repurchased (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r59",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r40",
      "r362",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Common stock repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r59",
      "r369",
      "r370"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury shares, at cost, 133 and 130 shares at June 30, 2022 and March 31, 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r497",
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Discrete tax benefit recognized due to statute of limitation expirations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r154",
      "r164"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in usd per share)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r153",
      "r164"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 20
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429468&loc=d3e288-107754"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(d)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r707": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r708": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r709": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r710": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r711": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r712": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r713": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>85
<FILENAME>0000927653-22-000077-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-22-000077-xbrl.zip
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MP5=)()[OO/R4!%%H':1(;8S<3 )%Q20PM57/V4?AI)25!/J>EK>(_ZEH.2?
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M]W4^Q.'G%RZC<PW%H)#)%6<X"%$029%7[&D1([)Z75;G>MM(WXB3S9-]X3C
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M9KPJ 7S)$9VK>ZT[FXIRL0%Q^@*)1A$^$XV:J\\TQ"N$5,@;XL@A6@X9G(?
M;V2],:G8T(39 "LNS"SC/8HH,*:L'*M&:;R*K!.8#S)8X45:?+_P162XK3M%
M9FV\-QZ.)DV$7;XF8E8!A-5U_UA'ACS8HE@W6*&S<'6B^OE^0 OL%E94F-D<
M3@XD 8.DDH'8)40$(UE%4BBTT)G OTH%OA$?X]_&@POBD5_'+1\;9K;1(!5N
M&1!D*B" 8TDT&'2*(EJK1&ZP8_B9V#"KQ!;1E>@YBLRH@%N,Z(.%**0E43L8
M9(-]@PYG_4Q/* [&.#B23'#EEX\,LW(-&&4A3<Y) A=,#"HQ!T(&1(6F ;F#
M5F287;]C,,X4*#(% !"9HPIC!',#<H!4&K HX(MD '>A!_I("WZ1L'P\F%4@
M(9.0)5F770;K%%I9C+ *,Z)@+C38*?P</)B1/Y#)4MV V-DDH<X'TT9)GYP,
M+CD+#>A;6*!^)BL^Z>]6 F1#'()B-1"IL!ZPQ!\%-P^!A!6ZU&XGUX#Y\C\[
M$68U!U]0T"99##4IGI!A,D^4 S";O1"^R;,5P/O/QJ-@"<>C9I5T(46/=3:W
M0 OL":(7FE2L&^;D9'631R9_%B;,RB?HNG6,T*;F8Q0U.U2FDD/0Q1K#/S38
M)T@CZIY7IVS8[+^?3C!SUQ@@:B A9M:GD+0RTCN.&@!+9*E@4.4<ZA2&[!N0
M.75%B-G.?O:DA)%@?"9(J*,N)3B5DR23"[@F>PBK+Q)B*XWZ=0!9+.?HU*RR
M&5@KM8^L&H2';""2]Y@E:J@)M7R3M<//Q8=9C4@8A1Y=D58X*-8'HI!E!!\4
MQY>B :LCOMP)+?4V8U4W2?JL,]HM9^?3K/H<I*V+T;B-"!:$3+[20R0??-+6
M86JPD_@)23&KU1(<=$H.+Z(P :RWJ R0M24YKT5QT[V> V-IFD:*;>IU^H/7
M/7Z$\8#R(_Y_9_0$4]W/_FBTSP)*B<L_SHHDETO]=*.;]_WN>^;IS=SZK_EY
M5AGU\$T25(:V"&UE9B%U'8&B%%2Q;I*+LL3L)?D2G6$),-G(:DK0]HJI*Z9^
M^RKQ3[GZ%ZO$/SWUAW:!4BS$C&)*1TC)1A>]"\X4$;444O],?O<1]C!WL+?>
M[W9Q\'#0&76&^R_ZXUX^;=2QEVL0,-P>QV[GH/,U1JSX/P]/+1-9E9C$TCN(
MP2&KS&2ML,$J0B$;M$O=BMO-Y?;\=_A+5+)S6+*"!,!N70%H%\QDE4F)3=I(
M:64(2V((<TF%0XD,@ PRL] 1I%GT>&VT4THED.B;V^.PXO_B\_]F$M$"L!,7
M+'$P@8LZ.E?WQS,%1=(H&Y! ;T7I9:'TK);$:PTR J'E4)2BC"6)2$:46%P
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MS^D]=;_P5,]ZA^/1<'*&;(B9VZPHEHS) P'&&(- 2;X8)$<0Q.*;^8I <_5
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MDG"D5+*AN%)WNUX:V!>D]VX&J= /!_T\3J,KLZ.<'#LMXMH)4AAQ$C8'93)
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M-6B?LRZ>8PQ )]!+6P CDO(E9UC)B1GS6%PA)R22I<)5;%P1'.-5)4&@6%.
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M$M>=5/+-H]ISE17_C[UO;6HC2=;^*PJ=/6_L1E!,W2^>/40P!GO9M80-\DS
M%T==C6PAL9*PP;_^K6I)YB*!$;102]39$XQ!W:WJRLRGGLS*RIS@4H*0497/
M!"B#$]V/7](['Q:+6%K-)N7HQG#3'@S.4S!G7"JT*$?HB]0$>Z/BEQY,[NC$
MKQD,XUJ8LJELL8&?6HMO3DK9OBD^B'>>=]LC=!B-HGXK0Q]"3F7$#$PM9<'J
MP)Q)Q14\M] S_FFO  J!53T"IFV?ZL[@_^I[S3<S4FF+D1;IX8?%5^U?O>_-
M'NAQ9H#K%4TNTP.CCQ0=G_@L^-+P9,>F)D<*.B0#$,2ELR24 TF5 -ZHX&F
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M3_GF"VR,?^A,?D_0VNFE+:)!;=OTSH>UANY_]</:07OP->/EVB@!7>>M\]4
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M,$007!07>S2^WA.A7X'PU9J;;PF\*9OO\YGO%$4BTA$J* 0HT&B^%%N@N/?
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M9W^C.M2@UCL?#H:ZFUYGK9.<<A6HE<W 6Y<J4.L9K+V348X IN02RNPVFYS
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MA)!:*@ZCG[0[F?^\%UPF9LW(XA >.T0L!I8D'\HY#J04%EBKA#<$.ILH"MZ
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M#D=*:TY=E$$):9XOPJLI;5OC*J$\=4#-65YEX]"'&8$)C3'FV &(2'1Q!$%
M.DL!AQH:)Q$ENMC.D%)4R,7)@8F*<HILPHLWX=M40C(EI+4,! E=-&$6@#2>
M <X9EU&0S@I6N 6H2B;\ H^-S.81"\P9K]P\/+P&\GPOOS8X7.ZYF R\Y0'O
MQQFI(%QH1SD'DD@#J*8,*,\UP#@Z=T@Y#V6H;W&\@559E3Q6XD1,1K2,: LZ
M^I,1K51$NTTEG114<ZR!]#( 2H("&G,"K Q&!V6]2,74.(F(5E9*S+,<^IF,
M8J+$M,"KY?:AFM%5N(+=LAXZRIET'LT9J_]9. ;.0/WB]W;718?R%5#3+11/
MV\YU_))ZJ+W;V_YC[]U>:V_WL+;=W*GM[+[9>[W76N-><O<W%>NTM6EWVL.V
M?UQGL1*5>6'/>%$E''?Z.@Q'!9*TM47GU]J9ODQ%TI^R$;&F)&\]J5QISNE8
M@=Z/]"<?YRZ=VGV==E:1M](:Y &-HHH_G .:6PNB\!BQ5FN'77V+J T!JY3M
M_$PN:<:D*KW;,MS+C$F+QZ3;[B97BLHH<N"I9M'=% A(F@Y@<!%P$ Y+IR,F
MR0THJY31] OB-^D 'P?K[X>QY[KR117UG+@@9[U^ 1Z]4.OTNI_!T/=/(P28
M7 %CX03O79SO5ISNG3C;18_&L_90=XH3;OLFSDA1A#@7#7P,C'Z9<;A$<^ZB
M?F)@TBXP99X# X,&Q$";:HRK0&U]2Z@G9Y+E#([JVFY91"C;[D)M]S8%HM$M
M\\I#@"/F1@H4/3))H "$(^F(B?]FIFJV^Z("7S/H1.]6#8R'!#M??-;Z8FI?
MO!M/_64&I,< THQ#)IAX19AT %D* <7014#B$#A"O;;>!2](?0NK*K5AS$=,
M*DHFLK&6:ZRWV0,SWNN@%9"*IK:IZ3 8YPH8A0)&W@JHTRD2]>3$S^J=(5D-
M]O#NBAJ4T/[L13@RI04AKJ8^-T=:+G(UIFF&L4I%YR8 KJU)R.6 PBYAF+6.
M..U,2EK'&P33"GD^.6I14:*1C;U*QGZ;I@@)B3.! BQ3.4^!"3#$A.188(&5
MEY:G6N(;@JYA'8W5("JC4Z_:VGXTCQS1>.9TF#3IUR LHU+IJ#3CZ"LS4A(4
M(%!.TT@\ @8J-6A$' 6C4Y<#81(J05$E]RG'.BI*0;(9/X\93R61,(8%0QYX
MDP*6@1I@'-* ,>6AD5&PD!=]5FF50I9E1D%6Y/BKG2,W_ &.T4OMI;2 ^$@&
MJM*!:L9Q44L#UY19$->8R#<T<D AHH"0'GD)L2.:1: 2&QB6Y095X[AHB=&0
MEVKT"XB39*-?A-%/G:C$VG/LHM'CE-\!%4DUQFGT.001C"&DBS9J<H/R)Z>X
M/HO1OX3JHN^>GB_Z(ERGY\T7S4A5'E(=3=,303!DA$E@/4G=$$@Z!<X1P%Z2
M@+P7!(;D1^7JHFMMT\^;1YIMNE2;GBI@SJGF4$N@&,2 IL)^6CH-B,*4(NZ5
M(ZJ^Q3:@A!6RZ9=P4/XZQ0@^,G%7&^J+LF(CZPU19=&.G?',[W5M[]2W],4U
M[RA70"X5F^PTWW"!4<I4 -+!R#>TQZG!M -QY6&21S;B-1MU7ZK2IG#. *DH
MW\C&_)S&?)MH:!TPBNX#0$PJ0*F4P$@D .?(>NNA5 (G8Z:H2OV-7E8L(Q];
MJ=ZQE5PD>1$ ]7E&L@<TUFF- !(^)7NDMJTDM7[D% 4,D?:RZ/5(^)/S37-T
MH[KFO."#+=F<%V3.4ZU;&48<.9^\!3_.*)6< D,Y0L@7E&-DSE4*5KZLP$:B
M%J,P7PYK/&]BQV3>#WP<]3>?46D1J#2CQIK!!@<B-= N8A%ED5]$^7&@$;8$
M*^>QHO4ML8$(KI 7E$,:%249V9"?RY"GZ$703$=_ 0BO1:07&@(3L <!!D:Y
MIM0HG0PY2K%"AOP2PAG3W=ER&..Y6[1=CZQF1"H?D7YLS^K39A#T2*?>\0A$
M+T=%DD$$D%QQK".]8#P4NR6L2EGN.7Y146J1[?B9[/@VLT!<.T2] 5H&&XV9
M.2"AUD BHIC14.E1OT5&5R@C8VTKGE::"C7L?_Q@$/'B=:]_UAN=9X]CZ-FO
M)[V.\_W!__L?B9'X/668M&W[[CS6W(CA0<(>]L[B-[KVM\F#Q_>#=/$KA(L!
M+4,1WO<G*42%]#=J?[MO17GO^X<GNN]+65GVFF]N+RT_1W.8!O->]_?[AT,]
M].Y/W3GW5]\^7DE@7DD>L)(TAHW7-U>2^+R._]?!Y?%?[LQ@&I_W9R<^*3[S
MX^5QZX_XG1](H_7U1^/TWU^:7[Y>Q!%>''W91L=OBTJ4G[ D'J<VH7'-88"J
MX(&)@@.!*,YI""P8?C\UN4.1'N=J9$5:544*GF'). /0< %HX)'16*F (39P
MZ; S1M>WX.:,0VU3?ZB=Z7[M6Q+O1NU.U1LDL0\6Y.#>5+I"PP;;Y\.37C\"
MLLO\=YG*]N/C)R$4UPQ18!4*J=<Q!0H;#912QD-I*0[F'M2:J3IE^519=2JM
M.LY0%J +@. 408F2!)(J#ZB%DDB14N4C3D5&]0"8&NE13?^4[KQPM2"V-5*Z
MO<'@/"G<=4<^M"^\ S]\OY<5<8F*V&S93Y1'3T8B!YR $E".'=".TK1T2LJ#
MQMJK>3%L0:1KI$_[Y\/!4'>3KY.5JJ)*):!AG!,/L(-IZYE$%H88!P&3(+4P
MRL-J*54&J4KKDR,F!(\98)JDU1)BH(6SP'M(M0^2:<F>AVAED%H;I?($(6H4
M UX2#J@2&!@(6<J/@=*[U&,ZLO=N[]<,[.$<K5W@3*W7K_6N-.1G*-2UO^5M
MIL5M%]\TU")NDXVS+..<.L ?0=HIS8%#2H"4H@),.O;K@A;,(<.1PO6M8E,
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M<:@KF]Q\)C=5\-YH[3'" 'LD &7! &,<!YYA1)35% E8WWKR>:5\%+JZQKF
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MCPY!VEN63) @#8G01*>[7OPCARW6P80?3S+*,N%,/4JT[RGJX1QTT%N@J)6
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M#)#E90RO#FWW ![7[M;II/6-2*=M7;M3%15;K6J/]5++^O\];=?=8TJEL2?
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M!!(-.MO%E+'%VL6WTJ4'=JH5)"U(NG2>QX*D]XNDDR3?&N#Q,G!D8KZ X,H
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M!$-9T CKQ!"7TB!G!$&46!9C!*$FM;*FR54%Q*X-1S^!A+OB5=<UMY^](C\
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MI^==(U9;WP[;_K!E^[%UT@= Z,,D +Z.X9<!/"5WYFK];0ZPHSPPL$!3+L+
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M2,9S12]9>J@\D#Z^;4(,XO>3[ &N7<]5,$-A3DL$3(V8@#/5[1<JMTP!J1N
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MV0B7INX7SX8C&./Q,CL(V^!QP#^.NAIA73BZ#(9/_\MJ2=PD&0F$$- 1NQY
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M(!A.* J=$(^ GU90C:(*(C#&-"$&2.>]^PH]/G:660&_EEW-WTRV3;_>YYS
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MFWMO(U2*NKZ*>J?*$Y6B/G P:2(8+JTQFOJ(M(H<<99 4R6GB 3'(U A')P
MDWKOY-0EJNI=SW(M>%SK\8+:]4X;>=L[&H>M[Q2Q?A$=_QXV8CW:<=N+_7XS
MAB_#4C]O86%@WE.GV[*Y@LN/_NO4^!$#.H_=3H5'B^#1V61P.TE82?#%D$P"
M7/' ,-).1"1H@$7V4EC!-MZ4M5[H;VO4 ;#JY3F/9O^R-C'NGZEVI<*+J/!$
MV!MC0;G._GE2N;BGQ<CE,EA<21\4!SX8Z,8;,:&\$V4]*KU=%[U=FXAW99$?
M6ITG@N.$^"!@'9&,*B NX"?PZ1A*A(./KSCFR546^05H]L.&R"O-?FC-GHBF
M,X6Q3"PA[:4#0TU<WI^F2$@!*&ZTB!Q7FOT"-'L),?4>O"_\5''NE:CR1+Q=
M**NDT0PIIT"5&0V@U&"IJ:-<<0>K&MDTSETI\;-1XH>-MU?F^<%#81.A>:X8
M)]P0E+M;HGP>%#GB!))4D<A8(EZ+=;3/2TI'7]_X?);[XL2>Y3SSNP7GG^X.
MX"(AO*5'YS^,YOR/3O<:.E58LP#6U-].AMV#I;G>ED+&&(JXE019&P423EM&
M>0C1R&F)-?/'[*JM^C56U*7'VBM%78ZB3@37(Q7"10Q$GQ"1B7X$E<4:R2@9
M\X(9%5BEJ,]649<>7:\4=3F*.A$VUYX(SJU'/L2$.(X16993S*VA/ECN7133
M<LHK17T6BKKT8'FEJ,M1U(DHN*/$@7\=D"$^5RXC'CF>*S1*JK7!Q-L0*XOZ
M;!5UZ?GDE:(N1U$G8MS21X%SQ0:;<$0\"HLT0"N*"K,$>AJ4RR4&[Y-84FGJ
M&FOJT@/<E:8N*9HT$;EFL"8XY1.4G&+$54XO3RPBK)6.TGL14@*;NB9&=:7Y
MY"OH_3%=U7;+5J,KZO0Q;0AW[?1!9W3Z>.9;?RL.M"^P@;^?^RPWRUY+F^U0
MRM5FR/U&,YI6X+D(>$YIB)$L,!G!/"+>&<2QSOZ(5L@3JKSPG$;,[Q<XJ';Q
MUW<7?R59[[<H<+6?OPS%G@C=$P.>"N<4>4PD^"^)(*UE0 $#J\4&!R7#.F[G
M5SK^%%/D*QU?@8Y/1/VYX8#9)""F\[EWIB,R,GF4$N7<A BKKBL=?ZHZON(-
M@(J2/XY63VP11,N8LBPB;6U"W'B*--AO1 6L;I0BLDCN&7FL='E][?7#EIRI
M-'CY&CRQ=X %Q4I(C@@L(.+6,60TD!ZF?"# PFF24W?C*XN\WEJ\XOV#RB(_
M4I!LLFQ-I$0F:I&6A"!.@T%:686,QS9ZH[AB='U,\ETSXD>5XX<W@Q'<LP%Y
MJQ%",ZY% _(_!^U8,/QT^X^S1?N/S[FD+[9;R-+G9[TMUR(=DX@BFO'D@S8\
M2NF,"PG,EF5*19_2J)O(G6AG98D6L413JO$;Q[C@%B,9!4,\.H5< **I&=6<
M."V"3F"(EE63=&GJL:*\EGDMV-Q-E2H8K6#T;C!JDPG&4PE8ZG,0SB5!B.8*
MP%/D)IL5C*X.1B<VQZQ+&I#2(Y*T0#E@BAPQ"46MC#,^8J_H$EJD5RA:H6B%
MHO>J N0!+HW4&A//+?S(A68RX-SLSGHC*A1='8I.-K+@1#'"<G$N0Q#7R2 G
MM$8\]^[DE(FHPO(:650H6J%HA:)W0E&LM23.*.K 2XPQ6*L%5C):X[BFIG+I
M5XBB4[J,*,.( =CTN6\7> E(:Z*15H$#3@I)#=EXPRL8K6"T@M%'A='$@Y',
M11L8YT!%C0XT8)8$4SX12BL871V,3NRY6ZL,V#>,/-!/@%$%"!I%1,3[X%7*
M#9O",GK)5S!:P6@%H_=*2$Z4$Z^H5B("HFH7*'.."L6YPBJH"D97N,$TV:[>
M.66X]\A)@% >%$$FR(A89,(Y:40B$IQZ(I\+D);9$K_VK6O&\>XZ_#,>=\MV
MOS7:X^$QT(717_* )/PZ&@+*4/6:Z.OXE3-P&NGL>D?[_*5E:ZFY34EIF;]$
M_O4@N0_S//WZ1*F:H'D6-GM%)Q4[MNN/"D:&^1FOBOY1+/J=OFT6W:%:%VZ8
MR5&<VE[Q_RV43)D2YCE:B!U/7EJGG0TB]W4,7B8RPAK&R%VPYNJQAO:@A4*G
MCT9W>>I U(S_^71V^"6<.,KEX?$!/MQOM@Z/ 7C>;P/GVCG?.?Z.=_<_G^V\
M_WA^N+6)#X^_G];IGZF^]9'OG'Z- !]<\(@D-F5O#HP<2PDQKKW V!@5#< (
MPQ,P4H#D->&'5UDR3H\:(!F+K+C6P3!871V8Y8PPS9BP6$>C0!9,3-6*/\"*
MB_JWKRQ:X[$V* "*(,Y$0D92@BB1A%$*_E'.D1-ZYH*7RMV-/@-^*!KM(A]<
MH?BWX5%RZWUW ']O-JQK-!O]1NR]*K] ?EM(/F2 Y7=8 ^7PX,0Q8RA.6D1"
M U-&\$H^EBX?QY]%_7R3[NY[&..[\YUO7S$%'UH)@0S)M89#!))AL4!.$:F\
MYI$%0 <VR3%NDY6_+J6C.(K-D!>DZ,&T7\B*;8>%Y 7$5RD3F"0I<0WF0P5C
MHI68ZB"E5Y6\+!]//I_5-[\& :;"2(\2CQ9QR172WAL4"2;,&:)D4'>2D2&>
MM'/7PT&W"Y3L*J:,Q02^GEG(VTXF;3VX'GXJN:?MPR^CQ-)B[RC&?NUZ:N9,
M\BBODT?VU,@C73?R.%S(DRYH2Q<>"&OFFX, C_2#UF"875OT+Q/C"WN1$=\K
M8:#\+,5N#\AFX<%'L+#JG?*F5R3BQO*.I*T^:,%[^.'O&3 :[4'YE&L",'H%
MGI-[)S-_3QNA?S3VGZ]<-9(7?'F)=2![@_[L2ZZ(C8?WB]V1C+SYM^O^^F:F
M@,ZZ;(71@U*V<L+BM4F^\N]1=SR:$_LM(M>-]CNR"0;[VC9/[5EOX]?K2@?Z
M-;JY C&9F+*9;YC2PZ2B9_DM)SID+"J%Y#7XP;$[S.W^MUV;L11'W6SS_@=0
MCBG%<!0:&\ZQ<MHD+AD&#\I+1\-70-[][#%GCOXVF\NR-+U=)TF;]NX;;W;\
M?]_M[>W6B[>[GS[L?MK<W]ZMWX;?&:W%=6Q^U'?X8[N^67^[O?E74=_=?[=7
M_/)VM[Z_7?_\;NM?<YHB0M?H=7[Y7-_\O+6]/S'\>5YB60;U!HH/&9<F(5(/
M_DP0'H K.G!:-?'>\4BM9G'6=4D8ZJFD+ ;.551:1<E3)-QY2JQTCV3 V;H9
M\&'TY]KAG&4&?QXVT%Q1]VG4_> \4W<C6(R>(/#N/.*1@WO')$/>YM@ \'E@
M\--CR/<,_CA#(V').L8X=QIK306%1QLL1" <5RO^ "N.ZZ=?B6#4>J90H"D@
MSHE"UCB-N!9)R^A$RJF <O)<RFJ#/TD3S&E,VEC  &X<HUE"B#)18)(J^7@(
M^6 [W[X"A_3)> GS851N+B60D4(B&V&N8TQ4V=SQ91T"/C)R+D$PI*"<"Z^T
M#XHIER3S HM0R<@#R(@_W?GXU0<&L\XXBESD#(Y<-<'A@(2C%ELPW$9HD)&[
M!I ?(N SX?M/^<L%B1VNZ6V>%6<;"S-?0I<?%)J3O//:<-MW\M]_7PN4+*$X
MPG7UVF[[3BONVQ];C9YO=GJ#;MR'^__>[/COCZT_9R/].=X\SS)^</YW:S=?
MO_61'GSYR ];'\\.MS[_V*%UT(\_X/[;_*;^[&S5X9K?C^M?0+_./3SO\.AP
MZZAUN/7G]_K^N_,#>MC:^?+W\<[Q$>C/YNGNYE<P9,I)G%"TN0<(%1HY*Q12
MS (E DLGL!YB'4AG#)L9A63"C( ,*BS .Y%*&\RDI9$"87(IL8TB BB=9 <>
M#/#&F^&L%S#M($*3L;"KWMM4S^C6YRW@M$YSYQXB/#IG#&NK!/JA^W+4C;%H
MP25'O2*V,QI=KT"0;1+\0%Z-,*<%XSV["EWE+/?MCR+^.,EPE.GP0D1XV=7+
M+]3MW7! O\=V3(W^$S%H*U;(W7W_57BCA*4)80V.$!?8(2L#0\2#_Q.(T8KE
M*EYF,B'QPIPMS%R8D 2>IIBWW%EODTD6Z(PA-G@CAY6CR'C12;7H2UWTG?UM
M\94;D0QA.B^X!>]'>F1MSJ/23G ,'X%B_I3GOLI1CY/H\P9!\ZQ6[%_B0UG'
M4?V6*<Y)I]N?CA-=H"LE#YHI-[!>+G:7BQ?LIN2\2VGX#A<B] D&]G9H#P F
M=T_B,/K<NY 71%^:P "5_@J0D(#: NDUBH*8*'"<,96(IV0)!\750F68J$W2
MWO\M 6*Q=;XG1%3K?*=U/J!?4Q#$8*.1*$O"82V0%5P@9X#Z8"=\I"*SZ4ED
M^-_2I5V05EP'D3^:V0\=KL.EHW,[J&0PZ16V&Z]LLH9!#L\6 5AW-P+6N*%-
M&#I>W]I F,+X$?\WL'#';JU8@!I-,J+1/6W1COW+Q^;AC1[]"-QH1F6VZ=KP
M"5ZB[<'=+!=@[PCF\W<+'F9^2<#L\J_O?OC8Z\$%(Q.[V>H,;A9.K@SMR-VY
MFD^T]5F ZV,L]50%A<"GX(A;BI'.30U"LI$(#3XWUZ!=D_79+KC6I8"7V_,@
M<"#DI<""H#5 &GTI9[V\>B@7YLK'+R[7;Q$9G\+ZER[C2Z>"G]N7X[P4T]ZG
M& ;E8."GWJ )J/_MCVZG]9<]Z<7=M'ERTFSXO$^\U[?]01_^]%>CU>B/+4(E
MW;=(]_Y'5O_X-08:91(122<#XB;WZ/#!(IWA*A#GI/4;;XR:D9'_4Q'O#1<F
MRU?S8FDRFVQT+^W%/W!99]#+ IEE_!A$O1<:PW6?-_MIS;WWF5N18S4]LHLY
M8W?<?-1S*MY\RF->F/+DTRT[IU^=8YPIQI#R)B%.P $SW&6RA055'G3&YG*=
MM2GVP(V4!81A<&7FKV)Q[XZ;DP\L$?M'MO^E,VB&[=):77"1$0NI!&:ZP'S_
M 0A+C$O6NX"HS_Q!,XET[J:<*-'4DN2CSLT>:Y,5H2X$YC1//2 KV,,XS3$O
M$PX!3^)X72X8=M%(5TC -2;1!N$I^J>Q^<^83[PJ@ PT,MNVO4X;3.M9<=+I
M]1HY%ZL/$E!T!MW9DENT[%F6K7PU4/>SPL*?!B#'"V96>*=(PMI%H@PWTCA.
MG7<&/%DM-(]S%S?;&@UENSU#J+>!5XQ?],/H/2O>,#W\=(!W][=I_?PCR6/;
M_?C5YE0+13CR% -O<)8B$X-$-&!KG*"4^;)J\>09G.O$ 6C"(L(AA+!!16=<
MI%Q@;1U5B@F"-<MU1.>NV50)QP.Y3!]Y/JYCM232@:-$HT'<>XZ<$ GAJ 57
MRE*2\]2(N4TX1O& 7NSWFW&86PW6<8A\0-3:(Q:9X>]VKCETK#K#\$&C/5S*
M_*71QBV@G?W'-IK9I:@5_^F<QG]B-_.TQA#:_)%M?XL9S:Y2M_&65YGG?60!
M2SOM;YV,L=G5&H#@Y&>?-OI'-YFN'?2/.MUA=@%X=9W!MZ/.H%_>_"S:;I%S
M#::]5&_X5O%5^=Z [_F*[!ZU,MYW8YG-?1O-@-&E,CL]@4<U?,?8&]X"#$U^
MT>L,]1169+2'5.3?<\9=?HAM3MU0ZE[XEC!=[9CC#[9[-H[=V).3;@<\ACS>
M$Z#4G3",1<\:;3G]H,B=_*RA>8$G7)B:D92D07_0A=]@V9J=DZ&TY)S[DT:G
M$=#8+<D;\]]&*?LP?;YI&RTP?+8W7J]AB.D/$*ZV;\#KU3LP2@*$?;3A#S,"
M*W&9Z#^,1W[+._]7\D5JHZW_Y^' 7-DH*%*C&7O7 GD1YOTR]O>YME<K4@RQ
M"Y-WU9M[=:$ Y5>R;,?K[MY0HL?? @6%,;1O>(2EH&SGC.(L>Y]@L4'YBKW8
M_:<!W.B7T2)M?]H;+<"_,J&YU/ A;HPIT,TX93DPD/&34?KZM-?, 5.*B1X%
M1(FYMH^2GP:RD%\>GM8;N&,@9%DZ[0 4)K.B*=I_Q0N^G)JA=,%'4^>A'$9J
M9)-3HD4O#X6/<:1\N7$^RI5O33EN,GF\9,Y4$OFD4DE$[6$J\U\^OKSC:\#H
M9L//,:"9F2T/.\J?CNF!LVIV&NTL\6>E]H*U6;_DFGIC3)VV^>%Q+H+Q7=2/
MOXO#_8\D4Z"=K3^:=;HC#K<^?:_3?/T?WR>HT_%1*Q?!V-W_#I2HV:QO?<;U
MUKO3G2^?V<%Y\WO]_4=VF,?ZY5-.8#P%#]%;3R1)#@50,,0-UGGK1B-0/LV<
M8-9Z?C.YAN1)3M082P,/ EQ^&YPCDG'C0Z+B9G+-)T#DV"J/U=0[[7RO;@=(
M%B#1>#F&@#/KPSODX]P^Q.NO)"1C4:H<4 [@\QF=3T1$E0CQR@5K?I:_(\?V
M<R7&<J:N3S>?<\S]L^,)%S;UI!O_R::M>6TWHGLY)>WK4]*X$,>I,>7,7?W5
M[$FPL;U&: "]?%7L^/\"TP3Y>S< @@DL_G,^?E9:0W#X8MZS'MK)T!E[#Z70
M QTMN2K\"(#4NSB\6=AOW5@Z'L4O^28C=K%U>?7F^ MCNC&DS3?>J=S9.>HT
M0V;<N2;)]7&6NZ!PCP9X.>5+PD3%',6Q>7B@4R7U!G.>[W5U9ZBPY59>OB4\
M'P#YMYFN=!QT/\1NN4%XLXP)20R#CKG #%=):Z&PPC)1Q64@/F27FG!"KQ]"
MWZ[_,<;WEO_^>K,<YJ?Q**]N/XX?V^]<%_X+V;_PG/$+@_^=\V_\JV&.1&L$
M,KGU!D\T(J<)1T3G$)B68!O4QAM<TU/B@^ \#66K5FP"?&?G#QS!&8E_=G3R
MR?;[W8:[<!'SKN"8YG;N(KP+[AX:Q;@.QF///#?4VQAQ4"'R:(CFFBR\>UB/
M_>&6^%^@NINCE\O(LM^Y!-[IHO<T CHK9R7[V^RKBS@JRRER 7/$8Q3($9^0
MLB$19I@/W&V\^4F^?)A_SSI[4. WC<!L1J)]_5).[95%SD([RX),I-]?MTPS
MTO'S=O(0\T&R+W.,+H+L,+*< 0,7YX>-L_W/KITD7.2PT=U&>:<J$6M.'ZY8
MZRD6]DZ6->^L B[FAV1).1GT+V($'^#G3_F#BT@!W+_1G?H$6/W^/4RLI(F'
MY#$1+' IE4E)Z20X32H2'N)<)G:&]837*-_BW8_8]8U>_ #L/+Y8D[J[_^W'
M5R,(=C"UN>2/0IQB#]CE#)*6YGZIW#D&V$5I;5J"](5-?741;0PC%@9,-(==
MQOAR$<Z\(&$+YDO>22KH59D8+_[?MCF(8Y'(.[)[0+MMN&;?0"M]MG&G@$R]
MV%Z?G,F5TZ[]35S?_ J&C)8E*)WV("6>4*23-<C#E'-K6*3";KQ)P,.G"DDN
M:V"_Q>*DTRA#P:Z3"7NYRS#<>3T9N&:C=P32DZ-^("?O(ZQ%N_@]U\3H.=O^
M7O1BJX'&LO6J: )T%<--A2D<OUM\&UAP3/H1;@D0WP"X!LELYH4^*TYLHWS0
M!0"66PZC5,TQLP,_*OX#=RCZ -NCT/LU/!RF!HX!\1Z)9^5P5DD+)S(9/MBS
M,DC_1Z?[*9X,NO[(YK2QY5#"QTYE6+G*'._0G6]? ZR)55@C;V4$E6$"Z6 =
MT$.5A$F.,Y?/WM=F[>NYRTW?\8K,QLRAX5VRF(BKZ+F(7)1FO7=Y1:A\AQF"
M(G8_?N4R8FP#"(HV'IQ: NZMH[E[#T]2.!P(R3W0^)0LJ>L[P"/V-879C;<Z
MXHCW#+>& 8(N>-T8=W]"&4>>QW@K<43P;;=[EK_Y3[:JX]O.$[&"!RZ$>=)0
MX[C$'B<N/3522A$\2U$;K:V<VQ6>30_'>0Z @F."N)O&K*$2X>DB_%GL;'XU
MR6M-J$61YK93'F#.21]1#"X*&2RA4FR\,=/",F/AG?-L!7EUX5M.!&U*?@EB
M[QNEUS=,\!J+Y,5N^ S7L7/:!AD_:IQ<4M8%@S71)"*Y8TS*R*EGF@KM3. T
M:)I/&BXDH9=-XWO[G<V+!((/0!6VVV_M28ZG5T(Z+X>]R,C"]?,# IC+>*XF
M*@0BA(%Q)OF(M@@**4Q#=-%)XG+2C?I)S,9F^GDI5F"F+U"WU^_X[R/4' G8
MU220S/<0B*$?+N-P3_P2B8<9*V7V32GY1%Q(?G^4[5KRZ!'2MNQPCWZ,_B#'
M%RRZ-=I%O(;CKX9TUT[![H4 F3/K%$T^D<@U4!O+A):&:4P5L\K,(>XW3N\,
M:89O@@XW4L.7C'XW[<=63C'HGKW[OP&\ROZ,R'@E^G.(/LWY9I)8P11#,GJ,
MN/4$Z(872/)<3PV,*^,Q5_>8/,5P>33V%*;\8N,GRVJ9&37RC3[=;OS'83Q0
MFG'$<MZPY,(!OJHNZ#+J@K*J+N@:C*6J"UK5!5V[NJ!3\UF6DI_R6!LO"Z:L
M/.\\E5F6.1]4SX5!2R+:Z 9T8KO -&/)TJY\;8:_=2TOI<SGR-F=4]-8WC9M
M=]#;K;\K]CH#\'A@%*,<UE[QUU\?2H?P;SN,,.^V\[Q\.RO^ V07O@EL]Z^_
MWI9;_I<YRV7\&>ATME$W.?;,>$694WWYSM.H]=27G\BSF9;X,^.I4ZX?9I>[
M."ZR?G'(/]?:&SN[[VJ?:_E]@9^ OY';/9W<FK9]F;7]GW'YOCVXY3@Y^UKB
MKFTV.[Y<GD4\!J*L)<2!@2*>9U=9*F("CC92JCQS"]="^DDV0^4DW-5)@.]]
M_&IHR UO-9))6W 2G,JY#1A1A5U07%KP^:;VPKUSS23-P&^,/+@4+8]86LY!
M5(2U.GB)15IFJDLE''<6CA^[FU^M3]('J9")Y7&V!!ZD, YQGC1/C*2HV,8;
M]I."6A.I5#-1]TIFS/Q),K,*L+P:A4_6)FNF=SUMIC:1*/R &>:7(X)'_Y6+
MGAS9]A<P9,VSW1Q#VKO(%?U@\]F(W7& =*POPX/-O=WTMCSLU8/I>\FYZ: 8
M#E,3M<QAQ)!K"T6++'$1&2MA76302N&;N>8S?+ U(X&C)<YR/E-5YZZ.5$:/
M;+X :,1I[_4B//EZTT>8C:&*7@1FRAZ5,"O-7/CD]?B'WS(7:MJSUXUV^6[E
M1;]=OWUV(&_TIRPG?_CQ992BAH>1BMRM\K*MYNCC6OG1C9:;P\\TKW$J9WZ,
M:V3F9S^[+6$UIOB\MYW2J7@\-;"N<?%OEDT[1U,QY9(;?4$?IZ6P6=RO*Y?X
ME^WVV&+U_G6SG>IB+SOTWQ^I4?"$5X_G\EH?260F&]1Z'^-E@]K)!K0WN\^N
M2>/JZ=,^"E6_NM%K=>YNO0M-QG/KY;W8RS^;1MV9Z:40M%7:<:,YT#[&@F+1
M1:]TG+MY[LU#A4_=J1DVZ3[^2 Y;]>/Z\::H?_GC^'#K(ZT??^.'[]_Q@]8[
MNO/ESV;]V./#+Y\NKADWZ:YO_=TZH#L4GD<.OM2_P[O0W:TC&/M1XV#_X,=!
MZS,X/I^:A^_!$1HWZ(;_PKN0G>.=KY(8S*5G".ND<H^-B%S2"L%Z.>8"=0YC
M<)/UK!ROAQ'\NS;@7@NP'W4C7T](GZ[)=_ ;9QI9NMC43 7X)XUU(5$,?J7R
MN3\1]M$0SKV2)#%.: PK"1)6J#@_*C8F4='9&)E/'#E-*>+,)92+4B$LF-,J
M:$J2FAH\7! 4IT/%TX6^$<@_)>@;'M3**?C=>!3;O7P0=PB%=T*X*3-0(=RM
M"%<NPMNK:W )>(!^NVG?_OC0Z>9Q5?BW;/P[F\0_;:Q6PLI<[LTAGM,,'6<$
M$6&#)8+F(GT;;V96>UN4%#X;_'N"U.]FNF*.Y\\H/P!LL#/K6.L+HX._/ 9:
M3LLN[=S,+NUWQG7)SBH87  &ZV\G89#0$+17#@GJ!>(N:F1L@%^94XQQ8R0E
M&V\F.U%.A%HK KB^ #@^.;AT9_?I4L%'0;>9=</&9YJZG=96HW=1S:0WB_W]
M9WA(H$*_1=!O2F@P<&Z2T!2IE$^8N&213BHW6O52):6,U(!^;++-S/SP][3Y
MW_UN7@WXA3#LTKFM^/%#6I IQ["FVX;MT6&WL5'9&L1^IUR@REPL8"YVIY!E
M$6$%B2=(LWST&ZN$;. $,4( XP7A*K<EFPR9OGBR/-H2&R7QT&>0&' M6>J.
M.X33IZ-*&KCGS*RWV5BD-02F$DQ!",X%3B4W.'@FB3-6*&<9F[<U1)51<!\[
M,,UM$)X(Z3SBR@G$F;+(V>B0!%_"T6"C(N V"#89-KE71L%]M&+MK,BOY?;&
MS\\XKF]^[3RU4W)Z^WWS<,D+S<.5NL;X R3,+I:QR^Z4"/SS)&&.]<.D%XNY
M;ENE M\%Q5Y,TO#X17%^S><T)XM4K*_RGZ?G/Y.[ZU25*5UE2E_X-8Q(8H((
MR5'#:2*:*,,8UU[29"6VI5]#7FRF]-]']?<?Z>%6L[F3[[D%8VOM</!+SG?W
M#VA]WY_FQG7U\\T?$W[-EW?X<.OP^^Z7S^<P?ACCQ[.#\Z.C^O$.//^ U,]_
M_[[['F9BZX^<*7UVTZ]1R5N:R\9B10WB1%)DB)8(AX0UT1R;G!-(S.1^R-/)
ME+['8&X:Q0K4*E"[ +64HF,48Y*DYB8GT$H5@C<V4H^-U/."VFUE6X<I,+EG
M7Z?]=E0;;ECD^%D?C5\U-N*)?.DD+(D*(QUS2ZNH-7(Y:9":H**0+L5<7)N\
MHNK>*=,K0<>7L"VYS#,?\[N-SW.[<[5%)ZO3(2M$N\8D$W11Z61L0E+G(@D1
M"Z29=,A1;N ORJLHIU8/6;?3(;<^<F:DHU+C917S7DI?JTJA%U'H"?K"L>(A
MD("2M@IQ"3\!?=&(6*%BHMX0.K7[U>/I\TM(S+W#R:SE\)"GF[C[F#QDZ6>X
MKCILJ?$C!G0>NYT*[!8!N[-)]B(#,^";"<0--XA;J9&6B2*: F<"&V$LSPVK
M-27TM[4_X'7K(^]$85X& BR;PE2G.!]5TR=H3:"&,I$2BE+$W-23(>U@-8/5
MAOOD;.(Y@7^-='S5<9<K&2*C6Z#\_7*3_6I>#3*/D5?S(.<SAV6OJP#.XQ.G
MQ8]S5HSHWCA9?SO)B!CP'YRP0T2ZW-W.**1M\(@SZAFUG&&!E\:(JJ#.&A]%
M66J+MA=X5'ME.CS!=8A305N14%"&@6LC#=*1<109," 9O&:<30OA/,KIDU5'
M;YX S5GH%/9#<IBGZ_HM!'3+COY4I[8? PBGI"DY1Y0RCB"-F<A] 7-?= 9H
M2+R*0D=M39BZ.;5&I[:KH,[Z!'66I]B5][(,A9]@/CBP7*-&HT@P,)^<G&B8
M@G\TUXG%LCG-.L9S7T*.S;NKW:HO^J-6:31K%H6Y=S/M"L[N!F?3DFMT;AE/
M&,(B48"SC&0\:"0% 5_.4:P(JX(Q3U7#'RT8<R<5KU1Y$56>8"8F>:T)M2A2
MK1'WUB$G?40QN"ADL(1*L?'&Z,D=J!<1E5F7W:2;[1GG.+Y=)>"L!8-9;O?Y
M"NWF1[NK>37[']G.L;]'5_HJIV:]E7IM=I J97X@9<;7E/G\X*OT3!O'//*1
M&,03C<@&ZA&.D403-$O!3U?F1PFC5GDSMU1=K+)>'I^MO/C:C(_ 3<9GU['E
MRFF,K%; 38@#3\QA^,?"NL: N39\6FW&*ISR?!3XX:,IE0(OGX]<I*@9KR0X
M%\+D%#7A)<IMNQ'5F!$:"+$<+R&5=PVB*<^[&NK#5PFJZJ96=5-_:@>4U)H3
M&;2DW!,@!CI1*H,B0C)GXJ@4QTNMF[H:B-^=DH7,.?9$,X-(/E#.O4W(D" !
M[)57.-C@M,Z=6/ESK9MZ/Y-PQ_I#%5Q6</DSN)0\,NJ#X@E[X,;8LJBCTHHH
MY9FU=EZXO$_EH@I8%P'6R6U(R:6R5* $/R&N@D:6&XUHB%)2Y9BV:N/-LL+R
MCPBK4TI'C]ZI/FB!IOCA[UGZ&NU!&5$>AO*&8F694@Q'H;$!6Z2<-N H,IR\
M]-+1\)6;C84K*Y>_7PL1YA+55]]K6AEKM)(ZUA.TO:QC+6OC%7^,*MI#F9O\
M=S5CFCXC_[XF0]?AT24._!%;Y;7ET5N3F.3&:F>4L2J*J;U;KB/C.]MM@W3T
M/L3NWI'MQGVX^>_-CO_^R'"WNS>&NP-R"#"W^WZ'U-\?G '<G>Z^_[MQV/KS
MZ "N.J"'S?I6:!WN?SH&Z&K&_WPZ._P23ASELG[\=VMW_SL_./^,#X__A.]M
M\L,O?[8.6G\<'YS7CP];GW$]7_^^GG;VM]G.MZ\B2"!\7" 7:$"<$8$,D#Y$
MI& X1,VYP$,;!3H<PV;.0),Z6<-C"$(Z[GUR6CH?&>?,QF1<VB@BV) 3F/1^
M=P ^Y7C*BU_RT>Q_%3#UQ=#T%.423,+&_&75U[="_;]O8-]0O&Z?N^MS';1-
MP >L)LEQ!__8J#46,F"J++$L._X]4),XGN.381&3/+F]/+E%_G\^MSOHQU"X
MLP+FLY'QL6A?5F2#/^<"^,/WB0%9 '[[+1;M0<O!_3KIVBU[16?0[_5MN[Q-
M&)1'@_/UW7B2S]O#;S"*1B?4BOVC\<,O\C]"HUD.9?:(&[VBUX 5L=U\/*=_
M9/OY.O?S]WQ5Q!\^@BDKOY]'DS,FX4O=F)K1YZ,^\+>33A_$HF&;PV&4QYCS
M]WUGT Q%Q_M!MVB,QI@+P/3RT>?R1'/1Z8Z..W<<B%OY.N7QH4:O-X@70^D#
MD@S[!,11AE?(5\*B9EL*OS3:<,W5;]>*#^-!-<^F/AD6J3D(\=JL#Q_4.2F'
M\:K(G Y4)S]@^$GFF/#WW/< 9JI,'FW[B& 2X2OYK\-WF7Y=K?@CPCODJ6D7
M,]GK4!9N$E@F)-&>*.8M!]9BDTE61FZ(#=Y(NO"!@$V8F?&D[%W,R;L?Y92$
M?"S@[:5\[::;\/Z4RG&NW@0<X-W];5H_A_<XWX11?B5"<,X31UKE&@Z4)62]
M,<A;'<$<2*Z4FK9S,Z[U?ZE@,V0Y]]J(UA]EC9ZCYP8M935+2BGC)Z#(<,/F
MV:NQC@W%H$@@!^7]%@8;6P+#V:BW!PP=C8==FT)?9UFF$?+SW(OCI--KY&^_
M[L:FS3>Z;,'QO]<WLT>&#%]>8AV0=!CQS$LF*ON/K-N;?[ONK[/'-^NR51M%
MPF_LD5_Y]ZA[N<G_#:"J&^UW9!,,]K5MGMJSWL:OU]D 4('1S56F C>G;.8;
MIO1@]'5(/@!8.MU28EZ#QQ:[^5LP)KLV8RE ZP"M_^=V+PRT?;_,S01E>IN!
MOIW3,>TZ2=IT-V+'__?=WMYNO7B[^^G#[J?-_>W=^FW$,KN08EK[C$=ZAS^V
MZYOUM]N;?Q7UW?UW>\4O;W?K^]OUS^^V_G5'CORHK_/+Y_KFYZWM_8GA#_^=
MRI=OY[\/["_N^:,8!LTX22U*XKW9#EM#&U.JR4OV)NL?OQ)+< R: E]@'/'H
M!-+.<J1P4MPRXX(S-[W#I]%O[(8C,R0R0Y<D,Y0Y>,:=6H?))]TY3(F:X7+I
M+;9,32CZ1-J!Y;$^0.^TI7]SSEYD,Q.>S!/M1;5?^A\[0__CW77_XX[)$R^E
MK=M%Q"5CW0CD2F][KH9O=VK.M88"-*WG\)U>=XXV;\]HSNZ1F;1J['LV_>6F
MJ_2P:.HP@C+BWSG V &M'E*=!^HV]*RS&5Y,PL*=/*R?Q7LO:_@.8[MC@=R]
MD,?M,AP.?WJ*Q7WOZ)B-LAJ^_:@?>WZX_W=C9[]YO+/_D=5;AT<[K3^.=K_\
MT3SX\OE\]\M'6J<'YS>S&G:WWM'Z^5&S_F7[Q^Z7G1_U+4\/6^_.#KZ\$P=?
M_CXZW,^9% <,1II[%DRTV6:$IB3R#@+C"7$9++(8,R0\<X$:XVDNXZWQDO,:
MUBHCK&I'5V'DG9*ZEKTG5F'D.F#D^4114*V,HC8BS9C*T2^)M*4 E#Y@DY>=
M4;SQ1K"GW+)S;3GY$RS7M<R6>,_SP-DB1^&7SD2?;J>[)P&@9U-(IE#:"A*1
ME9PB;H("NDD9HM(1!Q^HE#=\^&3ZP:,4\*G.C"Y;A9=.E"H5?F 5GN! 5"BI
MI;/(Z=S20'N!3.0,,9PDE7EE8P 5OD\ABP=7X;7E.#\IX5%JXTVR<[,VQEH!
MPZUQQPE2=%$Y[&VG>S)*:KD3(;J_$[Y^.+O>,;L*5Q? U?K;26I$C);&A8"X
MR[AJ/48Z:8$LRWVU:')*^(TW2CYEW_)!"X&]5&5_A.!3I>R+*?L$B5*18QX,
MJ'B0&$B4H<A9XE!R7'@BK;#<YK/9]V[Y7062GD4@:42E?FF6QZM*1@53<7&0
MZ JG>E6>^LFY]_;'"XLEK0]!VKJR-I>H.6Y96J'G(NBY-TF5A"$)<\Z1T8(C
M+A6XH%9RE(04R3ON6%0;;^@:%2^J(DEK&$FZ4>VX4N6'5^4)(J2)3[!&!M&8
M-.+82P3Z:Y$,RKDDK00",ZT.615,NFLP::UYSD\VS.:)#55)&552QHJV"ROD
M7P3YI^2;16T"EY&BF#LE<QK !8[6H_)L(L/,)<9SO&NRQ>K3<8$7CG=5 %8!
MV(HV2RL 6PS )JBKHT[)1!/RW!'P0J-")E&+O& D1&T9T64,[RD'[%?,;6\4
M6R!B>!IRR<[S'/>X,M<,)C1T!IF%+GR:9_V'6#DORX/V+S>+*\TLJ?1ZGO-D
M=]XK6[][K*V4/<&M@+(H0179_TF%JOLZ?N(F;QHK]N90K^MES;3=5-:(Z.U>
MJG6Y-!6O6H!7[4Z+[L-:X6@X4M%&Q'.FO>/*Y>@^=M(26+%<H8KS6A7A?]Z*
M?%\'J%+D52KR9&S?.R8L<R@RI1&/P2*G/$$J>"EE-%0$!XHLY!-0Y+5E,$^0
M)[]+*?K^1?&^Z_4#*VJ\)H+U$Y4B9LTE;.]J[=2**__$Q&H:@&TQ$XQ*/)*D
M"0[::\.,YUJ0Q;ERV;.K%=M]VQQ6@!X:U^M',\;5U6+X8,_RES>[7=O^5EY7
M!287.J$QLKFE[85QU?>WS[]JI:4V6B)-HD'<TH1L4A2QQ*+VS) 0^,8;7%NG
M]EX5?UZ^<C-OE& I.*\]IQ:XL[),J^""9YRDQ?ESI=RK5^ZS&\IMB%+@#GMD
M36Z]B7U"1K" 8A3<FL "H2(K]_HWWUQ;ZG-/3CVKF?'C%+<L<>/3U"KP%_7O
MECHD61-SC&E*$>V\E8%8;4K-RES4?EAB^1=RL[+L'4Z*/'O@MQXG8DB,1E#N
M/;>$LN M<=%;R1VM6-VZ __V)*OST6L>,$?&1X%X" H9B0.R-AD1C4XQX8TW
MI+:L?GYKE!93*?<5Y4XX<.())M()+C2S2E!AI!&&,48\KUC=$U#NFZPNZMPB
MR'@47>XIAQ-&5DB)N-:)2TZ=3"0K][*RX5X@JWN">[VCPO/WB6"]C%.QC[H/
M/%JEB5VD"A470L6=2<HC L:<.X.<T1KQ1#AXO=0B<(%5D(")/-B\%2QJ]SXH
MNY"Z/*$@UPO6_U5M'U?ZORS]O\F*DDA!&,Y0Q+DF!@L462P-PL8Z*YCF2?"\
M@ZR7%NVJDFQ7MTLZ.X/UWGFVZSC*YTJ,9X4[+S:)K]2G>JR,@XO^M,,""I.]
M>^8X;/CZ*89+Z6WATA5EJZ_X'FNK:T\P7><V)W3]<FJJO)PU%:7+6E)WZ3XR
M[[;]VKWV_"<=I[WB$W7)!KTP[J.XW+@,7;Q>&0SDJI-VX9CARC&;PS'SDX$9
M0S4QV.42SI8A[IE'!GN+&-8$%E($XNS&&U&C8NVS$!:F&Q4^/7-\NF?<J,*G
MU>/3S<"1!D0*$5 I<L(1YS0@*W!$F 3#E:?!6[7QAM7PLN+&SR8Z=%]7YFD0
MT:WIQ1/O4VOZ.873'XN[_;S86H62]T');Y,L+N%HE+(2I> 5L#CJ<CU:A005
M,5I/M,0IIY+B>T?7JY2B%:OV3TLI/ACO64)%Q4K)[ZGD-ZE0(,0QICS"/CK$
M$T[(><>1=TZ*((B4MCP,@B</8<Y?9+'**IKRYDRM.0O:[_1M\V%V2)^IX_OL
M2Y"MB/:--^3&CQM!?H7V"Z']]RD94\DIPXQ%A@9 >VXXTHY')#AQE&M/M1%E
M8.[>5<F>4L)4A6D5ICUXF*_"M"5AVDT&*S6UBD8#E-6G[*8"@TW1HD"=I9Y8
MHH0M@WGW;DW^<I+ GG7&PL]+I-TKYVMM4AF>>?G'*LOA^1./YTTO'B7+H42^
M*G"V,.TXGE)%A4G*<:0:82DUXH1)Y&C$*%&A.04?"YN072FV_I46JAR'"IW6
M(,>A0J>[H]--I\@&IKU)#C'A'>*".V1PABBB$K.&)XYI=HK(^A=Y6EL26F4X
M//5MT+7C;;=N?E88>4>,G%(Q);I\1I!$8'!*(1YI1("9#&&*C0C")I5\E=_P
M)!7[*><W5"I^=Q6?I$&62>T5,HPFE)$;:9D4B@*S0'S4#ILJN^&^8;A1L''X
M*O#^M\;$GW7JP_1IJ/80[SDSZVUPUH!)WMQ@O-ZEH#(A\YB0:45FDI'>,@W6
M@^726P98(A$$)<Z,(3PD['D9YUM6EX(E*,N*PH-SX?X=DRTJ%*U0=!W2-"H4
MO1.*WB3B'H= O<,HL91+]4B#G,YGKRSE.'&;K'%E/'+)E7K6!T572N)_+4N5
MC*MZ7"G!TK+=;XWV>%H8:.7H+WDN)/PZ49+ZZLL?#WK]1CJ[7K?E(>I6F]O@
M@I9>_F6UYY4__?I$J9J@>1; U6\. CSBHG5-'':S2>#Y%]WI9;9M.^22,ZG3
MA2'YB')]EFO?J%TOTC)S.0F]OI[LJ:TG7;?U? MZ;AOM7 WH9- ?AFJ*ECV#
MI4S-O*XE].14#AOR9);E;F\LUPC/ZH,6#,L/?Q]%@,H;#A=T:%8L4XKA*#0V
MG&/EM$F\['@NO70T?!5T8V$I*'^?(08/N>83-E]-7715&P+\Y+__OC9Q2W">
MKEOZ]YU..&TTFYOML-WNV_:W!D#F9J\7^[T<HVMV>H-NW(<G_MX$37Q<PT]V
M&B/#WP)C>[Q]6C\^$&#,17T+GG.\S>O[1\<[Q]_.#K<^GN_"_^OGWT[!B#?C
M?SZ='7X))XYR>?CEC];.\2:M'W\'8YZ?]_$,KB% (LYVM_[\7M_:X?!_MKOU
M>\ZTQ+N;7ZE5/&$CD#<I@O,3'7(\<?C5:$L2\]+*(2$KXYF;_3Q%6@4<5,(T
M!2XQ==$GI8-,. :A)!"X"&SJ!%:BWQV V1JO0XF#ERM1#)?B%<A9OYA4HOD!
M\1:\&XG^#:4<K?:MKW+CU2,/PFE%\L8"]<G2B#&'KQL9B<_%2%=-JTL5VS^*
MQ5M ,-L^*^(_M@FO"#?_-IYW,#Q% SYM=#-\%?#R-O\/9J)9@"UJ#"V4[><_
M-T 'NXU6$> 6KXI&@C\$($+]3K>7.[:==/IPBP9<>.6&\4>CUZ\55T?Q3Z<Y
M@)7NPKL6_B@7"@_%T!263[T8VI6[P)#[&6CSDX?F=-?W.RYV"_)8A=?HG0NO
M]?H/,N8YY2&7L-L\@<FOINXN4U>.J#AM](\*.Y)>4(.BWVB5.9VIZ%]*^O__
M/YH2]=N%9#<[8(1!A5H%$/=V]C2+DV['QUZO5FQZ#WX)_*EY]@I(1ML.R^>#
MMYHO@*$$N#.H8;[]Y6,M7#5H]X=W:K1]XP2P$W3V!"A*[)85"X&B@)J4ES6Z
M?M#*%6A]S!H)WQO=Z<CV"A<CW._DI-F 1\&P>B= <6!=0$E+A1O)S*LBF]0"
M+NC&_N6WAE?Z$7P"!8XP_)!5N/3D?#F4,"@+*.:Q--K6-9J-_EG^0\<=7SSK
MXGW+K]E>;] :MNHK<2AOLC42W"XC"T!"JP2S0:;,,!O1=F'TW<RG&YW0*U>I
M,QC.F8OMF!IE9\DC@*U>7M;KDW *[]3N](M\SVY&L=%0;RXFH'[I,]I,Y1.\
M"$P[?!OFM3_L>) G!YX4P*W,]PL@X+"FL%2QF7?\ #H!<^T_'?@\P^$E;$Y#
M/AA<]UL< NA(C*;@XLB#@ '9$HJO+]9X)".XCB667\'\=/'D2_8ZP5,GK.U(
M-7A6V$EM/FV$_M$XLG/EJI%QQI>76 ?3.>C/ON2*#?<QFZ"1)7WS;]?]=38;
MF'79JE&#B!LNP95_CRXJ[IZ PB/7C?8[L@D&^]HV3^U9;^/7ZPP'Z,WHYBK3
MFYM3-O,-4WHP%C\D5"'Z<2W4$G&&>/UONS9C*8ZZV7GXG]O]+ 6DJ<0K4(R<
MK9AU^M^_VG62M.G>U([_[[N]O=UZ\7;WTX?=3YO[V[OUV\ARMKKB.E%^U'?X
M8[N^67^[O?E74=_=?[=7_/)VM[Z_7?_\;NM?=^3]C_HZOWRN;W[>VMZ?&/[P
MW^F.QVV.Q W'(Z6D!3BYD2?-E73@%QL2C)#8":(<O@BM/Y0SO>>/8A@TXVX:
MNW,OV',^KW_\BADF4H:(M*(8<<$,TL0GY"1+3@8:8+)O>L+SQW3DW'[M8YB[
MMR6;ZI6D.)-.V^V>E3&R5F:J5\E&<1IS>>T>^*#-9N?T2GOO.SGVN5!]"=L7
M3*.,\\-[-^U)+[X>__#;.'#>:)>C+R_Z[?HCIC@AY0.''U^:W1H>FMY1WLSH
MR:./:^5'-_8LAI]1\)(8F?DQKLW^[&>W):R&]=UN^_-'$B(>8K!,L:<R6%P3
MYFZW?83!TIIA3V:PI";I?+>])45M+8XA7VPWE#=\W>C#P_P\2:O;[0*>T\RN
M[D3VX6(O.R0\C[2W/T&#RK?[7-NK%1_ E6U9'P?EL!9XQSD.*S^MZ?C0!=O?
M;92!C6(_^J,V//C;6;&7'>&?'L5X 9.S$T,YE+T!6&3XX1%F9=Z>)FO@9913
MMIV?W2Y=B"N*=5M3CV<K09,)O'<]WC5WKLAMT@-W>*3)^-TV<\#W5;%CN_ZH
M8*.@X*()[B\S^6ZQEW^Z^74WLY.)Q"PJ&H/T/%BKG?966*R2"P0;\G6[# 4P
M1JXUQ9.S=MDWBC*_)0<K?O1?MP<M%#IEF"Y?N2ZM\.X:+!CEUWTGN_N'WW>W
MPO><"W=P_*E5__*IL?/^S];.\5%K=^OSV4%KFQRT_FQ,Y-?M?Q;UUD=>IY^^
MUX]#H_[^@!R^WSX]:!V<[;X_@.?^V3@X_KL!UZ:+#&7X+[P+V3G>^2IB<H:R
M@*3W%/%<AT [^%7K1%***L#J;;QAK^ [2SK+MAZ)R',/9NXLY KK7A[669*H
MBHD1J11/-#KO<?3".)*8H4956/>(6'=^$^M82)0$AU&094X2]<A:KY$+,,,J
MJ2B8VGA#7@E^[Q,9%=956/?,L,YQ+$/BP0GJN*/*<28]3MX(%KG5L<*Z1\0Z
M<A/KC/)8P\(@ZHU'7&B*G(X&!:(#D\Q9&M+&&_J*BXK755A78=UUK%/&^2@D
M-8PH[L$)XL -C(._@)<DJ*RP[A&QCMW$.DNYHHYA)&((@'64(*NQ1H1A0B@%
M1U:)DM>Q"NLJK*NP[@;6A90P)S%(['CRTCK]_]A[\Z:VDBQ]^*LHF)DWJB.<
M5.Z+JW]$4 9[\)1$V9;+ ?\0N8*P0+068_CT[\DK";0!$@@0^'9U40+=)9>S
M/&?)<YP- J!=#%ZFTE_WG+).3,HZCGW4@.VRY9KKT@2%-%$:*:NTD5$X;N+:
MA@%<MZS:4X\KZ^X(KCS5V=?RRB64^5F] ?_*5Y:;]8*N7&H=>SP#DHT=VC4S
MCDD])UIYWVK'?#+*]]KM>.HO*MTV/*W93VL>.1_]IG(:NS<F<MQ6D'#>\M*K
MA^1N+4@X >5X5$1S%2C-.(!A%Y,)T5"36**6^3L*0V5,=T,EPB&X&^S4N\%&
MU:_WZ8-MG.9*A27"6P#AU1K3$5DKI&/,6^0I8X@[R9!6FB-.=,0\1:Y(6MN8
M8<K.7W=P]>K"OW(F7H"'@R%2246"5YXK&IT@-DE"7%+>J\CGX.'[L^ZHY98:
M/V- E['=*EEZ,9:>"CQR;Z06V"*B;69DK)$%-D:<"B:4QM)[O;91'!*E?ZQ\
M6?62N>_-W,(SG)+S5"C#A;.:1:>I,<QJ%SG%)7.O/'-/1=J(QQ8[+!'6'",0
MV089;S%2C)-HA?56QY*Y7RIS+P*_E>,2N)A+$30'Y6TIT<P0:G$D6!%9PN_5
M8^>I8)(PA)/ - *\90%^DX! 3!,$G"P8EYY&J=8VN"[A]^MDX@<65RZ9^!F8
M>"I*DK #C6PP(J"=$9=%MVJ*D6,Z!:V\)-BM;>CI$,FS,/%2^P>]..??;O<H
MMD>]?+]8*Z'5<O#]W6O[(]N)FU?%H3:O=Z:42XO(I8L1W][Q#HSO^X&CA/%$
M0!!Q"^!"$8H,XQ$Q[9)WU.IDV=K&0UQ[9<.@U;7^'\VU=P?3EH;_,ICY<I*9
M+29$,,J0]50@SB,8_E$)E'QRA$CN6<1+,_Q+OEY=OGXTKU[)UT_ UV22KPF5
M5F/AD4\X(BZ(1\#J&FF-L8_4NZ!4R=>_ %\OP9]7@NQ'YU\VR;_2$*R]3BA%
MQQ$':(VT, 8Y[)3 -&*M[=I&V9KSI7'N:GGQ2AY>(@^+21Y.GDCI%4$L"=#!
M48+Z380!2W,J@TK!:KZVL2*]-Y^B^^4+J!'SL7<:*PPO6"*F;-[V!"NSVH)]
M ;E.C6*"*P>Z''-*J=7&244-SQ:8E6)P6&5N)%8>5GD4=^<@#.,)]X%[BCS7
M 7'N'$AQA1$UEDC.K;<BY.(R6JO7VKRM;(%92M&5DZ(:+*%H!2-)F.RWM";(
M9)0, )JQ#+B4HBOA9QY*41^T892BE+Q"/%G PI8K1"(&"0J*$$>[I+(UI10M
MI6@I1>>4HL1$E;B)*4@)0C0ZY97Q@$:!.[GPLI2B*^'5'TA1T'F&20"?FFB)
MN.816>T%TA(;CB4/G-$E%<0II6@I14LI.F]*$V;)I"1UT)X3JH 9G;">N22D
M\HZ64G0E8BL#*1J5)BY2@P3Q8-$;%9'3@$6]\-98883NE]KA6I92M)2BI11]
M*BF:*"<>H*<2D0>C7:#,.2H4YPJKH$HINA+1K>&1,:$H"=:AB)4&*<I9+KKM
M$6,$,TT]=BSD(CY,3A\S>7%2M(B._5XTRMJXH;']4W68>]\ #HI_-7[$J<;M
M1=/&7[CS'*F>'S@0(4:#2D\D'WV*."&=-$%8"R>4IT$K_%H[S^V<]@5>EK/M
M>&B+=LJY:?FPJ;PMR"2W)_XUF\ZQ=8G5TAMXZ77-7TK/.0U/O?G;51LK,/(+
M&:M:%W/V<%OD.[JNZ/T:!)8T\"PT,&?3P9?0QT_/!>]G([GK)#[R0CMHW9H'
M=,N6W9C.2,0+78E;NF:]!#*^=SO*K0Q<VD4;WT7:4MYHA]R1#_>4.S_)VK,W
M_EOQ2PSHWZ[]^\8FC,P>QN+SYWABP0HY/>Q_<]*",5\6L+/XP]_PNE8H/OZV
M%V$-E[9N<S3J>SWK_Z'=ZG2*57PW:"$]7.[>Z<T%!,L5O7E%-[WOG?2:%HAZ
MFG++!5U\06NQ^P "_267K.3JDJM7?$'GY>IG[RG[K(&-=[T.O#RV*^W8+WS3
M.6J<S=.A>;GK\JP6PZTAGYFN<,V$Y$0X*A/G-KN_B_(?@8FHO?:SCR..N\)O
M<8!? =-1&="'HV0L&@13\V]#KWT!\/1E^LG[\9^3?TYJEWNL1N&>R^V?NUN?
M&[63SXW]NK^L;>WPZK$G^UM?:976OD_&?_:_P7W'GNT??V?5^C:O?=BA^Q\^
M-F'<.+^O=OG/]UI][W*/?D[5&25^J4A1Z92;KMJ <O,T9)TA"%.CD\Y-AZA?
MVR!T*E#RJ!Q2=HDIN\3<&&!F2A'J,98R21ZQ<R0*DGS*Y6P857,?O+E% A7P
M[A<(/#^=X)E*)8_!!F*-0EH)GLL/>V02,0@#2</NLBBYS4F0BC_X0$[9*:N4
M@2]!!BYRJOP)A."(138*Q$JQN$2Q.)4;#AM&(K<>12$LX#%OD!,"\)BU/#&!
ML2+%"1MIQ,-/G)<2L92(*RT15TL@UF*W%'Y+%'[3W5-]/K.4K4\C(^)2&F1-
M<D@Y890VWE 9L_##XL''"TL)6$K 5R8!HXN6R<"<IKE4&+7*@"7E*-=,N43F
M[IY:VL5/* .GNZJZI&U, C'I=:X7'I'1\*N5,D0FG56$%7:Q*NWB4@;^$C)P
M$;OX"81@:1<_09PBB\1"--8_G=?J.Y<'4EL<-8ZPHJGHHY"0B9$@#[OJ!0W!
MP986AO%#6BF4(K$4B2]!)*Z61"P-XV5+OXL)Z9<,]L$8C53$-A=X%\BP))$Q
M5A*CI1:Y%118Q@\_[/PD(G!)3:976C)]B>T?#1\K]K =X^WM9!XV\Q>6/"*D
M$XI&D8!HN?+4.4Z$LBP:JCA3LWM/E,DCSRV69A55],YHHPRR08-4HI8A$W1$
MQ&HKO)9"8)!*9BFY([]VV[@%]+U50O- A931\:2QCL(QSZA+5,!?YZYB4KJ!
MGI"UIM(C"#$\$$^1B\HCGD_H:^LELH[9W*E9<<4*A:^6=2Z_[ &YBOZ,)^#F
M&_T9)0LOPL)3H7P70DS6 4A70H!VY $93Q5*5%,IJ PTA+4-V-[5:/U8\N[+
M4\2%X5VRZ2)L.A5T3IIIT*<Q)S^+G''#@6&31I)[:J,+S :QML'--)N6>O;5
M\"J/C*80:< >;%!*K$S)DT"C2AYD."MCIRO(RE.Q4QPB%]8)Y!/-58.B0IJY
MA @+UC*G&<.I[R6;3IXKF7FUF7FQWL2/SLTE:%Z.2VDJSF<IQ\XJBB1A"M2Q
MY,CR7'%><1$9-Q1C JA9/:0S<<F\O[0F+E'S/?AT,B(EC.1!48:,)ASQ$#'
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M,"<Q2.QX\M(Z[6P0'J<8O$RD[.BW@@)V*L1-3)'W*9$PP2*N<T<_GK.F&0V
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MW_DD6-S]\,])[=OG?-51#4!G;2O M3M\C^[1_9,]"F.$9S>/=NM'J7:\\Q/
MHN0L4!T2TE@DQ&$YD2:,HZ!2B($!8!2ZC_T!'@$BSY#;<48T]1@K'+@PT00M
M/"B*Z!,&M FF7@1X=98%?KL'RBTO>('_ /';4Y\-D\UL>0 6BIT;Z[D6?#\S
M5'CW^\?'2^$*3[#E6GMN'-RA0J(&4R,5!ZC\Z!3WQ1_%T&O&W927HM"9OS+9
MU38/&!%41!F1)]F?KC%#3A"+""8^6!*"P622C&Y $BL6W?ZK!8H'].@)V+U
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M%'@Z6P!:W&H!]/UA _C/[G!&_/)5Y>_'9J4:6R8;3>%EEA)F06&4L'*@QJQ
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M2E9G?>F79>>LE][+)GTUZ0:@.TYBNP L?]NSV'Y]6O%:(?85VF"V9WFV.1L
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M$: $7$@!-I^AY))$' N*= 0E8(@T.1.210UBG$PWK+@BBBQX%O0[C9X\[6>
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M=.5$F%BK68M3B-B3'$3K#Q96L7#*C![U[\M<?^T3\;;=OLB>@:NTO[[SMBB
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M^^D##[B?7I*/X%;[1W"WQX_@7O'% @LT8]8Y7O T<S9W!@NF!%>Q"+^!-3J
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M0F)/,2>,<^N,UR*9B GSWF">ENLI*T74,D746/8 JWXZX#8&:ZT!JF(2<9Y
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M(+,/_ J@F1JG%@R*PIZ O>CV^IH>KLR=1_OW9)W?AYTW:?X^QNQU>V!!NQ:
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M0<L!2P[F-AVS+F/4#Y0M%)<QZA482QFC+F/4+R-&_9"8\TN#F+L%H-@Y[3O
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MG_C1*:@P!S 4]? B %N$6TL::1&:-8=5&\N$:P'BU@"OLL$Q'G>)A4Q&Q,V
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MJ1_%61AJ4,%KHPU7'?<TYN^":,.MQ1G:M+G;3YMC%Z?-M1EP;09<FP'WZV;
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M9F\\/]O=.>3*9R)7C&29SP!]:TE@Q3P1H"\Q ZO4FF]LEU>UO[SR<%@HEZG
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M$G"1DT0&5U1+'J>=<9,5& '1 6#=?:3[L<P4>?"<%L8*&*<N<D6YSWS)10$
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M3V]UM65BST.<#6RX$IOZ)%NYAIYE'E]<(J-H9.A5\[SB4$0JL*I=ZLK$5D2
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M0/JN7+YWX">NY/+-8L3-P.^:6&^L\KM1B-=QQ@4M\M);)K+<J4QHI9E1S(K
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MO6; JWI3^,U.O-=X_M+)LWG:'5E<&1SL:%QGM"[X8S,]7@^@$]\., [("\Q
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M/I-](&TL/#-8>F-E+Q!N^J>1]N7B]=5V-#6(X<YLJ[Z;DDWRT,B&;1K93+6
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M!M:_/S@'N,++^X.1#0U*;T6 UL!Y*:TH',UYJFFAF:! D#I)0>M)>4> FT^
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MPOR2K9RA<]_,4AJ.((/.7$\D3\9P&E5X%8Q);LQ8HK,*H?5_;F"ZAN/,J]7
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MKI]F7%Y;K^T\0_@#=4UMI]3:[6C4VA&V(PU3]F\<CB]PCF%XK:8Z;.T,P*/
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M4X$#9;/&VU.'.)Z@=E1.9 #9\_E<=;A$-;YH? $^6B4$R0-*E/V9\%@8PL4
MO=48Z8*Q5P #/0!4'P>%'EAT9?N]U>T(VF$9CVWM:@S'^JP.N3T?^-F&&(IF
MT,. +75Q00?DAJ5'1I<6A([7Z!F1@8L^ $#U)WB-/PU(^!;#=?^251N'#Z+0
M<#19H)!NYT.)I!<8X&SP<ZR'X(\@#+'PP=IA0@MI9D%WF:M,$\*?YLO73+MK
MIB6W$!IU":<<4A'6KL-RBXT<Y\8XP N)Q.2C!.$[?%(((8+3<B?:ZP'*XQD(
M2I@OY>@<5KCST4<7%:9 A'"R0$K!\QD$_<89>@XGV)F$D0_ZL\.LSQ$WQH#
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MN<^3M:@ ;A*&3UT0\D6CY\>E=2E>39>?KBG:^:IB*:F2OQ\;]Y])4A7PTKC
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M+0'[QFS(H\"G(5("6AJ\$XX]QSWBKY4 2L@2,0X$O.:4]UWVTL2)^^!GWKK
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M';46,(%[P,BN!!CE22&$]'Q@VWA-HR)K8L6[)^#W?.O[A@(L7SG \BD;8"D
MM5FB>U ESKH@'/XCA[W5^AOFW.; 'D>L6H/C^Q$-!I]R260$,U@!]LT#U=VF
M"7D%^1J#HSM9;@'*/J ],W;!\X.:Z@+.J#YP@.4G=NTH1^1[5&SY1ZR\MD>;
M<NQD1XK(CF;T QR]>FQ?"5&RH1=5;A_E*IG$W_5K7?LV,_VY.1$13>LI/;@.
MM#U>C9K@]0>M46_+/HX5ZG77$%VMB*[=:ANCVA-=/,9A-E@TMFR.V319;)HL
M/JL35DO+Z9LO@HEO<XK_C9C,7"ZKN,:$+XQ+/:4C5QVE2ZL]V++7X1Z::3U)
M!=3WD$Y.C.:(JGU$G0,ZH2HKJTHHP#J'#KX*BZ9R'?FW^(\G:K[ZVM6=5G_4
MJ9UI_<J<'SBDSDES2-4^I+)]ABM\0%564Y50?77V_3*P[J_,SQNT^KVRH;X*
MFZB'>4BC5J?7..,5/Z2CSJAT4_(JGDZ5U5(E5)VT&4HWE.\.*ZX'N1_>NJR3
M)^U'L<2< [WZV\7.5%OV#88MH[_E?=0.=N>%O(1"'%_VZKMAFU?,-IW68-BP
MS5-#(X4U<4TLR2WS?4H;)%4X]SI(KB8E(&,KJ]+P \,OVI0[6?&5;FH6NP'&
M8%-9&>'VW 6ZEJFWJ#504\X!Q\Y.<2RCI#7FVX$^TL82>,GS-\!S3*<[6UH^
M[3XW$N3&?35Z?RD,T/T'0V$R:+QLGQF8#J,.+OAL5/-"VP7R"2/9VW 6MQ!
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MT?<S>O7$6"5$8YW1J1I@Z])+K':-VV!4%M"B>NA #<75BN).&E2WBA>^UN^
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M_F"HIXZTDA;?_9A64(V_'?;*TP[^$$V(%M!.L !J 6IP'EII2D(R$' T<_K
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M2$+^34V2@+4F.++Q#4JB$;S=-'7'&E_)\+UJ2UVUMM0-Z^HU34:,/8%KNZ_
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M55UDJ"@;$U$P_4<P$HF)[5,0N14["EA4EAEZ&C::#:8/,-!/JLC$[K4$)I%
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MF@Y'10@%X]8HPUS]+QK#>N)1.+V5+'@I5'(K;K;3T:82_#I&0RZ?[8Q-%%W
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M&EB=ZF6L4F3O?OUSQ[C<J-@I#L=D-_]++8SX$J9G+> 2?/KI_P%02P,$%
M  @ =XP#5:'1%=@B)   \&H! !0   !M8VLM,C R,C V,S!?8V%L+GAM;-U]
M67-;R9'NNW^%;M_72:OVQ6%[@I*HMB+DID)23\\;HI8L$=,@H N 6N;7WRR
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M>##9N%(X*TSKPV2CMEO4[,] K;;J:9>AFLUP?A471LV+PJ3 2^U F9IJ";$
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MKA$U<'4.*K1&WL\R>5L1U\MZ7RZ=;X)PY7W/!C$['9-4X)*J_7^+A"!0 OK
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ME*O32QD$[J0@#TT)*5IG^S=#]H0,U#;<N6^):J2F3BS6W=@NCS&QR%C$>CT
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M3\ZZ[$751]/\AM'KQ?OUGQAF^,^__']02P,$%     @ =XP#5015RN[BC@
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M8!DR"0GP-0LRL6!,2JL')6M=N$IPSE/K3L57Q=956Z;PGWXPA8TS>#"!:(5
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MQ#I53$:AB;.6$^Y3LC+:Y'3M.[Q7(#Q1AWX?_A]X:BV$W$$X9YG=\OI;?[)
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M07?1<7X=-J8@T=)LGSDHA1?H'EF0J.=:ZQPU6,MJ]RHZ'OF/;//'X'X?^7;
M^?HCONMEVKZ,QAM<VD2Y!0UW-T>\$HIDGY4R44J>:E\QMA70\;?]]IPU70F\
MBXZ5=[:[I4$2@F922^(]H%6;*=HBQI;DP&2\!>$]K:T"#U&< >\M1=MYEY#9
MZF:<B<[BPI:5E6A]:DY<23,TP2B>/(^6UC;NGTZCH&YLO992[B#LOS'1>!=<
MWVN[H+TXV[5-S"$"/V:[H(2+FE?E8@%T<DLE2"(N<$.TD)ZC[@M%:U]8]=3;
M!76B!_O(N7*GD4\P[#>CFTC$_=5O<@E($%UKJ4 V(9=HEW"E"2_/EH1D''X
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M?MT W*R\'2".Z"C=@W=R]Z@-M1T6L!:\C.01W8?J-$_1&026'$W,42=P,F7
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M1K:_,%Z2WT\O?9*^%JTGYS!*[< J8Q!M*5XV[^C1&=VIDP4.5DBWKD!'$S)
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MZU)X];;H37',:/+Z16T0IQ(PF63,7@EKVLOF$*1G[Y.,0.  AP9;8&V*9'4
M-JS3\A#4:;R6,9C=OI(UHF4XMV8+0&-16JE\S68RZU(Y(M2^M;Y@$39IT7I&
M&EDOCS@V3THN?=@80"8/KA0(Y7J]#9J7B!Z!UE9"YE,&;X.!HG3TI=" =>O=
M\FXT)_-SCJ5L.HB]AVA=M;X*??^?\'GC<07T5F0&7M4<;^,C.%.+0,?:\I;E
MD&SS1E4/4)P+\T?:=Y!=3US<SH#+.<X(7N->:\$KZU9Q]L[2#L_SHIG)26+S
M$K0/4;P 3_0HPP]PY/XMHC?ATZ:P6A=< SF9NS"=RL<\CK.]$CC2X(//#7?P
M";0\6&' %"U E5 [Q2K"IXHOEK[WV/JV95PA/.H\CJ.#/G9N'$ST\_5L^A->
M33]-EB<R;VJ;S?6*)5W6GL4,AM4.>(DS<$+6TQXO12R><]NE'?/N)XR_VK=A
M8-K<?.,4E5PEBLRGY<?K^>2*?J%%D^7'/[1!.<>>R._58HS2EVBM3N1B*^MD
M3-'ED%G44F0?\:+#YQ^97+-ZP._XN=[/U_/.,IU]"FM#;-*3M&*,U $FAPA*
MB[H[,!$,*B<U[4&]:QW6U 77T;O.90??MV7UD.I/;<Q]$25J)#* 6%B?\KKL
M,L@DBK*9*\-:[SEVHSE!B=O6JGBP 6UC^H8;T&6_^C6J3=_Z'V?A*O\3\R2%
MR_?7LP_UW^]FTWR="">BK-&TM,JFFB:1G:N1*30QZQA4B 27Q0Z+4)]GGI$0
M!C7W$"=4:ZRO:SNQV:0& /[7QTGZ^//58K+X^O;SLFG _((Y92/MF<'+9.I>
M6D)PTD#.:&7FSA;?.ANQ&[(SDLZ E#2,]K@K\,W:O<)4#W,N#(O>(C(P2=/&
M/7D-T1,TH3(+SAIE1.HQ>SQ\PAD1WM"40\33SN=(\Y.)O%X+>XB!G'7%DP+R
ML0WMP;)5Y&-[$5NW1U\]^8R(/L*D YQ&;<J=ORU[!OSCU_4/5^=Q.BHK28U0
M3%&@),\0/ T]<Q,=:=%8W[PK0G^88]5!&%PH0U/TY$H@;*:_C;>\//E)EG:4
M@5QD&AJC$;D SAD/W*-..?DH9.NKU+V 3G5R/K@:=E5".)J5(;JVK+"L3Y&Z
M@!FJE=-=(">N?' \4?<E<+25!Z>>!X&R^D.Q(*VBDKF:;I2!&Y$-\EAL;%VE
M; 3*NU8X&)CQ/L9M?#Z^S'6X6F^=UZC6![PYH<(L,T2T=5++"9SBEO8]FC'N
M9!2AR^9B]Q-.YG,>8O9I<YLU/'::SQ:W8OT[UO:3GS_6@X^E4$5$1F,-D(T@
MWZ@H&K'A"(:E[(7G[@&1V]]=>LJ=]Y:^NWUG]P(X]Y6\G?4;GAPL0:U&=A?2
MYCZH Z@^*_ECTM@%9-R5O"%1TZ&LW'!^WP\N84V;EP%2J,N7T00N2 %>RF"*
M<:J$3H>,3XOZ'2OZV,SW,6YCQNN5[>=-C^ DC? ID(\2/ ?%I0:ODP*,TKND
MO',!&Y!\]YGCK>H-*9@VL-^)+KEO+[^FJ]/,JP_K\X*6M]Z//V6(:_">8[MW
M+ZX5>G*ZF$;AE4 6*NM2)6.RM4SF+??BCS]PA(MR*SD/6(,R:RERI5B"0*A!
M2.N=%!E#\]3>,2[*]SSCW6Q:)HL:D/@JSA>SD!87UD3N@Y003.+5$2OTYNH$
M,5OII-:!O.SQC/ 0X!,],.^CG1V;T@$(&B#$^W?\@E?7>(M'N%"23!'0+IOE
MTB8L&.[ ::V]Y<9+U?K\\CZ&)Z6)8RE[T+[J"'L/<#RUQK.LJ5-+-Q"D_YHL
M/KZ^GB^FGW#V\U_KBB'U%HC^SK4(MA0\:S0(W 9R"6(I$#V7D!P*Y"XZ=*VS
MH ^ .;Z*CN-VNU &(V:(DOB;M?XV,/[&%"8YSA,C#U!B+9S.# 3F ECT0A#F
MY%+K'K=[X)SS#-.*A0&*;6R!=J$\_9[0EH!(5<.E#3A#^PO:<H2HN7:L>7#?
M%ACC"Z(938_3W\O&C0_&7T]GI/BPP!M</__U&:_F&*Y6&34KF&]P<>%$Q6D8
M&!UIMN2<T^P5-- D*9)46!Q3CVRX^CWQ'&>! 6T^0+C.ID34&M]%M-DH'S,P
M+R0)G^!X(PQX,@2KYQ#!MG8^[T$X1TVTL/8 (3VW$]3&R9E<79,!;J/)5HU8
M5K]'_@W.?_Z+K$#/GUR%V=?E3FU'6RV)7NEZ@626!TXU%2\@MR!"<88TC05;
MNZ@##N>\1?DT5-"PTV6=@]?N^[*N .8ZM/<X^S)).'^'LT2F#1_PPD;%73T,
MC=+&>LU)[YXGI]VYY*UP&LFP'5:\+L]Z4A(Z[IQE$/,.&*6^):U")&<8=PE$
MK*E>WM'&T&* D%E04B:A9.OXU&>7T7+,$5PCTP^P!:J5'J[H5[[^]NLO;W_'
M.:D65TW)7W\,,Q)M-*E$)02@I)F*OG"D5Y%I42[!Y^@9QM8;Y<<PG:% FM(P
MB&.\QO=?L\D"?YK^Y^K"1YU%U@XRSP64J[FGHB"P$%@JLB256X>./41QSE(X
MS-1#5%Z8S#]/Y^'R[[/I]><WTP5]GU9^$>8;MZAZ3+5 T=NK6]RF(/>".> J
MIU4YZ:"]!A0\)>X<^MCIFKI/(OZ!6,]02*/0-D!#]@IIY7=_6/8]26EV'2Y?
MA]GL*_W1O\+E]7IJ)!=\AF%.7M?JWQ>T8 8KR*TR(1+P+#C$PC08$;B-R'1H
MOE8=#/8,!3<.<0W[KM\ )\M_6!KB/2X6J_2,S:&$#UJB0 ?52P-5L\B"H->B
M%D,P$K-.S2\*]L Y1]4T,OX0/=4/B#3E5DDK:JA9T0J4,00Y!P/HF"LIE\+N
M9WZ_^"2OHX(;!J;H>21Y9<=MCD%"\CF XEF#PU3[8FAF?3)9IM;'BV>3Y-5+
M#;V2O/JP,GBF3Q<P+S7)JQ=1>U-^#K'RX-0CXUPJPB.MJ?X\O4O.F@+)ND+"
M=XY^]OPH/RK)JQWC?8S;^"[[S_?O/@::U!)>+Y9E4;[)66)%LAAR@>PE+:VL
M7J0QQ<'E((7EO@1W[TQWZV'^WH><.M6KE_&G0UBN<9&A=S.<I]GD<S7B'Y@^
M7DTOIQ^^OI]>7B^OGF[*\#I3R ,&IYP%)4TMPVL5Z-I\P"@?&.N2PM?I8<^5
MXO:6;/SVWJME=(/L6RVBTSXS[2#PZITX%+7^;@3I6/#<<:6=[D!UIX<]5ZK;
M6[)QJ9\]F:4L6>N9=Q!YK*%0DOQ06G^ >ZLQ"*NT9QWX?;K9N(>2VLAF#>]"
M:A;1[6'%ZS#'E2MAI"Z)>]!IV4=.9-H_6 LYJ2PR[2FBZ.1=/9*+]?#)Y[[)
M:F#OQHFWWZ+Y@_Z+C=O? 5/#O-M=.,9/NSV6GYU4'VG<QLF7N['I$KS)'JRM
M_=09O4%!. Y9^.!=01="IVCA)T7XGF3;4?CN8=/&/MFFV.1=Y_'MYPGM)&_1
M;DI">%L,3QHP,TF>HS7D6%B:X*Q*0OAH N^R<'=_XK@)N&W8F0YNVL;5-EZ3
MVSB]G.0EG.7I]%+C-%9R$\EW+"XRTGBRX#13$%PJ&ID5)G6*=7CD-=_^])>P
MSC>P>V-/[R&B]0O0!5/#M7X7CO'7^A8<[:7\" ,W7N]W8D.&A4D509"4Z[FA
M@!B9!15*LB'26L@ZY7 _*=+WK/=C<=['KD-F"FX.B=<KD;!1EQ(4H"*/1I6:
M^(2.YC1ED:8YU)A;YW_L@#+NZM^&IUV98$<8>8BF8IOLI#<U N&;$Z,@378I
M@'8VT6*6);AB:T?Z8+-PHGC7FOV=8,Z _S:&'J*1T-U N=>783Z?E$E:CGW5
M5;%@=DP0*.E#=7E)FX;@(8LEB9AXEJU#.AZ!=.XNX1#,#!T8^RV\3:?5#@"'
MZDWV&+@3-2EK26EWN1S!Q[@SSHT3;((6A3RL6&@/'+BF]T<J2-G*(H4-:LPY
MYY3-S$ZJESXT#*V3?^!EIDF6OL5=T=P;ERH+7P06 1(%S;DJ1C**X\"],S$F
M[W1IG<]U(-03-%-K2_H^20W$V !.\+>AVQ.<__CU35A<S[!V4+F-Z%ZV$D3&
MDL$,4NH(RID",01:WC'GG+2HW7<&#;+?A^ZE.$8#\35\-L<*Y::1: =H WE'
M>V"=QB\:BM'].1I'TS' HK</8C2E<'0.K!:BID':&DW P*4H4G9&.6Q=G6=T
MI3SB$#T!H?1AX70W=($;IB5ZL)R<PGJ81#XBF: PRX0)PG#1)0#R*=[0-2?I
ML(NZ/A8>P&E9E>"X#?0-E^$JX?N/B(M75_E5SI/52*KC=3F=DVGH7?G&09O3
M1ZS*UFUWSE8-(3(-1MD 6AI-HU0"HI%D5RZ%%YP5GEH[/..,[*4X2T]0)P,D
M,?8"?*>'=!?88QQ1=8=\&@?M*:IHW^9S8 D,?=K1 [X718?$)*T[6$NHQ 1>
MZ0(IRF 5UY))<\[*?<1A/&/A]F&^L2/Z\Y^;Q"*<?P-_TV+ !29"0I"E$+3B
M8^U3X"!G<K^"2_G!,<E6[_.1QYSX^&PHJJ;#V'FTUDPY6DS%">#9%U!29G Z
M*J@]9YD5]$9@I_/7E]":Z="0L3;6;U@U8'_?DBZ@7EIKIEY$=6K0<XB51VO-
MQ)';I!2#XE6NV^4"GHL$@AMKE2-H[*6T9FK/?!_C-F0\+?O+?[WX\_T%/3CZ
MXATP6V\BH^ 0;'*UL%_TCF,H3NVA=X[IAP_3+W];?^**X?4WMP3?/N^I-&3J
M9?CI45;KVXII_<?U'S',\?_]O_X/4$L#!!0    ( '>, U4PW3UL\2H  '0L
M   3    ;6-K+3(P,C(P-C,P7V<Q+FIP9YVZ=U@3S?OHO?3>I-<H52FB((*T
M*#Z"@( @11 (BD@3$)$BA$2ZU @(*"H1$5$I >DU=!3I+5*D(QT2ZD+:B<_Y
MG=][WN_U_O&>,]EKK\SL[LS<]]SE,YM0?U%G 5X30V-#@(Z.#IBB?0#J)' 5
M8*"G_WO0"B/M8&)E8F)D9&)G86%FY63GY.1@Y^#@XC[!R\7-Q\W!P2O$R\<O
M("@HR,DC+"(D(')"0%#@;R=T#+1G&)G8F)C8!+@XN 3^CPNU&>!C!?3I7C'0
M20/T?'0,?'34=@ " '1,=/\6X+\*'3UMCLPLK&SL'+0;*GD!>CH&!GI&AK^S
MIET-IUT'&/F83IPZ?X69W_(NB[2_@%I$:BZKC$%9BZ#5(%Y6_=[C2#9V(6$1
M43$Y>8739Q0O:%S4U+JD??6?:X9&UXU-;EG;V-K=MG=PO>_VP-W#TRO@26!0
M<,C3T*CHF-BXY_$):>DO,S*S7KW._I#W,?]3P><O7[^55U165=?4UK6VM7=T
M=GW_T3TT/#(ZAOLU/C$WO["X]&=Y976-L+.[MW]P"!X=_Y6+#F"@^U_E_U,N
M/II<](R,#(PL?^6BHP_^>P,?(].I\\PGKEBRW/7GEU:+8!4P2,TM:V&34;?"
M"]Y[/,@N)'MA3H[P5[1_)?O_)UCD_Y5D_RW8_R/7!,#)0$=;/ 8^  J0Q<$6
M LP$5)U]@^9?/S?5[\H8+R[W-19>UCR;.C/=!*<"<5GPBU3@O6$C%4#(4('Y
M]:]4(/(9%?A1M0[9W_>A GE,B)NA=F-+E]PXW82UZZ= ^+IF^ZP_^SLEAZXU
M9"05F'V/YB;YS/?*7*XN&]T\JZ'TLC+!^[.EJVU C/)5O-KE59A%RM--6)20
MYM!J]=CAH_/&LZENABR,:F\C>4;L-@M:^B6O$93FT'&Z1AQQFF/^/Q0J7K6A
MB"MB?WIW?KG4NID^"%Q\6GP#>4$)?GT#Q.3HGT5,YC"!.@N)&(ZUS+IW6[E>
MSX<:7UX?_.+&*2P7IR6SBPD;T[A^P4QQ]V:MW]F),:%L0[V,*PI[@F \0:?S
M%OPR&#,/X;LQ^<:R,<T?%Z,<%+&99'O)D%YK(NT S7ZQ7_W,TM[\%_@-,O=_
MJ\?\O]4SCF! #$I)D=_O;=H>MAU4CY6M#GVT2ARQD2V5=>4,F<4MJ"#BJ$#+
M62JP:$EHH0(%DT@R7>%HS\Y;?6'.M>'&?O$S?66W>ZP]1BM?'Y"?NG?,3-QI
MAC#9_21(5: GE.NSS"JD?'YR=[D0WQ^7 3@=HC,\S"\"RGF_;K@;S>MUP^<)
MONV42%2= 70<4J*T8VH[IEI)MEJV'"GYU(2M#9#%\=>Z!^D9*Y (SD'V+\G^
M80XI@WHW%K2/DQHS!)\BC%:$RJ@ T^6!W!JW8;@H,H!5UUAOR-""Q,A 6C,3
MIK"'STW&CVI8L*Q=]'?_DSD])]>\/QF![FNZ MXAGB,9@1U>U4T2>&+5JSM^
M!S&+B8PLY*$N%2I QUSO)T!IQHKHJA=43G@<A Z=G!I<#;YG#!P8LM\FGI9O
MK)U]_-5OO-OA&*UG<;[/2]53I*J19P@9#14CJ1+:+F?9X1M[AB>O*F2H]3,8
M#NK333P^9\Z#3W?$=J$F$ML@Y;\/,GSF.?0,_I@9:J:IEG86 59T?;=#QU ;
MO?C/<$E0)]=#[=K2&O.I@+ N^>"C5Y!/!A3!'0N2( ?%T((1B2ONHD17[MYV
MU) PU/R%B;NU?OY5@Z&PZL'VPL!^,I3"?@V_?+.IJA)E@OLG_7O9&0\9!ME9
M"';->PUTXS=(4S6\V;;BC4>W+E 4?60H3?-48* #L>#D+82 X!>\'&+:@ZIL
MJR@/AZ\_^ORU5A;G[/<L/^J1M>VRO-%KVR[#QR4':@AYN,D A3_$\+ =<;*6
M>!'M5=NZ $\*E>;>L+@"TZ(";3^;Q)$#"LY=Y+ N*M"!^PZM+-B4"R;L=O9D
M^LEA8RZ,G2F8*)/IN=3RKNOPU2.6NUTE\,26)IXQW?!Y4Q46@V]I5.!60_K/
M!-GC'>,-8%EAJ/&&O.FUFP>OBB&+(6#?28RR47E+,51]7W@.M8F=LTC,42W'
M;\?!]3!3,XX2F1XR?.U1A?5^<T:A>Z@4B.0%Z+,F\:JQ_?6P^C=WXCOJBK.9
M?=KYIU*TBB#CZ(. (:3[#+.1IX@IEM?I<[B1Y60/BMRQ=ZT/V![!I2-;3+&+
MR2M4X$# @F;_S3'*>O"'GE;."^Y#YDVJ/,\R0GL#TOZ*C!"''$6OSX \$"H@
M;$32K9_#DND#MXF$OW78:T?<M4^D2P3;<E?!S;@X#=-)XUC7G.D^(\,6F5//
M]AD1@OM#/\[=M,M$J\_GM5^*WDM&?R?S_^NWFO^[WZY \5;;L51@CPV'Q4M!
M*6>Q>M@Y*W"2$J/B304 .=HM'E0@QG3![UB@$D,"LJA ?!$5^*9&!?Z0S*#5
MZM E$L]8_S-LA5T<UL,,:E./)Q?O%X4^+!3XL"]HK,S&>!>5']H(AU$!1AR^
MI'P.R14RJ!%^=M?T*>:DQ]@6\_-2UN99OJ'&MH-\< I-KR_HO.[/E&Y;X^]>
MT/Y;[ %CI-&'9[W@O::K?+$)'74"%U?"^_A%5;\HF\L8^9C-)* ANESX!Z/W
M">:-?F[^TEL)'3RO U3K.K$7H1-:4A_M>IVE:7$[)\1Y;"[=$)^9__D?'G['
M&R_<*0R[=LLS\;IF7T.Z'.O'- K'*R5-5GO2^G6$[EGXO9<$]@KUA?#0YPT^
M3WQ(T-PUL9&%K[<G=3^&!Z&6879&,FV6<1>E[9 1! TP4=@Y+T74/GR#F T!
M%57B7C4%1_@V?'MZ)K06 FZ&*D0A9S]0 0[2%=E':S,3SA(9-:J!OO?CD;/&
MZ50@!=>,@Y8K=(3=OO$-#L4EI)C_E'<]HB,KQ>!TU0O!!W/%^W^5]2[D_._F
MP8N(:%N4XL]"3[/UQ9ZQP.R;8Q^&>R'5SCQ@Q!SFN</31OQ8[=WB2?_:C1(A
ML^@]3KINM&N4$Q<\@*;\0;SG$$)H'7$J30_S%?8J[]ZEG86;6@<_(=WUZ$G8
M070-*(,_T#$3<D.U3PQZJ-Q?\UE@6,Z2RGNFUU\)#[P!(=YILPH>Z_IM1?/
M,F6G0)^S03-"2,_M.#2SZ'L"<[VXE\M]S\RK?;4DZ_ 9D$\4DZ.! <_0#&YS
M2_1"/XN7\,WE>-^S5FI&Q/>095@.#G>H_6[C,"O]9W"PNJA<]@/EK?;%-.-%
MLG=P*Y(+;K_0*=/6)#&J45S .6:+42P)ORX"B<=@"E+G/%I,&C @A,?NN7]-
M_,[<@MMA^9:X!:@HGSU,%S#K79F8Z[%],Q7TP5C@[4@",G,6"5):@1P_9[CZ
MIB";'(_O]1-7:Q *@D?KX40-DO5PKEK_+%>(H7I:ICEXJ"6I7]GBE:U"B7OD
MLR\NGL@V\L*U)CZU9C/R3$.!:@DV4 DJ+_?NSQ.Q0->";.ACDN9\L7BGMI>7
MME"A>^$O*(>_JW8OI$3SC(PNJJ\2^PZ^3&0 94'H0>#@GU3=VOWXI9&9J4OL
M<13R![LRN 48GP]7PIM_F?>Y9Y89=%YX@EO,4%=1M58+D@S7<]"M_"T6NNZZ
MIRV2 K_@/3ILFJ7KNM#(,$=)O%@XK^> NSZ\ +F LV)B^<5=%!YKC,EJ<*?E
M+T6\5**_K!@WZ@L8?:8+'>$G'BKX>Y=OG[[I!#A.J&]'2NHZZ9>7.%VJYFSM
M:[G]W"?O1^O7XP51UQ\ES-/3=[YDBH?D>-[9ZA+;<MT ,&6MBQ?RF'1-1T!'
M]Q.V;X_.??U.W(&"BAJ9!&QSEH[.9M--Y)[8OD4<!'\3$BNE51?[TZJV!E^\
M&'U:^P,=L_'JGZAG>I,>F%ZSJW.PI(IWNK!IT.YVY3<9J$=FIXU%21!.95A&
M F?]S5'P/CF'<F,N)?R595J@AK,'>;FR(9(R?E9ER7CV!;.QC$MW\][)E%$]
MA!VB"UT9FX=/;!_3ER!P;53K<S2^,/CG8_4OR13&1$HG8B>E/17VI;0GB_=C
M66G(%+/MK1=75KSG";_.S'Y];.H;MR+JZVIQ+K]?<FR%@$JA I7N,4CW36^S
MX4"BBN&?L!5.0N5+K^;3/@67[O9Y]R#GEK!<V!4^#'+F.14 ZP@SX)E#TDL+
M5N2O\[2HZ8E)/-\1K@][>;=,RV/T2UCYHKKRKG!,1U_RQ:(&U+@%#1@KJJ.Q
M'J<U+$"CY-[*L;?KR_;3GXV#SATY7590>F'D?'Y+:>S8;KYKXY 0N3V+:B>K
MMM]4?W-N^MJ>HKE<]3T&SM D9JDUI0/8E;$BDE'>^%HFOTIOQJ+2!;7<[VYW
M7UP+L?\$VU=LVF[MS_M1#MUD=Z8"G=67MA,A_$_ZH_59FPB&&*[V Z&PX/RO
ML2^V3G+2&Q7#-[#_$?3K,9.%%+/J]IG;R#T7S _VO6]OJV+5$M\Y)^V4%TWR
M1V#$G@1YD%M .P+$'*R>U5/M"+UQJZU@[=3$Z2T!Y:B'27$G^7_S(/;LWB#:
ML#O>%%8J4&('.;91$=RUF?TR^E+H1_EZ::6<;;2"RH2A)DF @S:8/17 %/J1
M191V(K%V?VD9MN-3UT\.OX-<Z2:A?3,.WT(I:V2+WI W9$+H"3.&R5)[WCR7
M<YSG'H5"NK%&M">RD7Q4H%I?RAO!6Y.N*:;R/4=0 2WMF*.?4GR4<,2_L-Q&
M!38@+/!S!.7S&55C>Q>,13AYM.5/4G1,QKHV- G\%,'#3;8\Y:&G0=I#%S/T
M0]V^GT<3P<_ZT3C#NR(+CZQ>!L-R?V2,9,)0D9G]^_I+Y/HF&0A HAL]&6N6
M5;?X);\MY;V6RBD2WQV"-%:A>"YM_GZLK*=L0(R-J,(O]F,J0&$W(T H)U3C
MLZ$Q*HN])7'>RR;O"<L_H_I=HZU)$PUO#DS!,"K MMS!YI8I(Y>9^&EJ[9;$
M?3?74W14(.(;836[32FA93:\HF[MB;N&7$J/7I*V1TC]&5O%-D8)/ECN#-X4
M>R30X$\%8%54X)C!;KFXGQ1N1@6<Q(^RR>RTS.=$!;[G+Z".R=4T+A.KZGN'
M5SD6P1]7W15<>SI#$EAPR%Z8#XZ]\*UWT6&U6,MY\N.+2/^]*T>X'@@;7$88
MU:0 WFFKYK2=M!PY%7F/FR?3T0\XSF"!6,+NT%C>0E=<5U\&GY5P0LWG4W5:
MJ[T.L^UT%(%S)@/N/3LCX!0BTS&A^5PYPWG[1GW*EL:]R_=2Q#UERCJA_#:9
MQ/%0Z\-RXH_>\*D^\Q(<S)^(RELY<.#.\BY8/1@<'Y\TE$Y@M5;\$/$,D/QZ
MZ#7;Q _WPF,Z5;DFO9H@(W/O%B\/C=='Z'*EV Q?8H2TUDN:WBX;+%JLQS9&
M=D^<S\Q^2G_Z.!WVUIP_:>I!)=0VW^KE^WSF(J=]3#\M?@F3DG)H-HKQ1I'9
MO/>D1=/F!=(T[?F:W=PN,4I%VRUW_;_A>/W^A.O=7=T;5,"1,7M'_RS^!\>\
MF5Q\:V*-L4(2?!UFBYB$5MXE+.8UZPO648$$1 _3B*JTKZH<PQ8#%= =20FW
M&&JZ+'E%0%/C6-)117OTKJT7J6!IQ#_CM.4[$6CBXS_)>=-@G'7E\)-)>U6_
MK8^WWU?'!*N7:0'L9'MR*A5P*U1]1A%QNFI]?5O7%?'L]Q1=1O6M[['J*SHY
MRY/T#>X4MFK\>DMPJ'/>?&<=RHKP\D0%\]AE];M\Q*+W^ZK]?7KG?RUOLX-3
MZ^=?_L$/#*J0^AOG2"6\D1W6HXT-D4U7:(9" [L?$H,TASF-/N:PP^WOL) $
MVBC7_Z"HP-U_:+;CT/"PG+R#_K+M#MG2".?I62,CR(E5R#8U4%PGX,!>FPK@
MGBKM,%<^)-F7>!ZL^GD7K0F5&K5V<(TD%/8] G0?6RS#D*]GW5(*1#IMRXY2
M;%X9G?VBF(;2Z/^-_'U<+(H:]<;7@ OMZ+US7EA07)4*"!K3/*,K'KKB,@K%
M7X11%)N"R4Y?J  4RK"&'<M&[JX3H('"DL^Z*N$T)&:ZD;/TA(8;Y[[<]1B:
MT<UYT]I23FC3"U<G*CKUAA-U0.ZPUQ]K<LPT1!<S$M4E<HQUT^UG*H.;W4 B
MOMM)<7Q(TK?3HG)U&/I[%SB9)]42(3,9-=&@*[$0W=G1?Y\6;2#74@J4?6%R
M9MZRZ#6$+MJ+K$>.I9R#Z_A%.T!C-U4?5OCQ3IPQ73?-O/TQQZS]]14H_"*2
M^UWAKE_'--=8 T/)E,<QY9W^Z\_-DP[BT8H6>E>VN+43NFSONZR9E%ZBN?.6
MTIZ$KY!HC*"@:@VIC2$IQ\ZIMW/;QV+ZU6**FZVAK:TH9\'),:,$7>'<D$FS
M,*Y@XXI1'PF7CD!>__Y/H0A!$#>+1:%Y*9 ?H@,DIR\3TE(G/7M2)4+S[O/M
M"^X=MEJ 9VPK[_K[N1%8C.-N5=P3K#33@->FCV9#ZV;PDHT\S$T&3<8)N=NW
M@DG]=6T$;AZ^+5N4ZF+XW*P%_<H,%TG=>XY,/[SAX/0E0$ GT6>J Z7P.QD!
M1[:8*=3Z)4Q+I%R^5N<9W;&*/K<%[<8:- @O^ C/0^*4]W_34U2,;M0Y$7KY
M2"V2S[>X0HPVRXA:3O!'>+>J_%Q%;'S%S7Y&V87-\WR9B7IOGAEA)=<354I*
MP0[M+H3/E?E'W%H!.V^2%I-PZYB->D+B7'^\ONB*-BQ.@T-2>VUH2*M@:-$M
MP6.1G>%$P?;]Q2W) %A:76<R<HYL&,9EWN>C?\ \*=?8*A!X<N]D H9SZ$[W
MMW\V)1(>ET1'ZK5@ZKI<\EY=D5.Z35H^VZ.0:>/3NKQ]W>TA7Y1C5TJ32 AL
MWC;S0$IV4'G_MHB/U!.7.F)A("0&\4^(PD$6^ 9_\ ^EBX!XGZI@&O9:%\0*
M/+H6;H-WI[#?Q EG'ONUARN>YOMN6>3I$N,\GB9M(;6&G)5N,J@R36PC[OW>
MG S8>G1TP"'H%6B#F7'=@G*!05VMH5RQR9^N'H3K=PI&LGXS'[%\!E4$:3T&
M$$[<7L171ZHL*4D\/WXWY4*>%;]O+_7Z!*39[G>H5*WKO-[92:MAW[S&LMHK
MLNJMDQDC*:P:1WXTU^ ><2 >I#;&)/)Y?IIHK:]SB4U'/:PE>RMGHRLZ2Q"Q
MX_LP]V=>.7W?C]"KL*\TON_?Z/I(.HT_^QKC-7;>$6RSBO!US[;A]!&,M97M
M-Z 3?[X6,(%5IPBOGE^?.=%PIN!&;F[=J,^]U#O/K+MSX^;5834OVDM;G^>Q
M?P4$-_V9I1\EG>X85U\&W=G8T]X]+9R\*QM[B2_OB:VAB*(1H]UR]2:9J+:*
M$"A/G(?$*@]U3AMG2IKW,4V*/)B3LY&\-+N0<@T1B\N@C&1?T#[<V"703P=.
ME:T<"E]&5IX0M:9X*/U1(]W @\^[5<T+?CUX91+R5GDD\XL'@K9)U28_)C^G
MR)@1^&>E$@X?B_I5M$[ >[J4_PEAM1CU/[);]$$DTC*9ZM9') "VTH\G:UQP
MDXINKZ48-/7K?RJ(65Y[C=?5M+4F-+P3T]VFL(=3 3GA5L@!)Y(L-DKP*M1A
MNFG_:O;TXEL\('B (@D0*28*T= -$5HVOH#[3F&[.:T^0+<H:3"%7+0I*?KJ
M6,.J_^.M??O3<M&N^O.O16\7TA<5,%DPAD9MPW(A>',_5)3ED*^^V+KFI;KR
MWLZT'4U5MJ5YJ37$W8VN ;M8Q-0,G44K,O[JG6&?[I" =J:"1(\CEYIU6?=?
MRX\.9&E[:X5(N.L7.)3P(&M>4OH6%P6MW2_N'A75C;ZG!A53:LWQCFX(#@N-
M%<MW1(M[/ID9(%N3Z["+DW#3_3@J8,A.>H$9GIE0G;=]1P@X.--(,'_5W!+.
MJ4Q8EC_#&.%\\="6$<& TSB*<7S*Z<;.GU2GCGV^9E@BS9_2"\% 2JD *7L[
M$KJ>T47),+WVGW7X127R?$$AJ7^P%+I50>9+IEDF/15(]QE#KJ]-_CLZ&C/&
M YX6)KWQ+:<AC>W,\3F[17)XYY6_(-@'_@5!F6TJD CC0<[1UC8R'#2RCE4Y
M;()4QI+9D]!*_L9& TJ^5. 9.ZAD-B(_%"A^9SUHW-]'L5><F]7M)&J$G1P"
M,LP1D8*(;GVQP9(!4V_D!W%/OCK!1]U&B]X[IAT(J1I\5OR^D]"JR93GH=4=
M_1 %5SYT.]W1<+=20'<ER^ W]2*= C&1Y_L)) YG74).+H&C8Z+@>:4A%_*S
MR8,LO\N/F%E*Z9M6R!$(*2K@2F(G]">6R$@OV!L7SSZ [+2*_+H?[H2F' D>
MD3V]Y?:GA 9*CC[YBZD6G@=X>A+(V7B_B'G0CZ@W&1*DP3ZF+?/QK<MKW0^.
MZ,?M0WV%BA?N&F@[45B+(J,PSH'+Q5GS_9VF&/#X#?F \@!K0$M26<B=T^ "
M!>M#@_L[-!K$D<(M_H,&\Q;0_]+@H,^=9>B6ZF+ (G1'#=5SC%J M>K)+/@]
M\R.I%S*(]6BV/'DO7/WR<8E^W)X\5E;_'(F-X->B%QK&P^OY+='RU&V-TR\J
M&];3*PJ#9'GJGJ[#*L1RBCT_C#>.[O?89JX?YK^._'R<[ECU90%#[VW[V,%+
MNPH5[GUR C]E+/&\;2 J-0%TE _C+'',D"\ZUG3=DV@[11EUQ"?^<;*J!=_=
M_>JT>HNMJ&2Y(JL$E+WO>TDB 5L4\A-&H&<<V2\V( NXJ'3\_*[_2AYKM8^)
MH +EB$;U'X&YX&,%A,6O+;//)$;S&I*B$\\L=F-Y[BCMCAE/V]G59*SW*T=4
MB=R#/XT%';76E3ZP4>3K7>_H "WBEWHX33?!&U"""3(>QO"DH^'L<6S*S/CP
M]6;2VK.'#P^/'FGM87*@LY]A.VHA,I1&7^B>'*81KBZ/DD_G.1 >9WZ+5;[W
M_722:^ED!UR09MJTY4C-:H'L;]+H/%?E\9)-[O,>&5MTZU;HZPZQ5_#BH<_;
M<J[S[X2&=#8?M(XY'MUR-!+WF=U\ ,P>S^(^( 8A#!J0"'UM'\5'NYZ:G@?)
MVH0X_FM3_.0E!1:\WGH$'DM*JC,B(Z[2>B]&-%(&8/05VR@8^Z1AS3\HF\CS
M^N]"C'HY6T*6B47Z5GH\I9B2+M>F N=W%.%:PJ4@I_T-/3M(O$/7DET+-G%B
MI@4J81^"^N?55G*DXT39J;-W%?XD-Z+\#.@PORRBJ8# !5@BA6V89);;_V=B
M"M,O"M55X_1-[KK'1C%J1"B&H-JJ*?PXOST?V]_%&N*BV6QS_I%%!8SA2CBD
M&VR"QH:S/,D9GYXJX)O>_Y3*>\"F\[3YM='A2X2K1G_V$J'SELUG$NSU:/J#
MM&:; \$F81!2"NG^;RH5_R\J9; ;K>.N=YWW$>NW&3[KVE!:'^\>&?+F<=VY
M[R=QW3"\%14XD@F%DF/XJ< 5+W"J4B/I$SI@6]WSC(NBQB]2'Z:)"KC#?@7,
MS71 H_3%".;E9TOK,O,X?IRKJK=&21M95CS4FC-".H GL"98-^S$FSGD,PH#
M:&& @]O[%*Q5!6V53U:HI45W;S ;\ VDQ#9-:N=("^1MJ(;M0?6^WXU]]S3\
MP5CU+6^*9#4^CQ*V3@5 "33)-YTB6?F_U^NW01^+2)I_ZCD@9W5I(=(7]9\-
M3=#)!TY+(#I@'YY787$#SQ/YEVREN(<:-/)%WY@/G^2][ L)V(1,:XE"8YXX
M>2>"?H2H5HBPBM]97;GB:T5M#]8E-@5\<T5C+Q^]#)(L9#EX 3;,,"+XUYH4
M8DYE'Y](=;BJ'_1#Z1S RZK5:2$5VS!JGF_R-CFLYR"\6-$Z_ -BWLAH@0I$
M4WC!_ (RJD.;*:>,5\0V!SJM4%=SE(67;G(F')+X-5M#B](LYO00-(4'_1"J
M=G$RX'$1F6L^SBSNCX'A+2WH0ZJF3^O:230)C-3I:+_VB5^0/;<8N*4TO3>3
M N4)?..O49!<P9;NNX'T:!?AL>*XC]!8Z5@H5<UP0ABERV7^L?P3A'Q]](6@
M><!#8ZVMH;#U,%/D"4]\<J]\9OMW%BOX-\U'>NHP;;6,>R*\1DP6+*L)Y @P
MF>@"5P&1G_IE<Q3*QWPCTR5S,A2G*N)*N]/R:!MU.?A=C&J"[IWB=6-OR30O
MNV&GX@I8T"G9)")+Z6]4:]//,QWW_,\00U:G0.5EENA6$ZCMN^V!XWX*6SE!
MD0J8@LE?0#7C;#-5RTKOFGG??QYW7I8-MZ9$8HU#,#T\H#P5B/'=]TO&90^=
M5=[KU;Z602!9G6/'YFH<^&W>)1J8$O5 )?-191\7[,BV:IK(IB\;.R&I(DXF
MMY,%V?A6["AI E791=16W$3?3;NGE^*TJ00-E$2WHR,0S&"UUV!(7EMF=M*K
MUJG9+FUDO?2+MEU,ENY3*L#8-;#5,-X F4]LO/2C>V+MN3PJIV5$B6Z?$?>!
M=/[OCY=P#4+%N8ZBJ1]S9M>><0GN9";Z+RREAG2-L!^$P9*1/-L^9NWZ%_&D
M%Y^G^LD%W,+KN_X@3M;+%:^V9&?T<'7I=?13M!)V&N$$=R GZ\N29,IJ1C 7
M5O:3I3E?JU[H4F.T)-WXZ,LP(SCGFIY-O@>.$Q_ U?&PF'T=;[,'N/;CCP.Z
MEK=7>^0-'U@Q+T-.2^SV(FY.F1TDQC_X5;;]F&CW_D<?<- ;WF27T'[/95KZ
M8MG1EG]TZYR77&P&%;A*2_R@/*S]YSH1<@*4V@G*F6B7SW4I"EA2.F]_,_3L
M9IQ4T73E$@1OI<)MIKFP7TRXM>@EIGM"R36Y>T>&\WC.F@HTQP3#\#=X6!V-
M2T)^=JB(WKG^/M$LY>I;G7(V25JTN:_H3B8XOZ'%;F'0")K4)/XK!&/Q[&?8
MW*KH)_9+1-U7/$>\!;L8EHGAMC];D^HKC<F.MH;IH\6(ZZ1Y? HMI;+B$BJ<
M7)FPY=LN=1.-YC\$"> \]G&%DSE7@&'9B(J;_>;6>^/Y5&Z;C)>\5VA[$1($
M4XF\[S<9V34W$Z<"%UW(NS2TJ6\J::6QRWE^65K!N=[N+=];3LY'2@/]YVZU
MMVJ<4:IXVJ#WZE:K=89B7[?12K\)@6=2IY,W!'H00 C[*?UQ(J;ZX E[:/V-
M(%[HK%S_G-D(UL<BJLXWV[<KR:<D]O=/K@:K"\DS=$%X1 WF&=8;,I&Y?A"-
M\RE^>"K= E^5TS,VMI/:Y*XKZA@Z^TB'/@S7NS0>&#HZOR0NVU_4&^"H)W$A
MCTU!'H6.,R$KT&SJ_LKC7R0E G>!](NLB5P^],W4KV@:'W9\6L5I=^9[WW7G
M<'1V,BF]RNF2&7Q/T)K'ZCIFG J,[\XEP$^!IN]#O#D.WH1H_J;!G$#O[B52
M'Y3]^ :EXNX5JZ:B(V>QMNZ0+(<)6;@-;4GTJ4!:XBP5(#)#*<E>1^+-5&!'
M.P1):16BH;:&]SKZW_>R,!8J\.^+66^[[].T[ZG#;53@@/<O[A0Z/?4C)>:M
M]$,U:.T?&^U6$!VD</"J*Z%\#E$P][/2\A'A:"Q JLS\_4N__J@-,\2%]6.N
M[=C GV0%RYCB[8U/'O+Q$4SVYJRD#L2VZG'9'J8?#9[&-<-*UX1F3NQY^Y0Y
M^E2-#IUO1J3V&-4<60Q:!,!T4A?"DXT,PDS];JW5Q*D>C&3*BW<AKRY1 1:X
M2P/^L!4M#)Z8;9BP+97)85H[56/+F+K1C(AL6!B+N!8^=:;S37K"*/IM7]':
MZ2\ZO\@A9!JD+^+@?%3 L02Z]]7A]'\V*.W<L"-V6-@=H:M=D+\]CV4@!U3
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M'$\BQT0VW\/J)4P$C1# ZC7X.WNB?7?X^$&%)Y'=,K\Q T4=_Q]02P,$%
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ME$813G,-L]@Z"HLLAQS9(/D\IIK$VFP@O+AEOXM+HQ,K(=B*"/ZP0GJ&?AP
MTHTHSH-G[(ML/V2\Z>"X\H$8X$ 'DT[ZXPH^G^<]3PZ;VN^*A3W)_V!#,CX4
MC!=SLQ.9Y5RSE-@# 6- 0$RHA)PDR/S!L@A+'B4Y\_-L/]B/SS<\C9-[(]]V
MLP!*/B]NF],9SZW"85S=)OO96(T\WSOY0"/@%=B(&&[&]R(0:-(?[F/2>=^K
MYO.IW__PP!U$>[G<>)Q\*Z1:R+KU+FC,B!F/&%$95C 1DD%L%G;((Y3#'"$9
M9RK2*DMGNPD<3AN\O1TZ?>,G,U.$]='JI 0/K)">6X1^<!UW".<#-M$&H1/4
M^C%\JHS1R:I'L)'Y"G1>*XW8 7<*3O"$VBCT=S;M/L%)\;UM@MM; P-JBH7Z
MI%^;34BQ?,=$PT^_L1_%_>K^55E5Y7?K1<_,YV-70LYCEB9<0ZWC#.*$:LB3
M2$!-$Y(*JB(<.[F_#^G\TG867Q[-)DTTAY*U6A1E!5:+6HF5W6U7ZELY_V:/
M*D2C&]"=<IYA-SYC@Z.(\)SF,,H0ACBB"%*92:@)S?(XRE@2Q;-UYJGI1Z8W
MJ5;(<=G90(-%:2]J?UH]@&7I>53DA;W;JC#6US[R&F'%MNM#*SA82WX%.MG!
M1GBPECY@1-0 S$+%1OET/6V4U !0]N*EAK0Q.,-)>:^^LA_6%7I>UH8B-XZF
M"AFBXCJ!F4 IQ'DD(64H@6E&!=81IRCBGME,CO5U:0M(%YAL9 5;85T\0;U!
M=J.G0-"-S$:#41N27>04'N$RB1SM:>JL(:=4/I AY.0K0T.]%[=?575O3\^N
M%]*046&S<=B=]*?M 4^7DFE&C2%*\S2'3,7(IG7 ,*<XASR.<HQ(BM+(,ZV#
M5_^7=RBVSG_VT*4Y,"OXW&@$#;7= VET\@T!]QD-$1,A.=8P2Z,(8L:DV2AH
M#@7B6:XQ4RKUVRB,-193$/T'5==_ \_&8TST'<W1L3 =VQZU7[$5'#17&/;8
MMST WDJ]R?X7,C1_ %K!HO1]^IXX8'\ +/NQ^T,:"7$K^HX5U=_9?*5F(D%,
MI6;[;%8-8X@FFD)*<D-;G"0J4X1%RHNQCO1S:=STMEX6]\TAAC8B@F]6QN8T
M<-X=5A?*\P[E&,!#KDP'P3;MO>D5L$*"1LH=BW2L>]0]1$:Y3-WV\H(WJGNJ
M]E^K[C_N'X[TKOBAY#KATV<S+;Y\9P_KN >5)RHGW.Q/A4VRQC6DQI"!-(UQ
MKE":QL0I"O9$/Y=&$(VHH.AD!941%M1&6D=6.(5J/RL$Q&KTVU4+TUI,8.4$
M5M !\3F]'Z%S\$T@V":*K#D&7Y@X&0<L>H)@^MZ>+,+%087=\!67QX,D8'O#
M[MFMJJ]M]D\E.U,*DRQ*[7%>0LP?**(PST@$,X0YCA5E,=)G)& [T.6ED>8Z
MMSQK9;19!=N$;(769V5>.P2WZVXO)(BC;_&>9U[KY 6=P%>MP35:YK4>>,;)
MO':HPY?,O-8#P(G,:WUO#J.<S\K:>&*YJDP7Y@=5?5.S+(MX$NL8"FGX!<L\
M@7E,":12"BQIQF.6SQZ>50-RJ*2PWY7/O'C>X7A3Y)6Z+1:V4 7@;&Y=C'RK
M5!S --98,RH%U#(WF%)CW7*D,<P3@5E&.*>1ZC!=5ZF9"-'#]7?"QL[)L&"Z
MT?*Y\(Q,Q$_$ YU\(>MG'-<^6!V, UU,7,_BN)+[=2EZGAV88T_*PAKO;'[#
M"F,3=J=KAD"9B.-,&-M,9A"G20QS@7,H"1$REBCCTBEWQHE^+LXTVXC9. ?"
M8@%$*ZEGOKPCL+I-^P!@C3SS=W"R(MK:#J]/X.2?OJX?A5"IZ8[T,FW:N7Y5
M]U+*G7C<_VCKIE+V>W_[PR;V,>;9HBURTYTKB SC1.4()J*Y/<UCR+(HADA(
MS25*S)].;A@G>[HT.NB$!:J3UK?JUVEH3Y]P!0-L9$I88_5V%ZNV!)?_*5<_
M:.[G7,' F^BDZSB(8<ZZG/#H.>WJ?W^R\RXG-79/O-Q>."_@XEU9[294:SIX
MO_AF;#9CK5V+9?&MN2^;T2Q*<ILADVD10RRD@C1!"B(>2YYC+;1 PR(P'"5P
M^NXG#<GH_\*#H.YF>8V!Y,2Q&KJLP$]KX9NBB'_M:'BC -AJ$#YLPQ.ZP'$<
MKKV_2&"')S3'(CU\F_&CM;I:SC[;M*3KQ98)E$4*P0S90WOS+&2QH2NI!)-<
M\R313@53GK5[:::>3>95& 2%V=+\IIB]I6\#G]^4]ZQ8.-HNS\'K9YTS(!F9
M30:CX4P;1W3OHP/SR@X5F)^V-/"\M4FF]Q$5UM/VV#\/]4QZJ)0H6I,WC37+
M,Y) G:3&A, \-28$8Q GB&9<I8PF7B7==AN_M(FY*YNOK]$.9&[K_U @1IZ.
M3A@,\!W:5S:8P]!.TQ-[">TKM>\:=."9$ Z#3^[4;79(>:,JFT*9W:H94W$>
MB3R#.DLQQ#2BD/*<0A7%,E-9@K-8#/<A[.OZTJ;T^R?^0N6B<3@'Q3;;R$\/
MK>R>47D>@^%*!V- /#I9/'-!?.(X<]4FJ)5@*_M8WH@N>(WBH-C;\0OZ++H
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M4)U*X,&J<046;99+O55E6-:M4&-[VL9[@1$;^[S&"@M:E<";CN0:I=;9G*[
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M[/PSGO%(>I7'Z>GKTHC!B@J^65FO0-%(>P7F5EX0^2WQ??BZK?B!4!N9&!K
M_MX"]KX#[$,+V @EFQTP"60;]/4TJ:G@H/)SR\'EE8&'".).R=7<V"4?2^LF
MP>:=:?Q)?]K:QML;T9NR+AIWBJ^,S]57]6/YRNCVYRR5-$T8$5"(+#=VA]:0
M:X2,&2)CSHA.L\2+80+)=6ELM%;+VM5KQ<!F,Z+!CFY@QRM@HYWGP46@P74\
MXYA^R,8^#CESM, ?C6K Z@8:Y4*>GX2%.]112R"IICV5"0OEW@%.X.8'5#/
M&=EF^'Y,D!FWO+-=2)IAA96&$<J)K2_"((\2"E.<XS35.2?,.<EN3S^7QL3X
MYXP\K63P"!+4I)///=+Q]P#;SYH!X1J9!7>1>O,,J2$5#'H@\ZA?$ :ZB>)?
M^B ,5+O@-!Y]E0MZWIZN;L%I%9Y4+7!X?)A-?/V=57)33UUA*9B()(R;!)^8
M8^M%8T_)!9(XHXF*4Q_+]DGKE\:*C7##:](_1<[-;!R,Q\BTYPZ%M^EV4.5
M!MC3MB<UHPZJ]=P8.OS0L(GZBM6%,:)NVA#:-B9Z(;\4MXM"%X(MEM>;M(4W
MY;P0A:JWFQK$$Y(HC2"C/($XSK1-P!E#*2G)\\00I"1^86/GB./SX4\30;8C
M-]@*#M:2^Q'#62/EQB-3H3\R[31JV,WEKB)-XN 3 V(VFV-L,T/ &HC:SA)E
M4B8, =ISX@S2YL"H!;6TG@?-1854\M7C[[62[Q==;-7B]EJ8;6N3OV(F=(2C
MF%,8Q6D,,4$1I"0A4""-F!(RB^/()\>\>]=>IM0$^>9M@0=A76A61F)0+-;A
MGF;*LHW0G@$-[N/@QIGCH#LR0UI@&]^DM=@VSNRGWUN4_PHVPH/KTS#[1SYX
M(Q8J"L*]XVDC(KP!V8N.\&]A&(UM6FQRO:^S[CR^[JK4(RH15DD&B;#!5QE1
MD+$DARP3,8V)(H;#?#9Z_=U=VLZO$PL\E%5C<1@+9$M8\Z9FP7QHYK 3P+MQ
M53@X1^:G+0$UDFZ3>CU>@4[:<'SDADH@#CK1V:2\XZ;X<ZYQ?&O "?MBL6+S
MSTJ8EDSSK\O[![6H&ROM1E5-Q/FR/!P'9HVF.$\RG$(5&[[!QFJ">1HS&*M<
M\4S2+!/2^0C^#$$NC9-:74"U5@;(PBX19B]D\V6H555Z)\PX>ZP<3O4G&H&Q
MS[]:\#=Z@%U%FI09C2HV6.Q(Z*E';;JSAL3CUF"BH9GH6F',(?*[?0B :]_U
MQ#G-3W=_$0"$)Q<<(=H;&!=0UG6;0^56+<3CM1"5$>4UJZI'\ZO&$ZDME_%^
M(2J[DKY1[7]G+"$XU9F"2$49Q"QA,">$0YXF.*,XS<W0>@41#)7DTM:R=86=
M)@2Y5D]*[)@1*^Z;'ZQUW1:@VEC;OI$(@X?.S0R?9$!&7MJL#F!'"=!IL2G2
MLY8=_+26_KAYX1__<"Z"H8(E!LLQ;63%N7#MA6&<W:#_]N#]HC%=;3]S9N;Z
M8MEY/*24LA0I"1/%8H@1M3D:,@*)B!21,<N8F]]D7R>71H77"U!L1'6W$8]B
M>-HD#X',R)RT%1&L91S@7',4(W<;.016$]F_!S +8\^>PJ#'5CWZZF1VZ"GA
M=VW,D\_Z49UHSE'$X^QZ/F_/5.PU5%=\A!(F$Y8R2!A5$&><089SPWR<"2V3
M+$O=TDWT=7)Q5#>?@ZV,GN5<>M'L)[U0&(U]QN )C_,D=M&_)^QL_7IK1JU_
MVII0O<U/,M%=%%Q/=*=G_6T:CTH%1XY=[>:UNP,@D<J26%"()1,08YE"EB4(
M\BQC*9%*QRIQM8-""G9IA+(MN'WV[4SP,3QMA[W4R(Q,8_YU7I[=$?V\>T>T
M5?&%QM'=5GRI\9S(OIQ\7+V,U#' [S%L@W8WF3$\!DB[!O0H[?NOQ1\VYX9?
MU'(Y;]+%-)ZV;:31U_*5LEX5KQZ;F//KA?Q@/JWYK^4W52WLL[,XM4FAH@0J
M11.(E<20*FY^C)E*<\(R+)R<'T((<VEK[LW6):+>* 18XQ^^+ %7K8L7?P1U
MDT3!.FO:J3L'MQN=@"XK4)DW9=$>[_YDO@9A_L'CWO+L03Z]0$\Y=&,?\FZ/
MTK>Z7('6K;]5!WPMP2L%?N]&[\MF]!JMP%:M"<?(??&=<JPF6G G&3.O1384
MR#T+Z]E=3+:8A@)C=P$-UJ9_(J4/ZI;-NXPL-EXIHPE7L8X@2:6"F&:V3 W%
M,$^Y$CA.<9XXU:HYT/:E+6F->*#+ >03Z74(M_YEY4PTQEXE/(#P2GQT1.5!
MN8Z>MS59>J,C2NQF-#KVB-]TK*OE-L_AKZJ\K=C#76$F>CLQ490I&U20T-B6
M]$44Y@JE,-,Z12*ADF@GX[2WETN;HKOR>4W1?BS[)VLPA$:>MC[@.$];)^7[
M+M]- SL7[^:G[33N;WN2">VDWGIJNST\T ]_>==4#'RHU)U:U$V=E77UIG6&
M4UM=7/W*BH7]Y6<EYJRNFS@G:RF\4F8WI;ZR'[-,$8XB2F$J>62/C07,XYS!
MU' $1BF.A$C\@CC#"><S7:8)Z=RF&*F![.JV&S.:U6V@DC:J@3NK6_TW3P?_
M<"/:ST\O.THCDUJC%'BB%7A2Q.YJFY,9--I= :O?YE^?*WD%>*,F,'H&##D(
MCGVH\(1P@DT;RA <T+VPA_ ]G%>$XL;,F3M6JVW,ZK7\CU6];"I?S!*ID$ R
MAH;$<X@%SR#/D())K"3F29PJZ96)VJG72[/_6C9@6P&'%:KH1]J-;8/C-[9U
MV,E[!=82[P;,7SM .KC(A1-$@0M?]/?Y(L4PG& X5B##[>6@H>SO%]^L$_9N
ML.FFP@.FB::V<'%.$(<X00)R3A#,4IGJ+#>$I)RBLX:+<&G4]/[CW]]^^?K^
MXZ_@^O77]W]___7]VR]!(MG[AL&-JL8%=V3>.A'9OE%B)[)]G/)^@T$<-]B]
M3X!+"'IW ,@Q^-VEI6$$^%6)NT4Y+V\?7[&FJZ7Y @L^5]=UK99UYRZ,B1):
M" *1%&9?38PMQE-A;#%"242Y3G'F58C4J==+H[FMT'[DY@:Q&Y\%!VYD"MO*
M"QN!P59BT(H\0A)Q+Y "491;GY.RDA<,SXG([^5AW/,\H.;]XJNZ?R@K5CV^
M_<>J6#Y^+N?S=V5EK_]F$4\2K(F&5&ID:Q)E,+?)%S51:8*R*%.$^5"03^>7
MQD2?E53JOLDE?5ZL]:"1<&.JL? =F; .A/K99$T;V4$K//C#B@\Z^0-RUQ#8
M E&85]>3,MD04)X3VJ VAE9C>EW>WY>++\M2_-D$9M<[B;UGL<KC/).V(D*N
M(58J@XR;_21*<BUSF=)$$K^:3'W=71IW=7?KK<B@D?FJS4M0[R;0]ZW/U(OX
M:8^$L#B.S%'G0CB@8I,+,F?4;>IM?N+J32ZJ[M=P<GKKS$I.OQG>6E7-%6R]
M^>6_%<IPF+A[[ +!"$HYC:FQCIA6$$<9APS'&*I4(:$E53)W\EH:U/NED<VV
M>!'82-IX!WZ\_KMG]-VPT7"SE4;#>&0B.@_>X<6A?& *72[*J>^7*2#E \O1
MDE)>C0PCM,_J6SG_9G/8-+4OWW4E5M=G35P)G1K+2 EK'F4<09;G#,:2YRP2
MC">QU_EZ;V^71E@;8;LRJ^#=H/JS_0B[D5(PW$8FH:.0C7"RY(1)(,;I[VM2
MAG%2^SFCN+TT6D*J=391H9(D2CF&C&0VKS^E,->,0*$(XAAI1"3U<PES[_SR
M7+[6:5T/));R3N/J,0ANC#,.L"/3S_/D45?;[%'!L[OZ S1=;J@7R?KJ#\B
M[$_G98-==W1C1D*9AN3.'O%]7:^4G"FM=1+9TB.QEA!SDI@M&Z&0$DU2R127
MJ5>2O.-=79JYLY$4U.TI1MV>8A2-M$U:U_8WCF&1#F"[45$8"$>FGBUZ3\^
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MQYE(O@2?=")?@4YH\+V5&EBQ1^*7TS"-P3<]O;X<_YR&HI>/'%X_(TSW@+.
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M>5#T]:^>I#IP4'5*<LP3":,T5F8++ GD2&DH4Z:)2*B4RNNJ8,S1G'*%Z]0
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ML>'D&*5<"BF@2 4VNR+,(6580Z1C*G+&8J*]=D7[75P:VVPD!,) >NM[['0
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M\EG5*_/!V?.!;7%*[^-G![2=CYW#8CC^<?-6WC:;A)$86)%W?)ZMT%-E3?#
M+]S)LT.?4Y\XN\-PX*39XV5_)^BO%;.A(%\>[WDYG]%$Q@3;!&8811#G*H),
MR!2J2)$LISE"V,G+<:_E2V.:3CC02N?NV/P4KGX:.0N$T8\]G/3W<E8^J.L@
M]^2G+4WFD'Q0@5T7Y,,/#(T\>%?,U<=5>S"9B"Q7&L,HR@C$L<@@RR4SJS\7
M$F-).-9^X0;;QB]MZG5^\U9 T$KH&U>P ]SI&7@.'"-/0@\D!D0-[*M\1JC
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M1)BY&2R-S& O]- 2(P,&QO6X=1JX1S^%W14F.="C<NH?#\+X>0I#H!J\ILD
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M>E.).SJ!*,6APTFIQ1V EQ3C\>;0Q.EFFE9IV>U9PHVNVKS^JS F"4(989&
M,;$%'7%JLR S"764YAEC/,O\ OS.]C0WBZ0^2C.SH?%^6QE]3SO/HNIXIAD"
MJ[&/"+Q@&I =O0>"8$G2S_4S<:[T'G6/4Z;WO1"J^K3U(RKY19GO9K5EMVH1
M"1D)RF(89SHWFY4T@40A9/Z#-4I($@OL=8K0W^7<*&(O&=B:[W!C4]?;J7!;
M*C,JE7'^4*[_NTZ1P)LRRFN^;&.4S,+;G$)49P[V>59%WX&?'NJF?[ZT7/71
MJ+DQ3]BQ&)F"3A6JO@*UP& O\9@UJL^A,UJ!ZJ,.7[DZ]3D ^DM3GWWS0DNF
MB09C1&BE&<Q%JFP]3@(YBA1DF&+%=1HC$@TR7^89Z-5*-S ZZSEVGD;*[&*J
MG,$8;I6,$N/TO/'7L3^Z(Y-./S4TZ&BU62\+65_85IO-]SNV^H=92I=/-JFQ
M_/;(-X4L6/E4>U]WF8[;M(7OM38KK+%]WIH7;Y7UX.YKA8B(YGD:22AHC"&*
MDPPR@@3DN419K*3&+/,+8!I1VKG122,B*%;@JY)*W5=.QC-)/.OKG.=^Z1M+
M->8WX<9KLQGIL3=PAWI> :NIL6;9"M2Z@DI9L-?VJCD@ _O$[:W&5Z#1N7(B
MU5K79VXU X-12M),,E#!(M+&E'7BZ+8)8#^.E)NBTTLO*SPKN;SIKKF\J8\>
M=TOJ&V9FIU#?[I2REZRNI2SL8VRYK^.SV5.9L5ZS5 BSLJDTLY%\&A)!-12)
MUHRS#./,*S[W%728VZ)7WW^K%K/#HO5_:XO6?_,N6O\:'X:C[3[OX1[;;]#H
M#&JE#^]2'.H-]HJ/NHZ]XF $OYTQG0:O=+MC\B$Z?SMD>E&&)M$ZD//S>GM2
M0!N"8_-BW*S^419;]6[]YVK!"9>Q/=_.E<WY232#G,8YS(6,!5$LBB+FES9G
MJ"@^Y#5-)IWWC^7Z01EKG3]NBI4QB,Q2==<N51OOI6KP&"$1$863%-((11!1
MFD":I]+&BB942,S2%'L=!DPP0E-8$U5VGNT:E&:ZL:HNIVQ7G5NKFOV=9D4Y
MY-;!X,%R/ .88 @F7>'-5G2]/;.TFXVOT03\9'7Y&:S-[M>J Z71)V1FMLL0
M#9:Y;: 8$V=VNPRLX\QO%[8W-(^U4,4/:S7:O69;Z2M"5,41CV&5#@[%AC-Y
MHA*81B23BF(MD=>^[60O<^/" R$'Y'@[#:0;E5T,S\@\]0R9SS:S?K!*:4X0
M!$M@?:J/B?-7=ZAYG+ZZZV'_THGOUJ*JP_S_/;+23*CE4QT2NB HRHG09HZG
MMK0'50P2(1F,J(X515QEVND0HJ./N<WU5DRPD[.)4W8OE7@.S>XI'PBCL0T3
M;WB\2B/V #"H*N*Y-B<KB-BCU&$MQ+Y'!V]@3^RHS;;Y^0Y\E_R.RP0S(C!4
M$G.(!.'0UC^'6A+"B8ABS'WW1#[]SXX2SOC4K*?UA2MN<#Y#WR%RW@F-!?SX
M&Z"0F _9\0Q!+MQ&QZOWJ?<W0Z YL:T9U,PP"JP/1]H<@.TL8CQ7B32FC18D
M@8A3#GF>9%!@SC&1C$4D]B&ZD[W,C<X:\9J(33^:.@VC&QE=#,[(E-.F,FWQ
M&8-6.C$(1!ZG^YB4(CK5?$D$W0\/3/10$\KJ]I-B9D(UQZ%/-LBGV7_+-$:)
M( )RQ%*(,DHA9T) 335"FN0)3;T*%O;V.#<:^+1>W4+3T3U8MZ*#I94=+/>G
MQY[W_GM1=V.*H%B.S!H[64$E[-7N[/WI"NP%#G@IWQ6;4-?N>_N;]F*]J_I'
M5^>=7PQP2&AC+O2ZM,=8YQRV;2V[#*%4J$3 -".&AZ@Q1D@6I3#".<Z2A"89
M20:?/[G+,3=VLI)#(SJ\\"C08R0&'"Z-@^_$9TO/H.XZ:AJC/N&%<(YQL.0A
MQ>N=*_E#U7FL-* Y/YK<E-O%5QNX6-TBQ1@SCA6!4N0$&G,K-:0G$4Q)2I),
MQSE!N0OI/6MU;A1F8U6*S;809JK]5I^AUY<Z/"[D/H>MFZ$&@S$RWPS$P9E*
M3NK=10SFA0-2,/_:$\+SMB:9WB?%;R?KZ5\.LU"^EQ7X3]5-VRKSQ.9:_.NQ
M*)5<8)8QDN4(YHK%$#$AS;Y(9S#B/&4DI3+ARL<*Z>AK;M.TR1FQJ6Z![U-Q
M2/!387Y:B>YYF;4+:#<C(Q!\(T_L5LJV&F MZ!5H10UG)3C@$<@2Z.IITM7>
M0>67*[K+*V%JFE\+\7C_6!7_LO=B1;%=Z%3A.$Y2*.+8+.D)D9 )DD-"9$PE
M):E(O>ZK]7<Y-R+9E?-606J=G\#8C3S"(C<RAQS70/_I0%[0"'R>@"\NB'X>
MG9&*HY_H\%4+I9\'H*]H>L>;?C1S+_ZYL %L;ZM-QZU:B:<V-]G[95$5=ZH"
MOS<+HE.=T22!6NL((BXQ),8X@3CBB4@133%Q.IEV[G%N)+//GJ<:.8WE8@5U
M(QMWI+NY9A3\1J::*D[V0. KL >S%1I\&P5,V81U5!OI:4%]UO6\P77F<F^@
M:BHWKU7T'&5I5%&T>SN3,+2W6BU!^[\XS P<< ?GS9/7+9_*S8&XR#A3 J8B
MRB&*,8),VI.Z!)-$("43Y)7Z9!JQY[92/'?S@L_FT4&YX"8:=#?;=GY#.:FS
MWFD4O4WB:4$-9%9/)/2DIOFT _'2O)^X]X%Q7&M1['HYF>K\>2*7-GU"<\87
M*1TEBL901QI#)#&%!"7F;QH3EJA,2)EZ!7Q=),[<EHSOMO@$.-Q_GZI,8"T-
MSZBQRP;-;6F8;BA&IOSKF[<?#V[TGZOV<"9AT0AGM&&0#17==IDPTX;!!0'N
M*%XN3*O^+IIO:KNU#?ZZ_J'*5;6I7+XW)&\#Q<P*4:T<-_K:/,[N63-W!65Y
MED4(9C*)(>)9#JE6&4PDBV.5Q<;"=\K"/+#_N3%LJP(XU &T2E31[94:=MO<
M*.+NBQ@R/OUNGI%1'_OPV1_P?@8-@KR[3VCD$9C(0Q3RT_?R%%T 7X??:$BK
MDWF1+E#YT*=T23,7)L%]_Z_'8FO+!#^L5[: 0.4C2&7$TRRG9O4@!")CM$.6
M4 :10H1SK+G*Z:"<N*=ZF]O24<L(]D)>EMG_),!NEG8PV$;F?F_$AJ?3[4(B
M=';=DWV]3K+=+K7/YM[M?&D8;7Q@15G5!SV(+]M\53:RV]!76Q)<8!;E)()<
MTP2BG"FS]X\%1+%B).:$:NEUJ]6ET[F1R$X\/]9PPM>-/$*C-C*'6''KJL!7
M8"?E"'ML'U@"$8I3EY/RB@\(+^G%ZUW_V.5/QNBIBU^\91OUW33P;GW/BM5"
M"II@A<VV-K.)3+5.((UR;FR2F.%<*ZU3Y!K*?*Z3N;'(7DY@!05_U&)ZQ#2?
MA;.;1$*!-#)I>./C%>O<!\ %H<]GFYXL$KI/N</ Z-YGAR?"^5!L!%O^EV+E
M!_.3S8)I9#8?@D E"34[CRB"3/ <QHE -$,Y8=HI/KJCC[E-\EVFEUI.8 4%
ME:3^F7!>PMD]RP.!-/;)K#\^@U+AG$'@HE0X+]N</!7.&:5.I<(Y]ZB___HZ
MBZ+/ZZW:O#-6@GGS+DXB%#?6*V-I1F*-((TSF_,F3B$C3,"$(,(32G(4.\4O
M]W4TMVF>_1)%_P8J:8%\5*"2%\17P(KL[@'MQ+;?R1P*L9'G_"%8[UZ"-<!O
MW(F:NX,X%'H3>8([40SC\W5!I,.YV_GZ9%Y<%R4.W;5.SP\L_:ZVQL:Z^U*N
M?Q12R3=/OV^4_+C:7:J_%MOB1^T7;I/"9)HF1"L)29S9*#YD-D:IS"%/4LPU
M5>8/+V>MOPASH]J;+^^_7G__^/E7</WV^\>_?_S^\?TWSPKQ_L/@YI49%]R1
M6=G6Z;'2@U9\P)_ 3U8#8',B[S-T[+48);G/<!!#E:+W%V#:$O6# 3HJ73^\
MI0L/ICX5*_71_'6S((0I',4)%)(Q0W"1ADS%#$K#=9AG&O%TV&G4KHNY$=A!
M84(K(ZB$''H M0?2\]1I$#PC4Y G,L,/FHZ4#WVZM._@=8Z4CA0\>XYT_.2P
MJ?W;^D?5WL?5;\5J71;;IS9BZNMZN?RP+O]DI5Q$E.9YGB"H"$HAPBR"7"H&
M=<(S,^W-+S.OV>[4Z]P(($R11#? W5@A.(RC$\5:_-.6VS:C]>^@.:%V#NVT
M.H%&J8#LX@5B(,)QZW-2#O*"X24M^;WL[[SZJL22;3:%+D2U/5_K[^K^85VR
M\JG^BK;K75*S111)$5$I8)I',412Y9#I',%,()YG!"4JRQ<K=6MCO+^[^;1\
M^G>:;[2>;T=2C'KX_4P%&VE6[LYTQ?K^0:TV]6_,)%Q7H>],B-(FP?+.B>@]
M9OU.LN!#,%F-B"/8=X*W%&@ W\D^$L#N_K2Q@)[(OQ8.<"^?VQ#4.GQP7LU-
MYI,;HN2ACV[0^Q<&1;UYVOWU;X79()?B[NF3^F$PLC%_<<95&B<13!51$&5I
M# E&%(HD)YQPQJ5T"F#PZW9NENT^S@?LA*WK@E__?5"@I2/Z;E9N>$Q'YOQ+
MX!P>.^6$3NCHJ>Y.7R=^R@F(LQ%4;F\/)*5B56S5I^*'===MS2=CDQ/4&<!_
M+=>;S0*9_36-<@)9A@A$J4HAQU$*=21PG@LBD.!^-3/[NO29-M/4QJS$ F]9
M63Y5;NO[]6-'"NEA.#L23T#LQJ:<2E18R0KVPH(VK7\E;T#2<40F%-WT=3<M
MT3@J?T0QKN\-=-*KRF'RJUH9UEI6E];O38_V &!K^GS_E]W@J041F!"%8ZA2
MG$+$$@4I2@FD<2R3.,-YIF*/W;%?[S/=&S?"7]DJK[4SJJHM>ELK<U6MW>R9
M/D#5"GDZ_QS'R/%,(!SD4UU';&!N1*YP?2XT:*0.>'C@A5*H P6W3J<]9/ "
MXNC@P>]M/PJKBQ"(I\7;ZW<+C*-$,A7#V :D(9IAR'*A($MR'<4DR6+F=-9P
MV.C<-EQ&)#?B>(9,-RT,U7?D2?^6K9AD5^#=>KED90 ;Y)2>'?&@[>/UM&W_
MM9^RSYJ;9$*>4J"=;B=_-\P>>)X3K5";[_:$92$U5UC'&G)&,X@28:97K#.8
M"T$85@G.,/'Q>)SN9FX3[D6&OBH(IA+4T[%Q!E2W!?MRJ$:>JP-0\EZ/NT$(
MM/Z>Z632];9;T9?K:\_3_D=FSW)3=:>F>E<RO=T88^Q:"+O9WGQA3[;WMEHW
M-P3.4B&A4(I E',!:9J;%9DEDD0\1QHYK<AAQ9H;Q=3BUGN%1F#P4$OL?J83
M<-3ZC]1>9RQ&YK"7!7[VN:1.U_4QELE^X%KM0*->?T7W,4?0_<SN=49RHA.]
MB4?4Z]@O// =AX(!.YOLR# \0(<'BB.T'J+DYM?B]FY[HW_?U.Z]A<9FW\JR
M#'**A4VWF$*64@I%EB4ICI6.\07E-E_T-K=U<1^!7A?8+*VX<*WAH_G'D#*\
MW5B[F>+!$!QY-3LJL/FU1<\(6WOWQZJN>0:442IKONSK%:MJGE&[NZ+FN9?\
MS?8JY^CG]:JAI4_[R*OF8AR648QH1F"2)QHBE6:04)M\(<=894HPF3B5S'3I
M;'944D6EK=8KV)0M'1:9UHMQO^D<$KFQ*:0"S<@*V]K>!](.N+;9BYZ[V1H2
MQ8F,T4XTP]B4KJAT6(J]34QF_[DJ<VC5.;\S]#;36OSSZ[[6W;M'&P+[197%
M6E9Q'PN.*<]4)"'.&((()Q1R)0WE9K$QV!1*HIP..2/MZWBFQZ-[D6TPI3@H
M&>A[^ZD/>"DDR>(\@CEF!*)8VL4M%U"B+")2<T*55SWH,(A/><FL*EQW6(DQ
M-,2.9\LA@1O[6+DJ7GD@+*BE!;6X5W4H7LCK:([8!+N=UM??Q)?5'-4_OKOF
M^N+ Z@C[U/W5"O(L<7]=WZ$MA&"/P+*4P)A*;F@F%9"1.(%$IBPS?$.HP'YA
M=LY]^\R;:>+M1JAXX#P0;F0T"K@CDU)5Q^#EU;8OK+(81RA2X(M0J'H$SOU.
M6WK %XZC*@/>#0PM+?O\0L0'HXJM<-!8OC4WOE%Z7:KO[*_G=0[JCVFA\BS)
M8YQ#+!"%*)$QY 0IF*<1TRHG(M72K_3LI2+-S:8Z=2/HEA6K#;!?#K SU;=8
M[<6CYD9\TX[%R(QX- P[]'=G,CN+C5<Z :/4U1D2#5D3-Q3(P6KF7BS0Q#5U
M0P%X7',W6,LACG7:\%R,N: X3V 6\Q2B"$E(<Q[#G!#*$R5E&GF%4)WL96XL
M:EU>PN896K\XSU$]$;L>P XYNYE?F//1F4WPF.9.!$8YH'F5B.5.-;L/9"Z+
M1S[,P/F]9,;JL^QCMJ[K<KN0@F6<&EL+2R$@2B6QN5 2J!6+$YI%>82<?%1=
MG<QM\N_2O>X%!;6D_NEPCP#MGO6A8!IYT@] :%!"W',07)01]ZC1R5/BGE/K
M5$[<L\_Z3_)/!O/EE[OU2M4EHQ><\2B)%88LRLW2GA($.9,)3(3U0R=<$>94
M??E4XW.;U)5\H!*PJ5?N/IF/@.N?Q)? ,?+D]4#":]*>4WG09#UJ;+))>DZ-
MP\EY]ID+#>_:V6)]D(N4JRR3/(,QC1*(%%60I(I"FF"1<Q)+%<G%UE9Q]32[
M]WUX3=%=3U.8DD4EXT C^P!$@2.I*==FVQ*9_\2"&!"-'1.E*LXXHHF*\D%[
MEX$@3E;8=[]M>2C7NMB"GY9&UI\O1]1STS(,I\FV++5XX*=/G> ,W[$<JQ]Z
MOW+0P^OL5HY5/+M7.?'H,+XT#95VW_-.U7]^7'U<_3"VTKHLE)GT'.<DBR3D
M9O*;F9\)2#*IH%)1%"<Q3O,8M?$,;M.^L[\!80PC4\"!<'X3OAM7MZE_.5;3
MD$ K)_BIE?1GL^P %^R\^< )DT#,T-W7I!SAI/9+MG![:6AJ^S^;>'A[%%^N
M5^:OHBX?]F6]+,13_=_OZJ_M&Z/(/Q<T2K',4@8Y910B;!-F,8S,5BGG BL<
M"^X5RNXKP-R,BZ]*&%F73^!:KA_L$?I>&_!<'=]D]YX#X\9%8\(],CT9T<^#
M>P5JP<$?S9]6 U"I$#3'_3#T@F6X]^Q^XOSVP\ YSFX_L)V!U^1W==1L;NW'
MNA0PL56/XA1#+6T*66(VG5PH!F6:F?\ADLK<:Y=TJI.Y,=E!W;Y:R$&9_T["
MZ<9-EX(TMI/(%Q__J_$= (2Z&'^JBVFOQ7<H>70IONO9H1$WFVWY*+95[*'Y
MARI_J,JAO*SZN5[5 3_7\K\?-UM+.@O!5!8CFD"IM32;)V8LGCC/C-F3<")R
M;'[BY!(>+,'<B*(2SS=BQA=U-\H8%<N1^>29[* 1_@H<B%]=8*Y#,O<:A Q\
M&0A>L#@7W_XG#FL9",]Q%,O0AH9:-"MUH]^62A;;#TQ4V92;B)DWZ[)<_VG$
M>,O,5VGS@L<XQE%B3!M.["7"Q-@\)!<2QGF>,<U3%$=.M5V'=#XW8OO=>N/N
MBZW=QG%F?B4\'>Y>R+L:1>/@.;JQM*HN"]6"@U;R?:3?3GC02A_2CO+'+)A]
MY='UQ':7/RC']MB -H:1V#^4O5*MY/4/5;+;YE#Q7;%\-#^K+TG=/&XW6[-"
MVH)G.^K<%V!,\IPD&$$NL3([.*H@RR6!A$>9CEB6,,Q\>.U">>9&=>^U5F)K
M9ZBT.MA['AM;#*2Z9?F??JQWZ5"Y$>&$ S R-[::@$:5)N3 #D9S_>] DRO0
MZ'AU8 ..4L Q$,"!B/12:2;EUD#0O:3;4,WZ9Z&HRLS=Z'^PS9UI>EL9J=\>
MN2Q^%!MCLNYR46!C-0JS-4YXGMA@ D.W,2<0XSB*A<J)DDZ' >Y=SHU'*ZGM
MS-W+7>W:#B5W3ZW@"'LW88X#YLB<Z(+C@%P5CH"Z9ZP(#^Q$>2LN^E"]TE?X
M0=21Q,*QH<E26?@I=IC0PO/-81;SK^NU_+-8+A=1K!%3>0P3%2.(,FJV])PC
MB".>"A0G68R\')9MPW/CWE8N/VMU!U."%6$\,4N6H-:O&Z>0JI1!2D2$$HUR
MGN'%0W7%R(Q?N1T/K)>=C ?9&W5;K%9VUSW(O['#CB<L03E+86R+VB.%#6Q4
M*TB$)@1%D;2?6*W6^Y5C2-%PY-HN1MPN52;6A:"Y[7.&P##RXMP[T;SW&B^5
M#+1IV#4[J?7_4IF79OS1[_WM\>?9H9_JG<"-?EMMUS\42R5O5F_4'5OJ&[V(
M=,PXCC,8V<)VB$44<L0(Y!@10DF<*>5T(]RWX[FM#U4V<[$7'JQV^VQ1)S_3
M5@%@+"%>J6!^XVY:>@U)O\4^%M!C^WF?9XQ_.O!EU**#2G9PLP*U].!F+(S=
MC?BQL)[(E ^*N9=I/P2X#@/?J[G)S/PA2AX:^X/>'WA+ILI-<BX/HR8RER3&
M$.$\L]Z9#)*$:Q@3G*4\YGD68Z^K'EV]S8W\FTQ&'CD:!R#L9M$%PVUD+C\+
MV0@)BYPP"74SI+.O:>^(N*A]=%O$Z:51*X0<=-L(TLP 01"7E!,H.3*V9B8$
M9$I+:.N%F"VT3$B>CE :Y)P\<V.APTETIY82Z'4)C(KC5 0Y.TK]YN?$V(_,
M9/X5(PZ4VL<H^/N;0PS6*%4_0@S:;,M]G!J\R<M[]"$<IJ['V5[F6-"C#Y*!
ME3QZFQUF3'^WEZL>RZ<J36E]O+H024IH1A1D1 J(F""02K.\Y2E),RX5SU3F
M8T*?Z&-N2U8K8IW@^0ILZI"$GXI5\U?/*].G8'6SFR\$:^0U9H?3MQJG6L!P
M%G*']H'LXE,]3&H-=ZCXT@;N>C1\%OCF,T4)BG)-4BAQILWLQQ1RF2BSGV8L
M3U(692(+G ;>XS.?4Q[XX?3@, PDCF@J<@$)C8G98T0YI#G-S >-4$HS'E$2
MATH*/T].KJ0Z2 I_ 1T[X.W&SF%1')FL>U/$AV9O=W0F2!+_&MSN#H!/FOB+
MF+^*Q%#;K?G5[:_K'ZI<5;N9Y7MC8!XX]7+.C<(H@YSD"*(HD9!P1:&0#%%%
M(QSG3C<BW+J;'=4T$H-#D4$KLT?D53_0_5Z)L/"-S3&=R T)7NN'T"-P+2B4
M4P6M#?L8_<+5G('I"E7K;V2Z,#5GA9Z%J+F_-; ZQRX^>?-]_55918JE^JRV
M^QQ(W]=OV>;N2[G^44@EWSS];MC_XVJ7+.E:;(L?E4"[JP.*,<YL3<U(<K,_
MIZF"),$Y5$+0F,7$V(W(QS0<0\BY,?R!CC:=>MEJ:?^Q4EM0)7E^M#:2L3'W
M6=/83C'/ZR&C#+R;C?K:PSGRBO-B)'<* J/A\T1N]M=63] J"O@3^.GW>I!_
M!OOT;WM]1[EC,N: A"II,H:(TU8_&1'DHT(I8_9U61ST]<ITLS7SI>#+NBSK
MQKJ3E^O-8ZGV>9-PID2:9!)23!.()(X@97D.B4CS7&E,.?5*]>+7_=P6AU;Z
MZF[ 7OZZTO#FRC++L.A7Q]%PX_7Q,!Z9L;OA!7OAP1^C)+ :!ES@Z%S'SE\E
MAM</F'.1OIZM^+LQKF,<19_76[5Y]Z@,T+C9#R(:"T)1#G$L;>BOT)#F*H5I
ME+!8)L8<SIS(K*./N3%6_(L1\]] )2@PD@(KJOLF^QR2_<Z) /B,S#8GH1G@
MB#B'D;OW(0!6$[D<_#XG+T]##P@=[H5S;T[F4^@1_="1T/?HX/S&QIS\SOYJ
M"KN\42NEB^V")(0F&4*0Z2B'*,84$D00S)(LH82E,<NH=V;C4ST-.)(;F?B:
M#=Z6_36L!-,Y2'F>,JQ3!C5.C4&<8VUL82*ABFA&$DZ21'H5%+P$T G7D6,X
MP4^\%O5G4*JZ/JK91C?Q*':SO&XC4OR32I]$WLWX#8#GR.M. Z41L2U]!7YJ
MI R84KX'AW#)HT_V,G7:Z"Y53R2,[GS<CX(WY7;Q3=W:M?=7M;XMV<-=(=CR
MW?J>%:M%R@A5AN4AU\P0<"X-%3/&(1,I5;GDN<Z<#N<[>YD;5QQ*"/ZH972T
MI[K1[&: 8!B-O<OU@L=YXCNIWS7M30,'4][\:S_=N]N>9+([J==.=;>'A]E:
M[Y1696F== V-' 1<?E;;A50<:T0Q3&*;]47G&:2QU% +0D1"I<I3IP)XCOW-
M;?)_6J]NH>GH'LA&\,IH6 Z]8M0'MYM5$!#$D=FAE10<F G/(KB[?(S>5H(C
M+H&LA;[>)K4:'%5_:3VXOC:,7+Z43?-5F,\75MZ45784^7>V?%1?5%F%^"R2
M7'.AE8!*<V;V=3&!#!-L=B*&:DC,5<2]O/)NW<Z-:G92M\'8#ZP$/ZS$50"@
M7"^7K-P LPVI@P$]8P$=Q\*-@,(C/#(/[<%M(KB-S.93!K74H!+;Q@?6L8'A
M&,D/J$#$Y-CII/SD!\1+FO)\^Q*W4]7NLY25/#/T))B"61IQB"05D&"=&'K*
M(YS$),FE%SV=Z6=N?-2LV#LY76($O'#U\8!<A-8T'A OH 8Z0,["$-0!<MS+
M*SA SJIZV@%R_O&A^Z*R^,%LKMR/*YO1O8IZ^-7LMVR4PYNGOREY6R5XK].Z
M;^Z*AZKXB:9*2QS9:GM,0L00@TRE&B8B2C-.>*(SS^W2$#'F1B6-F.!0SD$%
M9P:.BNNN:FRL1R:B(3 /V&-=@E*PK=<@(2;>D5T"U/%&[:+6AH;QRJKT.EM^
M8879([YE#\66+9L381Y+E5 MH-V_0<0SLV.3402QQHQ)E&..M%\\;D=O<Z.T
MO;# 2@O-#JV1US=@M@MB-^(*!MS(_'0>LQ&2SCB!$BR,M*NOB>-!'=0^#NQT
M>6D8A[RITVA^NU-J:^O&VWZ: Q":8\ER1B!EBD*4< DIBA/(M4XU1XSFE/@0
MR/FNYL8>C:2@$A6TLGJ>+CD@[,8?87 ;F3R&0N9-'/UH!&*-CHXFI8Q^A5_R
MA<,;?F0A5;%XU\1\?2@VPA!1=07T@_G99D%YSF1$$8P8B2"2*89,$P0Y%EAP
M&65IXG1)L[.7N5%$*RBH)6TN+X-*5C=^Z :UFQJ"037V^=(0E)PIP0F%$VRP
M4>*7V_6/_S#OUT1@_K*?_]VM3C+UG11K9[W;P\.L@_>LM!G*-ZT+]PW;%&+G
M(609SB.4<9@EJ=EAQ%2:'4:B8,92AF64Y''B=>.OL[>Y$4 EG)\ET(VFFS$0
M#*.19WXKY_[4Y@I4LH[B?G5")9!=T-W7I*:!D]HOK0.WEX;QQ=OU9GNC[=6+
MC2VKH<H?A5";;^NE7,0L2K)<::BR6$"D)84DT3F4,<YL7G2:I)%?=/#YSISF
MP:0!PE96FZC'YIOTC$GIP-2-,B[$:1J^: &JQ*RKX32" BMI.*KH1R,03W1T
M-"E)]"O\DB$<WA@:<+(62LG-!R/D-S,3;O3[?ST6VZ??U/9N+3^N?JCF_NI"
M9BE+-$Z@E!A!Q#F%7"48$D0S)D@:4^V4R]:[Y[F9&:W@P YL11]VEJA*^(,R
MD;[!)J[CX,8PHZ [,N$\!_9; VPM-Z@%!P>2AXPY\00K6-B):[\31YYXPG$<
M?.+;P. :C#?_7+*[]3T[7;DN93(FG,8PX9I"E*(,D@BG4,<T34F<:LR<:GVY
M=C@WJMJ5M6NEOKSZ8C?@W>0T!HPC<U(_@L/K+G9#Z5UU,1BD4]=<]/\XAU1<
M=(*GO]YB=S-35UMT4NI$K46W]RX-!/I4K-3'K;K?+)# .,(JA3B.;))2::-\
MF-EJ(I+%.!>(42>'=$<?<^/>O8C@#RLDJ*0<'+ZSQ]+- +P0H;&]T)[@7!!T
M<Z1^\(B:?0^O%"YSI.+Y6)CC1_U-K\]&OO5J:V0U#]Q^7)G99 RZS9?'[5=;
MD?O]7ZH4Q49]*<T>=9%D.A<I5Y!'+()(<PD9Q1',"":1DIDFTND&I&_'<Z,#
M(R0HK92@5%+=/U1GL0]6TOT%A>K:@GHLU_Z7%KS'I=]2&POMD:GEN=A@)_<5
ML$-0B7X%6N%!)?U($+M;<&-!/9$E%Q)R+]-N"&X=)IY7<Y.9>D.4/#3Y!KT_
MS/3[A[(M*GG]0Y7L5K7%_=X5RT?STSH]]<WC=K-E5<7@A>9:<*4DI"K)("(V
M/TF:8\B3&*DDRBG1S,<L].Q_;FM$(V>U##QNY.";:[[#$(E,,!VG-BV!6:,3
MDD-&4@X54B1)-(TX,VOT>LN6KS\,.RFF&89!501\\7>SZ$=$=>0EN94<-*(?
ME&2MQ08'<E^!1J-PFX&!R 7:*/CV/NDF8B T+S<80YL9MLR\K"'+MH^E:@(X
M%9&,9"RUE;TME]EC*D8)3%/-(AQEG"JONX<=?<UM^7A9^?@*U-(.C)+M0MF-
ML0)A-S([#8?-FX@<  E$.ET]34HP#BJ_)!.75RYU37Y@15E=A38D=> <J5,Y
M/-G*=IJ(3,$\YH9*4"PAYX+#7".EDAREQ"UODV_'<Z,4*VV34L$LUG(G\-4N
MH<O34(=FSPCX>CG#X3J=ZW,GWI4]]OAO);8VA=YO;&.&UN9YJ7/.EZ5YO;JI
M>P6XTFO#3#=:;\*F@?&#,;@+M:?;5_*KNH%QWMGJ^'X((ZA0F_T)02IUEB;4
M;*9U9DO;<PZIB&/(%):1$H+CU"M'Y?FNYL97+];RJE##X,.7#H2'V#]#<9O6
M_'&&[$+CYQ0:H]@^SSIZ1=/GE,+=EL_)-T8M9-^7;"WA*M,IC6&J*#>;*R8@
MBQ($HUQE<8RU0!2/4,_^_Z<I\ (/7O^)S^L,R=CVEG?!](M2\(TY@NX'2J\S
MDA,=-TT\HEXG4N&![SBO"MC99*=9X0$Z/.L:H?5AUGGK 7V[?EQM2]/DQ]4_
M[@IQ5Q4-?*J%4)M%DNH\2T4"$VQ6521B"BF1&B*%4TU2Q:/,*4#5K]NY+9C[
MXP#1RFVKZ_UI)0>J$AULZG2^359YW_!ZQ^%P,^O#@SQV2,0.W[?'^-92@YL^
M7+WM?3^8 MG^CIU.N@_P ^+EGL#S[:&W!&VU^BI79.6P6&"5<((Q@EQR A'.
MD2T=RB&6POQ=<"&(%S&][&!N%%3+UR:2_;^C7Z)XGT[V"I H:HZ" 7O<WJW+
MXG^,-6'CE9,\;_[$[1/%9F/M#[8%_^O1[*/3Z,J6R4FJQWXS0W,'TKC^T14P
MSS\H6^-/+3T]J4=#YD9>EPS$R#35C$&3;_;O-?(?*S!#7C8\K7^P*X8OFI_X
M8N%IY8ZO$YYYSM^[\'9=/JPM!>U*5C9E-<S7?K.]4V5M7]GM2TZ0UAG34 AL
M3)P,)]#FJH92IEJC1*2$[JH1?7=S(KCW[O2=/[^ _'T2WFD4, MR79&V*:^S
M^?G*UAMVWV=Z#$2_)R PKE/Q1XOEOF)O6V''<F\E>+,%]-S$>X#KODD?!^2)
M-N'AP/;:7_MCUK%_]FALLOVQOX*'^]\!;P],="F$6E:F9QW=\U4]F"_KCAGB
M^L[X4BT2R:D04095G%"(<EM".-;(7A=G1,5899E?[?F>#N=F4![(6P>Y@0.)
MP1^5S)[G4;V8NUF (9$<F=$O ]$_ Z8C,J&28/9U-VT>3$?ECU)ANKYW28T!
M>S!F;Y.?].19=]V-_L[^^J+*PXC#!4VXH(1G,$^R!*(T8I")!$$9Y5'.I>0B
MB1<_5,G7?I4(!DGC,ZT.91K5C[[WEN^K-5X<?G[)D.5,)UG*,=215A"9/0&D
MPNP1DD0D,B8R$I3[EXX8?<"FN1TPO^%R6W$F&H21%Z/F[.@GJ\?/=8Z2T^=-
M=;*DW2G56I][KK*+[>^-WE=56K;VZD'@HCH!!B!HO8QADKQ"38V+(#M==^.R
M)H?&O?+M/@O^9_.1-W'<6N4BQ9+"*&8"(BEM/B=%8)KD&),T)2+WO)=_NJ/9
M<:F1$^P%M2'?]T/CY,^"ZT:.(2 ;.X1B&%H#PE"[H0@6=GJFFXG#3+N5/0XK
M[7G>WW?[FY*V+.JWQ_*V^G-M",>24%,ZM4E$@W/"8QDCF+/8F&01RB%GL88R
M%22B,14H<@[Z<NIQ;F31" U;J<%.;'<'HAO4_8[9X ".3!WGL0.-R /R)[F!
MZ>Z(#0[J1#[8$.!Z>5^]@.IPO+JU,YG/U4NM0W>KWXO#C^:+.EW>]4H^BP[^
MLEX6XNF[^FO[QJCRST7*&,$2YS#)T]Q8<T)"+A&%*<988)4D<>1U:\F]Z[E1
M]H'DU6;LF>S^Y^R.^+N?P(='=8*S^;. FKUK)3CXH_G3:@ J%0):A_ZX!3S3
M=^QX\M-^/T!.Q0%XMC",Q+Z).R4?;2;0MVQS]V&Y_M/67[.Q3#9$TP9A7@NS
M9#XNK1NY.J@RHCV4ZDZM-E4%MW;G7+F4]S-.4(131#5D/,$0)1F!3(H$9@E6
MJ50IY\+KIM-(<LZ-'ELUJY! HRBPFH):5=#J:D,$#[1M3G2?Z0N>^<3\>'6L
M3\*-A&<PT",S]CACW!RZC</P(P]*H.5@+"DG73M&AOKE0C-V=\-6I5V01&.O
MMZEW$<L8%CF'G-M\2)F4D.4\A3C#.D]CC%'L%?QZII^YK0K[0)Y63C]&/P>G
M&R,' &ED1CW&9X0JG#TP!.*P<[U,RD$]JK[DD+['!^>0OS;_9N?2<,<HYT*P
M#"8\X1!%.($48P)5FN69HA)GS"F?D&-_<^.$79+N1NC+$\AWHMWO  V,X=A&
M6!]\P[/'=^+HG3P^%)Y3YX[W_BR'I(YW :<_<WQG*U,GCG=1Z43>>*?7!D>4
MM@;@.Z6+E9)OU,K\9?O%C/SF6O[W8UTTY+/:ME7<=Q<\OZQ+^[U=;[=EP1^W
ME8VX/IWWM)D@FJ<9BG(&XR27$&%-(<]3#N-,B"CG&4*8>H:G3B?]W!:)WU>E
M8LOJ2I15;E/O%979+>XCP:T]OUY51I.9M@TXH$+G, S&.R)VPF_&S8Z=[9<P
M\E)WZ$9H%'\^S&"O>SWB5OW6K;"_P]]@  Y!L&FQSB29'L$$?Y41#!=3/*'L
M4P<H3S\L)Z*=7T&(H;7]FA0'U46_.@GK]>[VZ@(K% N=2H@Y(C;V*X(D$1CF
MJ99:Z9CEF=<2V-W=W-:LG;3MG=_CZ[V#\S_W .^VCH2#<V3BWR/9W-QM<CKO
MA0U9J<\%E&#E^3H[F[@FGXOBQX7XG-ZZ]$S/D-V^J%_KV!UV>I,3$B=,YE H
M;>QRQABDF110:L0PQ8@@[A7_/X:0<Z.RPY,>:U?MU6R/>Z8ZR0OX(?@>X[W.
M\$YXAA=F9"<ZOPL_&L$/[P**^$HG=^%!/G]L-T)?0Z\RB%*QC6G>>AW$^G9E
ME[+O[*_&#M]\W'PUOU^O3*=/7TSOA;T9&T>*Y4132"6)(,J9@H0+ 55.THQI
M):@F?O<<!D@QMW6CE0O(1AO+)H\'^E1I*WFC$9"/I=UXFX$&*\L>VS_5TM#+
MO=F]W'F>% X;1+<E8?2A&9GSWQT,QJ$&5=+"5@=0;,!>"]"J$?(JQ@4H!KNG
M,42&B2]Q7 #3\0V/2QH;&%W,-G?V_[9 ]P^VM/[9KX;ERT(84K>_N%[)YS\X
M>'*1<*I01@G$,<:&5G,.2<8EI"E#,F69,=:3Q8,JB[79@;!RZT:N%\GD,Y-?
M2C9B^*P1\@H(&X:E]K)>5?[Q<J=*_0#;&LZ]+58KR[;&\*NE] Q:OFA88QW)
M7.L41FDN($(B@52935@6YQ'""4,D:X?U_4K.<E!;N68SI,K\^%4&TVW5G&QX
M1EX]ZU&IXAW?'X[*7G90/V*'Z<4/#]\(&+8> ME0D>P7R3)M<'L(V([BW8,T
MZA]H]+U\5']3;+F]>WM7E.N'DHEM(<P.Z1>U9<M??OSRF_C?:F-6]C9_4[%>
MV=^T,4A$2)4)##-*-42<44B0SJ&42:HP8QA3YQK*EXDRMRV,U0;4ZH!#?:S3
MXY<KH+; Z 1^_ ):K<"!6LWOW2-O+AS&;B:>=G!&IN$0XS(@-.K" 7*/FIIN
MH"8*J)IFP+R"K\)@W!&7=6$'DX5LA0'B,)HK4(O^"^%UGN%WBIOO^=%\O>\>
M594/.39#D[=K7:P0PWD&1<841#3&D'.<PTPS%448Q7'N5!+:J;>Y+6?Y+QG^
M-[ 7&4@S*^N4T77&Z-R="_NA[E^/@@(X\I)SA-V[E]@-6%#Z071?,X*".=&R
MT ]J&*YWQJ:#SOO;F(RQG=4Y)&7WEP;>=NHXHOFP+E5QNWK[6):VY.KWDJTV
M=DU8K\R.J/K7LOK2G@4X58FJ%HG,>2PB#:.J4H#.[ 4)@:#YH$2DI!*":K\D
MB^,(ZC.[ILF_V.@"1*,,V.[E!VRG@.\MK'&&V<V-]/I#-_(JTWO ?@7:86T5
M!0>:5FZG UV/8F)[HJ#]KY.-.B"A;J.-(^2TE]E&!?KH+MRXO?D;]J?#6-L3
M+2/2^[]4*8J-NM%?'K=?B]N[[4+D&:(Y5U!($4%D;'U(4HUAFFN1:R((1<Y7
MZP;T/S?C__#@=_4\V+UH]'$W7(>,1VY1YRB".1<,(I*:13P1"12YPB3F4A'-
M/.MSC#4LTQ?J: 6MKJ\864$E[+@#TK]!&_FS'WDQ/7.EP]9K;*:"7I>@56%"
MX-TW=2,/P$3;O#$&PFO_=P&,'3O"(:U.MD>\0.7#7>,ES?@O\\\+5#_5M>G6
MNKH=NEEHCA*B.8=*V&Q,<9I )M,8YBC.8B',1I9EK@MZ9T]S6[KW!18WE7S[
MZHK"]+&U00#V:DFIP(-:V:M [O35C7C_"A$,QY'7@A=EZ)_,=F@':BUL*,S<
MR3T8=A/1^ 48>K&U$RX=O-S]_F0,[*3&(=>ZO3"@AI[9S*W_J=3GZOMH',O4
M[(<2@C5,H]@F'I$,$A3E,)*",!EKD@NGD.5S'<R-0UL902VD1VVV4^CU$^.E
MF(S,AR_@&'!V<1(7C^IT%^(S51TZQ\_&K\I<A^Y=]>1.O39=Y;@.H9_5B.MZ
M;MC1PJ<U6VV^L"=[T:/YT%0N$T5Y#HE"AKZ8C0JF.(-)K%+*,\I3G?D="QQW
M,C^7_N>UM?X>:B']_/8G,,2:4AX)"47,$H@2 Q_/50IQJM)$1ZG"D?"YM7(9
M@I/$<ZGR'E@Q+\;.[;SB,D1&-XEMUHQ&NA'R7)Q7/I!?_T0'D_KDSROXTI_>
M\>0P1JSNR[4>>9>,#PL>,2HTT5!)$D-$-(%<QPJJ*(\1)0S3+/;PO@X69*;^
M5WLXUI1(9B\RPYQQEGN>F_J/F* \P0E1,"?V4J&().3$+':IHK'0&L6(1WY+
MW#B#->T*.+]Q<EL*1L5^;$=Z=3?\\)JW8_:D<(O)8/@"K37^_4^Z% V&Y^5*
M-;RAX.5'; 6[Y7KS6!ZD;3"D1Y'-FJP91<9D1<28_2J'*(KR+.)28^255,BO
M^[F9LV>K9FS!IX+Q8EEL0]8C.34@;N0W'LQCNTFZZI* O>S@CZEKDG3@-GY=
MDE.=SZ4V20<P'O5)NEH9Z,38S\@Z=F9[S3=;&QJ_0#2)F18:1@A)B&C*($LD
M@;F*DUPG+*'2J[#2^:YFQV"U>& YE*XZ4'7<H@?!:NRM^E[(*]!B]D<K:,@]
M>R\:H?;NYSN:=@_?J_#17K[_C>&FT'IUD$KMXV;SJ.0B(\;$B1"#.E$)1"CF
MD JD8,PRGE'*)&9>R67.]#,[:JC$?)$^L:A$'9XZ\1S&[F;,A<A-8*\8T)YE
M2KP"M9AAS9(.' +:'Z=ZF=S0Z%#UE$71]?C%IL.-;@N__UJN'Q]VR5]/EOMN
M^&F!,$$89P@J)HQ]D>0*4IP1J+.$,ZER3+2?H_\R>>;&- ?J@#NUE%4TFM'(
M]X3EPE'RME?&QGYDKFJ%!Y7T5P<YN@\5 #L-KL I,V@4V^<29,,;2(.D>2TK
MZA+H.DRMBYH=FM]Z+922FP]&W7>%34Y8V*MS-_K-XZ98*5N!P.P:6S^8S5>H
MM9&V"@+#6G"9B@PF&B>V5&X&.4DHI(G"@B,E!/$J\76!+'-CVU858#^CBF:K
MF'>^4Z1RM!2[;)!FJJ^48T!VB*%SH^&)!F1D"GX^%@=Z5$4TGH_(3I<J*>Q.
MFY#)MR^&-%AF[N&23)RV^V+(CG-Z7]ZD?XBB#[FO5YM"-O]X_]>#LKF4%EP)
MRC&34&I[N2C!%/+4_(>D*=%82T:Y<@UGO%28N3&NT6.S 0^FN3M[U^*A+(2C
M:1MD:+H)=6K 9V?4/M/H"K0Z33A [D&;4P[41 &>XP^85VAH*(0[PD@O[F*R
MD--08!R&IP9K<]BFXJO:%J6RW[6MZ//=-/)N?<^*U4(0EB2<QY *E4*41<)L
M%N(4TD@3I;!*L%]EBG,=S6UQVLM9E?$"5E+P1RVK8S1Z+[9N)GT(Q$9>78:!
MY6V)]R$1R,P^V\VD-G2?LB\-Y-[G_:W?RII>L>7RZ9WZH9;K!R6_K?7V3U:V
MX<8TY6F<1#DTAFU:^Q.H/3!.5400XDI+XN3!=>IM;A2Q%QC(5F*P:41VMY/Z
M4>ZW5(-B-S)9=,(VX,)//W[NAF10'">R%(=]AE[6GS,L'>9=?QN3V6_.ZAP:
M:.XO#2])\&&Y_M-6F3&67TNP"59YFJ>0"RPA(A)!@BF!!!'!&"4RDGZ'[*=Z
MF1NQ5EG)K92@$=,_<?PQDAKK**8J@5*0#")$"&3(+%HII2++TC3-:>X7MGXQ
MEM.$IK]39?'#<- /FUA3;8K;554SBVWJ)/W:XGQ7E3;ZSQ X.X8L7(K=V $+
M+S_!$2XB=6(0,/7]<1^3I[0_J^:I5/7G'Q[&K!]84?Z=+1_5]6:CJI#*@P.\
MWQ2ST93R9O55V8R$IE/SP.>U+453__,-VQ2;3\5*?=RJ^\U":R)0A'*8T3BR
M)J_9&L>1^0]B<91$-N^C5ZAW4.GFQN16.5!I=P5J_:HSF\/(AE9%L%Z!G9+5
M4X=J@DI/\(?5%%2J>F["PWX$;B3W:D,[,CF^RJAZT^LHZ >BY;"R34KGH\#Z
M<AD8IQ._Y4.J8G%M]F_2[N$^+-GM@F@:<<*-"<D9@2AF#)*JL")%N>0XE9E"
M+M1_U/+<:'LG'+#2N1'M,5S=)'D1"",3G*/^SI1T5M<3=+)1XI?;]8__,._4
M3&+^LB>0XY8FF?QG%6@G[OD'!E\DMZ;@EW+]HY!*OGGZ?:/DQU5=C-5.>&$V
M-!4;+#1+N4XR!>-4*3LK<TBSR&SQXH2H+*(QH\8@6V_9TLT@<^_::]KN!!CO
ML[7W8:L]W4,C.^!/X*='(SXH5C\WL4O5.KQ3P?L2LNNHN%E(XV ],CM8F*O]
MX9=#F']O8=X)#Z[[81YRX=@3L7 WC5T[GOJ*L2<@)^X6^[9PX4;TN<=$I9$F
MA,10"!L&S^PU.Q9GD*5I;NP+8W-@I]HOW=W,S<;8;R*&>?G.@.FY,YNK_^D8
MG1$<4-THA-[JO*(+JEO1LYN/H$ZH8E5LU:?BAZ66K1EJ6\6XWMU\5?:<UA+-
M_;K<%O]3G1=]J2JFQ@L6*TZQCF 42PH1R2)(B,IAPI,TSI%,/9-A#91C;NSQ
M#V53^BH)P?4/5;);!7;2@T/Q02T_^.F_%"M];^4-'3-'#AI_),8FJ4H#6*D
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MJ^3ZSU6\B%/))<\0%+F,(9)V@N=:0I$)%6,2R2AG;0S/=[=]R6!A!D3Y?)^
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MG\[Y7$[Y[(M>FL7RR3DDW,[5[M>+NM3ZQC^AROV^NY&6A<&\H!1@02A )H-
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M-_AQ\DA<[FZ,N22\0>J83\*__8Z>H76YX(,BP;>K3:!IG<@\(P51$!N0Y40
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MYC#G!1=9D08EWKE*FM%13.-8>J-.TEJ[PF5_K)1**JVNO1GH,J*A-P4]C].
M-P?]#-$5MPE70!O]=J&++*]TVW %;.=O'ZYIM*N[;M,5N&&P941#0QE0UD!S
M-<$%8#AW13"%U!JE>2:#+EK/]#,V,CUPN;_"7#L'K!_S18"K[X/X+DAU\,5M
MQ2&:%^[I7@;VOVU5]=CSMOWQ:[)B/O ?C8WC[MN54" D,0*0\-3:850 3A #
MJ<*"% 9)F'M=+WKU-C9J6*?&L](VST2N8(AVK/UX(AJ"/;/%->!US 5X 92H
M*?W.]?4*F?DNJ'TZP=ZEESIN^NJ:TE]U5:^EOB6I'2EVH8&IXC@U* 5I*@J
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M<0)1X"URH 3CNT3>B9PLMC(GOTSGR4NI$ON;^CK9,^-0UX'14B&6&@V@SC%
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MMK<'(UH/%9JTZO-XQS(4^TF$;QU'\-GMZBU?+G_:7U:5$B=I2I"2U(""Y!E
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MEJ7#JYG!UH(0I9KD'O1>>/3RO98N>?K/=S^DI9A'_<E^!I-,*X8REH%"% 5
M7'/ $&5V-T6XS+GB2G+?\.53'8R-C3<R)ALA$R>E?P#S21#;Z34&-#W3:2 J
M03',;:IW"F(^V>!@4<QMZC3#F%N?Z_7\9/W#_/&CYG8^;8[L-UNR%'*J<XJ
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MAXNO;P1(?H<%?\F"MC(KCA;01O+(%2,S)DP![PN3/AF!.6^#@,<_?BL$J%-
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M)?,@T5MI6$9N6[]'N4]#WU4TG6#E($$/ "C/<EX5$H7)NS"FV/0R S)2Q9:
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MK-U%LJ5M4;O;<A-BBMY8^FGWY^83U VM4?&1#LX6NAI$I+!]W>\(*8Z6)"[
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M]W*Q')^M7N9+$I'F.4-AN8ZGR Q<8A**8I%Y3,F8UE'+70IZGJ#8#8@.$/(
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M[<3@K8==TJ2,M36;2ZF^4Q:V=O=&X(XK"M63E*G7/GS_S9Z-[X2Z1L_&=X'
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M_\-"M3-=[0Y(OP;D%#\%6O!CK[TR@I7<D(,$R.JLN$(\.Y8">4J:A>1=EG8
MMY/;7<>P'P6\QU+H_K9TM@R37KMXW<A7IB)-B!!]4>3ETP$2G-#TQ696O(U1
MM\Y='$KSCU[+VN:._:C(&))7L9F]%_-05N_UKRZCWH5O]?+I.NKEJ'2-$K3S
MN38.(7LC52$C4+C#Z'74V[18;T=1OU?IQT71?GYR2Y6>#I!?SZ:?R/<Y>X'Q
M*A'Y6UA>S%>Z&FF+/MM$$2_)G3PPKL%;*4$:+C2SSEDCVL)X(SW]FNQ3 '$[
M=9X.A._F(:^T='V!JIU%79P#Q%#;2V)U_4P!&[Q,.JBH^3:C/)L1U.\5^"F
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MM@49C;5TW$KF6\]L>DC%"91['(*: \7>LY.S&O]POT?%30.-9RGAI":Z,;]
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M"H3-=;Z9-A!8S."X2L$*,B=JKVJNOW89Z  L[%<&.D3L';@2N[,(5?):.U'
M":-!>6;INR* W'*'7!EK9>NM<GRR[HG+1@<I?%"R[A#I=P"EYU-Y&&TEF9*
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M= >&ZO]BK;'"_.HKX?TC_GI5P_MWY7K@[;NK]6H=YM53O4_L)%^S]BX#H^M
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M3_/%Y>+CMP^+R^OAF#<,!9EDRJ& %)K82)Q"$4>&MH3D0C0J\+U@L==B$W>
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MLM79YY9#R)K I93,:$7"V#J%8ASC<I\@6S__T20-))9\G9M<2J!S4\D(7HD
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MSD%RJ]4^R-BUR+09#NV1T4R@4R.#^2?V3Q(K^H85E6K?54D2J75("D6"D*V
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MF_TB>[*H=3*L"_4&.]0;[. ]F"QCU$H8GEN7H3U<OR=7N0UN#I9N!\BX+H+
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MDW<=XNHV"+7&>^,=D"#H(.">40RA)6 -+@K]2*Y#8X!MIV9:A#52]V(4V7>
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M+1W@:T?NIU="ZOI Y4I-*94N0"PA@%=<*9%BPMRZ4/_\\FX'J7O_O-LALN\
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MO9 O05Y%"&31K<Q*E."+CJU#B7^CQOZ#P#5R8_\AFNX<Z _/ECTXUQ*]0Z6
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M90Z,ELY3VB6*[[18$TG'$^%17ZH#PV0O,WK#R5W<@U4N466)9^4,ML!+7_I
MA*7>,<NDLJH#3#HMUD22\$28U)=JN]5A-!KCJ+,DL(!<!(&>&IZQA#FCP',C
ME:,=L'%B=5C?B< 3 5%)?@-7:OQUO!Q?K9FX] O8N%I:J!R9(RJNAV/RA-ZY
M,21%F7A"CSWP3F[H,_4:]U=^>?5@QP0R%:3>%&:^X+_8;J6DLG<Z.6),S&6H
M+Q#/+2.).^]L!NM]IUOU@Y!SN_YP53^GZO-1:!PIW*'OF+96\6?7ZL.W,<9W
MM]SM"FF=R9I%12"5/FNB-*@J;W2#D9%S%[1G78Z:[BNV I)C-3OK7<P#6Y=+
M=*IFDW%:D[^^;UGO)Y0-.E'H664;*.ZG:(A55!)O8U9 #=>QT^N&9VS+PZN_
MO%JP8T^F"M)O#C\WCAYD*F0@'+DO*21.0J 8S/D<C0]HL&FGF7D'(VCHTZF&
M3I^$R!$";B#Y^F%WB[=+-&YM)3=!Y>PE 8GGM<P4;25@T.^E =Q2H"!5[TG\
M,"DM0>88'>\W[ZD@\ 9P<SF;H_G%4_;];+H7_7NADXV>*&LPE-1)$)M-(E9X
MD[CEV=G:R'F4F&&"J=ZP4T?H#:#G]7CQ;;;PDU_FL]6WRSNMJC:3;S,D2SDR
M(5QY6QUP'VAD!VC(D8?(4O7>&L^0-'"RYLSWBS7UTS;<MKO2&.T5S^@&A+QN
MU:I0;$*2F(S(@ALOSPFX%FXBJT*@.[R.T$=K /L+3!)N2OP6[?2RM,N:37&K
MKB#=UD/N(E+N,H?,B0".>U2&@$+$H)<YJT.(SJI<N[[P2%*;!>,Q@'D*CCUI
MKP&0EO:0EVMFKF :Q[!X]>.]7Z[F4"J[=W_]8S.(%2B-&A(10@4BK<XD>(]'
M":24HN+E14%E7':G;N#:V#,?Q3UIK3D\;KG:;N>@<V9@+3&*\])0T)3[*$IL
M##PFJZ6%VD_3GB!G6./7%P*>!-KQZG@Y:7?/-%4"'#$,O9<29Z,S@R++U%"N
M/=>,=ZD=:CWM7EW!QV7?#Y%V ]9ITU+YMA[/3_PTPN=K@.7%--T.@;AMAXK[
M\HXGL;AIK/^P%['IR9.0>6DP<!=:H50D)T$+U ,3W'%&,XNU3]KS<#;L:)IS
MG](-HJ6!/700@S\-?7<\*U]F_64*ED@7(G%291*#\$8R)6CU ;Q'DCJL16\1
M=4_%5CU!8&"/X\VONV)M6-QA=]>NQ'K*?00B,L:G,KM0>IY8DA*>K=[&="^8
M>M#->&:9A@+TOM0\ZT?F0W>4>K1[4@H&8K:<L.0RD4(D8E60I+R8I8;C[H-.
MV:%>6Y/U-MCKG!?^=70P-) >[;K$@)DH)279R51<[TP<XY%PIHV1%EG8'P_W
MS]^:["#%=FI-=HB4!X1*7'=Q^#'Z]?,("0TN.TNH*3G\P!GQ)EK"@PC.,O#9
M/C6J;0'Q3U>S[W_>?N(&&MMO;I%QNUZ+#<D.4MKL) DVX)!W>MAO!&,>E-X,
MED/91.)EU(0+XZS@"? @K>Q]5VM%UMMXOK._\*RMJ;;1]W$^R^-ER5#=]E?7
M@3DO!/$ZLM+(#7>F4)&$9(052ODD:G?[.8C )EX%5L1'=P">J*P&D/@)O@/&
M)+?T<^MS%#$0,.@22(7>@-?,HDN@E#-,.R%K%RWMT] LGDY5]ZRB[-O!SEL4
M8<FF%Q;^-EY>7ZX6R]E7F+_Y8QO[EAXW^%\JH_<$9TF!!L*,IV7L3";!,4&B
M!0[,!HM'0C_P.H3,81%X&BX>!EEO2FH AS>%I+?#'V]$IZ-E+-)$E( RZK$4
MDU+KB0''.?(8;<R5\?8$.4T\D#Z#9:NED3;!-9(.?X\K=&*I* \ZC296"TZB
M\#XHIBRMWB[V 3*&-5+55/P\= Z2]\ I\)O"Y!L^WOSQ#:8+\-/-/-P-6^]A
M.;*\\*4IT2J@56>,H97UBJ QYU%(R);NY1P>S(9W7[&)=_<]6I\>Y7\XJMP&
M55.X*J.0OU2\C=_,G=^R-0HF:>E"(M1Q@7L-N7"Z="U!^='28MZ;VO[Z'@E-
MO-X_PZ%VBN1/Q4_%0HXBCYTW.)ZN4&2W]U&;F=F;WT-'$!9O_D"YH0K'4S__
ML0ZEW\^FY2(+B9NLI;V1R4B DZI,P-'K2034ED<[S!#NL]6XD9#GVGY]C^PT
MVW2T.J3;0,3 A_8V1GH-\_%W2$44GV'^?1QA\1'FL:C^"D8F2&;+A(T@RN1H
MD7"G.XR,K(W.<*L %='AN.ZR5K-APFD)M5Y$W4"(\,1$ QZMILS&<@U2;O4M
M1NX&//&)>BE$Y%+4?M9PXF")89NSGY*GK:2&!@#U;HJ;!'_EQU_?O?WP"=4T
M_PZX/<:S='GMY[A!@HXY2,X)"+2H^(7%O<$3NA[9NQ0<A5 [J_$<3<UZ@77
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MGTWNIPP_!A.,?T(=7WA;EB8S+#'0I0:U8C6NNDLDWFR-54<5?WGE'<%+N#5
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M0I&XS4VU2]=(B(@K+*Y<5V%'YK-A_PF.#9E@>[\$42VF<*/FBMYP6]CP;QO
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MVZP#^+4MD]11MS-G^T$XY@(.(2S)O16@()(@YR AB!43':8M%+RX'!0^$ X
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MG5KJ:,P>,\C82T5MV\$-.(Q%.>_-;K(@^?I"TA41_3')C8)]VG3FR[ES@X"
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M-$3[8IGNW.S+@W-T'; $FD9!43]O8QM^!WF!"=U%V61[@^+()G'HW09)A8P
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M34_4.,<1?,X0F8CHQ?Q$KB^2,!(*S>? 'YQ:=Y_I$\-I^)>"41Y8A\CP!RS
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M++7P^KE!\?G\C#PHM(L)R$?_- ?NOS\F9L)V6#P^=S;>CH3HKV$#E_+(,]R
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M-P$@*]7/M'TA]V>A;!D.73#>9PK*)1$::-O66+Z+XUTX?4W&^+M&*)2H 38
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M<]T1HK>9H657;C8<@&&HR>UA6-&6ZBX)/B0WB6$[WY &I*$C:V+PT3." AN
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ME^^LWQ[R$">_]XF\L=_ QYM @(BO>=/)"0@>;E%@V"I8D!B"F<5+[V!KH.R
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MB:9((,OY\R&]K_/>O*\7QP?/C^A]9;H9Q^F2:X:2V#Z"[4[I3'@6[78&Q\'
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MRY!>TP"%S7= \.#T:A6<[RU9FQ)#/2Q96.6-]@J(AKI4#CR-4BJG7LY-K+L
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M(3_\_.&D75 ?L W=QW2[P!=[@[WXXLW!T3'NP_G%]>6G=U]..]7*5CG4UQX
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M(1B/4.RBU56LTPKGN$F2MN5=:6(@.BQ<:5E6B&3)D*>P!+[Q0#R@EUOC 7W
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M5$X1KP"^_S6/38_.36]H>7XP6/X#3LN*(.)AAXD]PJH+0]6S%V6]0."K3;4
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MKFI?K=.M'X=RXP*#5>R#)JH5FK6L+2/TB!<XT3[))N\;#$<^2^/@+II6>!!
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M_CA[3A0+^AN9"H%Y6\58I(_7UZ<TG$QL<Q5>($.P*9F^30+N^P%BFBEA$7O
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M;N1SH<:\WN<\1$YF.KE*$+]Z5$N4CMO!>3CJL0Z8K,@2XI:&QCAJ>2VP7)$
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MC]C"4Q*<!'K"V,$)X$@[<8QM*I <<*T?/-OOJ96N3:56 _(O4^I/VTAS5:$
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M7']@(0@&8""/XF^U?'^DV"V6RB6CIIQ)^VMS)EW M2%-XJ@'M+O 4U\'IZR
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M).*W;T,N<D.N2O=T( '(!I29=:87!\S9% /$C95;"A4L,K@#H-'%T\;,"C2
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M[5;SISK6FSH8G'3N^SD(T7[[^%A_P8,F0@A,J<?)Q'_KZQSO'QWVWQ"O6ZS
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M?EV:X*^1($/P)?J+R/'C\T79:$>4[;S;M\"V.T_LC#G@="8C@A*'V.=$B-P
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MJ_<:+<MU6S?>=BSW7O?PX<!KWFOD5XW=P?#6;Z76-H$H@H'AEHBAEY5Z9:U
MM+WL MS5M&H K$>\"/;#UP?S5+6]U=CK2/.I-UBG Z]P<:4PLL!'0\0"XF5,
MOGMWM8]W<,K1+MTR[^5*U*L>!X'D"8M@[M/3C-*5IPL3I7M#8"5:_UY@GV;L
MKD=8?\QHC!0%Z8IBYQ2&<<S"S3KZ4=/=R\^0%T"]>#C;9/GN6;Y#S?B?Q,PV
M5.WKM+*^NZ&5&UKYM56 *'E\3@F:3BH%;RSXP!1)>$HW-?)Q&.5#X.%&.GEO
M"&P8Y?XEE_R 3!).!)5,5VYSO%'0S</%X<>&;O[06-C0S0W=?#"ZN4(OO;UL
MK3O>6AQJ?[\M/G_,9-F<TLTK<V@<AN946'<:EHZC[]^*TF5:CO71=<I5%>A%
M2+-%;PH#H4MYV0N)()C]H[Z 0D3I!(6+/F YI#S+7C03T>",2[K:6FG>LIU2
M=.$FIO]X\^GX4\YL#XK>)7!\%,+M,2D\QW1/-1VA*1I$E.D^K41_'BJ=W#$&
M(: HF@E^SG0K%K-V;:M7YWC*,,6![FN5_8RUQ&B9.!<ID^-"TVU[MP*8DMK<
M.(8\PRO:7BK5U<3<9CFNO6*#&#'-DK:@"=$LX\I+-Y=DU*39N1Q" F2DN;IY
MR!W>"5CY+-XG,F\V[?\-4$L! A0#%     @ =XP#55NKREM&C@( ,F(= !
M             ( !     &UC:RTR,#(R,#8S,"YH=&U02P$"% ,4    " !W
MC -5*E/"=507   0_   $               @ %TC@( ;6-K+3(P,C(P-C,P
M+GAS9%!+ 0(4 Q0    ( '>, U6AT178(B0  /!J 0 4              "
M ?:E @!M8VLM,C R,C V,S!?8V%L+GAM;%!+ 0(4 Q0    ( '>, U4$5<KN
MXHX  +PT!@ 4              "  4K* @!M8VLM,C R,C V,S!?9&5F+GAM
M;%!+ 0(4 Q0    ( '>, U4PW3UL\2H  '0L   3              "  5Y9
M P!M8VLM,C R,C V,S!?9S$N:G!G4$L! A0#%     @ =XP#549@I<FR&0$
MEH,+ !0              ( !@(0# &UC:RTR,#(R,#8S,%]L86(N>&UL4$L!
M A0#%     @ =XP#5?3'@:LUNP  M'L( !0              ( !9)X$ &UC
M:RTR,#(R,#8S,%]P<F4N>&UL4$L! A0#%     @ =XP#5:P>H':3(@$ )/((
M !X              ( !RUD% &UC:U]E>#$P,GAS=&]C:W!L86YT97)M<V%N
M+FAT;5!+ 0(4 Q0    ( '>, U5Z.I.*3@@  (0I   >              "
M 9I\!@!M8VM?97AH:6)I=#,Q,7@V,S R,#(R,3 M<2YH=&U02P$"% ,4
M" !WC -5B"N7T6,(  "8*0  '@              @ $DA08 ;6-K7V5X:&EB
M:70S,3)X-C,P,C R,C$P+7$N:'1M4$L! A0#%     @ =XP#5;Z*XZ0Z!@
M-"4  !T              ( !PXT& &UC:U]E>&AI8FET,S)X-C,P,C R,C$P
<+7$N:'1M4$L%!@     +  L ] (  #B4!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
